{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.10.12","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[{"sourceId":10641480,"sourceType":"datasetVersion","datasetId":6588740}],"dockerImageVersionId":30839,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"!pip uninstall umap\n!pip install umap-learn","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-02-02T15:47:59.079705Z","iopub.execute_input":"2025-02-02T15:47:59.080051Z","iopub.status.idle":"2025-02-02T15:48:07.836656Z","shell.execute_reply.started":"2025-02-02T15:47:59.080020Z","shell.execute_reply":"2025-02-02T15:48:07.835421Z"},"collapsed":true,"jupyter":{"outputs_hidden":true}},"outputs":[{"name":"stdout","text":"\u001b[33mWARNING: Skipping umap as it is not installed.\u001b[0m\u001b[33m\n\u001b[0mCollecting umap-learn\n  Downloading umap_learn-0.5.7-py3-none-any.whl.metadata (21 kB)\nRequirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.10/dist-packages (from umap-learn) (1.26.4)\nRequirement already satisfied: scipy>=1.3.1 in /usr/local/lib/python3.10/dist-packages (from umap-learn) (1.13.1)\nRequirement already satisfied: scikit-learn>=0.22 in /usr/local/lib/python3.10/dist-packages (from umap-learn) (1.2.2)\nRequirement already satisfied: numba>=0.51.2 in /usr/local/lib/python3.10/dist-packages (from umap-learn) (0.60.0)\nCollecting pynndescent>=0.5 (from umap-learn)\n  Downloading pynndescent-0.5.13-py3-none-any.whl.metadata (6.8 kB)\nRequirement already satisfied: tqdm in /usr/local/lib/python3.10/dist-packages (from umap-learn) (4.67.1)\nRequirement already satisfied: llvmlite<0.44,>=0.43.0dev0 in /usr/local/lib/python3.10/dist-packages (from numba>=0.51.2->umap-learn) (0.43.0)\nRequirement already satisfied: mkl_fft in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (1.3.8)\nRequirement already satisfied: mkl_random in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (1.2.4)\nRequirement already satisfied: mkl_umath in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (0.1.1)\nRequirement already satisfied: mkl in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (2025.0.1)\nRequirement already satisfied: tbb4py in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (2022.0.0)\nRequirement already satisfied: mkl-service in /usr/local/lib/python3.10/dist-packages (from numpy>=1.17->umap-learn) (2.4.1)\nRequirement already satisfied: joblib>=0.11 in /usr/local/lib/python3.10/dist-packages (from pynndescent>=0.5->umap-learn) (1.4.2)\nRequirement already satisfied: threadpoolctl>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from scikit-learn>=0.22->umap-learn) (3.5.0)\nRequirement already satisfied: intel-openmp>=2024 in /usr/local/lib/python3.10/dist-packages (from mkl->numpy>=1.17->umap-learn) (2024.2.0)\nRequirement already satisfied: tbb==2022.* in /usr/local/lib/python3.10/dist-packages (from mkl->numpy>=1.17->umap-learn) (2022.0.0)\nRequirement already satisfied: tcmlib==1.* in /usr/local/lib/python3.10/dist-packages (from tbb==2022.*->mkl->numpy>=1.17->umap-learn) (1.2.0)\nRequirement already satisfied: intel-cmplr-lib-rt in /usr/local/lib/python3.10/dist-packages (from mkl_umath->numpy>=1.17->umap-learn) (2024.2.0)\nRequirement already satisfied: intel-cmplr-lib-ur==2024.2.0 in /usr/local/lib/python3.10/dist-packages (from intel-openmp>=2024->mkl->numpy>=1.17->umap-learn) (2024.2.0)\nDownloading umap_learn-0.5.7-py3-none-any.whl (88 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m88.8/88.8 kB\u001b[0m \u001b[31m3.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hDownloading pynndescent-0.5.13-py3-none-any.whl (56 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m56.9/56.9 kB\u001b[0m \u001b[31m2.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hInstalling collected packages: pynndescent, umap-learn\nSuccessfully installed pynndescent-0.5.13 umap-learn-0.5.7\n","output_type":"stream"}],"execution_count":1},{"cell_type":"code","source":"import pandas as pd\nimport numpy as np\nimport torch\nfrom transformers import AutoTokenizer, AutoModel\nimport umap.umap_ as umap\nimport plotly.express as px\nfrom tqdm.auto import tqdm","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-02-02T15:48:56.647244Z","iopub.execute_input":"2025-02-02T15:48:56.647657Z","iopub.status.idle":"2025-02-02T15:49:11.976711Z","shell.execute_reply.started":"2025-02-02T15:48:56.647621Z","shell.execute_reply":"2025-02-02T15:49:11.975531Z"}},"outputs":[],"execution_count":3},{"cell_type":"code","source":"tokenizer = AutoTokenizer.from_pretrained('michiyasunaga/BioLinkBERT-base')\nmodel = AutoModel.from_pretrained('michiyasunaga/BioLinkBERT-base')\n\ndef get_embeddings(texts, batch_size=32):\n    model.eval()\n    embeddings = []\n\n    for i in tqdm(range(0, len(texts), batch_size)):\n        batch = texts[i:i + batch_size]\n        inputs = tokenizer(batch, return_tensors='pt', padding=True)\n        with torch.no_grad():\n            outputs = model(**inputs)\n        cls_embeddings = outputs.last_hidden_state[:, 0, :].cpu().numpy()\n        embeddings.append(cls_embeddings)\n\n    return np.vstack(embeddings)\n\ndf = pd.read_parquet('/kaggle/input/bioassay-ner/ner_data_raw.prqt')\ntexts = df['description'].tolist()\n\nembeddings = get_embeddings(texts)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-02-02T15:51:56.316253Z","iopub.execute_input":"2025-02-02T15:51:56.316703Z","iopub.status.idle":"2025-02-02T16:08:18.723098Z","shell.execute_reply.started":"2025-02-02T15:51:56.316669Z","shell.execute_reply":"2025-02-02T16:08:18.721680Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"  0%|          | 0/253 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"e0974d3664cd4b1dbb8848dfbdac47ba"}},"metadata":{}}],"execution_count":6},{"cell_type":"code","source":"umap_reducer = umap.UMAP(n_components=2)\numap_embeddings = umap_reducer.fit_transform(embeddings)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-02-02T16:09:22.352663Z","iopub.execute_input":"2025-02-02T16:09:22.353274Z","iopub.status.idle":"2025-02-02T16:09:33.448799Z","shell.execute_reply.started":"2025-02-02T16:09:22.353227Z","shell.execute_reply":"2025-02-02T16:09:33.447076Z"}},"outputs":[],"execution_count":9},{"cell_type":"code","source":"umap_df = pd.DataFrame(umap_embeddings, columns=['x', 'y'])\numap_df['description'] = texts\numap_df = umap_df.query('15 > x > 0 and y > 0')\n\nfig = px.scatter(umap_df, x='x', y='y', hover_data=['description'], title='Assay descriptions space visualization')\nfig.update_traces(marker=dict(size=5, opacity=0.3))\nfig.update_layout(\n    width=700,\n    height=700,\n    xaxis=dict(\n        title=None,\n        showticklabels=False\n    ),\n    yaxis=dict(\n        title=None,\n        showticklabels=False\n    )\n)\nfig.show()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-02-02T16:12:49.532404Z","iopub.execute_input":"2025-02-02T16:12:49.532847Z","iopub.status.idle":"2025-02-02T16:12:49.658808Z","shell.execute_reply.started":"2025-02-02T16:12:49.532815Z","shell.execute_reply":"2025-02-02T16:12:49.657172Z"}},"outputs":[{"output_type":"display_data","data":{"text/html":"<html>\n<head><meta charset=\"utf-8\" /></head>\n<body>\n    <div>            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax && window.MathJax.Hub && window.MathJax.Hub.Config) {window.MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n        <script charset=\"utf-8\" src=\"https://cdn.plot.ly/plotly-2.35.2.min.js\"></script>                <div id=\"262bc8df-1440-455a-a700-3d3c855a19b6\" class=\"plotly-graph-div\" style=\"height:700px; width:700px;\"></div>            <script type=\"text/javascript\">                                    window.PLOTLYENV=window.PLOTLYENV || {};                                    if (document.getElementById(\"262bc8df-1440-455a-a700-3d3c855a19b6\")) {                    Plotly.newPlot(                        \"262bc8df-1440-455a-a700-3d3c855a19b6\",                        [{\"customdata\":[[\"Inhibition of human GST-tagged USP9X CD (1554 to 1995 residues) expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine110-glycine using Ubiquitin-Rhodamine110-glycine as substrate by fluorescence based analysis\"],[\"Inhibition of LSD1 in human MGC-803 cells assessed as increase in CD86 mRNA level at 2.5 uM for 48 hrs by qRT-PCR analysis\"],[\"Inhibitory concentration against human glutathione reductase in the presence of 200 uM exogenous NADP\"],[\"In vitro vitamin D receptor-mediated antiproliferative activity in rat osteosarcoma ROS 17\\u002f2.8 cells\"],[\"TRIM33(PHD,Bromo.) DiscoverX BROMOscan\"],[\"Inhibition of human IMPDH2 expressed in Escherichia coli strain BL21(DE3) after 60 mins\"],[\"Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate after 60 mins by ADP-glo assay\"],[\"Inhibition of HIF-1alpha in human HCT116 cells under hypoxia condition by HRE-luciferase reporter gene assay\"],[\"Activity at N-terminal HA-tagged human CB1 receptor expressed in HEK293 cells transfected with YFP-Epac-RLuc assessed as effect on forskolin-stimulated cAMP level by BRET assay\"],[\"Inhibition of human recombinant N-terminal histidine-tagged HDAC4 expressed in baculovirus by fluorimetry\"],[\"Inhibition of recombinant human full length sEH (1 to 555 residues) expressed in Escherichia coli BL21 DE3 cells assessed as reduction in 6-methoxynaphthaldehyde formation using PHOME as substrate incubated for 45 mins followed by substrate addition and measured for 45 mins by fluorescence based assay\"],[\"Inhibition of PAK2 autophosphorylation at Ser141 in human SU8686 cells at 0.009 to 20 uM after 30 mins by Western blot analysis\"],[\"Displacement of [3H]CCPA from recombinant human adenosine A1 receptor expressed in CHO cell membranes after 3 hrs\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition and measured after 2 mins by Ellman's method\"],[\"Displacement of [3H]naloxone from human mu opioid receptor expressed in CHOK1 cells at 10 uM\"],[\"Inhibition of human factor 10a assessed as CBS 31.39 substrate hydrolysis at 5 x 10'-9 M by spectrophotometric analysis\"],[\"Inhibition of human topoisomerase 2alpha-mediated decatenation of kDNA after 30 mins by agarose gel electrophoresis in presence of ATP\"],[\"Activation of procaspase-3 in mouse K7M2 cells assessed as increase in cell death by measuring combination index at 5 uM after 24 hrs in presence of 250 nM doxorubucin by alamar blue assay\"],[\"Inhibition of wild type human TRKA by high throughput ATP-[33P] radiolabeled assay\"],[\"Activation of rhesus monkey MrgX2 receptor expressed in NIH\\u002f3T3 cells incubated for 5 days by beta-galactosidase reporter gene assay\"],[\"Substrate activity at recombinant human NQO1 expressed in Escherichia coli assessed as compound metabolized at 600 uL in presence of NADH and FAD measured after 12 hrs by HPLC analysis\"],[\"Inhibition of recombinant human MAO-A using p-tyramine as substrate assessed as H2O2 production preincubated for 15 mins followed by substrate addition measured for 15 mins by amplex red assay\"],[\"FAK (h) Millipore kinase activity assay\"],[\"Inhibition of human His-tagged PDGFRbeta (558 to 1106 residues) expressed in baculovirus assessed as activity remaining at 1 uM by ELISA relative to control\"],[\"Inhibition of recombinant human BRD4 BD2 (333 to 460 residues) expressed in bacterial expression system by bromoscan assay\"],[\"Inhibition of human PIK3CA E545A mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of Akt2 in human C33a cells\"],[\"Inhibition of N-terminal 6x-His-tagged recombinant human cIAP2-BIR3 (244 to 349 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA\"],[\"Binding affinity against LTD4 receptor in guinea pig lung membranes.\"],[\"Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Competitive inhibition of N-terminal His6-tagged recombinant human c-MET (974 to 1390 amino acids) by spectrophotometry\"],[\"Inhibition of recombinant human N-terminal GST-tagged JMJD2C (2 to 372 residues) expressed in baculovirus infected Sf9 cells using H3K9me3-biotin labelled peptide as substrate measured after 30 mins by Lance TR-FRET assay\"],[\"Activation of ULK1 in human SH-SY5Y cells transfected with siRNA-NC assessed as LC3-2 levels at 5 uM after 24 hrs by Western blot analysis relative to control\"],[\"Inhibition of human JAK1 assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of MAGL in mouse brain membranes assessed as reduction in 2-OG hydrolysis preincubated for 15 mins followed by substrate addition and measured after 2 mins by liquid scintillation counting\"],[\"Inhibition of glucosylceramide synthase in human A549 cells at 10 uM after 35 mins by fluorometric analysis\"],[\"Inhibition of factor-10a (unknown origin)\"],[\"Inhibition of mushroom tyrosinase assessed as decrease in dopachrome production using L-tyrosine as substrate at 1.25 uM by spectrophotometric analysis\"],[\"Displacement of fluorescein-labeled estradiol from human recombinant ERalpha at 0.2 uM by fluorescence polarization assay\"],[\"Inhibition of human activated protein kinase C using H-D-Lys(Cbo)-Pro-Arg-pNA as substrate\"],[\"Binding affinity for HA-tagged wild type human Adenosine A2A receptor (WT) using [3H]CGS-21680 as radioligand expressed in COS-7 cells\"],[\"Inhibition of serotonin transporter (unknown origin) at 10 uM relative to control\"],[\"Inhibition of SARS coronavirus helicase assessed as duplex-DNA unwinding by FRET based assay\"],[\"Displacement of [35S]TBPS from GABA-gated chloride channel in Musca domestica (house fly) head membrane at 0.1 uM after 50 min by liquid scintillation counting\"],[\"Inhibition of recombinant human PDE5A using [3H]cGMP after 1 hr by scintillation proximity assay\"],[\"Inhibition of sheep seminal vesicle COX-1 assessed as reduction in oxygen consumption using arachidonic acid as substrate incubated for 12 mins followed by substrate addition measured for 2 mins\"],[\"Inhibitory activity of Cbz-Phe-Arg-AMC against Cathepsin B cysteine protease\"],[\"Intrinsic activity at beta2 adrenoceptor in guinea pig atrium relative to isoproterenol\"],[\"Inhibition of wild-type human partial length ICK (M1 to P314 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Percent inhibition against Dopamine receptor D5 at 1 uM\"],[\"Antagonist activity at Smo in mouse ASZ001 cells assessed as inhibition of Hh signaling pathway by measuring suppression of BMP2 mRNA expression at 10 uM after 48 hrs by qRT-PCR method\"],[\"Activation of human PPARgamma ligand binding domain-mediated transcriptional activity in human HepG2\\u002fC3A cells with Gal4 reporter plasmid at 1 uM after 20 hrs by cotransfection assay\"],[\"Inhibition of AMPKalpha1 (unknown origin) assessed as residual activity at 50 uM relative to control\"],[\"Binding affinity for human leukocyte elastase(HLE) serine protease\"],[\"Inhibition of HIV-1 integrase expressed in Escherichia coli using [32P]-labeled U5B-2\\u002fU5A DNA as substrate assessed as inhibition of strand transfer reaction after 2 hrs by PAGE analysis in presence of Mn2+\"],[\"Inhibitory activity against dihydrofolate reductase derived from Lactobacillus casei\"],[\"Non-competitive inhibition of G6PD (unknown origin) using glucose-6-phosphate and varying concentrations of NADP+ as substrate by Michaelis-Menten analysis\"],[\"Displacement of [125I]eotaxin from human CCR3 expressed in CHO CCR3\\u002f2 chimeric cells by scintillation counting\"],[\"Inhibition of wild type human TRKB by high throughput ATP-[33P] radiolabeled assay\"],[\"Inhibition of human group 5 Ca2+-dependent secretory phospholipase A2 assessed as XI(50) from 50% enzyme inhibitory concentration by mixed-micelle assay\"],[\"Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay\"],[\"Inhibition of human neutrophil elastase-induced increase in IL8 mRNA levels at 10 uM after 3 hrs by RT-qPCR analysis\"],[\"Inhibition of HDAC1 in human THP1 cells assessed as increase in histone H3 acetylation level at 100 uM after 12 hrs by Western blot analysis relative to control\"],[\"Agonist activity at human estrogen receptor-alpha by yeast two-hybrid assay in presence of SRC1\"],[\"Inhibition of FLT3 mediated C-MYC expression in human MOLM14 cells at 0.1 uM for 4 hrs by immunoblot analysis\"],[\"Inhibition of human FLT4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Binding affinity to wild-type human partial length INSRR (R950 to E1278 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of DDAH in fibroblasts isolated from late idiopathic pulmonary fibrosis patient assessed as upregulation of HO1 gene expression at 50 uM relative to control\"],[\"Binding affinity to AGPS (unknown origin) assessed as change in melting temperature at 180 uM by ThermoFAD assay\"],[\"Agonist activity at human mu opioid receptor expressed in HEK293 assessed as inhibition forskolin-induced cAMP accumulation after 15 mins by EIA\"],[\"Displacement of [3H]5-HT from human SERT\"],[\"Inhibition of human DAT expressed in COS1 cells\"],[\"Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in CTFalpha level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine\"],[\"The value of binding constant measured against human trypsin\"],[\"Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay\"],[\"Inhibition of human pyruvate kinase L at 10 uM by LDH assay\"],[\"Inhibition of HDAC8 in human MDA-MB-231 cells assessed as acetylation of non-histone proteins SMC3 at 0.5 to 5 uM measured after 24 hrs by Western blot analysis\"],[\"Inhibition of human STK38L at 10 uM using KKRNRRLSVA as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of starfish cdc2\\u002fcyclin B assessed as [32P] incorporation in histone H1 from 150 M [gamma32P]ATP\"],[\"Inhibition of TTK (unknown origin)\"],[\"Inhibition of human Abl Q252H mutant at 10 uM after 60 mins by TR-FRET assay\"],[\"Displacement of [3H]4-DAMP from human recombinant M5 receptor expressed in CHO cells measured after 60 mins by scintillation counting method\"],[\"Displacement of [3H]N-methylspiperone from human D3 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method\"],[\"Inhibition of c-MET (unknown origin) using poly(Glu, Tyr)4:1 as substrate after 30 mins by HTRF assay\"],[\"DDR2(h) Eurofins Kinase panel\"],[\"Inhibition of human HPK1 using MBP as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [125I]-[Nle4,d-Phe7]-alpha-MSH from human MC3R expressed in HEK293 cells at 10 uM after 40 mins by gamma counting analysis relative to control\"],[\"Inhibition of PDGFR-beta (unknown origin) at 10 uM after 30 mins by fluorescence assay\"],[\"Inhibition of MLK1 (unknown origin) by FRET method\"],[\"Inhibition of human EPHA5 at 1 uM using poly[Glu:Tyr] (4:1) as substrate\"],[\"Binding affinity against H1 receptor of Guinea pig ileum\"],[\"Inhibition of radioligand binding to human DOR at 10 uM\"],[\"Inhibition of PDK1 mediated PI3K\\u002fAkt\\u002fmTOR pathway activation in human HCT116 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis\"],[\"Inhibition of human full length PKD2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of tetracycline-inducible EGFP-DYRK1A (unknown origin) expressed in HEK293 cells coexpressing full length human EGFP-tau protein assessed as reduction in tau-Thr212 phosphorylation incubated overnight by immunofluorescence assay\"],[\"Displacement of NEt-C343 from human RXRalpha-LBD expressed in African green monkey COS-1 cells assessed as inhibition constant incubated for 2 hrs by competitive binding assay\"],[\"Inhibition of rat FAAH preincubated for 20 mins\"],[\"Inhibition of 5-HT6 receptor (unknown origin) at 10 uM relative to control\"],[\"Inhibition of GABA transaminase in rat brain at 60 uM after 30 mins by gel filtration\"],[\"NanoBRET (MAPK3)\"],[\"Inhibition of human MELK at 1 uM using [KKLNRTLSFAEPG] as substrate\"],[\"Inhibition of FLT3 autophosphorylation at Tyr-596 in human MV4-11 cells after 1.5 hrs by Western blot analysis\"],[\"Inhibition of Fu5AH Acyl coenzyme A:cholesterol acyltransferase at the concentration of 10 ug\\u002fmL\"],[\"Inhibition of human 20S proteasome LMP2 activity in MDCK-II cells using Ac-PAL-AMC as fluorogenic substrate by fluorescence assay\"],[\"Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP\"],[\"Inhibition of aurora B phosphorylation at Thr232 residues in human HeLa cells after 24 hrs by immunofluorescence assay\"],[\"Inhibitory constant determined against recombinant Fatty-acid amide hydrolase from rat expressed in Escherichia coli\"],[\"Binding affinity to amyloid beta plaques in healthy human brain by DANIR 3b staining based autoradiographic analysis\"],[\"BETA\\u002fR Eurofins-Panlabs selectivity data (BI)\"],[\"Increase of NRF2-mediated HO-1 expression in hormone-refractory human DU145 cells at 5 uM after 24 hrs by Western blotting\"],[\"Inhibition of PI3Kgamma (unknown origin) in presence of [gamma-32P]ATP by phosphorimaging assay\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition measured for 6 mins by Ellman's method\"],[\"PRKX DiscoveRx kinase panel\"],[\"Inhibition of CDK19(CDK11) (unknown origin) assessed as residual ligand binding level at 0.5 uM by kinome scan assay relative to control\"],[\"Inhibition of HGFR (unknown origin)\"],[\"Antagonism at 5HT4 receptor in rat tunica muscularis mucosa upto 100-1000 nM\"],[\"Non-competitive inhibition of human MAO-B expressed in baculovirus infected BTI insect cells at 0.2 to 20 nM preincubated with compound and p-tyramine for 22 mins followed by p-tyramine increase to 1 mM and measured every minute for 5 hrs by Lineweaver-Burk plot analysis\"],[\"Displacement of [3H]AVP from human V2 receptor expressed in CHO cells\"],[\"Displacement of [3H]U69563 from human kappa-opioid receptor expressed in CHO cells after 60 mins by scintillation counting\"],[\"Inhibition of PI3Kbeta (unknown origin) using diC8 PIP2 as substrate up to 20 uM after 60 mins by ADP-glo assay\"],[\"Inhibition of goat liver cathepsin B assessed as enzyme activity at 10 uM using BANA substrate pre-incubated 30 mins before substrate addition by colorimetry (Rvb = 5.65 +\\u002f- 0.0276 nmol\\u002fmin\\u002fml)\"],[\"Antagonist activity at human kappa opioid receptor expressed in CHO cell membranes assessed as reduction in U69,593-induced [35S]GTPgammaS binding incubated for 60 mins\"],[\"WNK2 Kinase panel\"],[\"Agonist activity at human RXRalpha expressed in HEK293 cells assessed as transcriptional activation up to 100 uM after 40 hrs by luciferase reporter gene assay\"],[\"Inhibition of human wild type p38alpha at 1 uM by qPCR analysis\"],[\"Inhibition of human telomerase activity at 100 ug\\u002fmL by TRAP assay\"],[\"Agonist activity at mouse GPR34 expressed in HEK293 cells co-transfected with Galphaq\\u002fi1 assessed as increase in calcium influx by calcium 5 dye based FLIPR assay\"],[\"Inhibition of recombinant His6-tagged human USP7 expressed in insect expression system at 20 mM using ubiquitin-Rh110 as substrate preincubated for 30 mins followed by substrate addition measured after 180 mins by fluorescence assay\"],[\"Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by fluorimetry\"],[\"Inhibition of full length human MARK3 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay\"],[\"Inhibition of human PDE5A catalytic domain using cAMP\\u002fcGMP substrate\"],[\"Inhibition of Jak2 in mouse BA\\u002fF3 cells expressing TEL-Jak2 assessed as inhibition of STAT5 phosphorylation by Western blotting analysis\"],[\"Inhibition of 6xHisGB1 tagged PI4KB (unknown origin) expressed in Escherichia coli BL21 Star\"],[\"Inhibition of FLT3 in human MV4-11 cells assessed as inhibition of ERK phosphorylation at Thr202\\u002fTyr204 site after 4 hrs by immunoblotting analysis\"],[\"Effective concentration against metabotropic glutamate receptor 5 of human transfected into CHO cells\"],[\"Effect on EGFR signaling in human A549 cells assessed as decrease in phosphorylated AKT levels at 2 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of human aromatase in placental microsomes\"],[\"Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 0.1 uM using serine\\u002fthreonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control\"],[\"Inhibition of recombinant human TAF1L bromodomain 2 expressed in bacterial system assessed as residual activity at 1 uM by bromoscan assay relative to control\"],[\"Binding affinity to human PD-L1 by surface plasmon resonance\"],[\"Inhibition of pig DAAO using D-serine as substrate after 20 mins by horseradish peroxidase-coupled assay\"],[\"Displacement of [3H]-Ketanserin from human 5-HT2A receptor expressed in HEK293 cells incubated for 1 hr\"],[\"Panlabs assay (ADRA2B)\"],[\"Inhibition of recombinant human full length PI3K p120gamma at 1 uM using phosphatidylinositol-4, 5-bisphosphate as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of MECL1 in human MOLT4 cell lysate after 1 hr by ELISA\"],[\"Inhibition of recombinant human PDGFRalpha (550 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to human phosphorylated ABL1 Q252H mutant expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at CRF1 receptor in rat brain homogenates assessed as CRF-stimulted cAMP production\"],[\"Inhibition of recombinant full-length human PIP5K1alpha assessed as residual activity at 10 uM using phosphatidylinositol 4-phosphate as substrate measured after 40 mins by HTRF assay\"],[\"Inhibition of HDAC6 in human HepG2 cells assessed as alpha-tubulin Lys40 acetylation level at 1 uM incubated for 4 hrs followed by stimulation with 100 ng\\u002fml growth factor IGF1 for 15 mins by Western blot analysis (Rvb = 0%)\"],[\"Inhibition of human recombinant cyclooxygenase COX1 expressed in baculovirus infected Sf9 cells at 10 uM using arachidonic acid as substrate preincubated for 15 mins followed by substrate addition and measured after 3 mins by ampliflu red reagent-based spectrofluorimetric method relative to control\"],[\"Inhibition of human RARbeta\"],[\"Displacement of [125I]-His5, D-Tyr6]GnRH from mutant GnRHR, GnRHR F313L\"],[\"Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 times their IC50 after 24 hrs by TARDIS assay\"],[\"Inhibition of SRC (unknown origin) at 0.49 uM relative to control\"],[\"Positive allosteric modulation of mGluR3 (unknown origin)\"],[\"Inhibition of N-terminal GST-tagged recombinant human AKR1C2 expressed in Escherichia coli BL21 (DE) Codon Plus RP cells assessed as reduction in NADPH production 50 uM using S-tetralol as substrate in presence of NADP+ by fluorimetry assay relative to control\"],[\"Inhibition of recombinant human 6xHis-tagged TNKS1 ART domain (1030 to 1317 residues) expressed in Escherichia coli Rosetta2 (DE3) cells using NAD+ as substrate preincubated for 10 mins measured after 30 mins by fluorescence assay\"],[\"Inhibitory activity against Dipeptidyl Peptidase II\"],[\"Inhibition of human N-terminal TEV protease cleavage site-fused-His6-tagged FPPS expressed in Escherichia coli BL21 (DE3) using GPP and [14C] IPP as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by scintillation counter method\"],[\"Inhibition of PDGF-BB-stimulated Rac1 activity in human aortic smooth muscle cells assessed as reduction of Rac1GTP level after 4 hrs by G-LISA\"],[\"Inhibition of rat CGRP\"],[\"Inhibition of human GSK-3beta at 5 x 10'-8 M\"],[\"Binding affinity to NT5DC1 in human MDA-MB-435 cells at 1 uM by Western blot analysis\"],[\"Inhibition of PKC-EPSILON (unknown origin) at 1 uM relative to control\"],[\"In vitro inhibitory activity against Catechol-O-methyltransferase from porcine liver; Competitive mode of inhibition\"],[\"Displacement of [3H]RTX form rat TRPV1 receptor expressed in CHO\\u002fVR1 cell system\"],[\"Inhibition of GST-fused human JNK1alpha1 expressed in Escherichia coli at 10 uM\"],[\"Inhibition of human steroid 5-alpha-reductase type I expressed in DU-145 cells using [1-beta-3H]-androstenedione at a concentration of 10 uM\"],[\"Selectivity for NF-kappaB expression over creatine kinase expression in Ad5-wt-ER-infected HAECT1 cells\"],[\"Allosteric enhancer (AE) activity against human adenosine A1 receptor at 50 uM\"],[\"Inhibition of recombinant human Erbb2 at 100 nM after 60 mins by ELISA relative to control\"],[\"Agonist activity at human CCK1 receptor assessed as increase in CCK8-induced calcium release incubated in dark for 30 mins followed by light incubation for 30 mins measured by FLIPR assay\"],[\"TP_TRANSPORTER: inhibition of Taurocholate uptake in canalicular membrane vesicles of rat liver\"],[\"Displacement of [35S]GTP-gamma-S from human cloned dopamine D3 receptor expressed in CHO cells after 30 mins\"],[\"Inhibition of DNA-tagged human HPK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of recombinant BACE1 (unknown origin) using FAM-SEVNLDAEFK-TAMRA as substrate at 100 uM incubated for 30 mins prior to substrate addition by fluorimetric analysis relative to control\"],[\"Binding affinity at delta opioid receptor (unknown origin)\"],[\"Agonist activity at human VDR expressed in african green monkey COS7 cells overexpressing GAL4 response element assessed as SRC1 peptide recruitment by luciferase reporter gene assay\"],[\"Inhibition of ALK phosphorylation in human KARPAS299 cells after 24 hrs by Western blot analysis\"],[\"Inhibition of steroid sulfatase in human MCF7 cells assessed as conversion of [3H]E1S to [3H]E1 and [3H]E2 at 1 uM after 5 hrs by liquid scintillation counting\"],[\"Inhibition of RPS6KA3 by FRET assay\"],[\"Binding affinity to human NK3 receptor at 1 uM\"],[\"Agonist activity at human melanocortin receptor 1b expressed in CHO cells assessed as cAMP accumulation at 1 uM relative to [125I]NDPalphaMSH\"],[\"Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay\"],[\"Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis\"],[\"Inhibition of HDAC6 (unknown origin) preincubated for 15 mins followed by addition of Fluor de Lys as substrate for 1 hr by fluorometric assay\"],[\"Inhibition of ALK1 (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control\"],[\"Inhibition of orthovandate-induced Stat3 phosphorylation in human U251MG cells at 5 uM for 3 hrs by immunoblot analysis in presence of 10 to 300 uM orthovandate\"],[\"Inhibition of Abl (unknown origin) at 1 uM\"],[\"Inhibition of human 5-HT3 receptor\"],[\"Binding affinity to wild-type human full length ERK2 (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of USP7 in human RS4-11 cells assessed as decrease in DNMT1 incubated for 24 hrs by Western blot analysis\"],[\"Inhibition of human SBK1 using LCGRTGRRNSI as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"PKCmu (h) Millipore kinase activity assay\"],[\"Inhibition of human BRAF V600E mutant at 10 uM using MEK1 (K97R) as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of MSK1 (unknown origin) after 10 mins by mobility shift assay\"],[\"Displacement of [3H]PDBu from protein kinase C delta C1b domain mutant (T8G)\"],[\"Displacement of [3H]histamine binding to SK-N-MC cell membranes expressing human histamine H4 receptor\"],[\"Binding affinity to partial length human TGFBR2 expressed in bacterial system at 1 uM by KINOMEscan assay\"],[\"Inhibition of GRB7-FAK interaction in human SKBR3 cells assessed as FAK detection in whole cells at 20 uM preincubated for 1 hr followed by fibronectin stimulation measured after 10 mins by Western blot analysis\"],[\"Covalent binding affinity to human recombinant TRX-1 assessed as change in protein configuration at 50 uM by LC-ESIQTOF mass spectrometry\"],[\"Binding affinity to human 5-HT1A receptor\"],[\"Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in beclin-1 level at 3 uM measured after 24 hrs by immunoblotting\"],[\"Transactivation of PPARgamma in mouse 3T3L1 cells assessed as increase in adiponectin expression by qPCR method\"],[\"Inhibition of recombinant C-terminal His-tagged full length human HDAC2 expressed in baculovirus infected insect Sf9 cells using fluorogenic HDAC substrate 3 after 30 mins by fluorescence assay\"],[\"Binding affinity to BRD2 bromodomain 2 L383A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry\"],[\"Binding affinity to DDX17 in human A549 cells at 0.15 mM after 4 hrs by HPLC-MS based pull down assay relative to control\"],[\"Inhibition of human DDR2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Displacement of [3H]methylspiperone form human cloned 5HT2A receptor expressed in african green monkey COS7 cells at 30 uM by scintillation spectroscopy\"],[\"Inhibition of [3H]E2 binding to human placental 17beta-HSD2 after 20 mins\"],[\"Inhibition of GSK3alpha (unknown origin) at 1000 nM relative to control\"],[\"Binding affinity to guinea pig histamine H3 receptor at 10 uM by radioligand displacement assay\"],[\"Inhibition of human ABL1 (27 to end residues) assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of LCK (64 to 509 amino acids) (unknown origin) by HTRF assay\"],[\"Displacement of [3H]emopamil from Delta-(8)-Delta-(7) sterol isomerase in guinea pig liver membrane\"],[\"Binding affinity to human ENT1 in panc1 cells by flow cytometry\"],[\"Effective concentration against mGluR4 receptor expressed in CHO cells\"],[\"Inhibition of human GST-tagged PDE4D catalytic domain (183T to 510S residues) expressed in Escherichia coli cells\"],[\"Inhibition of human HDAC2 expressed in Escherichia coli\"],[\"Antagonistic potency at opioid receptor kappa (100 nM) (Ke =IC50 in the presence of antagonist divided by the control IC50 value)\"],[\"Inhibition of HER4 (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of Enterobacter cloacae Imi1\"],[\"Inhibition of P-gp mediated doxorubicin efflux in human HepG2\\u002fDox cells at 5 to 10 uM preincubated for 4 hrs followed by co-incubation with doxorubicin for 2 hrs followed by doxorubicin wash-out and measured after 120 mins incubation with drug containing culture medium by fluorescence based analysis\"],[\"Inhibition of ERalpha (unknown origin) after 18 hrs by dual luciferase reporter gene assay\"],[\"Displacement of biotinylated-ephrin-A1-Fc from EphA2-Fc receptor (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA\"],[\"Agonist activity at human recombinant 5HT2C receptor expressed in CHOK1 cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to serotonin\"],[\"Binding affinity to human H2R expressed in HEK293T-qs5-HA cells by flow cytometry analysis\"],[\"TRP selectivity screen (TRPC3)\"],[\"Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Antagonist activity at human cloned mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding\"],[\"Antagonist activity at ERalpha in human MCF7 cells assessed as reduction in E2-induced PS2 expression at 20 uM incubated for 2 hrs prior to E2-induction measured after 14 hrs by qPCR analysis\"],[\"Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured every 10 mins up to 48 hrs by Thioflavin T based fluorescence assay\"],[\"Inhibition of ROCK2 (unknown origin) using C-terminus recombinant MBS (654-880 residues) as substrate at 10 uM incubated for 30 mins in presence of ATP by ELISA relative to control\"],[\"Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel at 10 uM by electrophoresis\"],[\"Inhibition of IDO1 in IFNgamma\\u002fLPS stimulated human whole blood assessed as reduction in kynurenine production using tryptophan as substrate preincubated with compound for 15 mins followed by incubation with IFNgamma\\u002fLPS for overnight by LC\\u002fMS\\u002fMS analysis\"],[\"Inhibition of human MKK7beta assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of recombinant human sEH expressed in baculovirus expression system assessed as reduction in ACPU binding incubated for 1 hr by FRET displacement assay\"],[\"Inhibition of COQ7 in human PANC1 cells assessed as DMQ10 accumulation at 10 uM after 1 day by HPLC analysis relative to control\"],[\"Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assay\"],[\"Inhibition of MAO-A in rat brain using [14C]-5-hydroxytryptamine creatinine disulfate as substrate preincubated for 60 mins followed by substrate addition and measured after 30 mins by liquid scintillation counting method\"],[\"Inhibition of recombinant FLT3 ITD mutant (unknown origin) by RBC kinase assay\"],[\"Inhibition of human recombinant topoisomerase 1-dependent DNA cleavage using 751-bp BamHI-EcoRI fragment of SV40 DNA at 50 uM incubated for 30 mins by PAGE method\"],[\"Inhibition of human GRK6 using casein as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of full length human catalytically inactive KDM5B H499A\\u002fE501A mutant transfected in HeLa cells assessed as change in H3K4Me3 level measured after 24 hrs by cell analyser based immunofluorescence assay\"],[\"Inhibition of GABAalpha1 receptor (unknown origin) at 10 uM by radioligand binding assay relative to control\"],[\"Activity of Klebsiella pneumoniae SHV-1\"],[\"Binding affinity to human NET F207T mutant expressed in african green monkey COS1 cells\"],[\"Inhibition of FLT3 ITD mutant in human MOLM13 cells assessed as ratio of phosphorylated STAT5 to beta-actin level at 30 nM after 2 hrs by Western blot analysis relative to control\"],[\"Inhibition of mouse HDAC1\"],[\"Inhibition of FGFR2 N549H mutant (unknown origin) at 0.45 uM\"],[\"Displacement of [3H]methylspiperone from human dopamine D4 receptor expressed in CHO cells at 1 uM\"],[\"Inhibition of FITC-BAK binding to His6 tagged MBP fused recombinant human MCL1 (172 to 327 residues) expressed in Escherichia coli by fluorescence polarization competition assay\"],[\"Inhibition of human CDKL2 (1 to 327 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control\"],[\"Inhibition of recombinant KDM3B (842 to 1761 residues) (unknown origin) expressed in baculovirus infected sf9 cells using biotin-H3K9me as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by AlphaLisa assay\"],[\"Binding affinity to human GLS1 expressed in Escherichia coli strain BL21 (DE3) assessed as change in melting temperature at ratio of 1:2 by SYPRO orange dye based protein thermal shift assay\"],[\"Inhibition of wild-type human partial length JAK1 JH1 catalytic domain (V856 to K1154 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity at human PrPC at 40 uM by SPR assay\"],[\"Inhibition of 20S proteosome beta 5 purified from human HCT116 cells using Suc-LLVY-AMC as substrate incubated for 30 to 120 mins by fluorimetry\"],[\"Inhibition of human GST-tagged FLT3 at 3 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-SpotSM kinase assay\"],[\"Inhibition of CXCR4-mediated chemotaxis in human MDA-MB-231 cells assessed as reduction in CXCL12alpha-induced cell invasion after 22 hrs by hematoxylin\\u002feosin dye-based matrigel assay relative to control\"],[\"Inhibition of recombinant human TDO expressed in Escherichia coli BL21 using L-Trp as substrate incubated for 30 mins by enzymatic assay\"],[\"Inhibition of human ERG at 10 uM by patch express assay relative to control\"],[\"Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP\"],[\"Binding affinity to dopamine D3 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay\"],[\"Inhibition of human leukocyte elastase.\"],[\"Inhibitory constant against Alpha-1B adrenergic receptor using [3H]-7-MeO prazosin radioligand\"],[\"Agonist activity at human cloned CB2 receptor by [35S]GTP-gamma-S binding assay\"],[\"Inhibition of human Indoleamine 2,3-dioxygenase using L-tryptophan as substrate by emission fluorescence analysis\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 1.25 uM incubated for 16 to 18 hrs in presence of 0.0024 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Inhibition of SETD7 (unknown origin) at 1 to 10 uM\"],[\"Inhibition of human LYN at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of Hsp90 in human SKBR3 cells assessed as Her2 degradation\"],[\"Inhibition of recombinant C-terminal FLAG-tagged human GCN5 expressed in a Baculovirus-infected Sf9 cell expression system\"],[\"Binding affinity to human RXRalpha LBD by ITC\"],[\"Agonist activity at human muscarinic M4 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay\"],[\"Inhibition of HER2 in human BT474 cells assessed as reduction in Erk1\\u002f2 phosphorylation at 0.1 IC50 incubated for 24 to 48 hrs by western blot analysis\"],[\"Inhibition of N-terminal GST-tagged human recombinant PDE3A assessed as substrate hydrolysis using cAMP as substrate at 1 uM after 30 mins by homogenous time-resolved fluorescence method\"],[\"Blockade of mouse HCN1 expressed in HEK293 cells at 5 uM at -120 f-current amplitude by patch-clamp electrophysiological assay relative to control\"],[\"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of BTK (unknown origin) at 0.1 uM by caliper mobility shift assay relative to control\"],[\"Displacement of [3H]ZM2413853 from human adenosine A2A receptor expressed in human HeLa cells at 0.1 uM by liquid scintillation counting\"],[\"Inhibition of recombinant human EGFR d746-750\\u002fT790M\\u002fC797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method\"],[\"Inhibition of recombinant EPHA2 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA\"],[\"Inhibition of TBK1 (unknown origin) at 30 uM\"],[\"Inhibition of VEGFR2 phosphorylation in VEGF-induced HUVEC cells pretreated at 0.5 to 20 uM by Western blot analysis\"],[\"Inhibition of VEGFR2 (unknown origin) at 0.1 uM incubated for 1 hr by ELISA relative to control\"],[\"Inhibition of human Glycine Transporter type-2\"],[\"Uncompetitive inhibition of electric eel BChE using varying levels of butyrylcholine chloride as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of PPL assessed as half inactivation time at 100 molar excess in presence of NaTDC\"],[\"Irreversible inhibition of recombinant human MAO-B at 30 nM using p-tyramine as substrate preincubated for 15 to 60 mins followed by substrate addition and subsequent two-fold enzyme dilution measured after 15 mins by amplex red reagent based fluorescence assay\"],[\"Binding affinity to CCR5 in T-cell (unknown origin)\"],[\"Agonist activity at human GHS receptor assessed as intracellular myo-IP1 secretion after 90 mins by HTRF analysis\"],[\"Inhibition of IDO1 in IFNgamma\\u002fLPS-stimulated human whole blood preincubated for 4 hrs followed by IFNgamma\\u002fLPS stimulation and incubated for 18 hrs by Rapid-fire mass spectrometry analysis\"],[\"Displacement of (+)-[3H]-ditolylguanidine from recombinant rat sigma 2 receptor expressed in rat PC12 cell membranes after 90 mins in presence of sigma 1 receptor blocker (+)-SKF-10047 by scintillation counting method\"],[\"Tested in vitro against HIV-1 MDR using MAGI assay\"],[\"Displacement of [3H]WIN-3542 from human DAT at 10 uM\"],[\"Activation of Nrf2 in mouse BV-2 cells assessed as upregulation of NQO-1 protein expression measured after 24 hrs by Western blot analysis\"],[\"Inhibition of CYP4F2-mediated gamma-tocopherol metabolism in human HepG2\\u002fC3A cells at 20 nM preincubated for 4 hrs and continued for 48 hrs\"],[\"Inhibition of HDAC1 (unknown origin) using Ac-Leu-GlyLys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins by fluorescence analysis\"],[\"Percent displacement of [3H]DPCPX from human adenosine A1 receptor at 10 uM\"],[\"Displacement of [3H]glibenclamide from rat voltage-gated heart KATP at 10 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Inhibition of human dopamine D1 receptor expressed in HEKT cell membranes at 10 uM relative to control\"],[\"Inhibition of recombinant human PDGFRalpha (550 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of recombinant full length human HDAC-1 expressed in baculovirus expression system using acetyl-Gly-Ala-Lys(acetyl)-AMC as substrate after 2 hrs by fluorescence microplate reader analysis\"],[\"Binding affinity to nuclear export signal of topoisomerase 2alpha in human NCI-H929 cells assessed as potentiation of doxorubicin-induced apoptosis by measuring increase in cleaved caspase-3 levels at 25 uM pre-incubated for 20 hrs followed by addition of doxorubicin for 4 hrs\"],[\"Binding affinity to PHF2 (unknown origin) assessed as induction of thermal shifts at 20 uM measured for 25 mins by SYPRO orange dye thermal shift assay\"],[\"Inhibition of human ETB receptor at 10 uM by CEREP assay\"],[\"Inhibition of Enterobacter cloacae beta-lactamase at 200 uM incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of 1 mM DTT by spectrophotometric analysis relative to control\"],[\"Inhibition of human Hsp90alpha in human HCT116 cells in assessed as Raf1 down-regulation at 0.5 to 50 uM\"],[\"Inhibition of human intestinal CES2 expressed in U373MG cells assessed as 7-ethyl-10-hydroxycamptothecin formation at 5 uM using irinotecan as substrate preincubated for 1 hr followed by substrate addition measured after 5 mins by HPLC method relative to control\"],[\"Inhibition of STAT3 phosphorylation at Ser727 residue in human HCC70 cells at 3 uM after 3 hrs by Western blotting analysis\"],[\"Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1alpha by fluorescence polarization assay\"],[\"Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibitory concentration against human cytochrome P450 11B1 expressed in fission yeast, incubated with [14C]deoxycorticosterone; not determined\"],[\"Binding affinity to human serum albumin assessed as dissociation constant radiometric ultrafiltration assay\"],[\"Inhibition of human DHFR at 30 degC under pH 7.4 by spectrophotometry\"],[\"Displacement of [3H]-SCH- 58261 from human adenosine A2A receptor expressed in CHO cells; range 1024-1396\"],[\"Increase in ATPase activity of human histidine-tagged Pgp TM3 F194C mutant expressed in HEK293 cells at 2 mM relative to control\"],[\"Inhibition of FLT3-mediated signalling pathway in human U-937 cells assessed as inhibition of eIF4E phosphorylation upto 20 x GI50 concentration incubated for 6 hrs by western blot analysis\"],[\"Inhibition of TRAP1 in human PC3 cells assessed as loss of mitochondrial membrane potential at 10 uM measured after 2 hrs by TMRM dye based flow cytometry\"],[\"Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method\"],[\"Inhibition of HDAC6 in human MOLM14 cells assessed as increase in acetylated tubulin level at 15 uM up to 48 hrs by immunoblot method\"],[\"Intrinsic agonist activity at human D3 receptor expressed in HEK293 cells assessed as inhibition of a forskolin-dependent whole cell adenylyl cyclase activity after 20 mins relative to quinpirole\"],[\"Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM for 48 hrs by TEM analysis\"],[\"Inhibition of recombinant human GST-tagged FLT3 (571 to 993 residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins\"],[\"Competitive inhibition of human S1PL using varying levels of RBM13 as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of human MAO-B using p-tyramine as substrate assessed as H2O2 production by amplex red assay\"],[\"Antagonist activity at human TRPV1 expressed in CHO-K1 cells assessed as inhibition of capsaicin-induced intracellular Ca2+ influx by FLIPR assay\"],[\"Inhibition of PDGFRalpha phosphorylation at Y849 in human GISTT1 cells up to 10 uM after 2 hrs by Western blot analysis\"],[\"Inhibition of PI3Kbeta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay\"],[\"Displacement of [125I]-IAAP from human P-gp expressed in high five insect cell membrane vesicles at \\u003e5 uM preincubated for 10 mins followed by photocrosslinking for 10 mins by exposing under UV light for 10 mins by SDS-PAGE based method\"],[\"Inhibition of human HDAC5\"],[\"Inhibition of glucocerebrosidase in human A549 cells using 4-methylumbelliferyl beta-D-glucoside as substrate at 10 uM after 45 mins by spectrophotometry\"],[\"Inhibition of SMYD2 (unknown origin) using [3H]-p53 (361 to 380 residues) as substrate after 1 hr in presence of [3H]-SAM by scintillation proximity assay\"],[\"Inhibition of human C-terminal DNMT3A at 32 uM after 1 hr by fluorescence assay\"],[\"Antagonist activity at Smo in Ptch1-\\u002f- mouse MEF assessed as inhibition of Hh signaling pathway by measuring suppression of Ptch1 mRNA expression at 5 uM after 48 hrs by qRT-PCR method\"],[\"TTBK2(h) Kinase panel\"],[\"Inhibition of Influenza Virus A\\u002fPR\\u002f8\\u002f34 neuraminidase chemiluminescence-based enzyme inhibition assay\"],[\"Displacement of [3H]-GR113808 from guinea pig brain 5HT4 receptor at 0.01 uM in presence of serotonin incubated for 30 mins\"],[\"Inhibition of NLRP3 inflammasome activation in LPS-primed human PMA-differentiated THP-1 cells assessed as reduction in MSU-induced IL-1beta level at 1.25 to 5 uM preincubated for 30 mins followed by MSU addition and measured after 4 hrs by ELISA method\"],[\"Activation of Nrf2 in rat PC12 cells assessed as increase in GCLC protein level at 20 uM after 24 hrs by Western blot analysis\"],[\"Binding affinity at human TRPV1 at Kd relative to control\"],[\"Displacement of [3H]BTCP (1-[1-(2-benxo[b]thienyl)cyclohexyl]piperidine) from rat forebrain dopamine transporter\"],[\"Reversal of ABCG2 (unknown origin)-mediated multidrug resistance in human H460-MX20 cells assessed as fold change in mitoxantrone IC50 at 0.5 uM after 72 hrs by MTT assay relative to mitoxantrone IC50\"],[\"Noncompetitive inhibition of acetylcholinesterase (unknown origin) using acetylthiocholine iodide as substrate by Michaelis-Menten plot analysis\"],[\"In vitro rate of EPMP-inhibited acetylcholinesterase reactivation by anionic (oximate) form.\"],[\"Inhibition of human LYN assessed as remaining enzyme activity at 0.01 uM\"],[\"Stabilization of TTR V3OM mutant (unknown origin) assessed as suppression of TTR tetramer dissociation at 3 uM incubated for 9 days by glutaraldehyde cross-linking assay based SDS-PAGE analysis relative to control\"],[\"Inhibition of TRKA (unknown origin) at 0.5 uM relative to control\"],[\"Displacement of [3H]WIN35428 from DAT (unknown origin) transiently expressed in COS7 cells incubated for \\u003e 90 mins by beta scintillation counting method\"],[\"Inhibition of human mitogen-activated protein kinase kinase 4 (MKK4)\"],[\"Antagonistic activity against VP-16 transcriptional activation domain protein\"],[\"Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount method\"],[\"Inhibition of PDGFR-beta (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis\"],[\"Inhibitory concentration against Lactobacillus casei dihydrofolate reductase\"],[\"Irreversible inhibition of human TGase 2 using Z-Glu(HMC)-Gly-OH as substrate up to 25 uM measured at 20 secs interval over 900 secs by fluorimetric assay\"],[\"Displacement of 6-Amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)-naphthalen-1-yl)phenyl)piperidin-1-yl)butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)-phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate from recombinant human P2Y14 receptor expressed in CHO cells preincubated for 30 mins followed by tracer addition and measured after 30 mins by flow cytometry\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 0.039 uM incubated for 16 to 18 hrs in presence of 0.078 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Inhibition of recombinant human CaMK2beta (1 to 315 residues) using calmodulin a substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis\"],[\"Thermal Shift Assay. Domain start\\u002fstop: A1040-G1161\"],[\"Inhibition of RIP1 in human PDOTS (spheroid derived from tumors from pancreatic, colorectal, breast, gastric cancer patients) assessed as CD8+ cytolytic T cells at 0.5 nM incubated for 3 days by flow cytometry\"],[\"Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis\"],[\"Inhibition of PDGFRbeta (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay\"],[\"Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 10 mins by spectrofluorimetry\"],[\"Inhibition of DAPK1 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of human MST3 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of FLT4 (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Binding affinity to wild-type human partial length JAK1 JH2 pseudokinase domain (R537 to D855 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control\"],[\"Percent inhibition of [3H]CHA binding at Adenosine A1 receptor in bovine cortical membrane at 10 uM\"],[\"Binding affinity to human A1A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay\"],[\"Inhibition of recombinant human factor B expressed in drosophila cells assessed as decrease in C3a formation using CVF-Bb complex and human complement C3 substrate in presence of human factor D after 1 hr by ELISA\"],[\"Antagonist activity at CCR2 receptor (unknown origin) by [35S]GTPgammaS binding assay\"],[\"Functional potency was determined in pooled human preadipocytes by measurement of PPARg aP2 gene induction\"],[\"Binding affinity to human muscarinic M1 receptor expressed in insect Sf9 cells\"],[\"Agonist activity at mouse MC3 receptor expressed in HEK293 cells after 2 hrs by cAMP alpha screen assay\"],[\"Inhibition of PDGFRalpha T674I mutant (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of NADA-induced intracellular calcium level preincubated with cells followed by NADA addition by Fluo-4 dye based FLIPR assay\"],[\"Displacement of [3H]MSX-2 from human recombinant adenosine A2A receptor expressed in CHO cells\"],[\"Inhibition of BRD4 in human MDA-MB-231 cells transfected with BRD4 shRNA incubated for 24 hrs by Western blot analysis\"],[\"Inhibition of recombinant human C-terminal His6-tagged cathepsin L (Glu113 to Val333 and Ala114 to Val333 residues) expressed in mouse myeloma cells using Z-Leu-Arg-AMC as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins\"],[\"BMPR2 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Agonist activity at recombinant full length human LRH1 expressed in HeLa cells after 24 hrs by dual-glo luciferase reporter gene assay\"],[\"Inhibition of c-MET activation (unknown origin) expressed in human HCT116 cells\"],[\"In vitro inhibitory concentration against human Heparanase\"],[\"Inhibitory activity against human TRAFbeta\"],[\"Activity at human recombinant topoisomerase 2alpha using supercoiled plasmid pBR322 as substrate assessed as stabilization of enzyme-DNA cleavage at 100 uM after 20 mins by ethidium bromide staining based agarose gel electrophoresis\"],[\"Inhibition of wild-type human partial length MAP2K4 (S84 to D399 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of PIP5K1A (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Agonist activity at human PPARgamma by transactivation assay\"],[\"Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 5 uM\"],[\"Binding affinity to CD81 (unknown origin) by surface plasmon resonance assay\"],[\"Inhibition of PI3K alpha (unknown origin) using PIP2 as substrate irradiated with 365 nm of UV exposure for 2 mins and incubation in dark at room temperature for 1 hr in presence of ATP measured by ADP-Glo luminescent assay\"],[\"DAPK1 DiscoveRx kinase panel\"],[\"Displacement of [3H]DPCPX from recombinant human adenosine A2A receptor\"],[\"Inhibition of GRP78 in human HCT116 cells assessed as increase in unfolded protein response marker ATF4 level measured after 16 hrs by Western blot analysis\"],[\"Inhibition of human MEK1 in human MIA PaCa-2 cells assessed as decrease of p42\\u002f44 MAPK phosphorylation in presence of U0126 at 10 uM measured after 5 hrs by Westren blot assay\"],[\"Inhibition of rat liver microsomal 17beta HSD2 using unlabeled- and labelled [2,4,6,7-3H]-E2 as substrate incubated for 20 mins by HPLC analysis\"],[\"Inhibitory constant against human Carbonic anhydrase I; NT, Not tested\"],[\"Displacement of [3H]-methyltrienolone from human androgen receptor overexpressed in HEK293 cells by microbeta counting assay\"],[\"Inhibition of human GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE peptide substrate at 1 uM by 33P Hotspot assay\"],[\"Inhibition of coffee bean alpha-galactosidase assessed as p-nitrophenol release at 1000 uM by spectrophotometrically\"],[\"Activation of Bombyx mori Ecdysone receptor (amino acids 272-606) expressed in HEK293 cells transfected with cytomegalovirus promoter-driven expression construct encoding chimeric transactivator composed of DBD and homodimerization domains of yeast Gal4 (amino acids 1-146) and VP16 activation domain (amino acids (413-490) at 10 uM exposed for 16 hrs by Gal4 dependent luciferase reportre gene assay relative to untreated control\"],[\"Inhibition of human neuropeptide Y1 receptor at 10 uM by radioligand binding assay\"],[\"Inhibition of human dopamine D4 receptor at 100 nM\"],[\"Activation of 15-LOX in human PMN assessed as 15-HETE production at 6.2 to 40 uM pre-incubated for 15 mins before A23187, Ca2+ and Mg2+ stimulation for 1 hr by LC-MS method\"],[\"Inhibition of recombinant wild type HIV-1 His-tagged reverse transcriptase p66\\u002fp51 expressed in Escherichia coli JM109 using poly(rA)\\u002foligo(dT)16 as template\\u002fprimer incubated for 40 mins by pico-green based spectrofluorometric analysis\"],[\"Inhibition of TDO in human A 172 cells assessed as reduction in L-kynurenine formation using L-tryptophan as substrate incubated for 24 hrs\"],[\"Inhibition of tyrosinase (unknown origin) at 200 uM relative to control\"],[\"Inhibition of c-Abl at 10 uM\"],[\"Inhibition of human SRPK2 using GRSRSRSRSR as substrate by [gamma-33P]-ATP assay\"],[\"Ability to stimulate the Dopamine receptor D1 like was assayed by measuring cAMP production in cell free homogenates of goldfish retinal tissue\"],[\"Inhibition of recombinant HDAC6 (unknown origin) at 1 uM incubated for 15 mins before substrate addition and measured after 30 to 45 mins by HDAC-Glo substrate\"],[\"Inhibition of human AurB in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of human IRR at 1 uM using MBP as substrate\"],[\"Inhibition of GAT-1 (unknown origin) expressed in african green monkey COS7 cells using [3H]-GABA as substrate after 10 mins by scintillation counting\"],[\"Inhibition of recombinant human N-terminal poly histidine-tagged PTP1B (Glu2 to Asn321 residues) expressed in Escherichia coli using pNPP as substrate measured for 4 mins\"],[\"Downregulation of RANKL-induced p65 nuclear translocation in mouse bone marrow macrophages at 5 to 20 uM after 30 mins by Western blot analysis in presence of M-CSF\"],[\"Inhibition constant for human matrix metalloprotease-9 (MMP-9)\"],[\"Agonist activity at human FSHR receptor expressed in CHO-K1 cells assessed as inhibition of FSH-induced luciferase activity at 10 uM by CRE-driven luciferase reporter gene assay relative to control\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 dxr at 4 fold MIC by microarray analysis\"],[\"Binding affinity to wild type FLT3 (unknown origin)\"],[\"Inhibition of HDAC6 in human NCI-H929 cells assessed as increase in acetylated tubulin level by measuring ratio of acetylated tubulin to total tubulin level at 1 uM by immunoblot analysis relative to control\"],[\"Inhibition of EPHA2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Inhibition of human factor D using CVF-FB as substrate assessed as decrease in formation of factor B cleavage product Ba by ELISA\"],[\"Inhibition of human dihydrofolate reductase at \\u003e30 uM\"],[\"Inhibition of PARP10 (unknown origin)\"],[\"Inhibition of human ASK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control\"],[\"Inhibitory effect of compound was measured in bovine trypsin; no data\"],[\"Inhibition of Bfl-1 (unknown origin) expressed in Eu-Myc cells assessed as induction of cell death at 25 to 100 uM incubated for 24 hrs by violet LIVE\\u002fDEAD fixable dead cell staining based flow cytometry\"],[\"Transactivation of PPARgamma in human adipocytes assessed increase in aP2 gene expression at 30 uM after 3 days by RT-PCR method relative to rosiglitazone\"],[\"Binding affinity for GST-tagged human Bcl-2-like protein 1 Y101H mutant expressed in Escherichia coli BL21 cells at 35 nM Bodipy-labelled compound after 3 hrs by fluorescence polarization assay\"],[\"Inhibition of CREBBP (unknown origin) by FRET assay\"],[\"Inhibition of SUV39H1 (unknown origin) at 1 to 10 uM\"],[\"Inhibition of Lck (unknown origin) at 10 uM\"],[\"Activation of caspase 3 in MDA-MB-231 cells by Western blot analysis at 0.1 uM\"],[\"Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]CP-55940 from human CB1 receptor expressed in HEK293 cells at 0.1 uM\"],[\"Inhibition of human cKit assessed as residual enzyme activity at 0.1 uM\"],[\"Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 6\"],[\"Aggregation based inhibition of Escherichia coli AmpC assessed as increase in deuteration of AmpC peptide fragment spanning 323-332 amino acid sequence after 10 mins by hydrogen-deuterium exchange mass spectrometry relative to control\"],[\"Inhibition of N-terminal His6-tagged human CDC25B (377 to 550 residues) expressed in Escherichia coli BL21(DE3) cells at 3 uM by spectrofluorimetric analysis\"],[\"Inhibition of recombinant ATX from transfected HEK293 cells\"],[\"Inhibition of Aurora B phosphorylation at Thr232 residue in human HeLa cells at 5 uM after 6 hrs by Western blot method\"],[\"DYRK3(h) Eurofins kinase panel\"],[\"Displacement of [3H]CP-559440 from human CB2 receptor expressed in HEK293 cells\"],[\"Inhibitory activity against human TRAFalpha\"],[\"Antagonism of retinoic acid receptor gamma activity induced by retinoic acid at 10e-6 M\"],[\"Decrease of cdc2 protein phosphorylation at Tyr15 in human HeLa cells at 10 to 100 nM after 24 to 48 hrs by Western blot analysis\"],[\"Activity of human NTPDase3 expressed in COS7 cells assessed as amount of inorganic phosphate released using ATP as the substrate at 100 uM after 15 mins by malachite green reagent method\"],[\"Destabilization of CDK2 in Homo sapiens (human) HeLa cells by immunoblot analysis\"],[\"Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 10 uM after 30 mins by spectrophotometric analysis\"],[\"Reversal of P-gp-mediated multidrug resistance in human K562\\u002fA02 cells assessed as potentiation of mitoxantrone-induced cytotoxicity at 75 nM by measuring mitoxantrone IC50 after 48 hrs by MTT assay\"],[\"Inhibition of human GRK5 using tubulin as substrate measured after 0 mins by [gamma-32P]-ATP assay\"],[\"Inhibition of recombinant His-tagged human Met expressed in baculovirus expression system at 1 uM by FRET assay relative to control\"],[\"Inhibition of rat full length DYRK1a expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Percent increase in the Forskolin-Stimulated cAMP formation, in HeLa cells transfected with the 5-HT 1A receptor at 10 uM concentration\"],[\"Inhibition of human CCKB receptor at 10 uM by CEREP assay\"],[\"Inhibition of human GRK7\"],[\"Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as [1,2,6,7-3H]-cortisol oxidation to [1,2-3H]-cortisone at 20 uM after 10 mins in presence of NAD+\"],[\"Inhibition of recombinant human Met M1268T mutant (974 to end residues) assessed as residual activity at 0.5 uM using KKKGQEEEYVFIE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of human full length PKG-1beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to human recombinant VEGFR1 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control\"],[\"Inhibition of recombinant MARK4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM\"],[\"Inhibition of recombinant human N-terminal His6\\u002fT7-tagged PAK2 (3 to end residues) expressed in Escherichia coli at 1 uM relative to control\"],[\"Activation of human 5-LOX using lionleic acid as substrate assessed as formation of 13-HPOD at 50 uM incubated for 10 mins prior to substrate addition measured after 10 secs by UV absorbance assay\"],[\"Inhibition of recombinant full length human Lyn at 10 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control\"],[\"Inhibition of wild type KRAS expressed in human PC9 cells assessed as cell growth inhibition at 1 uM measured after 6 hrs by TQ-UPLC\\u002fMS analysis\"],[\"Inhibition of DYRK1A in human 293T cells assessed as reduction of GLI1 transcription activity at 50 uM after 12 hrs by dual-luciferase reporter gene assay\"],[\"Inhibition of human FLT3 D835V mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of MMP-9 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay\"],[\"Inhibition of A23187 stimulated COX1 in human whole blood assessed as reduction in TXB2 level at 10 uM by enzyme immunoassay relative to control\"],[\"Inhibition of biotinylated ligand binding to wild-type human partial length PLK4 (M1 to S273 residues) expressed in mammalian expression system at 50 nM measured after 1 hr by kinomescan assay relative to control\"],[\"Inhibition of human MKK7-beta at 1 uM relative to control\"],[\"Inhibition of human JNK1alpha1 assessed as residual activity at 10 uM using ATF2 as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control\"],[\"Inhibition of wild-type human partial length TIE2 (N804 to T1112 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of human KDR (790 to end residues) assessed as residual activity at 1 uM using myelin basic protein as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control\"],[\"Inhibition of recombinant human ALDH2 using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis\"],[\"JAK3 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Binding affinity to SCPL48 in Arabidopsis thaliana leaf extracts pre-incubated with 100 uM paraoxon for 30 mins at 5 uM after 1 hr using SDS-PAGE followed by nanoLC-ESI-MS\\u002fMS analysis\"],[\"Inhibition of recombinant TCPTP (unknown origin) using pNPP as substrate by spectrophotometric analysis\"],[\"Percent inhibition of human placental Cytochrome P450 19A1 at 3:1 inhibitor: androstenedione (0.7 uM) ratio\"],[\"GRK5(h) Eurofins kinase panel\"],[\"Inhibition of Grp94 in human SKBR3 cells overexpressing HER2 assessed as degradation of HER2 at 100 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of VEGFR1 phosphorylation in growth factor-stimulated HUVEC at 3 uM after 24 hrs\"],[\"Inhibition of bovine pancreas alpha-chymotrypsin at 50 uM after 30 mins using N-Succinyl-L-phenylalanine- p-nitroanilide measured for 30 mins\"],[\"Binding affinity to human adenosine A3 receptor at 10 uM\"],[\"Inhibition of human recombinant cathepsin K using Z-Leu-Arg-AMC as substrate after 80 mins by fluorimetric analysis\"],[\"Inhibition of human ROS using KKKSPGEYVNIEFG as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human MAOB at 5 uM\"],[\"Binding affinity to human IDO1 assessed as change in spectral signal at 200 uM by CPMG NMR spectrometry analysis\"],[\"Inhibition of human recombinant histone acetyltransferase PCAF assessed as acetylation of histone H3 at 0.15 to 0.6 mM\"],[\"In vitro for histamine H1 receptor antagonist activity against histamine-induced contractions on isolated guinea pig ileum\"],[\"Inhibition of ASK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of HGF induced mTOR activation in rat liver assessed as inhibition of AKT phosphorylation at S473 at 100 mg\\u002fkg, ip 6 hrs prior to HGF stimulation by MSD analysis\"],[\"Antiviral activity against HIV1 reverse transcriptase Y181I mutant\"],[\"Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of casein and mouse serum albumin\"],[\"Agonist activity at human adenosine A3 receptor after 15 to 30 mins\"],[\"Inhibition of PIM1 (unknown origin) at 10 uM\"],[\"Displacement of [3H]AVP from human recombinant V1a receptor expressed in H recombinant CHO cells\"],[\"Inhibition of full length human ABCB1 expressed in Flp-In-293 cells assessed as potentiation of vincristine-induced cytotoxicity by measuring vincristine IC50 at 10 uM after 72 hrs by SRB assay (Rvb = 823.13 +\\u002f- 15.79 nM)\"],[\"Inhibition of human ERG channel expressed in CHO cells at 1 uM\"],[\"Binding affinity to human ALK at 50 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of LYP (unknown origin) using p-nitrophenyl phosphate as substrate preincubated for 10 mins followed by substrate addition measured every minute for 10 mins by UV-VIS spectrophotometric analysis\"],[\"Binding affinity against adenosine A1 receptor in rat cortex by using [3H]- PIA as a radioligand\"],[\"Inhibition of human non-phosphorylated ABL1 H396P mutant (S229 to K512 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Irreversible inhibition of rat liver mitochondrial MAO-A using 5-hydroxytryptamine as substrate at 6 nM preincubated for 30 mins measured after three consecutive washes with buffer\"],[\"Inhibition of ROCK2 activity at 10 uM\"],[\"Inhibition of biotinylated VEGFR1 binding to NRP1 (unknown origin) measured after 2 hrs chemiluminescence analysis\"],[\"Inhibition of 5-HT1B receptor (unknown origin) by radio ligand displacement assay relative to control\"],[\"Inhibition of P-gp-mediated daunorubicin efflux in human CCRF-CEM\\u002fVCR1000 cells measured within 1 hr by FACS flow cytometry\"],[\"Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA\"],[\"Inhibition of human plasma thrombin using Biophen CS-21(66) as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis\"],[\"Inhibition of recombinant human OGA expressed in Escherichia coli BL21 (DE3) at 20 uM using 4-Mu-GlcNAc as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by fluorescence assay relative to control\"],[\"Inhibition of GRK7 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of human full length PKC beta2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Displacement of [3H]GR-113808 from human 5HT4b receptor expressed in COS7 cell membrane at 1 uM by scintillation counting\"],[\"Inhibition of human recombinant topoisomerase 2alpha assessed as relaxation of supercoiled plasmid DNA pBR322 at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to etoposide\"],[\"Antagonist activity at rat mGlu5 receptor expressed in HEK293 cells assessed as inhibition of glutamate-induced response at 10 uM\"],[\"Inhibition concentration (binding affinity) exhibited against human melanocortin receptor 5 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)\"],[\"Agonist activity against human GPR109a assessed as forskolin-induced cAMP accumulation\"],[\"Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells\"],[\"Inhibition of CBP in human PBMC derived naive CD4-positive T cells assessed as FOXP3 protein level in CD4positive-CD25positive T cells at 0.25 uM measured after 4 days by flow cytometry (Rvb = 59.3%)\"],[\"Binding affinity to wild-type human partial length RIOK2 (M1 to D313 residues) expressed in mammalian expression system by Kinomescan method\"],[\"Reactivation of diisopropyl phosphorofluoridate-inhibited electric eel AChE activity at 0.0001 M and pH 8 after 10 mins by Ellman's method relative to control\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 10 mins prior to substrate addition by Ellman's method\"],[\"Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of Akt degradation at 10 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of human ERG expressed in HEK293 cells at 50 nM by whole-cell patch-clamp technique relative to control\"],[\"Effect on beta-catenin phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control\"],[\"Inhibition of human adrenergic alpha 1D receptor at 10 uM relative to control\"],[\"Inhibition of human Kif20A at 200 uM\"],[\"Inhibition of p53-MDM2 interaction in human HCT116 cells assessed as p53 activation by measuring p21 accumulation at 5 to 20 uM after 7 to 24 hrs by Western blot analysis\"],[\"Positive allosteric modulation of human mGlu5 receptor expressed in HEK293 cells assessed as potentiation of L-glutamate-induced activity after 1 hr by FLIPR assay\"],[\"Inhibition of N-terminal His10-tagged mouse GOAT expressed in baculovirus infected sf9 insect cell membrane using proghrelin-His8 and [3H]octanoyl CoA as substrate by scintillation counting method\"],[\"Antagonist activity at human SUCNR1 expressed in human CHEM1 cells incubated for 60 mins in presence of [35S]GTPgammaS by scintillation proximity assay\"],[\"Displacement of [33P]-S1P from human S1P1 receptor expressed on CHO-K1 cell membranes after 60 mins by scintillation counting method\"],[\"Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake at 25 uM after 5 hrs relative to control\"],[\"Inhibition of Pyk2-mediated stimulation of human SF767 glioma cell migration at 5 uM by radial migration assay relative to control\"],[\"Displacement of [3H]-S-citalopram from human SERT expressed in African green monkey COS7 cells incubated for 10 mins prior to [3H]-S-citalopram addition measured after 2 hrs by scintillation counting analysis\"],[\"Biochemical assay (AKT1)\"],[\"Activation of RXRalpha in human KM12C cells assessed as increase in p21 (WAF1\\u002fCIP1) protein expression at 25 to 50 uM incubated for 15 hrs by Western blot analysis\"],[\"Antagonist activity at mouse GHSR1 receptor assessed as intracellular Ca2+ concentration by aequorin luminescent assay\"],[\"Inhibition of human CSF1R using poly[Glu:Tyr] (4:1) as substrate after 120 mins in presence of 1 uM [gamma-33P]-ATP by filtration method\"],[\"Inhibition of recombinant human MPO incubated for 10 mins in presence of 120 mM NaCl by aminophenyl fluorescein based assay\"],[\"Displacement of S-phenyl 3-(4-hydroxy-3,5-dimethylstyryl)benzothioate from human TTR assessed as fluorescence at 37 degC after 3 hrs\"],[\"Inhibition of human CHK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control\"],[\"Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT\\u002fFASN positive feedback loop by measuring reduction in AKT expression at 100 uM after 48 hrs by Western immunoblot based densitometric assay relative to control\"],[\"Binding affinity to human BRD4 bromodomain 1 expressed in Escherichia coli BL21 (DE3) cells by isothermal titration calorimetry\"],[\"Inhibition of mTOR in human MDA-MB-231 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by fluorescence assay\"],[\"Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting\"],[\"Binding affinity to CDK2 (unknown origin) assessed as remaining unbound target protein level at 10 uM relative to control\"],[\"Inhibition of human recombinant DAPK3 at 1 uM\"],[\"Activation of recombinant full length human CB2 receptor expressed in HEK293 cell membranes at 10 uM after 90 mins by topcount scintillation counting analysis relative to control\"],[\"Inhibition of PRAK at 10 uM relative to control\"],[\"Binding affinity to PPP2CB in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes assessed as dissociation rate constant by TR-FRET assay\"],[\"Inhibition of human recombinant PRKCT at 0.5 uM by radiometric filter-binding assay\"],[\"Inhibition of human DAT expressed in HEK293 cells assessed as reduction in [3H]-DA uptake by micro beta scintillation counting analysis\"],[\"Inhibition of human AXL using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [3H]-N-alpha-methylhistamine from human H3 receptor expressed in HEK293 cells at \\u003e=30 uM after 60 mins by liquid scintillation counter assay\"],[\"Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Mixed-type inhibition of human tissue kallikrein-2 expressed in baculovirus infected insect cells using Abz-KLRSSQ-EDDnp as substrate assessed as substrate Km at 4 uM by Lineweaver-Burk plot analysis (Rvb = 0.62 +\\u002f- 0.02 uM\\u002fsec)\"],[\"Inhibition of human recombinant HDAC3 using fluorogenic peptide p53 residues 379-382 (RHKK(Ac)AMC) as residues at 10 uM by fluorescence method\"],[\"Activation of human TLR9 transfected in HEK293 cells at 10 uM after 20 to 24 hrs by SEAP assay\"],[\"Inhibition of full length recombinant human His-tagged cytoplasmic BLK expressed in baculovirus expression system assessed as inactivation rate by KT236 probe based TR-FRET assay\"],[\"Inhibition of PLK1 in human MM1.S cells assessed as reduction in c-Myc levels incubated for 6 hrs by immunoblotting analysis\"],[\"Inhibition of human recombinant MAO-A expressed in baculovirus infected BTI-TN-5B1-4 insect cells using p-tyramine as substrate after 15 mins by resorufin dye-based spectrometric analysis\"],[\"Displacement of [3H]U69593 from human kappa receptor at 10 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Competitive antagonist activity at human NPFF1 receptor expressed in COS1 cells assessed as fold decrease in NPVF-induced [3H]inositol phosphate accumulation at 10 uM after 2 hrs by liquid scintillation counting relative to control\"],[\"Agonist activity at mouse NMUR2 expressed in HEK293 cells assessed as induction of calcium mobilization at 1 uM after 18 hrs by Fluo-4 AM dye based FLIPR assay\"],[\"Inhibition of human recombinant interstitial collagenase MMP-1 at 100 uM\"],[\"Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate\"],[\"Inhibition of BCL-XL (unknown origin) incubated for 1 hr in presence of 1% human serum by TR-FRET assay\"],[\"Reactivation of VX-inhibited human recombinant AChE assessed as dissociation constant of inhibited enzyme-compound complex incubated for 1 to 10 mins by spectrophotometry based Ellman's assay\"],[\"Inhibition of TAMRA-labelled WNK4 binding to recombinant rat C-terminal GST-fused SPAK (452 to 553 residues) expressed in Escherichia coli BL21 measured for 15 secs by FCS assay\"],[\"Inhibition of EGF-induced EGFR phosphorylation at Tyr1173 in human MDA-MB-231 cells at 0.1 uM by ELISA\"],[\"Induction of ubiquitination of MCM4 in human NCI-H1975 cells incubated for 48 hrs by immunoblot analysis (Rvb = 1 No_unit)\"],[\"Substrate activity at recombinant human N-terminal His-tagged SHIP2 (419 to 832 residues) expressed in Escherichia coli Rosetta2 (DE3) cells assessed as 5-OH-Bz(1,2,4)P3 product formation at 100 uM incubated for 2 hrs in presence of AS1949490 by fluorescence based HPLC analysis\"],[\"Inhibition of human recombinant PARP12 at 100 uM incubated for 1 hr using using NAD+, biotinylated NAD+ and activated DNA by luminescence based assay\"],[\"Inhibition of SETDB1 (unknown origin) at 10 uM relative to control\"],[\"Displacement of [3H]-DPCPX from human Adenosine A1 receptor expressed in CHO cells; range 269-326\"],[\"Inhibition of CK1-GAMMA1 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of DCN1-mediated CUL3 neddylation in human HCC95 cells after 48 hrs by Western blot analysis\"],[\"Inhibition of human hepcidin-stimulated recombinant C-terminal Halo-tagged human FPN internalization in MDCK cells at 10 uM incubated for 15 to 20 mins by Halo-tagged TMR based fluorescence assay relative to control\"],[\"Inhibition of serotonin 5-HT2A receptor (unknown origin)\"],[\"Binding affinity to human BAZ2A expressed in bacterial system assessed as remaining binding level at 1 uM by BROMOscan assay relative to control\"],[\"Agonist activity at human CB2 receptor expressing CHO cells co-expressing Galpha16 by calcium mobilization assay relative to CP55940\"],[\"Antagonist activity at rat GPR91 receptor expressed in CHO-K1 cells co-expressing Galpha and Gqi5 G-protein assessed as inhibition of succinate-induced increase in intracellular calcium level by FLIPR assay\"],[\"Displacement of biotinylated acetylated peptide from recombinant human partial length BRD4 long isoform bromodomain 1 (N44 to E168 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method\"],[\"Inhibition of human histamine H2 receptor at 3 uM by radioligand binding assay\"],[\"Inhibition of wild type HIV1 reverse transcriptase at 400uM\"],[\"Inhibition of protoporphyrin oxidase in Hordeum vulgare (barley) etioplast using protogen as substrate incubated for 15 min prior to substrate addition measured for 60 secs by spectrophotometric analysis\"],[\"Binding affinity to human recombinant CA2 at 37 degC and pH 7.0 by isothermal titration calorimetry\"],[\"Inhibition EGFP-CK2alpha (unknown origin) expressed in human HeLa cells induction of EGFP-CK2alpha translocation from nucleoli to nuclear matrix and cytoplasm at 8 uM after 12 hrs by Hoechst-33342-staining based microscopy\"],[\"Inhibition of AChE (unknown origin) by spectrophotometric analysis\"],[\"Inhibition of MMP9 (unknown origin) at 24.88 uM after 16 hr by gelatin zymographic analysis\"],[\"Activation of p53 in human U2OS cells harboring p53-dependent EGFP reporter gene assessed as increase in p53 transcriptional activity at 5 uM after 48 hrs by propidium iodide satining-based automated fluorescent imaging analysis relative to Nutlin-3a\"],[\"Inhibition of human adenosine A3 receptor at 1 uM relative to control\"],[\"Ratio of Kcat to Km for mouse carbonic anhydrase 13\"],[\"Binding affinity to recombinant human full length SIRT6 (1 to 355 residues) expressed in Escherichia coli M15 after 20 mins in presence of ADP-ribose by fluorescence-based SDS-denaturation assay\"],[\"Inhibition of human PI3Kgamma\"],[\"Inhibition of human MPSK1 (1 to 305 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control\"],[\"Antagonist activity at human glucocorticoid receptor expressed in GRAF cells assessed as inhibition of dexamethasone-induced alkaline phosphatase expression after 48 hrs by reporter gene assay\"],[\"Inhibition of DPP4 in rat spleen incubated for 60 mins using H-lys-Ala-pNA.2HCl substrate\"],[\"Inhibition of human neutrophil elastase-induced increase in nuclear translocation of p65 after 3 hrs by Western blotting analysis\"],[\"Inhibition of IDH1 R132C mutant (unknown origin) assessed as reduction in 2-HG levels after 90 mins in presence of NADPH by resazurin-based assay\"],[\"Agonist activity at human 5HT6 expressed in HeLa cells assessed as intracellular cAMP level by radioimmunoassay\"],[\"Inhibition of human AChE assessed as ratio of k2\\u002fI using acetylthiocholine iodide as substrate after 30 mins\"],[\"Inhibition of soluble epoxide hydroxylase by kinetic fluorescent assay\"],[\"Binding affinity to ESRP1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of bovine trypsin at 0.2 uM\"],[\"Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)\"],[\"Inhibition of EZH2-mediated proliferation of human SKBR3 cells after 6 days by chemiluminescence analysis\"],[\"Percent inhibition of the spread ofhuman immunodeficiency virus type 1 infection in cell culture at compound concentration 0.39 uM\"],[\"Percentage inhibition against tryptase at 10 uM\"],[\"Agonist activity at Pseudomonas aeruginosa PAO1 RhlR expressing rhlI coexpressing LVA-GFP at 100 to 200 uM after 24 hrs by fluorescence assay\"],[\"Agonist activity at delta opioid receptor in mouse assessed as inhibition of electrically evoked vas-deferens contraction by MVD test\"],[\"Inhibition of human recombinant Fyn at 1 uM\"],[\"Displacement of [3H]naltrindole from human cloned delta opioid receptor expressed in CHO cells\"],[\"Displacement of [3H]DPDPE from human delta opioid receptor expressed in CHO-K1 cells after 60 mins by scintillation counting\"],[\"Inhibition of recombinant human catalytic GST-tagged ACVR1 expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control\"],[\"Displacement of [3H]DPDPE from human delta opioid receptor expressed in CHO cells\"],[\"Inhibition of human carbonic anhydrase 9 catalytic domain in presence of 0.25 mM threitol\"],[\"Inhibition of human PDE3A catalytic domain using cAMP\\u002fcGMP substrate\"],[\"Inhibition of JAK1 in LPS-stimulated mouse RAW264.7 cells assessed as reduction in STAT1 phosphorylation at Y701 residue pretreated for 1 hr followed by LPS-stimulation by Western blot analysis\"],[\"Binding affinity to human CRF2beta receptor up to 10 uM\"],[\"Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells assessed as total radioligand binding at 1 uM incubated for 60 mins by microbeta plate reader based method\"],[\"Reversible inhibition of human steroid sulfatase using 4-methylumbelliferyl sulfate substrate by Lineweaver-Burk plot analysis\"],[\"Negative allosteric modulation of D2R (unknown origin) assessed as negative co-operativity factor\"],[\"Inhibition of human GSK3alpha\"],[\"Agonist activity at rat GPR40 expressed in HEK293 cells assessed as increase in intracellular Ca2+ flux by Fluo-4-AM dye based FLIPR assay\"],[\"Displacement of fluorescent labeled MV151 from 26S proteasome beta 1 in human HEK293 cell lysate assessed as residual activity at 1 uM after 1 hr by SDS-PAGE\"],[\"Inhibition of protease activity of Clostridium botulinum BoNT\\u002fE light chain using SNAP-25 as substrate after 15 mins by Dixon plot analysis\"],[\"Inhibition of recombinant human caspase-3 at 1 uM using Ac-DMQD-AMC as substrate measured at 15 sec interval over 30 mins by fluorogenic assay relative to control\"],[\"Inhibition of BRAF (unknown origin)-mediated ERK phosphorylation\"],[\"Inhibition of recombinant LSD1 (157 to 852 residues) (unknown origin) expressed in Escherichia coli BL21 (DE) at 10 uM using H3K4me2 as substrate by amplex red assay relative to control\"],[\"Percent stimulation of [35S]GTP-gamma-S, binding by the compound (10 uM) in guinea pig caudate membranes for mu opioid receptor selective condition\"],[\"Inhibition of equine serum BuChE at 100 uM using butyrylthiocholine iodide as substrate incubated for 5 mins followed by substrate addition measured after 180 secs by Ellman's method relative to control\"],[\"Antagonist activity at GR (unknown origin) by Alpha Screen assay\"],[\"Agonist activity at human TLR2 expressed in HEK-Blue cells assessed as increase in TLR2 expression at 10 uM incubated for 24 hrs by Western blot analysis relative to control\"],[\"Inhibition of MSK-1 kinase at 10 uM\"],[\"Inhibition of VEGF-165-induced VEGFR2 autophosphorylation at Tyr996 in serum-starved HUVEC at 2 uM preincubated for 2 hrs followed by VEGF-165 induction measured after 5 mins by Western blot analysis\"],[\"Displacement of 2-[125I]Iodomelatonin from human MT2 receptor expressed in CHO cell membranes after 120 mins\"],[\"Inhibitory activity against angiotensin converting enzyme at 26 uM; No inhibition\"],[\"Antagonist activity at human 5-HT2AR expressed in HEK293 cells assessed as inhibition of serotonin-induced IP1 accumulation after 60 mins by HTRF method\"],[\"Inhibition of Thermus flavus MDH pre-incubated for 4 mins before reaction initiation in presence of OAA and NAPH in absence of 0.01% Triton X100 by UV-Vis spectrophotometry\"],[\"Concentration required to inhibit the Pneumocystis carinii Dihydrofolate reductase by 50% was determined (reported by workers at Hoffman-LaRoche)\"],[\"Agonist activity at rat GPR17 expressed in HEK293 cells assessed as induction of intracellular calcium mobilization by calcium 5-dye based assay\"],[\"Activation of human liver glucokinase expressed in CHO cells at 2.5 mM glucose concentration by glucose-6-phosphate coupled continuous spectrophotometric assay\"],[\"Inhibition of FLT4 (unknown origin) at 100 nM\"],[\"Inhibition of full length human N-terminal GST-tagged QIK expressed in baculovirus expression system at 10 nM relative to control\"],[\"Displacement of [125I]DOI from cloned human 5HT2A receptor expressed in CHO cells\"],[\"Inhibition of CCL2 in human PBMC assessed as reduction of cell migration into TNFalpha\\u002fIFNgamma-stimulated HMEC-1 cells at 50 uM after 4 hrs\"],[\"Inhibition of ABCB1 in human MCF7\\u002fADR cells assessed as potentiation of vinblastine-induced cytotoxicity by measuring vinblastine IC50 at IC10 after 7 days by SRB assay\"],[\"Inhibition of PRMT1 (unknown origin) assessed as reduction in incorporation of [3H]-labeled methyl group into biotinylated substrate using [3H-SAM] at 50 uM incubated for 1 hr by scintillation proximity assay relative to control\"],[\"Inhibition of human recombinant HDAC2 using Fluor de Lys green as substrate by fluorometric assay\"],[\"Binding affinity to wild type human BRD4 BD2 (349 to 461 residues) assessed as change in melting temperature at 0:7 compound to protein ratio by thermal shift assay\"],[\"Inhibition of HDAC2 in human HeLa-S3 cell lysates assessed as remaining activity at 1.6 x 10'-5 M preincubated for 15 mins followed by HDAC-Glo substrate addition measured after 30 to 40 mins by fluorimetric method relative to control\"],[\"Displacement of [3H]diprenorphine from human kappa opioid receptor in CHO cells at 10 uM\"],[\"Binding affinity to PDE2 (unknown origin) by SPR analysis\"],[\"Inhibition of alpha-crystallin B R120G mutant (unknown origin)-induced intracellular protein aggregation expressed in human HLE-B3 cells at 4 uM incubated for 6 to 8 hrs by fluorescence microscopy relative to untreated control\"],[\"Positive allosteric modulation of human mGluR5 expressed in HEK293 cells assessed as Ca2+ influx by FLIPR assay\"],[\"Agonist activity at human FXR LBD assessed as SRC1 peptide recruitment by FRET assay\"],[\"Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 500 nM by Kinomescan method relative to control\"],[\"Inhibition of Aliivibrio fischeri LuxR quorum sensing system expressed in Escherichia coli MG1655 pVFR1 harboring Prf promoter assessed as reduction in LuxR transcriptional activity by measuring Lux gene expression in presence of LuxR protein activator and presence of 10'-7 M AHL by bioluminescence assay relative to control\"],[\"Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system at 0.1 uM using serine\\u002fthreonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control\"],[\"Inhibition of FGFR1 (unknown origin) after 10 mins by mobility shift assay\"],[\"Agonist activity at human FXR expressed in COS1 cells after 5 hrs by CRE-driven luciferase reporter gene assay relative to 6ECDCA\"],[\"Binding affinity to recombinant human full length N-terminal GST-tagged RPS6KA3 expressed in baculovirus expression system using S6K peptide as substrate incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human PLK3 at 100 nM using casein as substrate by [gamma-33P]-ATP assay\"],[\"Antagonist activity at human recombinant CB2 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay\"],[\"Inhibition of human RSK2\"],[\"Allosteric inhibition of C-terminal His-tagged recombinant human HDAC3 expressed in Sf9 cells pre-incubated for 2 hrs before acetylated lysine-aminomethyl coumarin-BOC addition and measured after 2 hrs by fluorescence based assay\"],[\"Inhibition of human IRR at 100 nM\"],[\"Inhibition of human recombinant 20-alpha HSD expressed in BAEC assessed as inhibition of progesterone metabolism at 10 uM treated 2 hrs before progesterone challenge measured after 6 hrs by LC-MS analysis\"],[\"Inhibition of coffee beans alpha-galactosidase at 1 mM pre-incubated for 1 hr followed by p-nitrophenyl-alpha-D-galactopyranoside substrate addition by fluorescence detection based assay\"],[\"Antagonist activity at human recombinant ERalpha LBD expressed in HEK293 cells assessed as inhibition of 0.3 nM estradiol-induced transcriptional activation at 30 uM after 16 to 18 hrs by GAL4-dependent luciferase reporter gene assay\"],[\"Displacement of [125I]CCK-8s from human recombinant CCK1 receptor at 10 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Inhibition of EGFR T790M\\u002fL858R double mutant (unknown origin) assessed as ratio of observed rate constant to inhibitor concentration at 5 uM\"],[\"Inhibition of GST-tagged ALK5 kinase domain (unknown origin) using GST-tagged SMAD3 as substrate in presence of [33P] gammaATP by liquid scintillation counter method\"],[\"Inhibition of human MAPK2 assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of human plasmin using H-D-Val-Leu-LyspNA (S-2251) peptide as substrate assessed as reduction of enzyme hydrolytic activity\"],[\"Affinity towards cloned Opioid receptor mu 1\"],[\"Inhibition of BRD4 in human MV4-11 cells assessed as downregulation of c-Myc protein expression after 6 hrs by Western blot method\"],[\"Antagonist activity at estrogen receptor beta in human Ishikawa cells after 72 hrs by alkaline phosphatase assay\"],[\"Inhibition of electric eel AChE preincubated for 15 mins followed by addition of acetylthiocholine iodide substrate by Ellman's method-based spectrophotometric analysis\"],[\"BMPR2(h) Eurofins kinase panel\"],[\"Antagonist activity at C5aR in human neutrophils assessed as inhibition of C5a-stimulated intracellular calcium mobilization at 50 uM by FLIPR assay\"],[\"Agonist activity at human VP16 tagged-VDR-LBD after 16 hrs by luciferase reporter gene based transcription assay relative to 1,25-dihydroxyvitamin D3\"],[\"Binding affinity to recombinant full-length DDK-tagged human c-Myc expressed in HEK293T cells assessed as inhibition of Max\\u002fc-Myc protein-protein interaction incubated for 1 hr by ELISA\"],[\"Inhibition of Escherichia coli dihydrofolate reductase (DHFR) enzyme by Iclaprim\"],[\"Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of PDK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method\"],[\"Effect on STAT5b at Y699 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin\"],[\"Inhibition of human recombinant aldose reductase expressed in Escherichia coli using DL-glyceraldehyde as substrate at 100 uM in presence of NADPH by spectrophotometric analysis\"],[\"Binding affinity to His-tagged BRD4(1) (unknown origin) expressed in Escherichia coli BL21(DE3) at 50 uM by thermal shift assay\"],[\"Antagonist activity towards rat TRPV1 expressed in CHO cells; Not effective\"],[\"Modulation of full length human Nurr1 expressed in HEK293T cells co-transfected with luciferase reporter plasmid harboring NurRE response element assessed as decrease in luciferase activity at 1.55 to 15 uM incubated for 18 hrs by luciferase reporter gene assay\"],[\"Inhibition of His-tagged human brain tau 3R MBD aggregation after 16 hrs by thioflavin T fluorescence method\"],[\"Competitive inhibition of ovine COX2 using arachidonic acid substrate by Ellman's spectrophotometric assay based Lineweaver-Burk double reciprocal plot\"],[\"Inhibition of human DCN4-mediated cullin neddylation assessed as reduction in transfer of fluorescein-5-maleimide-tagged NEDD8 from N-terminally acetylated human UBE2M to CUL2-CTD at 50 uM measured for 1 min by pulse-chase assay\"],[\"Inhibition of human neuropeptide YY2 receptor at 10 uM relative to control\"],[\"Inhibition of ATX in human whole blood\"],[\"Inhibition of N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in 50 nM SOS1-mediated GDP\\u002fGTP nucleotide exchange upon 2 uM N-terminal-GST-tagged H-Ras (1 to 166 residues) at 10 uM by BODIPY-FL-GDP dissociation assay\"],[\"In vitro binding of cysLT1 receptor to guinea pig lung membranes.\"],[\"Inhibition of rat ROMK1 expressed in HEK293 cells after 20 mins by Thallos-AM dye based fluorescence assay\"],[\"Displacement of [125I]AB-MECA from human Adenosine A3 receptor expressed in HEK293 cell membranes at 100 uM\"],[\"Inhibition of recombinant human CHK2 I157T mutant (5 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"ret proto-oncogene  Millipore kinase panel\"],[\"Inhibition of CK1delta (unknown origin) at 10 uM relative to control\"],[\"Agonist activity at CB2 receptor in human U266 cells assessed as decrease in MIF mRNA expression at 50 uM after 2 hrs by qRT-PCR method\"],[\"Non-competitive inhibition of recombinant human GFP-fused ABCG2 expressed in MDCK2 cells up to 100 nM preincubated for 30 mins followed by varying levels of Hoechst 33342 addition measured immediately at 60 sec time interval for 120 mins by Lineweaver-Burk plot analysis\"],[\"Binding affinity to human somatostatin sst2 receptor at 10 uM by radioligand binding assay\"],[\"Inhibition of recombinant human GST-tagged LRRK2 (970 to 2527 residues) expressed in baculovirus expression system by Z'-LYTE assay\"],[\"Antagonist activity at adenosine 2A receptor (unknown origin) in presence of 1 uM adenosine\"],[\"Inhibitory activity against rabbit Coagulation factor X\"],[\"Inhibition of recombinant human prostanoid receptor EP4 expressed in HEK293 cells by radioligand displacement assay relative to control\"],[\"Inhibition of KDM5A in human BT474 cells assessed as increase in H3K4me3 level up to 38 uM after 48 hrs by Hoechst staining based immunocytochemistry\"],[\"Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells\"],[\"Inhibition of TYRO3 (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay\"],[\"Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells at 10'-4 M\"],[\"Inhibition of human carbonic anhydrase 2 at 10'-6 M incubated for 10 mins prior to testing measured for 5 to 10 secs by phenol red-based stopped-flow CO2 hydration assay relative to control\"],[\"Inhibition of caspase-1 (unknown origin) at 10 uM\"],[\"Inhibition of DNA-tagged human PCTK3 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of human IDO1 assessed as unbound compound concentration by human whole blood assay\"],[\"Binding affinity to CXCR5 receptor (unknown origin)\"],[\"Binding affinity to recombinant human PTP1B assessed as on-rate constant, Kon measured by Surface plasmon resonance assay\"],[\"Inhibition of CDK9 in human A2780 cells assessed as reduction in RNAP2 phosphorylation at ser5 residues after 24 hrs by Western blot analysis\"],[\"Inhibition of human MDR1 transfected in multi-drug resistant mouse L5178Y cells at 2 uM incubated for 10 mins by rhodamine 123 accumulation assay relative to verapamil\"],[\"Activity at human TAS2R16 expressed in HEK293\\u002f15 cells assessed as effect on calcium response up to 100 mM by FLIPR assay\"],[\"Inhibition of recombinant human GST-tagged full length SRM expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Induction of STING in human PBMC assessed as increase in IFNbeta secretion\"],[\"Antagonist activity at human glucagon receptor expressed in CHO-K1 GCGR Gs cells assessed as inhibition of glucagon-induced cAMP accumulation pre-incubated for 10 mins before glucagon and forskolin addition and further incubated for 30 mins by luminescence-based assay\"],[\"Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC3R expressed in HEK293 cells\"],[\"Activity at human VIPR expressed in PSC-HEK293 cells incubated for 30 mins by HTRF cAMP assay\"],[\"Reactivation of GB-induced inhibition of AChE in human erythrocyte membranes at 10 to 1000 uM using acetylthiocholine as substrate measured after 2 to 60 mins by Ellman's method\"],[\"Inhibition of recombinant human NEK1 (1 to 505 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Binding affinity to recombinant full-length N-terminal hexahistidine-tagged c-Myc (353 to 437 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS) assessed as changes in COSY spectra in alpha1H region at 500 uM by NMR spectroscopy\"],[\"Inhibition of human recombinant MAO-B assessed as kynuramine oxidation to 4-hydroxyquinoline after 40 mins by LC-MS\\u002fMS analysis\"],[\"Inhibition of human 5HT2A receptor relative to control\"],[\"Inhibition of human PDK1 using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of human CDK1 at 10 uM by kinase inhibition assay\"],[\"Displacement of 5'-FAM-GpYLPQTV-NH2 from His-tagged STAT3-SH2 domain (127 to 722 residues) (unknown origin) assessed as binding rate at 50 uM incubated for 30 mins followed by incubation with fluorescent probe for 1 hr by fluorescence polarization assay\"],[\"Inhibition of HIV1 recombinant protease L10I\\u002fL24I\\u002fL33F\\u002fM46L\\u002f154V\\u002fL63P\\u002fA71V\\u002fV82A\\u002fI84V mutant expressed in Escherichia coli by spectrophotometric assay\"],[\"Inhibition of [125I]MCP-1 binding to Chemokine receptor 2B at 10 uM\"],[\"Antagonist activity at neuropeptide S receptor (unknown origin) assessed as intracellular calcium level by cell based assay\"],[\"Antagonist activity at human TLR4 in LPS-stimulated HEK-Blue hTLR4 cells assessed as inhibition of LPS-induced SEAP production at 0.1 to 2.5 uM incubated for 18 hrs by QUANTI-blue assay\"],[\"Agonist activity at rat delta opioid receptor expressed in rat C6 cells assessed as stimulation of [35S]-GTPgammaS binding at 10 uM after 1 hr by liquid scintillation counting analysis relative to DPDPE\"],[\"In vitro ability to contract isolated guinea pig ileum was used to estimate M2\\u002fM3 agonist effect\"],[\"Inhibition of FAAH in rat brain homogenates using [14C]anandamide as substrate assessed as formation of [14C]ethanolamine after 30 mins by scintillation counting analysis\"],[\"Inhibition of recombinant human full length GST-tagged GRK3 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay\"],[\"Inhibition of mTOR in human MDA-MB-231 cells assessed as reduction in p70S6K(Thr389) protein level at 0.5 to 2 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of MANT-uracil binding to wild-type Magnetospirillum gryphiswaldense CRBN isoform 4 by FRET assay\"],[\"Inhibition Assay: Human recombinant adrenergic β2 receptors expressed in CHO cells are used in modified Tris-HCl buffer pH 7.4. A 50 aliquot is incubated with 0.2 nM [3H]CGP-12177 for 60 minutes at 25° C. Non-specific binding is estimated in the presence of 10 μM ICI-118551. Receptors are filtered and washed, the filters are then counted to determine [3H]CGP-12177 specifically bound. Compounds are screened at 10 μM.\"],[\"Inhibition of BCRP expressed in human HEK293 cells assessed as maximal mitoxantrone accumulation at 20 uM relative control\"],[\"Inhibition of MARK1 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP\"],[\"Inhibition of FGFR2 (unknown origin) after 40 mins by scintillation counting analysis\"],[\"Binding affinity towards human cloned carbonic anhydrase IX\"],[\"Displacement of [3H]DHT from androgen receptor in human MDA-MB-435 cells after 30 mins\"],[\"Binding affinity to recombinant C-terminal His-tagged BTN3A1 intracellular domain (unknown origin) expressed in BL21(DE) assessed as change in enthalpy at 240 uM by isothermal titration calorimetry\"],[\"Intrinsic activity at human mu opioid receptor expressed in CHO cell membrane assessed as increase in [35S]GTPgammaS binding at 10 uM after 1 hr by scintillation counting method\"],[\"Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Displacement of FITC-conjugated JQ1 from wildtype BRD4 BD1 (unknown origin) expressed in Escherichia coli BL21-DE3 rosetta cells incubated for 15 mins by competitive fluorescence polarization assay\"],[\"Inhibition of Clostridium botulinum toxin BoNT\\u002fA light chain by HPLC-based assay\"],[\"Inhibitory activity against cyclic AMP production in human Adenosine A1 receptor assay\"],[\"BMPR2(h) Millipore kinase panel\"],[\"Inhibition of NLRC4 inflammasome activation in LPS-induced human THP-1 cells at 1 uM for 40 mins followed by flagellin stimulation for 6 h by ELISA\"],[\"Inhibition of BRDT BD1 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay\"],[\"Antagonist activity at CXCR2 (unknown origin) assessed as inhibition of chemotaxis at 10 uM\"],[\"Inhibition of PTPN12 (unknown origin) assessed as change in enzyme activity at 150 uM using tyrosine phosphopeptide-2 substrate incubated for 15 mins relative to control\"],[\"Inhibition of DDAH in fibroblasts isolated from idiopathic pulmonary fibrosis patient assessed as downregulation of ITGB3 gene expression at 5 to 50 uM relative to vehicle-treated control\"],[\"Binding affinity to human MARK3 at 500 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Binding affinity to CK2alpha (unknown origin) by ITC analysis\"],[\"Inhibition of HDAC9 in human PBMC cells assessed as increase in histone H3 K9 acetylation incubated for 24 hrs by Western blot analysis\"],[\"Binding affinity for human endothelin B receptor expressed in CHO-K1 cells.\"],[\"Inhibition of PRKACA (unknown origin) at 1 uM by single point assay\"],[\"Inhibition of pig FLAG3-tagged DGKalpha expressed in African green monkey COS7 cells using 1,2-dioleoyl-sn-glycerol as substrate measured after 30 mins by ADP-Glo luminescence assay\"],[\"Inhibition of TERT in human H1299 cells assessed as residual transcriptional activity at 100 uM after 24 hrs by SEAP reporter gene assay\"],[\"Inhibition of TSPO in mouse HT22 cells assessed as protection against amyloid beta (1 to 42)-induced mitochondrial membrane potential loss by measuring recovery of ATP production at 5 uM preincubated for 10 mins followed by amyloid beta (1 to 42) addition measured after 7 hrs by luciferase reporter gene assay relative to control\"],[\"Displacement of [3H]-341495 binding to membranes expressing recombinant human Metabotropic glutamate receptor 3\"],[\"Binding affinity to human PPARgamma receptor at 10 uM by radioligand displacement assay relative to control\"],[\"Mixed-inhibition of recombinant human SIRT2 defatty-acylase activity assessed as substrate Km at 20 uM using varying levels of SFP3 as substrate measured at 1 min interval for 30 mins in presence of NAD+ by Michaelis-Menten plot analysis (Rvb = 0.55 +\\u002f- 0.04 uM)\"],[\"Displacement of biotinylated acetylated peptide from recombinant human partial length BRD3 bromodomain 1 (P24 to E144 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method\"],[\"Binding affinity to full length C-terminal Avi\\u002fHis6-tagged human PCSK9 expressed in Expi293 cells assessed as association rate constant (Kon) by surface plasmon resonance assay\"],[\"Activation of human TLR2 expressed in HEK293 cells at 100 to 300 nM after 4 hrs by luciferase reporter gene assay\"],[\"Inhibition of PTP1B in human insulin resistant HepG2 cells assessed as induction of 2-NBDG uptake incubated with compound for 24 hrs followed by treatment with insulin for 30 mins and later incubated with 2-NBDG for 30 mins by fluorimetric method\"],[\"Inhibition of DGKalpha in OKT3-induced human Jurkat cells harboring SAP ShRNA assessed as restoration of restimulation-induced cell death at 1 uM measured after 24 hrs by trypan blue exclusion method\"],[\"Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay\"],[\"Inhibition of human recombinant KDR\"],[\"Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method\"],[\"Inhibition of N-terminal His tagged human JAK2 (826 to 1132 end residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of 1 mM ATP relative to control\"],[\"Inhibition of MDM2-p53 interaction in human HCT116 p53+\\u002f+ cells assessed as upregulation of p21 expression after 12 hrs by immunoblotting method\"],[\"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay\"],[\"Induction of degradation of cIAP1-BIR3 domain in human MDA-MB-231 cells\"],[\"Inhibition of human CK2A2 assessed as residual activity at 1 uM using RRRDDDSDDD as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of ABL G250E mutant (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of N-terminal GST\\u002fHis6-fused recombinant human FLT3 (R571 to S993 residues) D835Y mutant expressed in Sf9 insect cells using poly (Ala,Glu,Lys,Tyr) 6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP\"],[\"Inhibition of human neutrophil elastase using N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin as substrate at 5 uM after 7 hrs by fluorescence microplate reader analysis\"],[\"Inhibition of AChE (unknown origin) using acetyl thiocholine iodide as substrate at 0.5 mM after 30 mins by Ellman's method\"],[\"Effect on AhR-mediated NAPDH quinine reductase activation in mouse Hepa1c1c12 cells at 20 uM after 18 hrs by Western blot analysis\"],[\"Inhibitory activity against rat brain FAAH by [14C]anandamide hydrolysis\"],[\"Inhibition of IDH1 R132C mutant in patient-derived peripheral blood cells assessed as reduction in intracellular 2-HG level at 0.5 uM after 6 days by cytometric analysis relative to control\"],[\"Inhibition of mouse Rac1 assessed as decrease in B-max for GTP-binding on Rac1 by mant-GTP binding kinetics real-time assay\"],[\"Inhibition of KDM1A in human THP1 cells assessed as increase in CD86 mRNA expression level at 0.5 uM after 24 hrs by qRT-PCR analysis relative to control\"],[\"Binding affinity to recombinant human full-length N-terminal His-tagged CHEK1 expressed in baculovirus expression system using CHKtide as substrate incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of P-gp (unknown origin) assessed as reduction in ATPase activity at 2.08 to 6.25 uM incubated over 20 mins by inorganic phosphate release assay\"],[\"Increase in non-lysosomal activity of glucocerebrosidase N370S mutant in human L444P cells at 75 uM relative to Conduritol B epoxide\"],[\"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding\\u002fcontrol specific binding)x100) obtained in the presence of various concentrations of the test compounds.\"],[\"Inhibition of FITC-GDA binding to dog GRP94 incubated for 2 hrs by fluorescence polarization assay\"],[\"Inhibition of thrombin (unknown origin) by chromogenic substrate assay\"],[\"Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP\"],[\"Inhibition of human recombinant carbonic anhydrase 7 using carbon-dioxide as substrate preincubated for 10 mins prior to substrate addition by stopped flow cytometry\"],[\"Agonist activity at glucocorticoid receptor in rat INS-1 832\\u002f13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as induction of receptor transactivation by luciferase reporter gene assay\"],[\"Inhibition of human 11beta-HSD1 in expressed in HEK293 cells microsomal fractions incubated with NADPH and [3H]-cortisone at 10 uM by scintillation proximity assay\"],[\"Inhibition of AChE (unknown origin) at 100 ug\\u002fml for 15 mins by spectrophotometry\"],[\"Inhibition of human thymidine phosphorylase\"],[\"Displacement of radiolabeled serotonin from human 5HT6 receptor\"],[\"Inhibition of recombinant human EGFR T790M mutant (696 to end residues) using GGMEDIYFEFMGG as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis\"],[\"Inhibition TLR4-mediated NO production in mouse RAW264.7 cells at 300 uM\"],[\"Inhibition of Cryptosporidium parvum calcium-dependent protein kinase 2\"],[\"Binding affinity to wild-type human partial length JAK1 JH1 catalytic domain (V856 to K1154 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Competitive inhibition of mushroom tyrosinase using L-tyrosine as substrate at 1.25 uM by Line-Weaver-Burk plot analysis\"],[\"Activation of procaspase-3 in mouse B16F10 cells assessed as increase in cell death by measuring combination index at 7.5 uM after 24 hrs in presence of 250 nM doxorubucin by alamar blue assay\"],[\"Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control\"],[\"Inhibition of GSK3-beta phosphorylation in human BT474 cells\"],[\"Displacement of [3H]WIN35428 from human DAT receptor expressed in HEK cells by radioligand binding assay\"],[\"Displacement of [3H]R-PIA from human adenosine A1 receptor expressed CHO cells at 10 uM after 60 mins by gamma counting relative to NECA\"],[\"Agonist activity at human S1P5 expressed in bla TANGO U2OS cells assessed as inhibition of cAMP formation preincubated for 4 hrs followed by FRET-based beta-lactamase fluorescent substrate addition measured after 2 hrs\"],[\"Inhibition of RET M918T mutant (unknown origin) at 0.19 uM relative to control\"],[\"Inhibition of Huntingtin protein (unknown origin) incubated for overnight in presence of MW1\\u002fMAB2166 monoclonal antibody by MSD assay\"],[\"Inhibition of SREBP2 activation in human DU145 cells assessed as down-regulation of LDLR gene by quantitative RT-PCR analysis\"],[\"Inhibition of human EphA2 assessed as residual activity at 1 uM relative to control\"],[\"Displacement of [3H]19 from human mGlu2 receptor expressed in CHO cells\"],[\"Inhibition of NLK (unknown origin) at 1 uM relative to control\"],[\"Number of uptake sites for [3H]paroxetine receptor binding after sub-acute dosing against Frontal cortex\"],[\"Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells after 60 mins by liquid scintillation counting\"],[\"Inhibition of Mcl1 (unknown origin) assessed as inhibition of Mcl1-Noxa interaction by TR-FRET assay\"],[\"Inhibition of recombinant human N-terminally GST-His6 tagged ERBB4 (R676 to V1307 residues) C-terminal fragment harboring thrombin cleavage site expressed in Baculovirus infected Sf9 cells assessed as residual activity at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method relative to control\"],[\"Displacement of [3H]DAMGO from human MOR expressed in CHO cell membranes at 1 uM after 60 mins\"],[\"Agonist activity at human TLR2 expressed in HEK-Blue cells harboring NFkB promoter-driven secreted alkaline phosphatase assessed as induction of NFkB after 12 hrs by spectrophotometric assay\"],[\"Percentage aromatase activity before dialysis (control)\"],[\"Inhibition of recombinant HIV1 protease V32I mutant assessed as residual activity at 10 uM by fluorogenic substrate assay\"],[\"Binding affinity to Staphylococcus aureus PBP2a measured after 6 hrs by ELISA in the presence of Ceftizoxime\"],[\"SLK(h) Eurofins kinase panel\"],[\"Inhibition of neuropilin-1 in human DU145 cells assessed as decrease in cell adhesion to extracellular matrix proteins at 10 to 100 uM after 1.5 hrs by calcein-AM dye based fluorescence assay\"],[\"Inhibition of porcine pancreatic lipase preincubated for 10 mins followed by 4-MUO addition and measured at 60 sec interval for 40 mins by multi plate micro plate reader\"],[\"Inhibition of N-terminal 6His-tagged recombinant human insulin receptor (1005 to 1310 residues) expressed in baculovirus infected Sf21 insect cells at 3 uM relative to control\"],[\"Reduction in DNA binding activity of NF-kappaB p65 subunit in human HA22T\\u002fVGH cells after 1.5 hrs relative to control\"],[\"Binding affinity to cathepsin B in human HT-29 cells assessed as intracellular adduct formation at 0.74 MBq incubated for 4 hrs using 177Lu labelled compound by SDS-PAGE analysis\"],[\"Inhibition of human partial length EGFR E746-A750del mutant expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Antagonist activity at CB1 receptor in rat cerebellar homogenates assessed as inhibition of CP-55,940-stimulated [35S]GTPgamma binding\"],[\"Binding affinity to human MCL1 (173 to 329 aa) at 25 uM by differential scanning calorimetry assay\"],[\"Displacement of [3H]cfitalopramfrom human recombinant serotonin transporter expressed in HEK cells after 90 mins by scintillation counting analysis\"],[\"Inhibition of human recombinant MAOB using kynuramine as substrate at 5.94 uM after 60 mins by fluorescence assay\"],[\"Inhibition of human recombinant EGFR by fluorescence polarization assay\"],[\"Inhibition of human TGase2\"],[\"Inhibition of PAK2 (unknown origin) assessed as residual enzyme activity at 10 uM\"],[\"Inhibition of human p38-delta assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of MMP14 (unknown origin) catalytic domain using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay\"],[\"Inhibition of N-terminal truncated Plasmodium falciparum recombinant DHODH assessed as ubiquinone reduction to 2,6-dichloroindophenol at 10 uM by spectrophotometric analysis relative to control\"],[\"Inhibition of recombinant human PDE5A\"],[\"Inhibition of recombinant human HIPK2 I471N mutant (165 to 564 residues) at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Competitive inhibition of Equine serum BChE by Lineweaver-Burke plot\"],[\"Inhibition of human N-terminal His-tagged TEV protease site linked ALK2 Q207D mutant (201 to 499 residues) expressed in baculovirus infected Sf9 insect cells\"],[\"Displacement of [3H]nemonapride from rat dopamine D2 receptor\"],[\"Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 80 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\"],[\"Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP\\u002f10 uM ATP addition measured after 120 mins by radiometric assay\"],[\"Displacement of [3H](+)-pentazocine from guinea pig opioid sigma1 receptor\"],[\"Induction of Nur77-SRC1 interaction in human 293T cells by GST-pull-down assay\"],[\"Antagonist activity at rat GPR4 expressed in HEK cells assessed as inhibition of IBMX-induced cAMP accumulation after 15 mins by HTRF assay\"],[\"Inhibition of ABCB1 (unknown origin) expressed in HEK293T cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring doxorubicin IC50 at 20 uM after 72 hrs by MTT assay (Rvb = 1.17 +\\u002f- 0.09 microM)\"],[\"Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in EBNA gene-positive HEK293 cells after 120 mins\"],[\"Inhibition of BACE1 (unknown origin) expressed in HEK293-APP751swe cells assessed as reduction in amyloid beta (1 to 40) level by sandwich-ELISA method\"],[\"Antagonist activity at PAR2 receptor in human HT-29 cells assessed as inhibition of intracellular calcium release at 50 uM relative to SLIGRLI-NH2\"],[\"Effect on SHC phosphorylation in RET deficient human 8505C cells at 1 to 100 nM measured after 2 hrs by western blot analysis\"],[\"Inhibition of CDK2 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method\"],[\"In vitro inhibitory activity against prostaglandin G\\u002fH synthase 1 from the microsomal fraction of ram seminal vesicles\"],[\"Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells\"],[\"Binding affinity to Staphylococcus aureus FtsZ E185A mutant self-polymerization at 20 ug\\u002fmL by microtiter plate-based light scattering assay\"],[\"Inhibition of Mycobacterium tuberculosis DHFR expressed in Saccharomyces cerevisiae TB5 assessed as yeast growth inhibition after 3 days by radial spoke assay\"],[\"Efficacy at human adrenergic beta 2 receptor transfected in CHO cells assessed as stimulation of adenylyl cyclase at 100 uM relative to isoproterenol\"],[\"Binding affinity to CDK5 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Activity of Streptomyces antibioticus OleD P67T\\u002fS132F\\u002fA242V mutant assessed as conversion rate of compound to produce glucoside 3 using NDP sugar UDP-glucose after 3 hrs by HPLC\"],[\"Inhibition of human HGPRT using Prib-PP as substrate by spectrophotometric assay in presence of guanine\"],[\"Inhibition of human recombinant NEP ectopeptidase activity using Abz-dRGL-(EDDnp) as substrate preincubated for 10 mins with substrate by fluorimetric analysis\"],[\"Inhibition of calcium mobilization in human eosinophils\"],[\"Inhibition of recombinant human N-terminal GST\\u002fHis6-tagged JAK2 (P717 to G1132 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control\"],[\"Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor\"],[\"Inhibition of human PARP1 at 1 uM by scintillation proximity assay\"],[\"Inhibition of IDH1 R132C mutant (unknown origin) expressed in HEK293T cells assessed as reduction in D2-HG level after 30 mins by resazurin-based fluorescence assay\"],[\"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142T mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay\"],[\"Stimulation of [35S]GTP-gamma-S, binding to cloned human 5-hydroxytryptamine 1F receptor expressed in Mouse LM(tk-) cells; NA = Not available\"],[\"Inhibition TRKA (unknown origin)\"],[\"Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization\"],[\"Binding affinity to Src kinase SH2 domain (unknown origin) at 100 uM by STD-NMR spectroscopy\"],[\"Inhibition of MDR1 (unknown origin) expressed in MDCK-MDR1 cells assessed as increase in Rh123 accumulation at 100 uM after 30 mins by spectrofluorometric analysis relative to control\"],[\"Inhibition of ubiquinone binding site of Plasmodium falciparum dihydroorotate dehydrogenase\"],[\"Binding affinity to His6-tagged Mycobacterium tuberculosis Rv1284 expressed in Escherichia coli BL21-AI cells assessed as reduction in melting temperature at 250 uM by SYPRO orange dye based differential scanning fluorimetry\"],[\"Inhibition of MMP13-mediated collagen degradation in bovine nasal septum cartilage assessed as reduction in IL1beta\\u002foncastatin M-stimulated hydroxyproline release at 0.01 uM measured after 2 weeks relative to control\"],[\"Inhibition of full length recombinant human His-tagged PAK5 (295 to 591 residues) expressed in Baculovirus expression system by Z'-Lyte assay\"],[\"Inhibition of human SIK1 assessed as residual activity at 1 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Binding constant against wild-type human aldose reductase at 18.9 uM\"],[\"Reduction in amyloid beta 40 content (unknown origin) expressed in HEK293 cells expressing APP K595N\\u002fM596L Swedish mutant at 20 uM after 24 hrs by ELISA\"],[\"Inhibition of SHP2 in human SF268 cells assessed as downregulation of YAP-mediated ANKRD1 gene expression ay 10 to 20 uM after 2 hrs by qRT-PCR analysis\"],[\"Inhibition of GST P1-1\"],[\"Inhibition of AIM2 inflammasome (unknown origin) activation in bone marrow derived macrophages assessed as inhibition of poly(dA:dT)-induced IL-1beta secretion at 5 uM by ELISA\"],[\"Inhibition of SRPK1 (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Inhibition of PIK3CB in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VFGEDSVGVIFKNGDDLRQDMLTLQMLR probe by mass-spectrometric analysis relative to control\"],[\"Inhibition of PDE10A2 (unknown origin) at 10 uM relative to control\"],[\"Inhibition of human GRK3 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Agonist activity at TLR7 in human plasmacytoid dendritic cells assessed as upregulation of CD80 expression after 16 hrs by efluor 780 dye based flow cytometry\"],[\"Inhibition of human IDO1 at 10 uM pre-incubated for 10 mins before L-Trp as substrate addition and measured after 30 mins by colorimetry\"],[\"Displacement of [3H]N-methyl Scopolamine from human muscarinic M2 receptor expressed in CHO cells by scintillation proximity assay\"],[\"Partial agonist activity at human beta2-AR expressed in CHOK1 cells assessed as CRE-SPAP production after 5 hrs in presence of beta2-AR antagonist ICI118551\"],[\"Inhibition of PTP4A2 (unknown origin) expressed in Escherichia coli assessed as reduction in hydrolysis using DIFMUP as substrate incubated for 30 mins in presence of DTT by Fluorescence based method\"],[\"Binding affinity to angiotensin AT1 receptor in guinea pig adrenal cortex membranes\"],[\"Inhibitory activity against [125I]-rC5a binding to C5a anaphylatoxin chemotactic receptor in human polymorphonuclear leukocyte (PMNL) membranes\"],[\"Inhibition of human CYP1B1 expressed in yeast microsomal membranes at 10 uM using 7-ethoxyresorufin as substrate by fluorescence assay relative to control\"],[\"Inhibition of CSK\"],[\"Ratio of Kcat\\u002fKm against human carbonic anhydrase I\"],[\"NEK7(h) Eurofins Kinase panel\"],[\"Displacement of [125I]BDZ2 from CCK2R TM2 (unknown origin) containing N2.61T chimeric mutant expressed in CHO cells\"],[\"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion at 60 mM incubated for 1 hr prior to stimulation with nigericin for 1 hr by ELISA\"],[\"Inhibition of human histone deacetylase 8 prepared from 293T cells\"],[\"Antagonist activity at human CRTH2 receptor expressed in CHO cell membrane assessed as inhibition of PGD2-induced [35S]GTPgammaS binding at 2 uM after 30 mins by microbeta scintillation counting relative to control\"],[\"Inhibition Assay: Recombinant BACE-1 (extracellular domain, expressed in baculovirus and purified using standard methods) at 0.1 to 10 nM concentrations is incubated with the test compound at various concentrations for 1 hour at room temperature in 10 to 100 mM acetate buffer, pH 4.5, containing 0.1% CHAPS. Synthetic fluorescence-quenched peptide substrate, derived from the sequence of APP and containing a suitable fluorophore-quencher pair, is added to a final concentration of 1 to 5 μM, and the increase in fluorescence is recorded at a suitable excitation\\u002femission wavelength in a microplate spectro-fluorimeter for 5 to 30 minutes in 1-minute intervals.\"],[\"Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay\"],[\"Competitive inhibition of human PTP-MEG2 using p-nitrophenol phosphate as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of human SHH pathway in mouse S12 cells assessed as GLI-mediated transcriptional activity at 3 uM after 48 hrs by luciferase reporter gene assay in presence of 5 mg\\u002fmL human alpha-1-acid glycoprotein\"],[\"Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis\"],[\"Antagonist activity at human M1 receptor expressed in HEK293T cells assessed as inhibition of carbachol-induced response by BRET based beta-arrestin engagement assay\"],[\"Inhibition of full length GST-tagged recombinant human PRKD1 expressed in Baculovirus expression system at 0.1 uM using Fluorescein-CREBtide as substrate incubated for 1 hr by TR-FRET assay relative to control\"],[\"Inhibition of Mycobacterium tuberculosis PtpB\"],[\"Inhibition of human CYP11B1 expressed in hamster V79MZ cells using [1,2-3H]11-deoxycorticosterone as substrate preincubated for 60 mins prior to substrate addition measured after 25 mins by HPLC analysis\"],[\"Inhibition of ABCG2 in human MCF7\\u002fMX cells at 1 uM incubated for 2 hrs in presence of pheophorbide A by confocal laser scanning microscopic method\"],[\"Activation of caspase 3 in human SF188 cells\"],[\"Inhibition of recombinant human N-terminal GST\\u002fHis6-tagged MET (K956 to S1390 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control\"],[\"Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay\"],[\"Inhibition of recombinant ERK2 (unknown origin) by FRET-based Z'-LYTE assay\"],[\"Inhibition of dichloromethotrexate-resistant Lactobacillus casei thymidylate synthase by Dixon plot method\"],[\"Inhibition of recombinant human KDR (790 to end residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of hexahistidine-tagged human recombinant ARTD7 catalytic domain (459 to 656 amino acids) expressed in Escherichia coli BL21(DE3) assessed as inhibition of ADP-ribosyltransferase activity incubated for 15 mins using biotin-NAD+ by chemiluminescence detection based assay\"],[\"Binding affinity to XIAP-BIR3 domain (unknown origin)\"],[\"Inhibition of RIP2 in the presence of 100uM ATP\"],[\"Inhibition of recombinant full length N-terminal GST-tagged human PIM2 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of LRRK2 in human iPSC derived neuronal progenitor cells stably expressing TCF\\u002fLEF luciferase reporter gene assessed as modulation of Wnt\\u002fbeta-catenin signaling pathway by measuring TCF\\u002fLEF dependent beta-catenin mediated transcriptional activity at 1 uM measured after 24 hrs in presence of Wnt3a by Steady-Glo luciferase assay relative to control\"],[\"Agonist activity at human S1P1 in HLE cell membranes incubated for 45 mins by scintillation counting based [35S]GTP-gamma-S binding assay\"],[\"Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay\"],[\"Induction of N-terminal 6x-His-tagged BRAF R506A mutant (unknown origin) dimer formation at 25 uM by sedimentation velocity method\"],[\"Inhibition of c-kit in human GIST48 cells assessed as decrease in AKT phosphorylation at 1000 nM measured after 72 hrs by Western blot analysis\"],[\"Inhibition of human carbonic anhydrase 2 by Lineweaver-Burk curves\"],[\"Displacement of [3H]NAMH from rat histamine H3 receptor expressed in CHO cell membrane\"],[\"In vitro inhibitory activity against Aldose reductase 2 obtained from calf lenses at a concentration of 190 uM\"],[\"Inhibition of human carbonic anhydrase 4 after 15 mins by Lineweaver-Burk plot\"],[\"Activation of butyrophilin 3A1 in human K562 cells assessed as interferon-gamma production pretreated for 15 mins followed by HMBPP-treated Vgamma9Vdelta2 T cells addition and measured after 20 hrs by ELISA\"],[\"Inhibition of recombinant human PAK2 (3 to end residues) assessed as residual activity at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate after 90 mins by fluorescence assay\"],[\"Binding affinity to transthyretin (unknown origin) assessed as free energy changes by ITC method\"],[\"Inhibition of Clostridium botulinum BoNT\\u002fA using SNAP-25 (141-206) as substrate by HPLC analysis\"],[\"Inhibition of Lp-PLA2 in rat plasma at 50 nM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay relative to control\"],[\"Inhibition of equine serum BChE using S-butyrylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition and measured for 5 mins by Ellman's method\"],[\"Inhibition of full length recombinant FLAG-tagged human MAO-B expressed in baculovirus infected sf9 cells at 0.1 uM preincubated for 15 mins followed by luciferin derived substrate addition measured after 60 mins by luciferase reporter gene assay relative to control\"],[\"Inhibition of pig FBPase expressed in Escherichia coli EK1601 by spectrophotometry\"],[\"Binding affinity to wild-type human partial length DCAMKL1 (L270 to A662 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of recombinant human N-terminal His6-tagged Abl (27 to end residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control\"],[\"Effect on mouse ribonucleotide reductase R2 protein measured by tyrosyl radical concentration in anaerobic condition at 3 mM, 298 K after 15 mins\"],[\"Inhibition of human EGFR catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IL29 mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Inhibition of cyclooxygenase 2 in human whole blood assessed as prostaglandin H2 level\"],[\"Inhibition of ZIPK (unknown origin) at 100 nM\"],[\"Inhibition of HIV1 recombinant integrase strand transfer activity at 10 ug\\u002fml using biotin-labeled double-stranded HIV-1 LTR U5 donor DNA substrate incubated for 5 mins after substrate addition for 30 mins by ELISA\"],[\"Inhibition of human CYP17 expressed in Escherichia coli co-transfected with rat NADPH-P450 reductase using progesterone as substrate for 30 mins measured as formation of 17alpha-hydroxyprogesterone and 16alpha-hydroxyprogesterone in presence of NADPH\"],[\"Inhibition of calf thymus TOP1-mediated relaxation of supercoiled pBR322 DNA at 25 uM after 30 mins by agarose gel electrophoresis relative to camptothecin\"],[\"Inhibition of human placental cytosolic 17beta-HSD1 using [3H]-E1\\u002fE1 substrate and NADH after 10 mins by HPLC based radio-detection method\"],[\"Inhibition of Human papillomavirus type18 derived E6 in human HeLa cells assessed as increase in p21 protein expression at 2 to 4 uM after 48 hrs by Western blot analysis\"],[\"Inhibition of human STAT6 expressed in 293-EBNA cells assessed as inhibition of IL4-induced STAT6 transcriptional activation at 10 uM after 1 hr by Photinus pylaris luciferase reporter gene assay\"],[\"Inhibition of Aurora A kinase in human HeLa Kyoto cells assessed as induction of defective chromosome alignment during metaphase incubated for 20 hrs\"],[\"Inhibition of human recombinant GST-tagged AKR1C3 expressed in Escherichia coli BL21 at 100 uM\"],[\"Non competitive inhibition of Electrophorus electricus AChE by Lineweaver-Burke plot analysis\"],[\"Binding affinity to human dopamine D4.4 receptor by radioligand displacement assay\"],[\"Activity at MT1 receptor expressed in NIH3T3 cells assessed as inhibition of forskolin-stimulated cAMP synthesis\"],[\"Inhibition of LDH-B (unknown origin)\"],[\"Displacement of [3H]SNAP-7941 from recombinant human MCHR1 expressed in African green monkey COS7 cell membranes\"],[\"Binding affinity to wild-type human full length AURKC (M1 to S275 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of [3H]rauwolscine binding to Alpha-2C adrenergic receptor\"],[\"Inhibition of DCN1-mediated CUL3 neddylation in human SK-MES-1 cells at 10 uM after 16 hrs by Western blot analysis\"],[\"Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis at 0.1 nM after 2 hrs by microtiter format trans-well migration assay\"],[\"Antagonist activity at alpha1D adrenoreceptor in Rattus norvegicus (rat) aorta assessed as inhibition of phenylephrine-indued contraction\"],[\"Inhibition of wild-type human partial length PLK1 (A33 to F325 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of partial length human BTK expressed in mammalian system at 1 uM\"],[\"Binding affinity to mouse mitochondrial dihydrolipoyl dehydrogenase by chromatographic analysis relative to rosiglitazone\"],[\"Agonist activity at human CCK1R M3.32A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysis\"],[\"Inhibition of recombinant full length human Aurora A at 1 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay\"],[\"Inhibition of AURC in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of human ERG by patch clamp based electrophysiology method\"],[\"Inhibition of amyloid beta (25 to 35 residues) (unknown origin) aggregation at 100 uM incubated for 7 days by atomic force microscopic method\"],[\"Inhibition of aurora B (unknown origin) by HTRF assay\"],[\"Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay\"],[\"Inhibition of HDAC2 in human HeLa-S3 cell lysates assessed as remaining activity at 4.8 x 10'-5 M preincubated for 15 mins followed by HDAC-Glo substrate addition measured after 30 to 40 mins by fluorimetric method relative to control\"],[\"Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay\"],[\"Inhibition of HDAC3 in human 2C4 cells assessed as activation of HIV latency\"],[\"Inhibition of human TERT-regulated Wnt\\u002fbeta-catenin signalling in human MGC803 cells assessed as decrease in cyclin D1 protein expression at 3 mmol\\u002fL after 48 hrs by Western blotting method\"],[\"Inhibition of JNK3 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of [3H]-ATRA binding to Retinoic acid receptor gamma; ND means not detectable (because relative IC50\\u003e1000)\"],[\"Modulation of full length human NOR1 expressed in SK-N-BE(2) cells co-transfected with RXRalpha and luciferase reporter plasmid harboring NurRE response element assessed as increase in luciferase activity incubated for 18 by luciferase reporter gene assay\"],[\"Inhibition of human GSK3-beta at 1 uM relative to control\"],[\"SAPK2b(h) Kinase panel\"],[\"Inhibition of human full length N-terminal GST-tagged PRKX expressed in insect cells using kemptide as substrate at 100 nM by radiometric assay in presence of [32P]ATP\"],[\"Inhibition of full-length recombinant PKCepsilon (unknown origin) using ERMRPRKRQGSVRRRV peptide substrate by coupled-enzyme assay\"],[\"Inhibition of PI3Kalpha (unknown origin) by lipid kinase assay\"],[\"Inhibition of human recombinant eNOS expressed in baculovirus infected Sf9 cells assessed as conversion of [3H]L-arginine to [3H]L-citrulline preincubated for 15 mins measured after 45 mins by liquid scintillation counting\"],[\"In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells\"],[\"KinomeScan assay: inhibition of AURKC\"],[\"Inhibition of [3H]dexamethasone binding to human Glucocorticoid Receptor\"],[\"Displacement of [3H]CPX from human adenosine receptor A1 expressed in CHO-K1 cell membranes incubated for 2 hrs by radioligand competitive binding analysis\"],[\"Agonist activity at human GPR109a expressed in human adipocytes assessed as decrease in intracellular cAMP level by HTRF assay in relative to niacin\"],[\"Induction of proteasome-mediated topoisomerase-1 degradation in human MCF7 cells at 10 uM up to 12 hrs in presence of proteasome inhibitor MG132 by Western blot method\"],[\"Downregulation of VDR expression in human MCF7 cells at 10 uM after 6 hrs in presence of proteasome inhibitor MG132 by Western blot method relative to lamin B\"],[\"Concentration required to inhibit the Mycobacterium avium Dihydrofolate reductase by 50% was determined\"],[\"Inhibition of recombinant human PTP1B preincubated for 10 mins followed by protein addition using pNPP substrate\"],[\"Competitive inhibition of P-gp overexpressed in human MDA435\\u002fLCC6MDR cells assessed as accumulation of doxorubicin by Lineweaver-Burk plot analysis\"],[\"Activation of GAL4 fused human PPARgamma ligand binding domain transfected in african green monkey CV1 cells by CAT reporter assay\"],[\"Inhibition of human CYP21 transfected in HEK293 cells assessed as decrease in conversion of progesterone to 11-deoxycorticosterone at 100 nM preincubated for 5 hrs followed by progesterone addition measured after 20 hrs by ELISA relative to control\"],[\"Displacement of [3H]-NAMH from human histamine H3 receptor expressed in CHO cells\"],[\"Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated with enzyme for 10 mins followed by substrate addition measured for 15 mins by Ellman's method\"],[\"Agonist activity at recombinant human S1P1 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method\"],[\"Inhibition of ICE\"],[\"Inhibition of FGFR2 (unknown origin)\"],[\"Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay\"],[\"Inhibition of human ERG expressed in CHO cells by patch clamp technique\"],[\"Inhibition of Electrophorus electricus AChE using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method\"],[\"Inhibition of human recombinant A3 receptor at 10 uM by radioligand binding assay\"],[\"Inhibition of human recombinant PARP8 at 100 uM incubated for 1 hr using using NAD+, biotinylated NAD+ and activated DNA by luminescence based assay\"],[\"Inhibition of rat liver DHFR by continuous spectrophotometric assay\"],[\"Inhibition of biotinylated consensus sequence binding to NF-kB p65 in human HeLa nuclear extracts after 3 hrs by ELISA\"],[\"Inhibition of DPDPE stimulated [35S]GTP-gamma-S binding to cloned human delta opioid receptor expressed in CHO cells\"],[\"Inhibition of c-KIT 560 to 578 deletion mutant in human GISTT1 cells assessed as reduction in ERK phosphorylation at T202\\u002fY204 residue at 0.1 uM to 3 uM after 1 hr by Western blot analysis\"],[\"Inhibition of SETD7 (unknown origin) at 50 uM using biotin-labeled peptide as substrate and [3H]-SAM measured after 1 hr by scintillation proximity assay\"],[\"Inhibition of human 20S constitutive proteasome beta 5 subunit assessed as inhibition of BMV037 probe labeling at 10 uM incubated for 1 hr by SDS-PAGE analysis\"],[\"Inhibition of recombinant MIF (unknown origin) tautomerase activity using dopachrome methyl ester as substrate measured for 2 to 20 secs by spectrophotometric analysis\"],[\"Inhibition of human RET assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control\"],[\"Activity at human recombinant VDR in ROS 17\\u002f2.8 cells transfected with growth hormone fusion gene VDRE assessed as growth hormone level by transcriptional assay\"],[\"Displacement [3H]-DTG from sigma 2 receptor (unknown origin) expressed in HEK cell membranes\"],[\"Inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using dGTP as substrate measured after 30 mins by malachite green dye based inorganic phosphatase coupled absorbance assay\"],[\"Competitive inhibition of SETD8 (unknown origin) catalytic domain expressed in Escherichia coli using varying levels of biotinylated H4 (1-24) peptide substrate by scintillation proximity assay\"],[\"Pseudo-irreversible inhibition of human erythrocytes AChE assessed as enzyme recovery activity at IC50 using undiluted compound relative to control\"],[\"Inhibition of KDR (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control\"],[\"Inhibition of human ALK5\"],[\"Displacement of radiolabeled estradiol from human estrogen receptor beta by scintillation proximity assay\"],[\"Inhibition of human PRK1 V901I mutant (498 to end residues) at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Non competitive inhibition of human thrombin assessed as substrate Km at 1 uM using varying levels of spectrozyme TH as substrate measured after 10 mins by Michaelis-Menten plot analysis (Rvb = 9.3 +\\u002f- 2.8 uM)\"],[\"Inhibitory effect on human reticulocyte 15-lipoxygenase\"],[\"Inhibition of human recombinant HDAC1 expressed in Sf9 cells incubated for 2 hrs using RHKK-Ac fluorogenic substrate\"],[\"Inhibition of 15-LO1-mediated 15-HPETE formation in human eosinophil using arachidonic acid as substrate assessed as residual activity at 100 uM preincubated for 15 mins before substrate addition measured after 10 mins\"],[\"Induction of ERalpha degradation in human MCF7 cells assessed as ERalpha level at 3 uM measured after 24 hrs in presence of chloroquine by Western blot analysis\"],[\"In vitro affinity for cloned rat metabotropic glutamate 1 receptors stably expressed on CHO cells determined using [3H]-R214127 as radioligand\"],[\"Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).\"],[\"Inhibition of ITK (unknown origin) at 1 uM\"],[\"Agonist activity at FFA2R in mouse mature adipocytes assessed as inhibition of isoproterenol-induced glycerol production\"],[\"Inhibition of human carbonic anhydrase 2 incubated for 15 mins prior to testing by CO2 hydration-based stopped flow assay\"],[\"Inhibition of human PIM1 at 10 uM using KKRNRTLTK as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of DHT-induced androgen receptor nuclear translocation in human LNcaP cells by DAPI staining based assay\"],[\"Antagonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inositol-1-phosphate accumulation at 1 uM after 30 mins by HTRF assay\"],[\"Inhibition of human ERG by GLP study\"],[\"Effect on mu opioid dependent JNK phosphorylation in U50488 treated HEK293 cells expressing GFP tagged mu opioid receptor at 10 uM after 1 hr\"],[\"Inhibition of human RIPK3 at 10 uM using myelin basic protein as substrate in presence of [gamma33P]ATP relative to control\"],[\"Inhibition of TNFalpha\\u002fIL4\\u002fIL1-beta-induced NFkappaB p65 nuclear translocation in human A549 cells at 50 uM after 15 mins by Western blotting analysis\"],[\"Displacement of [3H]-SR-27897 from human CCK1 R336A mutant receptor expressed in COS7 cells after 60 mins by gamma counting\"],[\"Inhibition of human SET7\\u002f9 at 20 uM relative to control\"],[\"Displacement of [3H]DPCPX at human A1 receptor expressed in CHO cell membrane at 1 uM after 120 mins by scintillation counting method\"],[\"Inhibition of human SYK at 0.1 uM relative to control\"],[\"Inhibition of PI3Kbeta in PTEN-deficient human LNCaP C4-2 cells assessed as reduction in AKT phosphorylation at Ser473 residue after 2 hrs by mesoscale assay\"],[\"Inhibition of DGKH in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Efficiency against CCKB\\u002fGastrin receptor for stimulation of gastric acid secretion in lumen-perfused mouse stomach; activity measured as midpoint agonist concentration-effect curve parameter\"],[\"Inhibition of recombinant HGFA (unknown origin) using Boc-QLR-AMC as substrate by chromogenic proteolytic assay\"],[\"Inhibition of human non-phosphorylated ABL1 F317I mutant (S229 to K512 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of human MST3 (1 to 431 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control\"],[\"Binding affinity to human NET S225H mutant expressed in african green monkey COS1 cells\"],[\"IRAK4 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of human CLK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human hERG by automated patch clamp assay\"],[\"Binding affinity for matrix metalloprotease 13\"],[\"Activity at adenosine A3 receptor expressed in HEK293 cells by inhibition of isoprotenol-stimulated cAMP gated channel\"],[\"Agonist activity at human DOR expressed in HN9.10 cell membranes by [35S]GTPgammaS binding assay\"],[\"Inhibitory effect on capsaicin (0.5 uM)-induced calcium uptake in rat DRG neurons upon incubation at RT for 10 minutes; NE = Not effective\"],[\"Displacement of [3H]8-OH-DPAT from recombinant human 5-HT1A receptor expressed in cell membrane after 1.5 hrs by scintillation counting analysis\"],[\"Inhibition of Toxoplasma gondii thymidylate synthase at \\u003e2.3 uM\"],[\"Binding affinity to His-tagged PXR-LBD (unknown origin) expressed in Escherichia coli BL21 Gold at 60 uM by ITC analysis\"],[\"Inhibition of catalytic activity of immunoproteasome 20s subunit beta5\\u002fconstitutive 20s subunit beta5 in human AMO1 cells assessed as accumulation of ubiquitinated-GFP at 3 uM after 1 hr by FACS analysis\"],[\"Activation of wild-type human STING expressed in HEK293T cells assessed as IRF3 reporter activation at 100 uM measured after 20 hrs by luciferase reporter gene assay\"],[\"Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR at 30 uM after 24 hrs by Dual-Glo luciferase reporter gene assay\"],[\"Displacement of [3H]Prazosin from human adrenergic alpha1A receptor at 10 uM\"],[\"Affinity for Adenosine A1 receptor by displacement of [3H]DPCPX from human cerebral cortex\"],[\"Inhibition of human CSF1R using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay\"],[\"Antagonist activity at 20% inactivated human NaV1.7 channel by electrophysiology-based screening assay\"],[\"In vivo efficacy against oxytocin-induced uterine contractions in nonpregnant rats administered iv\"],[\"Inhibition of human BTK assessed as residual activity using poly (Glu,Tyr) as substrate in presence of ATP and Ci(gamma33-P) ATP at 1 uM measured by microplate reader assay\"],[\"Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 10 uM after 60 mins by scintillation counting\"],[\"Inhibitory concentration against human p21 deficient cell (p21+\\u002f+) proliferation\"],[\"Inhibition of cyclin K (unknown origin) at 0.5 uM\"],[\"Displacement of [3H]-LSD from human 5-HT7 receptor by liquid scintillation counting method\"],[\"Inhibition of recombinant full-length human PrKX at 1 uM using RRRLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of PRKAA2 (unknown origin) at 100 nM\"],[\"Inhibition of KIT T670I mutant (unknown origin) at 0.45 uM relative to control\"],[\"Antagonism of retinoic acid receptor beta in ATRA treated CV-1 cells co-expressing CRBP-I-tk-CAT reporter; control assay without compound\"],[\"Binding affinity to Pseudomonas aeruginosa apo-HemO by HXMS method\"],[\"Non-competitive inhibition of Electric eel AChE using ATCI as substrate incubated for 5 mins followed by substrate addition and measured after 5 mins by spectrophotometric based Lineweaver-Burk plot analysis\"],[\"IL-8B (h) (CXCR2) CEREP panel\"],[\"FGFR4(h) Eurofins Kinase panel\"],[\"Inhibition of human dopamine transporter expressed in CHO-K1 cells at 10 uM relative to control\"],[\"Inhibition of His-tagged BRD4 bromodomain 2 (E352 to E168 residues) (unknown origin) after 1 hr by TR-FRET assay\"],[\"Inhibition of hypoxia-induced HIF1alpha transcriptional activity in human Hep3B cells after 24 hrs in hypoxic condition by HRE-dependent dual luciferase reporter gene assay\"],[\"Inhibition of human recombinant 5-LO expressed in Escherichia coli BL21 using arachidonic acid as substrate assessed as residual activity at 10 uM after 10 mins\"],[\"Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay\"],[\"Inhibition of Dihydrofolate reductase of Toxoplasma gondii\"],[\"Antagonist activity at TLR8 in human PBMC assessed as inhibition of CL075-induced CCL2 release after 12 hrs by bead array assay\"],[\"Induction of ERalpha degradation in human MCF7 cells assessed as decrease in ERalpha protein expression at 10 uM incubated for 24 hrs by Western blot analysis\"],[\"Binding affinity to Grb2 SH2 domain (unknown origin) by ELISA\"],[\"Inhibition of PAR-1B-ALPHA (unknown origin) at 1 uM relative to control\"],[\"Displacement of [3H]-ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 10 uM\"],[\"Modulation of human Nav1.7 by automated patch clamp electrophysiology assay\"],[\"Inhibition of human recombinant CA7 after 15 mins by CO2 hydration stopped flow assay\"],[\"IRAK4 Kinase panel\"],[\"Inverse agonist activity at full-length human RORgammat C393S mutant co-transfected with ROR response element by luciferase based reporter gene assay\"],[\"Inhibition of BRD4 in human HT-29 cells assessed as reduction in c-Myc protein expression at 0.3125 uM to 5 uM uM after 24 hrs by Western blotting method\"],[\"Inhibition of ovine COX-1 assessed as using arachidonic acid as substrate preincubated for 5 mins prior to substrate addition measured after 2 hrs by enzyme immunoassay\"],[\"Inhibition of recombinant human MAP4K3 (1 to 291 residues) using RLGRDKYKTLRQI as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis\"],[\"Inhibition of GSK3beta (unknown origin) at 20 uM using FITC-RRRRAAEELDSRAGS(PO4)PQL as substrate after 10 mins by capillary electrophoresis relative to control\"],[\"Antagonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as inhibition of UTP-induced intracellular calcium mobilization by FLUOstar plate reader\"],[\"In vitro inhibitory concentration against human placental cytochrome P450 19 with 2.5 uM testosterone; nd= not determined\"],[\"Competitive binding affinity to wild type Klebsiella pneumoniae 6xHis-tagged metallo-beta-lactamase NDM-1 expressed in Escherichia coli BL21 (DE3)pLysS at 250 uM compound treated for 5 mins post captopril addition followed by further captopril addition by SPR assay\"],[\"Inhibition of Streptomyces R61 DD-carboxypeptidase using Ac2-L-Lys-D-Ala-D-Ala as substrate at 10 to 100 ug\\u002fml\"],[\"Displacement of biotinylated-VEGF-A125 from human NRP1 expressed in human DU145 cells\"],[\"Inhibition of MDM4 in human U87MG cells assessed as increase in PUMA mRNA expression at 100 nM after 24 hrs in presence of MDM2 inhibitor nutlin-3 and alphaVbeta3 inhibitor cilengitide by RT-PCR method\"],[\"Inhibition of COX2 in human whole blood assessed as effect on thrombin-induced TXB2 production\"],[\"Mixed type inhibition of microtubule-stimulated ATPase activity of N-terminal His6-tagged\\u002fSUMO-fused human MPP1 motor domain expressed in Escherichia coli BL21 CodonPlus at 1 to 20 uM in presence of ATP by pyruvate kinase\\u002flactate dehydrogenase-linked assay\"],[\"Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in HEK293 cells\"],[\"Inhibition of JAK2 in human monocytes expressing CD14 assessed as inhibition of GM-CSF-stimulated STAT5a phosphorylation\"],[\"Agonist activity at H2R in spontaneously beating guinea pig right atrium assessed as increase in heart rate in presence of 100 uM H2R antagonist cimetidine\"],[\"Activation of RXRalpha in human SW620 cells assessed as reduction in c-Myc protein expression at 40 to 80 uM incubated for 15 hrs by Western blot analysis\"],[\"Inhibition of activated human tPA using methylsulfonyl-D-cyclohexylalanyl-Gly-Arg-pNA as substrate by spectrophotometry\"],[\"Inhibition of p38alpha (unknown origin) incubated for 1 hr by spectrophotometric analysis\"],[\"Activity at human M1 receptor\"],[\"Displacement of radiolabeled T0901317 from LXRalpha LBD (unknown origin)\"],[\"Inhibition of human PAK6 (2 to 681 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by scintillation counting method relative to control\"],[\"Binding affinity to human partial length EP300 expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of PLA2 (unknown origin) using soybean phosphatidylcholine as substrate preincubated for 30 mins followed incubated for 60 mins after substrate addition by microplate reader relative to control\"],[\"Inhibitory activity against IGF1R at 25 uM\"],[\"Binding affinity to purified Keap1 Kelch domain (unknown origin) by isothermal titration calorimetry\"],[\"Binding affinity to recombinant full length N-terminal GST-tagged human survivin expressed in Escherichia coli BL21 incubated for 1 hr under shaking condition by fluorescence microplate reader assay\"],[\"Time-dependent inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells at 8 uM pretreated with compound up to 30 mins followed by addition of benzylamine as substrate\"],[\"Inhibition of KSR1 activation loop (unknown origin) at 10 uM\"],[\"Agonist activity at PPAR-alpha in human HepG2 cells harboring PPAR-alpha siRNA assessed as reduction in intracellular TG level at 100 uM after 24 hrs by enzymatic method\"],[\"Inhibition of Plasmodium falciparum purine nucleoside phosphorylase assessed as slow onset inhibition constant by xanthine-oxidase coupled assay\"],[\"Inhibition of HIF1alpha in human Hep3B cells at 10 uM preincubated with 26S proteosome inhibitor MG132 followed by compound addition and measured after 12 hrs in hypoxic condition by Western blot analysis\"],[\"Inhibition pf human plasmin using Mes-Darg-Phe-Arg-AMC as substrate by fluorescence assay\"],[\"EPHB6 DiscoveRx kinase panel\"],[\"Inhibition of StrepTag-tagged human SARM1 TIR (561 to 724 residues) expressed in HEK293T cells assessed as reduction in NADase activity at 5 uM in presence of NAD+ incubated for 60 mins by LC-MS\\u002fMS analysis\"],[\"Binding affinity to recombinant human LTA4H hydrolase assessed as change in melting temperature at 10 uM by SYPRO orange dye-based thermofluor assay\"],[\"Inhibition of human partial length BUB1 (Q724 to K1085 residues) expressed in bacterial system assessed as residual activity at 10 uM by kinome scan method relative to control\"],[\"Inhibition of recombinant human full length N-terminal His6-tagged NEK2 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control\"],[\"Binding affinity to Staphylococcus aureus 15N-labelled SrtA deltaN59 mutant at 1:0 and 1:1 molar ratio of protein and compound by 2D 1H-15N HSQC spectra method\"],[\"Inhibition of MMP9 (unknown origin) expressed in Escherichia coli BL21(DE3) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 20 to 30 mins by spectrofluorimetric analysis\"],[\"Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis\"],[\"Antagonist activity at MTL receptor in rabbit duodenum homogenate\"],[\"Inhibition of IKK2\"],[\"Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting\"],[\"In vitro inhibition of Fas-associated phosphatase-1 binding from HFAP-10cDNA subcloned into bluescript vector\"],[\"Inhibition of human group 2A secreted phospholipase A2 by fluorescence assay\"],[\"Reversible inhibition of recombinant human GSK-3beta at 10 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays\"],[\"Inhibition of [2H10]NO 711 binding to mouse GAT1 expressed in HEK293 cell membranes after 40 mins by LC-ESI-MS-MS analysis\"],[\"Displacement of [3H]DAMGO from recombinant human mu opioid receptor expressed in CHO cell membranes after 60 mins by scintillation counting method\"],[\"Displacement of [3]NECA from human adenosine A3 receptor expressed in HeLa cells at 1 uM\"],[\"Inhibition of human 5HT7 receptor\"],[\"Inhibition of GSTM2-2 (unknown origin) using reduced GSH and CDNB as substrate incubated for 10 mins followed by substrate addition by microplate reader analysis\"],[\"Inhibition of 5HT1A receptor (unknown origin)\"],[\"Inhibition of recombinant human GST-tagged CLK3 expressed in baculovirus expression system by lantha screen kinase binding assay\"],[\"KinomeScan assay: inhibition of MERTK\"],[\"Inhibition of histamine H1 receptor (unknown origin) at 1 uM relative to control\"],[\"Inhibition of human cathepsin-B using Cbz-Phe-Arg-AMC as substrate by spectrofluorometer analysis\"],[\"Inhibition of Mycobacterium smegmatis DNA gyrase B ATPase activity at 3.7 uM after 100 mins relative to novobiocin-treated control\"],[\"Inhibition of CDK7 (unknown origin) at 10 uM relative to control\"],[\"Antagonist activity at ERalpha in human MCF7 cells assessed as inhibition of 17beta-estradiol-mediated cell proliferation incubated for 5 days by WST-8 assay\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IFNA17 mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Inhibition of PLK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Inhibition of human ABCC1 expressed in MDCK2 cells at 10 uM after 60 mins by calcein-AM dye based fluorescence assay relative to 30 uM reversan\"],[\"Inhibition of LSD1 in human MGC803 cells assessed as accumulation of H3K4me2 up to 4 uM after 5 days by Western blot method\"],[\"Agonist activity at mouse PPARalpha ligand binding domain expressed in COS-1 cells co-transfected with Gal4 by luciferase reporter gene assay\"],[\"Agonist activity at mouse PPARalpha receptor in monkey COS7 cells assessed as activation of CAT reporter gene at 300 uM by transactivation assay relative to Wy,14-643\"],[\"Displacement of [3H]8-OH-DPAT from 5HT1A receptor in rat cortical membrane\"],[\"Binding affinity to GST-tagged human PPAR-gamma receptor by FRET assay\"],[\"Inhibition of MAP3K2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC\\u002fMS analysis\"],[\"Antagonist activity at human PPARalpha LBD by cell based luciferase reporter gene assay\"],[\"Binding affinity to BRD1 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric assay\"],[\"Antagonist activity at muscarinic acetylcholine receptor in isolated guinea pig ileum.\"],[\"Inhibition of recombinant full length human GST-tagged PTK2 expressed in baculovirus expression system at 500 nM using Tyr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control\"],[\"Inhibition of biotin-dUTP labeled HIV-1 reverse transcriptase after 30 mins colorimetric streptavidin alkaline phosphatase reporter system\"],[\"Binding affinity towards human peroxisome proliferator activated receptor gamma (PPAR alpha) by HTRF assay; Weakly active\"],[\"In vitro binding affinity for human Adenosine A1 receptor expressed in CHO-K1 cells\"],[\"Inhibition of Anthrax lethal factor activity at 55 uM by microplate assay\"],[\"Antagonist activity at GLP2R (unknown origin) at 10 uM by cAMP accumulation based assay relative to control\"],[\"Inhibition of ERBB2 (unknown origin) assessed as residual activity at 1 uM\"],[\"SRMS Invitrogen selectivity data (BI)\"],[\"Inverse agonist activity at RORgammat in human CD4-positive T cells assessed as effect on T cell differentiation to Th17 cells by measuring reduction in IL-17A mRNA expression at 12.5 to 100 nM by qRT-PCR analysis\"],[\"Inhibition of RON (unknown origin) after 40 mins by scintillation counting analysis\"],[\"Activity at human GGPPS\"],[\"KDR Invitrogen selectivity data (BI)\"],[\"Inhibition of FGFR3 (unknown origin) expressed in baculovirus infected insect cells using biotinylated-GGGGQDGKDYIVLPI peptide as substrate incubated for 1 to 4 hrs by TRF assay\"],[\"Inhibition of GRK4 (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Inhibition of VEGF-induced phosphorylation of p70S6 at 10 uM\"],[\"Inhibition of human 5HT7 receptor at 1 uM\"],[\"Displacement of [3H]NMS from rat muscarinic M1 receptor expressed in CHO cells\"],[\"Inhibition of human recombinant VEGFR2 expressed in Sf9 cells after 60 mins\"],[\"Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"A2A\\u002fH Eurofins SafetyScreen44 (BI)\"],[\"Activation of STING pathway harboring WT\\u002fHAQ genotype in human PBMC cells assessed as increase in iFIT3 mRNA expression incubated for 6 hrs by RT-PCR analysis\"],[\"Inhibition of RANKL-induced NFkappaB signaling pathway in mouse RAW264.7 cells assessed as reduction in NFkappaB p65 nuclear translocation at 10 uM preincubated for 4 hrs followed by RANKL stimulation for 10 mins and measured by DAPI staining based immunofluorescence analysis\"],[\"Inhibition of muscarinic M1 receptor (unknown origin) at 10 uM\"],[\"Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration method\"],[\"Inhibition of HIV1 protease dimerization transfected in COS7 cells relative to darunavir\"],[\"Antiviral activity against HIV1 Y181C mutant in MT4 cells by MTT assay\"],[\"Activation of STING pathway harboring WT\\u002fWT genotype in human PBMC cells assessed as increase in iFIT3 mRNA expression by measuring maximum response incubated for 6 hrs by RT-PCR analysis relative to 2',3'-cGAMP\"],[\"Inhibition of PRCP binding to FP-biotin in[12C][14N]-lysine, arginine and [13C6][15N2]-lysine, arginine labeled HEK293T cells at 20 uM after 1 hr by isotopic activity-based protein profiling-MudPIT assay\"],[\"Inhibition of HDAC2 (unknown origin) pre-incubated for 5 mins before fluorogenic substrate Boc-Lys (acetyl)-AMC or Boc-Lys (triflouroacetyl)-AMC addition and measured after 30 mins by fluorescence based assay\"],[\"Inhibition of human plasma lipoprotein-associated phospholipase A2 using 2-thio-PAF as substrate preincubated for 20 mins measured 1 hr post substrate addition by spectrophotometric analysis in presence of 50 uM CoCl2\"],[\"Inhibition of RIPK1 (unknown origin)\"],[\"Inhibition of ALK downstream signalling in human SR cells assessed as reduction in ratio of pALK at 0.1 to 50 nM by Western blot analysis\"],[\"Inhibition of recombinant human 5-HT3A receptor expressed in HEK293 cell membranes using 5-HT as substrate in presence of [3H]GR65630\"],[\"Inhibition of recombinant human His6-tagged BRD2 bromodomain 2 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells\"],[\"Inhibition of human KV4.2 expressed in HEK cells by patch clamp method\"],[\"Inhibition of human EPHA3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate\"],[\"Induction of p53 phosphorylation at Ser15 in human HCT116 p53+\\u002f+ cells at 5 uM after 24 hrs by immunoblotting method\"],[\"HIPK4(h) Kinase panel\"],[\"Inhibition of human CPT1A expressed in Saccharomyces cerevisiae mitochondria assessed as palmitoylcarnitine by HPLC method\"],[\"Agonist activity at human CB1 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation\"],[\"Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay\"],[\"Inhibition of N-terminal GST-tagged full length human BTK (2 to 659 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay\"],[\"Inhibition of of N-terminal (His)6 and Xpress-tagged LTA4H (unknown origin) expressed in Escherichia coli BL21(DE3) cells assessed as reduction in aminopeptidase activity by measuring PGP hydrolysis incubated for 30 mins\"],[\"Activity at human M5 receptor up to 10 uM\"],[\"Inhibition of human eNOS expressed in HEK293 cells assessed as NO production at 100 uM by transient transfection assay relative to BBS-4\"],[\"Inhibition of ovine COX-1 assessed as inhibition of [14C]arachidonic acid to radiolabeled prostaglandins preincubated for 15 mins by TLC-based assay\"],[\"Ratio of Ki for displacement of [3H]CP-55,940 from CB1 receptor in rat brain membranes incubated for 15 mins to Ki for Displacement of [3H]CP-55,940 from CB1 receptor in rat brain membranes incubated for 90 mins\"],[\"Binding affinity to wild-type TTR (unknown origin) assessed as increase in bound resonance at L55 residue at 0.5:1 to 1:1 ratio of compound to protein by 2D TROSY [1H-15N] spectroscopy\"],[\"Displacement of [125I]-CXCL10 from human CXCR3 expressed in HEK293 cells\"],[\"Inhibition of human MINK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Activation of HSF1 in human L132 cells assessed as increase in HSP70 mRNA expression at 3 uM after 12 hrs by RT-PCR analysis\"],[\"Inhibitory activity against dihydrofolate reductase DHFR from Toxoplasma gondii at 32 uM concentration\"],[\"Agonist activity at human RXRalpha expressed in human Caco-2 cells assessed as induction of RXRE-mediated transcriptional activity at 100 nM after 24 hrs by luciferase reporter gene assay\"],[\"Displacement of [3H]dexamethasone from human progesterone receptor; Not determined\"],[\"Inhibition of recombinant human JAK3 (781 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of sEH in spontaneously hypersensitive rat kidney assessed as production of 14,15-dihydroepoxyeicosatrienoic acid at 300 mg\\u002fkg relative to control\"],[\"Inhibition of recombinant human full length C-terminal His6 tagged ZAP70 expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control\"],[\"Transcriptional activation in CV-1 cells expressing retinoic A receptor RAR gamma\"],[\"Inhibition of estrogen binding to GPR30 (unknown origin)\"],[\"Inhibition of KCNQ1 (unknown origin)\"],[\"Inhibition of human full length RSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA\"],[\"Binding affinity to 6-His-tagged-BRD4 (1 to 477 aa) Y97A mutant (unknown origin) by TR-FRET competitive assay\"],[\"Inhibition of human ACAT2 by liquid scintillography\"],[\"Inhibition of NOD1 in human PBMC-derived macrophages assessed as reduction in C12-iE-DAP-stimulated TNFalpha mRNA expression at 1 uM preincubated for 1 hr followed by C12-iE-DAP stimulation for 90 mins by RT-qPCR analysis\"],[\"Inhibition of factor2a (unknown origin) at 100 uM\"],[\"Inhibition of human recombinant AChE-induced Abeta1-40 aggregation at 100 uM by thioflavin T fluorescence method\"],[\"Inhibition of eIF4E\\u002feIF4G interaction in human CRL2813 cells assessed as downregulation of cyclin D1 mRNA expression at 30 uM after 6 hrs by RT-PCR analysis\"],[\"Inhibition of NEK3 (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of human TrkB at 3 uM in presence of 10 uM ATP\"],[\"Inhibition of TBK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled TGDLFAIKVFNNISFLRPVDVQMR probe by mass-spectrometric analysis relative to control\"],[\"Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay\"],[\"Activation of ERAP2 (unknown origin)-mediated Arg-AMC substrate hydrolysis after 60 mins by Rapidfire-MS analysis\"],[\"Effect on HSP90alpha in human U-937 cells assessed as JNK p46 protein level at 10 uM after 48 hrs by Western blot analysis (Rvb = 1.22 No_unit)\"],[\"Inhibition of recombinant human C-terminal His6-tagged p110gamma expressed in insect cells using phosphatidylinositol as substrate in presence of gamma-32P-ATP after 5 mins by thin layer chromatographic method\"],[\"Inhibition of c-Kit (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay\"],[\"Inhibition of LCK long (unknown origin) at 1 uM\"],[\"Inhibition of recombinant PCSK9 (unknown origin) expressed in human HepG2 cells assessed as increase in LDL uptake at 1.25 uM after 16 hrs by fluorescence assay\"],[\"Inhibition of human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production relative to CP-55940\"],[\"Inhibition of wild type human IGF1R by high throughput ATP-[33P] radiolabeled assay\"],[\"Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells at 10 uM\"],[\"Inhibition of recombinant full-length human CLK3 assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of GATA4-DNA interaction in HEK293 nuclear extract at 50 uM after 15 mins by EMSA assay\"],[\"Inhibition of FLT3 ITD mutant in human MV4-11 cells assessed as inhibition of ERK phosphorylation at 0.01 to 0.1 uM incubated for 2 hrs by Western blot analysis\"],[\"Activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation by CRE\\u002fbeta-galactosidase reporter gene assay\"],[\"Inhibition of recombinant PI3K-alpha Q589D mutant (unknown origin) expressed in baculovirus infected Sf21 cells assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 100 uM ATP as substrate measured after 60 mins by luminescence assay\"],[\"Percent stimulation of cofactor association with recombinant liver X receptor-beta at 83 nM\"],[\"Inhibition of human erythrocyte AchE by Ellman's method\"],[\"Activity at human 5-LOX up to 10 uM\"],[\"Inhibition of ABCG2 in topotecan-cultured human MCF7 cells using Hoechst 33342 as substrate measured after 2 hrs by fluorescence assay relative to FTC\"],[\"Percent Inhibition of the ovine Prostaglandin G\\u002fH synthase 1 was determined by thin-layer chromatography assay\"],[\"Inhibition of inducible nitric oxide synthetase in LPS-stimulated mouse ANA1 macrophages\"],[\"Inhibition of recombinant human TEC (174 to end residues) using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of human N-terminal GST fusion tagged FGFR3 cytoplasmic domain (460 to 802 end residues) expressed in baculovirus infected Sf21 insect cells\"],[\"Displacement of [125I]hCGRP from human CGRP receptor expressed in HEK293 cells coexpressing RAMP1\"],[\"Enzyme Inhibition Assay: Compounds were tested for their ability to inhibit carbonic anhydrase isozymes II and IX in vito.\"],[\"Binding affinity to human recombinant HGF-stimulated Grb2-SH3 in human SK-LMS1 cells assessed as presence of associated protein Sos1 at 3 uM by immunoblot analysis\"],[\"Inhibition of Erk2\"],[\"Binding affinity to wild-type human partial length DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant IDE expressed in Escherichia coli BL21 (DE3) cells using ATTO 655- Cys-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Trp as substrate at 50 uM preincubated for 10 mins followed by substrate addition and measured after 30 mins by spectrophotometric analysis relative to control\"],[\"Inhibition of kappa opioid receptor (unknown origin) assessed as effect on ERK1 phosphorylation relative to control\"],[\"Inhibition of ovine COX1 using arachidonic acid as substrate assessed as production of PGF2alpha at 30 uM preincubated for 10 mins followed by substrate addition measured after 2 mins by EIA in presence of stannous chloride relative to control\"],[\"Displacement of [3H]vesamicol from human VAChT expressed in rat PC12 cells after 24 hrs by liquid scintillation counting\"],[\"Induction of STAT3 degradation in human MOLM-16 cells for 4 hrs by western blot analysis\"],[\"Inhibition of GST-tagged human LCK at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay\"],[\"GABAB (1b) (h) CEREP ligand profiling\"],[\"Inhibition of human adenosine A1 receptor at 3 uM by radioligand binding assay\"],[\"Agonist activity at mouse melanocortin-5 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay\"],[\"Binding affinity to wild type recombinant human N-terminal 6His-tagged peroxiredoxin-2 expressed in Escherichia coli BL21 after 1 hr by LC-MS\\u002fMS analysis\"],[\"Inhibition of mouse SphK2\"],[\"Inhibition of human recombinant full length His-tagged PRKCI expressed in baculovirus expression system\"],[\"Inhibition of PTPgamma (unknown origin) expressed in Escherichia coli using pNPP substrate after 5 mins by spectrophotometric analysis\"],[\"Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as beta-arrestin2 recruitment by enzyme fragment complementation method\"],[\"Activity at mineralocorticoid receptor (unknown origin)\"],[\"Inhibition of recombinant full length human CaMKIgamma assessed as residual activity at 1 uM using KKLRRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of L3MBTL3 (unknown origin) after 30 mins by AlphaScreen assay\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 0.312 uM incubated for 16 to 18 hrs in presence of 0.0097 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Antagonist activity at NK2 receptor in guinea pig trachea as inhibition of [beta-Ala8]NKA(4-10)-induced bronchoconstriction relative to control\"],[\"Inhibition of PDGFR-beta (unknown origin) at 1000 nM relative to control\"],[\"Displacement of [3H]-(S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHOK1 cells by radioligand binding assay\"],[\"Inhibition of STAT1 in human MDA-MB-231 cells assessed as reduction in STAT1 phosphorylation at Y701 site at 2.5 to 10 uM after 12 hrs by immunoblot analysis\"],[\"Inhibition of recombinant human VEGFR2 using Ulight-CAGAGAIETDKEYYTVKD as substrate after 60 mins\"],[\"Inhibition of N-terminal GST-His 6 tagged full length human IKK-beta (M1-F365) expressed in Sf9 insect cells using Poly(Glu,Tyr)4:1 as substrate at 1 uM by Filter binding assay relative to control\"],[\"Inhibition of full length human recombinant C-terminal GST-tagged HDAC2 (1 to 488 residues) expressed in insect cells using RHK-K(Ac)-AMC as substrate incubated for 60 mins by fluorescence assay\"],[\"Inhibition of human NaV1.5 at -140 mV holding potential by whole-cell patch clamp assay\"],[\"Agonist activity at human muscarinic M1 receptor expressed in CHO cells\"],[\"Antagonist activity at alpha2-adrenergic receptor in prefrontal cortex of human brain assessed as increase in UK14304 EC50 for [35S]GTPgammaS binding after 120 mins by liquid scintillation spectrometric analysis\"],[\"Inhibition of N-terminal His-tagged human recombinant p300 catalytic domain (1284-1673 residues) using histone H4-8 peptide and [14C]acetyl CoA as substrate pretreated with enzyme and H4-8 peptide for 10 mins followed by [14C]acetyl CoA addition for 5 to 10 mins by phosphor-imaging analysis\"],[\"Negative allosteric modulation of rat mGlu3 receptor transfected in human TREX cells assessed as non-competitive decrease in glutamate EC80\"],[\"Inhibition of PIM2 (unknown origin) using 5FAM-ARKRRRHPSGPPTA as substrate after 90 mins in presence of ATP by caliper microfluidic mobility shift assay\"],[\"Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of recombinant human MKK6 (4 to end residues) at 1 uM using inactive SAPK2a as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of topoisomerase-2 alpha catalytic activity in human T47D cells assessed as appearance of free protein band at 50 uM measured after 2 hrs by Western blot analysis\"],[\"Inhibition of recombinant human N-terminal GST\\u002fHis6-tagged c-KIT (544 to 976 residues) expressed in baculovirus infected sf9 cells using biotinylated peptide substrate GGLFDDPSYVNVQNL in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay\"],[\"Displacement of [3H]CCPA from adenosine A1 receptor in rat brain cortical membrane after 90 mins by scintillation counting\"],[\"Compound ability to inhibit the production of HIV reverse transcriptase (RT) in culture supernatant of monocytic U937 on at 11 days at a concentration 25 uM\"],[\"Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay\"],[\"Inhibition of recombinant human GST-tagged cytoplasmic MUSK (519 to 869 residues) expressed in baculovirus expression system at 1 uM relative to control\"],[\"Agonist activity at human muscarinic M5 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay\"],[\"Inhibition of human MAO-B expressed in baculovirus infected BTI insect cells preincubated at 100 uM for 15 mins\"],[\"Average Binding Constant for PDGFRB; NA=Not Active at 10 uM\"],[\"Agonist activity at rat BRS-3 expressed in HEK293AEQ cells assessed as induction of intracellular calcium mobilization by aequorin bioluminescence assay\"],[\"Inhibition of mushroom tyrosinase using L-tyrosine as substrate assessed as amount of dopachrome produced at 0.1 uM after 30 mins by spectrophotometry\"],[\"Binding affinity to full length human N-terminal His6-tagged LDH-H expressed in Escherichia coli Rosetta (DE3) assessed as melting temperature heated up to 95 degree C for 3 mins by nano differential scanning fluorimetry analysis\"],[\"Inhibition of human HDAC7 using (Boc-Lys(trifluoroacetyl)-AMC) as substrate measured after 2 hrs by Cheng-Prusoff analysis\"],[\"Inhibition of human MEK2 (M1 to V400 residues) expressed in mammalian expression system at 1 uM by KINOMEscan assay relative to control\"],[\"Inhibition of human MST1 using [KKSRGDYMTMQIG] as substrate\"],[\"Inhibition of full length active AKT2 (1 to 481 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate\\u002fPDK1\\u002fMAPKAPK2\\u002fDOPS\\u002fDOPC\\u002fPtdIns(3,4,5)P3 addition measured after 30 mins by Alphascreen assay\"],[\"Inhibition of BMP4 in mouse C2C12BRA cells after 14 hrs by luciferase reporter gene assay\"],[\"Ratio of IC50 in presence of 100 uM Dihydrofolate reductase\"],[\"Reduction of AP1 binding to cyclin D promoter in human LNCaP cells by electrophoretic mobility shift assay\"],[\"Competitive inhibition of recombinant human MAOB expressed in Pichia pastoris using benzylamine as substrate by spectrophotometric method\"],[\"Competitive fluorescence polarization binding assay (FKBP3)\"],[\"Inhibition of human PARP-1 catalytic domain (662 to 1011 residues) expressed in Escherichia coli BL21(DE3) cells pre-incubated for 30 mins before addition of activated DNA and NAD by fluorescence based assay\"],[\"Inhibition of human full length PIM1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human TAOK1 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Binding affinity to rat 5HT3A receptor\"],[\"Inhibitory concentration against HCMV protease.\"],[\"Inhibition of HDAC2 (unknown origin) using Ac-Leu-GlyLys(Ac)-AMC as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence assay\"],[\"Inhibition of human CHK2 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human EGFR assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay\"],[\"Inhibition of Homo sapiens (human) HDAC8\"],[\"Displacement of PRO-128 from recombinant human N-terminal GST\\u002fHis6-tagged FGFR4 (391 to 802 residues) expressed in baculovirus infected Sf9 insect cells assessed as dissociation constant\"],[\"Binding affinity to MLKL N-terminal executioner domain (2 to 154 residues)(unknown origin) assessed as dissociation constant in presence of Nonyl-maltoside by TROSY-HSQC NMR titration analysis\"],[\"Inhibition of human BLK preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method\"],[\"Inhibition of C-Raf (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay\"],[\"Inhibition of human PKAcb assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human OATP1B1 expressed in HEK293 cells n presence of rosuvastatin\"],[\"Binding affinity for GST-tagged human BCL2A1 expressed in Escherichia coli BL21 cells\"],[\"Agonist activity at human LXR-beta transfected in HEK293 cells after 16 hrs by luciferase reporter gene assay\"],[\"Agonist activity at human TLR8 expressed in HEK293 cells assessed as induction of NFKappaB activity after 24 hrs by SEAP reporter gene assay\"],[\"Inhibition of amyloid beta (unknown origin) self aggregation assessed as maximum peak height at 10 uM after 10 days by atomic force microscopy\"],[\"Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay\"],[\"Reversible inhibition of electric eel AChE assessed as recovery of enzyme activity at 0.1 times IC50 using acetylcholine as substrate relative to control\"],[\"DNA-PK Invitrogen Lab (UK) kinase screen (BI)\"],[\"Activity at human A2B receptor expressed in HEK293 cells assessed as inhibition of NECA-induced intracellular cAMP levels by ELISA\"],[\"Agonist activity at ERRalpha in mouse C2C12 cells assessed as increase in fatty acid uptake using [14C]-oleic acid pretreated for 24 hrs by liquid scintillation counting\"],[\"Aldosterone (5 ug\\u002fkg) antagonist and agonist activity for urinary Na\\u002fk at 0 ug\\u002fkg\"],[\"Inhibition of SIRT2 in human U373 cells assessed as increase of alpha-tubulin acetylation at 2.5 uM after 8 hrs by Western blotting method relative to control\"],[\"Inhibition of human recombinant HDAC1 expressed using baculovirus expression system using Flour- De-Lys as substrate after 3 hrs by fluorescence analysis\"],[\"Inhibition of LPS-induced IkB-alpha degradation in human BV2 cells at 0.1 uM by Western blotting analysis\"],[\"Inhibition of human MDR1-mediated rhodamine efflux in mouse L5178 cells assessed as fluorescence activity ratio at 40 ug\\u002fmL by flow cytometry relative to untreated control\"],[\"Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins\"],[\"Inhibition of human ERG channel expressed in CHO cells at 1.1 uM by patch clamp method\"],[\"Inhibition of SERT in rat brain membrane at 10 uM\"],[\"Displacement of [125I]endothelin-1 from recombinant human ETA receptor at 10 uM after 120 mins by radiometric scintillation analysis relative to control\"],[\"Inhibition of recombinant HDAC1 (unknown origin) incubated for 10 mins using Boc-Lys(acetyl)-AMC fluorogenic substrate by homogeneous fluorescence release assay\"],[\"Agonist activity at GDH-tagged human TRPA1 receptor expressed in HEK293F cells assessed as increase in intracellular Ca2+ concentration by FLIPR assay\"],[\"Inhibition of GST-tagged recombinant human full length VPS34 expressed in baculovirus upto 20 uM preincubated for 15 mins followed by addition of cold ATP\\u002fgamma32P-ATP measured after 1 hr in presence of MnCl2\"],[\"Inhibition of human AXL\"],[\"Non-competitive inhibition of rat intestinal maltase using maltose as substrate assessed as dissociation of enzyme-substrate-inhibitor complex at 0.1 to 1 mg\\u002fml by secondary plot analysis\"],[\"Binding affinity to human C-terminal His6-tagged\\u002fN-terminal T7 gene leader sequence-tagged LTA4H assessed as change in melting temperature at 1 mM by circular dichroism spectroscopic analysis\"],[\"Inhibition of HSP90-mediated antiapoptotic activity in human MRC5 cells assessed as increase in caspase-3 activity at 10 uM after 96 hrs by fluorescence assay\"],[\"Activation of PPARdelta in mouse C2C12 cells assessed as induction of ANGPTL4 mRNA expression at 10 uM after 24 hrs in presence of GW501516 by quantitative RT-PCR analysis\"],[\"Antagonist activity at human dopamine D3 receptor expressed in CHO cells assessed as inhibition of quinperol-induced [35S]GTPgamma binding by scintillation proximity affinity assay\"],[\"Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis\"],[\"Inhibition of human PRK2 (501 to end residues) at 10 uM using AKRRRLSSLRA as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of human partial length BRD2 BD1 (K71 to N194 residues) expressed in bacterial expression system assessed as residual activity at 500 nM relative to control by BROMOscan assay\"],[\"Inhibition of PAK4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Inhibition of human MAO-A by enzyme assay\"],[\"Inhibition of human carbonic anhydrase-7 preincubated for 15 mins by stopped flow CO2 dehydration assay\"],[\"Inhibition of Epb41l1in mouse C2C12 cells assessed as reduction in phospho-sites occupancy at 4 uM after 5 hrs by SILAC based LC-MS\\u002fMS analysis relative to control\"],[\"Agonist activity at human GPR40 expressed in HEK293 cells assessed as receptor activation in presence of FFA1 agonist TUG-499 by dynamic mass redistribution assay\"],[\"Inhibition of human aurora A kinase using LRRASLG as substrate by scintillation counting in presence of [gamma-33P]ATP\"],[\"Inhibition of USP8 in HEK293T cell lysates at 25 uM using HA-tagged vinyl-sulfone as substrate measured after 2 to 30 mins by Western blot analysis\"],[\"Inhibition of human carbonic anhydrase 2 pre-incubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Displacement of (S)-N-((S)-1-((S)-3-amino-1-((S)-3-cyclopentyl-1-((S)-2-((S)-1-(dimethylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-1-oxopropan-2-ylamino)-3-methyl-1-oxobutan-2-yl)-1-((S)-4-methyl-2-(6-(5-((3aR,4S,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)pentanoyl)pyrrolidine-2-carboxamide from Myc-tagged AF9 CxxC domain (unknown origin) expressed in HEK293T cells at 100 nM measured after overnight incubation by pull down assay relative to control\"],[\"Inhibition of ERK2 (unknown origin) using 5FAM-IPTSPITTTYFFFKKK as substrate after 1 hr by LC3K assay\"],[\"Inhibition of Caspase 10 (unknown origin) at 10 uM\"],[\"Binding affinity to H12 region of zebrafish VDR LBD assessed as stabilization of structural elements at 10 fold excess compound concentration in presence of SRC1 NR2 coactivator peptide by HDX-MS analysis\"],[\"Inhibition of p38alpha (unknown origin)\"],[\"Inhibition of rat cortex homogenate acetylcholinesterase by spectrophotometric method\"],[\"Displacement of SAENTA-fluorescein from human ENT1 in HL60 cells by flow cytometry\"],[\"15LO Eurofins-Panlabs selectivity data (BI)\"],[\"Irreversible inhibitory activity against human leukocyte elastase\"],[\"Inhibition of recombinant HDAC2 (unknown origin) at 2 uM incubated for 15 mins before substrate addition and measured after 30 to 45 mins by HDAC-Glo substrate\"],[\"Activation of human CaSR\"],[\"Inhibition of recombinant RET (unknown origin) at 1 uM by off-chip mobility shift assay\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate incubated for 6 mins prior to substrate addition measured after 60 to 180 secs by Ellman method\"],[\"Inhibition of human CA9 by CO2 hydration activity based stopped flow assay\"],[\"Inhibition of PAK4 kinase domain (unknown origin)\"],[\"Inhibition of wild-type human partial length SLK (S14 to A307 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of human SIRT1 assessed as deacetylation activity using acetylated lysine as substrate measured after 1 hr in presence of NAD+ by by Fluor de Lys assay\"],[\"Binding affinity to COX2 (unknown origin)\"],[\"Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells coexpressing phospholipase C-activating G protein assessed as inositol phosphate production by scintillation proximity assay relative to UTP\"],[\"Inhibition of bovine erythrocyte acetylcholinesterase using acetylthiocholine as substrate incubated for 15 mins by Ellman's method\"],[\"Increase in ERRgamma mediated transcriptional activity in primary mouse embryonic fibroblasts assessed as increase in ERRalpha mRNA levels by quantitative real time PCR assay\"],[\"Inhibition of dopamine transporter (unknown origin) expressed in cells incubated for 60 mins by amine transporter assay\"],[\"Displacement of [3H]PK11195 from rat cerebral cortex peripheral benzodiazepine receptor (type 2)\"],[\"Inhibition of C-24 reductase in Dhcr7-deficient mouse Neuro2a cells assessed as increase in zymosterol levels at 1 uM by LC-MS\\u002fGC-MS analysis\"],[\"Inhibition of TDP1 in human MCF7 cells assessed as potentiation of camptothecin-induced cytotoxicity at 1.25 to 5 uM after 96 hrs by MTT assay\"],[\"Binding affinity to recombinant 6xHis-tagged JHDM1A (unknown origin) expressed in Escherichia coli BL21 under anaerobic conditions by fluorescence polarization assay in presence of Fe2+\"],[\"Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of SMS2 in human HuH7 cells assessed as down regulation of apoB secretion incubated for 17 hrs followed by further incubation for 2 hrs in presence of [35S]-methionine\"],[\"Binding affinity to Vitamin D3 receptor relative to 1,25D3\"],[\"Inhibition of Akt phosphorylation in human HBL cells at 1 to 10 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of rat NMDA NR2A receptor expressed in xenopus oocytes coexpressing NMDA NR13b assessed as effect on glycine-induced current response at -70 mV by voltage clamp method\"],[\"Inhibition of human CES2 at 10 uM\"],[\"Inhibition of IDO1 in IFNgamma-stimulated human OCI-AML2 cells assessed as reduction in kynurenine production\"],[\"Inhibition of radiolabeled somatostatin-14 binding to human recombinant SSTR5\"],[\"Inhibition of human STC1 in cell based assay\"],[\"Inhibition of CHK1 in human HT-29 cells assessed as increase in phosphorylation at S296 residue at 1.1 uM incubated for 12 hrs by Western blot analysis\"],[\"Binding affinity to JAK2 JH1 domain (unknown origin) assessed as increase in melting temperature by fluorescence based thermal shift assay\"],[\"Binding affinity to human dopamine D2 long receptor\"],[\"Inhibition of cross-linking of human Pgp TM6 F343R\\u002fTM6 L339C\\u002fTM7 F728C mutant expressed in HEK293 cells assessed as drug level causing 50% inhibition of cross linking by immunoblot\"],[\"Inhibition of DNA-tagged human PCTK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Deactivation of human BchE F329A mutant assessed as residual enzyme activity at 2.1 uM after 15 mins\"],[\"Reversal of inhibition of PBCV1 Thy X at 20 uM in presence of dUMP\"],[\"Inhibition of human SOAT2-mediated [14C]Cholesterol ester synthesis in CHO cells after 6 hrs in presence of [14C]Oleic acid by TLC analysis\"],[\"Inhibition of CDK4-mediated Rb phosphorylation at ser 795 in human HCT116 cells at IC90 after 4 hrs by immunoblot analysis\"],[\"Modulation of 12-LO-mediated 14-HDHA level in human M2 macrophages derived from IL4-polarized human monocyte derived macrophages at 3 uM preincubated for 15 mins followed by Escherichia coli (O6:K2:H1) challenge for 90 mins by LC-MS\\u002fMS analysis\"],[\"Agonist activity at human cloned CB2 receptor assessed as stimulation of [35S]GTPgammaS binding at 10 uM relative to basal [35S]GTPgammaS binding\"],[\"Inhibition of RIPK2 in rat whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs\"],[\"Inhibition of human IGF-1R\"],[\"Inhibition of Trypanosoma cruzi glycosomal GAPDH\"],[\"Inhibition of HIV1 wild type p66\\u002fp51 reverse transcriptase\"],[\"Inhibition of rat FAAH preincubated for 60 mins\"],[\"Inhibition of human BRPF3 (E588 to G701 residues) expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Binding affinity to recombinant human PDE5A1 catalytic domain (535 to 860 residues) expressed in Escherichia coli BL21 DE3 Rosetta2 pLysS cells assessed as change in gibbs free energy at 200 to 250 uM by by isothermal titration calorimetry\"],[\"Inhibitory activity against bovine liver Dihydrofolate reductase at pH 7.2.\"],[\"Relative binding affinity for human sex hormone-binding globulin (SHBG) compared to testosterone \"],[\"Inhibition of beta-crystallin B2 V187E mutant (unknown origin)-induced intracellular protein aggregation expressed in human HeLa cells at 4 uM incubated for 6 to 8 hrs by fluorescence microscopy relative to untreated control\"],[\"Non-competitive inhibition of electric eel AChE by Lineweaver-Burk plot analysis\"],[\"Displacement of [26,27-methyl-3H]1alpha,25-dihydroxyvitamin D3 from chick intestinal VDR after 1 hr by liquid scintillation counting\"],[\"Inhibitory concentration against herpes simplex virus type 2 thymidine kinase\"],[\"Inhibition of human PKD2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of human PKAcg assessed as residual activity using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Partial agonist activity at human beta1-AR expressed in CHOK1 cells assessed as CRE-SPAP production after 5 hrs in presence of beta1-AR antagonist CGP20712A\"],[\"Binding affinity to wild-type human partial length SgK110 (L22 to R329 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of GSK3beta (unknown origin) at 1 uM by single point assay\"],[\"Displacement of 5 nM [3H-pyrilamine from human H1R expressed in Sf9 cell membranes co-expressing RGS4 by competition binding assay\"],[\"Competitive binding affinity to EGFR L858R\\u002fT790M mutant in human H1975 cells assessed as fluorescent band formation at 5 uM pretreated with compound followed by subsequent addition of copper-catalyzed azide-alkyne cyclo with rhodamine azide measured after 1 hr in presence of osimertinib by in-gel fluorescence assay\"],[\"Binding constant for TGFBR1 kinase domain\"],[\"Inhibition of human GMP synthase\"],[\"Ratio of Kinact to Ki for human recombinant caspase 3\"],[\"Binding affinity to human BRAF at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay\"],[\"Displacement of [3H]U69593 from KOR (unknown origin) expressed in HEK cells\"],[\"Inhibition of human recombinant renin using fluorogenic substrate by microplate spectrofluorimeter\"],[\"Inhibition of HIV-1 Reverse Transcriptase in an in vitro enzyme assay\"],[\"Inhibition of human partial length FLT3 ITD mutant expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]CP55940 from rat brain membrane CB1 assessed as reduction in maximum binding capacity at 4 nM incubated for 1 hr followed by compound washout and measured after 60 to 180 mins by TopCount scintillation counting method\"],[\"Inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate expressed in human KG1A cells assessed as free 7-amino-4-methylcoumarin release preincubated for 22 hrs followed by substrate addition by fluorescent spectrophotometric analysis\"],[\"Inhibition of HDAC1 in human MDA-MB-231 cells assessed as accumulation of acetylated H4 at 1.5 uM by western blot analysis\"],[\"Noncompetitive inhibition of human GLS1 expressed in Escherichia coli strain BL21 (DE3) assessed as decrease in Vmax using varying concentrations of glutamine as substrate by Michaelis-Menten plot analysis\"],[\"Displacement of radioligand from human adenosine A2A receptor at 1000 nM relative to control\"],[\"Inhibition of G9a (685 to 1000) (unknown origin) expressed in Escherichia coli BL21 assessed as reduction of H3K9me2 level by DELFIA assay\"],[\"Binding affinity to human [U-15N]CXCL12 L36C\\u002fA65C dimer mutant expressed in Escherichia coli assessed as induction of chemical shift perturbations at Y61 residues by 2D 1H-15N SOFAST HMQC NMR spectroscopy\"],[\"Inhibition of human full-length ABL expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of DNA2 in human U2OS cells assessed as reduction in homologous recombination pathways by I-Scel\\u002fGFP-based reporter gene assay\"],[\"Induction of human NQO1 activity in mutant mouse BPrc1 cells assessed as concentration require for 2 fold induction after 48 hrs\"],[\"Inhibition of recombinant human full-length N-terminal GST-tagged HDAC5 expressed in baculovirus infected Sf9 insect cells using AcLeu-Gly-Lys(Tfa)-AMC as substrate measured after 30 mins by fluorescence assay\"],[\"Inhibition of human IKKalpha using KKKKERLLDDRHDSGLDSMKDEE as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of recombinant human AChE\"],[\"Inhibition of human MPO assessed as reduction in enzyme-mediated chlorination by measuring reduction in HOCl formation in presence of H2O2\\u002fNaCl measured at 30 secs time interval for 5 mins by APF dye based fluorescence assay\"],[\"Binding affinity to human Bcl-XL by surface plasma resonance based biosensor system\"],[\"Antagonist activity at D3 receptor (unknown origin)\"],[\"Inhibition of Mycobacterium tuberculosis recombinant beta-carbonic anhydrase Rv1284 preincubated for 15 mins by stopped-flow CO2 hydrase assay\"],[\"Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in buculovirus system at 10 uM by liquid scintillation counting\"],[\"Inhibition of CDK2 in human MDA-MB-468 cells assessed as decrease in caspase 3 expression level at 15 uM measured up to 36 hrs by Western blot analysis\"],[\"Binding affinity to cerebellum myelin in central nervous system of mouse at 100 uM after 20 mins by fluorescent microscopy\"],[\"Time dependent inhibition of CYP2A6 in human microsomes assessed as reduction in enzyme-mediated coumarin 7-hydroxylation at 10 times IC50 in presence of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and NADPH-generating system by fluorometry\"],[\"Inhibition of human recombinant MMP-2 using Mca-ProLeuGlyLeuDpaAlaArg-NH2 as substrate after 45 mins by fluorescence plate reader analysis\"],[\"Binding affinity to serotonin 5-HT3 receptor (unknown origin)\"],[\"Inhibition of IKKbeta (unknown origin) by TR-FRET assay\"],[\"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis\"],[\"Inhibition of Actinomadura sp. R39 penicillin-binding protein at 0.5 mM preincubated for 60 mins before addition of substrate mixture of (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid and 5,5'-dithiobis(2-nitrobenzoic acid)\"],[\"Displacement of [3H]SCH23390 from human dopamine D5 receptor expressed in HEK293T cell membranes by radioligand binding assay\"],[\"Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 7\"],[\"Binding affinity for human placental microsome Cytochrome P450 19A1 by nonlinear regression analysis\"],[\"Inhibition of Escherichia coli VIM-2 assessed as reduction in bacterial growth incubated for 24 hrs by broth microdilution method\"],[\"Inhibition of human ERK2 using myelin basic protein as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control\"],[\"Displacement of [3H]menthol from human TRPM8 L1009R mutant expressed in HEK293 cell membranes at 100 uM by scintillation counting\"],[\"Activation of human S1PR5 expressed in CHO cells assessed as suppression of forskolin-induced intracellular cAMP level at 1 to 10 uM measured after 15 mins by ELISA\"],[\"Inhibition of FAK phosphorylation at Tyr397 residue in human HCC1806 cells at 50 to 200 nM after 48 hrs by Western blot analysis\"],[\"Inhibition of recombinant human activated IR (1005 to 1310 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of human PIM1 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay\"],[\"Inhibition of N-terminal His-6-tagged full length human PI3Kalpha expressed in baculovirus-infected sf9 cells after 30 mins by TR-FRET assay\"],[\"Inhibition of recombinant human BRAF at 200 nM using inactive MEK as substrate measured after 30 mins by LANCE method relative to control\"],[\"Inhibition of human MAOA at 100 uM incubated for 15 mins using p-tyramine substrate by Amplex red reagent based fluorescence assay\"],[\"Inhibition of rat delta-5 desaturase activity expressed in human HEpG2 cells\"],[\"Binding affinity to recombinant His-tagged ERalpha LBD (307 to 554 residue) (unknown origin) expressed in Escherichia coli preincubated for 15 mins followed by ligand addition and measured after 1 hr by fluorescent polarization assay\"],[\"Displacement of [3H]Nalpha-methylhistamine from histamine H3 receptor in guinea pig brain at 1 uM\"],[\"Inhibition of human CAMK1B assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells at 1 uM using p-tyramine as substrate preincubated for 30 mins followed by substrate addition and measured after 1 hr by fluorimetric analysis relative to control\"],[\"Activity of HIV1 Reverse transcriptase T165A mutant\"],[\"Inhibition of trypsin-like activity of proteasome beta7 subunit (unknown origin)\"],[\"Inhibition of MMP-1 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay\"],[\"Binding affinity to MDM2 (unknown origin) expressed in Escherichia coli BL21(DE3) by HSQC NMR spectroscopic analysis\"],[\"Inhibition of human recombinant LSD1 incubated for 30 mins using H3K4me2 peptide substrate by fluorescence assay\"],[\"Antagonist activity at mouse CXCR3 expressed in L1.2 cells assessed as inhibition of I-TAC-induced Ca2+ mobilization by FLIPR assay\"],[\"Binding affinity to human CAMKK2 at 10 uM relative to control\"],[\"Inhibition of recombinant human IR activated (1005 to 1310 residues) at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of TESK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay\"],[\"Inhibition of human EIF2AK3 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Antagonist activity at human kappa-opioid receptor expressed in CHO cells assessed as inhibition of U69593-induced [35S]GTPgammaS binding after 60 mins by scintillation counting\"],[\"Agonist activity at human PPARgamma expressed in HEK293 cells assessed as induction of receptor activation at 5 uM incubated for 18 hrs by luciferase reporter gene assay relative to untreated control\"],[\"Inhibition of full length human Nav1.4 channel expressed in HEK cells co-expressing human sodium channel subunit beta1 by automated voltage clamp analysis\"],[\"Agonist activity against human 5HT2A receptor by FLIPR assay relative to 5HT\"],[\"Inhibition of human ABCB1 expressed in mouse L5178Y cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring combination index at 2:25 doxorubicin to compound ratio after 48 hrs by MTT assay\"],[\"Agonist activity at human recombinant SSTR1 expressed in CHO cells assessed as effect on cAMP accumulation by time-resolved fluorescence assay\"],[\"Inhibition of microsomal PGES1 transfected in human HEK293 cells assessed as PGE2 production after 60 mins by HTRF assay\"],[\"Inhibition of human human recombinant CP4H1 expressed in Escherichia coli Origami B(DE3) pre-incubated for 2 mins followed by alpha-ketoglutarate addition using dansylGlyProProGlyOEt substrate in Tris-HCl buffer at pH 7.8 at 30 degC by HPLC method\"],[\"Inhibition of PME1 overexpressed in HEK293T cells assessed as reduction in demethylated PP2A level at 20 uM after 1 hr by Western blot analysis relative to control\"],[\"Inhibition of human JAK2 at 10 uM after 60 mins by TR-FRET assay\"],[\"Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor expressed in CHOK1 cell membranes after 30 mins by liquid scintillation counting\"],[\"Inhibition of human ARK5 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Binding affinity to M4 receptor (unknown origin) assessed as inhibition of ligand binding\"],[\"Inhibition of human VEGFR2 at 100 nM relative to control\"],[\"Binding affinity to human Vegfr2 assessed as residual binding at 10 uM by site dependent competitive binding assay\"],[\"Inhibition of cdc7-mediated Rb phosphorylation at ser807\\u002f811 in human HCT116 cells\"],[\"Inhibition of recombinant human GST-tagged full length PAK1 expressed in baculovirus expression system using Ser\\u002fThr 19 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IFNA5 mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Binding affinity to wild-type human partial length FLT3 (V592 to Y969 residues) expressed in bacterial expression system at 5 uM by Kinomescan method relative to control\"],[\"Inhibition of FAK Tyr397 phosphorylation in human L3.6pl cells after 60 mins by Western blot analysis\"],[\"Inhibition of recombinant Cdc25B (unknown origin) assessed as reduction in Cdk1\\u002fcyclin B Tyr15 dephosphorylation by Western blotting method\"],[\"Inhibition of DYRK1A (unknown origin) at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method\"],[\"Inhibition of B lymphoid tyrosine kinase\"],[\"Inhibition of human 15-LOX-1 using arachidonic acid as substrate at 10 uM\"],[\"Inhibition of human BRD4 BD1 (67 to 152 residues) preincubated for 15 mins followed by addition of C-terminal biotinylated synthetic K5,8,12,16 tetra-acetylated histone H4 (1 to 20 residues) peptide as substrate measured after 1 hr by TR-FRET assay\"],[\"Inhibition of COX2-mediated 2-arachidonoylglycerol oxygenation in LPS\\u002fIFN-gamma-stimulated mouse RAW264.7 cells assessed as 2-AG to PGE2-G\\u002fPGD2-G conversion treated 2 hrs after LPS\\u002fIFN-gamma stimulation measured after 6 hrs\"],[\"Positive allosteric modulation of human mGlu4 receptor expressed in L929sA cells assessed as calcium mobilization by fluorescence analysis\"],[\"Inhibition of HDAC3 (unknown origin) pre-incubated for 5 mins before fluorogenic substrate Boc-Lys (acetyl)-AMC or Boc-Lys (triflouroacetyl)-AMC addition and measured after 30 mins by fluorescence based assay\"],[\"Displacement of [3H]PGD2 from human CRTH2 receptor expressed in CHO cells after 90 mins by scintillation proximity assay\"],[\"Agonist activity at human recombinant PPARgamma expressed in CHO cells cotransfected with pGL3-PPRE3-TK-luc reporter assessed as beta-galactosidase activity at after 24 hrs by luciferase based transactivation assay\"],[\"Activation of ABCG2 ATPase activity (unknown origin) expressed in baculovirus infected high5 cell membranes assessed as enzyme activity at 1000 nM after 20 mins by ascorbic acid ammonia molybdate reaction based colorimetric assay relative to control\"],[\"Inhibition of cathepsin B from human hepatocytes using Suc-LLVY-AMC as substrate\"],[\"Inhibition of human VRK2 at 10 uM after 60 mins by TR-FRET assay\"],[\"Transrepression activity at glucocorticoid receptor alpha in phorbol myristate acetate-stimulated human A549 cells assessed as inhibition of AP1 response element by luciferase reporter gene assay\"],[\"Inhibition of [3H]PIA binding to Adenosine A1 receptor in rat brain membranes at 100 uM\"],[\"Inhibition of recombinant full length human CaMKK2 T85S mutant assessed as residual activity at 10 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of PI3Kalpha in human HCT116 cells assessed as cell growth inhibition after 24 hrs by MTT assay\"],[\"Inhibition of recombinant PDGFR-alpha (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA\"],[\"Inhibition of human full length PKD1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human BMX at 1 uM\"],[\"Inhibition of human recombinant PDE9 assessed as inhibition of [3H]cAMP hydrolysis by scintillation proximity assay\"],[\"Inhibition of human Haspin (471 to end residues ) assessed as residual activity at 1 uM using RARTLSFAEPG as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control\"],[\"Binding affinity to human TRKA (G475 to G790 residues) expressed in mammalian expression system by KINOMEscan assay\"],[\"PKG1α(h) Millipore kinase panel\"],[\"Inhibition of radiolabeled [D-Ala2,MePhe4,Gly-ol5]enkephalin binding to delta opioid receptor in rat brain membrane\"],[\"Inhibition of human recombinant calcium-independent PLA2 using PLPC as substrate assessed as reduction in 16:0 LPC formation after 30 mins by HPLC-MS analysis\"],[\"Inhibition of wild-type human full length OSR1 (M1 to S527 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of PKC-zeta (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate after 30 mins by spectrophotometric analysis\"],[\"Inhibition of CRAF (unknown origin) at 10 uM relative to control\"],[\"Inhibition of TYRO3 activation loop (unknown origin) at 10 uM\"],[\"Residual activity at human Lck at 10 uM in presence of 10 uM ATP relative to control\"],[\"Inhibition of Lin28a in human PA1 cells assessed as reduction in IMP1 expression at 10 uM after 24 hrs by Western blot analysis\"],[\"Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 1 uM after 12 hrs by luciferase reporter gene assay relative to control\"],[\"Binding affinity to human recombinant G9a catalytic domain amino acid 913 to 1193 expressed in Escherichia coli BL21 (DE3) by isothermal titration calorimetry assay\"],[\"Inhibition of human recombinant DNA ligase 1 by radioactive gel-based ligation assay\"],[\"Binding affinity to wild-type human partial length IRAK3 (V147 to E596 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of dopamine D5 receptor (unknown origin) at 10 uM by radioligand binding assay relative to control\"],[\"Ratio of Kcat to Km for HIV1 reverse transcriptase M41L\\u002fD67N\\u002fL210W\\u002fT215Y mutant assessed as nucleotide excision activity in presence of 0.5 uM dCTP\"],[\"Inhibition of topoisomerase-1 (unknown origin) at 100 uM using pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\"],[\"Inhibition of full length human recombinant full length CA1 cytosolic isoform after 15 mins by stopped-flow CO2 hydration method\"],[\"Inhibition of wild-type human partial length FGFR3 (R442 to S771 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged TGFBR2 (unknown origin) (194 to 567 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Binding affinity to mouse SMO\"],[\"Inhibition of DHOH in human ARN8 cells assessed as increase in cleaved PARP level at 20 nM incubated for 24 hrs by Western blot analysis\"],[\"Downregulation of ERalpha in human MCF-7 cells assessed as reduction of estradiol-induced PgR mRNA levels after 24 hrs by RT-PCR method\"],[\"Inhibition of JAK2 JH1JH2 domain (unknown origin) at 100 nM\"],[\"Displacement of [3H]N-methylscopolamine from human muscarinic M1 receptor expressed in CHO Flp-In cells at 10 uM by liquid scintillation counting\"],[\"Inhibition of human recombinant DAAO expressed in Escherichia coli assessed as H2O2 production from D-serine degradation after 30 mins by fluorescence assay\"],[\"Reversible inhibition of SHP2 (unknown origin) using DiFMUP as substrate by enzyme kinetics based dialysis assay\"],[\"Inhibition of recombinant human MAO-B expressed in baculovirus infected insect cells assessed as reduction in H2O2 production at 100 uM using p-tyramine as substrate pretreated for 15 mins followed by substrate addition and measured over 15 mins by Amplex red reagent based fluorimetric assay relative to control\"],[\"Inhibition of G9a in p53-deficient human HCT116 cells assessed as reduction of H3K9me2 after 48 hrs by In-Cell Western assay\"],[\"Binding affinity to human ERG by dofetilide binding assay\"],[\"Inhibition of human PDE10A catalytic domain (449 to 770 residues) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method\"],[\"Displacement of [3H]DHA from beta1 adrenergic receptor in rat ventricular muscle by competitive binding assay\"],[\"Inhibition of human MAPKAP-K2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control\"],[\"Inhibition of B-Raf (unknown origin)\"],[\"Inhibition of MAOB (unknown origin) using luminogenic substrate at 10 uM incubated for 1 hr by luminescence based assay relative to control\"],[\"Inhibition of [3H]-phorbol dibutyrate binding to Protein kinase C alpha\"],[\"Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding\"],[\"Inhibition of PKC-zeta (unknown origin) at 0.078 uM relative to control\"],[\"Binding affinity for rat progesterone receptor compared to progesterone\"],[\"Binding affinity to wild-type human partial length HIPK3 (M153 to N562 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Biochemical assay: ELISA, cell free\"],[\"Inhibition of chromatin binding to PB1 in human 1BR-hTERT cells assessed as reduction in chromatin bound PB1 level at 10 uM after 48 hrs by Western blot analysis\"],[\"Inhibition of TRbeta-mediated MMP11 gene expression in human HepG2 cells at 10 uM after 24 hrs by RT-PCR analysis\"],[\"Inhibition of human Nav1.5 by V1\\u002f2 protocol based analysis\"],[\"Inhibition of ABL Q252H mutant (unknown origin)\"],[\"Inhibition of pig microsomal aminopeptidase N using L-leu-p-nitroanilide as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by spectrophotometric analysis\"],[\"Binding affinity to wild-type human partial length ANKK1 (M1 to A305 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Modulation of full length human Nurr1 expressed in HEK293T cells co-transfected with RXRalpha and luciferase reporter plasmid harboring NBRE response element assessed as decrease in luciferase activity at 1.56 to 6.25 uM incubated for 18 by luciferase reporter gene assay\"],[\"Activation of human estrogen receptor alpha expressed in HEK293 cells at 10 uM in presence of ICI-182780 beta-galactosidase reporter gene assay relative to control\"],[\"Displacement of fluorescein-labeled BAK from His-tagged BCL-XL (unknown origin) at 100 uM after 1 hr by fluorescence polarization assay relative to control\"],[\"Inhibition of human ERG channel by patch clamp technique\"],[\"Inhibition of human full-length ABCB1 expressed in FLp-In-293 cells assessed as potentiation of vincristine-induced cytotoxicity by measuring vincristine IC50 at 2.5 uM measured after 72 hrs by SRB assay (Rvb = 823 +\\u002f- 16 nM)\"],[\"Inhibition of human recombinant caspase-7 using Ac-DEVD-AMC as substrate at Km after 20 mins by fluorescence assay\"],[\"Inhibition of COX-2 in rat peritoneal macrophages assessed as reduction in PGE2 production using radiolabelled-arachidonic acid as substrate pretreated for 30 mins followed by substrate addition measured after 30 mins\"],[\"Inhibition of human cloned MC4R expressed in CHO cells at 10 uM relative to [125I]NDPalphaMSH\"],[\"Average Binding Constant for STK10; NA=Not Active at 10 uM\"],[\"Inhibition of MET (unknown origin) at 30 uM by microfluidic assay relative to control\"],[\"Binding affinity to CDK7 in human Jurkat cells assessed as target occupancy level incubated for 2 hrs by measuring Bio-THZ531 bound protein level by spectrophotometry based plate based target engagement assay\"],[\"Inhibition of human plasma kallikrein for 15 mins using H-D-Pro-Phe-Arg-p-nitroanilide as substrate\"],[\"Agonist activity at human kappa opioid receptor expressed in HEK293 cells assessed as induction of beta-arrestin 2 recruitment incubated for 60 mins by fluorescent microscopy\"],[\"HMGCOARED Eurofins-Panlabs selectivity data (BI)\"],[\"Binding affinity at human Adenosine A1 receptor expressed in CHO cells\"],[\"Inhibition of DCAMKL2 (unknown origin) at 100 nM\"],[\"Inhibition of wild-type human partial length DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of LCK (unknown origin) after 120 mins in presence of 33P-ATP\"],[\"In vitro for antagonism against neurokinin NK2 receptor in rat colon muscularis mucosae\"],[\"Inhibition of ALK (unknown origin) at 10 uM after 30 mins relative to control\"],[\"Inhibition of human Ret by millipore radiometric assay\"],[\"Inhibition of human estrogen receptor alpha expressed in HEK293 cells assessed as reduction in estrogen-induced transcriptional activation after 6 hrs by beta galactosidase reporter gene assay\"],[\"Inhibition of recombinant human full-length HDAC6 using RHKK(Ac)AMC as substrate preincubated for 5 to 10 mins followed by substrate addition and measured after 2 hrs by fluorescence assay\"],[\"Ratio of IC50 of morpholine (agonist) after 10 min of incubation along with compound (antagonist) and IC50 of agonist in absence of compound for Opioid receptor mu 1 at 1 uM in GPI assay (exp 1)\"],[\"Inhibition of human FBPase S124A mutant expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry\"],[\"Percentage A2780 cells in sub-G1 after 24 hr r at 20 nM (IC50)\"],[\"Binding affinity to drosophila NCS1 expressed in Escherichia coli BL21 (DE3) by STD-NMR method\"],[\"Inhibition of human ACAT1 expressed in CHO cells assessed as inhibition of [3H]cholesterol ester accumulation at 5 uM in presence of 0.1 mM [3H]oleate-conjugated BSA\"],[\"Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release relative to CP-55940\"],[\"Inhibition of CAMK2A at 10 uM by FRET assay\"],[\"Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay\"],[\"Bimolecular reactivation rate constant; e=Not determined\"],[\"Inhibition of CSF1R (unknown origin) assessed as inhibition of IL34-stimulated cell growth by cell based assay\"],[\"Displacement of [3H]N-R-methylhistamine binding to SK-N-MC cell membranes expressing human H3 receptor\"],[\"Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1\\u002f2 (S473) phosphorylation rate by cellular assay\"],[\"Inhibition of cdk4-mediated Rb phosphorylation at ser807\\u002f811 in human A2780 cells at 10 uM after 24 hrs\"],[\"Binding affinity to wild-type human full length CDK2 (M1 to L298 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human Nav 1.3 assessed as reduction in use dependent block at 1 uM measured at 10 Hz by manual patch clamp assay\"],[\"Reactivation of human p53 R175H mutant in human SKBR3 cells assessed as cell cycle arrest at G2\\u002fM phase at 2.5 uM after 24 hrs by propidium iodide staining based flow cytometric analysis\"],[\"Inactivation of tyrosinase (unknown origin) assessed as total oxygen uptake using 4-methylcatechol substrate at 850 uM by spectrophotometry\"],[\"Displacement of [3H]melatonin from human MT2 receptor expressed in CHO cells after 60 mins by microbeta scintillation method\"],[\"Displacement of [3H]diprenorphine from human recombinant delta opioid receptor expressed in C6 cells\"],[\"Inhibition of AKT1 (unknown origin) at 50 ug\\u002fml by mobility shift assay relative to control\"],[\"Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins to 72 hrs measured after 6 hrs by stopped flow CO2 hydration method\"],[\"Binding affinity to human recombinant NLuc\\u002fGPCR-fused H4R expressed in HEK293T cells assessed as dissociation half life measured after 30 mins in presence of thioperamide by furimazine substrate based BRET assay\"],[\"Binding affinity to wild-type human partial length TRKC (Q531 to G825 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"MYLK Invitrogen Lab (UK) kinase screen (BI)\"],[\"Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells at 10 uM\"],[\"PLK1 DUNDEE kinase screen (BI)\"],[\"Inhibition of ABCB1 (unknown origin) expressed in human A2780 ADR cells assessed as reduction in calcein AM efflux at 10 uM preincubated for 30 mins followed by calcein AM addition and measured at 60 secs interval for 1 hr by fluorescence assay relative to control\"],[\"Binding affinity to dopamine D5 receptor\"],[\"Inhibition of human IKKalpha using KKKKERLLDDRHDSGLDSMKDEE as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [3H]DPDPE from rat cortex delta opioid receptor after 2.5 hrs by liquid scintillation counting analysis\"],[\"Inhibition of recombinant human caspase 9 expressed in Escherichia coli at 10 uM using Ac-LEHD-AFC as substrate after 60 mins by spectrophotometric analysis relative to control\"],[\"Inhibition of wild-type human partial length MAP3K4 (G1319 to E1608 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of [3H]nitrendipine binding to membrane homogenates of rat cardiac muscle.\"],[\"Agonist activity at PPARgamma in mouse 3T3L1 cells assessed as downregulation of CD36 mRNA level at 10 uM after 6 days by oil red-O staining-based spectrophotometric analysis relative to control\"],[\"Inhibition of microtubule-stimulated ATPase activity of N-terminal His6-tagged\\u002fSUMO-fused human MPP1 motor domain (57 to 491 residues) expressed in Escherichia coli BL21 CodonPlus by pyruvate kinase\\u002flactate dehydrogenase-linked assay\"],[\"Inhibition of PKC delta (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of recombinant human GST-tagged SGK1 catalytic domain (60 to 431 residues) expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine\\u002fthreonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control\"],[\"Binding affinity to PDE-4D (unknown origin) at 10 uM\"],[\"Inhibition of 5-lipoxygenase in cell free S100 freshly isolated human PMNL cells assessed as inhibition of A23187-stimulated 5-LO product formation preincubated for 15 mins measured after 10 mins by HPLC analysis\"],[\"CAMK1 DUNDEE kinase screen (BI)\"],[\"Displacement of [3H]folic acid from human FRbeta in Chinese hamster D4 cells\"],[\"Inhibition of human JNK3 assessed as inhibition of GST-tagged ATF2 (19 to 96) phosphorylation incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]-ATP\"],[\"Agonist activity at human adenosine A2B receptor expressed in CHO cells assessed as stimulation of cAMP production\"],[\"Binding affinity to human CREBBP bromodomain by isothermal titration calorimetry\"],[\"Competitive binding affinity to Mcl-1 (unknown origin) using 5-FAM-Bid-BH3 peptide preincubated for 30 mins before 5-FAM-Bid-BH3 peptide addition and measured 20 mins after 5-FAM-Bid-BH3 peptide addition by fluorescence polarization assay\"],[\"Agonist activity at FPR1 in human neutrophils assessed as calcium mobilization incubated for 30 mins and measured for 5 sec for 240 sec by fluorometry\"],[\"Inhibition of recombinant human RAF1 Y340D\\u002fY341D mutant (S306 to F648) expressed in Sf9 insect cells at 20 nM incubated for 60 mins in presence of [33P]-ATP by scintillation counting method\"],[\"Inhibition of 5-LO (unknown origin)\"],[\"Inhibition of MELK in human MDA-MB-231 cells assessed as upregulation of p53-dependent p21WAF1\\u002fCIP1 expression at 5 uM by Western blot method\"],[\"Displacement of biotinylated ephrin-A1-Fc from EphA8 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA\"],[\"Inhibition of IKKbeta (unknown origin) at 0.8 ug\\u002fml\"],[\"Inhibition of type-3 17 beta-hydroxysteroid dehydrogenase expressed in HEK293 cells at 0.3 uM 37 degree C pH 7.4\"],[\"Antagonist activity at GluN2B receptor (unknown origin) by FLIPR assay\"],[\"Prostanoid EP4 Eurofins-Panlabs radioligand binding assay\"],[\"Inhibition of human HDAC8 up to 5 uM\"],[\"Induction of internalization of human GFP-tagged PD-L1 transfected in human HEK293T cells assessed as decrease in cell surface PD-L1 protein level by measuring cytosol level measured after 24 hrs by flow cytometry assay\"],[\"Inhibition of wild-type human full length CDK3 (M1 to H305 residues) expressed in bacterial expression system at 1 uM by Kinomescan method\"],[\"Inhibition of human vanin-1 in whole blood\"],[\"Inhibition of HIV1 reverse transcriptase at 40 ug\\u002fml\"],[\"Inhibition of TXK (unknown origin) at 0.1 uM relative to control\"],[\"Agonist activity at human kappa opioid receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation by TR-FRET assay\"],[\"Inhibition of human GRK5 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP\"],[\"In vitro P50 value of free haemoglobin of murine was determined after incubation with compound (concentration 60 mM)\"],[\"Inhibition of BACE1 expressed in human H4 cells assessed as reduction in sAPPbeta level at 10 uM incubated for 16 hrs in presence of 25 uM metalloprotease inhibitor batimastat by HPLAP-APP reporter assay\"],[\"Displacement of [3H]DPDPE from delta opioid receptor (unknown origin) expressed in CHO cells after 90 mins by liquid scintillation counting\"],[\"Binding affinity to PRL-3 (unknown origin) at molar ratio of 1:1 by fluorescence spectroscopy\"],[\"Inhibition of GST-fused FAK (411 to 686 residues) (unknown origin) expressed in sf9 cells using poly(Glu:Tyr) (4:1) copolymer as substrate by spectrophotometric method\"],[\"Inhibition of human wild type partial length ACVR1 (C188 to C509 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition constant against Escherichia coli Peptide deformylase (PDF)\"],[\"Inhibition of Notch1 intracellular domain fragment transfected in human HeLa cells co-transfected with CBF1-PGL3 luciferase reporter vector by transactivation assay\"],[\"Inhibition of N-terminal GST-tagged recombinant human full length Pim-1 expressed in Escherichia coli after 1 hr by Alphascreen assay\"],[\"Inhibition of DDR1 in KPfC mouse CT1A-C11 cells assessed as reduction in epithelial-mesenchymal transition in 3D culture by measuring down regulation of collagen-induced N-Cadherin expression at 1 uM incubated for 48 hrs by phalloidin\\u002fDAPI staining based immunofluorescence method\"],[\"Inhibition of horse serum BChE using S-butyrylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured after 30 mins by Ellman's microplate assay\"],[\"Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser338 phosphorylation level at 10 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control\"],[\"Inhibition of p38alpha (unknown origin) at 1 uM by direct binding assay\"],[\"Antagonist activity at rat P2Y6 receptor expressed in human 1321N1 cells assessed as inhibition of UDP-induced increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis\"],[\"Inhibition of human recombinant IDO1 using L-tryptophan as substrate after 15 mins by Dixon plot analysis\"],[\"Inhibition of recombinant human GST-tagged full length p38 alpha expressed in Escherichia coli expression system using Ser\\u002fThr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of Cav2.2-mediated calcium influx in HEK cells by FLIPR assay\"],[\"Inhibition of Phosphodiesterase 5 from human corpus cavernosum at 1 uM\"],[\"Inverse agonist activity at RORgammat in human whole blood assessed as IL-17 production by ELISA\"],[\"Inhibition of wild-type human partial length RAF1 (I330 to T640 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of recombinant activated human Tie2 R849W mutant (771 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"STK16 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of DYRK3 (unknown origin) using KKISGRLSPIMTEQ-NH2 as substrate at 1 uM after 15 mins in presence of [gamma-32P]-ATP\"],[\"Binding affinity to rho-related GTP-binding protein in human Hela cells lysates assessed as protein enrichment by measuring normalized heavy\\u002flight ratio at by nano-LC-ESIMS\\u002fMS analysis\"],[\"Binding affinity to recombinant human full-length N-terminal GST-tagged PAK4 expressed in baculovirus expression system using SGKtide as substrate incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human AKT1 using biotinylated GSKalpha peptide (SGRARTSSFA) as a substrate after 1 hr\"],[\"Inhibition of human EF2K (2 to 725 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay\"],[\"Binding affinity to CK2alpha (unknown origin) in presence of CX4945 by ITC analysis\"],[\"Irreversible inhibition of ITK in anti-CD3\\u002fCD28 beads-stimulated human Jurkat cells assessed as reduction in Plcgamma1 phosphorylation at 3 uM incubated for 2 hrs followed by compound washout with PBS and later stimulated with antiCD3\\u002fCD28 for 15 mins by Western blot analysis\"],[\"Agonist activity at PPARbeta\\u002fdelta in human HepG2 cells assessed as induction of ADRP mRNA expression at 10 uM incubated for 24 hrs by qRT-PCR method\"],[\"Binding affinity to human Keap1 Kelch domain (322 to 609 residues) expressed in Escherichia coli (DE3) by isothermal titration calorimetry\"],[\"First order rate constant (kon) for human growth factor receptor bound protein 2\"],[\"Inhibition of human cytosolic carbonic anhydrase 1 assessed as inhibition of CO2 hydration preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay\"],[\"Inhibition of human TIE2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Histamine H2 receptor antagonism at a concentration of 1 umolar on the isolated guinea pig right atrium.\"],[\"Inhibition of human 11-beta-HSD1 in CHO cells assessed as conversion of cortisone to cortisol\"],[\"Inhibition of recombinant human VEGFR2 at 10 uM using Ulight-CAGAGAIETDKEYYTVKD as substrate after 60 mins by LANCE assay relative to control\"],[\"Inhibition of human recombinant cathepsin S using Z-Phe-Arg-pNA as substrate after 80 mins by fluorimetric analysis\"],[\"Inhibition of N-terminally MBP-fused human CYP24A1 by cell-free assay\"],[\"Positive allosteric modulation of human metabotropic glutamate receptor 2 expressed in CHOK1 cells assessed as cellular impedance at 600 nM incubated for 5mins followed by compound washout in presence of endogenous glutamate levels by RTCA\"],[\"Inhibition of GSK3beta in mouse MA-10 cells assessed as stimulation of progesterone production at 50 uM after 15 to 120 mins by RIA\"],[\"Inhibition of human CK2alpha (2 to 391 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control\"],[\"Inhibition of horse serum BChE using butyrylthiocholine as substrate by spectrophotometry\"],[\"Inhibition of N-terminal His6-tagged recombinant human SYK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control\"],[\"Inhibition of recombinant mouse brain PDXP-mediated pyridoxal 5' phosphate hydrolysis expressed in Escherichia coli BL21 (DE3) cells assessed as enzyme Vmax at 2 mM preincubated for 4 mins followed by substrate addition measured after 2 mins\"],[\"Inhibition of human 5-HT7 receptor at 10 uM by CEREP assay\"],[\"Inhibition of full length recombinant human GST-tagged MARK3 expressed in baculovirus expression system at 1 uM relative to control\"],[\"Agonist activity at human PPARgamma at 1 uM by GAL4 transactivation assay relative to rosiglitazone\"],[\"Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control\"],[\"Agonist activity at recombinant human EP2 receptor expressed in HEK293-EBNA cells co-expressing Gqs5 assessed as induction of c-AMP accumulation\"],[\"Inhibition of human recombinant MAOA assessed as conversion of kynuramine to 4-hydroxyquinoline preincubated for 15 mins by fluorimetric assay\"],[\"Antagonist activity at wild-type ERalpha in human MCF7 cells assessed as inhibition of estradiol-induced PR expression level incubated for 24 hrs by immunofluorescence assay\"],[\"Inhibition of Plasmin (unknown origin) using H-D-CHA -Ala-Arg-AMC.2AcOH substrate incubated for 15 mins prior to substrate addition measured for 2 hrs\"],[\"Transcriptional activation in CV-1 cells expressing human Retinoic acid receptor RAR beta; Not active\"],[\"Binding affinity to survival of motor neuron-related-splicing factor 30 in human INA-6 cells after 3 hrs by nanoLC-MS\\u002fMS method\"],[\"Inhibition of human factor 11a using pyro-Glu-Pro-Arg-pNA as substrate measured after 10 to 120 mins by spectrophotometric method\"],[\"Inhibition of NBD-cholesterol binding to recombinant Aedes aegypti SCP-2 protein by fluorescence based assay\"],[\"Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Ratio of IC50 for BACE1 in human KBV1 cells expressing APP 751 Swedish mutant in absence of tariquidar to IC50 for BACE1 in human KBV1 cells expressing APP 751 Swedish mutant in presence of tariquidar\"],[\"Binding constant for full-length CSNK1G2\"],[\"Activation of NAE1-mediated protein degradation in human HGC-27 cells assessed as decrease in c-IAPI level at 9 uM measured after 48 hrs in the presence of proteosome inhibitor, MG132 by western blot analysis\"],[\"Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis\"],[\"Agonist activity at delta opioid receptor in mouse vas deferens\"],[\"Displacement of [3H]ZM241385 at human A2A receptor expressed in CHO cell membrane after 60 mins by scintillation counting method\"],[\"Inhibition of ERK2 in human HEK293 cells after 1 hr by competition binding assay\"],[\"Inhibition of human CLK3 at 10 uM after 60 mins by TR-FRET assay\"],[\"Inhibition of human placental microsome aromatase expressed in human MCF7 cells using [1beta-3H] androstenedione as substrate after 1 hr by liquid scintillation counting\"],[\"Inhibition of human recombinant N-terminally 6X-His-tagged SIRT3 at 50 uM after 4 hrs in presence of NAD+ by fluorescent deacetylase assay\"],[\"Inhibition of Hsp90 (unknown origin) at 50 uM preincubated for 1 hr followed by denatured luciferase addition measured at 30 mins by bright glo luciferase refolding assay in presence of Hsp70\\u002fHsp40\\u002fHOP relative to control\"],[\"Antagonist activity at TLR2 in human THP1 cells assessed as inhibition of PGN-stimulated TNFalpha level at 10 uM by bead based immunoassay\"],[\"Antagonist activity at human P2X3 receptor by cell-based calcium influx assay\"],[\"Antagonist activity at human adenosine A1 receptor assessed as inhibition of R-PIA-mediated [35S]GTPgammaS binding to G protein\"],[\"Binding affinity for human adenosine A3 receptor expressed in HEK293 cells\"],[\"Inhibition of N-terminal GST tagged\\u002fC-terminal His6-tagged recombinant full length human Mek1 expressed in Escherichia coli cells at 10 uM relative to control\"],[\"Displacement of fluoromone from human recombinant PPARgamma assessed as reduction of maximum polarization by fluorescence polarization assay\"],[\"Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS404 antibody after 6 to 24 hrs by Western blotting analysis\"],[\"Inhibition of TLK1 (unknown origin)\"],[\"Induction of CHOP (unknown origin) expressed in CHOK1 cells by luciferase reporter gene assay\"],[\"Inhibition of MLK3 in human monocytes assessed as inhibition of HIV1 Tat-induced IL-6 release incubated for 30 mins prior to HIV1 Tat induction measured after 8 hrs\"],[\"Inhibition of HSP90 alpha in human HeLa cells assessed as effect on HSP90 expression at 20 uM after 48 hrs by Western blot analysis relative to alpha-tubulin (Rvb = 1 No_unit)\"],[\"Inhibition of HDAC3 in human MDA-MB-231 cells assessed as reduction in beta-catenin expression at 0.5 to 5 uM by immunoblotting\"],[\"Antagonist activity at human MT2 receptor expressed in CHO cells assessed as inhibition of 3 nM melatonin-induced response by [35S]GTPgammaS binding assay\"],[\"Inhibition of PLK1 in human HT-29 cells assessed as monopolar spindle formation incubated for 24 hrs by immunofluorescence microscopic analysis\"],[\"Inhibition of PAK1 phosphorylation at Thr212 residues in human MDA-MB-231 cells at 10 to 40 uM measured after 24 hrs by Western blot analysis\"],[\"Inhibition of PAK6 (unknown origin) at 0.1 uM\"],[\"Displacement of [3H]PGD2 from human CRTh2 receptor expressed in 293 cells by liquid scintillation counting\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins prior to substrate addition measured after 5 mins by Ellman's method\"],[\"Antagonist activity at rat mGlu3 receptor expressed in CHO cell membranes in presence of glutamate by GTPgammaS binding assay\"],[\"Binding affinity to hound collagen 1a1 (unknown origin) at 50 uM after 1 8 hrs by 1H NMR spectroscopic analysis\"],[\"Displacement of [3H]CP55,940 from human CB2 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation analysis\"],[\"Displacement of [3H]quisqualic acid from full length human recombinant mGlu5 receptor expressed in CHO-K1 cells at 10 uM measured after 120 mins by radiometric scintillation analysis relative to control\"],[\"Binding constant for FLT3 kinase domain\"],[\"Noncompetitive\\u002fmixed type inhibition of human ALDH1A1 by Lineweaver-Burk plot analysis in presence of NAD+\"],[\"Binding affinity towards guinea pig Opioid receptor mu 1 using radioligand [3H]DAMGO\"],[\"Inhibition of wild-type human full length TESK1 (R37 to S626 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human MET at 0.1 uM relative to control\"],[\"Noncompetitive inhibition of OGT (unknown origin) using fixed UDP-GlcNAc levels and variable CKII peptide level by UDP-Glo glycosyltransferase assay\"],[\"Inhibition of human ROCK2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of ovine COX2 after 5 mins by enzyme immuno assay\"],[\"Displacement of fluorescent labeled MV151 from 26S proteasome beta 1 in human HEK293 cell lysate assessed as residual activity at 100 uM after 1 hr by SDS-PAGE\"],[\"Ratio of compound activity over MK571 activity for inhibition of MRP1-mediated doxorubicin transport activity in human 2008\\u002fMRP1 cells\"],[\"Time dependent inhibition of Electric eel AChE assessed as stability constants of inhibitor-enzyme complex using acetylthiocholine as substrate after 60 mins\"],[\"Inhibition of human TNFalpha expressed in Escherichia coli assessed as increase in TNFalpha monomer level after 15 mins by SDS-PAGE analysis\"],[\"Inhibition of HDAC8 (unknown origin) using R-H-K(Ac)-K(Ac)-AFC as substrate at 10 uM by fluorescence based assay\"],[\"Irreversible inhibition of SMYD3 (unknown origin) using MAP3K2 peptide as substrate assessed as kinact\\u002fKi ratio pretreated for 5 mins followed by substrate addition and measured after 60 mins by MTase Glo reagent based luminescence assay\"],[\"Inverse agonist activity at full length human RORgammat expressed in human Jurkat cells assessed as inhibition of constitutive receptor activity incubated for 18 hrs by Gal4-Luc reporter gene assay\"],[\"Inhibition of NPC1 in human HeLa cells assessed as increase in cholesterol accumulation in subcellular localization at 5 uM incubated for 24 hrs by filipin-staining based immunofluorescence assay\"],[\"Inhibition of FAAH in human U937 cells assessed as decrease in [ethanolamine-1-3H]AEA uptake at 10 uM preincubated for 2 mins followed by AEA addition after 5 mins by liquid scintillation counting method\"],[\"Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)\"],[\"Inhibition of human MAG after 1 hr by competitive ELISA\"],[\"Inhibition of plasma kallikrein (unknown origin)\"],[\"Inhibition of SIRT2 in human HeLa cells assessed as tubulin hyperacetylation at 20 uM after 1 hr by Western blotting method relative to control\"],[\"Inhibition of human PRMT4 assessed as inhibition of methylation activity using biotin-labeled peptide as substrate and [3H]-SAM by scintillation proximity assay\"],[\"Modulation of P-gp in human HCT15 cells assessed as increase in DINIB-induced cytotoxicity at 3.1 to 50 ug\\u002fmL\"],[\"Inhibition of caspase 3 in human SK-N-SH cells assessed as decrease in fluorescence intensity-associated with accumulation of fluorogenic 7-amino-4-methyl coumarin at 5 mM by fluorometric assay relative to control\"],[\"Inhibition of DPP8 activity\"],[\"Inhibition of ASCT2-mediated glutamine transport in human HEK293 cells using [3H]-glutamine after 15 mins by scintillation counting\"],[\"Inhibition of LSD1 in human MGC803 cells assessed as increase in cellular H3K4me3 levels at 2 uM incubated for 24 hrs by Western blot\"],[\"Agonist activity at PSGR\\u002fOR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring alpha-ketoglutaric acid level at 100 nM incubated for 72 hrs by GC\\u002fMS analysis\"],[\"Inhibition of 3 nM [3H]R5020 binding to progesterone receptor of human T47D cell cytosol\"],[\"Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in beclin-1 level at 250 uM measured after 24 hrs by immunoblotting\"],[\"Inhibition of N-palmitoylated Shh in mouse Shh Light2 cells at \\u003e 30 uM after 30 hrs by firefly luciferase reporter gene assay\"],[\"Inhibitory concentration against Lactobacillus casei DHFR(Dihydro folate reductase).\"],[\"Induction of EIF2alpha phosphorylation in human U87MG cells at 1 uM measured after 2 hrs by Western blot analysis\"],[\"Inhibition of sigma2 receptor (unknown origin) relative to control\"],[\"Agonist activity at FXR in human HepG2 cells assessed as upregulation of OST-beta mRNA level at 50 uM after 18 hrs by RT-PCR assay\"],[\"Inhibition of DHODH in human HEK293 cells transfected with ISRE-luciferase reporter gene assessed as increase in 60 IU\\u002fml IFN-alpha stimulated MX2 mRNA expression at 80 uM measured after 16 hrs by RT-qPCR analysis relative to control\"],[\"Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay\"],[\"Activity at adrenergic alpha2A receptor (unknown origin) at 10 uM\"],[\"Inhibition of human Rsk1\"],[\"Inhibition of human SGK3 assessed as residual activity at 1 uM using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of CAMK1 (unknown origin) at 10 uM\"],[\"Inverse agonist activity at human GPR6 expressed in CHO-K1 cells assessed as modulation of cAMP level incubated for 20 hrs by TR-FRET assay relative to control\"],[\"Inhibition of human plasma butyrylcholinesterase using butyrylthiocholine as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by Ellman's method\"],[\"CDK17\\u002fcyclinY(h) Kinase panel\"],[\"Inhibition of human JAK2 catalytic domain after by scintillation counting\"],[\"Activation of human Pgp ATPase in human Caco-2 cells at 100 uM\"],[\"Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS assessed as zinc ions ejection from Cys4-Zn finger at 2.5 to 100 uM after 500 to 3500 secs by FluoZin-3 based fluorescence assay\"],[\"Inhibition of human recombinant MARK3 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Inhibition of factor11a (unknown origin) at 100 uM\"],[\"Inhibitory activity against Topoisomerase I\"],[\"Inhibition of human recombinant carbonic anhydrase 9 expressed in Escherichia coli BL21 (DE3) by stopped-flow CO2 hydration assay\"],[\"Inhibition of porcine brain GSK3-beta assessed as incorporation of [gamma-33P]-ATP into YRRAAVPPSPSLSRHSSPHQSpEDEEE substrate after 30 mins by scintillation counting\"],[\"Inhibition of DOT1L (unknown origin) at 200 uM using chicken nucleosome as substrate in presence of [3H]SAM incubated for 1 hr by TopCount method\"],[\"Inhibition of human MDR1 expressed in mouse NIH-3T3 cells assessed as ratio of IC50 for daunomycin-induced cytotoxicity in absence of drug to IC50 for daunomycin-induced cytotoxicity in presence of 10 uM of drug by MTT assay\"],[\"Agonist activity at rat CB1 receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins\"],[\"Inhibition of P-gp overexpressed in human DU145-TxR cells assessed as decrease in intracellular compound accumulation after 2.5 hrs in absence of tariquidar by LC-MS\\u002fMS analysis\"],[\"Inhibition of full length recombinant human His-tagged GRK2 expressed in baculovirus expression system at 1 uM relative to control\"],[\"Agonist activity at glucocorticoid receptor in human HeLa cells transfected with luciferase gene linked to MMTV promoter assessed as induction of luciferase transactivation activity at 2 uM after 6 hrs by luminescence assay\"],[\"Effective concentration (binding affinity) exhibited against human melanocortin receptor 4 by radio labeled ligand assay (Displacement of [125I]NDP-alpha-MSH from the human receptors expressed in CHO cells)\"],[\"Inhibition of microtubule-stimulated ATPase activity of human Kif15 at 200 uM by pyruvate kinase\\u002flactate dehydrogenase-linked assay\"],[\"Inhibition of VEGFR2 (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins by caliper mobility shift assay\"],[\"Inhibition of VEGFR2 tyrosine kinase activity in VEGF-stimulated human U251 cells after 60 mins by ELISA\"],[\"Inhibition of mouse iNOS at 10 uM relative to control\"],[\"Binding affinity to human sFRP1 by fluorescence spectroscopy\"],[\"Inhibition of IDO1 in IFN-gamma\\u002fLPS stimulated human THP-1 cells assessed as reduction in kynurenine production at 1 uM after 24 hrs relative to control\"],[\"Inhibition of human recombinant carbonic anhydrase 3 pre-incubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Inhibitory activity against adrenergic alpha-1A receptor\"],[\"Competitive inhibition of BODIPY-GDP binding to nucleotide binding site of wild-type GST-tagged Rab7 GTPase (unknown origin) expressed in Escherichia coli BL21(DE3) 200 nM using varying BODIPY-GDP levels after 2.5 hrs by FACScan flow cytometry\"],[\"Inhibitory activity against binding of [3H]CGS-21680 to human A2a receptor (hA2a) using competition binding assay\"],[\"DAPK2 ProQinase selectivity panel\"],[\"Inhibition of human PI3Kgamma (2 to 1102 residues) at 50 uM by ADP Glo HTS assay\"],[\"Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as stabilization of enzyme-25mer duplex oligonucleotide cleavable complex formation at 5 to 25 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\"],[\"Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay\"],[\"Inhibition of human p70S6K assessed as residual activity at 1 uM relative to control\"],[\"Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane\"],[\"Modulation of full length human Nurr1 expressed in HEK293T cells co-transfected with luciferase reporter plasmid harboring NurRE response element assessed as decrease in luciferase activity at 1.56 to 6.25 uM incubated for 18 by luciferase reporter gene assay\"],[\"CSNK1E Invitrogen selectivity data (BI)\"],[\"Reversal of human MDR1-mediated multidrug resistance in mouse L5178Y cells expressing MDR1 assessed as forward scatter count measured by cell size ratio at 0.5 uM after 10 mins by flow cytometry\"],[\"Inhibition of human recombinant MMP3 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor\"],[\"Inhibition of DTK phosphorylation in growth factor-stimulated HUVEC at 3 uM after 24 hrs\"],[\"Inhibition of recombinant human sPLA2-5 expressed in Escherichia coli BL21(DE3) at 30 uM using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substrate addition and measured after 60 mins\"],[\"Stabilization of Nrf2 in human BEAS2B cells harboring (HA)-ubiquitin assessed as suppression of Nrf2 ubiquitination at 1 uM after 8 hrs in presence of MG132 by immunoblot analysis\"],[\"Activity at mushroom tyrosinase assessed as decrease in absorbance using L-dopa as substrate by oxygen consumption assay\"],[\"Activation of NAE1 in human MGC-803 cells transfected with NEDD8 siRNA assessed as decrease in c-Myc level at 3 uM measured after 48 hrs by western blot analysis\"],[\"Inhibition of full-length C-terminal FLAG-tagged human PLAAT2 expressed in human U2OS cells assessed as reduction in arachidonic acid level at 10 uM incubated for 4 hrs by LC-MS\\u002fMS analysis\"],[\"Binding affinity to human partial length DNA-tagged CREBBP expressed in bacteria by BROMOscan method\"],[\"Inhibition of rat ROCK2 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human CYP19 using [1beta-3H]androstenedione as substrate at 500 nM by 3H2O method\"],[\"Binding affinity for dopamine receptor D2\"],[\"Inhibition of CSK (unknown origin) at 10 uM relative to control\"],[\"Inhibition of recombinant human GST-tagged VEGFR3 cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay\"],[\"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1\"],[\"Inhibition of recombinant human carbonic anhydrase 1 incubated for 15 mins prior to testing measured for 10 to 100 secs by phenol red-based stopped-flow CO2 hydration assay\"],[\"Binding affinity to human PHD2-Mn(II) using 12.5% H2O\\u002f87.5% D2O MQC spectrometer operated at 500 MHz at 313K temperature\"],[\"Inhibition of EGFR L858R\\u002fT90M double mutant phosphorylation in gefitinib-resistant human NCI-H1975 cells at 0.01 to 1 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells using L-tryptophan as substrate after 24 hrs\"],[\"Inhibition of wild-type human partial length CSNK1A1 (M1 to L450 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Irreversible inhibition of human plasma BuChE assessed as decarbamylation rate constant at 100 nM using S-butyrylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 5 mins by Ellman's method\"],[\"Inhibition of N-terminal GST tagged human recombinant HDAC7 (518 to 991 residues) expressed in Baculovirus infected insect cells in presence of ATP\"],[\"Inhibition of full length recombinant mouse N-terminal GST-tagged PAD2 expressed in baculovirus infected Sf9 cells using benzoyl arginine ethyl ester as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assay\"],[\"Binding affinity towards human D1 dopamine receptor was determined by using [3H]-SCH- 23390 as radioligand\"],[\"Modulation of full length human Nurr1 expressed in SKNBE(2) cells co-transfected with luciferase reporter plasmid harboring NBRE response element assessed as increase in luciferase activity at 1.56 to 6.25 uM incubated for 18 by luciferase reporter gene assay\"],[\"Binding affinity to MDM2 (25 to 109 amino acids) (unknown origin) after 30 mins by surface plasmon resosnance analysis\"],[\"Inhibition of biotinylated ligand binding to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control\"],[\"Inhibition of human Vascular endothelial growth factor receptor 2\"],[\"Inhibition of VEGFR2 in HUVEC assessed as decrease in VEGF-induced SRC phosphorylation pretreated for 30 mins followed by VEGF stimulation for 20 mins by Western blot analysis\"],[\"Binding affinity towards human sst1 receptor expressed in CHO-K1 cells\"],[\"Inhibition of AMPK in mouse 3T3L1 cells assessed as inhibition of FAS gene expression by RT-PCR\"],[\"Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence-based Envision plate reader assay\"],[\"Inhibition of recombinant guinea pig PL-RP2 expressed in Aspergillus oryzae preincubated for 1 hr at 25 degreeC\"],[\"Antagonist activity at rat striatal dopamine D2 receptor assessed as dissociation rate constant\"],[\"Inhibition of full length human IKK-alpha assessed as enzyme activity at 10 uM by KINOMEScan assay\"],[\"Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at 15 uM after 5 mins by SDS-PAGE analysis\"],[\"Inhibition of N-terminal His-tagged human FPPS expressed in Escherichia coli at 10 uM\"],[\"Inhibition of SGK (unknown origin) at 1 uM by kinome scan method\"],[\"Inhibition of human NEK8 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of HDAC2 (unknown origin) using RHKK(Ac)AMC as substrate assessed as remaining activity at 1.23 x 10'-7 M after 1 to 2 hrs by fluorescence assay (Rvb = 94.78 to 103.8%)\"],[\"Displacement of [3H]DADLE from human delta opioid receptor expressed in CHO cells after 2 hrs by liquid scintillation counting\"],[\"Inhibition of human cathepsin B using Z-Arg-Arg-pNA as substrate after 80 mins by spectrophotometric analysis\"],[\"Binding affinity to ARPC5 in human spontaneously immortalized CDH-\\u002f- MCF10A cell lysates assessed as change in melting temperature at 3.125 uM for 3 hrs by thermal proteome profiling assay\"],[\"Inhibition of human partial length MET Y1235D mutant (D1010 to S1367 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of mTOR (unknown origin) using ULight-4E-BP1(Thr37\\u002f46) peptide as substrate measured after 2 hrs by HTRF assay\"],[\"Inhibition of 10 uM Cbz-Phe-Arg-AMC binding to human cathepsin K by fluorescence assay\"],[\"Binding affinity against human Melanin-concentrating hormone receptor 1 stably transfected CHO cells was determined using scintillation proximity assay (SPA)\"],[\"Displacement of [125I]2-iodomelatonin from human recombinant ML1A receptor expressed in CHO cells\"],[\"Displacement of [125I]-His5, D-Tyr6]GnRH from mutant GnRHR, GnRHR E111K\"],[\"Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells after 60 mins by gamma counter\"],[\"Inhibition of GSK-3-beta-mediated activation of beta-casein signaling in heterozygous transgenic zebrafish embryo assessed as effect on gata1 gene expression at 0.5 uM by in-situ hybridization analysis\"],[\"Inhibition of SIRT1 deacetylation activity (unknown origin) using H3K9Ac (4 to 15 residues) as substrate by HPLC analysis\"],[\"Inhibition of Trypanosoma brucei PDEB1 catalytic domain using cAMP as substrate incubated for 20 mins by PDELight HTS cAMP phosphodiesterase Kit based luminometry\"],[\"Transactivation of GAL4-fused PPARalpha ligand binding domain transfected in human HepG2 cells after 20 hrs by luciferase reporter gene assay\"],[\"Inhibition of ABCC1 in human H69AR cells assessed as reduction in calcein AM levels at 10 uM preincubated for 30 mins followed by calcein AM addition measured immediately at 60 sec time interval for 60 mins by fluorescence assay relative to Cyclosporine A\"],[\"Inhibition of human HDAC5 using fluorogenic HDAC substrate\"],[\"Inhibition of PIM1 (unknown origin) at 0.49 uM relative to control\"],[\"Inhibition of Mycobacterium tuberculosis InhA at 15 uM\"],[\"Binding affinity to C-terminal 6x-histidine tagged wild type beta-catenin (138 to 686 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 by ITC method\"],[\"Inhibition of N-terminal 6His-tagged recombinant human IGF-1R (959 to end residues) expressed in baculovirus infected Sf21 insect cells at 3 uM relative to control\"],[\"Inhibition of human PAK2 using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] substrate\"],[\"Inhibition of PPARgamma in mouse RAW264.7 cells assessed as inhibition of LPS-induced ERK1\\u002f2 phosphorylation at 10 uM after 4 hrs by Western blot analysis in presence of PPARgamma antagonist GW9662\"],[\"Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]PGF-2 from human Prostanoid FP receptor\"],[\"Binding affinity to human Lp-PLA2 by ITC assay\"],[\"Displacement of [125I]AB-MECA from human recombinant A3 receptor expressed in HEK293 cells at 10 uM after 120 mins by scintillation counting analysis\"],[\"Effective concentration to increase glycogen deposition in rat skeletal muscle L6 myoblast cells\"],[\"Inverse agonist activity at human histamine H3 receptor assessed as decrease of basal activity of [35S]GTPgammaS binding\"],[\"Inhibition of human BCRP expressed in MDCK2 cells assessed as accumulation of Hoechst 33342 up to 10 uM preincubated for 30 mins before Hoechst 33342 addition measured after 120 mins by fluorescence assay\"],[\"Inhibition of p-chloroamphetamine-induced excitation in sc dosed Wistar rat after 0.5 hrs\"],[\"Inhibition of ZAP-70 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis\"],[\"Binding affinity to recombinant human KEAP1 Kelch domain (321 to 609 residues) expressed in Escherichia coli BL21 (DE3) assessed as compound-adduct formation by measuring molecular mass at 20 uM measured after 1 to 3 hrs by LC-MS analysis\"],[\"Inhibition of HDAC6 (unknown origin) at 10 nM incubated for 60 mins by microplate reader analysis relative to control\"],[\"Inhibition of human MARK2 assessed as enzyme activity at 1 uM relative to control\"],[\"Inhibition of JNK3 in rat primary neuron assessed as reduction in phosphorylation of APP at T688 residue at \\u003c 10 nM incubated for 30 mins by Western blot analysis\"],[\"Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA\"],[\"Inhibition of PRAK (p38 regulated\\u002factivated kinase) in presence of 10 uM ATP\"],[\"Binding affinity to human HGK at 10 uM relative to control\"],[\"Binding affinity at Opioid receptor kappa 1 by displacement of [3H]U-69593 in guinea pig brain membranes\"],[\"Percent inhibition against hepatitis C virus helicase at 25 ug\\u002fmL; Range 6-13\"],[\"Inhibition of wild type Myc-ectopic MPS1 (unknown origin) expressed in human HCT116 cells assessed as autophosphorylation at Thr33\\u002fSer37 after 2 hrs by electrochemiluminescence assay in presence of MG132\"],[\"Inhibition of Aurora A by TR-FRET analysis\"],[\"Inhibition of SMAD3 (unknown origin) phosphorylation transfected in NIH3T3-pCAGA12-Luc cells cotransfected with firefly luciferase at 5 uM by CAGA-based luciferase reporter assay relative to control\"],[\"Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human 5alpha reductase 1 expressed in HEK293 cells assessed as inhibition of conversion of [14C]4-androstene-3,17-dione to [14C]5R-androstane-3,17-dione at 0.3 uM after 1 hr\"],[\"Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation at 10 ug\\u002fml using xanthine as substrate preincubated for 15 mins followed by substrate addition by spectrophotometric analysis\"],[\"Time-dependent inhibition of rat liver mitochondrial MAO-A using 5-hydroxytryptamine at 6 nM by scintillation counting\"],[\"Inhibition of N-terminal His6-tagged recombinant human CK1gamam3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of MDR1-mediated efflux-pump activity in mouse L5178Y cells expressing human MDR1 assessed as mean fluorescence intensity at 20 uM preincubated for 10 mins followed by rhodamine-123 addition measured after 20 mins by flow cytometry (Rvb = 7.1 to 18.6 No_unit)\"],[\"Inhibition of DPP4 in rat liver microsomes in presence of NADPH\"],[\"Inhibition of human DYRK2 assessed as residual activity at 1 uM relative to control\"],[\"Inhibitory activity against phosphodiesterase was determined in vitro using bovine aorta, at 1 uM cGMP for cGMP-PDE;Compound is insignificant.\"],[\"Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay\"],[\"Agonist activity at PPARgamma in human HepG2 cells assessed as activation of PPRE at 0.78 ug\\u002fml incubated for 24 hrs by dual luciferase reporter gene assay\"],[\"Binding affinity to C-terminal His-tagged CDYL2 (1 to 75 residues) (unknown origin) expressed in Rosetta2 BL21(DE3)pLysS cells after 30 mins by fluorescence polarization assay\"],[\"Inhibition of HIV1 Reverse transcriptase p51\\u002fp66 L100I mutant at 10 uM after 30 mins using alpha-[32P]dATP by liquid scintillation counting\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 50 uM by Thioflavin T based fluorometric assay relative to control\"],[\"Inhibition of human GST-rTEV-tagged insulin receptor (979 to 1382 residues) expressed in baculovirus infected insect Sf9 cells assessed as decrease in biotin-aminohexyl-AEEEEYMMMMAKKKK-NH2 phosphorylation after 1 hr by fluorometer\"],[\"Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Binding affinity to His-tagged Dvl-1 PDZ domain (247 to 337 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as association rate by SPR analysis\"],[\"Binding affinity to human partial length WDR9 bromodomain 2 (A1310 to E1430 residues) expressed in bacterial expression system after 1 hr by bromoscan assay\"],[\"Inhibition of recombinant N-terminal His-6 tagged Mycobacterium tuberculosis dihydrodipicolinate synthase using (S)-ASA as substrate preincubated for 5 mins followed by substrate addition measured over 10 mins by spectrophotometric analysis relative to control\"],[\"Inhibition of full length human ERG expressed in HEK293 cells assessed as reduction in tail current at holding potential of -70 mV after 6 to 7 mins by IonWork patch clamp method\"],[\"Inhibition of human factor 2a after 10 seconds\"],[\"Inhibition of human thrombin assessed as residual activity at 2.9 mM by spectrophotometry\"],[\"Inhibition of human recombinant HDAC1 expressed in NIH3T3 cells\"],[\"Intrinsic activity at mouse GPR119 receptor assessed as increase in cAMP level after 45 mins by HTRF assay relative to oleoylethanolamide\"],[\"Inhibition of CE1 in human liver microsomes using D-Luciferin methyl ester as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by luminescence assay\"],[\"Non-competitive inhibition of human N-terminal His6-tagged PTP1B catalytic domain (1 to 393 residues) expressed in Escherichia coli strain Rosetta2 (DE3) at 500 uM in presence of 4'-aminoxanilic acid by STD-NMR spectroscopic method\"],[\"Inhibition of Trypanosoma cruzi cruzaine using mMBz-Pro-Phe-Arg-pNA substrate incubated for for 5 mins by UV-vis spectrophotometry\"],[\"Inhibition of human truncated PKC epsilon expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells (inactive)\"],[\"Inhibition of human cSrc in COS7 cells at 1 uM by ELISA\"],[\"Inhibition of microtubule-stimulated EG5 (unknown origin) ATPase activity of assessed as decrease in free phosphate levels by malachite-green assay\"],[\"Agonist activity at human 5HT1AR expressed in CHO cells assessed as increase in [35S]GTPgammaS binding by liquid scintillation spectrometry\"],[\"Inhibition of human SAPK2a at 10 uM after 60 mins by TR-FRET assay\"],[\"Modulation of human PPARalpha-LBD expressed in african green monkey COS7 cells co-transfected with Gal4 assessed as activation of transactivation activity at 10 uM by luciferase assay\"],[\"Inhibition of COX-2-mediated PGE2 production in LPS-stimulated mouse J774 cells at 0.1 uM after 24 hrs by radioimmunoassay\"],[\"Agonist activity at PR (unknown origin) by cell based GAL4 reporter gene assay\"],[\"Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay relative to control\"],[\"Inhibition of ACLY in human HepG2 cells assessed as reduction in cholesterol synthesis at 30 uM relative to control\"],[\"Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay\"],[\"Inhibition of human recombinant PDE5A1 using FAM-labelled cGMP as substrate after 60 mins by fluorescence polarization assay\"],[\"Inhibition of human recombinant IKKepsilon using Ulight-FLGFTYVAP as substrate after 90 mins relative to control\"],[\"Inhibition of human PI3K p110gamma by HTRF assay\"],[\"Inhibition of human recombinant full length carbonic hydrase 5A by stopped-flow assay\"],[\"Inhibition of electric eel AChE at 10 uM by Ellman's assay\"],[\"Binding affinity to human His6-tagged ASH1L (E2433 to E2564 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay\"],[\"Inhibition of mouse PrCP\"],[\"Inhibition of SAPK2a\\u002fp38 at 10 uM relative to control\"],[\"Inhibition of rat liver DNA topoisomerase 1 preincubated before addition of DNA\"],[\"Inhibition of recombinant human PNKP assessed as reduction in PNKP 3'-phosphatase activity by measuring 3'-phosphate removal from 5'-[32P]-labeled-20-mer single-stranded oligonucleotide at 0.001 to 10 uM incubated for 3 hrs by radio gel assay\"],[\"Inhibition of human recombinant lysosomal GCase at 1 mM using 4-methylumbelliferyl-beta-D-glucopyranoside as substrate preincubated for 45 mins followed by substrate addition and measured after 30 mins by fluorescence spectrophotometric assay relative to control\"],[\"Inhibition of human recombinant GST-Tie2 by HTRF method\"],[\"Inhibitory activity against non-receptor tyrosine kinase Src in enzyme assay\"],[\"Inhibition of PDE4B (unknown origin) at 2 uM relative to control\"],[\"Inhibition of STAT3 in human MCF7 cells assessed as reduction of IL-6 induced transactivation incubated for 1 hr prior to IL-6 challenge measured after 16 hrs by luciferase reporter gene assay\"],[\"Inhibition of wild-type human partial length C-terminal MSK2 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of SK2 (unknown origin) at 10 using sphingosine as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence based assay relative to control\"],[\"Inhibition of specific binding of [125I]BH-CCK-8 in guinea pig pancreas.\"],[\"Inhibition of bovine milk xanthine oxidase assessed as hypoxanthine-stimulated ROS generation by measuring H2O2 production at 25 to 50 uM by fluorescence assay\"],[\"Inhibition of wild-type human partial length VEGFR2 (R787 to P1253 residues) expressed in mammalian expression system at 100 nM by Kinomescan method relative to control\"],[\"Inhibition of GAR transformylase isolated from murine lymphoma cell line L5178Y\"],[\"Reactivation of sarin-inhibited human AChE assessed as reactivation rate constant incubated for 30 mins by Ellman's method\"],[\"Activity at human PTPN6 up to 10 uM\"],[\"Agonist activity at LXRbeta in mouse RAW264.7 cells assessed as upregulation of ABCA1 protein expression at 1 uM after 18 to 48 hrs by Western blot analysis\"],[\"Activity at human CFTR delta F508 mutant expressed in forskolin-stimulated FRT cells assessed as increase in iodine influx measured as decrease in YFP fluorescence after 18 to 24 hrs at 37 degC in presence of genistein\"],[\"Non-competitive inhibition of human recombinant PTP1B-mediated para-nitrophenyl phosphate hydrolysis preincubated for 30 mins measured by spectrophotometric analysis\"],[\"Inhibition of MST4 at 10 uM by FRET assay\"],[\"Inhibition of electric eel AChE\"],[\"Ratio of IC50 for human catalytic domain of TACE to IC50 for MMP14 (unknown origin)\"],[\"Inhibition of human PKBalpha assessed as residual activity at 1 uM relative to control\"],[\"Displacement of [3H]glibenclamide from COS-1 cells expressing Sulfonylurea receptor 1 (SUR-1)\"],[\"Inhibition of BChE (unknown origin) using butyrylthiocholine chloride as substrate preincubated for 30 mins before substrate addition measured after 30 mins by Ellman method\"],[\"Cell based cAMP Assays (pA2)\"],[\"Agonist activity at recombinant human GPR40 expressed in HEK293 cells assessed as increase in IP1 accumulation measured after 60 mins in presence of 100% human serum by HTRF assay\"],[\"Inhibition of His6-tagged wild type human HePTP catalytic domain overexpressed in Escherichia coli BL21(DE3) cells at 25 uM using pNPP as substrate incubated for 90 mins by quenched phosphatase activity assay\"],[\"In vitro transcriptional activation of hPPAR delta\"],[\"Inhibition of recombinant human DYRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Stimulatory effect on [35S]-GTP gammaS binding to Opioid receptor mu1 expressed in CHO cells compared to 10 uM DAMGO\"],[\"Inhibition of human thrombin after 10 mins by chromogenic assay\"],[\"Inhibition of HSP90 alpha (unknown origin) ATPase activity at 5 to 10 uM measured after 40 mins by malachite reagent based UV spectrophotometric analysis\"],[\"Inhibition of human CCR1 receptor\"],[\"Displacement of [3H]GR127543 from human 5HT1D receptor\"],[\"Inhibition of autocatalytic maturation of procathepsin-S (unknown origin) assessed as reduction in mature active cathepsin-S formation at 100 uM after 5 hrs by SDS-PAGE analysis\"],[\"Binding affinity to human recombinant His-tagged HSP90beta-CTD expressed in Escherichia coli BL21(DE3) at 80 uM after 2 hrs in presence of 18-fluro vibsanin B by Western blot analysis\"],[\"Agonist activity at TRPC3 in rat primary glomerular mesangial cells assessed as increase in intracellular calcium level at 1 uM by Fluo4-AM dye-based fluorescence assay\"],[\"Antagonist activity at KOR in mouse vas deferens assessed as inhibition of U69593-induced response\"],[\"Inhibition of LRRK2-pSer935 in LRRK2 WT expressing human HEK293 cells and measured after 48 hrs by ICW assay\"],[\"Inhibition of human CSE using H-Cys as the substrate by LC\\u002fMS\\u002fMS-based assay\"],[\"Inhibition of human recombinant Trx-1 expressed in Escherichia coli at 2.5 to 20 uM by insulin reduction assay in presence of thioredoxin reductase\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AKT3 (unknown origin) (108 to 479 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Agonist activity at PPARgamma in human HT29 cells assessed as reduction in TNFalpha-induced MIP3alpha gene expression in at 10 uM after 48 hrs by ELISA\"],[\"Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser37 at 30 uM after 24 hrs by Western blot analysis in presence of control siRNA\"],[\"Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.1 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry\"],[\"Inhibition of NF-kappaB p65 phosphorylation in cytosol of LPS-stimulated mouse RAW264.7 cells preincubated for 1 hr followed by LPS stimulation for 90 mins by Western blot method\"],[\"Inhibition of DYRK1A (unknown origin) at 50 uM by ADP hunter plus assay\"],[\"Inhibition of yeast alpha-glucosidase assessed as inhibition of p-nitrophenyl-alpha-D-glucopyranoside substrate hydrolysis after 35 mins by spectroscopy\"],[\"Inhibition of N-terminal GFP tagged mouse DOCK5 expressed in HEK293T cells assessed as reduction in exchange activity incubated for 1 hr by Western blot analysis based Rac-GTP pull-down assay\"],[\"Inhibition of Gst-tagged human SAPK4\\u002fp38delta expressed in Escherichia coli at 10 uM\"],[\"Binding affinity to human His-tagged and [15N-13C-2H], delta1[13CH3]-Ile, [13CH3]-Leu\\u002fVal and [13CH3]-Met-labeled USP7-catalytic domain (208 to 554 residues) expressed in Escherichia coli Rosetta 2 (DE3) cells by 2D[1H-15N]-based TROSY spectrum NMR analysis\"],[\"Displacement of [3H]8-OH-DPAT from rat brain hippocampus 5-HT1A receptor by radioligand binding assay\"],[\"Displacement of [3H]DAMGO from human mu opioid receptor expressed in CHO cells after 120 mins by liquid scintillation counting\"],[\"Competitive binding affinity to recombinant human galectin-2 after 5 mins in presence of fluorescent probe ,3'-dideoxy-3-[4-(fluorescein-5-yl-carbonylaminomethyl)-1H-1,2,3-triazol-1-yl]-3'-(3,5-dimethoxy-benzamido)-1,1'-sulfanediyl-di-beta-D-galactopyranoside by fluorescence polarization assay\"],[\"Ratio of inhibition of recombinant human N-terminal His-tagged ALOX15 in human Hodgkin lymphoma L-1236 cells using linoleic acid as substrate to inhibition of recombinant human N-terminal His-tagged ALOX15 expressed in human Hodgkin lymphoma L-1236 cells using arachidonic acid as substrate by measuring 15-HpETE\\u002f 12-HpETE at 5 uM by HPLC analysis\"],[\"Competitive binding affinity to STK11 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of human NEK6 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay\"],[\"Inhibition of HDAC1 in human MDA-MB-231 cells assessed as inhibition of deacetylation activity at 100 nM using Fluor-de-Lys as substrate measured after 15 mins by fluorimetric assay\"],[\"Inhibition of human RIP1 (1 to 375 residues) expressed in baculovirus infected insect cells assessed as on rate constant by stopped-flow tryptophan fluorescence assay\"],[\"Inhibition of SRMS (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of Brk (unknown origin) using [gamma-33P]-ATP after 60 mins by scintillation counting\"],[\"Effect on GCase activity in fibroblasts derived from gaucher disease patient up to 100 uM using 4-methylumbelliferyl beta-D-glucopyranoside as substrate after 96 hrs by luminescence spectrophotometry\"],[\"TYK2 Kinase panel\"],[\"Inhibition of [3H]CGS21680 binding to human adenosine A2A receptor expressed in HEK293 cells at 10 uM after 60 mins by liquid scintillation counting\"],[\"Inhibition of wild-type human full length p38-gamma (M1 to L367 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of recombinant wild-type PAD4 (unknown origin) using N-alpha-Benzoyl-L-arginine ethyl ester as substrate assessed as residual activity at 10 uM preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay relative to control\"],[\"Binding affinity to human partial length TRIM33 PHD bromodomain (D882 to A1087 residues) expressed in bacterial expression system after 1 hr by bromoscan assay\"],[\"Binding affinity to human hexahistidine-tagged Max p21 bHLH-ZIP domain expressed in Escherichia coli M15 (pRep4) at 10 uM by fluorescence polarization assay\"],[\"Inhibition of human EGFR using poly (Glu,Tyr) 4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control\"],[\"Inhibition of RSK4 (unknown origin) at 180 nM relative to control\"],[\"Inhibition of His-tagged BRD4 bromodomain-1 (unknown origin) expressed in Escherichia coli BL21(DE3) using SGRGK(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVGG-K-Biotin as substrate preincubated for 15 mins followed by substrate addition measured after 10 mins by Alphascreen assay\"],[\"Inhibition of NLRP3 inflammasome activation in LPS-primed immortalized mouse BMDM cells assessed as inhibition of LPS\\u002fATP induced IL-1beta release by ELISA\"],[\"Inhibition of PI3Kgamma in mouse lymph node cells assessed as inhibition of ConA-stimulated IL-6 release at 5 uM pretreated for 2 hrs followed by addition of 5 ug\\u002fmL ConA for 22 hrs by ELISA\"],[\"Inhibition of 12\\u002f15-lipoxygenase in mouse HT22 cells assessed as reduction of 12-HETE production at 10 uM after 24 hrs by HPLC\\u002fMS analysis\"],[\"Inhibition of human Itk assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of CLK (unknown origin) by TR FRET assay\"],[\"In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells; NA= not active\"],[\"Antagonist activity at human calcium receptor expressed in HEK293 4.0-7 cells assessed as inhibition of intracellular calcium release by FLIPR assay\"],[\"Inhibition of PTPRZ1 in human SH-SY5Y cells assessed as increase in TrkA tryrosine 490 phosphorylation at 1 to 10 uM after 20 mins by Western blot analysis relative to control\"],[\"Inhibition of COX2-mediated PGE2 production in LPS-stimulated mouse RAW 264.7 cells after 24 hrs by ELISA\"],[\"Induction of MCL1 short isoform degradation in CRBN-\\u002f- human OPM2 cells assessed as protein abundance at 500 nM after 48 hrs by immunoblot analysis relative to control\"],[\"Inhibition of recombinant human N-terminal His6-tagged full length PI3K p120gamma expressed in baculovirus infected Sf21 insect cells by ELISA\"],[\"Binding affinity to wild-type human partial length PIK3CB (P118 to S1070 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at LXRbeta in mouse BV2 cells assessed as upregulation of apoE protein expression at 0.1 uM after 48 hrs by Western blot analysis relative to vehicle-treated control\"],[\"Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble\"],[\"Inhibition of recombinant human GST-tagged cytoplasmic LTK (450 to 864 residues) expressed in baculovirus expression system at 1 uM relative to control\"],[\"Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl-alpha -D-glucopyranoside by microbeta counting method\"],[\"Inhibition of ATR in human HT29 cells assessed as decrease in Chk1 phosphorylation at Ser 345 preincubated for 1 hr followed by 4NQO addition and measured after 1 hr by Hoechst 33342 dye-based immunofluorescence assay\"],[\"Binding affinity to N15-tagged human PPARgamma LBD at 2 equiv by 19F-NMR spectroscopy\"],[\"Antagonist activity at ERalpha in human MCF7:WS8 cells assessed as E2-induced ERE activation after 18 hrs by luciferase reporter gene assay\"],[\"Displacement of [3H]ketanserin from 5HT2A receptor in rat cortical membranes incubated for 15 mins by liquid scintillation spectrometry\"],[\"Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of acid-induced calcium influx\"],[\"Inhibition of human CA12 catalytic domain by CO2 hydration stopped flow assay\"],[\"Binding affinity to wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Induction of Nrf2-mediated GCLC mRNA expression in mouse RAW264.7 cells at 100 uM after 20 hrs by quantitative RT-PCR analysis relative to control\"],[\"Inhibition of FGFR4 in FGF19-stimulated human Huh-7 cells assessed as MAPK T202\\u002fY204 phosphorylation level incubated for 30 mins and measured at 1 hrs after compound wash out by Western blot analysis (Rvb = 1 No_unit)\"],[\"Binding affinity to recombinant full length EP300 (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by scintillation proximity assay\"],[\"Agonist activity at C5a2 receptor in LPS-induced IHMDM assessed as effect on L10 release at 0.1 to 100 uM by ELISA\"],[\"Inhibition of CD73 in human MDA-MB-231 cell membranes at 500 uM using [2,8-3H]AMP as substrate measured after 25 mins by scintillation counting method\"],[\"Binding affinity to TSPO in frontal cortex of healthy human\"],[\"Inhibition of human Aurora B using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay\"],[\"Inhibition of HSP90 alpha in human HeLa cells assessed as effect on ERK1 phosphorylation at 10 uM after 48 hrs by Western blot analysis relative to GAPDH (Rvb = 1 No_unit)\"],[\"Binding affinity to wild-type human partial length autoinhibited KIT (Y545 to D952 residues) expressed in mammalian expression system at 1 uM by Kinomescan method\"],[\"Time-dependent inhibition of Trypanosoma cruzi trypanothione reductase assessed as dissociation constants for enzyme-inhibitor binding using TS2 as substrate by DTNB-coupled assay\"],[\"Displacement of FITC-geldanamycin from full length dog GRP94 at 277 K after 5 hrs by fluorescence polarization assay\"],[\"Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Binding affinity to human recombinant His-tagged HSP90beta-CTD expressed in Escherichia coli BL21(DE3) at 80 uM after 2 hrs in presence of vibsanin B by Western blot analysis\"],[\"Inhibition of SUV39H1 (unknown origin) at 1 uM using biotin-labeled peptide as substrate and [3H]-SAM measured after 1 hr by scintillation proximity assay\"],[\"Inhibition of PRMT5 (unknown origin) using SAM as substrate preincubated for 10 mins followed by substrate addition measured after 4 hrs by AlphaLISA method\"],[\"Inhibition of recombinant full-length human MSSK1 assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of STAT3 phosphorylation at Tyr705 residues in human DU145 cells assessed as ratio of phosphorylated STAT3 protein level to GAPDH protein level at 10 uM after 24 hrs by Western blot analysis (Rvb = 1 No_unit)\"],[\"Inhibition of human IKKbeta assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of full length His6-tagged GST-fused recombinant human HDAC6 expressed in High5 insect cells using Boc-Lys (e-acetyl)-AMC as substrate after 3 hrs by fluorescence assay\"],[\"Percent AGT inactivation in HT-29 cell extract at 1 mM\"],[\"Antagonist activity at dog recombinant C5a receptor expressed in HEK cells assessed as inhibition of C5a-induced calcium mobilization at 30 uM\"],[\"Mu (h) Ligand binding assay\"],[\"Beta adrenergic activity as cAMP production in human Beta3 adrenergic receptor expressing COS-7 cells with propranolol\"],[\"Increased [Ca2+] influx in HEK293 cell membranes expressing human vanilloid receptor subtype 1 (inactive)\"],[\"Delta TM value showing the stabilisation of CAMK2B produced by compound binding\"],[\"Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control\"],[\"MAPKAP-K2(h) Kinase panel\"],[\"Antagonist activity at FXR expressed in human HepG2 cells assessed as inhibition of CDCA-mediated transactivation at 10 uM after 48 hrs by luciferase reporter gene assay\"],[\"Inhibition of human PKBalpha at 0.1 uM\"],[\"Displacement of [3H]DPCPX from human Adenosine A2B receptor expressed in HEK293 cells; range 178-310\"],[\"Antagonist activity at human recombinant P2Y2 receptor in 1321N1 cells assessed as inhibition of UTP-induced calcium mobilization\"],[\"Inhibition of HIV-1 integrase strand transfer activity by scintillation proximity assay\"],[\"Transcriptional activation in CV-1 cells expressing hPPARalpha\"],[\"Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells\"],[\"Displacement of (-)-[3H]CGP-12177 from human recombinant adrenergic beta1 receptor expressed in HEK293 cells assessed as remaining radioligand binding at 10 uM after 60 mins by scintillation counting method relative to control\"],[\"Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 1.5 hrs by scintillation counting analysis\"],[\"Inhibition of human platelets COX1 assessed as PGE2 production using arachidonic acid as substrate preincubated for 15 mins measured after 15 mins by EIA\"],[\"Displacement of [3H]GBR-12935 from human cloned DAT expressed in HEK293 cells\"],[\"Displacement of HYSGRGKacGGKacGLGKacGGAKacRHRK(Biotin)-OH from human BRD4 by alpha screen assay\"],[\"Ratio of Kcat to Km for mushroom tyrosinase\"],[\"Inhibition of Abl1 in human HEK293 cells after 1 hr by competition binding assay\"],[\"Binding affinity to BIKE (unknown origin)\"],[\"Inhibition of human c-SRC at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay\"],[\"Percent response without GABA relative to current produced by 1 uM GABA alone in rat hippocampal cells (No response)\"],[\"Competitive inhibition of human recombinant MAO-A assessed as dissociation constant for enzyme-inhibitor-substrate complex by Lineweaver-Burk plot analysis\"],[\"Inhibition of recombinant Leishmania infantum trypanothione reductase using T[S]2 as substrate preincubated for 5 mins followed by substrate and NADPH addition measured for 1 hr\"],[\"Vitamin D3 agonistic activity as effective dose for HL-60 monocytic cell differentiation\"],[\"Inhibition of recombinant human HDAC6 at 10 uM using fluorogenic HDAC substrate 3 by fluorescence assay relative to control\"],[\"Binding affinity to wild type CXCL12 (unknown origin) by NMR spectroscopy\"],[\"Displacement of [3H]PSB-11 from recombinant human adenosine A3 receptor expressed in CHO cell membranes after 180 mins by liquid scintillation counting method\"],[\"Ratio of Kcat to Km for Streptomyces antibioticus OleD P67T\\u002fS132F\\u002fA242V mutant assessed as rate of glucoside formation at 10 mM using varying NDP sugar UDP-glucose concentration by enzyme kinetics assay\"],[\"Agonist activity at rat mu opioid receptor expressed in rat C6 cell membranes assessed as stimulation of [35S]GTPgammaS binding measured after 1 hr\"],[\"Induction of quinone reductase activity in mouse Hepa1c1c7 cells assessed as maximum fold change at 50 uM incubated for 24 hrs by MTT based assay\"],[\"Inhibition of recombinant N-terminal-GST-Th-tagged full length human PDE2A1 expressed in Sf9 cells using FAM-cAMP as substrate at 1xIC50 incubated for 60 mins by fluorescence plate reader analysis\"],[\"Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate after 20 mins preincubation by Ellman method\"],[\"Inhibition of human cathepsin L assessed as product formation at 1 uM using Z-Phe-Arg-pNA as substrate incubated over 60 mins by spectrophotometric method\"],[\"Inhibition of recombinant human N-terminal GST-tagged cKIT (544 to end residues) expressed by baculovirus infected Sf21 insect cells at 10 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control\"],[\"Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate measured upto 60 mins by fluorescence based assay\"],[\"Inhibition of human ABHD6 expressed in HEK293 cells using 2-OG as substrate preincubated for 30 mins followed by substrate addition measured after 5 mins by liquid scintillation spectroscopy analysis\"],[\"Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system\"],[\"Inhibition of human carbonic anhydrase 9 catalytic domain\"],[\"Displacement of [3H]dexamethasone from human GR at 10 uM after 360 mins by scintillation counting analysis relative to control\"],[\"Inhibition of GST-tagged full length XIAP (unknown origin) assessed as caspase 3\\u002f7 reactivation in S-100 cell extract after 4 hrs by fluorescence assay\"],[\"Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Antagonist activity at GNRH receptor in rat pituitary cells assessed as inhibition of D-Trp6-GnRH-induced LH accumulation after 3 hrs by RIA\"],[\"Inhibition of TEL fused wild type TRKA (unknown origin) transfected in mouse BaF3 cells assessed as reduction in phosphorylation at Y490 residue after 2 hrs by Western blot analysis\"],[\"In vitro inhibition of placental cytochrome P450 19A1 at 0.1 uM\\u002fkg\"],[\"Inhibition of wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]U69593 from human KOR expressed in CHO cell membranes at 1 uM after 60 mins\"],[\"Induction of ESR2-mediated osteoblast differentiation in mouse calvarial osteoblast assessed as increase in ALP activity at 1 pM measured after 48 hrs by spectrophotometric analysis\"],[\"Inhibition of human ARTD10 by fluorescence analysis\"],[\"Percentage inhibition of dexamethasone-induced glucocorticoid receptor transactivation of the mouse mammary tumor virus(MMTV) luciferase gene in HeLa cells at a concentration of 5 uM\"],[\"Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins\"],[\"Substrate activity at full length CYP3A4 L210F mutant (unknown origin) expressed in s9 cells assessed as enzyme-mediated benzoic acid (6R,7S)-2,6,10-trihydroxy-1,3,11,12-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydro-dibenzo[a,c]cycloocten-5-yl ester formation after 60 mins in presence of NADPH by UFLC-DAD analysis wild type CYP3A4\"],[\"GPCRScan assay: inhibition of 5-HT4\"],[\"Inhibition of human CKIdelta\"],[\"Inhibition of recombinant human mPGES-1 expressed in CHO cells assessed as reduction in PGE2 formation at 1 uM using PGH2 a substrate preincubated for 10 mins followed by substrate addition measured after 1 min relative to control\"],[\"Binding affinity against blood clotting factor X\"],[\"BRAF V599E Invitrogen Lab (UK) kinase screen (BI)\"],[\"Ki for human Neurokinin 2 receptor\"],[\"Inhibition of human recombinant FLAG-tagged PTGES expressed in baculovirus infected Hi-5 insect cells using prostaglandin H2 as substrate preincubated for 20 mins followed by substrate addition and incubated for 60 sec by TR-FRET assay\"],[\"Inhibition of human recombinant PDE4D\"],[\"Inhibition of TLR9-mediated IFN-gamma production in CpGA-stimulated human PBMC at 100 uM after 20 hrs by ELISA\"],[\"Binding affinity to wild-type human full length DYRK1B (M1 to S629 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Enhancement of steroid receptor coactivator 1 binding to mouse CAR I252L mutant expressed in HEK293 cells at 2 uM by yeast two-hybrid assay\"],[\"Percent residual activity, relative to control, of ROCK-II at 1 uM concentration of inhibitor in presence of 20 uM ATP\"],[\"Binding affinity to human partial length DNA-tagged GCN5L2 expressed in bacteria by BROMOscan method\"],[\"Agonist activity as maximal effect in [35S]-GTP-gamma binding assay compared to 10 uM DAMGO\"],[\"Inhibition of human MDR1 expressed in mouse L5178 cells assessed as fluorescence activity ratio at 11.2 uM by rhodamine 123 exclusion test relative to wild type mouse L5178 cells\"],[\"Inhibition of human recombinant EphA2 assessed as reduction in substrate phosphorylation at 50 to 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method\"],[\"Agonist activity at N-terminal Gal4 fused human PPARdelta LBD transfected in HEK293 cells at \\u003c 10 uM after 24 hrs by luciferase reporter gene assay\"],[\"Mer(h) Millipore kinase panel\"],[\"Inhibition of cyclin B-mediated phosphorylation of RNA pol3 in human HCT116 cells after 4 hrs by immunoblotting analysis\"],[\"Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate assessed as inhibition of uric acid formation after 30 mins by spectrophotometric method\"],[\"Agonist activity at human NMUR1 expressed in CHO cells at 100 nM by Fluo-4-AM dye based calcium mobilization assay\"],[\"Inhibition of Mycobacterium tuberculosis HA-tagged PTPB transfected in mouse RAW264.7 cells assessed as reduction in IFNgamma-stimulated AKT phosphorylation preincubated for 2 hrs followed by IFNgamma-stimulation measured after 1 hr by Western blot analysis\"],[\"Inhibition of human CBS by methylene blue method\"],[\"Inhibitory activity against Prostaglandin E receptor in functional cell based assay\"],[\"Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter\"],[\"Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of wild type recombinant human lysosomal beta-glucocerebrosidase using 4-methylumbelliferyl-beta-D-glucopyranoside as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay\"],[\"Inhibition of CYP51 in Candida albicans SC5314 assessed as eburicol content at 8 ug\\u002fml after 16 hrs by GC\\u002fMS analysis relative to control\"],[\"Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay\"],[\"KinomeScan assay: inhibition of RET(M918T)\"],[\"Tested for the ability to inhibit Beta-lactamase of Bacillus cereus (class A enzyme) with 10 minutes pre-incubation; Not determined\"],[\"Inhibition of FAAH (unknown origin) expressed in human HeLa cells using [3H]AEA as substrate after 18 hrs\"],[\"Inhibition of recombinant rat sEH expressed in baculovirus expression system using MNPC as substrate by fluorescence-based assay\"],[\"Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells\"],[\"Induction of pheomelanogenesis assessed as mushroom tyrosinase-mediated simulation of pheomelanogenesis by measuring oxidation of L-DOPA at 4.5 to 184.4 mM after 48 hrs by Vis-spectrophotometer analysis in presence of 0.65 to 3.2 mM of glutathione\"],[\"Inhibition of human BACE1 using MR121-labeled WSEVNLDAEFRC peptide as substrate incubated for 4 mins prior to substrate addition measured after 2 mins by fluorescence assay\"],[\"Ratio of dissociation rate constant for His-tagged human Brd2 bromodomain 1 (1 to 473 residues) to dissociation rate constant for His-tagged human Brd2 bromodomain 2 (1 to 473 residues)\"],[\"Inhibition of full length recombinant human N-terminal His6-tagged LYN expressed in Sf21 cells at 1 uM by radiometric assay relative to control\"],[\"Inhibition of [3H]-nisoxetine binding to Norepinephrine transporter from rat cortex\"],[\"Inhibition of full length 6His-tagged HDAC6 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 17 hrs in presence of FAM-labeled acetylated peptide substrate by fluorescence assay\"],[\"Drug glucuronidation reaction catalyzed by human recombinant UGT2B7\"],[\"Inhibition of Trypanosoma brucei rhodesiense recombinant rhodesain by fluorescence technique\"],[\"Agonist activity at LXRalpha in human THP1 cells assessed as upregulation of LPS-stimulated ABCA1 mRNA expression at 10 uM after 6 hrs by RT-qPCR analysis\"],[\"Intrinsic activity at mouse GPR119 expressed in HEK293S cells assessed as cAMP accumulation incubated for 45 mins by HTRF assay relative to oleoylethanolamide\"],[\"Binding affinity to RAD1 (unknown origin) by surface plasmon resonance method\"],[\"Displacement of [3H]QNB from rat brain stem muscarinic receptor 2 (M2)\"],[\"Inhibition of human Kv1.5 channel expressed in HEK293 cells at 11 uM by whole cell patch clamp assay\"],[\"Activation of human recombinant PXR up to 10 uM by alphascreen method\"],[\"Increase in nuclear co-repressor receptor binding to wild type mouse CAR expressed in HEK293 cells at 2 uM by yeast two-hybrid assay\"],[\"Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Displacement of [125I]alpha-Btx from nicotinic acetylcholine receptor alpha7 (unknown origin) at 10 uM relative to control\"],[\"Inhibition of LPS-induced NFkappaB p65-mediated iNOS induction in mouse RAW264.7 cells assessed as reduction in NO production at 1 ug\\u002fml using 12 hrs PBS incubated compound preincubated for 30 mins with cells followed by LPS addition measured after 24 hrs by Griess assay\"],[\"Inhibition of urokinase (unknown origin) at 10 uM\"],[\"Inhibition of JNK2 (unknown origin) at 300 nM relative to control\"],[\"Inhibition of recombinant human ecto-5' nucleotidase expressed in COS7 cell membranes assessed as inorganic phosphate release using AMP as substrate preincubated for 10 mins followed by substrate addition and measured after 20 mins by malachite green dye based spectrophotometry\"],[\"Inhibition of recombinant human ALDH1A2 using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis\"],[\"Time-dependent inhibition of JAK3 (unknown origin) using CSKtide as substrate in presence of [gamma32P]ATP by top-count liquid scintillation counting method\"],[\"Inhibition of ovine COX-2\"],[\"Inhibition of full length human Nav1.7 channel expressed in HEK cells co-expressing human sodium channel subunit beta3 at -150 mV by manual voltage clamp analysis\"],[\"Agonist activity at human PPARdelta receptor expressed in HEK293 cells upto 20 uM by GAL4 transactivation assay\"],[\"Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay relative to untreated control\"],[\"Antagonist activity at rat TRPV1 expressed in HEK293 cells assessed as blockade of acid-induced receptor activation by FLIPR assay\"],[\"Antagonist activity at human adenosine A3 receptor expressed in CHO cells by [S35]GTPgammaS binding assay\"],[\"Inhibition of CK1a in human NCI-H929 cells by mass spectroscopic analysis\"],[\"5LO Eurofins-Panlabs selectivity data (BI)\"],[\"Displacement of fluorescent ES2 from recombinant human ERalpha after 2 hrs in absence of light by fluorometric analysis\"],[\"Inhibition of EGFR L858R\\u002fT790M\\u002fC797S triple mutant (unknown origin) expressed in mouse Ba\\u002fF3 cells assessed as inhibition of EGF-stimulated receptor phosphorylation incubated for 4 hrs followed by EGF stimulation for 10 mins by western blot analysis\"],[\"Inhibition of glutamate-induced calcium influx in HEK293 cells expressing human GLUA3\"],[\"Binding affinity to wild type DDR2 (unknown origin) by FLiK assay\"],[\"Agonist activity at human TRbeta expressed in COS1 cells after 1 day by luciferase reporter gene assay\"],[\"Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as stabilization of topoisomerase 1-DNA cleavage complex at 1 uM after 1 hr by DNA immunoblotting analysis\"],[\"Inhibition of TGFBR1 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Inhibition of KEAP1 interaction with Nrf2 in human HEK293 cells transfected with ARE-LUC assessed as activation of Nrf2 signaling pathway measured after 18 hrs by steady-Glo luciferase assay\"],[\"Inhibition of (14-(2-{[3-({2-{[4-(cyanomethyl)phenyl]amino}-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-4-pyrimidinyl}amino)propyl]amino}-2-oxoethyl)-16,16,18,18-tetramethyl-6,7,7a,8a,9,10,16,18-octahydrobenzo[2''3'']indolizino[8'',7'':5',6']pyrano[3',2':3,4]pyrido-[1,2-a]indol-5-ium-2-sulfonate binding to mouse RIP1 (1 to 378) expressed in baculovirus expression system preincubated for 10 mins followed by fluorescently labeled ATP-competitive ligand addition and measured after 20 mins by fluorescence polarization assay\"],[\"Agonist activity at human GPR84 expressed in CHO cells assessed as beta-arrestin recruitment after 90 mins by beta-galactosidase complementation assay\"],[\"Irreversible inhibition of Clostridium botulinum BoNT\\u002fA light chain expressed in Escherichia coli BL21 (DE3) assessed as inactivation rate constant using SNAPtide flp6 as substrate preincubated for 0.5 to 30 mins followed by substrate addition by fluorescence assay\"],[\"Inhibition of human PI3Kdelta-mediated Akt phosphorylation at Ser473 residue expressed in mouse MEF-3T3 cells after 0.5 to 2 hrs by Western blot analysis\"],[\"Binding affinity to KSRP\\u002fFUBP2 in human HCT116 cell lysate by Western blot analysis\"],[\"Inhibition of human COT1 using MEK1 as substrate by [gamma-33P]-ATP assay\"],[\"Reversal of P-gp-mediated drug resistance in human KBV cells assessed as potentiation of paclitaxel-induced cytotoxicity by measuring fold reduction in paclitaxel IC50 at 10 uM after 72 hrs by MTT assay relative to paclitaxel alone\"],[\"Chaperone activity at Lysosomal alpha-mannosidase P356R mutant in human fibroblasts derived from alpha-Mannosidosis patient assessed as increase in Lysosomal alpha-mannosidase activity at 2 to 20 uM using 4-methylumbelliferone alpha-D-mannopyranoside as a reporter substrate incubated for 4 days by fluorescence method relative to control\"],[\"Inhibition of human delta opioid receptor at 1 uM\"],[\"Tested for percentage specific binding of compound at 2.5 nM against [3H]U-69593 on kappa-opioid receptor binding site protected with 1 uM naloxone\"],[\"Inhibition of recombinant human topoisomerase 1 assessed as linear DNA at 50 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\"],[\"Binding affinity for human 5-hydroxytryptamine 1F receptor \"],[\"Inhibition of human EGF at 3 uM\"],[\"Displacement of radiolabeled [Sar9,Met(O2)11]-SP from human NK1 receptor\"],[\"Inhibition of FLT3 (unknown origin) assessed as residual activity at 1 uM\"],[\"Inhibition of human AChE up to 200 ug\\u002fml by Ellman's assay\"],[\"Inhibition of PHGDH-mediated serine synthesis in human Carney cells in serine free medium at uM preincubated for 1 hr followed by 13C6 labelled glucose addition and measured after 2 hrs by LC\\u002fMS analysis based 13C6-Glucose tracing assay relative control\"],[\"Intrinsic activity against human sympathetic ganglionic type nAChRs in IMR-32 cells containing alpha-3 subtype\"],[\"Inhibition of mouse PrCP in 30 mg\\u002fkg, po qd for 5 days established diet-induced obese wild type C57BL\\u002f6 mouse heat inactivated plasma measured on day 6\"],[\"Displacement of [125I]IL-8 from human CXCR1 expressed in mouse BaF3 cells by liquid scintillation counting\"],[\"Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced stat4 phosphorylation pretreated for 20 minutes prior to addition of cytokine by cell-based assay\"],[\"V2\\u002fH Cerep selectivity data (BI)\"],[\"Inhibition of human recombinant ACHE using acetylthiocholine as substrate after 30 mins by spectrophotometric relative to control\"],[\"Inhibition of recombinant human GST-tagged InsR (1011 to 1382 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control\"],[\"Antagonist activity at PAR4 in human platelet rich plasma assessed as inhibition of gamma-thrombin-induced platelet aggregation preincubated for 5 mins followed by gamma-thrombin addition and measured in presence of recombinant hirudin\"],[\"Inhibition Assay: The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).\"],[\"Inhibition of Mycobacterium tuberculosis HA-tagged PTPB transfected in mouse RAW264.7 cells assessed as increase in IFNgamma-stimulated ERK1\\u002f2 phosphorylation by measuring phosphorylated ERK1\\u002f2 level at 20 nM preincubated for 2 hrs followed by IFNgamma-stimulation measured after 1 hr by Western blot analysis relative to GAPDH (Rvb = 1.5 +\\u002f- 0.1 No_unit)\"],[\"Induction of Nrf2 nuclear translocation in rat PC-12 cells assessed as SNP-induced GSH level incubated for 1 hr followed by SNP stimulation and measured after 24 hrs\"],[\"Inhibitory concentration against endothelin converting enzyme 1 using bradykinin-derived substrate\"],[\"Inhibition of MAPK12 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of PI3Kalpha in human MCF7 cells assessed as reduction in AKT phosphorylation at 1 uM after 2 hrs by ELISA relative to control\"],[\"Binding affinity to T7-tagged Src (unknown origin) expressed in Escherichia coli BL21 incubated for 1 hr\"],[\"Activation of human TLR3 expressed in HEK293 assessed as induction of NF-kappaB activity reporter gene assay\"],[\"Inhibition of human FLT3 assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control\"],[\"Inhibition of GABA uptake at murine GAT-3 expressed in HEK293 cells at 100 uM relative to control\"],[\"In vitro inhibitory activity against Class B (CCRA) beta-Lactamases\"],[\"Inhibition of biotinylated-THZ1 binding to CDK7 in human Jurkat cells assessed as reduction in cyclin H pull down at 500 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay\"],[\"Binding affinity to GST-tagged GRB7-SH2 (415 to 532 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) in 50 mM sodium phosphate buffer by SPR analysis\"],[\"Inhibition of PI3K2beta (unknown origin)\"],[\"Inhibition of biotinylated-H4KAc4 binding to human His6-tagged ATAD2 expressed in Escherichia coli BL21(DE3) at 50 uM after 2.5 hrs by luminescence-based AlphaScreen assay relative to control\"],[\"Binding affinity to BRD4 in human MDA-MB-231 cells assessed as increase in thermal stability at 5 uM after 6 hrs by CETSA based western blot analysis\"],[\"Inhibition of recombinant human PDE2A assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay\"],[\"D3  (h) Ligand binding assay\"],[\"Inhibition of human PDE5 isolated from corpus cavernosum after 30 to 60 mins by scintillation counting method\"],[\"Displacement of [33P]2-MeS-ADP from human cloned P2Y1 receptor expressed in HEK293 cells by SPA analysis\"],[\"Inhibition of EGFR 19D\\u002fT790M\\u002fC797S mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in EGF-stimulated Akt phosphorylation at 5 to 100 uM pretreated for 3 hrs followed by EGF stimulation by Western blot analysis\"],[\"Inhibition of human full length recombinant ZAP70 at 5 nM by radiometric scintillation counting analysis relative to control\"],[\"Displacement of [3H]- ZM-241385 from human adenosine A2B receptor expressed in HEK cell at 50 uM\"],[\"Inhibition of CXCR4 expressed in human CAL1 cells assessed as reduction in SDF1alpha-induced intracellular calcium ion concentration preincubated for 45 mins followed by SDF1alpha addition\"],[\"Inhibition of Naja naja venom group 1 secretory phospholipase A2 at 10 uM by liquid scintillation counting\"],[\"Inhibitory activity against recombinant ec dihydrofolate reductase(in 50 uM dihydrofolic acid); ND= Not determined\"],[\"Inhibition of Halo-tagged histone H4 binding to C-terminally NanoLuc luciferase conjugated human TAF1 BD2 (1528 to 1640 residues) expressed in human HCT116 cells after 4 to 24 hrs by BRET assay\"],[\"Decrease in nuclear co-repressor receptor binding to mouse CAR L212A mutant expressed in HEK293 cells at 10 uM by yeast two-hybrid assay\"],[\"ACE (h) CEREP ligand profiling\"],[\"Binding affinity to recombinant human iNOS assessed as dissociation constant by surface plasmon resonance assay\"],[\"Functional activity at human EP4 receptor\"],[\"Agonist activity at Homo sapiens (human) LXRalpha expressed in HepG2 cells assessed as transactivation of SREBP1c gene expression at 10 uM after 48 hr by luciferase reporter gene assay relative to control\"],[\"Inhibition of IL-1-beta-induced tissue factor activity in human PBMC preincubated for 4 hrs assessed after 5 hrs of IL1-beta challenge by one stage clotting assay\"],[\"Inhibition of IKKbeta (unknown origin) at 200 nM by electrophoretic mobility shift assay\"],[\"Agonist activity at beta-2 adrenergic receptor in guinea pig trachea assessed as tracheal relaxation in presence of propranolol\"],[\"Agonist activity at recombinant human GPR119 expressed in HEK293 cells after 24 hrs by steady-glo luciferase assay\"],[\"Non-competitive inhibition of pacific electric ray AChE pre-incubated with enzyme for 15 mins followed by acetylthiocholine chloride substrate addition by spectrophotometric method based Lineweaver-Burk plot analysis\"],[\"Irreversible inhibition of LSD1 (unknown origin) using H3K4me2 peptide substrate assessed as compound-FAD adduct formation after 22 hrs by MALDI-TOF mass spectrometric analysis\"],[\"Antagonist activity at Wnt3a-stimulated rat frizzled-2 expressed in CHO cells incubated for 24 hrs by luciferase reporter gene assay relative to control\"],[\"Agonist activity assessed by stimulation of [35S]GTPgammaS binding in CHO cells expressing 5HT1A receptor relative to 5HT\"],[\"Inhibition of human recombinant HDAC8\"],[\"Inhibition of methionine aminopeptidase 1 in human HeLa cells assessed as increase in ratio of unprocessed 14-3-3gamma to total 14-3-3gamma at 10 uM after 24 hrs by immunoblotting analysis relative to DMSO-treated control\"],[\"Inhibition of ETB receptor (unknown origin) at 10 uM\"],[\"Ratio of Kcat to Km of Escherichia coli KPC2 assessed as drug hydrolysis by spectrophotometry\"],[\"Inhibitory activity against 5-hydroxytryptamine 1D receptor at 10 uM\"],[\"Inhibition of human recombinant microsomal MAO- A expressed in baculovirus infected BTI-TN-5B1- 4 cells assessed as reduction in production of H202 at 50 uM using p-tyramine as substrate incubated for 30 mins followed by substrate addition by horse radish peroxidase\\u002fAmplex red reagent based fluorescence assay\"],[\"Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay\"],[\"Effective dose against rat Metabotropic glutamate receptor 5 occupancy after ip dosing of 10 mg\\u002fkg of 50% PEG400\\u002fH 20\"],[\"Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells at 10 uM by liquid scintillation counting relative to control\"],[\"Binding affinity to FPPS (unknown origin) expressed in Escherichia coli BL21(DEscherichia ) at protein\\u002fligand 1:10 to 1:100 molar ratio by saturation transfer difference NMR analysis\"],[\"Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis\"],[\"Inhibition of radioligand binding to human adrenergic alpha2c receptor at 10 uM\"],[\"Inhibition of recombinant human NEK9 (1 to 324 residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Displacement of [3H]spiperone from human dopamine D2S receptor at 10 uM\"],[\"Antagonist activity at human P2X4 receptor expressed in HEK cells assessed as reduction in ATP induced calcium influx\"],[\"Inhibition of recombinant human MEK5 at 20 nM using Ulight-ARTKQTARKSTGGKAPRKQLAGCG as substrate measured after 120 mins by LANCE method relative to control\"],[\"Inhibition of human IDO1 expressed in HEK293-EBNA cells assessed as reduction in kynurenine formation using tryptophan as substrate at 12.5 uM incubated for 24 hrs by HPLC analysis relative to control\"],[\"Agonist activity at M4 receptor (unknown origin) at 3 uM by calcium mobilization assay\"],[\"Inhibition of N-terminal GST-tagged recombinant human B-Raf (1 to 415 residues) expressed in baculovirus infected Sf21 insect cells using MEK1 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA\"],[\"Inhibition of p38alpha in human MM1S cells assessed as reduction in MSK1 phosphorylation at T581 up to 10 uM by Western blot analysis\"],[\"Inhibition of human IRAK1 at 1 uM\"],[\"Inhibition of c-Kit (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay\"],[\"Stabilization of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as formation of TTR tetramer band formation at 100 mM after 4 mins by SDS-PAGE analysis based glutaraldehyde cross-linking assay\"],[\"Agonist activity at GR in human OVCAR-5 cells assessed as induction of HRE\\u002fLuc activity at 1 to 10 uM incubated for 24 hrs by luciferase reporter gene assay\"],[\"Displacement of [125I]-MCH from rat MCHR1 expressed in CHO cells after 60 mins by scintillation counting\"],[\"Percent residual activity, relative to control, of NEK2a at 1 uM concentration of inhibitor in presence of 50 uM ATP\"],[\"EPHB4 Invitrogen selectivity data (BI)\"],[\"Inhibition of human recombinant full-length topoisomerase-2-alpha-mediated DNA cleavage assessed as relaxation of supercoiled pBR322 at 50 uM after 10 mins using ethidium bromide staining by SDS-PAGE analysis relative to etoposide\"],[\"Inhibition of LPS-induced COX1 in human whole blood assessed as reduction in TXB2 levels by radioimmunoassay\"],[\"Inhibition of wild type C-terminal FLAG-tagged human TEL fused ABL (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay\"],[\"Antagonist activity at human TRPV2 expressed in HEK293T cells assessed as LPC-induced intracellular Ca2+ influx at 100 uM by Fluo-4 AM staining-based fluorescence analysis\"],[\"Activation of TRPM5 in SV40 expressing transgenic mouse Beta-TC-6 cells assessed as induction of 1 mM glucose-mediated insulin secretion after 2 hrs by ELISA\"],[\"Decrease in mouse CAR F171L mutant activation expressed in HEK293 cells at 10 uM by mammalian one-hybrid assay\"],[\"Inhibition of CDC7 in human SW-620 cells assessed as reduction in phosphorylation of MCM2 at Ser40 residue incubated for 48 hrs by Western blot analysis\"],[\"Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibitory constant against human adenosine A3 receptor\"],[\"Negative allosteric modulation of mGlu8 receptor (unknown origin) up to 30 uM\"],[\"Agonist activity at PPARgamma in human HepG2 cells assessed as induction of CD36 mRNA expression at 30 uM incubated for 8 hrs in presence of PPARgamma antagonist GW9662 by qPCR analysis\"],[\"Binding affinity to wild-type human partial length MST1R (I1057 to L1363 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Increase of SERT-mediated [3H]-5HT uptake in rat brain cortex synaptosomes at 10 to 30 uM after 7 mins by scintillation counting\"],[\"Inhibition of human MET by kinase-profiling analysis\"],[\"Displacement of PRP-1 peptide from human Fyn kinase SH3 domain by fluorescence polarization; No competition\"],[\"Binding affinity to human ABL1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of wild-type human partial length EPHA7 (Y608 to S912 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant GST-tagged ALK4 catalytic domain (150 to 505 residues) expressed in baculovirus expression system\"],[\"Inhibition of Bos taurus (calf) intestinal mucosa adenylate deaminase\"],[\"Inhibition of NDR2 Lysine 2 labelling site (unknown origin) at 10 uM\"],[\"Inhibition of full length recombinant human GST-tagged Dyrk1B expressed in baculovirus expression system at 0.5 uM using KKISGRLSPIMTEQ-NH2 peptide as substrate in presence of [gamma-32P]-ATP relative to control\"],[\"Activation of Nrf2 in human L02 cells harboring control siRNA assessed as increase in GCLM mRNA expression at 10 uM measured after 10 hrs by trizol reagent based qRT-PCR analysis\"],[\"Inhibition of recombinant human GST-tagged TIE2 cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control\"],[\"Agonist activity at rat APJ receptor stably expressed in CHO cell membranes in presence of [35S]GTPgammaS by scintillation proximity assay\"],[\"Inhibition of recombinant human PDE3A expressed in HEK293 cells using 3',5'-[3H]cAMP as substrate\"],[\"Inhibition of EGF-induced EGFR phosphorylation at Tyr992 in human MCF7 cells at 1 uM by ELISA\"],[\"Inhibition of human SNARK at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate\"],[\"Inhibition of human acetylcholine esterase in HEK293 cells assessed as reduction in 5-thio 2-nitrobenzoic acid at 10 uM using acetylcholine as substrate after 30 mins by photometry relative to control\"],[\"Inhibition of Flt1\"],[\"Inhibition of human MMP3 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry\"],[\"Agonist activity at Galphaq16-fused human APJ receptor expressed in CHO cells assessed as stimulation of Ca2+ mobilization incubated for 1 hr by Calcium 5-dye based fluorescence based assay\"],[\"Inhibition of [125I]AB-MECA binding to human recombinant adenosine A3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting\"],[\"Agonist activity at human melanocortin 3 receptor expressed in CHO cells assessed as cAMP release at 10 uM relative to alpha-MSH\"],[\"Inhibition of human IR using poly[Glu:Tyr] (4:1) as substrate\"],[\"Antagonist activity at human CX3CR1 expressed in CHO-K1 cells by PathHunter beta-arrestin assay\"],[\"Binding affinity to JMJD6 in human HeLa cells assessed as inhibition of temperature-dependent protein degradation by CETSA\"],[\"Binding affinity to human recombinant BHMT expressed in Escherichia coli by intrinsic tryptophan fluorescence studies\"],[\"Inhibition of human recombinant Pyk2 using poly[Glu:Tyr] as substrate at 1 uM by [gamma-33P]ATP-based assay\"],[\"Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of RSK2 Kin.Dom1.1-N-terminal (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Activation of human 20S immunoproteasome beta-2 at 50 uM using BocLRR-AMC as substrate incubated for 15 mins measured for 45 mins by fluorescence assay relative to control\"],[\"Binding affinity to norepinephrine transporter by radioligand binding assay\"],[\"Inhibition of T4 polynucleotide kinase at 100 uM relative to control\"],[\"Binding affinity to HSP90 in human NCI-H69 cells after 24 hrs by fluorescence polarization assay\"],[\"Inhibition of 20s immunoproteasome beta5 chymotrypsin-like activity in human spleen using Suc-Leu-Leu-Val-Tyr-AMC as substrate after 10 mins by fluorescence assay\"],[\"Displacement of [3H]-ketanserin from 5HT2A receptor in rat cortex measured after 30 mins\"],[\"Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Binding affinity to C-terminal V5 epitope tagged human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as incorporation of Cy5.5 pretreated with methyl 4-(1-butyl-3-(3-(4-(fluorosulfonyl)benzamido)propyl)-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)bicyclo[2.2.2]octane-1-carboxylate for 90 mins followed by labeling addition and measured after 90 mins by immunoblotting analysis\"],[\"Inhibition of recombinant human PEK (536 to end residues) at 1 uM using RSRSRSRSRSRSRSR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"FRAP1 (MTOR) Invitrogen Lab (UK) kinase screen (BI)\"],[\"Displacement of [3H](+)-pentazocine from sigma 1 receptor in guinea pig brain membranes measured after 120 mins by scintillation counting method\"],[\"Displacement of [3H](+)-pentazocine from sigma-1 receptor in guinea pig brain cortex after 120 mins by scintillation counting analysis\"],[\"Agonist activity at Homo sapiens (human) FXR ligand binding domain expressed in HepG2 cells assessed as transactivation of GAL4 gene expression at 100 nM after 48 hr by luciferase reporter gene assay relative to control\"],[\"Agonist activity at histamine H1 receptor in human A431 cells at 1 uM preincubated for 1 hr followed by histamine addition by DMR assay\"],[\"Inhibition of Steroid 5-alpha-reductase type 2 from human benign prostatic hyperplasia (BPH) tissue\"],[\"Inhibition of PBK (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of wild type human IKKbeta (M1 to S756 residues) expressed in mammalian cells assessed as residual activity at 1 uM by KINOMEscan assay relative to control\"],[\"Inhibition of amyloid beta 1 to 42 (unknown origin)-induced cytotoxicity in human SH-SY5Y cells at 1 to 5 uM incubated for 24 hrs by MTT assay\"],[\"Inhibition of jack bean urease using urea as substrate assessed as ammonia production incubated for 15 mins by indophenol method\"],[\"Inhibition of FLT3 ITD mutant (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay\"],[\"Binding affinity to HSP90alpha (unknown origin)\"],[\"Displacement of [3H]DPCPX from human Adenosine A2B receptor expressed in HEK293 cells; range 157-268\"],[\"Inhibition of Caspase-6 (unknown origin) assessed as inhibition of release of AMC fluorescent product using Ac-VEID-AMC as substrate at 10 uM incubated for 30 mins by microplate reader relative to control\"],[\"Inhibition of IGF1 receptor (unknown origin) after 60 mins\"],[\"Displacement of (1-(2-aminoethyl)-3,5-dimethyl-1H-pyrazol-4-yl)(4-((1-neopentyl-1H-benzo[d]imidazol-2-yl)methyl)piperazin-1-yl)methanone from FNTA in vorinostat-stimulated human Jurkat 2C4 cells infected with latent HIV-1 by pull-down experiment based competitive binding assay\"],[\"Inhibition of COX-2 in human 143982 cells\"],[\"Displacement of [3H]CGS21680 from human A2A adenosine receptor expressed in HEK293 cell membranes after 120 mins by radioligand displacement assay\"],[\"Inhibition of PRMT6 (unknown origin) by scintillation proximity assay\"],[\"Inhibition of human group 6A iPLA2 using PAPC\\u002f[14C]-labeled PAPC as substrate at 0.091 mole fraction after 30 mins by mixed micelle-based assay relative to control\"],[\"Inhibition of P300 (unknown origin)\"],[\"Inhibition of N-terminal His-tagged truncated human PI3Kbeta (deltaN 1 to 108 residues) after 2 hrs in presence of [33P]ATP by BetaPlate liquid scintillation counting analysis\"],[\"Inhibition of c-Kit (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay\"],[\"Inhibition of CDC7 in human MDA-MB-231T cells assessed as inhibition of MCM2 phosphorylation at Ser53 after 4 hrs\"],[\"Inhibition of human recombinant trypsin 1 using tosyl-GPR-pNA substrate by spectrophotometry\"],[\"Agonist activity at human mGluR7a assessed as effect on cAMP production in RGT cells upto 100 uM\"],[\"Transactivation of PPARgamma in mouse 3T3L1 cells assessed as increase in FABP4 expression at 2 uM by qPCR method\"],[\"Inhibition of VPS15 (unknown origin)\"],[\"Agonist activity at human adrenergic beta3 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay\"],[\"Displacement of [3H]mesulergine from human recombinant 5-HT2B receptor at 10 uM incubated for 60 mins by radiometric scintillation analysis\"],[\"Inhibition of ram seminal vesicle COX1 assessed as reduction in PGE2 formation pre-incubated for 5 mins before arachidonic acid addition and measured after 20 mins by ELISA\"],[\"Inhibition of recombinant HIV1 integrase 3^-end processing and strand transfer activity after 1 hr\"],[\"Inhibition of wild type EGFR T790M mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay\"],[\"Inhibition of STAT3 phosphorylation at Ser727 residue in human MDA-MB-231-4175 cells at 3 uM after 3 hrs by Western blotting analysis\"],[\"Displacement of [125I]PYY from human NPY2\"],[\"Inhibition of human recombinant COX-2 by enzyme immunoassay\"],[\"Inhibition of human AURKA activity using Ser\\u002fThr 1 peptide as substrate by FRET assay\"],[\"Inhibition of RSK2 domain 1 ATP binding site (unknown origin) at 10 uM\"],[\"Inhibition of wild-type human partial length MAPKAPK5 (M1 to D322 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of mouse ACC1\"],[\"Inhibition of human DYRK2 assessed as residual activity at 1 uM using RRRFRPASPLRGPPK as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of MALT1 C domain (329 to 824 residues) (unknown origin) using Ac-Trp-Leu-Arg-Ser-Arg-Cys(PT14)-NH2 as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins by fluorescence lifetime-based microtitre plate reader analysis\"],[\"Inhibition of human MINK1 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human PDE5A1 catalytic domain (535 to 860 residues) expressed in Escherichia coli BL21 using 3H-cGMP as substrate after 15 mins by liquid scintillation counting method\"],[\"Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Reversal of ABCB1-mediated multidrug resistance in human A2780\\u002fADR cells assessed as potentiation of daunorubicin-induced cytotoxicity by measuring daunorubicin GI50 at 5 uM incubated for 72 hrs by MTT assay (Rvb = 0.710 +\\u002f- 0.034 uM)\"],[\"Inhibition of human ERG up to 25 uM\"],[\"Inhibition of Clostridium perfringens neuraminidase at 1.56 uM by fluorimetry\"],[\"Inhibition of human recombinant Rsk1\"],[\"Antagonist activity at alpha2 adrenoreceptor in rat brain cortical membranes assessed as inhibition of [3H]-RX821002 binding to receptor after 45 mins by competition assay in presence of GTP\"],[\"Inhibition of PDGFRbeta (unknown origin) assessed as residual activity at 1 uM\"],[\"Binding affinity to norepinephrine transporter (unknown origin) 10 umol\\u002fL by radioligand binding assay\"],[\"Agonist activity at human recombinant PPARalpha by transactivation of TK-MH100x4-LUC reporter gene in HEK293 cells\"],[\"Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter\"],[\"Inhibition of IL1beta-induced NFkappaB p65 nuclear translocation in human SK-N-SH cells after 15 mins by ELISA\"],[\"EGF-R T790M\\u002fL858R ProQinase selectivity panel\"],[\"Inhibition of COX1 in human whole blood assessed as effect on A23187-induced thromboxane B2 production at 10 uM relative to control\"],[\"Inhibition of LCK (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control\"],[\"Inhibition of MAGL in rat brain homogenate assessed as accumulation of 2-AG at 10 uM measured after 15 mins by HPLC-MS analysis relative to control\"],[\"Inhibition of Rb phosphorylation at serine 807\\u002f811 in human A549 cells after 24 hrs by Western blot analysis\"],[\"Inhibition of SCD1 in human A431 cells assessed as conversion of 13C-palmitic acid to 13C-palmitoleic acid after 4 hrs by LC\\u002fMS analysis\"],[\"Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human EGFR autophosphorylation expressed in Sf9 cells DELFIA assay\"],[\"Inhibition of recombinant human Rsk2 (2 to end residues) assessed as residual activity at 10 uM using KKKNRTLSVA as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Antagonist activity at rat glutamate N1\\u002f2A receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology assay\"],[\"Inhibition of ATX in human plasma assessed as inhibition of LPA 18:2 production after 2 hrs by LC-MS\\u002fMS analysis relative to control\"],[\"Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 13.7 to 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis\"],[\"Inhibition of fluorescein-labeled kinase tracer binding to TYK2 JH2 domain (unknown origin) after 90 mins by HTRF assay\"],[\"Inhibition of human recombinant pancreatic lipase expressed in Pichia pastoris at 200 molar excess compound concentration pre-incubated for 2 hrs with enzyme before substrate addition by pH-stat technique\"],[\"Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells at 1 uM\"],[\"Percent inhibition of papain by the compound at pH 8.0\"],[\"Binding affinity to wild-type human partial length BRAF (S429 to E741 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human carbonic anhydrase 2 at 200 uM using p-nitrophenyl acetate as substrate preincubated for 15 mins followed by substrate addition and measured every 1 min for 20 mins\"],[\"Inhibition of MDM2 in human U87MG cells assessed as increase in p53 accumulation at 100 nM after 24 hrs by Western blot method\"],[\"Inhibition of recombinant full-length human TSSK2 using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis\"],[\"Binding affinity to CB2 receptor (unknown origin) at 25 uM relative to control\"],[\"Binding affinity to human biotinylated Avi-tagged BCL6 BTB domain C8Q\\u002fC67R\\u002fC84N triple mutant expressed in Escherichia coli BL21 (DE3) using 1 % DMSO by SPR analysis\"],[\"Inhibition of mouse HDAC6 using fluorescent substrate Ac-KGLGK(Ac)-MCA after 30 mins by fluorescence plate reader\"],[\"Substrate activity at recombinant His6\\u002fSUMO-tagged human cN3B (1 to 300 residues) expressed in Escherichia coli BL21(DE3) RIL assessed as compound dephosphorylation by measuring ratio of Kcat to Km up to 30 mins by malachite green dye based assay\"],[\"Displacement of 2OG from catalytic domain of PHD2 (181 to 426) (unknown origin) Zn2 expressed in Escherichia coli at 150 uM\"],[\"Inhibition of 9 (2 nM) binding to Opioid receptor kappa 1 of rat brain homogenate\"],[\"Binding affinity to wild-type human full length ADCK3 (M280 to Q647 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of MEK1 (unknown origin) at \\u003c1 uM using GST-ERK1 as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in presence of [gamma33P]ATP by scintillation counter method\"],[\"Inhibition of cMET (unknown origin) using FAM-labeled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay\"],[\"Inhibition of recombinant JMJD2E (unknown origin) incubated for 15 mins prior to substrate addition by AlphaScreen method\"],[\"Inhibition of human factor 10a assessed as cleavage of S-2222 substrate\"],[\"Inhibition of FGFR3 (unknown origin) transfected in mouse BA\\u002fF3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay\"],[\"Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells\"],[\"Increase in insulin-induced IRbeta phosphorylation in HepG2 cells after 2 hrs at 20 nM\"],[\"Displacement of [125I]-Tyr0-sauvagine from CRF1 receptor (unknown origin)\"],[\"Inhibition of GLP (unknown origin) assessed as reduction in incorporation of [3H]-labeled methyl group into biotinylated substrate using [3H-SAM] at 10 uM incubated for 1 hr by scintillation proximity assay\"],[\"Inhibition of human reticulocyte N-terminal His6-tagged 15-lipoxygenase by UV-vis spectrometry\"],[\"Binding affinity to His-6-tagged rat VDR R270L mutant over expressed in Escherichia coli C41 assessed as increase in transition temperature by at 5 mM by CD-based spectropolarimetric analysis\"],[\"Inhibition of human placental CYP19 using [1beta-3H]androstenedione substrate at 500 uM\"],[\"Antagonist activity at human PPARgamma transfected in HepG2 at 5 uM in presence of PPARgamma agonist rosiglitazone by luciferase reporter assay\"],[\"Inhibition of human recombinant His-tagged TNF-alpha-mediated E-selectin expression in HUVEC cells preincubated for 30 mins in presence of TNFalpha and measured after 3 hrs by flow cytometry analysis relative to control\"],[\"Inhibition of human recombinant AChE by Ellman's method\"],[\"Transactivation of GAL4-fused human PPARdelta LBD expressed in human HepG2 cells up to 2 uM after 20 hrs by luciferase reporter gene assay relative to L-165,041\"],[\"Agonist activity at human recombinant 5-HT2A receptor expressed in CHO-K1 cells by luminescence analysis\"],[\"Inhibition of human recombinant ADAMTS5 expressed in HEK293 cells using Abz-TESEwSRGAIY-Dpa-KK as substrate at 5 uM measured for 2 hrs by fluorometric analysis\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 1.25 uM incubated for 16 to 18 hrs in presence of 0.019 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Inhibition of HER4 (unknown origin) at 1 uM after 1 hr relative to control\"],[\"Inhibition of recombinant human C-terminal His-tagged CD73 (27 to 549 residues) expressed in HEK293 cells using AMP as substrate preincubated for 1 hr followed by substrate addition and measured after 30 sec by malachite green based assay\"],[\"Inhibition of kappa opioid dependent ERK1\\u002f2 phosphorylation in U50488 treated HEK293 cells expressing GFP tagged kappa opioid receptor\"],[\"Inhibition of human ERG current in HEK293 cells at 10 uM by patch clamp method relative to control\"],[\"COX2(h) CEREP ligand profiling\"],[\"Ratio of compound IC50 to (S)-4-((S)-1-acetylpyrrolidine-2-carboxamido)-5-((2S,4R)-2-((2S,3R)-1-((S)-1-((S)-2-((S)-2-((S)-1-((S)-1-amino-4-carboxy-1-oxobutan-2-ylamino)-4-carboxy-1-oxobutan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-3-hydroxy-1-oxobutan-2-ylcarbamoyl)-4-(3,4-dimethoxybenzylideneaminooxy)pyrrolidin-1-yl)-5-oxopentanoic acid IC50 for human Tsg101 binding to GST-tagged P6 protein\"],[\"Binding affinity to human VLA4 at 37 degC after 3 hrs\"],[\"Inhibition of Mer phosphorylation in human 697 cells preincubated for 1 hr by densitometry\"],[\"Inhibition of wild-type human partial length ERBB3 (G684 to A987 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of N-terminal His6-tagged recombinant human PI3Kgamma (468 to 1203 residues) using biotinylated PIP3 as substrate by HTRF analysis\"],[\"Inhibition of human FXIIa\"],[\"Mean percent of maximum efficacy against human peroxisome proliferator-activated receptor gamma\"],[\"Inhibition of rabbit skeletal muscle glycogen phosphorylase b assessed as inorganic phosphate release using glucose-1-phosphate as substrate at pH 6.8 at 250 uM\"],[\"Inhibition of recombinant SRPK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM\"],[\"Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips\"],[\"Inhibition of MT1-MMP-mediated proMMP-2 activation in human HT1080 cells stimulated with type I collagen for 24 hrs followed by compound addition assessed as increase in proMT1-MMP (65 KDa) level at 1 to 10 uM and measured after 24 hrs by Western blot analysis\"],[\"Non-competitive inhibition of Trypanosoma cruzi trypanothione reductase assessed as reduction in NADPH consumption using varying levels of trypanothione disulfide as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of P-gp in human KB-V1 cells assessed as increase in rhodamine 123 accumulation at 200 nM\"],[\"Inhibition of human JNK2alpha2\"],[\"Inhibition of STAT3 phosphorylation at tyr705 in human A549 cells at 4 uM after 24 hrs by Western blot analysisis\"],[\"Activation of procaspase-3 in mouse EL4 cells assessed as increase in cell death by measuring combination index at 5 uM after 24 hrs in presence of 500 nM doxorubucin by alamar blue assay\"],[\"Inhibition of SUV39H2 (unknown origin) at 1 to 10 uM\"],[\"Agonist activity at mouse NMUR1 expressed in HEK293 cells by calcium mobilization assay\"],[\"Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis\"],[\"Displacement of [3H]-folic acid from human FRalpha expressed in Chinese Hamster MTXRII-OuaR2-4 R2 cells after 15 mins by liquid scintillation counting method\"],[\"Antagonist activity at rat TAAR1 assessed as reversal of endogenous beta-PEA effect\"],[\"Inhibition of AICARFT in human MDA-MB-231 cells assessed as increase in ZMP levels using regular folate media after 16 hrs by LC-MS method\"],[\"Antagonist activity at human vasopressin V1B receptor at 10 uM\"],[\"Reactivation of sarin inhibited human erythrocyte AChE assessed as residual activity at 10 to 1000 uM using acetylthiocholine iodide as substrate preincubated for 2 to 120 mins followed by substrate addition measured for 3 mins by Ellman's method\"],[\"Inhibition of human FLAG-tagged HDAC1 expressed in human 293T cells assessed as formation of amino methyl coumarin from Ac-KGLGK(Ac)-MCA measured after 30 mins by fluorescence analysis\"],[\"Inhibition of rabbit skeletal muscle glycogen phosphorylase b at 625 uM by Lineweaver-Burke plot analysis\"],[\"Inhibition of human recombinant N-terminally His6-tagged SIRT2 after 4 hrs by homogeneous fluorescent deacetylase assay\"],[\"Binding affinity to wild-type human full length DYRK1B (M1 to S629 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control\"],[\"Tyrosine Kinase Activity Assay: Tyrosine kinase activity assay (NADH Read-Out)using human c-Met protein (Invitrogen, Carlsbad, Calif., USA). The amount of phosphorylated substrate is evaluated by measurement of the decrease of NADH fluorescence.\"],[\"Inhibition of wild-type human full length PCTK3 (M3 to F474 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of human cloned MC4R expressed in CHO cells at 5 uM relative to [125I]NDPalphaMSH\"],[\"Reversible inhibition of recombinant human MAO-B assessed as recovery of enzyme activity at 5 uM preincubated for 20 mins followed by overnight dialysis\"],[\"Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response\"],[\"Inhibition of Torpedo california AChE at 0.1 mM by Ellman's method\"],[\"Inhibition of RET V804M mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in RET phosphorylation at Y905 residue at \\u003e 0.3 uM incubated for 24 hrs by Western blot analysis\"],[\"Activity at human Prostanoid EP3 receptor up to 10 uM\"],[\"Inhibition of aromatase in SK-BR-3 cells by tritiated water release assay at 2.5 uM\"],[\"Inhibition of CHK1 (unknown origin) assessed as residual activity at 10 uM relative to control\"],[\"SGK3 ProQinase selectivity panel\"],[\"Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP\"],[\"Inhibition of KDM4D (unknown origin) using biotinylated H3K9me3 peptide and alpha-ketoglutarate as substrate pretreated for 1 hr followed by substrate addition measured after 20 mins by LANCE TR-FRET assay\"],[\"Uncompetitive inhibition of human DNMT3A using AdoMet as substrate\"],[\"Inhibition of ABCB1 in human SW620\\u002fAD300 cells assessed as potentiation of cisplatin-induced cytotoxicity by measuring fold reduction in cisplatin IC50 at 10 uM after 72 hrs by MTT assay relative to cisplatin\"],[\"Binding affinity to HPS6 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of wild-type human partial length MTOR (L1382 to W2549 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human c-SRC assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control\"],[\"Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins in presence of 100 uM ATP by ELISA\"],[\"Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by atomic force microscopy\"],[\"Competitive inhibition of human HDAC6 CD2 expressed in Escherichia coli BL21 (RIL) assessed as substrate Vmax using Boc-Lys (Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by fluorescence assay\"],[\"Inhibition of human partial length BRD7 (L125 to R254 residues) expressed in mammalian expression system assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control\"],[\"Binding affinity to CNKSR1 PH-domain (unknown origin) assessed as binding RUmax by SPR spectroscopy\"],[\"Inhibition of mPGES-1 in human A549 cells assessed as PEG2 formation preincubated for 30 mins followed by recombinant human interleukin 1beta addition measured after 18 hrs by LC\\u002fMS analysis\"],[\"Competitive inhibition of recombinant wild-type human TRAP1 ATPase activity expressed in Escherichia coli BL21 (DE3) assessed as ratio of substrate Kcat to Km at 5 uM preincubated for 0.5 hrs followed by varying levels of ATP addition and measured after 3 hrs using PiColorLock Gold reagent by colorimetric assay-based Lineweaver-Burk plot analysis (Rvb = 10.3 +\\u002f- 0.54 10'-5 \\u002fs\\u002fuM)\"],[\"Inhibition of MAPK\\u002fNF-kappaB in mouse BMM cells assessed as down regulation of RANKL-induced NFATc1 expression at 10 uM pre-treated for 30 mins before RANKL-stimulation for 24 hrs by Western blot analysis\"],[\"Inhibition of human recombinant NEP using Mca-RPPGFSAFK(Dnp)-OH as substrate incubated for 15 mins prior to substrate addition measured after 20 to 30 mins by fluorimetric analysis\"],[\"Inhibition of HER2 (unknown origin) at 10 uM relative to control\"],[\"Effective concentration against human Cannabinoid receptor 1 (hCB1)\"],[\"Inhibition of EL in human HT1080 cells using D31-POPC-HDL as substrate incubated for 2 hrs in presence of human serum by LC\\u002fMS analysis\"],[\"Inhibition of RIPK1 in Z-VAD-fmk (TSZ)-induced human HT-29 cells assessed as reduction in RIPK1-RIPK3 necrosome formation at 1 uM measured after 6 hrs by Western blot analysis\"],[\"Displacement of [3H]-CP55,940 from human CB1 receptor transfected in CHOK1 cells at 10 uM\"],[\"Inhibition of human recombinant NQO1 by spectrophotometry\"],[\"Inhibition of human c-SRC at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of human recombinant PTP1B catalytic domain using p-nitrophenyl phosphate as substrate by micro plate reader method\"],[\"Inhibition of wild type mouse COX2 at 25 uM by discontinuous radioactive TLC assay relative to control\"],[\"Agonist activity at human delta opioid receptor expressed in CHO cells assessed as [35S]-GTP[gammaS] binding relative to SNC80\"],[\"Inhibition of Myc-tagged ULK1 (unknown origin) expressed in HEK293T cells cotransfected with wild-type Flag tagged Vps34 assessed as decrease in pVPS34 Ser249 at 10 uM measured after 1 hr by Western blot analysis relative to control\"],[\"Inhibition of DprE1 in Mycobacterium tuberculosis H37Rv assessed as accumulation of trehalose dimycolates at 10 times MIC measured after 24 hrs in presence of [14C]-acetate by TLC-based autoradiography\"],[\"Ratio of tacrine IC50 to compound IC50 for electric eel AChE in presence of horseradish peroxidase and H2O2 and DETAPAC\"],[\"Inhibition of beef liver dihydrofolate reductase by amide-linked conjugate of MTX (4 M\\u002fM of IgG) and rabbit IgG (NRG) in experiment 1\"],[\"Activity of human leukocyte 5-lipoxygenase by UV-visible spectrophotometry\"],[\"Antagonist activity at mouse mGluR1 expressed in CHO cells assessed as calcium flux by FLIPR assay\"],[\"Inhibition of CYP17 at 2.5 uM\"],[\"Agonist activity at PSGR\\u002fOR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring hydroquinone level at 100 nM incubated for 72 hrs by GC\\u002fMS analysis\"],[\"Binding affinity to wild-type human partial length N-terminal RSK1 Kinase domain 1 (M1 to E388 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of human PIK3CG (144 to 1102 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay\"],[\"Inhibition of recombinant rat N-terminal GST-tagged DYRK1A (1 to 499 residues) expressed in Escherichia coli using KKISGRLSPIMTEQ-NH2 as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control\"],[\"Beta 2-adrenergic receptor agonistic activity as cAMP accumulation in CHO cells\"],[\"Inhibition of FAAH-mediated [14C]anandamide hydrolysis in rat brain membrane assessed as [14C]-ethanolamine production up to 50 uM after 30 mins by scintillation counting\"],[\"Inhibition of NAMPT in mouse cells assessed as reduction in NAD level after 48 hrs by mass spectrometry\"],[\"Inhibition of PTP1B (unknown origin) using nitrophenyl phosphate as substrate after 30 mins by spectrophotometry\"],[\"Inhibition of MMP9 expression in human MDA-MB-231 cells after 24 hrs by gelatin zymography assay\"],[\"Binding constant for PTK2 kinase domain\"],[\"Inhibition of human Rsk3\"],[\"Progestational activity by Clauberg test in rabbits as McPhail index after 30 mg peroral dose\"],[\"Inhibition of ALDH1A1 in human drug-tolerant MDA-MB-231\\u002flapatinib cells assessed as after 24 hrs\"],[\"In vitro binding affinity against HIV protease was measured\"],[\"Binding selectivity to transthyretin in human blood plasma after 24 hincubation with 10.8 uM inhibitor\"],[\"Displacement of [125I](S)-1-(3-iodophenyl)-3-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea from human CCK1 receptor expressed in CHO cells by gamma spectrometry\"],[\"BACE Assay: For each compound being tested, the BACE activity was monitored in a fluorescence quenching assay (FRET) using the ectodomain of BACE (aa 1-454) fused to a myc-his tag and secreted from HEK293\\u002fBACEect. cells into OptiMEM (Invitrogen) as enzyme source and a substrate peptide derived from the APP-Swedish mutation which possesses a Cy3-fluorophore at the N-terminus and a Cy5Q-quencher at the C-terminus (Cy3-SEVNLDAEFK-Cy5Q-NH2; Amersham).\"],[\"Agonist activity at GLP1 receptor in mouse BetaTC6 cells assessed as increase in insulin secretion at 10'-15 to 10'-12 M after 120 mins by sandwich ELISA\"],[\"Displacement of [3H]kainate from rat GLUK6 receptor expressed in HEK293 cells\"],[\"Binding affinity for human adenosine A1 receptor using [3H]DPCPX; insoluble\"],[\"Inhibition of fibril formation of human alpha-synuclein A53T mutant expressed in Escherichia coli BL21(DE3) assessed as reduction in mature fibrils formation at 2 uM after 100 hrs by uranyl acetate staining based transmission electron microscopic method\"],[\"Displacement of [3H]histamine from human recombinant H4R expressed in CHO cells incubated for 60 mins by microbeta scintillation counter method\"],[\"Inhibition of mTOR in human A2058 cells assessed as reduction in phosphorylation of S6 at ser235\\u002f236 residues after 1 hr by in-cell Western method\"],[\"Compound ability to inhibit the production of HIV reverse transcriptase (RT) in culture supernatant of CEM-CL13 on at 22 days at a concentration 0.2 uM\"],[\"Inhibition of human Protein kinase C epsilon\"],[\"Activation of N-terminal (His)6 and Xpress-tagged LTA4H (unknown origin) expressed in Escherichia coli BL21(DE3) cells assessed as increase in aminopeptidase activity by measuring Km for p-nitroanilide release at 0.1 uM using L-Alanine-p-nitroanilide incubated for 10 mins by UV plate reader based assay (Rvb = 1.59 +\\u002f- 0.09 mM)\"],[\"Agonist activity at mouse P2Y10 receptor expressed in McA-RH7777 cells assessed as actin stress fiber formation at 1 uM after 30 mins by confocal microscopy\"],[\"Inhibition of recombinant full length human HDAC9 expressed in SF9 baculovirus using FAM- labelled acetylated peptide as substrate measured by Electrophoretic mobility shift assay\"],[\"Binding affinity towards Opioid receptor kappa 1 from guinea pig brain using [3H]U-69593 as radioligand\"],[\"Inhibition of recombinant human carbonic anhydrase 9 at 1 uM preincubated for 15 mins by phenol red dye based stopped flow CO2 hydration assay (Rvb = 0%)\"],[\"Binding affinity to NK1 receptor (unknown origin)\"],[\"Induction of GFP-tagged PKC gamma translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 20 uM\"],[\"Binding affinity to human MLK3\"],[\"Inhibition of CCK-B receptor in lumen perfused albino mouse stomach assessed as reduction in boc-pentagastrin-induced gastric acid secretion at 100 nM after 45 mins relative to control\"],[\"Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system by measuring active site-directed competition binding based Kinomescan method\"],[\"Inhibition of GST-MLK3 expressed in baculovirus\"],[\"Inhibition of MRP4 in 7 mW\\u002fcm'2 irradiated human M14 cells assessed as reduction in MRP4 ATPase activity at 5 uM measured after 20 mins by spectrophotometric method\"],[\"Inhibition of PARP2 (unknown origin) after 1 min in presence of NAD by top count analysis\"],[\"Displacement of [3H]CCPA from rat adenosine A2a receptor\"],[\"Inhibition of recombinant PAK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM\"],[\"Inhibition of wild type His-tagged TGFbetaR2 (unknown origin) after 1 hr by HTRF assay\"],[\"Inhibition of human wild type BRAF at 10 uM by ELISA\"],[\"Inhibition of recombinant human 6His-tagged MMP9 catalytic domain (112 to 445 residues) expressed in Escherichia coli at 4 to 25 nM using 5-FAM\\u002fQXL520 FRET peptide as substrate preincubated for 15 mins followed by substrate addition and measured at 3 mins interval for 60 mins by fluorescence assay\"],[\"Agonist activity at Gal4 DNA binding domain-fused human ERRalpha LBD transfected in human HepG2 cells at 1 uM after 24 hrs relative to control\"],[\"Inhibition of human Tie2 at 0.1 uM\"],[\"Binding affinity to NET (unknown origin)\"],[\"Inhibition of RET (unknown origin) pre-incubated for 3 mins before substrate addition in presence of 9 uM ATP by microfluidic assay\"],[\"Inhibition of PI3Kbeta in PTEN-null human MDA-MB-468 cells assessed as inhibition of Akt phosphorylation after 2 hrs\"],[\"Inhibition of human plasma lipoprotein-associated phospholipase A2 using 2-thio-PAF as substrate preincubated for 20 mins measured 1 hr post substrate addition by spectrophotometric analysis in presence of 50 uM FeCl3\"],[\"Residual activity against rabbit muscle class1 Aldolase at 1 mM after 15 min\"],[\"Displacement of [35S]-labeled MK-499 from cloned human ERG receptor expressed in HEK cells\"],[\"Binding affinity to human PlGF-2 by surface plasmon resonance study\"],[\"Inhibition of human recombinant MAGL assessed as remaining activity at 10 uM after 10 mins by spectrophotometry relative to control\"],[\"Ratio of Kcat to Km for bovine eNOS by Michaelis-Menten equation analysis\"],[\"PKC-mu ProQinase selectivity panel\"],[\"Inhibition of PHGDH (unknown origin) by FLINT method\"],[\"Inhibition of HGF-induced c-Met phosphorylation in human A549 cells at 10 uM pretreated for 2 hrs prior to HGF addition measured after 15 mins by Western blot analysis\"],[\"Binding affinity to human 5HT7 receptor at 10 uM by radioligand binding assay\"],[\"In vitro inhibition of [125I][Leu8,D-Trp22,Tyr25] somatostatin 28 binding to human somatostatin receptor type 3 expressed in CCL39 cells; (n=5)\"],[\"Antagonist activity at Gal4 DNA binding domain-tagged human progesterone receptor ligand binding domain expressed in HEK293 cells assessed as inhibition of receptor-mediated transcriptional activity by luciferase reporter gene assay\"],[\"Inhibition of human topoisomerase 2alpha-mediated relaxation of supercoiled pBR322 DNA after 30 mins by agarose gel electrophoresis\"],[\"Inhibition of NF kappaB p50 subunit signaling pathway in human HeLa cells by biotinylated-ELISA\"],[\"Binding affinity to HuR (unknown origin) assessed as positive STD factor by measuring interaction of protons of ring B and its methoxy group with protein at 400 uM in 100% D2O buffer by DEEP-STD NMR analysis\"],[\"Binding affinity to human GalR1\"],[\"Blocking activity was assessed by antagonism of (-)-phenylephrine induced contraction of rat spleen (alpha1B adrenoceptor)\"],[\"Inhibition of c-KIT mediated signaling pathways assessed as reduction in S6K phosphorylation at T389 in human GIST882 cells at 1 uM measured after 2 hrs by immunoblotting\"],[\"Activation of Nrf2 expression in human HCT116 cells after 8 hrs by western blot analysis\"],[\"Inhibition of human MDR1 expressed in mouse L5178 cells assessed as accumulation of Rh123 by measuring fluorescence activity ratio preincubated for 10 mins followed by Rh123 addition measured after 20 mins by FACS analysis\"],[\"Induction of human recombinant topoisomerase 2-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 uM after 2 hrs by TARDIS assay\"],[\"Binding affinity to Pin1 (unknown origin) assessed as Cys113-compound adduct formation at 88.8 uM after 2 hrs by IAA probe based LC-ESI-MS analysis\"],[\"Inhibition of ABCB1 in multidrug-resistant human KB-C2 cells assessed as increase in reversal of resistance to paclitaxel-induced cytotoxicity by measuring reduction in paclitaxel IC50 at 4 uM pre-incubated for 4 hrs followed by paclitaxel addition and measured after 72 hrs by MTT assay\"],[\"Antagonist activity at human mu opiod receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding incubated for 4 hrs by microbeta liquid scintillation counting method\"],[\"Inhibition of MAO-A (unknown origin) by fluorescence assay\"],[\"Inhibition of PRMT1 in human MV411 cells assessed as reduction in arginine methylation after 48 hrs by Western blot analysis\"],[\"Activation of recombinant human TASK1 expressed in HEK293T cells assessed as increase in K+ current amplitude at 10 uM by whole cell voltage clamp electrophysiological analysis\"],[\"Binding affinity to recombinant GST-tagged mouse SPSB2 (12 to 224 residues) expressed in Escherichia coli BL21 (DE3) assessed as association rate by SPR analysis\"],[\"Inhibition of UBC12 in human A549 cells assessed as decrease in Cullin1-Nedd8 adduct level at 50 uM measured after 6 to 12 hrs by Western blot analysis\"],[\"Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug\\u002fmL\"],[\"Inhibition of CSF1-stimulated human FMS autophosphorylation expressed in growth factor dependent mouse FDC-P1 cells assessed as phosphorylated receptor level at 10 uM relative to control by Western blot\"],[\"Binding affinity to human partial length BRD4 (BD1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of p56 Lck tyrosine kinase catalytic domain at 5 uM ATP (not tested)\"],[\"Inhibition of JAK2 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay\"],[\"Upregulation of EGFR phosphorylation at Ser1070 residue in human HCC cells at 30 uM by KEGG analysis relative to control\"],[\"Inhibition of human recombinant CA4 expressed in Escherichia coli preincubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Reactivation of paraoxon-inhibited bovine red blood cellular AChE at 5 mM after 1 hr\"],[\"Displacement of [3H]Iloprost from human prostanoid IP receptor expressed in CHO cells after 30 mins by liquid scintillation counting\"],[\"Binding affinity to biotin-labeled human recombinant laminin-1 at 10 ug\\u002fml in pH 7.4 Tris buffer by fluorescence microarray method\"],[\"Displacement of [3H]5-CT from recombinant human 5HT1B receptor stably expressed in HEK cells measured after 90 mins by microbeta scintillation counting method\"],[\"Inhibition of human NTS1 receptor at 1 uM relative to control\"],[\"Displacement of [3H]phorbol 12,13-dibutyrate from PKC gamma-C1A\"],[\"Inhibition of human wild type partial length SYK (D354 to N635 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control\"],[\"Displacement of [3H]N-methylspiperone from human D3 receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method\"],[\"Binding affinity to Max in human P493-6 cells assessed as decrease in Myc protein levels\"],[\"Displacement of [3H]NMS from human muscarinic acetylcholine receptor M1 expressed in CHOK9 cells after 3 hrs by liquid scintillation counting assay\"],[\"Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human SAPK2a T106M mutant at 10 uM after 60 mins by TR-FRET assay\"],[\"Displacement of [3H]epibatidine form human alpha7 nAchR expressed in HEK293 cells\"],[\"Displacement of [125I]CCK-8s from human recombinant CCK2 receptor expressed in CHO cells at 100 uM measured after 60 mins by scintillation counting method relative to control\"],[\"Displacement of TAMRA-labeled dexamethasone from glucocorticoid receptor (unknown origin) by fluorescence polarization competitive binding assay\"],[\"Inhibition of FITC-labeled Bak BH3 peptide binding to GST-tagged BFL1 (1 to 151 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 10 uM incubated for 30 mins fluorescence polarization-based competitive binding assay relative to control\"],[\"Inhibition of PI3K p110alpha in mouse embryonic fibroblast cells assessed as reduction in PDGF-induced AKT phosphorylation at S473 residue preincubated for 2 hrs followed by PDGF stimulation and measured after 10 mins\"],[\"Binding affinity to wild-type human full length p38-delta (M1 to L365 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of HIV-1 protease V82A mutant assessed as hydrolysis of fluorogenic substrate Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg after 10 mins by fluorescence assay\"],[\"Inhibition of cyclin D1 in human HCT116 cells assessed as decrease in protein level at 1 umol\\u002fL after 24 hrs by immunoblotting analysis\"],[\"Mixed type inhibition of bovine xanthine oxidase assessed as half maximal activity using xanthine as substrate preincubated for 25 mins followed by substrate addition measured at first 2 mins by spectrophotometry based Lineweaver-Burk plot analysis\"],[\"Inhibition of JAK3 in human NAMALWA cells assessed as reduction in STAT3 phosphorylation after 48 hrs by immunoblot analysis\"],[\"Inhibition of human placental lysosomal hexosaminidase A at 5 uM\"],[\"Agonist activity at human Gal4-fused PPARalpha LBD expressed in African green monkey CV1 cells cotransfected with pRL-SV40 plasmid measured after 24 hrs by luciferase reporter gene assay\"],[\"Inhibition of recombinant full length GST-tagged human FAK expressed in baculovirus expression system at 100 nM relative to control\"],[\"Agonist activity at human mu opioid assessed as stimulation of GTPgammaS binding\"],[\"Competitive inhibition of Plasmodium falciparum FabG using acetoacetyl-CoA as substrate by Michaelis-Menten steady state analysis\"],[\"Reactivation of cyclosarin-inhibited human AChE using acetylthiocholine as substrate at 20 uM after 4 hrs by robotic spectrophotometric assay\"],[\"Inhibition of HHAT mediated Wnt pathway activity in mouse L cell expressing Wnt3a assessed as decreased firefly luciferase reporter expression at 0.25 uM to 1 uM\"],[\"Displacement of [125I]AB-MECA from human recombinant adenosine A3 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control\"],[\"Slow reversible inhibition of PSMA (unknown origin) at 0.1 uM pre-incubated for 10 mins before PABGgG substrate addition by HPLC method\"],[\"Inhibition of EGFR T790M\\u002fL858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA\"],[\"Inhibition of Galpha-12-stimulated serum response factor-luciferase expression in human PC3 cells at 100 uM by Matrigel cell invasion assay\"],[\"Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control\"],[\"FGFR1 (h) Millipore kinase activity assay\"],[\"Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA beta3 receptor\"],[\"Inhibition of perforin-mediated lysis of human [51Cr]-labeled K562 cells assessed as release of [51Cr] at 5 uM preincubated for 20 mins with human KHYG-1 cells followed by addition of human [51Cr]-labeled K562 cells measured after 4 hrs by gamma counting analysis in absence of mouse serum\"],[\"Relative potency was measured against P2Y purinoceptor 11\"],[\"Intrinsic activity at dopamine D3 receptor\"],[\"Inhibition of wild-type human full length PHKG1 (M1 to Y387 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of biotinylated VEGF-A165 binding to recombinant KDR (unknown origin) at 100 uM measured after 2 hrs by competition binding assay relative to VEGF-A165\"],[\"Inhibition of LPS-induced NF-kB p65 nuclear translocation in mouse RAW264.7 cells at 1.25 to 5 uM by Western blot analysis\"],[\"Displacement of [3H]dexamethasone from glucocorticoid receptor of human blood mononuclear cells at 1 uM; no data\"],[\"Inhibition of mouse plasma DPP4\"],[\"Inhibition of wildtype FLT3 (unknown origin) using TAMRA-Src-tide as substrate measured after 1 hr in presence of ATP at its Km concentration by IMAP-FP assay\"],[\"Evaluated for antagonist activity against histamine H1 receptor and represented as KB\"],[\"Induction of citrate synthase activity in BCAEC at EC50 after 48 hrs in presence of L-NAME\"],[\"Inhibition of UCHL5 in human MDA-MB-231 cells assessed as reduction in enzyme-Ub-VS conjugation at 25 to 50 uM preincubated for 30 mins followed by incubation with Ub-VS for 11 mins in presence of Ub-VS by Western blot analysis\"],[\"Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells\"],[\"Inhibition of CDK2 in human G361 cells sensitized with nocodazole assessed as NPM phosphorylation at Thr199 at 640 nM after 4 hrs by immunoblotting analysis\"],[\"Inhibition of integrin alpha-10 binding to collagen 1 at 50 uM\"],[\"Inhibition of human ASK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Binding affinity to calf recombinant PNP Phe200Trp mutant expressed in Escherichia coli BL21 (DE3) by fluorimetric titration analysis\"],[\"Covalent binding affinity to N-terminal deficient RGS17 (unknown origin) assessed as covalent protein-compound adduct formation at 50 uM incubated for 1 hr by MALDI-TOF mass spectrometry\"],[\"Inhibition of human uPA using pyroGlu-Gly-Arg-p-NA.HCl as substrate preincubated for 15 mins prior substrate addition measured for 10 mins by spectrophotometry\"],[\"Competitive inhibition of full-length microsomal PGES-1 (unknown origin) expressed in Escherichia coli Rosetta(DE3) using PGH2 as substrate preincubated for 15 mins relative to control in presence of higher glutathione disulfide concentration\"],[\"Disaggregation of self-induced pre-formed amyloid beta (1 to 40) (unknown origin) fibrils assessed as disassembly of fibril after 24 hrs by TEM analysis\"],[\"Inhibition of PLK4 (unknown origin) at 0.5 uM relative to control\"],[\"Inhibition of recombinant human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration assay\"],[\"Inhibitory activity was calculated for the model Acetylcholinesterase (Expt-2)\"],[\"PKCalpha (h) Upstate kinase activity assay\"],[\"Inhibition of DNMT1 (unknown origin) by TR-FRET assay\"],[\"Inhibition of p21 (unknown origin)-induced transcription in human HT1080 p21-9-CMV-GFP cells after 3 days by fluorescence assay\"],[\"Inhibition of human recombinant carbonic anhydrase-1 using CO2 as substrate preincubated for 10 mins by stopped-flow CO2 hydrase assay\"],[\"Poison activity at human topoisomerase1 assessed as accumulation of nicked DNA at 10 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis relative to control\"],[\"Inhibition of CAMK1D (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of inducible nitric oxide synthase\"],[\"Inhibition of BRD4 in human MCF7 cells assessed as increase in ATG13 phosphorylation at ser318 at 1.5 uM up to 36 hrs by Western blot analysis\"],[\"Inhibition of Met-mediated tumorigenesis in HGF-stimulated human HepG2 cells assessed as impairment in anchorage-independent growth by soft agar growth assay\"],[\"Inhibition of MEK1 in human HT-29 cells assessed as inhibition of ERK phosphorylation by Western blot analysis\"],[\"Inhibitory activity against MMP3\"],[\"Inhibition of human recombinant 5-LOX expressed in Escherichia coli BL21 assessed as Km for substrate at 10 uM preincubated with enzyme followed by arachidonic acid substrate addition by Lineweaver-Burk plot method (Rvb = 0.09 uM)\"],[\"In vitro intrinsic activity against histamine H3 receptor from synaptosomes of rat cerebral cortex\"],[\"Inhibition of mu-calpain in human SH-SY5Y cells assessed as reduction in GOx-induced p25 phosphorylation pretreated with GOx for 4 hrs followed by compound treatment by Western blot analysis\"],[\"Displacement of 2-[1251]-iodomelatonin from human MT1 receptor expressed in COS7 cells incubated for 1.5 hrs by gamma counting method\"],[\"Inhibitory potency against fatty acid amide hydrolase activity in mouse brain microsomes in presence of 58 uM anandamide at 160 uM\"],[\"Binding affinity to HSP90 in human NCI-N417 cells after 24 hrs by fluorescence polarization assay\"],[\"Inhibition of kallikrein-mediated intrinsic coagulation pathway in human plasma assessed as reduction in factor 12a generation at 160 nM by colorimetric assay\"],[\"Binding affinity to mouse mitochondrial isocitrate dehydrogenase by chromatographic analysis\"],[\"Inhibition of human ERG expressed in CHO cells by automated Q-patch clamp assay\"],[\"Cell-based assay with CellTiter-Glo readout for ATP production with SLC2A4\"],[\"Inhibition of human adrenergic beta2 receptor at 10 uM\"],[\"Inhibition of BTK (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay\"],[\"Inhibition of human recombinant ARTD1 by fluorescence assay\"],[\"Inhibition of MuSK (unknown origin) at 0.1 uM\"],[\"Inhibitory activity against human Chymotrypsinogen\"],[\"Inhibition of TAK1 (unknown origin) after 60 mins by biochemical assay\"],[\"Inhibition of human serum BuChe using butyrylthiocholine iodide as substrate incubated for 25 mins by DTNB reagent based Ellman's method\"],[\"Inhibition of MNK1 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis\"],[\"Activation of mouse TLR9 expressed in HEK293 cells assessed as induction of NF-kappaB activity at 1 to 10 ug\\u002fml after 18 hrs by SEAP assay\"],[\"Inhibition of PDE5A1 (unknwon origin) using [3H]cGMP as substrate after 30 mins by SPA\"],[\"Induction of human recombinant PKCdelta assessed as phosphorylation of amphiphilic peptide substrate at 1 uM in presence of 10 uM phosphatidylserine\"],[\"Inhibition of human CA12 measured after 15 mins by stopped flow carbon dioxide anhydrase assay\"],[\"Binding affinity to paraoxon-human AChE complex\"],[\"Displacement of [3H]imipramine from recombinant human serotonin transporter after 120 mins by scintillation counting analysis\"],[\"Binding affinity to human plasma wild type TTR assessed as dissociation constants for second binding site of TTR by isothermal titration calorimetric method\"],[\"Inhibition of rabbit muscle glycogen phosphorylase-a assessed as formation of inorganic phosphate from glucose-1-phosphate at 444 uM by colorimetry\"],[\"Displacement of [3H]-methylspiperone from human cloned dopamine D4 receptor expressed in HEK293 cells at 10 '-6 M by liquid scintillation counter\"],[\"Transactivation of human PPARgamma LBD expressed in african green monkey Cos7 cells co-transfected with fused GAL4-DBD after 14 hrs by Dual-Glo Luciferase reporter gene assay\"],[\"Inhibition of FucT-4 (unknown origin)\"],[\"Binding affinity to recombinant TrkC (unknown origin) at 10 to 25 uM incubated for 1 hr in dark in presence of azide fluor 488 staining by SDS-PAGE based fluorescence imaging\"],[\"Binding affinity to 5-lipoxygenase (unknown origin) at 400 uM by STD-NMR assay\"],[\"Binding affinity to cathepsin B in 8 day old human MCF10A cells grown on reconstituted basement membrane assessed as protein labeling exposed to 1 uM for 3 hrs followed by washing overnight with growth media by confocal fluorescence microscopy\"],[\"Inhibition of human BRAF V600E mutant at 10 uM using MEK1 (K97R) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Activity of human CaMK2-beta kinase at 1 uM\"],[\"Inhibition of wild type human P-gp in human MES-SA\\u002fDx5 cells incubated for 3 days by MTT assay\"],[\"Inhibition of recombinant GST-tagged human DDR1 by FRET assay\"],[\"Inhibition of NTRK1 at 10 uM by FRET assay\"],[\"Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation\\u002fnicking of supercoiled DNA using supercoiled DNA as substrate at 10 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\"],[\"Displacement of BODIPY-GTP from nucleotide binding site of wild-type GST-tagged Rab7 GTPase (unknown origin) expressed in Escherichia coli BL21(DE3) in EDTA buffer after 2 hrs by flow cytometry\"],[\"Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting\"],[\"Inhibition of alpha-chymotrypsin in bovine pancreas at 300 uM using SPpNA as substrate pretreated with enzyme for 30 mins followed by substrate addition and measured for 12 mins by spectrophotometric analysis relative to control\"],[\"In vivo binding of H1 receptor Agonists measured by binding of [3H]mepyramine to Mouse cerebral cortex at the dosage of ( 10 mg\\u002fkg(no. of mice treated=5 )\"],[\"Inhibition of CDK2 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of FabG in presence of NADPH\"],[\"Agonist activity at human GPR40 expressed in HEK293 cells assessed as induction of intracellular calcium mobilization by Fluo-8 dye based FLIPR assay\"],[\"Beta-2 adrenergic receptor intrinsic symphaticomimetic activity relative to salbutamol\"],[\"Inhibition of [3H]E2 binding to human Estrogen receptor-alpha ligand binding domain (LBD) expressed in Escherichia coli lysates\"],[\"Non-competitive inhibition of electric eel AChE using acetylthiocholine as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of [3H]NMS binding to rat submaxillary gland Muscarinic acetylcholine receptor M3\"],[\"Thermal Shift Assay. Domain start\\u002fstop: D1522-D1656\"],[\"Inhibition of mouse BuChE\"],[\"Inhibition of biotinylated VEGF165 binding to NRP1 (unknown origin) by ELISA\"],[\"Inhibition of PI3K gamma (unknown origin)\"],[\"Inhibition of HDAC6 in human HCT-116 cells assessed as increase in Hsp90(AcLys294) acetylation at 10 uM measured after 12 to 24 hrs by Western blot analysis\"],[\"Inhibition of N-terminal His-tagged human ARTD1 (1 to 1014 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+\"],[\"Inverse agonist activity at mouse melanocortin receptor 5 expressed in HEK293 cells assessed as inhibition of basal cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay relative to control\"],[\"Inhibition of MMP9 activity in human H1299 cells at 1 uM after 24 hrs by gelatin zymography\"],[\"Ratio of IC50 for human ORL1 receptor high affinity binding site to IC50 for human ORL1 receptor high affinity binding site\"],[\"Binding affinity against adenosine A1 receptor using [3H]CPX in guinea pig DDT membrane; 158+\\u002f-21\"],[\"Binding affinity to human CAMKK2 isoleucine residue assessed as residual binding at 1 uM by site dependent competitive binding assay\"],[\"Binding affinity to human TRPV1 expressed in CHO cell membranes preincubated for 30 mins followed by PMA addition at final 5 mins by scintillation counting method\"],[\"Antagonist activity at human H4 receptor assessed as inhibition of imetit-induced GTPgamma[35S] binding after 30 mins by microbeta scintillation counting method\"],[\"Inhibitory activity against telomerase\"],[\"Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin\"],[\"PRKX Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of FASN in human SK-BR-3 cells assessed as oxidation of NADPH at 26 uM after 24 hrs by Spectrophotometric analysis relative to control\"],[\"Inhibition of mouse MKK4 at 10 uM after 60 mins by TR-FRET assay\"],[\"Binding affinity to wild-type human partial length PRKD3 (S543 to E863 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Relative potency was recorded in endothelium-denuded guinea pig; value ranges from 5.68 to 5.93\"],[\"Inhibition of HDAC9 (unknown origin) by fluorescence assay\"],[\"Inhibition of GABA transaminase in rat brain at 45 uM after 40 mins in presence of alpha-ketoglutarate\"],[\"Inhibition of human TTBK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control\"],[\"Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli at 20 nM to 20 uM after 1 hr incubation followed by overnight incubation by Alpha screening technique\"],[\"Displacement of [3H]-dexamethasone from human GR receptor at 1 uM relative to control\"],[\"Displacement of [3H]N-alpha-methylhistamine from recombinant human histamine H3 receptor transfected in CHO cell membranes after 1 hr by scintillation counting analysis\"],[\"Inhibition of JNK2 phosphorylation in LPS-stimulated human U937 cells\"],[\"Inhibition of MEK2 (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of human KIT D816V using gamma-33P-ATP as substrate by scintillation counting\"],[\"Binding affinity to human adrenergic beta3 receptor expressed in HEK Flp-In cells at 10 uM after 90 mins by microbeta counting analysis\"],[\"Binding affinity to GST-tagged Grb2-SH2 domain (58 to 160 amino acid residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) using 20 mM Tris\\u002f1 mM NaPO4 buffer by SPR analysis\"],[\"M4 Eurofins Bayer panel\"],[\"Inhibition of human recombinant GST-tagged JAK1 using 5-FAM-KKSRGDYMTMQIG as substrate by peptide mobility shift assay\"],[\"Inhibition of protoporphyrin oxidase in Cucumis sativus (cucumber) cotyledon disc assessed as increase in extraplastidic protoporphyrin 9 accumulation at 10 uM incubated in dim light for 2 hr by HPLC analysis relative to control\"],[\"Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA\"],[\"Binding affinity to human PDGFRalpha\"],[\"Inhibition of human amyloid beta (1 to 42) aggregation incubated for 48 hrs under dark condition by ThT fluorescence assay\"],[\"Inhibition of RAD51 in human HeLa cells expressing DR-GFP construct assessed as reduction in DSP-induced homologous recombination at 20 uM\"],[\"Inhibition of human TRK-B using ATP as substrate\"],[\"Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay\"],[\"Inhibition of HDAC6 in human HL60 cells assessed as acetylated tubulin\\u002fGAPDH ratio at 0.1 uM after 4 hrs by Western blot assay relative to control\"],[\"Inhibition of recombinant full-length human MEK1 at 10 uM using unactive MAPK2 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of BAT5 binding to FP-biotin in [12C][14N]-lysine, arginine and [13C6][15N2]-lysine, arginine labeled HEK293T cells at 20 uM after 1 hr by isotopic activity-based protein profiling-MudPIT assay\"],[\"Inhibition of N-terminal His6-tagged recombinant full-length human Lck using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method\"],[\"Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method\"],[\"Inhibition of recombinant human N-terminal GST tagged HDAC6 expressed in baculovirus infected Sf9 insect cells using Ac-Leu-Gly-Lys (Ac)-AMC as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence microtiter plate reader assay\"],[\"Inhibition of HIV1 reverse transcriptase Y181I mutant by RNA-dependent DNA polymerase activity assay\"],[\"Inhibition of AKT phosphorylation in human MKN45 cells after 1 hr by Western blot analysis\"],[\"Inhibition of full length recombinant human His-tagged SRPK1 expressed in baculovirus expression system at 5 uM relative to control\"],[\"Inhibition of human carbonic anhydrase 9 by stopped flow technique\"],[\"Antagonist activity at adrenergic beta3 receptor (unknown origin) by PDSP assay\"],[\"Binding affinity to human MET by KINOMEscan scanMAX assay\"],[\"Inhibition of electric eel AChE using acetylthiocholine as substrate preincubated for 5 mins followed by substrate addition and measured after 5 mins by Ellman's method\"],[\"Displacement of [3H]-dexamethasone from glucocorticoid receptor (unknown origin) at 1 uM\"],[\"Displacement of [3H]CP55,940 from human recombinant CB2 receptor expressed in HEK293 cells\"],[\"Binding affinity to NR2B receptor in rat cerebral cortex at 0.09 to 0.14 nM after 30 mins by autoradiography in presence of DTG relative to control\"],[\"Inhibitory concentration against human Cathepsin D\"],[\"Inactivation of recombinant human NQO1 expressed in Escherichia coli using DCPIP as substrate assessed as partition ratio up to 200 nM by spectrophotometric analysis\"],[\"Antagonist activity at human muscarinic M3 receptor assessed as inhibition of carbachol-induced bronchus contraction\"],[\"Inhibition of caspase-6 (unknown origin) at 10 uM\"],[\"Concentration required for displacement of [33P]-labeled S1P from human sphingosine 1-phosphate receptor 5 expressed in CHO cells\"],[\"Inhibition of CLK3 (unknown origin) at 1 uM relative to control\"],[\"Substrate activity at recombinant human caspase-3 assessed as enzyme-mediated compound cleavage after 1 hr by RP-HPLC analysis\"],[\"In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand\"],[\"Inhibition of p38-beta (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Modulation activity at human mineralocorticoid receptor in human EA.hy926 cells assessed as blocking of nuclear translocation of mineralocorticoid receptor in presence of aldosterone by receptor translocation assay relative to control\"],[\"Inhibition of SOX18 in HUVEC assessed as reduction of SOX18-SOX7 interactions incubated for 45 mins by Alpha-screen assay\"],[\"Displacement of [33P]2-Mes-ADP from human recombinant P2Y1 receptor expressed in human U20S cells\"],[\"Competitive inhibition of recombinant human cathepsin K expressed in Pichia pastoris using Z-FR-MCA as substrate by Dixon plot method\"],[\"Inhibition of Electrophorus electricus (electric eel) AChE using acetylthiocholine iodide as substrate at 10 mg\\u002fml by TLC-B assay\"],[\"Inhibition of PKCz (unknown origin) at 1 uM\"],[\"Inhibition of wild-type human partial length MAK (M1 to P314 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human ABHD6 at 10 uM\"],[\"Covalent binding affinity to GDP-loaded hexahistidine-tagged KRas G12C mutant (1 to 169 residues) (unknown origin) expressed in Escherichia coli assessed as rate constant by liquid chromatography-electrospray mass spectrometry analysis\"],[\"Inhibition of N-terminal GST-tagged human PRMT1 (2 to end residues) expressed in Escherichia coli assessed as enzyme remaining activity at 50 uM pre-incubated for 15 mins followed by AdoMet addition and measured after 1 hr by luminescence method relative to control\"],[\"Inhibition of human liver cathepsin L peincubated for 5 mins followed by Z-FR-MCA addition by spectrofluorimetric method\"],[\"Inhibition of recombinant human Lp-PLA2 using [3H]PAF as substrate at 10 nM incubated for 5 mins prior to substrate addition measured after 10 mins by liquid scintillation counting analysis\"],[\"Inhibition of mTOR (unknown origin) incubated for 1 hr by ELISA relative to control\"],[\"Inhibition of Kir4.1 (unknown origin)\"],[\"Intrinsic activity against dopamine D4 receptor expressed in CHO cells by GTPgammaS assay\"],[\"Antagonist activity at human kappa-opioid receptor expressed in CHO cell membranes assessed as inhibition of U69593 agonist-induced [35S]GTPgammaS binding after 4 hrs by scintillation counting method\"],[\"Intrinsic activity at muscarinic M3 receptor in guinea pig ileum assessed as inhibition of electrically-stimulated muscle contraction relative to bathanecol\"],[\"Inhibition of human recombinant SRPK1 assessed as reduction in substrate phosphorylation at 50 to 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method\"],[\"Inhibition of human EPHB1 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control\"],[\"In vitro inhibition against bovine cytochrome P450 11B with 200 uM corticosterone\"],[\"Inhibition of SARS-CoV-2 3CL (3264 to 3569 residues) preincubated for 30 mins followed by addition of Dabcyl-KTSAVLQSGFRKME(Edans) substrate and measured after 1 hr by flourescence based plate reader assay\"],[\"Inhibition of mouse GAT2 expressed in HEK293 cells assessed as reduction in [3H]GABA uptake at 100 uM preincubated for 25 mins followed by [3H]GABA addition and measured after 10 mins by liquid scintillation counting method relative to control\"],[\"Binding affinity to wild-type human partial length autoinhibited KIT (Y545 to D952 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of endogenous FLT3 autophosphorylation in EOL1 cells\"],[\"Inhibition of STAT3 phosphorylation in human MIA PaCa-2 cells at 1 to 1.5 uM measured after 4 hrs by Western blot analysis\"],[\"Inhibition of human ARK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Upregulation of HDAC1 inhibition-mediated histone H3 acetylation-induced extracellular SOD expression in human THP1 cells at 100 uM after 12 hrs by chromatin immunoprecipitation method\"],[\"Activation of Nrf2 in human Hepa1c1c7 cells assessed as increase in NQO1 activity at 0.313 uM using menadione as substrate incubated for 20 mins followed by substrate addition and measured after 30 mins by spectrophotometry relative to control\"],[\"Inhibition of bovine brain mitochondria MAOA\"],[\"Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells after 2 hrs by Western blot analysis\"],[\"Activity at human adenosine A3 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells\"],[\"Inhibition of PI3Kalpha (unknown origin) using 1alpha-phosphotidylinositol by luminescence assay\"],[\"Modulation of full length human Nur77 expressed in PC12 cells co-transfected with luciferase reporter plasmid harboring NurRE response element assessed as increase in luciferase activity incubated for 18 by luciferase reporter gene assay\"],[\"Positive allosteric modulation of GABAA alpha2 (unknown origin) relative to control\"],[\"Binding affinity to NMDA NR2B receptor\"],[\"Percent efficacy for human Androgen receptor agonist activity compared to dihydrotestosterone\"],[\"Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation\"],[\"Inhibition of CAMK1 (unknown origin) at 250 nM by radioactive filter-binding assay\"],[\"Inhibition of STK4 (unknown origin)\"],[\"Displacement of [3H]U69593 from human KOR expressed in CHO cell membranes incubated for 30 mins by liquid scintillation counting\"],[\"Inhibition of recombinant AKT1 (unknown origin) by FRET-based Z'-LYTE assay\"],[\"Inhibition of human recombinant tissue plasminogen activator by Lineweaver-Burke plot\"],[\"Inhibition of human FMS assessed as remaining enzyme activity at 0.01 uM\"],[\"Concentration required for inhibition of beef liver dihydrofolate reductase\"],[\"Displacement of [3H]-Ketanserin from recombinant human 5-HT2A receptor after 1.5 hrs by Microbeta scintillation counting analysis\"],[\"Inhibition of TGFbeta1 (unknown origin) expressed in HEK293 cells at 0.3 to 10 uM incubated for 4 hrs by dual luciferase reporter gene assay\"],[\"Agonist activity at human Nav1.4 expressed in HEK293 cells up to 1 uM incubated for 30 mins by FLIPRTetra fluorescent membrane potential assay\"],[\"Inhibition of P-gp activity in human paclitaxel-resistant A549 cells potentiation of 5 uM paclitaxel-induced cytotoxicity at 0.1 uM by SRB assay\"],[\"Dissociation constant was determined in vitro using rat pituitary membranes and [125I]-leuprolide as radioligand, at concentration 3.16*10e-6 M\"],[\"Inhibition of alpha-L-fucosidase from bovine kidney at 1 mM at pH 6\"],[\"Inhibition of HIF1alpha protein level in human Hep3B cells after 12 hrs in normoxic condition by Western blot analysis\"],[\"Inhibition of N-terminal His-tagged human ARTD4 (250 to 565 residues) expressed in Escherichia coli Rosetta2 (DE3) using TCEP as substrate after 2.5 hrs in presence of NAD+\"],[\"Inhibition of CD45 (unknown origin) at 25 to 30 uM\"],[\"Tested for the inhibitory activity against beta-lactamase, Enterobacter cloacae at dose of 0.66 ug\\u002fmL using substrate cephaloridine (CER)\"],[\"Inhibition of N-terminal his6-tagged human SIRT2 (25 to 389 amino acids) using ZMAL as substrate at 500 uM after 4 hrs by fluorescence-based microplate reader method\"],[\"Displacement of H4KAc4 from BRD4 (unknown origin) up to 50 uM preincubated for 30 mins with non-biotinylated peptide followed by addition of biotinylated peptide measured after 30 mins by AlphaScreen assay\"],[\"Reactivation of tabun inhibited human erythrocyte AChE assessed as reactivation rate constant using acetylthiocholine iodide as substrate preincubated up to 60 mins followed by substrate addition measured for 3 mins by Ellman's method\"],[\"Binding affinity against human adenosine A3 receptor in CHO cell membranes using [3H]NECA\"],[\"Inhibition of FAAH T488A mutant (unknown origin) expressed in human HeLa cells using [3H]AEA as substrate after 2 hrs by liquid scintillation counting analysis\"],[\"Displacement of 2-[125I]-iodomelatonin from human melatonin receptor-2 transfected in CHO cell membranes after 120 mins\"],[\"Percentage of maximal glutamate (1 mM) response of human metabotropic glutamate receptor 2 done at 30 degree C for 1 hr\"],[\"Inhibition of cKIT in human GIST882 cells assessed as suppression of ERK phosphorylation at T202\\u002fY204 up to 10 uM after 2 hrs by Western blot analysis\"],[\"Effective concentration of progesterone receptor agonist induction of alkaline phosphatase activity in human T47D breast carcinoma cells\"],[\"Inhibition of human DHFR assessed as reduction in consumption of NADPH using DHF as substrate incubated for 3 mins measured for 2 mins by spectrophotometric method\"],[\"KinomeScan assay: inhibition of FGFR3(G697C)\"],[\"Inhibition of HER2 in mouse B16\\u002fF10 cells assessed as down regulation of HEr2 protein levels after 24 hrs by Western blotting method\"],[\"Effect on basal adenylate cyclase activity relative to potency of methiothepin using rat 5-HT7 receptor expressed in HEK cells; ND=Not determined\"],[\"Inhibition of human DRAK2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay\"],[\"Antibacterial activity against Escherichia coli DHFR\"],[\"Inhibition of HDAC2 (unknown origin) assessed as remaining enzyme activity at 0.025 uM by ELISA-based assay\"],[\"Binding affinity to wild-type human partial length SBK1 (P23 to P348 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human C-terminal hexa-His tagged DHODH expressed in Escherichia coli by DCIP reduction assay\"],[\"Displacement of [3H]nicotine from cholecystokinin receptor type B (unknown origin)\"],[\"In vitro inhibition of angiotensin I converting enzyme from rabbit lung\"],[\"Inhibition of SAPK2a T106M mutant (unknown origin) at 0.49 uM relative to control\"],[\"Inhibition of recombinant human full length N-terminal GST-tagged PDE8A1 expressed in baculovirus infected Sf9 insect cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay\"],[\"Inhibition of trypsin-like activity of human 20S proteasome beta 2\"],[\"Maximum percentage inhibition of 5-HT stimulated cAMP production in HeLa cells expressing 5-hydroxytryptamine 6 receptor\"],[\"GRK6(h) Kinase panel\"],[\"Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M\\u002fL858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay\"],[\"Inhibition of human immunoproteasome beta 1i subunit using Ac-PAL-AMC as substrate preincubated for 30 mins followed by substrate addition measured for 120 mins by fluorescence based assay\"],[\"Inhibition of HIV1 wild type RT using poly(rA)\\u002foligo(dT)15 homopolymer template after 1 hrs by ELISA\"],[\"Inhibition of GFP-fused Huntingtin protein Q103\\u002fQ25 mutant (unknown origin) expressed in human PC12 cells assessed as protection against cell death incubated for 48 hrs by Cytox-Glo based protease release HTT f3(pro) method\"],[\"Competitive binding affinity to PAK7\\u002fPAK5 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of PDGFRb (unknown origin) after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method\"],[\"Inhibition of human full length recombinant Syk at 5 nM by radiometric scintillation counting analysis relative to control\"],[\"Agonist activity at human prostaglandin EP4 receptor\"],[\"Inhibition of 20s immunoproteasome LMP2 in human erythrocytes using Ac-Pro-Ala-Leu-MCA as substrate preincubated for 10 mins followed by substrate addition and measured after 6 hrs by fluorescence assay\"],[\"Percentage binding to muscarinic M3 at 10 uM\"],[\"Inhibition of RSK3 (unknown origin) at 180 nM relative to control\"],[\"Binding affinity to MDM2 (unknown origin) after 30 mins by fluorescence polarization assay\"],[\"Inhibition of recombinant human RET V804M mutant using KKKVSRSGLYRSP as substrate incubated for 15 mins followed by Mg\\u002fATP addition and measured after 40 mins by [gamma-33P]-ATP assay\"],[\"Binding affinity to biotinylated Staphylococcus aureus HPPK in presence of 1 mM ATP by SPR assay\"],[\"Inhibition of STAT5 (unknown origin)\"],[\"Displacement of [3H]SP from recombinant human neurokinin-1 receptor expressed in CHO cells incubated for 20 mins by liquid scintillation counting\"],[\"Inhibition of sheep COX1 at 125 ug\\u002fmL\"],[\"Inhibition of G9a (685 to 1000 residues) (unknown origin) expressed in Escherichia coli BL21\"],[\"Inhibition of recombinant human BRAF (416 to end residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Displacement of [3H]-CP55940 from CB1 receptor (unknown origin) expressed in CHO cell membranes after 90 mins by liquid scintillation counting analysis\"],[\"Stimulation of recombinant wild-type human TRAP1 ATPase activity expressed in Escherichia coli BL21 (DE3) up to 20 uM preincubated for 0.5 hrs followed by 0.2 mM ATP addition and measured after 3 hrs by PiColorLock Gold reagent based colorimetric assay\"],[\"Inhibition of alkaline phosphatase in mouse Sarcoma 180\\u002fTG cells\"],[\"Inhibition of human Ret V804L mutant at 10 uM after 60 mins by TR-FRET assay\"],[\"Inhibition of constitutively activated c-Met phosphorylation in human EBC1 cells assessed as cell viability after 72 hrs by CCK8 assay\"],[\"Antagonist activity at ER in rat GH3 cells assessed as inhibition of estradiol-induced prolactin gene expression at 10'-10 to 10'-6 M after 48 hrs by RT-PCR analysis\"],[\"Inhibition of Iks (unknown origin) by patch clamp analysis\"],[\"Inhibition of ATG13 binding to full-length ULK1 (unknown origin) expressed in HEK293T cells preincubated for 15 mins followed by human C-terminal FLAG-tagged ATG13 addition measured after 30 mins by Alphascreen assay\"],[\"Binding Intensity was determined against CD45+ HH-leukemic cells at 5 ug\\u002fmL; Not available\"],[\"Inhibition of recombinant N-terminal GST-fused full-length human PKCzeta expressed in Baculovirus expression system using STK1-biotin as substrate after 1 hr in presence of ATP by TR-FRET analysis\"],[\"Agonist activity at human BRS-3 expressed in HEK293AEQ cells assessed as induction of intracellular calcium mobilization by aequorin bioluminescence assay relative to dY peptide\"],[\"Inhibition of Amyloid beta (1 to 40) (unknown origin) fibril formation at Abeta:compound ratio of 1:10 after 4 days by Thioflavin-T fluorescence assay\"],[\"Displacement of [3H]GR65630 from recombinant human 5HT3 receptor transiently expressed in HEKT cells measured after 90 mins by microbeta scintillation counting method\"],[\"Inhibition of BRAF V600E mutant (unknown origin) at 10 uM relative to control\"],[\"Antagonist activity at human full length LXRalpha expressed in human BHK21 cells co-expressing human pSG5\\u002fRXRalpha assessed as inhibition of GW3965-induced receptor activation at 10 uM after 18 hrs by luciferase reporter gene assay\"],[\"Induction of human recombinant topoisomerase 1-mediated cleavage of 32P-labeled linearized pRYG plasmid DNA at 25 uM after 30 mins by agarose gel electrophoresis\"],[\"Binding affinity to human recombinant HGF-stimulated Grb2-SH3 in human SK-LMS1 cells assessed as presence of associated protein Gab1 at 3 uM by immunoblot analysis\"],[\"Inhibitory activity for binding of PGD-2 to hTP in hTP binding assay using HEK293 cell membranes\"],[\"Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells\"],[\"Mixed-type of inhibition of mushroom tyrosinase assessed as Vmax using L-DOPA as substrate at 0.5 uM measured at 475 nm by Lineweaver-Burk double reciprocal plot analysis (Rvb = 0.09 deltaOD\\u002fmin)\"],[\"Binding affinity to DDR1 (unknown origin)\"],[\"Antagonist activity at human delta opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay\"],[\"Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation assessed as inhibition of fibril formation at 100 uM by thioflavin T-based fluorescence method\"],[\"Binding affinity to TK1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Antagonist activity at recombinant human CXCR3 receptor expressed in Ba\\u002fF3 cells assessed as hI-TAC-induced chemotaxis\"],[\"Competitive binding affinity to CDK9 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"MSK2(h) Kinase panel\"],[\"Agonist activity at human recombinant CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production relative to CP-55940\"],[\"Inhibition of human full-length BMX (1 to 675 residues) expressed in baculovirus expression system by mobility shift assay\"],[\"PAK4(PAK4CGY1) Takeda global kinase panel\"],[\"Binding affinity to wild-type human full length ERK1 (M1 to P379 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]dofetolide from human Erg\"],[\"Inhibition of full length human 11beta-HSD2 expressed in HEK293 cells using cortisone as substrate incubated for 2 hrs by HTRF assay in presence of NAD+\"],[\"Inhibition of IL1-beta-induced p38alpha phosphorylation in human A549 cells pre-incubated for 30 mins before IL1-beta stimulation and measured after 7 to 8 hrs post IL1-beta stimulation by Bright-Glo luciferase reporter gene assay\"],[\"Inhibition of wild type EGFR C797S mutant (unknown origin) at 2 nM pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay relative to control\"],[\"Inhibition of MARK2 (unknown origin) labeling at conserved Lysine2 at 10 uM relative to control\"],[\"Inhibition of LPS-stimulated COX2 in human whole blood assessed as reduction in PGF2alpha production by measuring remaining activity at 5 uM preincubated for 15 mins followed by LPS addition measured after 24 hrs by LC-MS\\u002fMS analysis\"],[\"Transactivation of PPARgamma in human adipocytes assessed increase in aP2 gene expression at 0.1 uM after 3 days by RT-PCR method relative to rosiglitazone\"],[\"Effect on augmentation of [125]GLP1 binding to human GLP1\"],[\"Inhibition of human HDAC6 incubated for 30 mins by fluorescence method\"],[\"Competitive inhibition of human DHODH expressed in Escherichia coli BL21 (DE3) using L-dihydroorotate as substrate at 1 to 2 uM after 10 mins by DCIP dye reduction assay in presence of ubiquinon\"],[\"Inhibition of human carbonic anhydrase 4 up to 100 uM by CO2 hydrase stopped flow assay\"],[\"Inhibition of carbachol stimulated phosphatidylinositol (PI) turnover in chinese hamster ovarian cells expressing human muscarinic M1 receptor\"],[\"Inhibition of N-terminal His-tagged Cdc25b catalytic domain expressed in Escherichia coli BL21(DE3) using 3-O-Methylfluorescein phosphate as substrate by secondary plot analysis\"],[\"Inhibition of recombinant human mEH expressed in baculovirus expression system assessed as formation of 6-methoxy-2-naphthaldehyde preincubated for 5 mins followed by addition of CMNGC as substrate by fluorescent-based assay\"],[\"Inhibition of JAK2 in HEL 92.1.7 cells assessed as inhibition of STAT3 phosphorylation\"],[\"Inhibition of thrombin (unknown origin) using S-2238 as substrate after 15 mins by spectrophotometry\"],[\"Inhibition of xanthine oxidase (unknown origin) at 30 uM using xanthine as substrate preincubated for 5 mins followed by substrate addition measured every min for 10 mins by spectrophotometric method relative to control\"],[\"Agonist activity at rat kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition and measured up to 180 secs by Ellman's method\"],[\"Dithiothreitol (10 nM) reactivation of human placental aromatase following 1.0 uM inactivation for 5 minutes\"],[\"Inhibition of recombinant human TAO2 (1 to 320 residues) using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis\"],[\"Inhibition of SIRT2 in human HepG2 cells assessed as increase in acetylated p53 at Lys382 and alpha-tubulin level at 2 to 4 uM after 6 hrs by Western blot analysis\"],[\"Inhibition of p53-dependent transcription of puma in UV-induced human MCF7 cells\"],[\"Binding affinity to human partial length BRDT bromodomain 2 (K250 to E382 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control\"],[\"Inhibition of human N-terminal GST-tagged BRD7 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay\"],[\"Inhibition of rat ecto-5'-nucleotidase\"],[\"Inhibition of EGFR L858R\\u002fT790M mutant-mediated Erk phosphorylation in human NCI-H1975 cells up to 50 nM after 24 hrs by Western blot analysis\"],[\"Inhibition of PCTAIRE1 Lysine 2 labelling site (unknown origin) at 10 uM\"],[\"Inhibition of Matrix metalloprotease-13 (MMP-13)\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 rplB at 4 fold MIC by microarray analysis\"],[\"Binding affinity to KDM5B (unknown origin)\"],[\"Inhibitory activity against human TRAFalpha; Not tested\"],[\"Binding affinity to human phosphorylated ABL1 E255K mutant (S229 to K512 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at human histamine H2 receptor expressed in HEK293T cells co-expressing ELucC assessed as intrinsic activity at \\u003e= 30 uM by beta arrestin2 recruitment assay relative to histamine\"],[\"Inhibition of chicken liver Dihydrofolate reductase (dihydrofolate reductase)\"],[\"Inhibition of TRKA (unknown origin) assessed as residual activity at 1 uM\"],[\"Inhibition of mouse GAT2-mediated [3H]GABA uptake expressed in human HEK cells at 1 mM\"],[\"Inhibition of recombinant human GST-tagged EPHB3 catalytic domain expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay\"],[\"Percentage inhibition against cathepsin D at 1.0x10E-5M\"],[\"Activation of human STING expressed in human PBMC cells assessed as phosphorylation of IRF3 at (Ser396) at 10 uM incubated for 2 hrs and measured by Western blot analysis\"],[\"Inhibition of human IKBKE at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control\"],[\"Inhibition of recombinant human TGFBR1 (200 to end residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Agonist activity at mu opioid receptor in rat brain assessed as maximal stimulation of [35S]GTP-gamma-S binding\"],[\"Agonist activity at human PPARgamma expressed in HepG2 cells co-transfected with PPRE3-TK-luc assessed as beta-galactosidase activity after 20 to 22 hrs by luciferase based transactivation assay\"],[\"Transactivation of human ERbeta expressed in HEK293 cells after 18 hrs by luciferase reporter gene assay\"],[\"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A93V mutant expressed in Escherichia coli BL21 cells at 10 uM after 3 hrs by fluorescence polarization competition assay\"],[\"Inhibition of PF-06422899 binding to recombinant C-terminal FLAG-tagged DUS2L (unknown origin) expressed in HEK293T cells after 1 hr by gel-based ABPP assay\"],[\"Displacement of [3H]PSB11 from recombinant human adenosine A3 receptor expressed in CHO cells at 1 uM relative to control\"],[\"Inhibition of prolyl oligopeptidase\"],[\"Average Binding Constant for PAK4; NA=Not Active at 10 uM\"],[\"Agonist activity at human 5HT1B receptor at \\u003c5 uM by scintillation proximity assay\"],[\"Inhibition of Cathepsin L (unknown origin)\"],[\"Inhibition of Zika virus NS2B-NS3 protease\"],[\"TAOK1 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by stopped flow CO2 hydration assay\"],[\"Inhibition of human full length CSNK1A1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human group 6A calcium-independent PLA2 treated in mixed-micelles by modified Dole assay\"],[\"Non-competitive inhibition of human recombinant-Sialin expressed in HEK293 cells assessed as reduction in [3H]Neu5Ac uptake incubated for 15 mins by liquid scintillation counting method\"],[\"Inhibition of diphenolase activity of mushroom tyrosinase using L-dopa as substrate at 0.05 mM by spectrophotometric assay\"],[\"Binding affinity to HLA-DR1 in surface of human monocyte derived immature DC isolated from positive donor cultured with GMCSF\\u002fIL4 by Western blot analysis\"],[\"Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control\"],[\"Intrinsic activity at human V2 receptor expressed in CHO cells assessed as increase in cAMP level relative to arginine vasopressin\"],[\"Competitive inhibition of recombinant human KDM4A (1 to 347 aa) expressed in Escherichia coli using H3K9me3 (3 to 17 aa) peptide as substrate after 30 mins by double-reciprocal plot method\"],[\"Inhibition of human PKBbeta using gamma-33P-ATP as substrate by scintillation counting\"],[\"Inhibition of PI3K delta (unknown origin) using PIP2 as substrate after 1 hr by kinase-Glo luminescent assay\"],[\"Inhibition of recombinant human GST-tagged MAP3K9 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control\"],[\"Inhibition of Akt phosphorylation in human H1975 cells harboring EGFR L858R\\u002fT790M mutant at 1 uM by Western blotting analysis\"],[\"Mean negative logarithim of binding affinity was measured for the rat serotonin transporter; n\\u003e\\u002f=3\"],[\"Antagonist activity at human cloned adenosine A2b receptor expressed in CHO cells assessed as inhibition of NECA-stimulated cAMP accumulation\"],[\"Covalent binding affinity to GRK5 (unknown origin) assessed as covalent adduct formation at 1 mM measured at 3 hrs by LC\\u002fMS analysis\"],[\"Inhibition of allosterically sensitized His6-tagged human PTP1B catalytic domain P87C\\u002fA122C mutant at 2000 nM using pNPP as substrate incubated for =\"],[\"Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of Colony stimulating factor 1 receptor (CSF-1R) autophosphorylation\"],[\"Inhibition of Tel-fused LYN in mouse BA\\u002fF3 cells\"],[\"Inhibition of wild-type human partial length EPHB6 (Q634 to P948 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Ratio of Bmax to Kd at NMDAR NR2B in Sprague-Dawley rat brain striatum\"],[\"Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting\"],[\"Inhibition of human thrombin using Z-Gly-Gly-Arg-AMC.HCl as substrate measured for 30 mins by spectrophotometry\"],[\"Inhibition of PI3Kgamma (unknown origin) using PIP2 as substrate in presence of ATP incubated for 60 mins by ADP-glo based luminescence assay\"],[\"Inhibition of tracer 178 binding to recombinant human GST-tagged DDR1 catalytic domain (440 to 876 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control\"],[\"Displacement of [3H]paroxetine from SERT in rat cortical membranes after 6 mins by liquid scintillation counting\"],[\"Displacement of [3H]LSD form human recombinant 5HT7 receptor\"],[\"Inhibition of MMP-9 activity in human HT1080 cells at 5 uM by gelatin zymography\"],[\"Mixed inhibition of equine serum BChE using butyrylthiocholine iodide as substrate\"],[\"Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay\"],[\"Effective concentration required for the activation of human C296A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate\"],[\"Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to PARP-2 in human SK-OV-3 cells assessed as thermal stabilization after 3 hrs by ITDRF-CETSA\"],[\"Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as residual conversion of [1,2,6,7-3H]-cortisol to cortisone at 1 uM by scintillation counting\"],[\"Displacement of [3H]-mesulergine from serotonin 5-HT2C receptor in rat brain cerebral cortex homogenates incubated for 15 mins by liquid scintillation counting\"],[\"Inhibition of recombinant Escherichia coli KPC-2 using nitrocefin as substrate preincubated for 10 mins followed by substrate addition and measured every 10 secs for 10 mins by spectrophotometric analysis\"],[\"Inhibition of p-glycoprotein (unknown origin) overexpressed in human KBV20C cells assessed as potentiation of vincristine-induced cytotoxicity at 1 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay\"],[\"Displacement of [1,2,3-3H]-triamcinolone acetonide from glucocorticoid receptor in soluble fraction of mouse L929 cells at 10'-7 M preincubated for 4 hrs followed by [3H]-triamcinolone acetonide addition measured after 18 hrs by double reciprocal plot analysis\"],[\"Inhibition of ThRS in human UMSCC14A cells assessed as increase in PUMA mRNA level at 5 uM after 6 hrs by RT-qPCR analysis\"],[\"Inhibition of DNA-tagged human MST2 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of Kir2.3 channel (unknown origin)\"],[\"Inhibition of human EphA3 assessed as residual activity at 1 uM relative to control\"],[\"Agonist activity at human GPR120\"],[\"Ratio of kcat to km for bovine xanthine oxidase at 25 uM preincubated for 10 mins\"],[\"Binding affinity to CSF-1R in C57BL\\u002f6 mouse BMDM cells assessed as increase in melting temperature at 100 nM after 1 hr by CETSA\"],[\"Inhibition of human recombinant matrix metalloprotease 1\"],[\"Inhibition of Trypanosoma cruzi Cruzipain using Z-Phe-Arg-AMC as substrate measured for 10 mins by spectrofluorimetric analysis relative to control\"],[\"Inhibition of TAK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"In vitro agonist activity at P2Y1 receptor in turkey erythrocyte membranes; No effect at 100 uM.\"],[\"Binding affinity to Hsp90alpha (unknown origin) by fluorescent polarization assay\"],[\"Inhibition of recombinant human GST-His-tagged HDAC6 at 0.1 to 1 uM using fluorogenic HDAC substrate incubated for 30 mins by microplate reader assay\"],[\"Induction of human PXR at 10 uM relative to rifampicin\"],[\"Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis after 45 mins in presence of 0.5 M bovine serum albumin\"],[\"Inhibition of cdk7 at 1000 nM\"],[\"Inhibition of N-terminal His-tagged human recombinant IDO1 expressed in Escherichia coli using tryptophan as substrate by UV-visible absorption spectroscopy\"],[\"Inhibition of recombinant EPH-A2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA\"],[\"Inhibition of human carbonic anhydrase II by spectrophotometry at pH 7.5\"],[\"Induction of PARP1 degradation in human MDA-MB-231 cells at 5 uM incubated for 48 hrs in presence of proteasome inhibitor, bortezomib by immunoblotting analysis\"],[\"Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)\"],[\"Displacement of [3H]CGP 12177 from human recombinant beta2 adrenergic receptor expressed in CHO cells at 100 uM measured after 120 mins by scintillation counting method relative to control\"],[\"Displacement of [3H]-naloxone from Opioid receptor delta 1\"],[\"Inhibition of recombinant human PDGFRbeta at 20 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 30 mins by LANCE method relative to control\"],[\"Transcriptional activation in human endometrial carcinoma (HEC-1) cells expressing estrogen receptor alpha in presence of 1 nM estradiol\"],[\"Binding affinity to EphA2 in human MDA-MB-231 cells assessed as induction of EphA2 receptor internalization at 50 uM after 1 hr by immunofluorescence microscopy\"],[\"Second order rate constant for inhibition of Human leukocyte elastase (major diastereomeric 2 pairs of enantiomer)\"],[\"Activity of human LIMK1 kinase at 1 uM\"],[\"Inhibition of human VEGFR2 at 30 uM\"],[\"Binding affinity to mouse CCR5\"],[\"Inhibition of factor 10a (unknown origin) using S-2765 as substrate assessed as compound potency preincubated with AT-3 followed by factor 10a addition for 60 secs and subsequent addition of substrate for 60 secs measured after 4 mins\"],[\"Inhibition of wild type rabbit N-terminal His-tagged ALOX15 expressed in Escherichia coli using linoleic acid as substrate by spectrophotometric assay\"],[\"Inhibition of LTA4H in human PBMC assessed as reduction of calcium ionophore A23187-stimulated prostaglandin E2 generation at 1 uM preincubated for 15 mins followed by ionophore stimulation and measured after 2 hrs by LCMS\\u002fMS analysis relative to control\"],[\"Binding affinity to Stat3 (unknown origin) by NMR analysis\"],[\"Rsk1 (h) Upstate kinase activity assay\"],[\"Inhibition of recombinant human IGF1R using Ulight-TK peptide as substrate after 60 mins by LANCE method\"],[\"Binding affinity to PIK3R4 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Displacement of [3H]raclopride from human cloned D2 receptor expressed in HEK293 cells by radioligand binding assay\"],[\"Displacement of [125I]IL-8 from human recombinant CXCR2 receptor at 1 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Inhibition of rat SPPL2a expressed in human U2OS cells using EGFP-labeled TNFalpha (1 to 77 residues) NLS as substrate after 24 hrs by Hoechst staining based high content imaging assay\"],[\"Induction of ERK1 phosphorylation at Thr202 residues in UV-irradiated human TIG3 cells using 50 mJ\\u002fcm2 of UV radiations followed by compound addition by immuno fluorescence staining based analysis\"],[\"Agonist activity at androgen receptor expressed in human PC3 cells assessed as stimulation of receptor transactivation at 0.1 to 1 uM by luciferase reporter gene assay\"],[\"Inhibition of RIPK3 phosphorylation in human HT-29 cells assessed as reduction in TNFalpha\\u002fsmac mimetic\\u002fZ-VAD-fmk-induced necrosome formation at 1 uM treated prior to TNFalpha\\u002fsmac mimetic\\u002fZ-VAD-fmk stimulation and measured after 4 hrs by immunoprecipitation based assay\"],[\"Inhibition of recombinant c-Met (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA\"],[\"Activation of BAX (unknown origin)\"],[\"Inhibition of human 5-LOX by intact cell based assay\"],[\"Inhibition of EGF-induced EGFR L858R\\u002fT790M mutant-mediated Akt phosphorylation in human HCC827 cells after 1 hr by immunoblotting method\"],[\"Binding affinity to human partial length BRD2 (BD1,2) (K71 to D455 residues) expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of human FIH using HLEVVKLLLEAGADVNAQDK-CONH2 as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by RapidFire Mass spectrometry assay\"],[\"Inhibition of GPAT1 (unknown origin) expressed in Sf9 cell membranes assessed as reduction in glycerol 3-phosphate acyltransferase activity at 3 uM using [3H]-glycerol 3-phosphate and palmitoyl CoA incubated for 60 mins by scintillation counting assay relative to control\"],[\"Inhibition of PI3Kalpha (unknown origin) at 500 nM relative to control\"],[\"Inhibition of recombinant human 5HT7 receptor expressed in CHO cells at 1 uM by radioligand displacement assay relative to control\"],[\"Inhibition of PTP1B (unknown origin) at 10 uM\"],[\"Inhibition of human ErbB4 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of BACE1 at pH 4.5\"],[\"Inhibition of Onchocerca volvulus L3 larvae chitinase using 4-methylumbelliferyl-N,N',N''-beta-chitotrioside as a profluorescent substrate after 10 mins by fluorometric analysis\"],[\"Activity at ERbeta in human MCF7 cells assessed as change in p21 protein level at 1 uM after 12 hrs by Western blot analysis relative to actin\"],[\"Ratio of KI to that of Kinact was determined against gamma-aminobutyric acid aminotransferase\"],[\"Inhibition of human dihydrofolate reductase at \\u003e28 uM\"],[\"Inhibition of human recombinant FGFR3 (447 to 761 residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis\"],[\"Agonist activity at TLR8 in human PBMC cells assessed as induction of TNFalpha production incubated for 16 hrs by immunoassay\"],[\"Inhibition of recombinant human DNA topoisomerase-2alpha using supercoiled pBR322 plasmid DNA as substrate at 20 uM after 30 mins by agarose gel electrophoresis relative to control\"],[\"Inhibition of [3H]-5-norepinephrine reuptake in human NET expressed in HEK293 cells by liquid scintillation counting method\"],[\"Inhibition of biotinylated Bim BH3 peptide binding to GST-tagged mouse Mcl-1 expressed in Escherichia coli BL21 (DE3) pre-incubated for 1 hr followed by incubation with shaking for 2 hrs and subsequent Bim BH3 peptide addition measured after 1.5 hrs by ELISA\"],[\"Inhibition of recombinant human ALDH3A1 using benzaldehyde as substrate at 100 uM preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis\"],[\"Inhibition of recombinant human topoisomerase 2alpha mediated decatenation using kDNA as substrate at 50 uM incubated for 30 mins by agarose gel electrophoresis\"],[\"Inhibition of recombinant KDR (unknown origin) by FRET-based Z'-LYTE assay\"],[\"Binding affinity to ARID\\u002fPHD1\\u002fZn binding domain truncated human N-terminal His-SUMO-tagged KDM5A (1 to 588 residues) expressed in Escherichia coli by ITC\"],[\"Inhibition of human MTNR1 receptor at 500 nM to 5 uM using TMB as substrate preincubated for 1 hr followed by substrate addition by ELISA relative to control\"],[\"Concentration required for agonistic activity against histamine H1 receptor in guinea pig ileum\"],[\"Inhibition of PKG1b (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Photoactivated inhibition of PHD2 (181 to 426 residues) (unknown origin) at 1.23 uM using FITC-HIF1alpha (556 to 574 residues) as substrate incubated for 60 mins using laser irradiated compound at 405 nm light by fluorescence polarization assay\"],[\"Inhibition of CHK1 in human MDA-MB-231 cells assessed as potentiation of gemcitabine-induced antiproliferative activity relative to control\"],[\"Activation of recombinant human STING haplotype G230A\\u002fR293Q mutant expressed in 293T cells measured after 30 mins in presence of digitonin A by bright Glo-luciferase reporter gene assay\"],[\"Average Binding Constant for PHkg2; NA=Not Active at 10 uM\"],[\"Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rat ventricular myocytess\"],[\"Antagonist activity at human FXR expressed in COS1 cells assessed as inhibition of CDCA-induced receptor activation after 2 days by luciferase reporter gene assay\"],[\"Inhibition of human PIM3 at 1 uM using [RSRHSSYPAGT] as substrate\"],[\"Inhibition of HDAC1 in human A549 cells assessed as increase in H4 acetylation after 24 hrs by immunoblot analysis\"],[\"Inhibition of recombinant human 5-LO expressed in Escherichia coli BL21 (DE3) using arachidonic acid as substrate preincubated for 10 mins followed by CaCl2 and substrate addition measured after 10 mins by RP-HPLC analysis\"],[\"Inhibition of VEGF-induced VEGFR2 phosphorylation at Tyr1175 residues in HUVEC pretreated for 30 mins followed by VEGF stimulation for 20 mins by Western blot analysis\"],[\"Binding affinity to human recombinant CA9 catalytic domain assessed as dissociation constant calculated from kinetic parameters at pH 8 by surface plasmon resonance assay\"],[\"Inhibition of Pseudomonas aeruginosa MurF ATPase activity by spectrophotometric assay\"],[\"Inhibition of mouse SPPL2a cotransfected with EGFP-NLP-fused TNFalpha (1 to 77 residues)-NTF incubated for 24 hrs by Hoechst staining based Cellomics ArrayScan analysis\"],[\"Inhibition of human Src T341M mutant\"],[\"Inverse agonist activity at human RORgamma in cytostim stimulated human PBMC cells assessed as increase in IL-17 production by measuring maximal efficacy preincubated with cytostim for 72 hrs by ELISA relative to control\"],[\"Partial agonist activity against rho-1 subunit GABA-C receptor expressed in Xenopus oocytes with low efficacy\"],[\"Binding affinity to human polo-box domain of PLK1 after 1 hr by fluorescence polarization-based assay\"],[\"Displacement of [3H]citalopram from SERT in rat cerebral cortex by liquid scintillation counting\"],[\"Inhibition of BCRP in human HEK293\\u002fR2 cells assessed as potentiation of toptoecan-induced cytotoxicity by measuring fold reduction in toptoecan IC50 at 1 uM after 5 days by MTS assay relative to toptoecan alone\"],[\"Antagonist activity at dopamine D4 receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM\"],[\"Inhibition of human ERG after 3.5 hrs by fluorescence polarization assay\"],[\"Inhibition of EphB4 (unknown origin) by FRET-based enzymatic assay in presence of 30 uM ATP\"],[\"Inhibition of baculovirus expressed human VEGFR2\"],[\"Inhibition of recombinant human N-terminal and C-terminal His-tagged PRMT8 (61 to 394 residues) expressed in Escherichia coli using histone H4 as substrate at 10 uM by radiometric HotSpot assay relative to control\"],[\"Inhibition of recombinant human full length ULK3 using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis\"],[\"Transactivation of GAL4-fused human PPARalpa LBD expressed in human HepG2 cells up to 2 uM after 20 hrs by luciferase reporter gene assay\"],[\"Inhibition of MRP1 (unknown origin) expressed in MDCK cells assessed as reduction in calcein-AM efflux preincubated for 30 mins followed by calcein-AM addition measured after 30 mins by spectrofluorimetric method\"],[\"Displacement of [3H]diprenorphine from human recombinant mu opioid receptor expressed in HEK cells after 60 mins\"],[\"Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to human brain sigma1 receptor\"],[\"Inhibition of full-length recombinant human His-tagged RPS6KA3 expressed in baculovirus expression system by Z'-LYTE assay\"],[\"Inhibition of DprE1 in Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth at \\u003c0.004 uM measured in MABA media\"],[\"Inhibition of BTK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control\"],[\"Inhibition of tumor growth in SUDHL4 xenografted SCID mouse at 50 mg\\u002fkg, ip in combination with etoposide at 20 mg\\u002fkg, ip\"],[\"Binding affinity to wild-type human partial length autoinhibited FLT3 (H564 to Y969 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]-(+)-pentazocine from sigma1 receptor in guinea pig brain cortex membrane after 120 mins by scintillation counting method\"],[\"Binding affinity to Staphylococcus aureus type-1 signal peptidase using decanoyl-LSSPAYNO2A-ADKabzPD and decanyol-LTPTAYNO2A-ASKKabzDD as substrate by fluorescence assay\"],[\"Inhibition of Mycobacterium tuberculosis DXR assessed as reduction of 1-deoxy-D-xylulose 5-phosphate into 2-C-methyl-D-erythritol-4-phosphate measured for every 5 secs upto 500 secs by spectrophotometry analysis\"],[\"Ratio of IC50 for inhibition of Mycobacterium tuberculosis H37Rv DprE1 using FPR as substrate in presence of SAM by resazurin dye-based spectrofluorimetric analysis to IC50 for inhibition of Mycobacterium tuberculosis H37Rv DprE1 using FPR as substrate in absence of SAM by resazurin dye-based spectrofluorimetric analysis\"],[\"Inhibition of mouse group2A phospholipase A2 fluorimetric assay\"],[\"Inhibition of CECR2 (unknown origin) at 140 nM by BROMOscan method relative to control\"],[\"Inhibition of human cysteinyl leukotriene-1 receptor at 10 uM relative to control\"],[\"Inhibition of FLT3 in human MV4-11 cells assessed as reduction in ERK1\\u002f2 phosphorylation at Thr202\\u002fTyr204 residues after 4 hrs by Western blot analysis\"],[\"Inhibition of human PIM2 assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of human RIPK3 using MBP substrate\"],[\"MMP13 collagen degradation assay\"],[\"Inhibitory activity against MMP9 upto 50uM\"],[\"Inhibition of transport activity of human GLUT4 expressed in hexose transporter deficient W4000fgy1 erg4 yeast cells assessed as reduction in transporter-mediated [14C]-hexose uptake into cells at 100 uM measured after 10 mins by scintillation counting method relative to control\"],[\"Inhibition of LDL receptor-mediated LDL internalization in HepG2 cells\"],[\"Inhibition of BRD4 in human MOLM-14 cells harboring FLT3-ITD mutant assessed as decrease in metabolic activity at 10 uM measured after 72 hrs by MTT assay\"],[\"Modulation of P-gp (unknown origin) transfected in human MDA435\\u002fLCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 10 uM after 5 days by CellTiter 96 Aqueous assay\"],[\"Inhibition of human MKLP1 at 10 uM\"],[\"Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP\"],[\"Inhibition of PKCbeta1 (unknown origin) at 1 uM by FRET method\"],[\"Partial agonist activity at human 5-HT2C receptor expressed in human tsA201 cells after 30 mins by inositol phosphate turnover assay relative to 5-HT\"],[\"Binding affinity to recombinant human C-terminal 4His-tagged CYP46A1 delta(2 to 50) mutant expressed in Escherichia coli in presence of substrate by UV-spectrophotometric method\"],[\"Inhibition of equine serum BuChE using butyrylthiocholine iodide as substrate preincubated for 3 mins followed by substrate addition by Ellman's method\"],[\"Binding affinity to human EPHA8 tyrosine residue assessed as residual binding at 1 uM by site dependent competitive binding assay\"],[\"Agonist activity at human RoRc-LBD expressed in Jurkat cells assessed as IL-17 reporter activity by luciferase assay in absence of anti-CD3\"],[\"Inhibition of F13-A in human plasma assessed as inhibition of fibrin clot formation at 2 X 10'-7 M by biotin incorporation assay in presence of 10 X 10'-3 mol\\u002fl reduced GSH\"],[\"Inhibition of PGES-1 in human A549 cell microsomes using PGH2 as substrate assessed as remaining enzyme activity of interleukin-1beta-stimulated PGE2 production at 10 uM incubated for 15 mins post interleukin-1beta challenge for 72 hrs by RP-HPLC analysis\"],[\"Inhibition of recombinant human TSP1 P123 expressed in baculovirus system binding to recombinant human LAP at 10 nM preincubated for 10 mins followed by recombinant human LAP addition and measured after 2 hrs by ELISA relative to control\"],[\"Binding affinity to F9a\"],[\"Binding affinity to recombinant human KOR transiently expressed in CHOK1 cells at 50 nM measured 20 mins post compound washout by TIRF microscopic analysis relative to control\"],[\"Inhibition of wild-type human full length IKK-alpha (M1 to E745 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Agonist activity at human PPARalpha ligand binding domain expressed in COS-1 cells co-transfected with Gal4 at 10 uM by luciferase reporter gene assay\"],[\"Inhibition of recombinant human AChE using acetylthiocholine as substrate after 1 min by Ellman's method\"],[\"Inhibition of PARP1 (unknown origin) incubated for 30 mins in presence of NAD\"],[\"Inhibition of human PKCgamma at 10 uM\"],[\"Activation of human Gi protein alpha1 subunit expressed in Escherichia coli assessed as protein bound [35S]GTPgammaS levels at 50 uM by scintillation spectroscopy\"],[\"Inhibition of wild-type human partial length ITK (R335 to L620 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Non-competitive inhibition of electric eel AChE using acetylthiocholine chloride by Lineweaver-Burk plot method and Ellman's method based spectrophotometry\"],[\"Displacement of 25-[3H]hydroxycholesterol from ROR gamma (unknown origin) by competitive binding assay\"],[\"Antagonist activity at progesterone receptor beta (unknown origin) by NH Pro assay\"],[\"Inhibition of SphK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate\"],[\"Binding affinity to LRRFIP1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of PTP1B (unknown origin) expressed in CHO cells over-expressing human IR assessed as increase in insulin-mediated IR-beta phosphorylation at 1.25 to 10 uM preincubated for 2 hrs followed by insulin challenge for 10 mins by Western blotting analysis\"],[\"Inhibition of human ERG transfected in CHO cells assessed as blockade of tail current at 25 uM by patch clamp assay\"],[\"Inhibition of human recombinant HDAC11 expressed in baculovirus\\u002fsf9 cells using RHKKAc as substrate\"],[\"Displacement of [125I]-iodoproxyfan from human recombinant histamine H3 receptor expressed in HEK293 cells after 1 hr by gamma counting analysis\"],[\"Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control\"],[\"Activation of KCNQ2 (unknown origin) expressed in CHO cells at 10 uM after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assay\"],[\"Inhibition of human recombinant RON at 0.5 uM by radiometric filter-binding assay\"],[\"Inhibitory activity against chitin synthase from Candida albicans at a concentration 5 uM\"],[\"Inhibition of EGFR (unknown origin) using PolyE4Y1 as substrate at 1 uM by ADP-Glo assay relative to control\"],[\"Ratio of Kcat to Km for cloned deoxycytidylate deaminase in human HepG2 cells by spectrophotometric analysis\"],[\"Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting\"],[\"Inhibition of human USP30 CD (57 to 517 residues) expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine110-glycine using Ubiquitin-Rhodamine110-glycine as substrate by fluorescence based analysis\"],[\"Inhibition of human CAMK1D assessed as residual activity at 0.1 uM relative to control\"],[\"In vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase in rat hepatic microsomes was measured by using AIV assay\"],[\"Binding affinity for Phencyclidine receptor (1 uM) using 2 nM [3H]- TCP radioligand.\"],[\"Agonist activity at human beta2 adrenergic receptor expressed in HEK293 cells assessed as stimulation of cAMP accumulation\"],[\"Inhibition of C-terminal NanoLuc-fused full length p38alpha (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay\"],[\"Inhibition of human recombinant carboxy-terminal his-tagged MDH-2 (20 to 338) expressed in Escherichia coli using oxaloacetic acid as substrate after 10 mins by UV endpoint analysis\"],[\"Displacement of [3H]dofetolide from human Erg at 3 uM\"],[\"Binding affinity to wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Ratio of acetazolamide Ki to compound Ki for human full length cytosolic carbonic anhydrase 3\"],[\"Inhibition of YAP1 in human A549 cells assessed as reduction in c-Myc protein expression at 10 uM incubated for 72 hrs by Western blot analysis\"],[\"Inhibition of human Pgp expressed in mouse L5178Y cells assessed as potentiation of doxorubicin-induced cytotoxicity after 48 hrs by MTT assay\"],[\"Inhibition of KDM6B (unknown origin) expressed in Escherichia coli using H3 (21 to 44 residues) K27Me3-GGK-Biotin JMJD3 Cognate Ligand\\u002f10 uM alpha-ketoglutarate as substrate\\u002fcofactor preincubated for 5 mins followed by substrate addition measured after 5 mins by alphascreen assay\"],[\"Displacement of [3H]DPCPX from A1 adenosine receptor (unknown origin) expressed in CHO cell membrane incubated for 60 mins at room temperature by NXT microplate scintillation counter analysis\"],[\"Inverse agonist activity at RORgammat in human PBMC derived CD4-positive T cells assessed as suppression of T cell differentiation to Th17 cells by measuring reduction in IL-17 level at 1.2 uM after 1 hr relative to control\"],[\"Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein at 25 ug\\u002fml after 24 hrs\"],[\"Agonist activity at rat GPR109A receptor assessed as GTPgammaS binding\"],[\"Inhibition of recombinant human EGFR L858R\\u002fT790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay\"],[\"Binding affinity to recombinant human IL-17A assessed as protection from deuterium uptake at 92 to 101 residues at 10 uM after 10 to 3600 secs by HDX-MS\"],[\"Inhibition of recombinant human GST-tagged cytoplasmic EPHB3 (623 to 907 residues) expressed in baculovirus expression system at 1 uM relative to control\"],[\"Agonist activity at GLP1 receptor in mouse BetaTC6 cells assessed as increase in glucose-dependent insulin secretion after 120 mins by sandwich ELISA\"],[\"Inhibition of human ABCB1 expressed in KBV1 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring doxorubicin IC50 at 50 nM after 72 hrs by MTT assay (Rvb = 5.07 +\\u002f- 0.19 uM)\"],[\"Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis relative to control\"],[\"Irreversible inhibition of papain after 1 hr incubation at 100 uM by ESI-MS analysis\"],[\"Activation of beta-2 adrenergic receptor in rat L6 cells assessed as enhancement of 2-deoxyglucose uptake at 10 uM preincubated for 4 hrs followed by 2-deoxyglucose addition measured after 20 mins by fluorescence assay in presence of PI3K inhibitor LY294002\"],[\"Agonist activity at rat delta opioid receptor expressed in rat C6 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by radioimmunoassay\"],[\"Inhibition of CDK5 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method\"],[\"Inhibition of rat SGLT1 expressed in COS7 cells assessed as reduction of [14C]-AMG uptake\"],[\"Inhibition of rat 5HT-1B receptor at 10 uM relative to control\"],[\"Inhibition of human KHS at 100 nM using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Stimulation of [3H]phosphatidylinositol accumulation by rat Metabotropic glutamate receptor 4 co-expressed with Gqi9 protein in HEK 293 cells; Active\"],[\"Inhibition of human SGK1 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of recombinant human EPhA1 (568 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of etoposide-enhanced human topoisomerase 2alpha-mediated DNA cleavage at 100 to 400 uM incubated for 2 mins in presence of 100 uM etoposide by ethidium bromide staining based gel electrophoresis method\"],[\"Selectivity ratio of Ki for rat brain CB2 receptor to Ki for rat spleen CB2 receptor\"],[\"Inhibition of JAK2 signaling pathway in C57 mouse assessed as reduction in GM-CSF induced STAT5 phosphorylation in spleen at 20 mg\\u002fkg, po preincubated for 30 mins followed by GM-CSF addition and measured after 30 mins by ELISA\"],[\"Binding affinity to electric eel AChE after 24 hrs by LC\\u002fMS-SIM analysis\"],[\"Inhibition of human recombinant BCKDK at IC50 incubated for 60 mins by ADP-Glo kinase assay relative to control\"],[\"Agonist activity at human recombinant mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay relative to control\"],[\"Induction of annexin 2-mediated F-actin disruption in human WI38 cells at 4 uM after 2 hrs by confocal laser scanning microscopy\"],[\"Inhibition of full length Mycobacterium tuberculosis His6-tagged ptpB expressed in Escherichia coli BL21(DE3) using pNPP as substrate measured after 5 mins by spectrophotometric method\"],[\"Vitamin D receptor mediated transcriptional activity in rat osteosarcoma ROS 17\\u002f2.8 cells\"],[\"Displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes incubated for 90 mins by Cheng-Prusoff equation based analysis\"],[\"Binding affinity towards Dopamine receptor D3 using CHO cell line and [3H]-spiperone as radioligand \"],[\"Inhibition of TBK1 in human THP1 cells assessed as decrease in baculovirus-stimulated IFNbeta secretion preincubated for 45 mins followed by virus addition and measured after 20 hrs by electrochemiluminescence method\"],[\"Agonist activity at estrogen receptor beta (unknown origin) by NH Pro assay\"],[\"Inhibition of GSTO1-1 in mouse bone marrow derived macrophage cells assessed as reduction in LPS-induced IL-1beta release by measuring IL1 beta level at 5 uM pretreated with LPS for 3 hrs followed by compound addition and measured after 1 hr by ELISA relative to control\"],[\"Inhibition of BRAF V599E mutant (unknown origin) at 10 uM relative to control\"],[\"Percent inhibition against DYRK1a at 10 uM using 100 uM ATP\"],[\"Inhibition of recombinant human C-terminal 10-His tagged hepsin (Arg45 to Leu417) expressed in mouse myeloma cells mediated pro-HGF activation preincubated for 30 mins followed by pro-HGF addition and measured after 1 hr by immunoblotting analysis\"],[\"Inhibition of full length human GST-tagged TSF1 expressed in Sf9 cells assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of TXK (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control\"],[\"Inhibition of wild-type human partial length PIM2 (M1 to E291 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter\"],[\"Inhibition of TYK2 (unknown origin) at 100 nM\"],[\"Ratio of Kpol\\u002fKd for DNA-dependent DNA polymerase activity of HIV 1 reverse transcriptase M184V mutant assessed as incorporation of dTMP by burst assay using DNA\\u002fDNA Primer\\u002fTemplate combination\"],[\"Inhibition of recombinant mouse macrophage iNOS expressed in Escherichia coli using L-arginine as substrate after 30 secs by hemoglobin capture assay\"],[\"Displacement of [35S]GTPgammaS from human S1P1 receptor expressed in CHO cells\"],[\"Inhibition of CDYL in human SH-SY5Y cells assessed as decrease in enrichment of H3K27me3 at MYT1 promoter site at 150 uM incubated for 24 hrs by ChIP-qPCR analysis\"],[\"Inhibition of recombinant human sEH using PHOME as substrate preincubated with enzyme for 10 mins prior to substrate addition by fluorescence based assay\"],[\"Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 80 uM after 24 hrs by luciferase reporter gene assay relative to control\"],[\"Agonist activity at PPAR-alpha receptor (unknown origin)\"],[\"Activation of Nrf2 in mouse BV-2 cells assessed as upregulation of GCLM protein expression after 24 hrs by Western blot analysis\"],[\"Inhibition of mouse PDS stably expressed in FRT cells coexpressing EYFP-H148Q\\u002fI152L\\u002fF46L assessed as reduction in I-\\u002fCl- exchange incubated for 10 mins by fluorescence based assay\"],[\"Inhibition of PTP1B in mouse C2C12 cells assessed as suppression of PA-induced insulin resistance by measuring increase in insulin-mediated IRS1 phosphorylation at Y632 residue preincubated for 1 hr followed by palmitic acid stimulation for 16 hrs and subsequent insulin addition measured after 30 mins by Western blot analysis\"],[\"Inhibition of LG190178-induced VDR-LBD interaction to Alexa Fluor 647-labeled SRC2-3 by fluorescence polarization assay in presence of 10 mM 2-mercaptoethanol\"],[\"The inhibitory concentration for 50% was measured on potassium channel complex\"],[\"Inhibition of 5-lipoxygenase in human polymorphonuclear leukocytes assessed as inhibition of LTB4 production preincubated for 15 mins measured after 10 mins by HPLC method\"],[\"Inhibition of human recombinant MAGL using 2-arachidonoylglycerol substrate assessed as arachidonic acid at 10 uM by HPLC analysis\"],[\"Inhibition of IkappaBalpha phosphorylation in human MDA-MB-231 cells at 5 to 20 uM after 12 to 24 hrs by Western blot analysis\"],[\"Inhibition of human galactosidase at \\u003e50 uM after 30 mins by Kinase-GloTM assay\"],[\"MC4 (h) CEREP panel\"],[\"Inhibition of human CYP11B1 expressed in hamster V79MZh11B1 cells\"],[\"Positive allosteric modulation of mGlu3 receptor (unknown origin) relative to control\"],[\"Inhibition of [Leu8,D-Trp22,125I-Tyr25]SRIF-28 binding to human somatostatin receptor type 2\"],[\"Inhibition of human BTK using KVEKIGEGTYGVVYK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of HIV-1 reverse transcriptase using 25 ug\\u002fmL of Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay\"],[\"Partial agonist activity at human recombinant adrenergic alpha-1D receptor expressed in rat RBL cells assessed as stimulation of intracellular calcium levels incubated at room temperature by fluorimetry\"],[\"Binding affinity to PDGFRalpha (unknown origin)\"],[\"Inhibition of PDE10A (unknown origin) using tritium labeled cAMP as substrate after 1 hr by scintillation proximity assay\"],[\"Binding affinity to His6-tagged\\u002fTEV fused SIRT3 (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as thermal stability at 90 uM using H3K18Ac as substrate incubated for 20 mins in presence of NAD+ by GloMelt thermal shift assay\"],[\"Inhibition of HO-1 in rat spleen microsomes incubated for 15 mins\"],[\"Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled pBR322 plasmid DNA at 100 uM incubated for 30 mins by agarose gel electrophoresis relative to control\"],[\"Inhibition of LMWPTP (unknown origin) using pNPP as substrate at pH 7 at 25 degC by spectrophotometric analysis\"],[\"Binding affinity to human 5-HT6 receptor expressed in HEK293 cells\"],[\"Thermal Shift Assay. Domain start\\u002fstop: S759-K917\"],[\"Inhibition of human STK25 (1 to 308 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Irreversible inhibition of Clostridium botulinum BoNT\\u002fA light chain expressed in Escherichia coli BL21 (DE3) using SNAPtide as substrate preincubated with enzyme for 0.5 to 30 mins followed by substrate addition by Michaelis-Menten equation analysis\"],[\"Agonist activity at human PPARdelta ligand binding domain in human HuH7 cells co-transfected with fused Gal4-DBD by transactivation assay\"],[\"Displacement of [3H]CP-55940 from CB1 receptor in rat brain by filtration assay\"],[\"Inhibition of EZH2 Y641F mutant in PRC2 complex (unknown origin) using RKQLATKAARK(Me3)SAPATGGVKKP-NH2 peptide substrate preincubated for 30 mins followed by addition of [3H]-SAM measured after 2 hrs by Topcount scintillation proximity assay\"],[\"Inhibition of recombinant human N-terminal GST-tagged full length Aurora A expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control\"],[\"Antagonist activity at human TRPV1 expressed in CHOK1 cells assessed as inhibition of heat 45 degC-induced activity after 5 mins by FLIPR assay\"],[\"Inhibition of human 5-HT3 receptor at 3 uM by radioligand binding assay\"],[\"Binding affinity to 5-HT 2C (unknown origin) by competition binding assay\"],[\"Displacement of [125I]I-AB-MEAC from human adenosine A3 receptor expressed in CHO cells\"],[\"Inhibition of human methionine aminopeptidase 1 at 100 uM in presence of Mn2+ relative to control\"],[\"Activity at human mGluR5 transiently transfected in BHK cells assessed as decrease in maximum response of L-glutamate for calcium flux at 15 nM by FLIPR assay\"],[\"Selectivity ratio of IC50 for human TRKA at active state to IC50 for human TRKA at inactive state using fluorescently-labelled peptide as substrate by caliper assay\"],[\"Inhibition of Plasmodium falciparum plasmepsin 2 using PM-2 peptide substrate incubated for 60 mis by fluorescence based assay\"],[\"Inhibition of human thymidylate synthase expressed in Escherichia coli incubated for 1 hr using varying dUMP levels by spectrophotometry based Lineweaver-Burk method\"],[\"Displacement of [3H]-LSD from cloned human 5HT6 receptor expressed in HeLa cells\"],[\"Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Apparent receptor density at 3.16*10e-5 M concentration\"],[\"Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEK cells after 90 mins by scintillation counting analysis\"],[\"Agonist activity at human kappa-type opioid receptor expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation up to 10 uM after 30 mins in presence of forskolin by luminescence-based HitHunter cAMP assay\"],[\"Chaperone activity at beta-galactosidase R201C mutant isolated from human patient fibroblasts assessed as increase in enzyme activity at 10 uM using 4-nitrophenyl beta-D-galactopyranoside as substrate relative to untreated control\"],[\"Agonist activity at human GPR142 expressed in HEK293 cells assessed as IP1 accumulation incubated for 1 hr by IP-one HTRF assay relative to control\"],[\"Ratio of activity of aliesterase in Laodelphax striatella Ibaraki (small brown planthopper) homogenate to activity of aliesterase in susceptible Laodelphax striatella homogenate\"],[\"Binding affinity against human IKr channel\"],[\"Inhibition of full length human recombinant PKA catalytic subunit type alpha using GRTGRRNSI peptide substrate and [gamma33P]-ATP incubated for 20 mins by scintillation counting method\"],[\"Inhibition of recombinant human EphA7 (613 to 909 residues) assessed as residual activity at 10 uM using KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of Nav1.7 (unknown origin) expressed in CHO cells after 45 mins by FLIPR assay\"],[\"Inhibition of HDAC6-mediated tubulin acetylation in human DU145 cells at 90 nM after 4 hrs by Western blot analysis\"],[\"Agonist activity at mouse TRH-R1 expressed in HEK293 cells assessed as IP1 formation after 1 hr by ELISA\"],[\"Inhibition of B-Raf in human A549 cells at 5 to 20 uM after 48 hrs by Western blot analysis\"],[\"Displacement of [3H]CP55940 from human CB2 receptor expressed in HEK293 EBNA cells after 90 mins by liquid scintillation spectrophotometer\"],[\"Binding affinity to wild-type human partial length CAMK1D (M1 to K299 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of p-glycoprotein-mediated doxorubicin efflux in human KB cells assessed as doxorubicin accumulation preincubated for 1 hr prior doxorubicin addition measured after 3 hrs by fluorometric assay\"],[\"Binding affinity to wild-type human partial length STK39 (P43 to I357 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant PDE3A-mediated [3H]cAMP hydrolysis after 20 mins by scintillation proximity assay\"],[\"Partial agonist activity towards mouse Melanocortin-4 receptor\"],[\"Inhibition of human recombinant MGL relative to control\"],[\"Inhibition of human cathepsin-K using Z-Leu-Arg-AMC as substrate up to 20 mins by fluorescence assay\"],[\"Inhibition of UCHL1\"],[\"Inhibition of HSP1 activity in human NCI-H460 cells assessed as reduction of hsp70 promoter activity after 12 hrs by luciferase reporter gene assay\"],[\"Displacement of [3H]MRE3008-F20 from human adenosine A3 receptor expressed in CHO cells; range 0.63-0.1.00\"],[\"Inhibition of recombinant human GST-tagged SGK3 catalytic domain (87 to 496 residues) expressed in baculovirus expression system at 0.1 uM using serine\\u002fthreonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control\"],[\"Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells\"],[\"Activity at human oxytocin receptor expressed in CHO cells assessed as inositol phosphate accumulation at 1 uM\"],[\"Inhibition of p38-beta2 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of papaya papain assessed as cleavage of (EDANS)-EPLFAERK-(DABCYL) at 100 uM by fluorescence spectrometer\"],[\"Inhibition of LKB1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"Displacement of 500 uM PPi from NS5B in Hepatitis C virus\"],[\"Inhibition of full length wild type human N-terminal GST-tagged MALT1 catalytic domain (325 to 760 residues) expressed in Escherichia coli BL21 (DE3) assessed as increase in fluorescence at 0.5 uL using Ac-LRSR-AMC as substrate preincubated for 20 mins followed by substrate addition measured after 60 to 120 mins by fluorescence plate reader assay\"],[\"GABAB1B Eurofins-Panlabs radioligand binding assay\"],[\"Inhibition of human AChE pretreated for 20 mins followed by acetylthiocholine iodide substrate addition measured for 5 mins by Ellman's method\"],[\"Inhibition of BChE\"],[\"In vitro inhibitory concentration against Prostaglandin G\\u002fH synthase 2 in human whole blood assay\"],[\"Inhibition of DCN1 in human CAL33 cells assessed as decrease in cullin4 neddylation at 10 uM after 48 hrs by Western blot analysis\"],[\"Effect on AKT phosphorylation in human Bel7402\\u002f5-FU cells assessed as ratio of phosphorylated AKT to beta-actin level at 0.1 uM after 48 hrs by Western blot analysis (Rvb = 0.39 No_unit)\"],[\"Binding affinity towards aminopeptidase N (APN) from pig kidney\"],[\"Activation of human AURA activity expressed in baculovirus cells by time course assay\"],[\"Reversible inhibition of human recombinant MAGL at 320 nM pre-incubated for 60 mins before 4-NPA substrate addition by dilution assay\"],[\"Inhibition of human EGFR L858R mutant expressed in mouse Ba\\u002fF3 cells\"],[\"Inhibition of human YES1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Activation of Nrf2 in mouse BV-2 cells assessed as increase in nuclear Nrf2 level by Western blot analysis\"],[\"Displacement of [3H]DSLET from rat brain membrane delta opioid receptor\"],[\"Inhibition of mTOR binding to DEPTOR in human RPMI8226 cells assessed as increase in mTORC1-associated p70 phosphorylation at 0.05 to 0.2 uM after 6 hrs by Western blot analysis\"],[\"inhibition of human c-Raf\"],[\"Inhibition of wild-type human full length PAK3 (M1 to R544 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of PASK (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of human AchE-induced amyloid beta (1 to 40) aggregation after 48 hrs by thioflavin T fluorescence spectroscopic method\"],[\"Displacement of [125I]NDP-MSH from human MC4 receptor expressed in HEK293 cells\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 folC at 8 fold MIC by microarray analysis\"],[\"Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate by spectrophotometer analysis\"],[\"Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 1 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis\"],[\"Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as stimulation of [3H]inositol phosphate accumulation by liquid scintillation counting\"],[\"Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA\"],[\"Inhibition of recombinant IKKepsilon (unknown origin) using ulight-rpS6 as substrate at 20 uM after 1 hr by LANCE ultra TR-FRET assay relative to control\"],[\"Inhibition of ANKRD3 Lysine 1 labelling site (unknown origin) at 10 uM\"],[\"Inverse agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of forskolin-stimulated cAMP production by TR-FRET assay\"],[\"Inhibition of PAK4 (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of human recombinant PDE3A assessed reduction in [3H]cAMP hydrolysis preincubated with enzyme for 5 mins prior to substrate addition measured after 20 mins by scintillation proximity assay\"],[\"Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay\"],[\"Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydrase assay\"],[\"Inhibition of human ALK5 kinase expressed in Sf9 cells\"],[\"Antiviral activity against SARS-3CLpro\"],[\"Inhibition of AchE in brain homogenates of scopolamine-induced albino mouse memory deficit model at 5 uM using acetylthiocholine iodide as substrate incubated for 10 mins measured for 2 mins by Ellman's method relative to control\"],[\"Activity of human DAPK1 kinase at 1 uM\"],[\"Binding affinity to human full length human adenosine A1 receptor expressed in CHO cells up to 100 nM after 10 mins by confocal microscopic analysis\"],[\"Percent inhibition (1 uM) against CC chemokine receptor 3 expressing in rat Y3 cell line\"],[\"Binding affinity to human 5-hydroxytryptamine receptor 7\"],[\"Inhibition of human IKK2 assessed as reduction in substrate phosphorylation at 10 uM by ELISA\"],[\"Positive allosteric modulation of human D1R expressed in HEK293 cells assessed as increase in dopamine-induced cAMP accumulation after 60 mins by HTRF assay\"],[\"Binding affinity to human STK16 at 10 uM relative to control\"],[\"Binding affinity to alpha-1A adrenergic receptor (unknown origin) transfected in HEK293 cells at 20 nM after 20 mins by flow cytometric analysis\"],[\"Inhibition of PRMT4 (unknown origin) using biotinylated histone H4 (1 to 24 residues) as substrate in presence of [3H]SAM by scintillation proximity assay\"],[\"Inhibition of COX2 (unknown origin) at 100 uM using arachidonic acid substrate by colorimetric assay\"],[\"Inhibition of human CDK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Displacement of [3H]WAY100635 from dopamine D1 receptor in porcine striatal membranes\"],[\"Inhibition of human TERT in H1299 cells at 1 uM after 24 hrs by SEAP reporter gene assay\"],[\"Binding affinity to BIR3 Lys322A mutant (unknown origin) assessed as covalent adduct formation incubated for 10 mins by Coomassie staining based SDS-PAGE gel electrophoresis\"],[\"Inhibition of human transglutaminase 2 using ((benzyloxy)carbony l)-L-glutaminylglycine peptide substrate assessed as Kinh\\u002fKi ratio by GDH coupled assay\"],[\"Inhibition of human 20S proteasome beta5 subunit using Suc-LLVY-AMC as substrate by fluorescence assay\"],[\"Inhibition of S1P4 (unknown origin)\"],[\"Inhibition of PDGF-BB-stimulated Rac1 activity in human aortic smooth muscle cells assessed as reduction of Rac1GTP level at 50 uM after 4 hrs by G-LISA relative to control\"],[\"Inhibition of recombinant GST-tagged human ALK2 catalytic domain (145 to 509 residues) expressed in Baculovirus expression system by FRET-based LanthaScreen Eu kinase binding assay\"],[\"Binding affinity to 5HT transporter (unknown origin) at 10 uM relative to control\"],[\"Binding affinity to CBP-BRD (unknown origin) assessed as change in melting temperature at 50 uM by thermal shift assay\"],[\"Binding affinity to GTP-binding nuclear protein ran in human Hela cells lysates assessed as protein enrichment by measuring normalized heavy\\u002flight ratio at by nano-LC-ESIMS\\u002fMS analysis\"],[\"Inhibition of human coagulation factor alpha-thrombin using Boc-Val-Pro-Arg-AMC as fluorogenic substrate measured at 1 min interval for 1 hr by fluorometric assay\"],[\"Reversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP\"],[\"Inhibition of human RIPK3 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system measured after 1 hr by kinomescan method\"],[\"Inhibition of COX2 in Mus musculus (mouse) peritoneal macrophage\"],[\"Agonist activity at human dopamine D2L receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding\"],[\"Inhibition of [3H]-AMPA binding to human GluR2 receptors expressed in HEK 293 cells\"],[\"Inhibition of human His-tagged Brd4 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay\"],[\"Inhibition of human kidney uPA using chromogenic H-D-Ile-L-Pro-L-Arg-p-nitoraniline as substrate by fluorescence assay\"],[\"Time dependent inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio after 1.5 hrs by SNAPtide FRET based assay\"],[\"Inhibition of recombinant human GST-tagged EPHB1 (613 to 881 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of PAK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control\"],[\"Inhibition of fluorescein-labeled ML349 binding to HEK293T cells-derived His-tagged PDXK expressed in Escherichia coli BL21(DE3) after 30 mins by fluorescence polarization assay\"],[\"Mixed inhibition of human recombinant cathepsin B exopeptidase activity using Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH substrate assessed as inhibition constant for enzyme-inhibitor complex\"],[\"Binding affinity towards human cloned carbonic anhydrase I\"],[\"Inhibition of Usp9x in human MM1.S cells assessed as reduction in MCL-1 protein levels at 5 uM incubated for 5 to 240 mins by by SDS-PAGE and immunoblotting\"],[\"Inhibition of human recombinant GST-fused SHP2 using p-nitrophenyl phosphate as substrate\"],[\"Inhibition of human MMP9 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis\"],[\"Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 2000 nM by liquid scintillation counting\"],[\"Inhibition of CLK2 (unknown origin) assessed as residual enzyme activity at 10 uM\"],[\"Inhibition of full length human PDPK1 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay\"],[\"Agonist activity at dog S1P1 receptor assessed as cAMP accumulation by HTRF assay relative to S1P\"],[\"Inhibition of CHK2 (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Agonist activity at PPARalpha (unknown origin) by Alpha Screen assay\"],[\"Displacement of [3H]-ketanserin from rat cerebral cortex 5-HT2A receptor after 30 mins by liquid scintillation counting\"],[\"Ratio of binding affinity to PKC delta C1b domain wild type versus mutant L21G\"],[\"Antiprion activity against sheep prion infected in mouse ScN2a-cl3 cells assessed as reduction in PrPSc level after 5 days by ELISA\"],[\"Inhibition of HDAC8 (unknown origin) using fluorogenic tetrapeptide RHK(Ac)K(Ac) substrate by fluorescence assay\"],[\"Displacement of [11C]flumazenil from TSPO in rat kidney cerebral cortex membrane after 90 mins\"],[\"Agonist activity at delta-type opioid receptor in mouse vas deferens assessed as inhibition of electrically stimulated contractions\"],[\"Inhibition of human PDK1 assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of NLRP3 inflammasome activation in LPS-stimulated mouse bone marrow-derived macrophages assessed as reduction in pro caspase1 p20 in cell lysate at 2 uM preincubated for 30 mins followed by ATP addition and measured after 0.5 hrs by Western blot analysis\"],[\"Inhibition of CYP1B1 in human MCF7 cells assessed as reduction in TCDD-induced CYP1B1-mediated EROD activity by EROD assay\"],[\"Inhibition of AKT in human JeKo1 cells assessed as down-regulation of S6 phosphorylation after 24 hrs by Western blot analysis\"],[\"Inhibition of human recombinant MAOA using kynuramine as substrate incubated for 10 mins by UPLC-ESI-MS\\u002fMS analysis based Eadie-Hofstee plot analysis\"],[\"Antagonism of retinoid X receptor alpha activity induced by retinoic acid expressed in Escherichia coli at 10e-5 M\"],[\"Antagonist activity against rat HNF4alpha1 expressed in African green monkey CV1 cells assessed as inhibition of LGOI00695-induced receptor activation incubated for 24 hrs by firefly luciferase reporter gene assay\"],[\"Inhibition of human liver GPa using Glc-1-P as substrate incubated for 15 mins\"],[\"Intrinsic activity at human cloned adrenergic beta3 receptor expressed in CHO cells assessed as cAMP accumulation relative to isoproterenol\"],[\"Inverse agonist activity at human recombinant CB1 receptor expressed in CHO-K1 cells assessed as stimulation of GTPgammaS binding\"],[\"Inhibition of maize Histone deacetylase 2 (HD-2) activity\"],[\"Binding affinity to 15N-labelled TFPI (1 to 160 residues) (unknown origin) reduction in amide exchange rate in enzyme-compound complex at TFPI residues 25, 26, 36, 62, 63, 127, 132 and 152 relative to control\"],[\"Inhibition of adenosine A3 receptor\"],[\"Inhibition of bovine 5-LOX assessed as inhibition of calcium ionophore A23187-induced leukotriene B4 formation at 10 uM by reversed phase HPLC analysis\"],[\"CSF1-R ProQinase selectivity panel\"],[\"Agonist activity at FXRalpha expressed in HEK293 cells assessed as increase in transcriptional activity after 18 hrs by luciferase reporter gene assay\"],[\"Inhibition of glutathione reductase in human A549 cells assessed as enzyme activity at 166 nM after 24 hrs relative to untreated control\"],[\"Binding affinity to free form of wild type HIV-1 p66\\u002fp51 reverse transcriptase using poly(rA)\\u002foligo(dT) as templates in presence of [3H]dTTP\"],[\"MAPK14 Invitrogen selectivity data (BI)\"],[\"Inhibition of recombinant SIRT2 (unknown origin) using RLIK(Ac)AMC as substrate assessed as reduction in deacetylase activity at 100 uM after 2 hrs in presence of NAD+ by fluorescence assay relative to control\"],[\"Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay\"],[\"Binding affinity for human beta-2 adrenergic receptor\"],[\"Binding constant for full-length CDK2\"],[\"Inhibition of EGFR in human DFCI076 cells assessed as reduction in cell viability after 72 hrs by MTS assay\"],[\"Inhibition of recombinant human HDAC4 using Boc-L-Lys(epsilon-trifluoroacetyl)-AMC as substrate by two-step fluorogenic assay\"],[\"Displacement of human recombinant [125I]IL8 from CXCR2 receptor expressed in CHO cells\"],[\"Binding affinity against 5-hydroxytryptamine 1B receptor\"],[\"Inhibition of DCN-1 in human KYSE-70 cell line assessed as increase in NRF2 expression at 2.5 to 20 uM incubated for 24 hrs by Western blot analysis\"],[\"Displacement of [3H]BTCP from human recombinant DAT at 10 uM after 120 mins by scintillation counting relative to control\"],[\"Displacement of [3H]PGE2 from from human EP4 receptor expressed in HEK293 cells membranes incubated for 60 mins\"],[\"Inhibition of human truncated PKC beta1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Agonist activity at human adenosine A2a receptor expressed in CHO cells assessed as stimulation of cAMP formation after 24 hrs\"],[\"Inhibition of recombinant CDK7 (unknown origin) at 1 uM after 3 hrs\"],[\"Agonist activity at mouse NPSR expressed in HEK293 cells up to 10 uM by calcium mobilization assay\"],[\"Upregulation of Bcl-2 phosphorylation at Ser70 residue in human MCF7 cells at 0.1 microM incubated for 12 to 36 hrs by western blot analysis\"],[\"Binding affinity to recombinant human MAO-B at 10 uM after 60 mins by luminescence analysis relative to control\"],[\"Inhibition of core catalytic domain of PDE4B\"],[\"Displacement of [3H]-pentazocine from sigma1 receptor in guinea pig brain membrane incubated for 150 mins by scintillation counting method\"],[\"Binding affinity to Granzyme K\"],[\"Inhibition of MALT1 (329-824 residues) (unknown origin) using PT14 as substrate incubated for 60 mins by fluorescence based assay\"],[\"Inhibition of human thrombin-induced cross-linked fibrin formation at 150 to 1000 uM after 5 to 30 mins by SDS-PAGE analysis\"],[\"Displacement of [3H]8-OH-DPAT from human 5HT1A receptor transfected in COS1 cells\"],[\"Inhibition of recombinant IRR (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM\"],[\"Binding affinity to ERalpha S463P mutant (unknown origin) expressed in Escherichia coli preincubated for 15 mins followed by ligand addition and measured after 1 hr by fluorescent polarization assay\"],[\"Inhibition of ALK4 (unknown origin)\"],[\"Inhibition of recombinant human MLK1 at 1 uM relative to control\"],[\"Dissociation constant of H2 receptor antagonist activity against guinea pig atrium\"],[\"Inhibition of ITK (unknown origin) at 10 uM relative to control\"],[\"Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in HEK293 cell membranes measured after 120 mins\"],[\"Inhibition of human Plasminogen activator inhibitor 1 using HRP substrate after 30 mins by chromogenic assay\"],[\"Inhibition of HIV1 integrase at 20 uM\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged GRK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibitory concentration against human Kv11.1 ERG potassium channel\"],[\"Binding affinity to human plasma kallikrein assessed as inhibition constant using H-D-Prolyl-L-phenylalanyl-L-arginine p-Nitroaniline as substrate measured upto 120 mins by spectrophotometric analysis\"],[\"Inhibition of CPT2 in rat mitochondria using [3H]carnitine by radiometric method\"],[\"Inhibition of HDAC3 from human HeLa cells at 5 uM\"],[\"Antagonist activity at human Alpha-2C adrenergic receptor expressed in CHO cells assessed as inhibition of clonidine-induced extracellular acidification after 30 mins by cytosensor microphysiometry\"],[\"Inhibition of partial length human FAK expressed in bacterial system at 1 uM\"],[\"Inhibition of human SGLT1 expressed in african green monkey COS7 cells assessed as methyl-alpha-D-[U-14C]glucopyranoside uptake at 100 uM by scintillation counting\"],[\"Antagonist activity at GR in human PBMC assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 6 hrs by RT-qPCR method\"],[\"Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay\"],[\"Mixed type inhibition of human serum BuChe assessed as increase in Km at 89 to 267 nM using varying level of butyrylthiocholine iodide as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of human PRK2 assessed as residual activity at 1 uM relative to control\"],[\"Displacement of C-terminally biotinylated-H3K4me3 (1 to 21 residues) peptide from KDM7A (PHD) (unknown origin) preincubated for 15 mins followed by peptide addition measured after 1 hr by luminescence-based AlphaScreen assay\"],[\"Inhibition of mouse CHIT1 catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis\"],[\"Binding affinity to recombinant human Abl T315I mutant using abitide as substrate\"],[\"Displacement of [125I]I-AB-MECA from human adenosine A3 receptor Q167E mutant expressed in COS7 cells\"],[\"Partial allosteric inhibition of thrombin (unknown origin) assessed as reduction in enzyme-mediated fibrinogen cleavage at 0.5 to 150 uM pretreated for 10 mins followed by fibrinogen addition measured after 1 min by SDS-PAGE analysis relative to control\"],[\"Binding affinity to immobilized recombinant human His-tagged p47phox SH3A-B domain (151 to 285 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as interaction with protein at one binding site at 1 mM by SPR assay\"],[\"Inhibition of human recombinant SRC using Ulight-Poly GAT[EAY(1:1:1) as substrate measured after 10 mins in the presence of ATP by LANCE method\"],[\"Inhibition of human MMP7 by fluorometric assay\"],[\"Inhibition of Hec1\\u002fNek2 interaction in human MDA-MB-468 cells assessed as induction of Nek2 degradation at 100 nM by western blot analysis\"],[\"Inhibition of c-KIT (unknown origin) using ATP and polyE4Y substrate by radiometric assay\"],[\"In vitro inhibitory activity against Shc\\u002fGrb2 interactions in B104-1-1 cells at 5 uM\"],[\"Inhibition of human C-src at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control\"],[\"Inhibition of full length human N-terminal GST-tagged TNKS1 ADP-ART catalytic domain (1001 to 1327 residues) using histone H2A as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter\"],[\"Activity at human P2Y2 receptor at 10 uM\"],[\"Activity at human recombinant GluA3 receptor flip isoform expressed in HEK293 cells assessed as effect on glutamate-induced calcium flux by Fluo-4\\u002fAM staining-based fluorescence assay\"],[\"Inhibition of recombinant human NEK7 (2 to end residues) at 1 uM using FLAKSFGSPNRAYKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting\"],[\"Antagonist activity at human CB1 receptor expressed in CHOK1 cells assessed as inhibition of CP-55940-induced response after 10 mins by GTPgamma[35S] binding assay\"],[\"Activity of luciferase in presence of variable luciferin level at 1 uM\"],[\"Inhibition of TCPTP (unknown origin) assessed as inhibition rate at 75 uM\"],[\"Inhibition of MTH1 (unknown origin) using 8-oxo-dGTP as substrate\"],[\"Inhibition of human ERG expressed in CHO-K1 cells at 10 uM by whole-cell patch clamp technique\"],[\"Inhibition of human GST-tagged PRMT1-mediated arginine methylation expressed in Escherichia coli BL21 (DE3) using H4(1-20) and [14C]-AdoMet by scintillation counting\"],[\"Binding affinity to XIAP BIR3 domain in Smac mimetic-sensitive human MDA-MB-231 cells assessed as increase in cleaved caspase-3 expression at 5 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of human RAF1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of cSrc T338M\\u002fS345C mutant (unknown origin) pre-incubated for 30 mins before substrate and ATP addition by HTRF assay\"],[\"Inhibition of human 6His-tagged DOT1L (1 to 420 residues) measured after 30 mins by AlphaScreen binding assay\"],[\"Inhibition of human PDE9A2 using FAM-cGMP substrate by TR-FRET progressive binding assay\"],[\"Inhibition DPP4 in human HCEC cell extracts using Gly-Pro-AMC substrate at 100 uM incubated for 30 mins by fluorimetric assay\"],[\"Displacement of [3H]-SCH- 58261 from human adenosine A2A receptor expressed in CHO cells; range 70-130\"],[\"Inhibition of c-Myc in rat TGR1 cells assessed as cell growth inhibition at 6 to 50 uM after 3 to 4 days by trypan blue exclusion assay\"],[\"Binding affinity to human GLS1 expressed in Escherichia coli strain BL21 (DE3)pLysS by fluorescence polarization binding assay\"],[\"Inhibition of human LIMK1 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP\\u002f10 uM ATP addition measured after 120 mins by radiometric assay\"],[\"Inhibition of mPGES-1 in human A549 cells using arachidonic acid as substrate assessed as inhibition of IL-1beta\\u002fTNF-alpha-induced PGE2 production incubated for 30 mins prior to substrate addition measured after 30 mins by EIA\"],[\"Inhibition of recombinant human full length MMP13 expressed in mouse NS0 cells assessed as reduction in enzyme-mediated type-2 collagen cleavage at 20 uM after 22 hrs by SDS-PAGE analysis relative to control\"],[\"Inhibition of recombinant human cytosolic carbonic anhydrase 1 assessed as inhibition of CO2 hydration up to 100 uM preincubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay\"],[\"Inhibition of human N-terminal His6-tagged KDM4E catalytic domain (1 to 337 residues) expressed in Escherichia coli using ARK(me3)STGGK as substrate preincubated for 15 mins measured after 30 mins by MALDI-TOF mass spectrometric analysis\"],[\"Inhibition of mouse GAT3 expressed in HEK cells assessed as reduction in [3H]GABA uptake by measuring remaining [3H]GABA uptake levels preincubated for 25 mins followed by [3H]GABA addition and measured after 4 mins by microbeta liquid scintillation counting analysis\"],[\"Displacement of [3H]Neurokinin A from human recombinant NK2 receptor expressed in CHO cells at 3 uM\"],[\"Displacement of [3H](+)-pentazocine from sigma-1 receptor in guinea pig brain\"],[\"Displacement of [3H]bradykinin from recombinant human bradykinin B2 receptor at 10 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Inhibition of human FER assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Binding affinity to human PAK2 at 10 uM relative to control\"],[\"Inhibition of plasma kallikrein (unknown origin) at 10 nM to 33.3 uM after 30 mins by gel-based ABPP assay\"],[\"Inhibition of Electrophorus electricus AChE at 10 uM using acetylthiocholine iodide as substrate incubated for 15 mins by Ellman's method relative to control\"],[\"Inhibition of rat ASIC3 receptor expressed in xenopus lavies oocytes assessed as inhibition of pH 6.4-gated currents by two electrode voltage clamp\"],[\"Agonist activity at human CAR expressed in human HepG2 cells assessed as induction of CYP2B6 mRNA expression at 1 to 10 uM after 24 hrs by qRT-PCR method\"],[\"Inhibition of human full length ERK2 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of Gst-tagged human SAPK3\\u002fp38gamma expressed in Escherichia coli at 10 uM\"],[\"In vitro inhibitory concentration against Butyrylcholinesterase of horse serum; value ranges from 4.9-11.2\"],[\"Agonist activity at TrkB in E17 rat primary cortical neurons assessed as AKT phosphorylation at S473 at 500 nM after 1 to 16 hrs by ELISA\"],[\"Inhibition of human erythrocytes mu-calpain after 30 mins by fluorometric assay using pep1 as substrate\"],[\"Agonist activity at HTR2C in human U2OS cells at 20 uM by PathHunter beta-arrestin assay relative to control\"],[\"Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control\"],[\"Agonist activity at kappa opioid receptor in guinea pig ileum assessed as inhibition of electric stimulation-induced contraction\"],[\"Inhibition of human recombinant MST2 using Ser\\u002fThr peptide 7 substrate after 45 mins by Z-Lyte assay\"],[\"Inhibition of GSK-3-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Inhibition of recombinant human SIRT2 measured after 30 mins by fluorescence microplate reader assay\"],[\"Inhibition of Kir7.1 potassium channel (unknown origin)\"],[\"Opioid antagonist potency, determined in the guinea pig ileum (GPI) preparation, by employing EK (kappa-opioid) as agonist, expressed as IC50 ratio; Not determined\"],[\"Displacement of [3H]CP-55,940 from recombinant human CB1 receptor expressed in HEK cells\"],[\"Inhibition of human N-terminal His6-tagged KDM3B (L882 to S1761 residues) expressed in insect cells using H3K9(Me2) as substrate preincubated for 15 mins followed by substrate addition and measured after 5 mins by Alphascreen assay\"],[\"Inhibition of human recombinant PTP1B in chemosensitive MUTU-I cells after 30 mins\"],[\"Inhibition of MAGL in human U937 cell homogenate assessed as decrease in [ethanolamine-1-3H]AEA levels preincubated for 30 mins followed by AEA addition measured after 15 mins by liquid scintillation counting method\"],[\"Inhibition of human NEK9 using MBP as substrate\"],[\"Induction of human recombinant N-terminal GST tagged-ULK1 (1 to 649 residues) kinase activity expressed in baculovirus infected insect Sf9 cells at 100 nM using MBP as substrate after 60 mins by ADP-glo assay relative to (R)-2-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-N-(2,4-difluorophenyl)-2-phenylacetamide\"],[\"Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine\"],[\"Inhibition of human SERT expressed in CHO-K1 cells assessed as inhibition of [3H]-5-hydroxytryptamine reuptake measured after 20 mins by Microscintillation counting analysis\"],[\"Inhibition of radioligand binding at human melanocortin MC4 receptor at 10 uM\"],[\"Inhibition of human WDR2 bromodomain 2 by BROMOscan assay\"],[\"Inhibition of ERK2 (unknown origin) at 10 uM relative to control\"],[\"Agonist activity at guinea pig H2R\"],[\"H2 receptor agonistic activity in isolated right atrium of guinea pig compared to histamine\"],[\"Inhibition of human MIF tautomerase activity\"],[\"Binding affinity to full length recombinant human N-terminal His6\\u002fSUMO-tagged eIF4A3 expressed in Escherichia coli BL21(DE3) assessed as change in entropy by isothermal titration calorimetric method\"],[\"Agonist activity at PPARalpha in mouse Hepa1-6 cells assessed as increase in Acox1 RNA expression at 1 to 5 uM by qRT-PCR analysis\"],[\"Inhibition of TACE in human PBMC\"],[\"Inhibition of recombinant HIV1 reverse transcriptase in cell free Quan-T-RT by scintillation proximity assay\"],[\"Inhibition of MAPKAPK2 (unknown origin) at 100 nM\"],[\"Binding affinity to EP3 receptor\"],[\"Inhibition of GSK3A (unknown origin) at 1 uM\"],[\"Competitive inhibition of recombinant His-tagged CHK1 (unknown origin) expressed in baculovirus expression system using CDC25C and ATP as substrate after 2 hrs\"],[\"Inhibition of [125I]CRF binding to human Corticotropin releasing factor receptor 1 tested at 6-12 doses\"],[\"Inhibition of thrombin (unknown origin) using Boc-Val-Pro-Arg-AMC as substrate at 25 uM preincubated with protein for 15 mins followed by substrate addition measured for 10 mins by continuous fluorimetric assay relative to control\"],[\"Binding affinity to human BRD2 assessed as thermal shift difference at 10 uM by DSF analysis\"],[\"Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in CD69 expression measured after 6 hrs by immunostaining based flow cytometric analysis\"],[\"Agonist activity at Gal4-fused mouse RAR-gamma transfected in human HeLa cells at 10 uM after 12 hrs by luciferase reporter gene assay\"],[\"Inhibition of recombinant full length human His-tagged p38gamma expressed in baculovirus expression system using serine\\u002fthreonine-3 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay\"],[\"Binding affinity to histamine H2 receptor (unknown origin)\"],[\"Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM by ThT fluorescence assay relative to control\"],[\"Inhibition of human Nk1 receptor at 10 uM by CEREP assay\"],[\"Inhibition of human recombinant TYK2 (875 to end residues) assessed as residual activity using GGMEDIYFEFMGG as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis\"],[\"Inhibition of recombinant full-length human CAMKK1 at 1 uM using calmodulin as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of mouse DNA topoisomerase 2 assessed as relaxation of supercoiled pBR322 plasmid DNA after 1 hr by electrophoresis relative to etoposide\"],[\"Inhibition of [3H]dopamine reuptake in HEK293 cells expressing human dopamine transporter\"],[\"Inhibition of DCN-1 in human KYSE-70 cell line assessed as increase in NRF2 expression at 5 to 10 uM incubated for 24 hrs by Western blot analysis\"],[\"Stabilization of recombinant human topoisomerase 2-pBR322 DNA cleavage complex assessed as linear DNA formation at 10 uM after 60 mins by agarose gel electrophoresis\"],[\"Competitive inhibition of jack bean urease using urea as substrate assessed as ammonia production after 15 mins by Lineweaver-Burk\\u002fDixon plot analysis\"],[\"Agonist activity at human FFA1 transfected in 1321N1 cells assessed as calcium mobilization by microplate assay relative to linoleic acid\"],[\"Antagonist activity at human recombinant bradykinin 2 receptor expressed in CHO cells assessed as inhibition of bradykinin-induced intracellular calcium mobilization\"],[\"Inhibition of probe binding to ITK (unknown origin) using rabbit reticulate lysate system at 250 nM after 1 hr by luminescence assay relative to control\"],[\"Displacement of [3H]-N-Methylspiperone from dopamine D3 receptor (unknown origin) incubated for 90 mins by microbeta counting method\"],[\"Agonist activity at recombinant rat GPR120 expressed in HEK293 cells\"],[\"Inhibition of wild type recombinant human histone lysine methyltransferase G9a (913 to 1193 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS assessed as zinc ions ejection from 3 types of Cys9-type Zn fingers at \\u003e50 uM after 1 hr by circular dichroism analysis\"],[\"Non competitive inhibition of electric eel AChE using acetylthiocholine iodide as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique\"],[\"Ratio of IC50 for arbutin to IC50 for test compound for inhibition of mushroom tyrosinase\"],[\"Inhibition of rat TRPV1 at pH 5 to 5.5\"],[\"Binding affinity to recombinant Gallus gallus (chicken) alpha4beta2 nicotinic acetylcholine receptor assessed as [3H]NIC binding by radioligand binding assay\"],[\"Inhibition of wild-type human partial length ACVRL1 (L164 to Q503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay\"],[\"Inhibition of EGFR phosphorylation at Tyr1069 residues in human MCF7 cell lysates at 3 uM after 48 hrs by Western blot analysis relative to control\"],[\"Binding affinity to recombinant TEV cleavage site-fused-His6-tagged Ube2g2 (unknown origin) expressed in Escherichia coli Rosetta2 (DE3) assessed as modification of Cys48 residue by measuring molecular weight of compound-protein conjugate at 5 uL measured after overnight incubation at pH 8.5 by LC\\u002fMS analysis (Rvb = 18491 Da)\"],[\"Inhibition of human TLK2 using casein as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of partial length human BRAF V600E mutant expressed in mammalian system at 1 uM\"],[\"Inhibition of tracer 178 binding to recombinant human GST-tagged WNK2 (166 to 489 residues) expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control\"],[\"Inhibition of VEGFR2 (unknown origin) after 1 hr by ADP-Glo reagent based luminescent assay\"],[\"Inhibition of human recombinant carbonic anhydrase 9 expressed in Escherichia coli by stopped flow CO2 hydration assay\"],[\"Inhibition of rat brain KAT2\"],[\"Inhibition of human Cdc7 in human A2780 cells assessed as inhibition of Ser53 phosphorylation of Mcm2 protein after 4 hrs\"],[\"Activity of HIV1 reverse transcriptase M41L\\u002fD67N\\u002fL210W\\u002fT215Y mutant assessed as nucleotide excision activity in presence of 10 uM dCTP\"],[\"Binding affinity to human CXCR4 expressed in HEK293 cells\"],[\"Displacement of [3H]R-PIA from adenosine A1 receptor in rat brain cortical membranes\"],[\"Inhibition of human KIT using poly(Glu, Tyr) as substrate by AlphaScreen assay\"],[\"Binding affinity to recombinant human PDL1 (Met1 to Arg238 residues) expressed in HEK293 cells assessed as activation constant at equilibrium by SPR analysis\"],[\"Binding affinity to human PDGFRA incubated for 1 hr by kinase binding assay\"],[\"Inhibition of ABCB1 in human SW620\\u002fAD300 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC50 at 10 uM after 72 hrs by MTT assay relative to doxorubicin\"],[\"Inhibition of MLK3 (unknown origin) after 20 mins by scintillation counting analysis in presence of [33P]-ATP\"],[\"Displacement of [3H]diprenorphine from human kappa opioid receptor expressed in CHO cells at 10 uM\"],[\"Displacement of europium-labeled NDP-alpha-MSH from human MC4R expressed in HEK293 cells\"],[\"Binding affinity to LSD1 in human A549 cells assessed as increase in stability of cellular LSD1 protein at 10 to 20 uM pre-incubated for 1 hr followed by heating at 52 degC for 3 mins by Western blot-based CESTA\"],[\"Inhibition of PRMT5 (unknown origin) assessed as incorporation of tritium-labeled methyl group to lysine or arginine residues of peptide substrate by radioactive assay\"],[\"Inhibition of calf thymus topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA after 15 mins by agarose gel electrophoresis\"],[\"Inhibition of ALR2 in rat lens assessed as reduction in sorbitol accumulation at 10 uM incubated for 3 hrs in presence of 28 mM glucose by gas chromatographic analysis relative to control\"],[\"Inhibition of human BrSK2 assessed as enzyme activity at 1 uM relative to control\"],[\"TR-FRET Assay: Compounds were screened in the TR-FRET assay for JAK2 and c-Src kinase inhibition. Ultra light poly GT (Perkin Elmer) was used as the substrate for JAK2 and c-Src with the ATP concentration of 10 μM and 50 μM, respectively. The Eu-labelled anti-phospho tyrosine antibody (Perkin Elmer) was added at 1 nM and the fluorescence emission at 615 nm and 665 nm was measured with an excitation wavelength of 340 nm.\"],[\"Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Agonist activity at mouse TLR9 expressed in HEK293 cells assessed as activation of NF-kappaB at 10 ug\\u002fmL by SEAP reporter gene assay\"],[\"Inhibition of human PDGFRB expressed in bacterial expression system at 1000 nM by KINOMEscan assay relative to control\"],[\"Agonist activity at rat alpha7 nAChR expressed in rat GH4C1 cells assessed as calcium flux by FLIPR assay\"],[\"Activity at glucocorticoid receptor in human A549 cells assessed as effect on GRE promoter response by luciferase reporter assay\"],[\"Inhibition of PHD2 in human Hep3B cells assessed as erythropoietin secretion at 100 uM measured at 24 hrs by MSD technology relative to control\"],[\"Inhibition of human cloned Alpha-2C adrenergic receptor by competitive binding experiment\"],[\"Inhibition of DH379 probe binding to full length recombinant human DAGLalpha expressed in HEK293T cell membranes at 0.1 to 10000 nM after 30 mins by gel-based competitive activity based protein profiling assay\"],[\"Inhibition of PAK1 in rat C6 cells assessed as inhibition of stathmin phosphorylation at S16 at 0.5 to 5 uM\"],[\"Percent binding affinity for bovine vitamin D receptor compared to 2-Et-1-alpha,2,5-dihydroxy-19-norvitamin D3\"],[\"Antagonist activity at TLR4 in mouse RAW264.7 cells assessed as reduction in LPS-induced cytosolic NO level at 80 uM by DAF-FM staining based FACS analysis\"],[\"Inhibition of human recombinant carbonic anhydrase-12 catalytic domain by stopped-flow CO2 hydration assay\"],[\"Antagonist activity at human mGluR1 expressed in 1321N1 cells assessed as effect on L-glutamate-induced calcium mobilization\"],[\"Inhibition of Edc4 in mouse C2C12 cells assessed as reduction in phospho-sites occupancy at 4 uM after 5 hrs by SILAC based LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of STAT5 in human KU812 cells assessed as downregulation of CYCLIN D1 mRNA levels at 10 uM after 15 hrs by qRT-PCR method\"],[\"Inhibition of SH2 domain of STAT1 (unknown origin) using FITC-GpYDKPHVL as substrate at 30 uM preincubated for 15 mins before substrate addition measured after 90 mins by alphascreen based assay\"],[\"Displacement of [3H]diprenorphine from delta opioid receptor in rat whole brain homogenate by liquid scintillation counting\"],[\"Inhibition of human Cx43 expressed in Escherichia coli LB2003 cells in medium containing 8 mM K+ and 10 uM IPTG by measuring cell growth after 18 hrs by plate reader\"],[\"Binding affinity to human recombinant CRTH2 receptor by cell based radioligand equilibrium competition assay\"],[\"Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay\"],[\"Inhibition of human CES2-mediated pNPA substrate turnover\"],[\"Inhibition of ovine COX1 using arachidonic acid as substrate\"],[\"Binding affinity to histamine H1 receptor (unknown origin) at 1 uM\"],[\"Binding affinity to recombinant full length N-terminal His-tagged human LDHA expressed in Escherichia coli assessed as reduction in fluorecence polarization at up to 10000 nM measured after 2 hrs by Alexa Fluor 488 based fluorescence polarization assay\"],[\"Inhibition of PLD2 (unknown origin)\"],[\"Inhibition of human cloned beta3 adrenergic receptor by competitive binding experiment\"],[\"Inhibition of CSNK1G3 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control\"],[\"FGFR2(h) Millipore kinase panel\"],[\"Inhibition of human PIM1 assessed as residual activity at 100 uM using KKRNRTLTK as substrate by [gamma-33P]-ATP assay relative to control\"],[\"In vitro inhibition of partially purified recombinant human Histone deacetylase 1\"],[\"Inhibition of human recombinant PDE2A\"],[\"Agonist activity at rat CB1 receptor assessed as inhibition of forskolin-induced cAMP accumulation\"],[\"Mixed-type inhibition of recombinant human AChE using acetylthiocholine iodide as substrate assessed as enzyme-substrate-inhibitor complex by Lineweaver-Burk double reciprocal plot method\"],[\"Activity at rat CaSR in CHO cells assessed as inhibition of calcium ion-induced [3H]inositol phosphate accumulation at 10 uM\"],[\"Binding affinity towards histamine H3 receptor using [3H](R)-alpha-methylhistamine as radioligand in guinea pig cortical homogenates\"],[\"Inhibition of West Nile virus serotype 2 NS2B-NS3 protease by homogeneous fluorimetric assay\"],[\"Inhibition of GCN2 (unknown origin)\"],[\"Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 20 uM after 24 hrs by thioflavin-T fluorescence method relative to control\"],[\"Inhibition of human MMP-9 after 60 mins by FRET assay\"],[\"Antagonist activity at P2X7 receptor in human THP1 cells assessed as inhibition of BzATP-induced pore formation\"],[\"Inhibition of GSK3alpha phosphorylation at Ser21 in human Hep3B cells assessed as ratio of phosphorylated GSK3beta to beta-actin level at 10 uM after 48 hrs by Western blot analysis\"],[\"HIV protease inhibition.\"],[\"Inhibition of BRAF (unknown origin) at 10 uM\"],[\"Agonist at human PPARgamma LBD expressed in human HEK293 cells cotransfected with GAL4-Luc assessed as transcriptional activation by luciferase reporter gene assay\"],[\"Inhibition of cellular cathepsin C (unknown origin)\"],[\"Inhibition of recombinant human EPHB2 (560 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Non-competitive inhibition of recombinant human GSK-3beta at 2 to 4 uM using varying concentration of GS-2 as substrate incubated for 10 mins in presence of ATP by double reciprocal plot analysis\"],[\"Inhibition of recombinant human PKA assessed as residual activity at 1 uM using Kemptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of IB-MECA agonist-mediated cAMP production in membranes of CHO cells expressing human Adenosine A3 receptor; range 1.2-4.9\"],[\"KinomeScan assay: inhibition of FLT3(D835H)\"],[\"Binding affinity to wild-type human partial length MYLK2 (D258 to K570 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human HDAC8 using RHKKAc as substrate by fluorescence assay\"],[\"Inhibition of AuroraC (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Activity of human SIRT1 assessed as decrotonylation of compound at 50 uM after 1 hr by trypsin developer-based fluorescence assay\"],[\"Inhibition of PPARgamma in mouse RAW264.7 cells assessed as inhibition of LPS-induced IkappaBalpha phosphorylation at 10 uM after 4 hrs by Western blot analysis in presence of PPARgamma antagonist GW9662\"],[\"Binding affinity to human serum albumin assessed as inhibition of compound aggregation at 200 to 500 uM by dynamic light scattering analysis\"],[\"Inhibition of uncoupled photosystem II electron transport and partial reactions in Spinacia oleracea (spinach) leaves assessed as electron transport rate from water to DCBQ at 300 uM measured per mg of chlorophyll relative to untreated control\"],[\"Inhibition of human cloned CA1 after 15 mins by stopped-flow CO2 hydration assay\"],[\"Inhibition of human CHK2 at 1 uM after 30 mins by fluorescence assay in presence of ATP\"],[\"Inhibition of mTOR in human A549 cells assessed as downregulation of p70S6K phosphorylation at thr389 at 6 uM after 3 to 24 hrs by Western blot analysis\"],[\"Binding affinity to wild-type human full-length PI4Kbeta (M1 to M828 residues) expressed in mammalian expression system by kinome scan assay\"],[\"Inhibition of human ACVR2A expressed in baculovirus expression system\"],[\"Displacement of [125I]-[D-Ala2]deltorphin 2 from human cloned delta opioid receptor\"],[\"Displacement of biotinylated ephrin-B1-Fc from EphB6 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA\"],[\"Inhibition of human PIM1 at 1 uM\"],[\"Inhibition of bovine lens ALR2 at 25 uM assessed as reduction of D,L-glyceraldehyde by spectrophotometry\"],[\"Agonist activity at C3a receptor in dbcAMP differentiated human U937 cells assessed as increase in intracellular calcium using Fluo-R staining by microplate reader\"],[\"Agonist activity at human LXRbeta transfected in HEK293 cells after 24 hrs by luciferase reporter gene assay\"],[\"Inhibition of recombinant human CA9 preincubated for 15 mins by phenol red dye-based stopped-flow CO2 hydration assay\"],[\"Inhibition of human MDR1 expressed in mouse L5178Y cells assessed as Rhodamine-123 accumulation measured as fluorescence activity at 2 uM after 20 mins by flow cytometry relative to control\"],[\"Inhibition of recombinant ALK (unknown origin) at 1 uM by off-chip mobility shift assay\"],[\"Inhibition of human RET using KKKSPGEYVNIEFG as peptide substrate in presence of [gamma33P]ATP by radiometric assay\"],[\"Displacement of [3H]Dofetilide from human ERG human\"],[\"Inhibition of EGFR Lysine 1 (unknown origin) at 10 uM\"],[\"Inhibition of TrxR1 in human HL60 cells incubated for 12 hrs by TRFS-green dye based fluorescence assay\"],[\"Inhibition of amyloid beta (1 to 42)-induced paralysis in transgenic Caenorhabditis elegans CL4176 expressing human amyloid beta (1 to 42) assessed as paralyzed worms at 200 uM treated for 49 hrs at 25 degreeC by microscopic analysis (Rvb = 87 %)\"],[\"Binding affinity to wild-type human partial length JAK2 JH1 catalytic domain (A829 to G1132 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of EPHB3 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of FGFR4 in FGF19-stimulated human Huh-7 cells assessed as MAPK T202\\u002fY204 phosphorylation level at 100 nM by Western blot analysis (Rvb = 1 No_unit)\"],[\"Agonist activity at human adenosine A2B receptor expressed in CHO cells assessed as stimulation of cAMP production at 10 uM\"],[\"Inhibition of recombinant human 17beta-HSD2 expressed in HEK293 cells assessed as residual activity at 20 uM using estradiol as substrate after 10 mins in presence of radiolabeled tracer substrate by scintillation counting method relative to control\"],[\"Inhibition of human COT1 using MEK1 as substrate\"],[\"Inhibition of human MMP14 assessed as fluorescence intensity using Mca-Pro-Leu-Ala-Cys(p-OmeBz)-Trp-Ala-Arg(Dpa)-NH2 as substrate at 10 uM incubated for 60 mins relative to control\"],[\"Inhibition of human JNK1alpha1\"],[\"Inhibition of DYRK1A at 10 uM relative to control\"],[\"Inhibition of human HDAC1 using rhodamine as substrate after 1 hrs by fluorescence assay\"],[\"Inhibition of human MAO-B preincubated for 15 mins followed by p-tyramine substrate addition and measured after 20 mins by Amplex red reagent based fluorescence assay\"],[\"Agonist activity against human GPR109a assessed as forskolin-induced cAMP accumulation at 100 uM relative to nicotinic acid\"],[\"Inhibition of wild type HIV1 reverse transcriptase using poly (A)\\u002foligo (dT)15 as template\\u002fprimer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA\"],[\"Inhibition of MRP1 (unknown origin) over-expressed in MDCK cells assessed as calcein accumulation incubated for 30 mins prior to Calcein-AM addition measured after 30 mins by fluorescence assay\"],[\"Inhibition of MAGL (unknown origin) at 500 uM after 10 mins relative to control\"],[\"Inhibition of recombinant human MTH1 expressed in Escherichia coli BL21 DE3 cells preincubated for 15 mins followed by 8-oxo-dGTP substrate addition measured after 15 mins by luminescence based assay\"],[\"Agonist activity at human KOR expressed in CHO cell membranes at 10 uM after 1 hr by [35S]GTPgammaS binding based liquid scintillation counting analysis relative to control\"],[\"Inhibition of human KRAS G12C mutant incubated for 2 hrs by scintillation counter based covalent competition assay\"],[\"Displacement of [3H]NAMH from human H3R expressed in HEK293T cells incubated for 2 hrs by microbeta scintillation counting analysis\"],[\"Inhibition of MATK1 (unknown origin) transfected in mouse Ba\\u002fF3 cells at 5 uM after 24 hrs\"],[\"Activity of human recombinant CA2 at 10 uM by stopped flow CO2 hydrase method\"],[\"Inhibition of Tie2 (unknown origin) assessed as residual enzyme activity at 10 uM using TK Substrate 2 (poly Glu-Tyr) substrate\"],[\"Inhibition of recombinant human His6-tagged SIRT6 using H2N-EALPK-[Nepsilon-myristoyl-lysine]-TGGPQ-CONH2 as substrate incubated for 12 mins in presence of beta-NAD+ by HPLC based assay\"],[\"Inhibition of recombinant full length human CLK3 using ERMRPRKRQGSVR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay\"],[\"Inhibition of recombinant human N-terminally GST-His6 tagged EGFR T790M mutant (H672 to A1210 residues) C-terminal fragment harboring 3C cleavage site expressed in Baculovirus infected Sf9 cells assessed as residual activity at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method relative to control\"],[\"Inhibition of human recombinant full length GST-tagged MAPK14 phosphorylation expressed in Escherichia coli in presence of 500 uM of ATP by direct Z-LITE assay\"],[\"In vitro inhibition of IL-6 in Lipopolysaccharide-stimulated human whole blood\"],[\"Inhibition of cathepsin-S in human Jiyoye cells assessed as conversion of invariant chain Lip10 to CLIP\"],[\"Inhibition of uptake of [3H]5-HT in synaptosomes from rat cortex\"],[\"Percent activation in CV-1 cell transactivation assay relative to Dexamethasone\"],[\"Binding affinity to human recombinant His6-tagged NAAA expressed in HEK293 cells assessed as formation of peptide adduct at 5 uM after 20 mins by ion chromatographic analysis\"],[\"Inhibition of human CDK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of human DP receptor assessed as LTD4-mediated intracellular calcium mobilization by cell-based aequorin luminescence assay\"],[\"Inhibition of subunit exchanging activity of His and Flag-tagged HIV-1 integrase expressed in Escherichia coli BL21(DE3) cells at 100 uM after 2.5 hrs by HTRF assay relative to control\"],[\"Inhibition of Clostridium botulinum BoNT\\u002fA protease light chain in stem cell-derived neurons (unknown origin) assessed as inhibition of SNAP-25 cleavage at 0.5 to 50 uM after 22 hrs by Western blot analysis\"],[\"Induction of LXRalpha enhancer activity in human THP1 cells after 24 hrs by luciferase reporter gene analysis\"],[\"Inhibition of HDAC1 (unknown origin) using RHKK(Ac)AMC as substrate assessed as remaining activity at 1.37 x 10'-8 M after 1 to 2 hrs by fluorescence assay (Rvb = 93.78 to 100%)\"],[\"Inhibition of human Nav1.7 sodium channel expressed in HEK293 cells at 1 uM with membrane potential of -120 mV by whole cell voltage clamp technique\"],[\"Induction of N-terminal 6x-His-tagged BRAF R509H mutant (unknown origin) dimer formation assessed as molecular weight of protein-compound complex at 20 uM by sedimentation equilibrium method (Rvb = 36 kDa)\"],[\"Inhibition of human Cav1.2 channel at \\u003c5 uM by electrophysiology\"],[\"Inhibition of MARK1 (unknown origin) at 10 uM relative to control\"],[\"Competitive inhibition of human NPP3 transfected in COS7 cells at 0.1 to 1 uM using pNP-TMP as substrate incubated for 35 mins by Lineweaver-Burk plot analysis\"],[\"Inhibition of recombinant full-length human LKB1 assessed as residual activity at 10 uM using LSNLYHQGKFLQTFCGSPLYRRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Agonist activity at human alpha7 nAChR expressed in human SH-SY5Y cells assessed as increase in intracellular calcium levels at 10 uM\"],[\"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay\"],[\"Inhibition of Mycobacterium tuberculosis NAD kinase by modified HPLC based assay\"],[\"Inhibition of HDAC1 in human HeLa nuclear extract using Boc-Lys(Ac)-AMC as substrate measured after 2 hrs by fluorescence based assay\"],[\"Inhibition of IFNgamma-stimulated GFP\\u002fFLAG-tagged STAT3 dimerization in human AD293 cells at 10 uM incubated for 6 hrs by Western blot analysis\"],[\"Competitive inhibition of VEGFR-2 tyrosine kinase (unknown origin) in presence of pazopanib\"],[\"Inhibition of Cav3.1 (unknown origin) by voltage clamp assay\"],[\"Ratio of IC50 for pemetrexed to IC50 for drug against human DHFR by spectrophotometry\"],[\"PKCdelta(h) Millipore kinase panel\"],[\"Inhibition of Bcr-Abl T315I mutant in mouse BA\\u002fF3 cells assessed as reduction of STAT5 phosphorylation at 4 to 500 nM after 4 hrs by Western blot analysis\"],[\"Inhibitory activity against thymidylate synthase of Lactobacillus casei\"],[\"Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells at 10 uM using kynuramine as substrate after 30 mins by fluorescence assay relative to control\"],[\"Binding affinity to recombinant GST-Malt1 (325 to 760 residues) (unknown origin) assessed as protein labeling at 1 uM after 1 hr by SDS-PAGE based activity-based protein profiling assay\"],[\"Inhibition of LSD1 in human MM1.S cells assessed as modulation of p21 mRNA expression at 0.5 uM after 6 to 24 hrs by qRT-PCR analysis\"],[\"Agonist activity at mouse MC5R by alphascreen cAMP assay\"],[\"Inhibition of HIF-PHD2 (unknown origin) by fluorescence polarization assay\"],[\"Inhibition of wild-type human full length CDK5 (M1 to P292 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Agonist activity at human TLR4 stably expressed in HEK293 cells cotransfected with secreted alkaline phosphatase assessed as induction of NFkappaB activation by quanti-blue SEAP reporter gene based spectrophotometric method\"],[\"Inhibition of wild-type human partial length SRC (L240 to L536 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of HDAC6 (unknown origin) using RHKK(Ac)AMC as substrate assessed as remaining activity at 1.11 x 10'-6 M after 1 to 2 hrs by fluorescence assay (Rvb = 96.3 to 101.70%)\"],[\"Effect on full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as protection against enzyme degradation by measuring increase in kynurenine production level at 20 to 100 uM pre-incubated for 120 mins in presence of ascorbate and MB reductants before jump dilution with incubation medium containing L-Trp and further incubated for 20 mins by HPLC analysis\"],[\"Average Binding Constant for CAMK1; NA=Not Active at 10 uM\"],[\"Non-competitive inhibition of Clostridium botulinum neurotoxin serotype A light chain using 66-mer peptide by LC\\u002fMS assay\"],[\"Displacement of [H]dexamethaxone from glucocorticoid receptor in HUH cells\"],[\"Inhibition of cathepsin B in goat liver assessed as residual enzyme activity using alpha-N-benzoyl-D,L-arginine-2-naphthylamide as substrate at 0.001 x 10'-4 M pretreated with enzyme for 30 mins prior to substrate challenge by colorimetric analysis relative to control\"],[\"Activation of human BKalpha channel expressed in CHOK1 cells assessed as increase in ionic current at 30 uM relative to control\"],[\"Covalent binding affinity to N-terminal His6-tagged human Pin1 expressed in Escherichia coli BL21 (DE3) assessed as increase in 292.1 Da molecular weight incubated for overnight by mass spectrometry\"],[\"Displacement of [3H]SR-141716A from human CB1 receptor\"],[\"Inhibition of full-length human CSNK1A1L expressed in bacterial system assessed as remaining enzyme activity at 1 uM by KINOMEscan assay\"],[\"Binding affinity to human FRK\"],[\"Displacement of [33P]-S1P from human S1P1 receptor expressed in CHOK1 cells after 60 mins by scintillation counting analysis\"],[\"Inhibition of COX1 in arachidonic acid-stimulated mouse J774 cells assessed as inhibition of PGE2 production after 15 mins by radioimmunoassay\"],[\"Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in human HeLa cell membranes at 1 uM after 30 mins relative to control\"],[\"Binding affinity to motilin receptor (unknown origin) at 1 to 2 uM by radioligand binding assay\"],[\"Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay\"],[\"Displacement of [3H]mesulergine from human 5-HT2C receptor expressed in CHO cells at 10'-6 M after 120 mins by scintillation counting analysis relative to control\"],[\"Inhibition of BRD4 (unknown origin) by fluorescence anisotrophy\"],[\"Inhibition of monkey CCR6 expressed in CHO cells assessed as decrease in CCL20-induced reduction of forskolin-stimulated cAMP accumulation preincubated for 30 mins followed agonist addition measured after 30 mins by HTRF assay\"],[\"Non-competitive partial inhibition of recombinant human ALDH1A1 using 800 uM NAD+ as cofactor by Lineweaver-Burk plot analysis in presence of 100 to 800 uM acetaldehyde\"],[\"Agonist activity at human TRPA1 expressed in CHOK1 cells at 100 nM by aequorin-based calcium mobilization assay relative to control\"],[\"Inhibition of human DAPK1 at 10 uM by ADP-Glo kinase assay\"],[\"Antagonist activity against CCK2 receptor estimated from single shifts of pentagastrin concentration-effect curves in the isolated rat stomach; not tested\"],[\"Intrinsic activity at human kappa mu receptor expressed in CHO cells upto 10 uM by [35S]GTP-gamma-S assay\"],[\"Inhibition of Bacillus anthracis edema toxin-mediated cAMP production in mouse RAW264.7 cells after 4 hrs by ELISA\"],[\"Inhibition of human recombinant TOP1-mediated relaxation of supercoiled Escherichia coli pBR322 DNA at 20 uM after 30 mins by transillumination\"],[\"Inhibition of tyrosinase in mouse B16 cells assessed as reduction in melanin production measured after 24 hrs\"],[\"Inhibition of human MLK1 (88 to 426 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay\"],[\"Inhibition of wild-type human partial length DCAMKL1 (L270 to A662 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of FGFR4 in FGF19-stimulated human Huh-7 cells assessed as MEK1\\u002f2 S217\\u002fS221 phosphorylation level at 10 nM by Western blot analysis (Rvb = 1 No_unit)\"],[\"Displacement of [3H]N6-R-phenylisopropyladenosine from human adenosine A1 receptor expressed in CHO cell membranes incubated for 60 mins by liquid scintillation counting analysis\"],[\"Displacement of FAM-Bim peptide from human Bcl2 by fluorescence polarization assay\"],[\"Inhibition of HSP90 in rabbit reticulocyte lysates at 5 uM pre-incubated for 5 hrs by firefly luciferase protein re-folding assay\"],[\"Displacement of [125I]galanin from human recombinant GAL1 receptor expressed in HEK293 cells at 10 uM after 60 mins by scintillation counting\"],[\"Inhibition of EZH2 (unknown origin) at 1 to 50 uM by scintillation proximity assay\"],[\"Inhibition of matrix metalloprotease-2 at 1 uM\"],[\"Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assay\"],[\"Ratio of binding affinity of Opioid receptor kappa 1 to Opioid receptor mu 1 to Opioid receptor delta 1; kappa:mu:delta = 36:8:1\"],[\"Inhibition of human PKCg using histone H1 as substrate in presence of [gamma-32P]ATP\"],[\"Binding affinity to 5HT5A receptor by radioligand binding assay\"],[\"Inhibition of methionine synthase (unknown origin) by cell free assay\"],[\"Synergistic inhibition of porcine pancreatic alpha-amylase assessed as combination index at 10.5 uM preincubated for 15 mins followed by starch addition measured after 10 mins in presence of 62.4 uM corosolic acid by dinitrosalicylic acid reagent based assay\"],[\"PKBbeta(h) Millipore kinase panel\"],[\"Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells\"],[\"Competitive binding affinity to NEK5 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of recombinant human N-terminal His-tagged GSTP1 (1 to 210 residues) expressed in Escherichia coli at 100 uM using reduced GSH as substrate measured after 0.5 hrs by CDNB assay\"],[\"Inhibition of recombinant full length His-tagged human Lck expressed in baculovirus at 1 uM by FRET assay relative to control\"],[\"Induction of ERalpha degradation in human MCF7 cells assessed as ERalpha\\u002factin ratio level at 0.3 uM after 6 hrs by Western blot analysis (Rvb = 100%)\"],[\"Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction followed by compound washout by spin-telomeric repeat amplification protocol\"],[\"Competitive binding affinity to DAPK1 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of TACE at 10 uM\"],[\"Inhibition of His-tagged bovine PI3K expressed in Sf9 cells at 20 uM\"],[\"Binding affinity to human 15N-labelled C-terminal flexible tail lacking Ube2T (1 to 154 residues) (unknown origin) at 500 uM by NMR spectrocopy\"],[\"Binding affinity to delta opioid receptor in rat brain membranes\"],[\"Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at 2.5 uM after 5 mins by SDS-PAGE analysis\"],[\"Inhibition of human 20S constitutive proteasome beta 2 subunit trypsin-like activity using fluorogenic peptide Ac-WLR-AMC as substrate in presence of PA28alpha incubated for 1 to 2 hrs by fluorescence microplate reader assay\"],[\"Inhibition of human FLT3 D835Y mutant at 0.1 uM relative to control\"],[\"Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of human recombinant Lck by ProFlour assay\"],[\"Positive allosteric modulation of human M3 receptor\"],[\"Inhibition of BRAF V599E mutant (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of tau (unknown origin) aggregation expressed in Escherichia coli (DE3) at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0.0 +\\u002f- 1.4%)\"],[\"Inhibition of BRD4 in human TY82 cells assessed as decrease in c-MYC expression level after 24 hrs by Western blot analysis\"],[\"Binding affinity to PIM1 (unknown origin)\"],[\"Inhibition of PKCz (unknown origin) at 10 uM relative to control\"],[\"Inhibition of human GRK5\"],[\"Inhibition of LIMK1 (unknown origin) at 1 uM relative to control\"],[\"Binding affinity to RUVBL2 in human Jurkat cells at 150 uM followed by UV irradiation for 30 mins with Wood's glass filtered medium pressure mercury arc light after cell lysis measured after denaturing wash by SDS-PAGE based pull down assay\"],[\"Efficacy at human Gal4-PPARalpha expressed in CV1 cells at 10 uM relative to control by transactivation assay\"],[\"Displacement of [3H]pyrilamine from recombinant human H1 receptor after 60 mins by scintillation counting analysis\"],[\"Inhibition of aurora A kinase (unknown origin) assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of human recombinant thrombin expressed in HEK293 cells using S-2238 as substrate preincubated for 30 mins followed by substrate addition and measured for 20 mins\"],[\"Inhibitory concentration against histone deacetylase 2\"],[\"Inhibition of chymotrypsin-like activity of proteasome in human NCI-H929 cells after 6 hrs by proteasomeGlo assay\"],[\"Inhibition of thymidylate synthase in human 2008 cells assessed as [5-3H]dUMP conversion to dTMP after 30 mins by liquid scintillation counting analysis relative to control\"],[\"Inhibition of full-length NanoLuc-tagged BRD4 (1 to 1362 residues) (unknown origin) expressed in human HCT116 cells after 18 hrs by NanoBRET assay\"],[\"Inhibition of recombinant full length human N-terminal GST-tagged PARP1 expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV\\u002fVis spectrophotometric analysis\"],[\"Displacement of 1,8-ANS from His6-tagged FABP9 (unknown origin) expressed in Escherichia coli BL21(DE3) cells at 25 uM by fluorescence assay relative to control\"],[\"Inhibition of human PNMT by radiochemical assay\"],[\"PLK4 DiscoveRx kinase panel\"],[\"In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrate\"],[\"Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA at 0.06 to 10 uM by electrophoregram\"],[\"WDR9 (BD2) DiscoverX BROMOscan\"],[\"Inhibition of ETB receptor (unknown origin)\"],[\"Partial agonist activity at C3a receptor in dbcAMP differentiated human U937 cells assessed as increase in intracellular calcium using Fluo-R staining by microplate reader\"],[\"Inhibition of human placental microsome aromatase using [1beta,2beta3H]-]testosterone as substrate measured up to 21 mins in presence of NADPH by liquid scintillation spectrometer method\"],[\"Inhibition of human recombinant CA6 by stopped flow CO2 hydrase assay\"],[\"Antagonistic activity against 5-hydroxytryptamine 4 receptor\"],[\"Intrinsic activity at human recombinant 5HT2C receptor at 3 uM expressed in HEK293E cells by FLIPR assay relative to control\"],[\"Inhibition of electric eel AChE at 0.781 ug using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition measured every 5 mins for 15 mins by spectrophotometric method relative to control\"],[\"Inhibition of recombinant FER (unknown origin) at 1 uM by off-chip mobility shift assay\"],[\"Inhibition of FTO (unknown origin) assessed as reduction in demethylation by measuring N6-mA and A level incubated for 2 hrs by HPLC-MS\\u002fMS analysis\"],[\"Inhibition of recombinant human ERG expressed in CHOK1 cells at -80 mV holding potential after 2 mins by patch clamp assay\"],[\"Inhibition of recombinant human SYK using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay\"],[\"Inhibition of alpha-D-[U-14C]glucopyranoside uptake at human SGLT1 expressed in african green monkey COS1 cells after 30 mins by liquid scintillation counting\"],[\"Dissociation constant for Retinoid X receptor alpha; NAA = Not an active agonist\"],[\"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as effect on calcium mobilization\"],[\"Inhibition of human PRAK at 10 uM after 60 mins by TR-FRET assay\"],[\"Binding affinity to Axin1 (unknown origin) by SPR analysis\"],[\"Agonist activity at recombinant human adenosine A2A receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity by [alpha-32P]ATP assay\"],[\"Non-competitive inhibition of recombinant His-tagged PRMT1 (unknown origin) expressed in Escherichia coli BL21 (DE3) using varying levels of biotin-labeled histone H4-20 as substrate\"],[\"Inhibition of RIPK2 (unknown origin) at 1 uM relative to control\"],[\"Agonist activity at FXR in human HepG2 cells assessed as reduction in AST level preincubated for 12 hrs followed by oleic acid challenge and measured after 24 hrs by colorimetric analysis\"],[\"Induction of Nrf2 nuclear translocation in rat PC-12 cells assessed as H2O2-induced GSH-px level incubated for 1 hr followed by H2O2 stimulation and measured after 5 hrs\"],[\"Inhibition of FYN (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of PAK4 (unknown origin) assessed as accumulation of ADP by ADP hunter plus assay\"],[\"Inhibition of NaV1.5 expressed in human HEK293 cells assessed as inhibition of late sodium current at -80 mV resting membrane potential by electrophysiology assay\"],[\"Inhibition of [3H]- naloxone binding to mu-opiate receptor at 10e-5 M\"],[\"Antagonist activity at human TRPM8 at \\u003c= 30 uM\"],[\"Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins\"],[\"Inhibition of P-gp (unknown origin) in primary MDCK-MDR1 cells assessed as increase in doxorubicin-induced cytotoxicity at at 500 nM incubated for 1 day followed by doxorubicin addition by MTT assay relative to control\"],[\"Binding affinity to wild-type human full length PIP5K2B (M1 to T416 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at human muscarinic M4 receptor expressed in BHK-21 cells assessed as calcium mobilization at 10 uM for 6 mins by Calcium4-based staining relative to acetylcholine\"],[\"Inhibition of human SIRT3 deacetylation activity using H3K9Ac as substrate preincubated for 15 mins in presence of NAD+ followed by substrate addition by HPLC analysis\"],[\"Inhibition of recombinant human PRK1 (498 to end residues) at 1 uM using KKLNRTLSFAEPG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Binding affinity to HER2 extracellular domain (unknown origin) at 25 to 100 uM by SPR analysis\"],[\"Inhibition of human IKKa\\u002fCHUK using KKKKERLLDDRHDSGLDSMKDEE peptide substrate at 1 uM by 33P Hotspot assay\"],[\"Inhibition of Clostridium botulinum botulinum neurotoxin type A light chain\"],[\"Competitive binding affinity to recombinant human galectin-4 C-terminal after 5 mins in presence of fluorescent probe 2-(fluorescein-5\\u002f6-yl-carbonyl)-aminoethyl 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1-3)-[alpha-L-fucopyranosyl-(1-2)]-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranoside by fluorescence polarization assay\"],[\"Inhibition of EPHA1 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control\"],[\"Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D4 was determined\"],[\"Inhibition of recombinant human COX-2 preincubated for 15 mins followed by fluorometric substrate\\u002fheme addition for 15 mins subsequently incubated with arachidonic acid for 2 mins by fluorescence analysis\"],[\"Inhibition of snake venom phospholipase A2 at 1 mM assessed as oxygen consumption for 3 mins\"],[\"Induction of human NTCP receptor inhibition-mediated autophagy in HBV-infected human HepG2.2.15 cells assessed as GFP-LC3 localization at 20 uM by transmission electron microscopy\"],[\"Inhibition of recombinant full-length human GRK1 at 1 uM using KKKKERLLDDRHDSGLDSMKDEE as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of human CAMKK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Corrector activity at CFTR F508del mutant (unknown origin) transfected in human HEK293 membrane cells assessed as increase in CFTR level at 3 uM incubated for 24 hrs by using pHTomato probe based fluorescence inverted microscopic analysis\"],[\"Inhibition of human GRK7 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Agonist activity at human PXR at 10 uM\"],[\"Inhibition of [3H]- ]DSLET binding to Opioid receptor delta 1 from rat brain membrane\"],[\"Agonist activity at human CXCR7 expressed in HEK293T cells co-expressing beta-arrestin2-YFP assessed as beta-arrestin2 recruitment after 1 hr by BRET assay\"],[\"Inhibition of human partial length PIK3CA H1047L mutant (R108 to N1068 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of tubulin beta polymerization in human HepG2 cells after 18 to 24 hrs by spectrophotometric method relative to control\"],[\"Inhibition of Clostridium botulinum BoNT\\u002fE light chain using GFP-tagged VAMP2\\u002fSNAP-25 (Ala128 to Gly206 residues) as substrate at 100 uM after 15 mins by GFP based micro plate reader method\"],[\"Inhibition of human AKR1B10 using D,L-glyceraldehyde as substrate incubated for 1 min and measured up to 4 mins using by spectrophotometric analysis\"],[\"Inhibition of HIV1 recombinant protease M46I\\u002fA71V\\u002fV82T\\u002fI84V mutant expressed in Escherichia coli by spectrophotometric assay\"],[\"Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay\"],[\"In-vivo inhibition of BTK in BALB\\u002fc mouse at 0.5 to 2.5 mg\\u002fkg, po single dose after 48 hrs relative to control\"],[\"Displacement of biotinylated-TM PAA from human DC-SIGNR at 1 mM after 3 hrs by colorimetry\"],[\"Inhibition of PKD2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-tagged STK32A (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of CBP in human PBMC derived naive CD4-positive T cells assessed as decrease in FOXP3 protein level in CD4positive-CD25positive T cells measured after 4 days by flow cytometry\"],[\"Inhibition of 5'--FAM-LTFEHYWAQLTS peptide binding to N-terminal domain human MDMX (1 to 134 residues) measured after 15 mins by fluorescence polarization assay\"],[\"Inhibition of MAP2K1 Lysine 1 labelling site (unknown origin) at 10 uM\"],[\"Inhibition of human RIPK3 using MBP as substrate by [gamma33-ATP] based radiometric assay\"],[\"Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay\"],[\"Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 100 uM\"],[\"Antagonist activity at human 5HT6 receptor expressed in COS7 cells assessed as inhibition of serotonin-induced cAMP accumulation by HTRF assay\"],[\"Displacement of [3H]MPEP from human mGlu5 receptor expressed in CHO cells after 45 mins by scintillation proximity assay\"],[\"Inhibition of the response to ACh when coapplied with Nicotinic acetylcholine receptor alpha7\"],[\"Inhibition of human carbonic anhydrase 1 by CO2 hydrase stopped flow assay\"],[\"Inhibition of IDO1 (unknown origin) at 100 uM using L-tryptophan as substrate by spectrophotometric method relative to control\"],[\"Inhibition of thrombin (unknown origin) at 45.5 uM\"],[\"Inhibition of Tel fused KDR (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay\"],[\"Chaperone activity at recombinant human GALNS expressed in HEK293 cells assessed as increase in extracellular enzyme activity at 0.001 uM using 4-methylumbelliferyl-beta-D-galactopyranoside-6-sulfate as substrate measured after 48 hrs by fluorescence assay relative to control\"],[\"Inhibition of Dyrk-1 (unknown origin) assessed as residual activity at 0.1 uM\\u002fL relative to control\"],[\"Competitive inhibition of ALK5 (unknown origin) by Michaelis-Menten plot analysis in presence of ATP\"],[\"Binding affinity to FGFR4 C552A mutant (unknown origin) at 1 to 300 nM incubated for 30 mins by In-gel fluorescence image analysis\"],[\"Binding affinity to wild-type human partial length MAST1 (S346 to V730 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Residual activity at mouse Blk at 10 uM in presence of 10 uM ATP relative to control\"],[\"Displacement of [3H]4-DAMP from recombinant human muscarinic M5 receptor expressed in CHO cells at 1 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Maximum response (E max) against histamine H1 receptor in guinea pig ileum\"],[\"Inhibition of KDM4B in human LNCaP cells assessed as increase in H3K9me3 level at 10 uM after 3 days by Western blotting\"],[\"Selectivity ratio of Ki for displacement of [3H]PSB-1584 from GPR84 in human HepG2 cell membranes to Ki for displacement of [3H]PSB-1584 from recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2\"],[\"Inhibition of Haspin (unknown origin)\"],[\"Substrate activity at MEG1 (unknown origin) expressed in Escherichia coli BL21 (DE3) incubated for 60 mins by fluorescence based assay\"],[\"Binding affinity to extracellular amyloid beta plaques in Alzheimer patient brain by fluorescence microscopic analysis\"],[\"Binding affinity to human partial length KIT D816H mutant (I571 to D952 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of Akt phosphorylation in human A549\\u002fCDDP cells at 0.6 to 1.2 uM after 24 hrs by Western blot method\"],[\"Inhibition of HDAC6 in human THP-1 cells assessed as ratio of acetylated H3\\u002fGAPDH at 1 uM incubated for 4 hrs by Western blot analysis relative to DMSO\"],[\"Inhibition of FGFR4 V550L mutant (unknown origin) at 0.19 uM relative to control\"],[\"Antagonist activity at human recombinant delta opioid receptor expressed in rat Chem-1 (RBL) cells assessed as inhibition of DPDPE-induced intracellular calcium levels incubated at room temperature by fluorimetry\"],[\"Inhibition of HSP90-mediated antiapoptotic activity in human WBA cells assessed as increase in caspase-3 activity at 10 uM after 48 hrs by Western blot analysis\"],[\"Inhibition of recombinant human His-tagged VEGFR2 cytoplasmic domain (789 to 1356 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control\"],[\"Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay\"],[\"Inhibition of AXL (unknown origin) at 100 nM\"],[\"Displacement of [3H]-ketanserin from human 5HT2A receptor expressed in HEK293 cells after 1 hrs\"],[\"Inhibition of wild-type human partial length MST2 (D17 to E318 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of STAT3-induced ERK1\\u002f2 phosphorylation in human DU145 cells assessed as ratio of phosphorylated ERK1\\u002f2 protein level to GAPDH protein level at 5 uM after 0.5 hrs by Western blot analysis (Rvb = 1 No_unit)\"],[\"Antagonist activity against human PPARdelta assessed as inhibition of GW501516-induced luciferase expression at 1 uM incubated for 24 hrs by luciferase reporter gene assay\"],[\"Displacement of propidium iodide from human AChE at 5 uM incubated for 6 hrs followed by propidium iodide addition and measured after 20 mins by fluorescence based assay relative to control\"],[\"Binding affinity to human D3R\"],[\"Inhibition of plasmin (unknown origin) assessed as reduction in amidolytic activity\"],[\"Inhibition of human recombinant DNA polymerase beta\"],[\"Binding affinity to wild-type TTR (unknown origin) assessed as induction of chemical shift at V94 residue at 1:1 ratio of compound to protein by 2D TROSY [1H-15N] spectroscopy\"],[\"Agonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin at 100 uM by luminometric analysis relative to quinpirol\"],[\"Inhibition of human recombinant N-terminal GST-tagged EGFR T790M\\u002fL858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 2 mins followed by substrate addition and measured after 2 mins by Ellman's method\"],[\"Ratio of Kcat to Km for Aeromonas hydrophila metallo-betalactamase CphA expressed in Escherichia coli BL21(DE3) by spectrophotometric analysis in presence of \\u003c 0.4 uM zinc ions\"],[\"Inhibition of Zika virus NS2B (1421 to 1469 residues) - NS3 (1503 to 1688 residues) expressed in Escherichia coli BL21(DE3) cells using Dabcyl-KTSAVLQSGFRKME-Edans as substrate after 11 mins by FRET assay\"],[\"Displacement of [3H]-mesulergine from human 5HT2A receptor at 10 uM by liquid scintillation counting\"],[\"Displacement of [3H]spiperone from dopamine D2 receptor of rat striatal membranes; not determined\"],[\"Inhibition of PKCtheta (unknown origin) by HTRF assay\"],[\"Agonist activity at human muscarinic M1 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay\"],[\"Activity of adenosine deaminase (unknown origin)\"],[\"Displacement of [3H]histamine from human histamine H4 receptor expressed in human SK-N-MC cell membrane incubated for 60 mins by liquid scintillation counting method\"],[\"serine\\u002fthreonine kinase 33 Millipore kinase panel\"],[\"Activity of human recombinant CA1 at 10 uM by stopped-flow technique\"],[\"Inhibition of rat OCT2 expressed in HEK293 cells\"],[\"Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate\"],[\"Agonist activity at human FFA1 receptor expressed in human 1321N1 cells measured for 50 intervals of 0.4 secs by calcium mobilization assay\"],[\"Inhibition of rat brain FAAH using [3H]AEA as substrate\"],[\"Inhibition of human partial length EGFR S752-I759del mutant expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of human Aurora B at 1 uM using [H-LRRASLG] as substrate\"],[\"Binding affinity to CCR4-NOT transcription complex subunit 6-like in human INA-6 cells after 3 hrs by nanoLC-MS\\u002fMS method\"],[\"Inhibition of recombinant human His-tagged cytoplasmic FLT3 receptor (564 to 958 residues) expressed in baculovirus expression system at 1 uM relative to control\"],[\"Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISA\"],[\"Activation of human PPARgamma ligand binding domain expressed in COS7 cells at 3 uM by dual luciferase reporter gene assay\"],[\"Beta-lactamase induction in Bacillus licheniformis\"],[\"IR(h) Eurofins Kinase panel\"],[\"Inhibition of reverse transcriptase M204I mutant expressing telbivudine-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in secreted DNA levels measured on day 7 by real-time PCR analysis\"],[\"Mixed-type inhibition of electric eel AChE using acetylthiocholine as substrate assessed as Vmax for substrate at 5 uM preincubated for 15 mins followed by substrate addition by Lineweaver-Burk plot analysis (Rvb = 0.089 +\\u002f- 0.006 deltaOD\\u002fmin)\"],[\"Inhibition of human recombinant ADAM10\"],[\"Inhibition of Mcl-1\\u002fBim interaction in human DMS53 cells harboring p53 mutant after 12 hrs by immunoprecipitation method\"],[\"Inhibition of human WNK2 (166 to 489 residues) using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of human wild type EZH2 using histone H3 as substrate after 1 hr in presence of 3H-SAM by filter paper detection analysis\"],[\"Inhibition of PDK\"],[\"Inhibition of PTP1B (unknown origin) using pNPP as substrate at 20 ug\\u002fml measured for 3 mins by colorimetric assay\"],[\"Inhibition of biotinylated-H4KAc4 binding to human His6-tagged BRD9 (L14 to Q134 residues) expressed in Escherichia coli BL21(DE3) after 2.5 hrs by luminescence-based AlphaScreen assay\"],[\"Inhibition of JAK1 (unknown origin) assessed as inhibition of STAT3 phosphorylation by cell-based assay\"],[\"Inhibition of N-terminal His6-tagged recombinant human MET expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of rat PACE4 assessed as fluorescent Pyr-RTKR-AMC substrate cleavage\"],[\"Inhibition of PI3Kgamma (unknown origin) by HTRF assay\"],[\"Inhibition of full length human KDM5B assessed as decrease in demethylation of substrate using peptide ARTK(me3)QTARKSTGGKAPRKQLA-GGK-biotin as substrate and 4 uM 2OG as cosubstrate pre-incubated for 10 mins before substrate addition followed by centrifugation for 1 min and measured after 15 mins by AlphaScreen assay\"],[\"Inhibition of human recombinant trypsin 4 using tosyl-GPR-pNA substrate by spectrophotometry\"],[\"Inhibition of Flag-tagged KDM3A (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as formaldehyde release using core histone as substrate preincubated with enzyme for 10 mins followed by incubation with substrate for 1 hr measured following 2 hrs incubation with ammonium acetate\\u002facetoacetanilide by fluorescence based analysis\"],[\"Inhibition of JAK3 (unknown origin) at 20 uM\"],[\"Inhibition of VEGFR2 in HUVEC assessed as reduction in expression of phosphorylated VEGFR2 at 1 uM incubated for 24 hrs by Western blot analysis\"],[\"Binding affinity to recombinant human N-terminal His-tagged PDI expressed in Escherichia coli BL21 (DE3) pLysS by ROX dye based thermal shift assay\"],[\"Negative allosteric modulation of mGlu7R (unknown origin)\"],[\"Displacement of [3H]Spiperone from D3 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis\"],[\"Agonist activity at human PPARdelta expressed in HepG2 cells after 16 hrs by luciferase reporter gene assay\"],[\"Antagonist activity at human recombinant adenosine A2A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR assay\"],[\"Agonist activity at rat recombinant muscarinic M5 receptor by HTS cell based assay\"],[\"Activity at human 5-HT2B receptor at 10 uM\"],[\"Inhibition of P-gp in human MCF7\\u002fADR cells assessed as increase in Rho123 accumulation measured after 2 hrs by flow cytometry\"],[\"Displacement of [3H]N-alpha-methylhistamine from human cloned H3 receptor\"],[\"Antagonist activity at human GHSR1 expressed in CHO-CREluc cells after 4 hrs by Luciferase reporter assay\"],[\"MSK1 (h)  Upstate kinase activity assay\"],[\"Effect on Nrf2 activation in HEK293 cells expressing human CYP2B6\"],[\"Inhibition of human recombinant matrix metalloprotease 9\"],[\"Inhibition of recombinant Plasmodium falciparum falcipain-2 expressed in bacterial expression system using ZFR-AMC as substrate at 100 uM measured for 30 mins by fluorimetric assay relative to control\"],[\"KinomeScan assay: inhibition of RSK2(Kin.Dom.2-C-terminal)\"],[\"Inhibition of DRAK2 (unknown origin) expressed in HEK293 cells by NanoLuc-luciferase reporter based intracellular ATP competitiveness assay\"],[\"Inhibition of N-terminal 6x-His-tagged recombinant human cIAP1-BIR3 (258 to 363 residues) expressed in Escherichia coli incubated for 2 hrs after 6 hrs pre-incubation with enzyme by biotinylated AVPI peptide based DELFIA\"],[\"Inhibitory activity against CRTH-2 in hCRTH-2 binding assay using HEK293 cell membranes\"],[\"Inhibition of human CK2A2 using RRRDDDSDDD as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"eEF-2K(h) Kinase panel\"],[\"Inhibition of recombinant N-terminal GST-tagged human BRAF (417 to 766 residues) expressed in Sf9 cells assessed as residual activity at 10 uM relative to control\"],[\"Binding affinity to Flag-tagged human HMGCR-dCat-ELuc membrane domain (1 to 499 residues) transfected in HEK293 cell membrane co-transfected with p-CMV-Insig1-myc-FLAG at 20 uM preincubated for 30 mins followed by irradiation with UV light for 3 mins in presence of 50 to 200 uM SRP3042 by immunoprecipitation analysis\"],[\"Inhibition of recombinant full length human CaMKIbeta assessed as residual activity at 1 uM using KKLRRTLSFAEP as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay\"],[\"Binding affinity to BCL-W (unknown origin)\"],[\"Binding affinity to human partial length BRD3 bromodomain 2 (G306 to P416 residues) expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of human MDR1-mediated rhodamine efflux in mouse L5178 cells assessed as fluorescence activity ratio at 10 ug\\u002fmL by flow cytometry relative to untreated control\"],[\"Inhibition of GST-tagged human recombinant wild type LRRK2 using fluorescein- ERM as substrate after 1 hr by TR-FRET assay\"],[\"Inhibition of ACAT1 in mouse N9 cells assessed as increase in autophagic flux by measuring LC3-2 levels in presence of Torin-1 by Western blot analysis\"],[\"Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]SIP production using D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method\"],[\"Binding affinity to N-terminal GST-tagged human BPTF (2914 to 3037 residues) expressed in Escherichia coli BL21-CodonPlus (DE3) cells assessed as change in melting temperature at 100 uM by thermal shift assay\"],[\"Inhibition of N-terminal 6-His-tagged full-length human 11beta-HSD1 assessed as conversion of cortisone to cortisol after 25 mins by competitive HTRF assay\"],[\"Inhibition of ULK1 mediated autophagy in human A549 cells transfected with GFP-mRFP-LC3 assessed as increase in LC3 puncta measured after 6 hrs by fluorescence microscopic analysis\"],[\"Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N at 10 uM by luciferase reporter gene assay\"],[\"Inhibition of recombinant Tdp1 (unknown origin) using 5'-(5,6 FAM-AAC GTC AGG GTC TTC C-BHQ1)-3' as substrate measured every 1 min by fluorescence analysis\"],[\"Displacement of [125I](BH)CCK8 from rat CCK1 after 30 mins by receptor binding assay\"],[\"Inhibition of recombinant INSR (unknown origin) using fluorescent dye-labelled KKSRGDYMTMQIG peptide peptide as substrate after 1 hr by IMAP assay\"],[\"Activation of Nrf2 in mouse BV2 cells assessed as inhibition of LPS-induced IL-6 production at 5 to 20 uM by ELISA\"],[\"Inhibition of human recombinant MAOB at 1 mM\"],[\"Inhibition of CK1alpha (unknown origin)\"],[\"Inhibition of human adrenergic beta-1 receptor at 3 uM\"],[\"Agonist activity at human LXRalpha expressed in Huh7 cells by Gal4 transactivation assay relative to TO901317\"],[\"Inhibition Assay: The assay is a capture of radioactive 33P phosphorylated product through filtration. The interactions of Btk, biotinylated SH2 peptide substrate (Src homology), and ATP lead to phosphorylation of the peptide substrate. Biotinylated product is bound streptavidin sepharose beads. All bound, radiolabeled products are detected by scintillation counter.\"],[\"Increase in human nuclear co-repressor receptor binding to human CAR-LBD expressed in HEK293 cells by yeast two-hybrid assay\"],[\"Substrate activity at NQO1 in human A549 cells assessed as induction of enzyme-catalyzed lipid peroxidation by measuring MDA equivalents per protein at 50 uM after 24 hrs by TBARS assay (Rvb = 3.53 +\\u002f- 1.12 nmol\\u002fmg)\"],[\"Inverse agonist activity at human ghrelin receptor Arg6:20Gln(Arg283) mutant expressed in african green monkey COS7 cells assessed as inhibition of constitutively stimulated inositol phosphate accumulation\"],[\"Binding affinity to human AKT2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of SRC (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control\"],[\"Inhibition of MAO-B (unknown origin) using p-tyramine substrate by HPLC method relative to selegiline\"],[\"Agonist activity at human LXRalpha expressed in human U2OS cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assay\"],[\"Binding affinity to human histamine H2 receptor at 10 uM relative to control\"],[\"Biophysical assay (SPR biosensor-based assay)\"],[\"Binding affinity to recombinant N-terminal His-FLAG-GST-tagged PAK7 (unknown origin) (425 to 719 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human SGK at 1 uM by radiometric Assay\"],[\"Inhibition of human topoisomerase-2alpha assessed as rate of ATP hydrolysis at 40 uM using linear pBR322 DNA as substrate measured up to 30 mins in presence of 0.1 mM ATP by pyruvate kinase\\u002flactate dehydrogenase enzyme coupled assay (Rvb = 1.152 to 1.563 microM\\u002fmin)\"],[\"Chaperone activity at beta-galactosidase R201C mutant isolated from human patient fibroblasts assessed as increase increase in thermal stability at 0.2 uM at 48 degC by thermal stability assay\"],[\"Inhibition of recombinant human GST-tagged DCN2 (62 to 259 residues) expressed in Escherichia coli BL21 (DE3) using MIKLFSLKQQKKEEESAGGTK-biotin as substrate incubated for 30 mins by HTRF assay\"],[\"Mixed-type inhibition of Electrophorus electricus AChE assessed as hydrolysis of acetylthiocholine by Lineweaver-Burk plot analysis\"],[\"Inhibition of SPHK1 in human U937 cells assessed as reduction of sphingosine 1-phosphate level at 100 nM after 2 hrs by LC\\u002fMS\\u002fMS analysis\"],[\"Inhibition of N-terminal GST-tagged recombinant human HDAC6 expressed in baculovirus infected Sf9 insect cells using Z-(Ac)Lys-AMC as substrate measured after 90 mins by fluorescence assay\"],[\"KinomeScan assay: inhibition of ERK1\"],[\"Antagonist activity at human muscarinic M5 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium response\"],[\"Inhibition of DAPK1 in HEK293 tau-BiFC cells assessed as reduction in forskolin-induced tau aggregation after 48 hrs by Hoechst staining based HCS analysis\"],[\"Ratio of etoposide IC50 to IC50 for drug against human DNA topoisomerase 2alpha-mediated decatenation of kinetoplast plasmid DNA by fluorescent plate reader\"],[\"Inhibition of PARP-1 (unknown origin) assessed as incorporation of biotinylated poly ADP-ribose onto histone proteins measured without activation by GSH by colorimetric analysis\"],[\"Competitive inhibition of BLM (unknown origin) using ATP by Lineweaver-Burk double reciprocal plot analysis\"],[\"Inhibition of HDAC6 (unknown origin) using Ac-peptide as substrate preincubated for 15 mins followed by substrate addition by fluorescence assay\"],[\"Displacement of [3H]methylspiperone from human cloned 5HT2A receptor expressed in HEK293 cells at 3 uM after 90 mins by liquid scintillation counting\"],[\"Binding affinity to human recombinant histamine H3 receptor by GTPgammaS binding assay\"],[\"Agonist activity at human NOD1 receptor expressed in HEK-Blue reporter cells at 10 uM after 48 hrs by SEAP reporter gene assay\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 glxK at 4 fold MIC by microarray analysis\"],[\"Inhibition of AKT in human SNU449 cells assessed as phosphorylated ERK1\\u002f2 level at 50 uM after 48 hrs by Western blotting relative to beta-actin\"],[\"GAK DiscoveRx kinase panel\"],[\"Displacement of [125I]I-AB-MECA from recombinant human adenosine receptor A3 expressed in HEK293 cell membranes at 10 uM after 1 hr by FACS analysis relative to control\"],[\"Inhibition of human Bmx activity at 10 uM by radiometric assay\"],[\"Antagonist activity at GHSR1a (unknown origin) assessed as inhibition of ghrelin-induced intracellular calcium mobilization\"],[\"Inhibition of anti-IgM-induced BTK phosphorylation at Y233 in human whole blood after 6 hrs\"],[\"Displacement of [3H]Ketanserin from human recombinant 5-HT2A receptor expressed in HEK293T cells after 1 to 1.5 hrs by scintillation counting analysis\"],[\"Inhibition of full length recombinant human His-tagged JNK2 expressed in baculovirus expression system at 1 uM relative to control\"],[\"Binding affinity to human recombinant VEGFR2 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control\"],[\"Irreversible inhibition of N-terminal GST-tagged recombinant human Histone-lysine N-methyltransferase G9a using S-(5'-adenosyl)-L-methionine chloride as substrate assessed as enzyme recovery at 10 fold IC50 preincubated for 30 mins followed by 100 fold dilution in absence of DTT\"],[\"Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method\"],[\"ACHE\\u002fH Cerep selectivity data (BI)\"],[\"Inhibition of COX1 in human whole blood assessed as effect on A23187-induced thromboxane B2 production at 1 uM relative to control\"],[\"Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometry\"],[\"Inhibition of B-myb-mediated mitotic deffects in wild-type zebrafish embryo assessed as accumulation of cells in early S phase at 8 mM at 24 hrs post fertilization for 6 hrs by flow cytometry\"],[\"Inhibition of human BRD2 bromodomain 1 expressed in bacterial expression system\"],[\"Inhibition of human GOAT expressed in baculovirus infected Sf9 cells at 10 uM using octanoyl-CoA and ghrelin-biotin as substrate preincubated for 20 mins followed by substrate addition and measured after = \\u003e 1 hr by HTRF assay relative to control\"],[\"Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysis\"],[\"Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human PDGFRbeta assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Activity of human full length SIRT1 enzyme at 50 uM after 1 hr by trypsin developer-based fluorescence assay\"],[\"Binding affinity to human CSNK1G3 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control\"],[\"Percent inhibition of [3H]- progesterone binding to rabbit uterine progesterone receptor, at 10e-9 M compound concentration\"],[\"Inhibition of [3H]-methyl-quinuclidinyl benzilate binding to rat heart muscarinic M2 receptor by radioligand binding assay\"],[\"Reversible inhibition of human recombinant DPP1 assessed as dissociation rate constant by surface plasmon resonance direct binding assay\"],[\"Antagonist activity at human TP receptor by FLIPR assay\"],[\"Inhibition of ovine COX1 by chemiluminescent enzyme assay\"],[\"Inhibition of human SRPK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control\"],[\"Inhibition of human recombinant Aurora kinase B using tetra(LRRASLG) as substrate at 1 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control\"],[\"Inhibition of human YES at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [3H]NAMH from histamine H3 receptor in rat cortex\"],[\"Binding affinity against human Melanocortin-4 receptor\"],[\"Displacement of [3H]-candesartan from human AT1 receptor expressed in CHO cells assessed as dissociation rate constant at 100 nM pre-incubated with cells followed by compound washout and subsequent addition of [3H]-candesartan up to 60 mins\"],[\"Inhibition of Flt-3 (unknown origin)\"],[\"Inhibition of PDK1 in human MCF7 cells assessed as decrease in extracellular acidification rate at 20 uM after 12 hrs\"],[\"Displacement of [3H]Spiperone from human dopamine D3 receptor\"],[\"In vitro activities of Leukotriene B4 receptor (LTB4) in human neutrophils\"],[\"Inhibition of recombinant human N-terminal GST-tagged BRD3 bromodomain-2 (306 to 417 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay\"],[\"Agonist activity at rat S1P1 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgamma-S binding measured after 45 mins by liquid scintillation counting method\"],[\"Inhibition of ALK (unknown origin) transfected in mouse BA\\u002fF3 cells\"],[\"Inhibition of Ca2+\\u002fcalmodulin-induced recombinant human full length N-terminal GST-tagged PDE9A2 expressed in baculovirus infected Sf9 cells using cGMP as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by kinase-Glo luminescence assay\"],[\"Inhibition of telomerase in human COLO 205 cells assessed as shortening of telomere length at 30 uM by measured after 56 days qPCR relative to control\"],[\"Inhibition of TC-PTP (unknown origin) using pNPP as substrate at 20 ug\\u002fml by spectrophotometry\"],[\"Displacement of [3H]R-alpha-methylhistamine from human histamine H3 receptor by cell-based assay\"],[\"Inhibition of recombinant human mu opioid receptor expressed in HEK293 cells at 1 uM by radioligand displacement assay relative to control\"],[\"Binding affinity to human f10a\"],[\"Y1\\u002fHUM Cerep selectivity data (BI)\"],[\"Inhibition of human placental 17betaHSD2 by radiodetection assay\"],[\"Reduction of VDR-mediated TRPV6 expression in human 1,25(OH)2D3-stimulated DU145 cells after 18 hrs by semiquantitative RT-PCR analysis\"],[\"Inhibition of human recombinant MAO-A assessed as hydrogen peroxide production at 20 uM\"],[\"Inhibition of STAT3 nuclear translocation in human U-87 MG cells incubated for 24 hrs by Hoechst staining based fluorescence confocal imaging analysis\"],[\"Inhibition of recombinant N-terminal FLAG\\u002fHis-tagged SMYD3 (unknown origin) expressed in baculovirus infected insect cells using 3H-SAM as substrate assessed as 3H-MEKK2 methylation incubated for 40 mins by scintillation proximity assay\"],[\"Inhibition of full length N-terminal GST-tagged human CHK1 expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of AurA (unknown origin)\"],[\"Inhibition of human NET at 10 uM relative to control\"],[\"Inhibition of ADAM9 (unknown origin) using MCA-PLAQAV-Dpa-RSSSR-NH3 substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs\"],[\"Positive allosteric modulation of human FSH receptor expressed in CHO cells assessed as effect on FSH-induced cAMP accumulation at 12 uM after 1 hr by HTRF assay relative to FSH\"],[\"Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of caspase-9 cleavage at 400 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of p97 cysteine-less mutant (unknown origin) at 200 uM after 10 mins by malachite green dye based visible spectrophotometry\"],[\"Inhibition of recombinant human His-tagged CSF1R catalytic domain (538 to 910 residues) expressed in baculovirus expression system using tyrosine-1 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay\"],[\"Inhibition of human matrix metalloprotease-2 (MMP-2)\"],[\"Inhibition of HIV1 protease expressed in Escherichia coli by immunoblotting\"],[\"p38beta(MP11LGI1) Takeda global kinase panel\"],[\"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes\"],[\"Inhibition of biotinylated ligand binding to wild-type human partial length SRPK3 (P41 to P567 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control\"],[\"Inhibition of recombinant human DGAT1 expressed in baculovirus infected Sf9 insect microsomal membranes using C10-DAG and C10-CoA as substrate pretreated for 30 mins followed by substrate addition measured after 60 mins by CPM dye based fluorescence assay\"],[\"Inhibition of rat ASIC1a receptor expressed in xenopus lavies oocytes up to 10 mM at greater than pH 5 by two electrode voltage clamp\"],[\"Inhibition of LCK in human Jurkat cells assessed as decrease in ZAP70 phosphorylation at Y319 after 1.5 hrs by immunoblot method\"],[\"Activity of human MELK kinase at 1 uM\"],[\"D4.4  (h) Ligand binding assay\"],[\"Inhibition of rat kidney ALR1 using sodium D-glucuronate as substrate preincubated for 10 mins followed by substrate addition measured for 4 mins\"],[\"Inhibition of [3H]NE uptake at human NET G193S mutant expressed in african green monkey COS1 cells after 48 hrs\"],[\"Inhibition of human FES assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Binding affinity by its ability to displace [3H]-U-69,593 from kappa receptor in homogenates of guinea pig brain\"],[\"Inhibition of human recombinant renin in presence of pH 7.4 buffer\"],[\"Inhibition of human PIK4 at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human recombinant PARP1 by fluorescence based multiwell assay\"],[\"Inhibition of EGFR (unknown origin) at 1 uM by KINOMEscanning assay relative to control\"],[\"Inhibitory concentration against human metabotropic glutamate receptor 1 transmembrane domain\"],[\"Inhibition of human neutrophil elastase using S1384 as substrate preincubated for 5 mins followed by substrate addition relative to control\"],[\"Inhibition of human JAK1 using 5FAM-KKSRGDYMTMQID as substrate by caliper microfluidic mobility shift assay\"],[\"In vivo effect on Cholesterol 7-alpha-hydroxylase activity in CF1 mice after 16 days at 40 mg\\u002fkg oral dose\"],[\"Inhibition of murine Lck by TR-FRET assay\"],[\"Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry\"],[\"Inhibition of human tripeptidyl peptidase2 from erythrocytes\"],[\"Inhibition of STK3 in HEK293 cells assessed as reduction in phosphorylated-MOB1 protein level at 10 uM preincubated for 4 hrs followed by H2O2 addition and measured after 2 hrs by Western blotting analysis\"],[\"Inhibition of human topoisomerase-2 assessed as DNA intercalation by measuring relaxation of supercoiled pBR322 plasmid DNA after 6 mins by agarose gel electrophoresis\"],[\"Ratio of Emax to EC50 for agonist activity at human PXR transfected in human HepG2 cells cotransfected with CYP3A4 by luciferase reporter gene assay\"],[\"Inhibitory activity against Opioid receptor kappa 1 in electrically stimulated guinea pig longitudinal ileal muscle (GPI) preparation.\"],[\"Antagonist activity at canine TRPM8 expressed in HEK293 cells assessed as inhibition of intracellular calcium accumulation at 0.2 uM by FLIPR assay\"],[\"Binding affinity to ACADM in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of recombinant human full length CK2alpha2 at 1 uM using RRRDDDSDDD as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Binding affinity to MetAP2 in HUVEC at 0.1 uM by Western blotting analysis\"],[\"Antagonist activity at human kappa opioid receptor expressed in CHO cell membrane assessed as inhibition of U50,488 induced [35S]GTPgammaS binding\"],[\"Inhibition of Toxoplasma gondii enoyl reductase assessed as conversion of trans-2-acyl-ACP to acyl-ACP\"],[\"Inhibition of His-tagged human SAPK4\\u002fp38delta expressed in Escherichia coli at 20 uM\"],[\"Inhibition of human PDGFRA D842V using gamma-33P-ATP as substrate by scintillation counting\"],[\"Inhibition of MKK7 in mouse DRG cells assessed as reduction in cJUN phosphorylation at 1 uM after 2 hrs by Western blot analysis\"],[\"Inhibition of PRL-3-mediated cell migration in human HEK293 cells expressing PRL-3 (unknown origin) assessed as reduction of cell migrated treated for 0 to 20 hrs by wound healing assay\"],[\"Inhibition of mushroom tyrosinase using L-dopa as substrate preincubated for 10 mins followed by substrate addition and measured for 1 min\"],[\"Inhibition of beta-galactosidase derived from human peripheral blood mononuclear cell lysate using 4-methylumbelliferyl beta-D-galactopyranoside as substrate after 2 hrs by fluorescence analysis\"],[\"Inhibition of Candida albicans ATCC SC5314 CYP51 incubated for 30 mins by spectrophotometric method\"],[\"Inhibition of HDAC7 (unknown origin) at 0.5 uM relative to control\"],[\"Inhibition of N-terminal GST-tagged ROS1 (1883 to 2347 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control\"],[\"Histamine H2 receptor agonistic activity (positive chronotropism) was evaluated by the inhibition of histamine-stimulated contraction in guinea pig atrium; Not determined\"],[\"Antagonist activity at human CGRP receptor expressed in HEK293 cells assessed as inhibition of CGRP-induced cAMP response after 5 mins in the presence of 50% human serum\"],[\"Inhibition of eIF4E-mediated mRNA translation in rabbit reticulocyte lysate by luciferase reporter gene assay\"],[\"Agonist activity at human mu opioid receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis relative to control\"],[\"Inhibition of human full length CHK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to human PI3Kgamma equilibrate for 1 hr by scan-kinetic platform assay\"],[\"Inhibition of ovine COX1 using ADHP as substrate after 20 mins by fluorescence assay\"],[\"Inhibition of drug-susceptible Nephotettix cincticeps Ageo (green rice leafhopper) acetylcholinesterase\"],[\"Displacement of [35S]-MK499 from human ERG\"],[\"Inhibition of SYK (unknown origin) in B cells assessed as reduction in alpha IgM-stimulated AKT phosphorylation at S473 residue\"],[\"Binding affinity to FKBP12 PPI domain (unknown origin) in water bulk solution by fluorescence spectrophotometric analysis relative to FK506\"],[\"Inhibition of microsomal epoxide hydrolase (unknown origin) using 7-(2-(Oxiran-2- yl)ethoxy) Resorufin by fluorometric method\"],[\"Inhibition of JAK2 V617F mutant in human HEL cells after 1 hr\"],[\"Inhibition of rat recombinant soluble epoxide hydrolase after 1 hr by fluorescence assay\"],[\"Induction of E2F1 translocation from nucleus to cytoplasm in human A549 cells at 0.1 uM after 12 to 24 hrs by DAPI staining-based immunofluorescence analysis\"],[\"Displacement of [3H]-PGH2 from human CRTH2 receptor expressed in HEK293 cells by scintillation counting in presence of buffer containing 50% human plasma\"],[\"Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting\"],[\"Induction of BCL6 degradation in human KARPAS422 cells incubated for 2 hrs by MSD electrochemiluminescent immunoassay\"],[\"Agonist activity at human glucocorticoid receptor by cell-based assay\"],[\"Agonist activity as stimu;ation of [35S]-GTP-gamma binding to human Opioid receptor mu 1; Partial antagonist\"],[\"Inhibition of STAT3 phosphorylation at Tyr705 in human MDA-MB-231 cells at 1 to 10 uM after 12 hrs by western blot analysis\"],[\"Inhibition of human topoisomerase 2 p170alpha assessed as retardation of supercoiled lambda ZAPII plasmid Bluescript KS+ DNA migration at 50 uM after 60 mins by electrophoretic mobility shift assay\"],[\"Inhibition of BCL6 in human SUDHL4 cells assessed as de-repression of CXCR4 mRNA expression at 5 uM incubated for 24 hrs by RT-PCR analysis\"],[\"Binding affinity to human wild type RIPK1 (M1\\u002fK305) expressed in bacterial expression system by Kinomescan method\"],[\"Competitive inhibition of human ALDH1A1 using propionaldehyde as substrate by Lineweaver-Burk plot analysis\"],[\"Activation of AMPK in rat L6 cells assessed as phosphorylation at Thr172 at \\u003e 0.5 mmol\\u002fL after 5 hrs by Western blot analysis\"],[\"H2 receptor antagonistic activity against histamine stimulated chronotropic response in isolated guinea pig right atrium at 1x10E-6 g\\u002fmL.\"],[\"Inhibition of wild-type human partial length HUNK (A31 to K354 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of recombinant full length human HDAC2 expressed in sf9 insect cells using Ac-peptide-AMC as substrate after 1 hr by fluorescence assay\"],[\"Inhibition of human recombinant cathepsin L after 30 mins by spectrophotometric assay\"],[\"Inhibition of P-glycoprotein in human MCF7\\u002fADR cells assessed as reversal fold by measuring reduction in doxorubicin IC50 at 0.5 uM incubated for 48 hrs by CCK-8 assay\"],[\"Binding affinity to Mycobacterium tuberculosis PtpB assessed as fluorescence quenching at 0.1 to 3.8 uM by spectropolarimetry\"],[\"Inhibition of BACE1 in human H4 cells expressing APP Swedish K595N and M596L double mutant assessed as inhibition of amyloid beta (1 to 40) production after 24 hrs by whole cell assay\"],[\"Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM phenylboronic acid\"],[\"Inhibition of IRAK4 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control\"],[\"Induction of human NTCP receptor inhibition-mediated autophagy in HBV-infected human HepG2.2.15 cells assessed as increase in LC3-2 level at 20 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay\"],[\"Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells\"],[\"Inhibition of STAT3 dimer DNA binding activity in human MDA-MB-231 nuclear extract at 1 to 5 uM preincubated for 24 hrs followed by addition of [32P]hSIE by electrophoretic mobility shift assay\"],[\"Inhibition of human recombinant BACE1 after 60 mins by FRET assay\"],[\"Inhibition of tyrosinase in alpha-MSH-stimulated mouse B16F10 cells at 25 uM preincubated for 48 hrs followed by L-DOPA addition relative to control\"],[\"Inhibition of 17beta-HSD3 at 100 uM\"],[\"Non-competitive inhibition of recombinant human C-terminal His-tagged PHGDH (1 to 533 residues) expressed in Escherichia coli assessed as reduction in NADH formation preincubated for 30 mins followed by constant concentration of 3-phosphoglycerate substrate addition in presence of varying levels of NAD+ by resorufin fluorescence based PSAT1\\u002fdiaphorase\\u002fPSPH coupled enzyme assay\"],[\"Inhibition of full-length human IDO1 expressed in Escherichia coli Rosetta (DE3) assessed as reduction in kynurenine production at 0.5 to 2.5 uM pre-incubated for 120 mins in presence of ascorbate and MB reductants and catalase before jump dilution with incubation medium containing L-Trp and further incubated for 20 mins by HPLC analysis\"],[\"Binding affinity to human VMAT2 expressed in HEK293 cell membranes in presence of 2 mM Mg-ATP by scintillation counting method\"],[\"Intrinsic activity at CB2 receptor assessed as induction of ERK1\\u002f2 phosphorylation in HL60 cells at 10 nM after 10 mins relative to control\"],[\"Inhibition of STAT3 in human MDA-MB-231 cells assessed as reduction in p-STAT3(Y705) level at 5 uM after 1 to 24 hrs by immunoblot analysis\"],[\"Inhibition of recombinant human GST-tagged full length BRAF expressed in baculovirus expression system at 500 nM using Ser\\u002fThr 03 peptide as substrate incubated for 1 hr in presence of 100 uM ATP by Z'-LYTE assay relative to control\"],[\"Inhibition of human LYN B at 1 uM using poly[Glu:Tyr] (4:1) as substrate\"],[\"Competitive Inhibition Assay: In vitro binding assay: The affinities of compounds for opioid receptors were determined by competitive inhibition of [3H]diprenorphine binding to kappa opioid receptors (KOPR).\"],[\"Inhibition of MYLK2 (unknown origin) at 100 nM\"],[\"Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system at 1 uM by Kinomescan method\"],[\"Inhibition of full length human His-tagged IKK1 expressed in baculovirus expression system at 10 uM by Z'-LYTE assay\"],[\"Increase in CPT1 activity in human MCF7 cells assessed as increase in radiolabeled palmitoylcarnitine relative to untreated control\"],[\"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.\"],[\"Agonist activity at TLR8 in human PBMC assessed as induction of IFN-gamma production after 16 hrs by multiplexed immunoassay\"],[\"Inhibition of human ABHD16A expressed in HEK293 cells assessed as residual activity at 10 uM preincubated for 30 mins followed by 1-LG substrate addition and measured after 90 to 120 mins by fluorometric assay relative to control\"],[\"Inhibition of mouse plasma BuChE using S-butyrylacetylthiocholine iodide as substrate at 10 uM measured after 30 mins by Ellman's method relative to control\"],[\"Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins\"],[\"Inhibition of HIV1 RT by ELISA\"],[\"Competitive inhibition of FLT3 D835Y mutant (unknown origin) in presence of ATP\"],[\"Inhibitory concentration against COX-2 upon incubation for 15 minutes at 37 degree C\"],[\"Inhibition of glucocorticoid receptor Dexamethasone response; not determined\"],[\"Inhibition of Clostridium botulinum BoNT\\u002fA light chain-mediated SNAP-25 substrate cleavage preincubated for 15 mins in presence of cysteine before substrate addition by FRET assay\"],[\"Inhibition of SK1 (unknown origin) using 5 uM of sphingosine as substrate\"],[\"Agonist activity at human GPR119 expressed in MIN6 cells assessed as intracellular cAMP level after 45 mins by ALPHAscreen cAMP assay\"],[\"Inhibition of glutathione reductase in human A549 cells assessed as enzyme activity at 158 nM after 24 hrs relative to untreated control\"],[\"Inhibition of human GST-PDE4D\"],[\"Inhibition of recombinant PLK1 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay\"],[\"Inhibition of the binding of [3H]LSD (radioligand) on human 5-HT6 receptor at concentration of 10e-8 M\"],[\"STK16 Kinase panel\"],[\"Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay\"],[\"MAP4K2 DiscoveRx kinase panel\"],[\"Displacement of [3H]DAMGO from human recombinant mu opioid receptor expressed in HEK293 cells incubated for 120 mins by radiometric scintillation analysis\"],[\"Binding affinity to human AT1 receptor expressed in CHO cells assessed as dissociation rate constant at 3 nM incubated for 60 mins measured after isotopic dilution\"],[\"Displacement of [3H]estrone human recombinant 17beta-HSD1 expressed in Escherichia coli BL21 (DE3)-RIL by competitive inhibition assay in presence of bacterial homogenate\"],[\"Inhibition of recombinant KDR (unknown origin) at 0.1 uM after 1 hr by microfluidic assay\"],[\"Inhibition of recombinant N-terminal FLAG\\u002fHis6-tagged human vanin-1 expressed in CHO cells at 10 uM by 1H NMR analysis\"],[\"Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes\"],[\"Inhibition of serotonin 5-HT1A receptor (unknown origin) at 1 uM\"],[\"Agonist activity at recombinant human adenosine A2A receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity relative to NECA\"],[\"Ratio of Kd for N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by isothermal titration colorimetric method to Ki for N-terminal His-tagged full length human PSD-95alpha PDZ2 domain (155 to 249 residues) without exon 4b expressed in Escherichia coli BL21(DE3)pLysS by fluorescence polarization assay\"],[\"Activity against 17beta-HSD 1 at 20 uM\"],[\"Inhibition of Staphylococcus aureus Russell beta-lactamase assessed as inhibition of nitrocefin hydrolysis pre-incubated for 5 mins by microtiter plate assay\"],[\"Inhibition of human 20S proteasome LMP2 activity in human NCI\\u002fADR-RES cells overexpressing ABCB1 using Ac-PAL-AMC as fluorogenic substrate incubated for 72 hrs in presence and absence of verapamil by fluorescence assay\"],[\"Activity at muscarinic M3 receptor in Albino Dunkin-Hartley guinea pig trachea assessed as inhibition of carbachol-induced contraction\"],[\"Inhibition of recombinant Trypanosoma cruzi cruzain at 20 uM using Z-FR-AMC as substrate by fluorometry relative to control\"],[\"Inhibition of ROCK1 (unknown origin) by ATP competition assay\"],[\"Agonist activity at human wild-type KISS1R expressed in HEK293 cells assessed as induction of intracellular Ca2+ mobilization after 30 mins by Fluo4 NW Ca2+ assay\"],[\"Inhibition of human p56 lck tyrosine kinase\"],[\"Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells\"],[\"Inhibition of GST-tagged full length XIAP BIR2 domain-mediated caspase 3\\u002f7 cleavage in human HeLa S3 cell lysates assessed as cleavage of Ac-DEVD-AFC after 4 hrs in presence of cytochrome C and dATP\"],[\"Ratio of IC50 for drug to IC50 for vesnarinone against human PDE3A by fluorescence microplate reader\"],[\"Displacement of [3H]lysergic acid diethylamide from full length human recombinant 5HT2B receptor expressed in CHOK-1 cells at 10 uM measured after 60 mins by radiometric scintillation analysis relative to control\"],[\"Inhibition of methyltransferase activity of flag-tagged EZH2 in human PRC2 complex expressed in Sf9 insect cells using biotinylated histone H3K27 peptide as substrate after 60 mins in presence of 3H-SAM by scintillation proximity assay\"],[\"Inhibition of N-terminal His6-tagged TRKA G667C mutant (unknown origin) (486 to 786 residues) expressed in Escherichia coli using poly-EAY substrate incubated for 60 mins in presence of [gamma33P]ATP by liquid scintillation method\"],[\"Inhibition of human MAO-B using Tyramine hydrochloride as substrate preincubated for 30 mins followed by substrate addition and measured for 1 hr by fluorometric method\"],[\"Binding affinity to Akt1 in human MDA-MB-231 cells assessed as shifted melting curve at 2 uM by CETSA assay\"],[\"Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Activity of Pseudomonas aeruginosa VIM4 beta-lactamase\"],[\"Displacement of [125I]Iodoproxyfran from human histamine H3 receptor expressed in CHO-K1 cells\"],[\"Inhibition of histamine H1 receptor (unknown origin) at 10 uM\"],[\"Inhibition of KDR (unknown origin) at 0.19 uM relative to control\"],[\"Inhibition of equine serum BuChE after 15 mins by spectrophotometric analysis\"],[\"Percentage activity of mouse MKK4 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control\"],[\"Mixed type inhibition of human wild-type full length SHP2 assessed as substrate Km at 10 uM using H-Glu-Phe-pTyr-Ala-Glu-Val-Gly-Arg-Ser-Pro-Pro-Asp-Pro-Ala-Lys as substrate by Lineweaver-Burk plot analysis (Rvb = 0.034 +\\u002f- 0.012 mM)\"],[\"Inhibition of human p38-gamma at 20 uM by FRET assay\"],[\"Agonist activity at mouse FFA4 receptor in mouse MIN6 cells assessed as induction of glucose-induced insulin secretion by AlphaLISA\"],[\"Inhibition of telomerase (unknown origin)\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation assessed as decrease in fluorescence plateau at compound\\u002fprotein ratio of 1\\u002f1 after 42 hrs by ThT fluorescence assay relative to control\"],[\"Inhibition of Leucyl-tRNA synthetase-mediated mTORC1 signaling activation in human HEK293 cells assessed as reduction in leucine-induced S6K phosphorylation at 200 uM preincubated for 50 mins followed by leucine-stimulation and measured after 10 mins by Western blot analysis\"],[\"TP_TRANSPORTER: uptake in rat canalicular membrane vesicle\"],[\"Agonist activity at rat VDR in ROS 17\\u002f2.8 cells transfected with Cyp24a1 reporter plasmid assessed as increase in Cyp24a1 transcription after 16 hrs by luciferase reporter gene assay relative to 1alpha,25(OH)2D3\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 0.625 uM incubated for 16 to 18 hrs in presence of 0.0024 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Inhibition of nuclear DNA binding to NF-kappaB p65 subunit in TNF-alpha-stimulated human KBM5 cells at 10 uM after 30 mins by EMSA relative to control\"],[\"Agonist activity at human GPR120 short isoform expressed in CHOK1 cells assessed as induction of IP1 accumulation after 60 mins by HTRF assay\"],[\"Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay\"],[\"MKK6 Kinase panel\"],[\"Inhibition of human TYK2 (875 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of ABCB1 in multidrug-resistant human KB-C2 cells assessed as increase in reversal of resistance to paclitaxel-induced cytotoxicity by measuring paclitaxel IC50 at 10 uM pre-incubated for 4 hrs followed by paclitaxel addition and measured after 72 hrs by MTT assay (Rvb = 1886.37 +\\u002f- 243.05 nM)\"],[\"Binding affinity to human MLK1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Binding affinity to recombinant human C-terminal His-tagged GLS1 after 3 hrs in presence of glycine by GDH coupled assay\"],[\"Activation of Nrf2 in mouse BV-2 cells assessed as increase in nuclear Nrf2 levels at 0.5 uM after 6 hrs by Western blot analysis relative to control\"],[\"Transactivation of human GAL4-fused PPARgamma LBD expressed in African green monkey COS7 cells co-expressing 5Gal4 pGL3 TK Luc after overnight incubation by luciferase reporter gene assay relative to rosiglitazone\"],[\"Ratio of MK886 IC50 to compound IC50 for mPGES1 (unknown origin)\"],[\"Inhibition of topoisomerase 2 in human DU145 cells assessed as stabilization of enzyme-DNA cleavage complex at 90 nM after 30 mins by immunoblot analysis\"],[\"Inhibition of ROCK2 in rat PAEC assessed as inhibition of hypoxia-induced IL6 up regulation at 50 nM measured after 72 hrs by ELISA\"],[\"Displacement of [3H]DPCPX from human recombinant adenosine A2B receptor expressed in HEK293 cells at 1 uM by beta scintillation counter\"],[\"Inhibition of N-terminal GST and C-terminal His6 tagged recombinant human CHK2 expressed in Escherichia coli cells at 10 uM relative to control\"],[\"Activity at beta-1 adrenergic receptor\"],[\"Inhibition of KAT3B (965 to 1810) (unknown origin) using biotinylated histone H3 as substrate at 100 uM after 10 mins by TR-FRET analysis relative to control\"],[\"Activation of Nrf2 in human BEAS2B cells assessed as upregulation of Nrf2 protein expression at 6.25 uM pretreated for 1 hr followed by co-treatment with PI3K inhibitor LY294002 for 18 hrs by immunoblot analysis\"],[\"Displacement of [3H]PSB11 from recombinant human adenosine receptor A3 expressed in CHO cell membranes at 1 uM\"],[\"Displacement of biotinyl-withaferin from bovine lung annexin 2 at 10 uM by chemiluminescence assay\"],[\"Inhibition of recombinant human topoisomerase 2alpha assessed as decrease in relaxation of supercoiled pUC19 DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\"],[\"Inhibition of FRK (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Competitive inhibition of thymidine kinase in mouse Ehrlich's ascites cells\"],[\"Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control\"],[\"Increase in SIRT1 (unknown origin) deacetylation activity\"],[\"ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Km for substrate at 2 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 6.08 +\\u002f- 0.4093 10'-6 M)\"],[\"Binding affinity to wild type human STING C-terminal domain (139 to 379 residues) expressed in Escherichia coli BL21 (DE3) by isothermal titration calorimetric method\"],[\"Inhibition of human CHK1 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate\"],[\"Inhibition of recombinant human SNK (65 to 409 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Displacement of [3H]RTX binding to Rat Vanilloid receptor 1 (VR1) at 10 uM\"],[\"Inhibition of KDM4E (unknown origin)\"],[\"Inhibition of serotonin 5-HT2C receptor (unknown origin) at 1 uM\"],[\"Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as MEK-ERK signaling relative to control\"],[\"Inhibition of human SGLT1 expressed in xenopus laevis oocyte assessed as decrease in amount of SGLT1 protein level in oocyte plasma membrane at 75 pmol after 1 hr by Western blotting relative to control\"],[\"Binding constant for RET kinase domain\"],[\"Induction of Nrf2 nuclear translocation in rat PC-12 cells assessed as Nrf2 accumulation in nucleus at 25 uM by Western blot analysis\"],[\"Activity of mouse FAP assessed as enzyme mediated drug cleavage by measuring increase in fluorescence intensity\"],[\"Inhibition of recombinant Top1 (unknown origin) assessed as Top 1 mediated DNA cleavage using 3'-[32P]-labeled 117 bp DNA as substrate at 0.1 to 100 uM after 20 mins by PAGE analysis\"],[\"Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human ABL1 at 1 uM using [EAIYAAPFAKKK] as substrate\"],[\"Binding affinity to human androgen receptor expressed in HEK293 cells at 0.1 uM relative to R1881\"],[\"Antagonist activity at human wild-type AVPR1A receptor expressed in CHO-K1 cells assessed as vassopressin-induced calcium by FDSS assay\"],[\"Binding affinity to wild-type human partial length SGK2 (L54 to C427 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant PKBalpha at 5 nM radiometric scintillation counting analysis relative to control\"],[\"Inhibition of FLT3 ITD D835V mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 48 hrs by CellTiter-Glo assay\"],[\"Inhibition of c-Met (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay relative to control\"],[\"Binding affinity towards human Alpha-1 adrenergic receptor\"],[\"Reversible inhibition of human recombinant soluble epoxide hydrolase assessed as residual enzyme activity at 10 uM after 15 mins relative to control\"],[\"Antagonist activity at HTR2A (unknown origin) by FLIPR assay\"],[\"Inhibition of Cdc25B in human K562 cells assessed as increase in Cdk1 phosphorylation at 20 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of Biotin-Ahx-PMQS(pT)PLN-NH2 binding to human N-terminal myc-tagged PLK1 polo-box domain (365 to 653 residues) expressed in HEK293T cells after 1 hr by ELISA\"],[\"Inhibition of AMCA-labeled MBP (83 to 99) binding to HLA-DR2b homodimer in human HTC-Lan B cells at 20 fold excess after 48 hrs by fluorescence spectrophotometric method\"],[\"Inhibition of LDHA in wild type CD1 mouse primary hepatocyte assessed as inhibition of lactate production using pyruvate as substrate measured after 30 mins by LC-MS analysis\"],[\"Inhibition of full length recombinant human GST-tagged SAPK3 expressed in Escherichia coli at 1 uM by radiometric assay relative to control\"],[\"Inhibition of ROCK2 (unknown origin) at 10 uM relative to control\"],[\"Selectivity ratio of apparent IC50 for inhibition of CPM binding to N-terminal His6-tagged human TEAD4 (217 to 434 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL cells to IC50 for inhibition of FITC-labeled palmitate tracer binding to N-terminal His6-tagged human TEAD4 (217 to 434 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL cells\"],[\"Inhibition of PTP1B catalytic domain (1 to 321 amino acids) (unknown origin) expressed in Escherichia coli Rosetta (DE3) incubated for 30 mins in absence of UV irradiation with 365 nm for 45 mins by pNPP assay\"],[\"Reversal of human ABCC1-mediated multidrug resistance in HEK293\\u002fMRP1 cells assessed as fold-change in etoposide IC50 at 0.5 uM after 72 hrs by CCK8 relative to etoposide IC50\"],[\"Inhibition of human recombinant carbonic anhydrase 2-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay\"],[\"Positive modulation of human mGluR2 expressed in CHO cells co-expressing Ga16 G-protein assessed as glutamate-induced response by FLIPR assay relative to glutamate\"],[\"Inhibition of RXRalpha in human HeLa cells assessed as increase in PARP cleavage after 8 hrs by Immunoblotting analysis\"],[\"Inhibition of human cathepsin E at 10 uM by enzyme assay\"],[\"Inhibition of CDK9 (unknown origin) by ATP competitive based analysis\"],[\"Antagonist activity at human 5-HT3A receptor F130A mutant assessed as inhibition of 5-HT-induced response after 45 mins by FLIPR assay\"],[\"Inhibition of renin in human plasma\"],[\"Inhibition of human CHK1 at 0.1 uM\"],[\"Inhibition of recombinant human full length AURKA expressed in baculovirus expression system using Ser\\u002fThr-01 peptide as substrate at 10 uM after 1 hr in presence of ATP by Z'LYTE assay\"],[\"Inhibition of DYRK1A (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control\"],[\"Binding affinity for Retinoic Acid Receptor beta(RAR beta);ND means not detectable.\"],[\"Agonist activity at human CaSR expressed in HEK293 cells assessed as increase in intracellular calcium mobilization by fluo-4AM dye based FLIPR assay\"],[\"Competitive inhibition of recombinant rat DNA polymerase beta using poly(dA)\\u002foligo(dT)18 as substrate by Lineweaver-Burk plot analysis\"],[\"Binding affinity to wild-type human partial length INSR (P997 to E1318 residues) expressed in mammalian expression system by Kinomescan method relative to control\"],[\"Inhibition of human 11beta-HSD2 in HEK293 cells at 10 uM\"],[\"Inhibition of human KCa3.1 overexpressed in HEK293 cells assessed as thallium influx preincubated for 15 mins followed by thallium\\u002fionomycin addition measured for 50 secs by FLIPR assay\"],[\"Activity at human PPAR alpha\"],[\"Displacement of [3H]-PK 11195 from peripheral (mitochondrial) benzodiazepine receptor (Not tested)\"],[\"Inhibition of Nav1.5 (unknown origin) up to 10000 nM\"],[\"Phosphodiesterase PDE4D2 Eurofins-Panlabs enzyme assay\"],[\"Inhibition of recombinant human HDAC1 using Z-(Ac)Lys-AMC as substrate after 90 mins by fluorescence based micro plate assay\"],[\"PRKCB1 Invitrogen selectivity data (BI)\"],[\"Reversal of ABCC1-mediated vincristine resistance in human KB-CV60 cells assessed as potentiation of vincristine-induced cytotoxicity by measuring change in vincristine IC50 at 5 uM incubated for 48 hrs by SRB assay relative to vincristine IC50\"],[\"Inhibition of ERK2 at 500 uM\"],[\"Inhibition of human recombinant carbonic anhydrase 4 pre-incubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Displacement of [125I]SS-14 from human SSTR3 expressed in CHO cells by TopCount analyzer\"],[\"Modulation of clathrin heavy chain 1 in human PC3 cells assessed as effect on transferrin endocytosis at 5 to 25 uM pretreated for 15 mins followed by trasnferrin conjugate addition measured after 15 mins by laser scanning confocal microscopic analysis\"],[\"Inhibition of RET isoform 15 M918T mutant (unknown origin) expressed in mouse BAF3 cells assessed as reduction in cell proliferation supplemented with fresh medium containing compound for every 2 to 3 days and measured daily\"],[\"Binding affinity against cruzaine\"],[\"Inhibitory constant against human Beta-1,4-galactosyltransferase I; N.I. is inactive\"],[\"Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay\"],[\"A-Raf(h) Kinase panel\"],[\"Effective concentration for Retinoic acid receptor alpha activity in CV-1 cells; Not determined\"],[\"Antagonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced [3H]cAMP accumulation after 20 mins by scintillation counting in presence of CP55940\"],[\"Displacement of [3H]NAMH from rat H3R expressed in CHO cells\"],[\"Activation of EIF2alpha kinase in mouse KLN205 cells assessed as reduction in eIF2-GTP-initiator methionine tRNA ternary complex measuring increase in firefly\\u002frenilla luciferase ratio at 5 uM after 16 hrs by dual luciferase reporter gene assay relative to control\"],[\"Inhibition FITC-labeled BCoR peptide binding to wild type human BCL6 BTB domain (5 to 129 residues) expressed in baculovirus infected Sf9 cells after 30 mins by TR-FRET assay\"],[\"Inhibition of PI3Kgamma at 1 uM\"],[\"Modulation of ABCB1 (unknown origin) expressed in mouse L5178Y-MDR cells assessed as multidrug resistance reversing activity by measuring fluorescence activity ratio at 2 uM by rhodamine-123 accumulation based flow cytometry (Rvb = 1.1 No unit)\"],[\"Stabilization of wild type TTR (unknown origin) expressed in Escherichia coli assessed as reduction in methanol-induced aggregation incubated for 60 min by absorbance method\"],[\"Inhibition of human TNIK (1 to 367 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"FLIPR functional assay (Ca influx activity of CHO cells)\"],[\"Transactivation of PXR in human HepG2 cells relative to rifampicin\"],[\"Inhibition of AR signaling pathway in testosterone-stimulated human LNCAP cells assessed as cell growth inhibition by flow cytometry\"],[\"Activity of RNA-dependent DNA polymerase activity of HIV 1 reverse transcriptase assessed as incorporation of 4-EdTMP by burst assay using RNA\\u002fDNA Primer\\u002fTemplate combination\"],[\"Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as increase in ACID level at 3 uM measured after 24 hrs by Western blot analysis relative to amodiaquine\"],[\"Inhibition of PP2A alpha (unknown origin) pre-incubated for 20 mins followed by fluorescence substrate addition and measured after 120 mins by DiFMUP assay\"],[\"Inhibition of FAAH in human U937 cell homogenate assessed as decrease in [ethanolamine-1-3H]AEA levels up to 10 uM preincubated for 30 mins followed by AEA addition measured after 15 mins by liquid scintillation counting method\"],[\"Inhibition of human recombinant BACE1 expressed in Escherichia coli\"],[\"Displacement of [3H]-mesulergine from human recombinant 5HT-2C receptor expressed in CHOK1 cell membranes at 10 uM after 30 mins relative to control\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by Ellman's method\"],[\"Chaperone activity at beta-galactosidase R201C\\u002fH281Y double mutant in GM1-gangliosidosis patient GM03348 cells assessed as enhancement of enzyme activity at 2 uM using 4-methylumbelliferyl beta-D-galactopyranoside as substrate after 2 hrs by fluorescence assay relative to control\"],[\"Inhibition of ABL1 Y253F mutant (unknown origin) at 0.164 uM relative to control\"],[\"Inhibition of MSK2 (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of DOT1L in human MV4-11 cells assessed as downregulation of HOXA9\\u002fMEIS1 mRNA expression after 6 days by real-time PCR analysis\"],[\"Inhibition of CMPK1 (unknown origin) by ADP-Glo kinase assay\"],[\"Inhibition of human TLR4 expressed in HEK-Blue cells assessed as reduction in LPS-EK-stimulated SEAP release preincubated for 3 hrs followed by LPS-EK addition measured after 20 hrs by spectrophotometric analysis\"],[\"Ratio of compound IC50 to progesterone IC50 for progesterone receptor in human T47D cells\"],[\"Binding affinity to human recombinant N-terminal SP-fused FLAG-tagged H4R expressed in HEK293T cells assessed as increase in membrane fluorescence at 200 nM measured after 16 secs by confocal microscopic analysis\"],[\"Inhibition of SIRT6 (unknown origin) using AMC containing peptide substructure by fluorogenic assay\"],[\"Inhibition of recombinant human GST-tagged EGFR L858R\\u002fT790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay\"],[\"Binding affinity to SARS-CoV-2 spike glycoprotein S-trimer measured by Surface plasmon resonance\"],[\"Inhibition of ovine AANAT by spectrophotometric assay\"],[\"Inhibition of MELK (unknown origin)\"],[\"Inhibition of human ALDH1A1 using all-trans-retinal as substrate preincubated for 15 mins followed by substrate addition measured for 30 mins by fluorescence assay\"],[\"ERK4(MAP4LGY1) Takeda global kinase panel\"],[\"Displacement of [3H]spiroperidol from dopamine receptor D2 binding sites of rat striatal membranes; inactive\"],[\"Inhibition of recombinant full length human GST-tagged IKBKB expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control\"],[\"Inhibition of human recombinant N-terminal Streptavidin2-tagged HDAC11 (1 to 347 residues) expressed in baculovirus infected insect cells using fluorogenic HDAC class 2a as substrate measured after 1 to 2 hrs by fluorescence assay\"],[\"Inhibition of human C-terminal FLAG-tagged KDM6B (1043 to end residues) expressed in baculovirus infected Sf9 insect cells at 25 uM using H3(21-44)-K27(Me3)-GK(Biotin)\\u002f2-OG as substrate measured after 1 hr by Alphalisa assay relative to control\"],[\"Inhibition of DYRK2 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of Braf (unknown origin) at 1 uM relative to control\"],[\"Agonist activity at human 5HT7 receptor expressed in CHO-K1 cells at 10 uM by calcium 4 dye based FLIPR assay relative to control\"],[\"Binding affinity to human EP3\"],[\"Inhibition of rat His6-tagged Hao2 expressed in Escherichia coli BL21\\u002fDE3 using 2-hydroxyoctanoic acid as substrate measured every 10 secs by spectrophotometry\"],[\"Inhibition of human PI3Kbeta incubated for 1 hr by ADP-Glo kinase assay\"],[\"Dex-NCS incubation on the subsequent inhibition of exchange binding with [3H]dexamethasone measured at pH 7.6 at 3h.\"],[\"Inhibitory activity against cyclic AMP production in rat Adenosine A1 receptor assay\"],[\"Inhibition of CSNK1A1L (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Lyn (m) Upstate kinase activity assay\"],[\"Inhibition of human SGLT2 expressed in CHOK1 cells assessed as inhibition of glucose uptake\"],[\"Inhibition of [3H]5HT reuptake at human SERT expressed in HEK293 cells\"],[\"Affinity on C6 glioma cells transfected with Dopamine receptor D2L\"],[\"Inhibition of human PKBalpha assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting\"],[\"Inhibition of human PDE1A at 10'4 nM using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay relative to control\"],[\"Inhibition of Plasmodium falciparum His-tagged PNP assessed as inhibitor constant for enzyme-inhibitor complex formation\"],[\"Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP\"],[\"Inhibition of human MAPKAPK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Reversible inhibition of mushroom tyrosinase assessed as L-DOPA oxidation at 1.2 to 2.4 uM\"],[\"Binding affinity to TRPV1 (unknown origin) at 10 uM\"],[\"Inhibition of N-terminal FLAG-tagged human HDAC10 (2 to 631 residues) expressed in baculovirus infected Sf9 cells using fluorogenic HDAC substrate 3 measured after 30 mins by fluorescence based assay\"],[\"Inhibition of interleukin-23 receptor in human DB cells assessed as reduction in IL-23-stimulated STAT3 phosphorylation incubated for 30 mins by HTRF assay\"],[\"Inhibition of human recombinant SIRT2 using Fluor-de-Lys as substrate at 10 uM incubated for 60 mins prior to substrate addition measured after 60 mins by fluorometric analysis\"],[\"Inhibition of human MYLK4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Compound ability to inhibit the production of HIV reverse transcriptase (RT) in culture supernatant of monocytic U937 on at 14 days at a concentration 25 uM\"],[\"Antagonist activity at recombinant mouse EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release measured for 3 mins by FLIPR assay\"],[\"Binding affinity to wild-type human partial length CAMK1G (M1 to A342 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of RET (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay\"],[\"Induction of GSK3alpha degradation in human SH-SY5Y cells assessed as maximum degradation at 1 uM measured after 9 hrs by western blot assay\"],[\"Agonist activity at GluR1 M686V mutant expressed in HEK293 cells by Fluo-4\\u002fCa2+ assay\"],[\"Inhibition of LSD1 in human MGC-803 cells assessed as increase in H3K9me1\\u002f2 level incubated at 0.2 to 0.6 uM for 48 hrs by western blot analysis\"],[\"Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 45 mins by flow cytometry in presence of 2-(3-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-methoxy-3,4-dihydroisoquinolin-1(2H)-one\"],[\"Inhibition of recombinant human full length C-terminal His\\u002fFALG-tagged HDAC1 expressed in Sf9 insect cells using FAM-labeled acetylated peptide A as substrate preincubated for 3 hrs followed by substrate addition and measured after 60 mins by fluorescence assay\"],[\"PKCzeta(h) Kinase panel\"],[\"Displacement of [3H]-Diprenorphine from kappa opiod receptor (unknown origin) expressed in CHO cells incubated for 90 mins in presence of peptidase inhibitors\"],[\"Inhibition of HIPK3 (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of ADAM17 in human A2774 cells assessed as inhibition of EGF-induced sALCAM release by ELISA\"],[\"Inhibition of INSR (unknown origin) after 60 mins by TR-FRET assay\"],[\"Inhibition of human carbonic anhydrase 5A after 15 mins by stopped flow carbon dioxide hydration assay\"],[\"Binding affinity to human MAPKAPK2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Binding affinity to human NPFFR2\"],[\"Inhibition of PRAK (unknown origin) at 100 nM\"],[\"Substrate activity for rat hexokinase III as 1:1 Mg complex at 5.0 mM\"],[\"Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT\\u002fFASN positive feedback loop by measuring reduction in AKT expression at 1 uM after 48 hrs by Western immunoblot based densitometric assay relative to control\"],[\"Inhibition of [125I]-NDP- alpha-MSH binding to human melanocortin 4 receptor expressed in CHO cells\"],[\"Inhibition of PKN1 (unknown origin) at 1 uM relative to control\"],[\"Binding affinity to GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli assessed as induction of protein destabilization by measuring reduction in melting temperature by thermal shift assay\"],[\"Competitive inhibition of human carbonic anhydrase 2 esterase activity by Lineweaver-Burke plot analysis\"],[\"In vitro inhibitory concentration against adipocyte fatty acid binding protein(A-FABP)\"],[\"Inhibition of recombinant human MAO-A using tyramine as substrate ampliflu red dye based fluorescence assay\"],[\"Inhibition of human recombinant HDAC6 at 10 uM using ZMAL (Z-(Ac)Lys-AMC fluorogenic substrate incubated for 90 mins by fluorescence method\"],[\"Inhibition of Wild-type Streptococcus mutans UA159 glucosyltransferase C at 50 uM by zymography\"],[\"Competitive inhibition of PTP1B (unknown origin)\"],[\"Inhibition of human recombinant GST-tagged ERK1 expressed in Escherichia coli using ser\\u002fthr 3 Peptide as substrate preincubated for 1 hr measured after 1 hr by Z-LYTE assay\"],[\"Inhibition of recombinant human CypA-mediated CD147-deficient leukocyte migration from mouse bone marrow at 1 uM after 2 hrs\"],[\"Binding affinity to ASK1 (unknown origin)\"],[\"Inhibition of human recombinant PDE10A using cAMP as substrate after 1 hr by IMAP-FRET assay\"],[\"CK2alpha2 Invitrogen kinase panel\"],[\"COX2(h) Eurofins-Cerep enzyme and uptake assay\"],[\"Inhibition of human MLK1 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Intrinsic activity at human recombinant mu opioid receptor expressed in CHO cells up to 10 uM\"],[\"Inhibition of recombinant human His-tagged USP7 (208 to 560 residues) expressed in Hi-five Sf9 cells using monoubiquitinated ubiquitin-rhodamine as substrate incubated for 1 hr by fluorescence based assay\"],[\"Agonist activity at human IP receptor expressed in HEK293 cells assessed as increase in cAMP production\"],[\"Log of inhibitory concentration against human immunodeficiency virus type 1 integrase\"],[\"Displacement of [3H]U69593 from human kappa-opioid receptor stably expressed in HEK cell membrane after 90 mins by scintillation counting method\"],[\"Decrease in IKBalpha phosphorylation in human HuH7 cells transfected with pHBV1.2 at 10 ug\\u002fml after 2 days by immunoblot method relative to control\"],[\"Antagonist activity at ERalpha expressed in yeast AH109 assessed as inhibition of 17-beta-estradiol induced alpha-galactosidase activity\"],[\"Inhibition of human cloned 5HT2B receptor by competitive binding experiment\"],[\"Inhibition of Escherichia coli thymidylate synthase at \\u003e2.3 uM\"],[\"Inhibition of human c-SRC at 1 uM assessed as residual enzyme activity\"],[\"Ki ratio of compound on Opioid receptor kappa 1, Opioid receptor mu 1, Opioid receptor delta 1 opioid receptor; 1\\u002f2.9\\u002f290\"],[\"Inhibition of human JAK1 using poly[Glu:Tyr] as substrate in presence of [gamma-33P]-ATP\"],[\"Binding affinity against A1 adenosine receptor\"],[\"Binding affinity to recombinant human carbonic anhydrase 2 expressed in Escherichia coli expression system in TRIS buffer assessed as protonation enthalpy change by ITC method\"],[\"Inhibition of FAK in human A498 cells assessed as reduction in FAK phosphorylation pretreated for 12 weeks followed by treatment for last 24 hrs by Western blot analysis\"],[\"Displacement of [3H]diprenorphine from rat kappa opioid receptor Y119A mutant expressed in HEK293 cells\"],[\"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined\"],[\"Inhibition of phosphorylation of ERK level in human SW620 cells expressing wild type B-Raf at 3 microM after 48 hrs by immunoblotting analysis\"],[\"Inhibition of wild-type human partial length ERK3 (M1 to P413 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Dopamine D1  receptor (h) CEREP ligand profiling\"],[\"Ratio of binding affinity of Opioid receptor kappa 1 to Opioid receptor mu 1 to Opioid receptor delta 1; kappa:mu:delta = 18:12:1\"],[\"Inhibition of MIF-induced NF-kappaB nuclear translocation in mouse RAW264.7 cells at 100 uM pretreated for 30 mins before LPS stimulation measured after 2 hrs by autoradiography\"],[\"Inhibitory concentration against human immunodeficiency virus 1 protease in MT-4 cells\"],[\"Binding affinity to 20S proteasome beta5 subunit in intact human HeLa cells at 1 uM by Western blotting analysis\"],[\"Inhibition of guinea pig atrial natriuretic factor at 10 uM relative to control\"],[\"Inverse agonist activity at ERRgamma in human CAL62 cells assessed as increase in TPO mRNA expression at 12 uM incubated up to 24 hrs by RT-PCR analysis\"],[\"Inhibition of human recombinant adenosine receptor A2b at 1 uM\"],[\"Inhibition of recombinant N-terminal GST-tagged TGFBR2 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control\"],[\"Displacement of [3H]-HT from human recombinant 5-HT1E receptor expressed in stable HEK cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control\"],[\"Inhibition of PTPgamma (unknown origin)\"],[\"pA2 value against histamine h4 receptor\"],[\"Factor VIIa (h) Protease assay\"],[\"Agonist activity at AhR in human HepG2 cells assessed as maximum increase in CYP1A1 expression at 3 nM after 24 hrs by ethoxyresorufin-O-deethylase assay\"],[\"Inhibition of AKT1 (unknown origin) at 0.164 uM relative to control\"],[\"Reversal of P-gp mediated multidrug resistance in human SW620\\u002fAD300 cells assessed as fold-resistance by measuring [IC50 for SW620\\u002fAD300 cells to doxorubicin IC50 for SW620 cells] at 2.5 uM after 48 hrs by MTT assay (Rvb = 38 No_unit)\"],[\"Inhibition of rat epididymis beta-mannosidase assessed as p-nitrophenol release at 1000 uM at pH 4.5 by spectrometric analysis\"],[\"Inhibition of full length recombinant human BTK using KVEKIGEGTYGVVYK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting based radiometry assay\"],[\"Reversible inhibition of human recombinant MAOA expressed in BTI-TN-5B1-4 cells assessed as AUF\\u002ft ratio at 20 nM by effective dilution method relative to untreated control\"],[\"Agonist activity at TLR-4 in mouse RAW264.7 cells assessed as increase in IL-6 production at 1 to 5 ug\\u002fml measured after 48 hrs by ELISA\"],[\"Inhibition of human PIM3 at 1 uM\"],[\"Inhibitory activity against human tissue type plasminogen activator using S-2444\"],[\"Inhibition of recombinant N-terminal GST-fusion protein tagged human full length IRAK4 (1 to 460 residues) expressed in baculovirus expression system assessed as decrease in fluorescence labelled IRAK1 phosphorylation at 200 nM by off-chip mobility shift assay relative to control\"],[\"Binding affinity to human recombinant M5 receptor\"],[\"Effect on H2-mediated adenylate cyclase stimulation of the guinea pig myocardium was determined; NT means not tested\"],[\"Antagonist activity at human adrenergic alpha1B receptor assessed as intracellular calcium by summary (Abse5) assay\"],[\"Inhibition of human Calpain1 at 50 uM using Ac-LLY-AFC as substrate preincubated for 5 mins followed by substrate addition and measured after 10 mins by fluorescence method relative to control\"],[\"Displacement of (-)-[3H]vesamicol from VAChT in Torpedo californica electric organ synaptic vesicles\"],[\"Non competitive inhibition of human thrombin assessed as reduction in substrate Vmax at 40 uM using varying levels of spectrozyme TH as substrate measured after 10 mins by Michaelis-Menten plot analysis relative to control\"],[\"Inhibition of CCK-B receptor in lumen perfused albino mouse stomach assessed as reduction in boc-pentagastrin-induced gastric acid secretion after 45 mins relative to control\"],[\"Agonist activity at human kappa-type opioid receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by luminescence-based assay\"],[\"Inhibition of telomerase activity in human MCF7 cells using biotin-labeled TeloTAGGG as primer at 250 nM preincubated for 48 hrs followed by primer addition measured after 30 mins by PCR-ELISA\"],[\"Displacement of [3H]estradiol from recombinant full length human recombinant ERalpha receptor expressed in Sf9 insect cells at 10 uMmeasured after 120 mins by radiometric scintillation analysis relative to control\"],[\"Inhibition of BRD4 in human MV4-11 cells assessed as reduction in BCL2 mRNA level at 31.25 to 125 nM measured after 6 hrs by SYBR green dye based RT-qPCR analysis\"],[\"Inhibition of IRAK4 (unknown origin) in presence of 1 mM ATP\"],[\"Displacement of [3H]-estradiol from human full-length ERalpha receptor by competitive radiometric binding assay relative to estradiol\"],[\"Inhibition of calf PNP in presence of 0.025 mM phosphate\"],[\"Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells at 100 uM measured after 120 mins by scintillation counting method relative to control\"],[\"Inhibition of P2X5R (unknown origin)\"],[\"Competitive inhibition of AChE (unknown origin) using acetylthiocholineiodide substrate\"],[\"Activity against murine PPAR gamma receptor\"],[\"Inhibition of human sigma 1 receptor at 10 uM by radioligand binding assay relative to control\"],[\"Uncompetitive type inhibition of human AOX assessed as inhibition constant using nicotine-1(S)-iminium ion as substrate incubated for 2 mins by HPLC-MS analysis\"],[\"Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H]-2-arachidonoyl glycerol hydrolysis at 3 uM preincubated for 60 mins followed by 0.15 uM compound treated after dilution by liquid scintillation\"],[\"Agonist activity at human recombinant S1P3 receptor expressed in CHO cells incubated for 30 mins prior to 35SGTP-gammaS addition measured after 1 hr by 35SGTP-gammaS binding assay\"],[\"Inhibition of human PIK3C2A using phosphatidylinositol as substrate at 1.01 nM after 1 hr by TR-FRET based Adapta universal kinase assay relative to control\"],[\"Inhibition of mouse recombinant AChE using acetylthiocholine iodide as substrate by Ellman's method\"],[\"Inhibition of recombinant VEGFR1 (unknown origin) by cell-free assay\"],[\"Binding affinity to TAB3 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of full length human KDM4A A482E mutant assessed as decrease in demethylation of substrate using peptide (ARTKQTARK(Me3)STGGKAPRKQLA-GGKbiotin) as substrate and 0.5 uM 2OG as cosubstrate pre-incubated for 10 mins before substrate addition followed by centrifugation for 1 min and measured after 15 mins by AlphaScreen assay\"],[\"Inhibition of 17beta-HSD1 in human T47D cells assessed as inhibition of transformation of [14C]-estrone into [14C]estrogen at 10 uM after 24 hrs\"],[\"Stimulation of P-gp ATPase activity (unknown origin) assessed as increase in ATP consumption at 0.2 to 1 mM preincubated for 5 mins followed by Mg-ATP addition by P-gp-Glo luminescence assay\"],[\"Antagonist activity at human recombinant H1 histamine receptor at 10'-5 M relative to control\"],[\"Binding affinity to legumain in human Jurkat T cells assessed as protein labeling at 10 uM after 30 mins by SDS-PAGE based affinity blotting\"],[\"Agonist activity at human CB1 receptor expressed in CHO cells assessed as [35S]-GTPgammaS binding preincubated for 25 mins measured after 30 mins by scintillation proximity assay\"],[\"Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of R1881 induced-AR transcriptional activity in AR-positive human 22Rv1 cells harboring ARE14 construct at 10 uM after 24 hrs by luciferase assay relative to control\"],[\"Covalent inhibition of wild type human SCP1 assessed as inhibition constant using Ac-EDLphosphoSPPSPPLPK-NH2 peptide as substrate preincubated for 0.5 to 18 hrs followed by substrate addition by malachite green reagent based assay\"],[\"CSK(h) Millipore kinase panel\"],[\"Inhibition of human ERG expressed in CHO cells at 2.5 uM by patch clamp assay relative to control\"],[\"Inhibition of STLK5 activation loop (unknown origin) at 10 uM\"],[\"Reversal of P-gp-mediated multidrug resistance in human K562\\u002fA02 cells assessed as potentiation of adriamycin-induced cytotoxicity at 20 uM by measuring adriamycin IC50 after 48 hrs by MTT assay\"],[\"Agonist activity at human 5HT2A expressed in HEK293 cells at 10 uM by calcium mobilization assay\"],[\"Displacement of NO711 from mouse GAT1 expressed in HEK293 cells by LC-MS\\u002fMS analysis\"],[\"Inhibition of human MetAP2 expressed in Escherichia coli BL21(lambdaDE3) using Met-AMC as substrate at 10 uM incubated for 30 mins prior to substrate addition measured for 15 mins fluorometric analysis\"],[\"Activity for Streptomyces coelicolor A3(2) prenyltransferase assessed as formation of 6-(3,7-Dimethyl-octa-2,6-dienyl)-5,7-dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one\"],[\"Inhibition of transactivation of human VDR in COS7 cells\"],[\"Displacement of [3H]AVP from human recombinant V1a receptor expressed in CHO cells at 1 uM\"],[\"Inhibition of human cSrc in COS7 cells by ELISA\"],[\"Inhibition of FGFR2 (unknown origin) at 1 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA\"],[\"Inhibition of Mycobacterium tuberculosis recombinant TMPK upto 2 mM\"],[\"Binding affinity to full length human DYRK1B (M1 to S629 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 10 uM by Kinomescan method relative to control\"],[\"In vitro inhibitory concentration against Butyrylcholinesterase of horse serum; value ranges from 1.00-1.20\"],[\"Binding affinity to rat brain alpha7 nAChR\"],[\"Inhibition of CNKSR1 in human NCI-H1573 cells expressing mutant KRAS assessed as reduction in EGFR phosphorylation at 3 to 10 uM incubated for 24 hrs\"],[\"Displacement of [3H]methyllycaconitine from alpha7 nAChR in tsA201 cells co-expressed with Ric3\"],[\"Displacement of [3H] dexamethasone from full length human recombinant glucocorticoid receptor expressed in insect cells at 10 uM after 24 hrs by scintillation counting method relative to control\"],[\"Displacement of Dexamethasone from human mineralocorticoid receptor by fluorescence polarization assay\"],[\"Inhibition of Aurora kinase B in human HCT116 cells assessed as reduced phosphorylated histone H3 levels by Western blot\"],[\"Agonist activity at mu opioid receptor in guinea pig ileum assessed as inhibition of electrically stimulated muscle contraction\"],[\"Inhibition of LRS-mediated mTORC1 activation in HEK293 cells assessed as decrease in leucine-induced S6K phosphorylation at T389 at 200 uM treated prior to leucine induction measured after 10 mins by Western blot method\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation assessed as normalized fluorescence intensity at 5 to 20 uM after 48 hrs by Thioflavin T based fluorometric assay\"],[\"TYK2(h) Eurofins Kinase panel\"],[\"Cytotoxic conc. which reduces the cell viability of HIV-1 LAI infected T4 lymphoblastoid CEM-SS cells by 50%\"],[\"Inhibition of recombinant human SLK (1 to 373 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of aurora A (unknown origin)\"],[\"Inhibition of DNA topoisomerase-1 in human T47D cells assessed as decrease in free topoisomerase-1 levels incubated for 2 hrs by band depletion assay\"],[\"Agonist activity at human delta opioid receptor expressed in HEK293 cells assessed as induction of intracellular calcium release by FLIPR assay\"],[\"Binding affinity to human sst5 receptor\"],[\"Concentration that causes 50% inhibition of mammalian alpha-mannosidase (golgi I) was determined in rat liver; NI is less than 50 % inhibition at 1000 uM\"],[\"Inhibition of plasma clot-bound thrombin (unknown origin) using S2238 as substrate\"],[\"Inhibition of mouse GAT3-mediated [3H]GABA uptake expressed in human HEK cells assessed as specific binding remaining at 1 mM\"],[\"Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced iNOS activity incubated for 30 mins prior to LPS challenge measured after 24 hrs by Griess assay\"],[\"Inhibition of recombinant Anopheles gambiae AChE1 G122S mutant expressed in sf9 insect cells using acetylthiocholine iodide as substrate measured over 60 secs by Ellman assay\"],[\"TRPM6 DiscoveRx kinase panel\"],[\"Binding affinity to human BTK at 10 uM relative to control\"],[\"Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay\"],[\"Displacement of [3H]GR125743 from human 5HT1D receptor at 10 uM\"],[\"Partial inhibition of human topoisomerase 2alpha-mediated relaxation of supercoiled pBR322 plasmid DNA at 25 uM after 15 mins using ethidium bromide staining by agarose-gel electrophoresis\"],[\"Inhibition of KRAS in human MCF7 cells assessed as reduction in ERK1\\u002f2 137F5 protein level at 35 uM measured after 24 hrs by Western blot analysis relative to control\"],[\"Inhibition of VEGFR2 in mouse BAF3 cells\"],[\"Binding affinity to amyloid beta (1-42) plaque in brain of patient with Alzheimer's disease at 185 KBq\\u002f100ul after 1 hr by immunofluorescence staining method\"],[\"Displacement of [3H]CGS21680 from adenosine A1 receptor in bovine striatum membrane\"],[\"Inhibition of Aeromonas hydrophila CphA using fluorogenic cephalosporin as substrate\"],[\"Competitive inhibition of N-terminal His6-tagged KAT8 catalytic domain (125 to 458 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as apparent Vmax for histone substrate at 10 uM using preincubated for 5 mins followed by varying levels of histone substrate addition measured after 15 mins in presence of AC-CoA by Michaelis-Menten plot analysis (Rvb = 11 +\\u002f- 0.5 pmol\\u002fmin)\"],[\"Agonistic activity towards Opioid receptor kappa 1 was determined in [35S]GTP-gamma-S, binding assay in guinea pig caudate; g = not active as an agonist\"],[\"Neutrophil elastase 2 (h) Protease assay\"],[\"Binding affinity to WDR5 (unknown origin) by isothermal titration calorimetry assay\"],[\"Inhibitory constant against human deoxyuridine 5'-triphosphate nucleotidohydrolase expressed in Escherichia coli BL21 (DE3) cells\"],[\"Hill coefficient, slope factors of reduction in dissociation rate of [3H]NMS from M2 receptor of pig heart\"],[\"Percent inhibition of Escherichia coli thymidylate synthase activity (a)\"],[\"Inhibition of recombinant human His6-tagged SIRT3 using H2N-HK-[Nepsilon-acetyl-lysine]-LM-COOH as substrate incubated for 10 mins in presence of beta-NAD+ by HPLC based assay\"],[\"In vitro inhibition of Prostaglandin G\\u002fH synthase 2 from sheep placental cotyledons; No activity\"],[\"Binding affinity to human recombinant adenosine 2a receptor\"],[\"Inhibition of human recombinant full-length PKCa expressed in insect Sf21 cells at 1 uM using histone H1 as substrate after 30 mins\"],[\"Inhibition of human chymase after 1 hr by fluorometric assay\"],[\"Agonist activity at human TRPA1 in WI38 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay\"],[\"Positive allosteric modulation of GABAA alpha3 (unknown origin)\"],[\"Inhibition of rat brain cortex AChE using acetylthiocholine iodide as substrate incubated for 15 mins by spectrophotometry\"],[\"Binding affinity to recombinant human EGFR L858R\\u002fT790M mutant kinase domain assessed as fluorescent band formation at 2 uM pretreated with compound followed by subsequent addition of copper-catalyzed azide-alkyne cyclo with rhodamine azide measured after 72 hrs by coomassie brilliant blue staining based in-gel fluorescence assay\"],[\"Inhibition of human MLK3 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Binding affinity to human EP1\"],[\"Inhibition of human recombinant PLK1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Inhibition of beta-glucuronidase (unknown origin) at 10 mg\\u002fml relative to control\"],[\"Inhibition of 5-lipoxygenase activity in human whole blood assay; not tested\"],[\"Inhibition of human CAMK2B assessed as residual activity at 100 uM using KKALRRQETVDAL as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant wild type HIV-1 reverse transcriptase p66\\u002fp51 using poly(rA)\\u002foligo(dT)16 as template\\u002fprimer after 40 mins by ELISA\"],[\"Protection against stimulated ischemia in chick cardiomyocytes transfected with human adenosine A3 receptor measured as percent of killed cells\"],[\"Inhibition of recombinant human His6-tagged BRD4 bromodomain 2 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells preincubated for 30 mins followed by HSGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRK(Biotin)-OH peptide substrate addition after 30 mins by alphascreen assay\"],[\"Displacement of [3H]DPCPX from adenosine A1 receptor in human HeLa cells at 100 uM by whole cell binding assay\"],[\"5-HT2B (h) CEREP ligand profiling\"],[\"Inhibition of purified human SARM1 TIR domain (561 to 724 residues) using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 1 hr\"],[\"Agonist activity at TLR2 in mouse BV2 cells assessed as increase in IL-6 secretion at 2 uM incubated for 24 hrs by ELISA\"],[\"Inhibition of FGFR4 in FGF19-stimulated human Huh-7 cells assessed as MEK1\\u002f2 S217\\u002fS221 phosphorylation level incubated for 30 mins and measured at 1 hrs after compound wash out by Western blot analysis (Rvb = 1 No_unit)\"],[\"Inhibition of human recombinant full length CA6 by stopped-flow CO2 hydration method\"],[\"Activation of human STING expressed in human PBMC cells assessed as phosphorylation at (ser366) at 10 uM incubated for 2 hrs and measured by Western blot analysis\"],[\"Inhibition of N-terminal His6-tagged recombinant human ROCK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of human recombinant ICAM-1 adhesion into human Jurkat cells after 1 hr\"],[\"Inhibition of PKBalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control\"],[\"Inhibitory activity against 5-hydroxytryptamine 4 receptor in guinea pig\"],[\"Binding affinity to human KIT (I571 to D952 residues) V559D\\u002fT670I double mutant expressed in bacterial expression system by KINOMEscan assay\"],[\"Inhibition of human recombinant 5-lipoxygenase expressed in Escherichia coli MV1190 assessed as residual activity at 10 uM by cell free assay\"],[\"Inhibition of CYP51 in Candida albicans ATCC SC5314 assessed as ergosterol content at 0.125 ug\\u002fml by GS-MS analysis relative to total sterols (Rvb = 98.7%)\"],[\"Displacement of [3H]-Ketanserin from recombinant human 5-HT2A receptor at 10'-7 M after 60 mins by radiometric scintillation counting analysis relative to control\"],[\"Inhibition of papaya papain at 60 uM\"],[\"Inhibition of recombinant human full length SAPK4 assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"In vitro binding affinity towards cloned human 5-HT6 receptor using [3H]5-carboximidotryptamine as radioligand\"],[\"Displacement of [3H]SR141716A from full-length recombinant human CB1 receptor expressed in human Chem1 cells at 10 uM measured after 60 mins by scintillation counting method relative to control\"],[\"Binding affinity to NRP1 in HUVEC assessed as ratio of phosphorylated ERK to total ERK at 50 uM by Western blot analysis\"],[\"Inhibition of human factor 10a by spectrometry\"],[\"Inhibition of human recombinant microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells using p-tyramine as substrate assessed as production of H2O2 incubated for 15 mins followed by substrate addition measured over 15 mins by fluorimetric analysis\"],[\"Non-competitive inhibition of human recombinant PTP-1B expressed in Escherichia coli TB1 using p-nitrophenyl phosphate as substrate\"],[\"Inhibition of human TLK1 using histone H3 as substrate\"],[\"Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 25 uM preincubated for 10 mins\"],[\"Inhibition of recombinant TBK1 (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Binding affinity to human galectin-8 C terminal domain assessed as dissociation constant measured up to 1500 uM by competitive fluorescence polarization assay\"],[\"Non competitive inhibition of rat recombinant NAAA expressed in HEK293 cells assessed per mg of protein at 100 nM by Michaelis-Menten equation analysis\"],[\"Antagonist activity at human recombinant NOP expressed in CHO cells by [35S]GTPgammaS binding assay\"],[\"Inhibition of HPK1 (unknown origin) at 1 uM relative to control\"],[\"Displacement of radiolabeled endothelin-1 from human endothelin ETA receptor\"],[\"Inhibition of human IGF1R catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of EPH-A4 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of NEK2 (unknown origin) in presence of ATP\"],[\"Reactivation of DFP-inhibited Electrophorus electricus (electric eel) acetylcholinesterase using acetylthiocholine iodide as substrate at 1 mM incubated at 15 min post DFP-inhibition for 10 min by Ellman method\"],[\"Inhibition of c-Kit (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay\"],[\"Binding affinity against Opioid receptor mu 1 from rat brain membranes using [3H]-DAMGO; No value available\"],[\"NACH\\u002fH Eurofins-Panlabs selectivity data (BI)\"],[\"Inhibition of human PAK3 assessed as residual activity at 100 uM using RRRLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells using p-tyramine as substrate preincubated for 30 mins followed by substrate addition and measured after 1 hr by fluorimetric analysis\"],[\"Competitive antagonist activity at human RXRB\\u002fRXRB expressed in African green monkey COS7 cells assessed as reduction in bexarotene-induced receptor activation at 1 uM by RXRE-dependent luciferase reporter gene assay\"],[\"Inhibition of recombinant firefly luciferase activity expressed in U87 cells at 10 uM after 48 hrs\"],[\"Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) aggregation after 1 hr by transmission electron microscopic method\"],[\"Inhibition of c-Met (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA\"],[\"Inhibition of 5-HT2A receptor (unknown origin) at 10 uM relative to control\"],[\"Effect on basal ATPase hydrolysis of recombinant mouse MDR3 expressed in Pichia pastoris measured after 30 mins in presence of NADH by coupled enzyme assay (Rvb = 100 +\\u002f- 7 %)\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged GSK3B (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human HDAC8 using Boc-Lys(tri-fluoracetyl)-AMC as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by colorimetric assay\"],[\"Intrinsic activity at human MT2 receptor expressed in CHO cell membranes after 1 hr by [35S]GTPgammaS binding assay relative to control\"],[\"Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system measured after 1 hr by Kinomescan method\"],[\"Time-dependent irreversible inhibition of N-terminal His-tagged PPM1A (unknown origin) expressed in Escherichia coli BL21 (DE3) cells at 80 uM preincubated with enzyme followed by p-nitrophenyl phosphate substrate addition\"],[\"Inhibition of human phosphodiesterase 9\"],[\"Agonist activity at Chilo suppressalis (rice stem borer) tyramine receptor TyR1 expressed in HEK293 cells assessed as reduction in forskolin-induced cAMP accumulation at \\u003c 1 umol incubated for 20 min\"],[\"Fixed inhibition of human carboxylesterase 2 using 4-benzoyl-N-butyl-1,8-naphthalimide as substrate by Dixon and Lineweaver-Burk plot analysis\"],[\"Inhibition of STARD3 in human MDA-MB-231 cells assessed as increase in FAK protein level at 100 uM incubated for 48 hrs by Western blot analysis\"],[\"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant human Trap-1 after 24 hrs by fluorescence polarization assay\"],[\"Inhibition of LCK (unknown origin) by microfluidic mobility shift assay\"],[\"Displacement of [3H]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells by liquid scintillation counting\"],[\"Inhibition of SETD8 (unknown origin) catalytic domain expressed in Escherichia coli by SPR assay\"],[\"Inhibition of ABCC1 in human H69AR cells at 10 uM preincubated for 30 mins before calcein AM addition by calcein AM assay relative to CsA\"],[\"Inhibition of palmitoyl-CoA oxidation in rat heart mitochondria\"],[\"Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control\"],[\"Inhibition of recombinant human FLT3 expressed in insect Sf21 cells preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay\"],[\"Inhibition of recombinant human 6His-tagged ALDH1A2 expressed in Escherichia coli BL21(DE3) at 25 uM using acetaldehyde as substrate measured for 30 mins by spectrometric assay relative to control\"],[\"Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA\\u002fTime-resolved fluorimetry\"],[\"Activation of human ERbeta assessed as induction of transcriptional activation incubated for 24 hrs in presence of 100 uM H2O2 by luciferase reporter gene assay\"],[\"Competitive binding affinity to MALT1 in wild type human Jurkat cell lysate assessed as PMA\\u002fionomycin stimulated ABP labeling by protein-compound adduct formation at 3 uM pretreated with 25 uM of MALT1 inhibitor z-VRPR-FMK for 2 hrs followed by PMA\\u002fionomycin stimulation for 30 mins and subsequent compound addition measured after 3 hrs by Western blot analysis\"],[\"Induction of p53-mediated p21 expression in human A549 cells after 24 hrs by Western blot analysis\"],[\"Inhibition of bovine xanthine oxidase assessed as inhibition of uric acid formation after 30 mins by spectrophotometry\"],[\"CDK4(CDK4CGS1) Takeda global kinase panel\"],[\"Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay\"],[\"Inhibition of Ezh1 (unknown origin) preincubated for 15 mins followed by addition of substrate measured after 1 hr by AlphaLISA assay\"],[\"Inhibition of IDO1 in mouse B16F1 cells assessed as CD4+\\u002fCD25+\\u002fFoxp3+ regulatory T cells level at 3 uM by flow cytometry (Rvb = 14.7%)\"],[\"Agonist activity at PPARdelta (unknown origin) at 1 uM by luciferase reporter gene assay\"],[\"Displacement of [3H]ZM241385\\u002f[125I]IABOPX from recombinant human A2B adenosine receptor expressed in HEK293 cell membranes measured after 3 hrs\"],[\"Inhibition of NFkappa p50 isolated from nuclear extract of human HeLa cells assessed as blockade of binding to biotinylated consesus sequence by chemiluminescence assay\"],[\"Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA\"],[\"MKK7 DiscoveRx kinase panel\"],[\"Transactivation of glucocorticoid receptor in human SKGT4 cells after 16 hrs by luciferase reporter gene assay\"],[\"Displacement of radiolabeled 4DAMP from human muscarinic M4 receptor\"],[\"Inhibition of human IRAK4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of SRC kinase at 10 uM\"],[\"Displacement of [3H]-5-CT from 5-HT7 receptor in rat cerebral cortex homogenates after 30 mins by liquid scintillation counting\"],[\"Displacement of GDP-BODIPY from C-terminal 6His-tagged BTN3A1 full interaction domain (unknown origin) expressed in Escherichia coli BL21 (DE) at pH 6 to 9 measured after 60 mins by fluorescence polarization assay\"],[\"Inhibition of ThRS in human UMSCC14A cells assessed as increase in cleaved PARP level at 5 uM after 8 to 36 hrs by immunoblot analysis\"],[\"Inhibition of KRAS G12C mutant in human NCI-H358 cells assessed as reduction in ERK phosphorylation measured after 3 hrs by Western blot analysis\"],[\"Inhibition of human FES assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human erythrocyte 20s proteasome trypsin-like activity using Boc-LRR-MCA as substrate pretreated for 10 mins followed by substrate addition measured after 3 hrs by spectrophotometric method\"],[\"Inhibition of EPH-B1 (unknown origin) at 1 uM relative to control\"],[\"Inhibitory activity against binding of rat Gonadotropin-releasing hormone receptor using [125I]buserelin at 10 uM\"],[\"Inhibition of human partial length EGFR L861Q mutant (R669 to V1011 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of full length LSD1 (unknown origin) using H3K4me1 as substrate incubated for 30 mins followed by substrate addition measured after 60 mins in presence of FAD by LC-MS analysis\"],[\"Displacement of [3H]WIN-552122 from human recombinant CB2 receptor expressed in CHOK1 cells\"],[\"Inhibition of human MEK3 at 100 nM using p38alpha as substrate by [gamma-33P]-ATP assay\"],[\"Binding constant for PRKR kinase domain\"],[\"NanoBRET (SGC Frankfurt) (FLT3)\"],[\"Displacement of [3H]CP55960 from human cloned CB2 receptor after 60 mins by scintillation spectroscopy\"],[\"Inhibition of Akt phosphorylation in human HBL cells at 0.1 to 10 uM after 24 to 48 hrs by Western blot analysis\"],[\"Inhibition of human recombinant PARP3 at 10 uM incubated for 1 hr using using NAD+, biotinylated NAD+ and activated DNA by luminescence based assay\"],[\"Effect on caspase 8 activation to initiate apoptosis in A549 human lung cancer cell line\"],[\"Inhibition of HDAC6 in human SEM cells assessed as increase in acetyl-histone H3 expression at 0.1 to 10 uM after 24 hrs by immunoblot assay\"],[\"Agonist activity at recombinant human GPR84 expressed in HEK293 cells co-expressing Gqi5 assessed as increase in myo-[3H]inositol phosphate accumulation measured after 2 hrs by topcount scintillation counting method\"],[\"SST4_HU Cerep selectivity data (BI)\"],[\"Inhibition of 15-LOX-1 in mouse HT22 cells assessed as protection against glutamate-induced cell death by measuring increase in cell viability up to 20 uM cotreated with glutamate for 14 to 16 hrs by MTT assay\"],[\"CASPASE8_CE Eurofins SafetyScreen44 (BI)\"],[\"Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by spectrophotometric analysis\"],[\"Inhibition of CLK1 (unknown origin) at 1 uM\"],[\"Binding affinity to wild-type human full length CLK1 (M1 to I484 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Activation of Nrf2 in human BEAS2B cells harboring Keap1-C288S mutant assessed as increase in Nrf2 protein expression at 2.5 uM after12 hrs in presence of Keap1-siRNA by immunoblot analysis\"],[\"Inhibition of human JNK1-alpha-1 at 10 uM\"],[\"Concentration required for its inhibitory activity against Escherichia coli K12(PSE4) class A beta-lactamase; Not tested\"],[\"Displacement of [125I]AB-MECA from human Adenosine A3 receptor expressed in HEK293 cell membrane\"],[\"Inhibition of HIF-PHD2 (181 to 426 residues) (unknown origin) using FITC-HIF1-alpha (556 to 574 residues) as substrate after 60 mins by fluorescence polarization assay\"],[\"Inhibition of TCPTP (unknown origin) assessed as hydrolysis of pNPP to pNP after 30 mins\"],[\"Inhibition of human placental Cytochrome P450 19A1\"],[\"Displacement of [3H]-SCH- 58261 from human adenosine A2A receptor expressed in CHO cells; range 880-1682\"],[\"Inhibition of PIK3C3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"Displacement of Kinase tracer 236 from biotinylated DYRK1A (unknown origin) expressed in Escherichia coli BL21 (DE3) incubated for 1.5 hrs by TR-FRET assay\"],[\"Binding affinity to human EGFR S752-I759 deletion mutant expressed in bacterial system assessed as control score at 1 uM by KINOMEScan assay\"],[\"Ex vivo inhibition of MCH-ADO binding to Melanin concentrating hormone receptor 1 in mice (n=3) 24 hr r after 30 mg\\u002fkg peroral dose\"],[\"Inhibitory activity against trypanothione reductase from Trypanosoma cruzi using 0.12 mM TSST substrate\"],[\"Inhibition of human topoisomerase 1 assessed as stability of enzyme-pBr322 plasmid DNA covalent binary complex at 20 uM after 60 mins by electrophoretic assay\"],[\"Inhibition of EPHB1 (unknown origin) at 0.49 uM relative to control\"],[\"Inhibition of human CYP2A6 in baculovirus-infected insect cell system using coumarin 7 as substrate incubated for 30 mins prior to substrate addition measured after 10 mins by fluorescence assay\"],[\"Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Opioid receptor kappa affinity, determined with [3H]etorphine in the presence of excess unlabeled [D-Ala2-MePhe4-Glyol5]-enkephalin\"],[\"Inhibition of human serotonin transporter at 10 uM relative to control\"],[\"Binding constant for PAK6 kinase domain\"],[\"Competitive inhibition of human GAT1 expressed in COS cells assessed as reduction in [2H6]GABA uptake by measuring [2H6]GABA Bmax at 1 uM preincubated for 25 mins followed by [2H6]GABA addition and measured after 4 mins by liquid scintillation counting method (Rvb = 79.5 +\\u002f- 5 pmol\\u002fmg)\"],[\"Inhibition of NEK6 (unknown origin) at 0.49 uM relative to control\"],[\"Binding affinity to wild-type human partial length IRAK1 (R194 to S712 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of ELAV1 (unknown origin)-ARE TNFalpha complex formation after 90 mins by AlphaScreen assay\"],[\"Inhibition of mTOR in human MDA-MB-231 cells assessed as eEF2 hyperphosphorylation on Ser 56 at 0.1 to 1 uM after 30 mins by Western blotting\"],[\"Inhibition of BCRP in 7 mW\\u002fcm'2 irradiated human M14 cells assessed as reduction in ATPase activity at 5 uM measured after 20 mins in presence of doxorubicin by immunoblotting\"],[\"Intrinsic activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production\"],[\"Inhibition of recombinant human His-tagged full length RSK2 expressed in baculovirus expression system using Ser\\u002fThr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of Tek at 10 uM\"],[\"Inhibition of Lyp in antiCD3-antibody-stimulated human JTAg cells assessed as increase in TCR-induced LCK Y394 phosphorylation in presence of Lyp siRNA by immunoblotting method\"],[\"Inhibition of human MAPKAPK5 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of human HGK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of antagonist activity towards Androgen receptor\"],[\"Inhibition of human recombinant full length N-terminal GST-tagged PDE4B1 expressed in baculovirus infected Sf9 cells at 10'-5.5 M using cAMP as substrate incubated for 20 mins followed by substrate addition by luciferase assay relative to control\"],[\"Inhibition MMP-9 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay\"],[\"Inhibition of His-tagged human JNK1a1\\u002fSAPK1c expressed in Escherichia coli at 1 uM\"],[\"Agonist activity at human TAS2R5 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay\"],[\"Displacement of [125I]-His5, D-Tyr6]GnRH from mutant GnRHR, GnRHR E295K\"],[\"Inhibition of human recombinant carboxylesterase 2 after 5 mins\"],[\"Binding affinity determined on Opioid receptor mu 1 in Guinea pig brain membranes using radioligand [3H]DAMGO.\"],[\"Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay\"],[\"In vitro inhibitory concentration against human Microsomal triglyceride transfer protein\"],[\"Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system by Kinomescan method\"],[\"Inhibition of HER2 (unknown origin) expressed in human BT474 cells assessed as reduction in AKT phosphorylation at 0.001 to 10 uM incubated for 2 hrs by Western blot method\"],[\"Inhibition of EphB4 at 10 uM\"],[\"Inhibitory activity against SERT upto 10 uM\"],[\"mu (h) CEREP panel\"],[\"Inhibition of CHK1 (unknown origin) at 500 nM relative to control\"],[\"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay\"],[\"Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells\"],[\"Inhibition of HSP1 activity in human NCI-H460 cells assessed as reduction of HSP1 protein expression at 20 uM by Western blot analysis\"],[\"Inhibition of human factor 10a using N-benzoyl-Ile-Glu-(OH, OMe)-Gly-Arg-pNA as substrate at 25 degC after 10 to 120 mins by spectrophotometric method\"],[\"Corrector activity at CFTR F508del mutant (unknown origin) expressed in human CFBE41o cells assessed as increase in size of cAMP-dependent current at 1 uM after 24 hrs measured at +100 mV by whole cell patch clamp assay\"],[\"Agonist activity at glucocorticoid receptor in HFF assessed as inhibition of IL1-induced IL-6 production after 18 to 24 hrs relative to Dexamethasone\"],[\"Inhibition of HIV1 reverse transcriptase up to 100 uM by ELISA\"],[\"Inhibition of porcine brain microtubule-stimulated human recombinant GST-tagged Eg5 ATPase activity at 1 mM by microplate reader in presence of Mg2+ ATP relative to control\"],[\"Binding affinity to human HIPk4\"],[\"Induction of p53 stabilization in human p53 +\\u002f+ HCT116 cells assessed as increase in MDM2 level at 5 uM after 24 hrs by immunoblot analysis\"],[\"Inhibition of PDE7B (unknown origin)\"],[\"Inhibition of full-length recombinant human DAPK2 at 10 uM using calmodulin as substrate after 40 mins by in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Activity at human CFTR F508 deletion mutant expressed in FRT cells assessed as maximal increase in iodine influx after 16 to 20 hrs by fluorescence assay\"],[\"Binding affinity to CAPZA1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Activity at oxytocin receptor in rat uterus\"],[\"Inhibition of recombinant wild type HIV1 p66\\u002fp51 using poly(rA) template\\u002foligo(dT)16 primer after 40 mins by PicoGreen-based spectrofluorometric method\"],[\"Inhibition of human GAT1 expressed in tcA201 cells assessed as inhibition of [3H]GABA uptake at 1 mM after 3 mins by scintillation counting\"],[\"Inhibition of human LCK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of MITF in mouse B16F10 cells assessed as inhibition of alpha-MSH-induced tyrosinase protein expression after 48 hrs by Western blotting analysis\"],[\"Inhibition of human recombinant GRK2 by LANCE assay\"],[\"Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS at 100 uM using ARTKQTARKSTGGKA as substrate preincubated for 5 mins followed by substrate\\u002fSAM addition measured after 60 mins by MALDI-TOF MS analysis\"],[\"Binding affinity to human 6xHis-tagged PPARgamma ligand binding domain (206 to 477 residues) by TR-FRET assay\"],[\"Modulation of [3H]Spiroperidol\\u002fN-Propylnorapomorphine binding to dopamine D2 receptor in bovine striatal membranes incubated for 1 hr by Cheng-Prusoff analysis\"],[\"Inhibition of p38alpha (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Agonist activity at human 5HT3 receptor assessed as change in intracellular calcium level at \\u003c5 uM by fluorescence assay\"],[\"Inhibition of HPK1 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Binding affinity to biotinylated TRIM28 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis\"],[\"Delta TM value showing the stabilisation of CHEK2 produced by compound binding\"],[\"In vitro agonistic activity against opioid receptor delta of mouse vas deferens\"],[\"Inhibition of recombinant N-terminal GST tagged and C-terminal His-tagged human PDE7B (109-ens aa) expressed in Sf9 cells using FAM-cAMP as substrate at 1xIC50 incubated for 60 mins by fluorescence plate reader analysis\"],[\"Inhibition of CDK3 (unknown origin) at 0.164 uM relative to control\"],[\"In vitro inhibitory activity towards ACAT by the displacement of [1-14C]oleolyl-CoA from the small intestine of cholesterol-fed rabbits\"],[\"Competitive binding affinity to partial length wild type human TAOK1 expressed in mammalian expression system at 10 uM by kinomescan method relative to control\"],[\"Reversal of Pgp-1-mediated multidrug resistance in human HEK293 cells assessed as potentiation of paclitaxel cytotoxicity at 10 uM treated for 2 hrs prior to paclitaxel challenge measured after 72 hrs by MTT assay relative to paclitaxel alone-treated control\"],[\"Displacement of [3H]DAMGO from rat cortical MOR by liquid scintillation counting method\"],[\"Reversible inhibition of human recombinant MAO-A using kynuramine substrate assessed as enzyme activity recovered at 4 times of IC50 concentration incubated for 15 mins and subsequently dialyzed for 24 hrs relative to control in presence of pargyline\"],[\"Inhibition of EHMT2 (unknown origin) at 10 uM relative to control\"],[\"Inhibition of ER beta-mediated transactivation of ERE in HeLa cell luciferase assay at 10 uM\"],[\"Non-competitive inhibition of human recombinant MAGL assessed as 7-hydroxycoumarin level using umbelliferyl arachidonate as substrate by luminescence spectrophotometer\"],[\"Inhibition of Escherichia coli beta-galactosidase assessed as substrate hydrolysis at 1 mg\\u002fml after 15 mins by competitive binding assay in presence of ONPG\"],[\"Inhibition of human CYP21 transfected in HEK293 cells assessed as decrease in conversion of progesterone to 11-deoxycorticosterone preincubated for 5 hrs followed by progesterone addition measured after 20 hrs by ELISA\"],[\"Inhibition of recombinant human FGFR4\"],[\"Activation of human beta-galactosidase R201C mutant expressed in mouse fibroblasts using 4-methylumbelliferone -conugated beta-D-galactoside as substrate at 0.2 uM preincubated for 48 hrs followed by substrate addition measured after 30 mins by fluorescence analysis relative to control\"],[\"Activation of NAE1 in human MGC-803 cells assessed as downregulation of YAP\\u002fTAZ level at 3 uM measured after 48 hrs in the presence of proteosome inhibitor, MG132 by western blot analysis\"],[\"Inhibition of PHD2 catalytic domain (unknown origin) after 24 hrs by alphascreen assay\"],[\"Inhibition of PAK2\"],[\"Inhibition of recombinant human GST-tagged EGFR (668 to 1210 residues) T790M\\u002fL858R double mutant expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay\"],[\"Displacement of S0586[K4]hpp from human NPY4 receptor expressed in CHO cells co-expressing Gqi5-mtAEQ by flow cytometric analysis\"],[\"Upregulation of Bcl-2 phosphorylation at Ser70 residue in human MDA-MB-231 cells at 0.1 microM incubated for 12 to 36 hrs by western blot analysis\"],[\"Inhibition of IKK alpha\"],[\"Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 1 uM by lantha screen kinase binding assay relative to control\"],[\"Inhibition of human ROMK1 channel expressed in CHO cells coexpressing DHFR assessed as inhibition of 86Rb+ efflux after 35 mins by TopCount method\"],[\"Inhibition of Enterococcus faecium VanA at 500 uM by pyruvate kinase\\u002flactate dehydrogenase coupled assay\"],[\"Ratio of EC50 for human 5HT2C receptor by calcium fiux-based fluorescence assay to EC50 for 5HT2A by IP1 accumulation-based TR-FRET assay\"],[\"Inhibition of His6-tagged PHGDH (unknown origin) expressed in Escherichia coli BL21 assessed as effect on NADH fluorescence pre-incubated for 30 mins before 3-PG substrate addition in presence of NAD+ and PSAT1 by diaphorase and resazurin dye based fluorescence assay\"],[\"Binding affinity to human TNFalpha assessed as sedimentation coefficient (S) value at 25 uM in presence of TNFR1 by ultracentrifugation analysis (Rvb = 3.5 No_unit)\"],[\"Inhibition of recombinant human DPP-4 assessed as H-Gly-Pro-AMC cleavage after 1 hr by fluorescence assay\"],[\"Inhibition of HDAC3 in human HeLa-S3 cell lysates assessed as remaining activity at 2 x 10'-6 M preincubated for 15 mins followed by HDAC-Glo substrate addition measured after 30 to 40 mins by fluorimetric method relative to control\"],[\"Inhibition of fluorescein-labelled VER160364 binding to PDHK2 (unknown origin) after 90 mins by fluorescence polarization assay\"],[\"Inhibition of EGFR phosphorylation in human SW1990 cells at 50 and 100 uM by immunofluorescence assay\"],[\"Inhibitory concentration of the PPAR gamma)\"],[\"Inhibition of EGFR L858R\\u002fT790M\\u002fC797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme and ATP at 10XKm for 3 hrs followed by substrate addition and measured after 1 hr by TR-FRET assay\"],[\"Inhibition of AKT phosphorylation in mouse Neuro2a cells at 8 ug\\u002fml after 24 hrs by Western blot analysis relative to beta-actin\"],[\"Binding affinity to activated Erk2 (unknown origin) by TdF assay\"],[\"Binding Assay: Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 287, 644-650, with membranes derived either from rodent tissues or from recombinant cell lines in which the human CB2 receptors were expressed (Munro et al., Nature 1993, 365, 61-65). The affinity of the compounds is expressed in the form of the IC50 (concentration causing 50% inhibition of specific binding of the tritiated ligand used in vitro).\"],[\"Inhibition of human recombinant MAOB expressed in Pichia pastoris assessed as fluoride ion release by ion-selective electrode experiment\"],[\"Inhibition of human recombinant MAO-A expressed in baculovirus-infected insect cells using p-tyraimne substrate\"],[\"Binding affinity to Penicillium digitatum recombinant N-terminal-His6 tagged CYP51 expressed in Escherichia coli BL21(DE3) by spectrophotometric analysis\"],[\"Inhibition of serotonin transporter (unknown origin)\"],[\"Inhibition of human recombinant MAO-B expressed in baculovirus infected BTI cells using tyramine as substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by peroxidase coupled enzyme assay\"],[\"Agonist activity at human RXRalpha expressed in HEK293 cells by luciferase reporter gene assay\"],[\"Inhibition of full length human N-terminal GST-tagged ITK (2 to 620 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control\"],[\"Inhibition of SHP2 (unknown origin) at 25 uM\"],[\"Inhibition of RSK1 domain 1 Lysine 2 labelling site (unknown origin) at 10 uM\"],[\"Inhibition of human neutrophil elastase using MeOSuc-AAPV-MCA as substrate at pH 7.2 and 298 K measured every 60 secs for 600 secs\"],[\"Inhibition of human recombinant HGF-mediated cMet phosphorylation in human PC3 cells\"],[\"Inhibition of eNOS (unknown origin)\"],[\"Inhibition of HT-01 probe binding to recombinant mouse DAGLbeta expressed in HEK293T cell membrane proteomes preincubated for 30 mins followed by HT-01 probe addition measured after 30 mins by gel-based competitive activity based protein profiling assay\"],[\"Inhibition of HDAC6 in human A549 cells assessed as induction of tubulin acetylation at 15 to 54 nM after 24 hrs by Western blotting analysis\"],[\"In vitro inhibitory concentration against ovine Cyclooxygenase-1\"],[\"KinomeScan assay: inhibition of ABL1(T315I)-phosphorylated\"],[\"Agonist activity at human RoRc-LBD in human PBMC cells assessed as inhibition of IL-17A production at 10 uM by luciferase assay\"],[\"Binding affinity to full length human CDK7 (1 to 344 residues) expressed in mammalian expression system by KINOMEscan competition assay\"],[\"Inhibition of human kidney SGLT2 expressed in CHOK1 cells assessed as decrease in [14C]-AMG uptake preincubated for 10 mins followed by [14C]-AMG addition and measured after 2 hrs by TopCount method\"],[\"Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 min\"],[\"Binding affinity to human serum albumin by HPLC method\"],[\"Inhibition of Phosphodiesterase 5 from human platelets\"],[\"Inhibition of human wild type partial length EPHA1 (V588 to I913 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control\"],[\"Inhibition of recombinant human ALK2 (147 to end residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of human PI3Kalpha by TR-FRET based Adapta assay\"],[\"Inhibition of His-tagged FAP1 (unknown origin) expressed in Escherichia coli BL21 cells using para-nitrophenyl phosphate as substrate incubated for 5 to 10 mins by microplate reader based spectrophotometric analysis\"],[\"Activation of ryanodine receptor in human IMR32 cells assessed as induction of calcium mobilization at 100 uM\"],[\"Inhibition of human FGFR3 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Average Binding Constant for PIM1; NA=Not Active at 10 uM\"],[\"Binding affinity for human fibroblast growth factor 1 in surface plasmon resonance (SPR) assay\"],[\"Agonist activity at human recombinant PAC1 receptor expressed in CHO cells assessed as PACAP38-induced calcium mobilization at 1 uM by FLIPR assay relative to PACAP38\"],[\"Inhibition of wild-type human partial length AURKB (D25 to A303 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by Kinomescan method relative to control\"],[\"TAO3(h) Eurofins kinase panel\"],[\"Displacement of [125I]RTI-55 from Dopamine transporter of rat caudate membranes\"],[\"Displacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation counting\"],[\"Inhibition of N-terminal His6-tagged truncated PHD2 (181 to 426 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 using H1F1-alpha NODD as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by mass spectrometry\"],[\"Inhibitory activity of compound dissolved in DMSO was determined against HIV-1 (K103N\\u002fY181C) mutant reverse transcriptase (1-2 nM) by using [3H]-dGTP (71 nM) as substrate, 50 mM Tris\\u002fHCl buffer, pH 7.8, incubated for 1 hr at 37 degrees C\"],[\"Inhibition of TLK1 (unknown origin) at 1 uM\"],[\"Activation of human IR-B expressed in mouse NIH3T3 cells assessed as increase in Akt phosphorylation at Ser473 residue incubated for 30 mins by HTRF method\"],[\"Inhibition of human MLK1 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant FLAG-tagged PKD1 (unknown origin) expressed in HEK293T cells using Syntide-2 as substrate measured after 15 mins by ADP-Glo assay\"],[\"Inhibition of N-terminal His6-tagged KDM4E (1 to 337 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3)-R3 assessed as Km at 1 uM in presence of alpha-KG by Michaelis-Menten analysis (Rvb = 12 uM)\"],[\"Inhibition of telomerase in human HT-29 cells by TRAP assay\"],[\"Competitive binding affinity to EGFR (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of human recombinant sEH expressed in baculovirus infected insect Sf9 cells using cyano(6-methoxynaphthalen-2-yl)methyl trans-[(3-phenyloxiran-2-yl)methyl] carbonate as substrate preincubated for 30 mins followed by substrate addition measured after 20 to 45 mins by fluorescence assay\"],[\"Displacement of specific CP-55940 binding in CHO cells stably transfected with human cannabinoid receptor 2; nd=not determined\"],[\"Inhibition of gamma-crystallin C G129C mutant (unknown origin)-induced intracellular protein aggregation expressed in human HLE-B3 cells at 0.4 uM incubated for 6 to 8 hrs by fluorescence microscopy relative to untreated control\"],[\"Functional cellular assay (HEK cells) (F2R)\"],[\"Inhibition of human PDE8A\"],[\"Inhibition of MLL3 (unknown origin) using biotin-labeled histone substrate assessed as residual activity at 50 uM in presence of [3H-Me]SAM by scintillation proximity assay relative to control\"],[\"Inhibition of MALT1 in human OCI-LY3 cells assessed as reduction in Relb cleavage at 1.25 uM by Western blot analysis\"],[\"Inhibition of Mycobacterium tuberculosis mycothiol disulfide reductase assessed as NADPH oxidation at 800 uM by Ellmans reagent method\"],[\"Inhibition of CK1-alpha1 (unknown origin) assessed as residual activity measured at 1 uM\"],[\"Inhibition of rat GSK3beta expressed in Sf9 cells incubated for 30 mins using GS-1 peptide substrate and [gamma-32P]ATP by scintillation counting method\"],[\"CHRM3 Eurofins SafetyScan (Receptor)\"],[\"Inhibition of ovine COX1 assessed as PGF2alpha production by enzyme immunoassay\"],[\"Displacement of biotinylated ephrin-A1-Fc from mouse EphA3 Fc preincubated for 1 hr followed by ephrin-A1-FC addition and measured after 4 hrs by ELISA\"],[\"Binding affinity to human Clk4 \"],[\"Antagonist activity at LPAR3 in rat glioma C62B cells assessed as inhibition of LPA3 agonist-induced reduction in isoproterenol-stimulated [3H]cAMP accumulation by liquid scintillation counting\"],[\"Inhibition of human wild type Pgp expressed in MDCK2 cells assessed as calcein-AM accumulation at 50 uM after 40 mins\"],[\"Inhibition of PKAP1\"],[\"Inhibitory concentration against [3H]spiperone binding to Dopamine receptor D3 expressed in CHO-K1 cells\"],[\"Inhibition of recombinant full-length human STK32C at 1 uM assessed as residual activity at 1 uM using casein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of human recombinant IDO1 assessed as reduction in kynurenine production incubated fro 15 mins using L-Trp substrate\"],[\"Activation of human glucokinase\"],[\"Inhibitory concentration against dihydrofolate reductase of Mycobacterium avium\"],[\"Inhibition of beta3 tubulin overexpressed in human HeLa cells after 48 hrs by SRB assay\"],[\"Inhibition of human EPHA7 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of c-Kit (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay\"],[\"Binding affinity to wild-type human partial length S6K1 (M1 to S421 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of P70S6K (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of wild-type human partial length PKMYT1 (A88 to G366 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Displacement of [3H]-dihydroalprenolol from human beta2-adrenoceptor expressed in HEK cells after 4 hrs\"],[\"Binding affinity to wild-type TTR (unknown origin) assessed as induction of chemical shift at R104 residue at 1:1 ratio of compound to protein by 2D TROSY [1H-15N] spectroscopy\"],[\"Inhibition of ANO1 (unknown origin) expressed in FRT cells assessed as reduction in ATP-induced chloride current after 20 mins by electrophysiological assay\"],[\"Displacement of [3H]T-3364366 from D5D in rat liver microsomal membrane preincubated for 15 mins followed by radioligand addition measured after 150 mins by TopCount microscintillation counting assay\"],[\"Inhibition of human kallikrein 7 at 296 nM to 1 uM at pH 8 by fluorescence assay\"],[\"Agonist activity at LXR-beta in human HeLa cells assessed as induction of ABCA1 by beta-galactosidase\\u002fluciferase reporter gene assay relative to control\"],[\"Inhibition of HDAC3 in LPS\\u002fIFNgamma-stimulated mouse RAW264.7 cells assessed as TNF-alpha gene expression at 1 uM pretreated for 16 hrs followed by LPS stimulation and measured after 4 hrs by RT-qPCR analysis\"],[\"Binding affinity for human adenosine A1 receptor by displacement of [3H]DPCPX\"],[\"Inhibition of recombinant GST-tagged human PASK catalytic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control\"],[\"Displacement of [3H]spiperone from human D3R expressed in CHO cell membranes by radioligand binding assay\"],[\"Covalent binding affinity to BTK in human blood assessed as reduction in biotinylated-probe binding at 300 nM measured up to 100 mins by immunoassay relative to control\"],[\"Inhibition of PTP1B in rat L6 cells assessed as increase in insulin-stimulated GSK3beta Ser9 phosphorylation at 10 to 25 uM pre-incubated for 16 hrs before insulin stimulation for 10 mins by Western blot method\"],[\"Displacement of 125I-hMCP1 from CCR2 expressed in human peripheral blood monocytes less than 10 uM after 60 mins\"],[\"Inhibition of wild-type human partial length CLK4 (R135 to K481 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of recombinant human OSR1 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human N-terminal Strep-tagged IDH1 R132H mutant expressed in Escherichia coli BL21(DE3) using alphaKG as substrate preincubated for 30 mins in presence of NADPH followed by substrate addition by LC-MS\\u002fMS analysis\"],[\"Inhibition of human adrenergic beta-1 receptor at 1 uM\"],[\"Inhibition of human SERT in HEK293 cells assessed as inhibition of [3H]serotonin uptake\"],[\"Inhibition of human recombinant TCPTP\"],[\"Binding affinity to mouse H4R expressed in HEK293T-SF-His6-CRE-Luc cells assessed as association rate constant by saturation binding study\"],[\"Inhibition of uncoupled photosystem II electron transport and partial reactions in Spinacia oleracea (spinach) leaves assessed as electron transport rate from water to SiMo at 200 uM measured per mg of chlorophyll relative to untreated control\"],[\"Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay\"],[\"Displacement of [125I]-MCH (4 to 19) from human MCH1 receptor expressed in CHO cell membranes at 0.1 uM after 1 hr by liquid scintillation counting analysis relative to control\"],[\"Inhibition of human CSNK1D using gamma-33P-ATP as substrate by scintillation counting\"],[\"Inhibition of Homo sapiens (human) endothelin converting enzyme-1\"],[\"Antagonist activity at human mu-opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-induced [35S]GTPgammaS binding at 10 uM after 60 mins by scintillation counting relative to control\"],[\"Agonist activity at human PTHR1 expressed in HKRKB7 cells assessed as accumulation of intracellular cAMP after 20 mins by enzyme immunoassay\"],[\"Displacement of [3H]reserpine from human VMAT2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting method\"],[\"Inhibition of SRPK1 (unknown origin) at 10 uM relative to control\"],[\"Ratio of EC50 for human C-terminal eYFP-tagged FFA1 receptor expressed in HEK-293 cells to Ki for N-terminal NLUC-tagged FFA1 receptor (unknown origin) expressed in human Flp-In T-REX-293 cell membrane coexpressing mGluR5\"],[\"Inhibition of AChE (unknown origin) assessed as minimum inhibitory concentration by bioautographic TLC assay\"],[\"Induction of Nrf2 activity in rat PC12 cells assessed as upregulation of GCLC mRNA levels at 2.5 to 10 uM after 24 hrs by RT-PCR method\"],[\"Binding affinity to 5-HT1A receptor (unknown origin)\"],[\"Effect on nuclear co-repressor receptor binding to mouse CAR F171A mutant expressed in HEK293 cells at 10 uM by yeast two-hybrid assay\"],[\"Inhibition of human MDR1 expressed in mouse L5178 cells assessed as fluorescence activity at 23 uM by rhodamine 123 exclusion test\"],[\"Binding affinity to amyloid beta plaques in Alzheimer disease patient brain by thioflavin-S staining method\"],[\"Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA\"],[\"Covalent binding affinity to human PRMT6 assessed as covalent adduct. formation at 300 uM pre-incubated for 1 hr by mass spectrometry\"],[\"Inhibition of kappa-type opioid receptor (unknown origin) at 10 uM relative to control\"],[\"Displacement of [3H]SCH23390 from bovine dopamine D1 receptor\"],[\"Inhibition of human AKT1 at 0.1 uM relative to control\"],[\"Binding affinity to GST-fused human carbonic anhydrase-2 expressed in Escherichia coli BL21 codon plus cells assessed as steady state dissociation constant by SPR method\"],[\"Positive allosteric modulation of rat mGluR5\"],[\"Binding affinity to BRD2 BD1 (unknown origin) by fluorescence anisotropy competition binding assay\"],[\"Inhibition of recombinant full length human Aurora-A assessed as residual activity at 1 uM using LRRASLG as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control\"],[\"Agonist activity at beta-1 adrenergic receptor in guinea pig atria assessed as increase in rate of contraction of spontaneously beating right atria at 4.8 x 10'-5 M\"],[\"Ratio of binding affinity of Opioid receptor kappa 1 to Opioid receptor mu 1 to Opioid receptor delta 1; kappa:mu:delta = 14:3:1\"],[\"Binding affinity to human partial length SMARCA2 expressed in bacterial expression system by BROMOscan assay\"],[\"Inhibition of human 11beta HSD2\"],[\"Induction of covalent topoisomerase 1-DNA adduct stabilization in human MIA PaCa cells at 20 uM after 1 hr by ICE assay\"],[\"Displacement of biotinylated tetra-acetylated histone H4 from human his-tagged BRD4 bromodomain1 (1 to 477 residues) expressed in Escherichia coli incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human recombinant UGT2B4 at 25 uM by fluorescence spectroscopy\"],[\"Inhibition of human endothelial lipase using HDL as substrate measured after 4 hrs\"],[\"Ca flux\"],[\"Inhibition of human full length MARK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to NPY1R in human MCF7 cells assessed as maximum binding\"],[\"Inhibition of rat muscle pyruvate kinase (PK-M) at 10 mM\"],[\"Inhibition of wild-type human full length TESK1 (R37 to S626 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Binding affinity against Adenosine A2A receptor in rat striatal membranes b displacement of [3H]-CGS- 21680\"],[\"Inhibition of FLT1 (unknown origin) at 10 uM relative to control\"],[\"Inhibition of recombinant full length human STK32A assessed as residual activity at 1 uM using casein as substrate incubated for 120 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control\"],[\"Positive allosteric modulator activity at rat mGlu6 receptor expressed in HEK293 cells assessed as glutamate-induced GIRK channel-mediated thallium flux treated 140s prior to gluatamate challenge by fluorescence analysis\"],[\"Displacement of [3H]-methylspiperone from dopamine D3 receptor (unknown origin) at 10 uM\"],[\"Inhibition of EGFR autophosphorylation in DiFi cells by ELISA\"],[\"Binding affinity to human partial length EGFR L858R\\u002fT790M double mutant (R669 to V1011 residues) expressed in mammalian expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control\"],[\"Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay\"],[\"BRaf(h) Millipore kinase panel\"],[\"Inhibition of glutathione peroxidase 1 in human cisplatin-resistant DOGUM cells assessed as decrease in cisplatin resistance ratio at 25 uM after 72 hrs by MTT assay\"],[\"Inhibition of wild-type human full length PCTK2 (M1 to F523 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Binding affinity to His-tagged recombinant human sRBP expressed in Escherichia coli BL21(DE3) assessed as disruption of sRBP-TTR protein interaction at 100 uM after 1 hr by SDS-PAGE and silver staining method relative to 10 uM ROH\"],[\"Inhibition of recombinant full length His-tagged human Aurora B expressed in baculovirus expression system at 10 uM in presence of ATP relative to control\"],[\"Inhibition of human recombinant SIRT5 assessed as inhibition of substrate desuccinylation using Fluor de Lys-Succinyl green peptide as substrate in presence of NAD+ measured by fluorometric assay\"],[\"Activity at human APJ receptor up to 10 uM\"],[\"Inhibition of STAT3 transcriptional activity in human HeLa cells by luciferase reporter gene assay\"],[\"Inhibition of recombinant human N-terminal GST-tagged FLT3 cytoplasmic domain (564 to 993 residues) expressed in baculovirus expression system\"],[\"Inhibition of mushroom tyrosinase using L-tyrosine as substrate by HPLC analysis\"],[\"Competitive inhibition of GLUT1 (unknown origin) expressed in CHO cells assessed as reduction in 2-[1,2-3H]deoxy-D-glucose uptake measured for 30 secs by double reciprocal plot analysis\"],[\"Inhibition of HDAC2 (unknown origin) using Boc-Lys(acetyl)-AMC as substrate preincubated with enzyme for 5 mins prior to substrate addition measured after 30 mins by fluorescence assay\"],[\"In vitro ability to antagonize LTC4-induced contractions of guinea pig smooth muscle (trachea) at 3 uM concentration.\"],[\"Inhibition of FOXM1 in human ER-positive MCF7 cells at 8 uM assessed as reduction in AURKB expression measured by qRT-PCR method\"],[\"Binding affinity to human TRPV1 expressed in CHO cells after 45 mins by scintillation counting method relative to RTX\"],[\"ChaK1(h) Millipore kinase panel\"],[\"Antagonist activity at human GnRH receptor assessed as inhibition of [D-Trp6]-GnRH-stimulated [3H]IP reduction\"],[\"Displacement of [3H]8-OH-DPAT from human cloned 5HT1A receptor\"],[\"Antagonist activity at rat recombinant 5HT7 receptor expressed in HEK293 cells assessed as decrease of 5-CT-induced increase of calcium level after 20 mins by competitive immunoassay\"],[\"Inhibition of human TNFalpha expressed in Escherichia coli assessed as trimer to dimer transition at 5 uM measured after 12 hrs by mass spectrometry\"],[\"Inhibition of Escherichia coli FabH overexpressed in Escherichia coli DH10B cells assessed as incorporation of [3H] in the product after 25 mins by liquid scintillation counting analysis\"],[\"Agonist activity at human APJ receptor assessed as increase in beta-arrestin recruitment\"],[\"Binding affinity to Keap1 in mouse Hepa1c1c7 cells assessed as reduction in Keap1 interaction by measuring induction of NQO1 activity measured after 24 hrs\"],[\"Activation of Nrf2 in normal human lung fibroblasts assessed as induction of HMOX protein expression by measuring HMOX positive cells level at 3 uM incubated for 16 to 18 hrs by immunostaining relative to control DMSO\"],[\"Inhibition of human CLK3 at 1 uM using MBP as substrate\"],[\"Displacement of [3H]spiperone from low affinity antagonist binding site of D2 receptor in Rattus norvegicus (rat) striatal membrane\"],[\"Inhibition of Lyn kinase against 100 uM cdc2 substrate\"],[\"Inhibition of HIV1 reverse transcriptase p66\\u002fp51 using template-primer [oligo(dT)12-18 + poly(rA)] by mixed type competitive inhibition assay\"],[\"Binding affinity to ACTR3 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"In vitro beta-2 duration was determined using electrically stimulated guinea-pig isolated trachea superfusion system\"],[\"Inhibition of human TLK2 using casein as substrate\"],[\"Inhibition of human cathepsin G using Suc-AAPF-MCA as substrate at pH 7.2 and 298 K measured every 60 secs for 600 secs\"],[\"Inhibition of recombinant human chymase expressed in Pichia pastoris X-33 cells assessed as decrease in angiotensin 1 cleavage to angiotensin 2 incubated for 120 mins at 298 K by UPLC-MS analysis\"],[\"Inhibition of human PDGFRalpha D842V mutant (550 to end residues) assessed as residual activity at 0.5 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Antagonist activity at NPY2 receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM\"],[\"Induction of recombinant Staphylococcus aureus FtsZ polymerization assessed as increase in bundling of protein protofilaments at 4 ug\\u002fml preincubated for 10 mins followed by GTP addition and measured after 15 mins by transmission electron microscopic method\"],[\"Binding affinity to 5-HT1A receptor (unknown origin) 10 umol\\u002fL by radioligand binding assay\"],[\"Inhibition of human recombinant HDAC3 at 10 uM using fluorogenic HDAC substrate measured after 10 mins by fluorimetry assay relative to control\"],[\"opioid receptor mu antagonistic activity was measured by the displacement of morphine in the guinea pig ileum at a concentration of 200 nM\"],[\"Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay\"],[\"Competitive inhibition of human HDAC6 CD2 expressed in Escherichia coli BL21 (RIL) using Boc-Lys (Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by fluorescence assay\"],[\"Antagonist activity at mouse melanocortin receptor 3 expressed in HEK293 cells assessed as inhibition of NDP-MSH-induced cAMP accumulation incubated for 2 hrs by cAMP Alpha-screen assay based Schild analysis\"],[\"Inhibition of KDM4A (unknown origin) at 0.01 uM relative to control\"],[\"Displacement of [125I]-NDP-alpha-MSH from human MC3 receptor expressed in HEK293 cells by gamma counting analysis\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control\"],[\"Inhibition of ALK G1202R mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control\"],[\"Agonist activity at human recombinant MC4 receptor expressed in BHK570 cells assessed as induction of cMAP accumulation in presence of 0.1% human serum albumin\"],[\"Inhibition of mTOR (unknown origin) at 10 uM after 40 mins by scintillation counting analysis\"],[\"Binding affinity to wild-type TTR (unknown origin) assessed as chemical shift perturbation at DE loops at 1:1 ratio of compound to protein by 2D TROSY [1H-15N] spectroscopy\"],[\"Displacement of [3H]DPCPX from human cloned adenosine A2B receptor expressed in HEK293 cells\"],[\"Activation of ERalpha in MCF7 cell line transfected with ER responsive luciferase reporter at 1 uM\"],[\"Inhibition of wild-type human partial length ULK3 (M1 to Q290 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Agonist activity at human CB2-receptor expressed in CHO-K1 cells coexpressing G-alpha16 by Fluo-4-AM dye based calcium mobilization assay\"],[\"Inhibition of calcium influx evoked by capsaicin in human TRPV1 expressing cells by fluorescence assay\"],[\"Agonist activity at human mu opioid receptor expressed in CHO cells assessed as dynamic mass redistribution by DMR assay\"],[\"Inhibition of KRAS in human MDA-MB-231 cells assessed as reduction in phosphorylated MEK1\\u002f2 at Ser217\\u002f221 residues protein level at 25 uM measured after 24 hrs by Western blot analysis relative to control\"],[\"Competitive\\u002freversible antagonist activity at P2Y12 receptor in platelets (unknown origin) assessed as inhibition of ADP-induced platelet aggregation\"],[\"In vitro inhibitory activity against Prostaglandin G\\u002fH synthase 1 (COX-1)\"],[\"Inhibition of recombinant human His-tagged IDO1 expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of kynurenine production at 10 uM using L-tryptophan as substrate after 1 hr by fluorescence assay relative to control\"],[\"Inhibition of MAP4K4 (unknown origin) in presence of 1 mM ATP\"],[\"Inhibitory activity against human DNA topoisomerase I mediated DNA cleavage; Weak activity\"],[\"Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR\"],[\"Displacement of [N-methyl-3H]LSD from human 5HT2C receptor expressed in HEK293 cells\"],[\"Inhibition of JH1 catalytic domain of TYK2 (unknown origin) at 1 uM relative to control\"],[\"Displacement of 2-[125I]-iodomelatonin from human melatonin receptor MT2 expressed in HEK293 cells after 120 mins\"],[\"Binding affinity to NET (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay\"],[\"Inhibition of photosystem I in Spinacia oleracea (spinach) leaves intact chloroplasts assessed as electron transport flow from TMQH2 to MV at 100 uM\"],[\"Inhibition of human Nav1.2 channel expressed in HEK293 cells at -120 mV by patch clamp method\"],[\"Inhibition of N-terminal his-tagged full-length human KDM4C transfected in U2OS cells assessed as inhibition of H3K9Me3 demethylation for 24 hrs\"],[\"Inhibition of PI3K-ALPHA (unknown origin) at 1 uM relative to control\"],[\"Displacement of [125I]NDP-alpha-MSH from human cloned MC4R expressed in HEK293 cells\"],[\"Inhibition of wild-type human partial length CAMK2G (R9 to A303 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Displacement of [3H]DPCPX from recombinant full length human adenosine A1 receptor expressed in CHO-K1 cells assessed as residual binding level for radioligand at 10 uM incubated for 90 mins radiometric scintillation analysis relative to control\"],[\"Inhibition of N-terminal FLAG-tagged TTK (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 10 mins by scintillation counting analysis\"],[\"Displacement of [3H]-RX821002 from adrenergic alpha 2 receptor (unknown origin) at 10 uM by scintillation analysis relative to control\"],[\"Inhibition ofRattus norvegicus alpha-glucosidase isolated from intestine using PNPG as substrate at 0.02 uM incubated for 15 min prior to substrate addition measured after 15 min by spectrophotometric analysis\"],[\"Agonist activity at human recombinant cannabinoid CB2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay\"],[\"Binding affinity to human partial length EGFR L858R mutant (R669 to V1011 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of human partial length FLT3 R834Q mutant (V592 to Y969 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Negative allosteric modulator activity at human muscarinic acetylcholine receptor M5 expressed in CHO cells by fluorometric imaging plate reader\"],[\"Inhibition of human JAK1 (837 to 1142 residues) expressed in baculovirus infected Sf9 insect cells using EQEDEPEGDYFEWLE as substrate after 1 hr by fluorescence assay\"],[\"Activation of Nrf2 in mouse BV-2 cells assessed as increase in nuclear Nrf2 levels after 6 hrs by Western blot analysis\"],[\"Inhibition of P-gp (unknown origin) at \\u003e30 uM\"],[\"Activity of ampD, ampDh1, ampDh2 and ampG deficient Pseudomonas aeruginosa PAO1 AmpC assessed as nitrocefin hydrolyzed per mg of protein at 10 ug\\u002fml by UV spectrophotometry\"],[\"In vitro radioligand binding assay, for inhibition of [3H]U-69593 binding to Opioid receptor kappa 1, in guinea pig brain membranes; not determined\"],[\"Activity at mushroom tyrosinase by Michaelis-Menten plot analysis\"],[\"Inhibition of human recombinant PDGFRbeta\"],[\"Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110alpha expressed in rat Rat1 cells\"],[\"Displacement of [3H]nisoxetine from NET in rat frontal cortex by scintillation counting\"],[\"Inhibition of recombinant full length N-terminal GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control\"],[\"Inhibition of human recombinant DyrK1b by fluorescence-based immunoassay\"],[\"Inhibition of CDK1-mediated phosphorylation of PP1a at Thr320 in human HCT116 cells after 24 hrs by immunoblotting analysis\"],[\"Inhibition of HIV-1 protease in vitro.\"],[\"Ratio of androstenedione-Ki to testosterone-Ki for human placental cytochrome P450 19A1\"],[\"Binding affinity to wild-type human partial length BIKE (S34 to N329 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Induction of translocation of RasGRP1 to plasma membrane in HEK293 cells\"],[\"Inhibition of human MOLT4 cell-derived PDE10A using [3H]cAMP as substrate measured after 2 hrs in presence of rolipram\\u002fmilrinone by topcount method\"],[\"Inhibition of TYK2 (unknown origin) using peptide as substrate preincubated for 10 mins followed by substrate addition by mobility shift assay\"],[\"Inhibition of human recombinant MAOA expressed in insect cells assessed as oxidation of kynuramine substrate at 6 mM measured after additional enzyme added after 120 mins incubation\"],[\"Inhibition of IRR (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of PKD2 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of PHGDH-mediated serine synthesis in human Carney cells in serine free medium preincubated for 1 hr followed by 13C6 labelled glucose addition and measured after 2 hrs by LC\\u002fMS analysis based 13C6-Glucose tracing assay relative control\"],[\"Inhibition of human HDAC8 (1 to 377 residues) expressed in Escherichia coli BL21(DE3) using Boc-Lys(TFA)-AMC as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by fluorescence assay\"],[\"Activity of human KDR kinase at 1 uM\"],[\"Positive allosteric modulator activity at human mGlu4 receptor\\u002fGqi5 assessed as maximum activity at 30 uM by calcium mobilization assay relative to glutamic acid\"],[\"Inhibition of human recombinant Sirt2 using ZMAL as substrate after 4 hrs by fluorescent deacetylase assay\"],[\"Inhibition of NAMPT in human HCT116 cells assessed as decrease in cellular NAD+ level after 24 hrs in presence of NMN by MTT assay\"],[\"Binding affinity to thrombin (unknown origin) assessed as change in gibbs free energy using Tos-Gly-Pro-Arg-AMCA-TFA as a substrate incubated for 40 secs and measured every 15 secs interval for 20 times by fluorescence based Dixon plot analysis\"],[\"Inhibition of alpha-glucosidase activity of sucrase in rat small intestinal brush border membrane fraction using maltose as substrate after 30 mins\"],[\"Antagonist activity at rat mGluR6 expressed in CHO cells by [35S]GTPgammaS binding assay\"],[\"Inhibition of tyrosinase in Melan-a cells\"],[\"Inhibition of human YES assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant full length human His-tagged AKT1 expressed in baculovirus expression system using ser\\u002fthr 6 as substrate after 1 hr by FRET-based Z'-Lyte assay\"],[\"Inhibition of STK2 (unknown origin) at 10 uM assessed as residual enzyme activity\"],[\"Tested in vitro to inhibit Acyl coenzyme A:cholesterol acyltransferase in intestinal microsomes isolated from cholesterol-fed rabbits.\"],[\"Agonist activity at human H2R-Gsalphas expressed in Sf9 cells at 0.1 nM to 10 uM by steady state GTPase activity assay\"],[\"Displacement of [3H]-Rauwolscine from human adrenergic alpha2C receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method\"],[\"Displacement of [125I]NDP-alpha-MSH from human recombinant MC 4 receptor at 10 uM measured after 120 mins by scintillation counter method relative to control\"],[\"Inhibition of beta-3 adrenergic receptor GDP binding in rat brown adipose tissue on oral administration relative to isoprenaline\"],[\"Inhibition of FER in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Binding affinity to human N-terminal His-tagged BRD4 bromodomain1 assessed as change in melting temperature at 10 uM by SYPRO orange dye-based fluorescence assay\"],[\"Inhibition of PI3Kgamma in human THP1 cells assessed as reduction in MCP1-induced Akt phosphorylation at Thr308\\u002fSer473 residue preincubated for 1 hr followed by MCP1 stimulation for 3 mins by FACS analysis\"],[\"Inhibition of HIF-1 dimerization in HEK293 cells after 24 hrs by renilla luciferase reporter gene assay\"],[\"Inhibition of recombinant human ecto-5' nucleotidase expressed in COS7 cell membranes assessed as inorganic phosphate release using AMP as substrate at 100 uM preincubated for 10 mins followed by substrate addition and measured after 20 mins by malachite green dye based spectrophotometry relative to control\"],[\"Inhibition of human GRK1 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of PIM1 (unknown origin) using PIM2tide as substrate in presence of [gamma-33P]ATP incubated for 60 mins by liquid scintillation counting\"],[\"Inhibition of LATS2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Antagonistic activity as H3-receptor dependent activation of G-proteins with GTP gamma-[35S] autoradiography of rat cortical tissue sections at 10e-6 M; maximal response\"],[\"Inhibition of human CaV3.2 expressed in HEK293 cells at -100 mV membrane potential by whole cell path clamp method\"],[\"Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1221\\u002f1222 residues after 1 hrs by Western blot analysis\"],[\"Inhibition of AR in human LNCAP cells assessed as reduction in R1881-induced PSA mRNA expression at 1 uM after 24 hrs by qRT-PCR analysis relative to control\"],[\"Binding affinity to wild-type human partial length ERBB4 (L690 to K994 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Displacement of [125I]SDF-1 from CXCR4 in human CEM-CCRF cells expressing CD4 by liquid scintillation counting\"],[\"Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in Sf9 cells co-expressing RGS4\"],[\"Inhibition of G9a (unknown origin)-mediated H3K9 methylation using histone H3 and SAM as substrate incubated for 30 mins by AlphaScreen assay\"],[\"Inhibition of C-terminal 10-His tagged recombinant human HGFA (Gln36 to Ser655 residues) expressed in mouse Ns30 cells 10 uM after 15 mins by fluorescence assay relative to control\"],[\"Inhibition of [35S]GTP-gamma-S, binding in guines pig caudate stimulated by U50, 488 of Opioid receptor kappa 1\"],[\"Inhibition of EZH2 Y641N mutant (unknown origin) using biotinylated nucleosome, H3K27me3 activator and [3H]-SAM incubated for 60 mins by top-count based method\"],[\"Binding affinity to N-terminal His6-tagged human SETDB1 Tudor domain (197 to 403 residues) expressed in Escherichia coli BL21(DE3)-pRARE2 cells assessed as induction of HSQC shift at 5 mM by 1H-15 N HSQC-TROSY NMR spectroscopy\"],[\"Binding affinity to wild-type human partial length C-terminal RSK2 kinase domain 2 (V402 to S715 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of ErbB4 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control\"],[\"Inhibition of human cathepsin D up to 100 uM using MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 as substrate after 10 mins by spectrophotometric method\"],[\"Inhibition of human recombinant COX2 by measuring PGE2\"],[\"Inhibition of MTH1 in human U2OS cells assessed as activation of p53 at 5 uM incubated for 4 and 24 hrs by Peggy sue Western blot assay\"],[\"Inhibition of human Kv1.5 expressed in CHO cells by patch-clamp technique\"],[\"Inhibition of human recombinant PDE10A expressed in baculovirus-SF21 cell system assessed as hydrolysis of [3H]cAMP at 1000 nM after 1 hr by liquid scintillation counting\"],[\"Inhibition of KRAS in human MDA-MB-231 cells assessed as reduction in phosphorylation of RAF measured after 24 hrs by Western blot analysis\"],[\"Activation of human recombinant S1P1 expressed in CHO cell membranes after 120 mins by GTP-gamma-35S-binding assay\"],[\"Displacement of [3H]GX-545 Nav1.7 (unknown origin) expressed in HEK cells by liquid scintillation counting based radioligand competition assay\"],[\"Antagonist activity at AR in human LNCAP cells receptor assessed as inhibition of R1881-induced transcriptional activation at 10 uM by ARE-luciferase reporter gene assay\"],[\"Displacement of H2K9(Ac)K13(Ac)K15(Ac) peptide from BRD9 bromodomain (unknown origin) by AlphaScreen assay\"],[\"Displacement of [3H]Prazosin from human recombinant alpha1D adrenergic receptor expressed in HEK293 cells after 60 mins\"],[\"Agonist activity at human DOR expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP accumulation by EIA method relative to control\"],[\"Inhibition of HIV-1 reverse transcriptase (HIV-1 RT)\"],[\"Inhibition of HIV1 reverse transcriptase p66 Y181C mutant associated RNA dependent DNA polymerase activity expressed in Escherichia coli assessed as reduction in [3H]dTTP incorporation using poly(rA)\\u002foligo(dT) as template\\u002fprimer by scintillation counting analysis\"],[\"Inhibition of EGFR kinase autophosphorylation in A431 cells\"],[\"Inhibition of human recombinant HDAC2 after 60 mins by fluorimetric assay\"],[\"Binding affinity to human 5HT5A receptor at 10 uM relative to control\"],[\"Binding affinity to EP3R in human platelet at 1 uM after 1 hr by fluorescence imaging\"],[\"Inhibition of human recombinant PTP1B (1 to 299 residues) expressed in Escherichia coli using pNPP as substrate preincubated for 30 mins followed by substrate addition and measured after every 30 secs for 15 mins\"],[\"Inhibition of NHE1 in human HT-29 cells assessed as intracellular pH change after 30 mins in presence of plasma protein\"],[\"Inhibition of fluorescently labelled tracer binding to human ERG by competitive binding assay\"],[\"Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis\"],[\"Inhibition of human SIK3 (2 to 1369 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control\"],[\"Inhibition of human ERG expressed in HEK293 cells up to 30 uM at -80 mV holding potential by whole-cell patch clamp assay\"],[\"Effective potency in transcriptional activation assay in CV-1 cells expressing retinoic acid receptor RAR alpha; Not active\"],[\"Inhibition of human NEK6 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Activation of PKCdelta (unknown origin) expressed in HEK293 cells harboring GFP-tagged RasGRP3 assessed as phosphorylation at ser299 residues after 30 mins by immunoblot method\"],[\"Displacement of [3H]sulpiride from rat striatal membrane Dopamine receptor D2 at 10e-7 M\"],[\"Concentration required to inhibit PGD-2 induced chemotaxis of Th2 cells expressing CRTH2\"],[\"Inhibition of N-terminal GST-tagged recombinant full-length human MAPK1 expressed in Escherichia coli using MBP1 as substrate after 3 hrs by kinase-glo luminescent assay relative to control\"],[\"Displacement of [3H]-LSD from human 5HT7 receptor by liquid scintillation counting\"],[\"Antagonist activity at human P2X7\"],[\"Induction of ERalpha degradation in human MCF7 cells after 18 hrs by Western blot analysis\"],[\"Displacement of [125I]Tyr10-NPS from neuropeptide S receptor (unknown origin)\"],[\"Inhibition of FAAH T488A mutant (unknown origin) expressed in human HeLa cells using [3H]AEA as substrate after 18 hrs\"],[\"Antagonist activity at CCR2b (unknown origin) at 10 uM\"],[\"Inhibition of full length recombinant human N-terminal His6-tagged PRAK expressed in baculovirus infected Sf21 cells\"],[\"Inhibition of human recombinant MYLK2 assessed as reduction in substrate phosphorylation at 50 to 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method\"],[\"Displacement of [125I]CYP from rat cerebral cortex 5-HT1B receptor at 100 nM measured after 120 mins by radioligand completion assay relative to control\"],[\"Inhibition of FAK (unknown origin) by enzyme immuno assay\"],[\"Inhibition of human SphK1 using sphingosine as substrate in presence of [gamma-32P]ATP\"],[\"Inhibition of recombinant full length His-tagged human PAK6 expressed in baculovirus expression system at 1 uM by FRET assay relative to control\"],[\"Inhibition of recombinant human MAOB expressed in insect cell microsomes using kynuramine as substrate measured after 20 mins by fluorescence spectrophotometry\"],[\"Reversal of human MDR1-mediated multidrug resistance in mouse L5178Y cells expressing MDR1 assessed as forward scatter count measured by cell size ratio at 20 uM after 10 mins by flow cytometry\"],[\"Activation of human recombinant CA6 after 15 mins by stopped-flow CO2 hydration assay\"],[\"Binding affinity to human FYN using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay\"],[\"Inhibition of MAPK14 (unknown origin) at 10 uM\"],[\"Inhibition of human full length carbonic anhydrase 6\"],[\"Inhibition of human recombinant full length GST-tagged CDC25A transfected in Escherichia coli BL21-DE3 using 3-O-methylfluorescein phosphate as substrate at 10 uM incubated for 20 mins followed by substrate addition measured every 10 mins for 2 hrs by fluorimetric assay in presence of 0.1% triton X 100 (Rvb = 88.6 +\\u002f- 1.3%)\"],[\"Modulation of full length human Nurr1 expressed in HEK293T cells co-transfected with RXRalpha and luciferase reporter plasmid harboring NBRE response element assessed as increase in luciferase activity incubated for 18 hrs by luciferase-reporter gene assay\"],[\"fibroblast growth factor receptor 1 Millipore kinase panel\"],[\"Inhibition of human 20S proteasome trypsin like activity using Boc-Leu-Leu-Arg-Arg-AMC as substrate at 20 uM measured over 10 mins by fluorescence assay\"],[\"Inhibition of ChoKalpha (unknown origin) in presence of 400 uM ATP by HTS assay\"],[\"Modulation of GFP-tagged survivin dimerization in human PC3 cells assessed as distorted, diffused or decondensed CPC organization at 10 nM after 72 hrs by real-time video microscopy relative to control\"],[\"Inhibition of human full length recombinant LCK at 500 nM by radiometric scintillation counting analysis relative to control\"],[\"Inhibition of human recombinant cytosolic thymidine kinase 1 assessed as inhibition of [methyl-3H]dThd phosphorylation after 30 mins by scintillation counting\"],[\"Inhibition of delta-selective antagonist binding to opioid receptor of mouse vas dferens\"],[\"Inhibition of CETP-mediated transfer of cholesteryl ester to LDL\\u002fVLDL in human plasma by Roar assay\"],[\"Inhibition of BCRP (unknown origin) expressed in HEK293 cells assessed as reduction in mitoxantrone efflux at 1 uM incubated for 30 mins by flow cytometric analysis relative to control\"],[\"Inhibition of dihydrofolate reductase in human acute lymphocytic leukemia cells\"],[\"Inhibition of collagenase (Matrix metalloprotease-13)\"],[\"In vitro percentage inhibition against ACAT derived from rat adrenals\"],[\"Competitive inhibition of human autotaxin at free state isolated from MDA-MB-231 cells assessed as blockade of FS3 substrate hydrolysis by FRET assay\"],[\"Antagonistic activity at human histamine H4 receptor in SK-N-MC cells by inhibition of forskolin-stimulated cAMP-mediated reporter gene activity\"],[\"Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins prior to testing by stopped-flow CO2 hydration assay\"],[\"Inhibition of Src (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 16 mins by agarose gel electrophoresis\"],[\"Displacement of [3H]U69593 from human recombinant kappa opioid receptor expressed in CHO cells\"],[\"Inhibition of fatty acid binding protein 4 in mouse 3T3-L1 cells assessed as reduction in cytochrome B5 Type A expression level at 10 uM dosed during day 2 to 6 and followed by drug replacement every 48 hrs by LC-MS\\u002fMS analysis based proteomic analysis\"],[\"Inhibition of LMP2 in human 20S immunoproteasome using Ac-PAL-AMC as substrate after 1 hr by fluorescence based microplate reader analysis\"],[\"Inhibition of horse serum BuChE using butylthiocholine chloride as substrate preincubated for 15 mins followed by substrate addition measured every 1 min by Ellman method\"],[\"Inhibition of PI3Kbeta in human PC3 cells assessed as suppression of AKT phosphorylation at Ser473 after 60 mins by ELISA\"],[\"GSK3α(h) Eurofins kinase panel\"],[\"Inhibition of DYRK1A (unknown origin) pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP\"],[\"Agonist activity at wild-type human PPARalpha LBD expressed in COS7 cells after 12 hrs by Dual-Glo luciferase assay\"],[\"Inhibition of human LOK at 10 uM using RLGRDKYKTLRQIRQ as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of CBP BRD (unknown origin) by TR-FRET assay\"],[\"Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate at 20 uM preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method relative to control\"],[\"Irreversible inhibition of human recombinant MAGL pre-incubated for 60 mins before 4-NPA substrate addition\"],[\"Inhibition of MSSK1 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of Influenza A virus (A\\u002fRI\\u002f5+\\u002f1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins\"],[\"Inhibition of wild-type human full length CDK3 (M1 to H305 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Binding constant for full-length CDK3\"],[\"Inhibition of recombinant human CYP1A2 using luciferin-ME as substrate preincubated for 10 mins followed by NADPH addition and measured after 10 to 30 mins by P450-Glo assay\"],[\"Inhibition of BTK (unknown origin) after 60 mins by TR-FRET assay\"],[\"Binding affinity to C-terminal AVI-tagged BMP2K (unknown origin) (38 to 345 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay\"],[\"Saturation binding of mutant human Adenosine A2A receptor (H250N) at pH 5.5\"],[\"Inhibition of sonic hedgehog pathway in mouse NIH-3T3 cells relative to control\"],[\"Competitive inhibition of rabbit muscle glycogen phosphorylase-b in presence of varying levels of glucose-1-phosphate and constant concentration of glycogen and AMP by double reciprocal plot method\"],[\"Agonist activity at human beta2 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay\"],[\"Activity at human LXRalpha by Gal4 transactivation assay relative to GW-3965\"],[\"Inhibition of human PDK1 using unactivated AKT substrate in presence of COPC, DOPS and PIP3 activators after 1 hr by scintillation counting method\"],[\"Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta\"],[\"Inhibition of recombinant full-length human GST-tagged IKKbeta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control\"],[\"Inhibition of JAK1 (unknown origin) in presence of [gamma33P]ATP\"],[\"Binding affinity to recombinant human HDAC4 at 10 uM after 30 mins by fluorescence analysis relative to control\"],[\"Activation of Nrf2 in mouse Hepa1c1c7 cells assessed as increase in quinone reductase activity at 2 uM incubated for 24 hrs by MTT based assay\"],[\"Inhibitory concentration against Lactobacillus casei Thymidylate synthase (TS).\"],[\"Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting\"],[\"Tested for MCH-1 induced [Ca2+] release from CHO cells transfected with human MCH-1R\"],[\"In vitro inhibitory activity against histamine H2-receptor in isolated Guinea pig right atria.\"],[\"Inhibition of c-Kit D816V mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of NEK11 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of human ENT1 expressed in porcine PK15NTD cells by cell-based [3H]5-uridine uptake assay\"],[\"Antagonist activity at human GABAc Rho1 receptor expressed in Xenopus oocytes assessed as whole cell current production at 600 uM by two electrode voltage clamp method\"],[\"Inhibition of recombinant human His-tagged TRKA (441 to 796 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of IL4-induced JAK2 autophosphorylation in human HT-29 cells at 100 uM by SDS-polyacrylamide gel electrophoresis and Western blot method\"],[\"Effect of combination of compound and testosterone propionate on androgen induced increase in ventral prostate weight; No change\"],[\"Inhibition of RIP1 in human U937 cells assessed as reduction in necroptosis incubated for 24 hrs by cell titer-glo luminescent cell viability assay\"],[\"Inhibition human topoisomerase 2alpha kDNA decatenation activity after 15 mins by agarose gel electrophoresis\"],[\"Inhibition of recombinant SK2 (unknown origin) expressed in Sf9 insect cells using D-erythro-sphingosine as substrate measured in presence of [gamma32P]ATP by scintillation proximity assay\"],[\"Activity at PPAR delta at 10 uM\"],[\"Inhibition of recombinant human His-tagged FLT3 N8411 mutant expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control\"],[\"Mixed-type inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Dixon plot analysis\"],[\"Binding affinity to MAPK3 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Effect on PLP interaction with human CSE assessed as effect on spectra of CSE-bound PLP\"],[\"Agonist activity at human TRPv1 receptor expressed in HEK293 cells assessed as stimulation of intracellular calcium level using Fluo4-AM dye based fluorimetric assay relative to 4 uM ionomycin\"],[\"Inhibition of ovine COX1 by colorimetric assay\"],[\"Displacement of [3H]CGS21680 from human recombinant adenosine receptor-2A expressed in HEK293 cell membrane after 60 mins by liquid scintillation counting\"],[\"Antagonist activity at dopamine D2S receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM\"],[\"Inhibition of HDAC2 (unknown origin) using (FAM)-labeled acetylated peptide as substrate measured after 17 hrs by fluorescence assay\"],[\"Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Displacement of [3H](+)-pentazocine from sigma1 opioid receptor from guinea pig brain cortex after 150 mins by scintillation counting\"],[\"Agonist activity at TLR7 in mouse BMDC cells assessed as immunostimulatory activity by measuring fold increase in IL6 secretion incubated for 18 hrs by ELISA relative to 1V209\"],[\"Maximum displacement of human recombinant CB2 receptor expressed in HEK293 cell membranes at 10 uM incubated for 90 mins by radioligand binding assay\"],[\"Percentage activity of human PKB alpha in the presence of 10 uM of compound and 10 uM of ATP in comparison with control\"],[\"Displacement of [3H]histamine displacement from human histamine H4 receptor expressed in SK-NM-C cells after 60 mins\"],[\"Antagonist potency towards human mu opioid receptor in [35S]GTP-gamma-S, assay\"],[\"Displacement of [3H](+)-Pentazocine from Sigma1 receptor in guinea pig brain membrane by liquid scintillation counting analysis\"],[\"Antagonist activity at rat glucocorticoid receptor in primary hepatocytes assessed as dexamethasone-induced tyrosine amino transferase activity preincubated for 30 mins followed by dexamethasone addition measured after 20 hrs\"],[\"Potentiator activity at wild type CFTR (unknown origin) expressed in HeLa cells\"],[\"Inhibition of human blood AChE using acetylthiocholine as substrate\"],[\"Inhibition of FPPS in human RPMI8226 cells assessed as inhibition of Ras-mediated ERK phosphorylation at 100 uM up to 20 mins by Western blot analysis\"],[\"Displacement of [3H]-CGS- 21680 from human adenosine A2A receptor expressed in HEK cells.\"],[\"Displacement of [125I]CYP from 5HT1B receptor in rat cerebral cortex assessed as remaining radioligand binding at 10 uM after 120 mins by scintillation counting method relative to control\"],[\"Inhibition of TTK (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay\"],[\"Inhibition of human SGLT2\"],[\"Activity of human JNK1-alpha-1 kinase at 1 uM\"],[\"Inhibition of GAL4-fused RORbeta (unknown origin)\"],[\"Inhibition of ovine COX1 using arachidonic acid as substrate assessed as conversion of PGH2 to PGF2alpha after 10 mins by EIA\"],[\"Partial agonist activity at mouse free fatty acid receptor 1 expressed in HEK293 cells assessed as inositol phosphate 1 accumulation incubated for 30 mins\"],[\"Binding affinity to unmodified human BRD4 phosphorylation-dependent interaction domain (287-530) expressed in Sf9 cells assessed as red fluorescence by SDS-PAGE method based one-bead binding assay\"],[\"Inhibition of human TASK3 expressed in CHO cells by Qpatch HT platform based assay\"],[\"Displacement of [3H]PK 11195 from rat heart peripheral-type benzodiazepine receptor at 10 uM\"],[\"Inhibition of human PI3K p110beta by HTRF assay\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IL28A mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Inhibition of recombinant Trypanosoma brucei brucei alternative oxidase using ubiquinol as substrate preincubated for 2 mins followed by substrate addition by UV-Vis spectrophotometry\"],[\"Increase in caspase 3 activation in human K562 cells at 25 uM relative to control\"],[\"Covalent binding affinity to N-terminal His tagged recombinant human XIAP-BIR3 Lys311Ser mutant expressed in Escherichia coli BL21(DE3) cells assessed as change in melting temperature incubated for 6 hrs by by SYPRO orange dye-based thermal shift assay\"],[\"Inhibition of MNK1 (unknown origin) at 0.5 uM relative to control\"],[\"Inhibition of C-terminal tagged human recombinant MMP13 catalytic domain expressed in Escherichia coli using (5-FAM\\u002fQX) FRET peptide as substrate by fluorescence assay\"],[\"Displacement of PRO-128 from recombinant human N-terminal GST\\u002fHis6-tagged FGFR4 (391 to 802 residues) expressed in baculovirus infected Sf9 insect cells assessed as association constant\"],[\"Inhibition of human Neuropeptide Y Y1 receptor at 10 uM by radioligand displacement assay\"],[\"Binding affinity to wild-type human partial length KIT (I571 to D952 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant AChE-induced amyloid beta aggregation at 100 uM by thioflavin T fluorescence method\"],[\"Inhibition of human ROCK1 at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of human DYRK1B assessed as residual activity using RRRFRPASPLRGPPK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of HIF-1alpha in human LN229 cells under hypoxia condition by HRE-luciferase reporter gene assay\"],[\"Inhibition of cSrc in human PC3 cells assessed as reduction of phosphorylated Src Y416 level at 1 to 10 uM after 5 hrs by immunoblot\"],[\"Inhibition of recombinant human aldose reductase using dl-glyceraldehyde as substrate after 10 mins by spectrophotometry\"],[\"Inhibition of human PDGFRalpha (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibitory activity against Toxoplasma gondii dihydrofolate reductase\"],[\"Inverse agonist activity at RORgammat in human TH17 cells assessed as inhibition of IL17 release incubated for 4 days by HTRF assay\"],[\"Inhibition of ATPase activity of SV40 T antigen expressed in baculovirus at 10 uM by antibody affinity chromatography relative to control\"],[\"Positive allosteric modulation at rat muscarinic acetylcholine receptor M1 expressed in CHO cells assessed as potentiation of acetylcholine-induced calcium mobilization\"],[\"Inhibition of SETDB1 (unknown origin) at 10 uM using SAM as substrate measured up to 960 mins by AlphaScreen microplate reader assay relative to control\"],[\"Binding affinity to rat M1 receptor by radio-ligand binding assay\"],[\"Inhibition of wild-type human full length HPK1 (M1 to R799 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Reduced radioligand binding following 30 min intravenous 10 mg\\u002fkg PK11195 in adrenal gland\"],[\"Binding affinity to human CXCR3 receptor\"],[\"Inhibition of recombinant human p300 (unknown origin) using [3H]acetylCoA as substrate measured after 60 mins by microbeta scintillation counting analysis\"],[\"Inhibition of human recombinant HDAC1 using Tosyl-Gly-ProLys(Ac)-AMC as substrate measured after 60 mins by fluorescence assay\"],[\"Inhibition of human ABL1 Q252H non-phosphorylated mutant (229 to 512 residues) expressed in mammalian expression system assessed as activity remaining at 1 uM by KINOMEscan assay relative to control\"],[\"Agonist activity at human recombinant mGlu5 receptor expressed in AV12 cells assessed as stimulation of Ca2+ mobilization after 1 hr by FLIPR assay\"],[\"Inhibition of ovine COX1 assessed as reduction in PGH2 formation by measuring PGF2alpha by colorimetric assay\"],[\"Inhibition of human NPP1 using ATP as substrate at 100 uM after 20 mins by reversed-phase HPLC analysis\"],[\"Inhibition of human recombinant TG1 by fluorescent transamidation assay\"],[\"Inhibition of human CYP1B1 expressed in HEK293 cells by fluorescence assay\"],[\"Agonist activity at human mGluR4 receptor expressed in HEK cells\"],[\"Activity at rat N-type calcium channel up to 10 uM\"],[\"Inhibition of EGFR phosphorylation in human NCI-H1975 cells at 0.01 to 1 uM after 6 hrs by Western blotting analysis\"],[\"Inhibition of human recombinant MAO-A assessed as inhibition of production of hydrogen peroxide at 100 uM after 15 mins by the Amplex Red fluorimetric method\"],[\"Antagonist activity at human recombinant delta opioid receptor expressed in CHO cells coexpressing alphaqi5 assessed as inhibition of DPDPE-induced intracellular calcium mobilization at up to 10 uM\"],[\"Induction of Nrf2 translocation from cytoplasm to nucleus in human HCT116 cells at 20 uM after 4 hrs by Western blot analysis\"],[\"In vitro inhibitory concentration against rat cerebellar neuronal nitric oxide synthase\"],[\"Inhibition of Bos taurus (bovine) brain tubulin polymerization at 200 uM\"],[\"Intrinsic activity at human dopamine 5HT1A receptor expressed in HeLa cells by FLIPR assay\"],[\"Inhibition of jack bean urease assessed as reduction in ammonia production using urea as substrate incubated for 15 mins by indophenol method\"],[\"Inhibition of recombinant amyloid beta (1 to 42) fibrils (unknown origin) by thioflavin-T fluorescence assay\"],[\"Inhibition of human MST1R assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Binding affinity to human NK3 H316W mutant expressed in HEK293 cells assessed as [3H]IP accumulation after 45 mins\"],[\"Inhibition of human intestinal sucrase in human Caco-2 cell membrane\"],[\"Displacement of [3H]-Ketanserin from human 5-HT2A receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method\"],[\"Inhibition of human MKK2 (2 to 400 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay\"],[\"Binding affinity at rat striatal Dopamine receptor D1 using [3H]- SCH-23390 radioligand\"],[\"Inhibition of porcupine-mediated Wnt signaling in mouse L-cells at 1 uM after 24 hrs by springerImage-Topflash reporter assay\"],[\"In vitro inhibitory activity against HIV-1 reverse transcriptase at 100 uM\"],[\"Inhibition of human liver LDHA using sodium pyruvate as substrate after 5 mins in presence of NAPDH and in absence of EDTA by diaphorase\\u002fresazurin based fluorescence assay\"],[\"Displacement of [3H]-DPCPX from human A1 receptor expressed in HEK293 cell membranes at 1 uM after 90 mins radioligand binding assay relative to control\"],[\"Agonist activity at glucocorticoid receptor in human fibroblast assessed as inhibition of IL-1-beta-induced IL6 production at 100 nM treated 1 hr before IL1-beta challenge measured after 24 hrs by transrepression assay\"],[\"Inhibition of D3 receptor (unknown origin)\"],[\"Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorescence assay relative to control\"],[\"Inhibition of EGFR L858R mutant in human PC9 cells assessed as reduction in AKT phosphorylation incubated for 4 hrs by Western blot analysis\"],[\"Inhibition of ABL (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control\"],[\"Inhibition of rat synaptosome SERT assessed as reduction in [3H]5-HT uptake\"],[\"Inhibition of wild-type human partial length CAMK1B (W9 to A311 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of BRPF3 (592 to 711 residues) (unknown origin) using biotin-acetylated histone H4 peptide as substrate after 30 mins by AlphaScreen assay\"],[\"Binding affinity against human Melatonin receptor type 1B by using 2-[125I]iodomelatonin as radioligand\"],[\"Binding affinity to rat recombinant adenosine A1 receptor\"],[\"Inhibition of recombinant human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control\"],[\"Inhibition of wild-type human partial length ANKRD3 (M1 to V303 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of human JNK3 assessed as enzyme activity at 1 uM relative to control\"],[\"Inhibition of human plasmin assessed as dissociation rate constant using Ac-RM(O2)YR-pNA as substrate after 30 mins\"],[\"Agonist activity at human FSH receptor by aromatase-based assay\"],[\"Inhibition of PAR1 in human washed platelets assessed as suppression of TRAP-induced platelet aggregation at 10 to 1000 nM preincubated for 5 mins followed by TRAP stimulation after 10 mins by light transmission aggregometric analysis\"],[\"Inhibition of atypical PKCiota (unknown origin) using CREBtide as substrate incubated for 1 hr measured every 2.5 mins by ADP Quest assay\"],[\"Irreversible inhibition of 1-(4-((2-((4-(4-(but-3-yn-1-yl)piperazin-1-yl)phenyl)amino)-5-(6-(methylamino)pyrazin-2-yl)-7H-pyrrolo [2,3-d]pyrimidin-4-yl)oxy)piperidin-1-yl)prop-2-en-1-one probe binding to recombinant human ITK at 20 uM preincubated for 2 hrs followed by probe addition and measured after 3 hrs by TAMRA azide-based fluorescence assay\"],[\"Binding affinity to carbonic anhydrase 9 in human MDA-MB-231 cell lysate at 5 uM preincubated for 3 hrs in dark followed by irradiation with LED UV flashlight at 365 nm for 30 mins by biotin-azide\\u002fneutravidin agarose gel based Western blot analysis\"],[\"Inhibition of recombinant human CYP1A1 expressed in Escherichia coli membranes co-expressing NADPH-P450 reductase assessed as reduction in ethoxyresorufin O-de-ethylation preincubated for 3 mins followed by NADPH addition and measured after 10 mins by fluorometric method\"],[\"Inhibition of wild-type human partial length MYO3A (M1 to K338 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of mouse myosin 5a by NADH-coupled spectrophotometric analysis\"],[\"Agonist activity at GPR40 in mouse MIN6 cells assessed as increase in glucose-stimulated insulin secretion at 10 uM measured after 2 hrs in presence of GPR40 antagonist GW-100 by ELISA\"],[\"Displacement of [3H]DPCPX from human Adenosine A2B receptor expressed in HEK293 cells; range 67-115\"],[\"Inhibition of PAK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"Inhibition of recombinant human NEK9 (1 to 324 residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 10 uM incubated with substrate for 6 hrs prior compound addition by HTRF assay\"],[\"Inhibition of human DNA ligase 1 using 52-mer DNA\\u002f25-mer DNA\\u002f27-mer DNA as substrate\"],[\"Displacement of mouse MDC from recombinant CCR4 receptor expressed in CHO cells coexpressing G-alpha-16 by FLIPR assay\"],[\"Inhibition of N-terminal GST-tagged human full length HDAC6 expressed in baculovirus infected sf9 insect cells using fluorogenic HDAC substrate3 as substrate incubated for 30 mins by\"],[\"Noncompetitive inhibition of mushroom tyrosinase assessed as inhibitory constant for enzyme-substrate complex using varying levels of L-dopa as substrate preincubated for 10 mins followed by substrate addition and measured for 1 min by Lineweaver-burk plot analysis\"],[\"Inhibition of recombinant human GST-tagged CLK1 catalytic domain (129 to 484 residues) expressed in Escherichia coli expression system in presence of 25 uM ATP\"],[\"Inhibition of DNA-tagged human BMX assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of cKit (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control\"],[\"Inhibition of KIT (unknown origin) using biotinylated peptide substrate\"],[\"Antagonist activity at recombinant human TRPV1 expressed in CHOK1 cells assessed as reduction in low pH-induced Ca2+ flux after 15 mins by fluo-4-based FLIPR assay\"],[\"Inhibition of Cyp51 in Candida albicans ATCC SC5314 assessed as obtusifoliol content at 0.125 ug\\u002fml after 16 hrs by GC-MS analysis (Rvb = 0.6%)\"],[\"Inhibition of recombinant human GST-tagged PDGFR-beta (557-end residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins\"],[\"Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells\"],[\"Inhibition of P-gp-mediated Rho-123 efflux in human Lucena 1 cells at 12.5 uM preincubated for 1 hr followed by Rho-123 addition measured after 1 hr by flow cytometry\"],[\"Inhibition of JARID1A (unknown origin) after 30 mins by AlphaScreen assay\"],[\"Binding affinity to human adrenergic beta2 receptor by radioligand binding assay\"],[\"Agonist activity at human melanocortin receptor 4 expressed in human T-REx-293 cells using high doxycycline assessed as stimulation of intracellular cAMP accumulation incubated for 45 mins by LANCE cAMP assay\"],[\"GluN2C-containing NMDA receptor (Ca2+ influx) assay (potentiation)\"],[\"Effective concentration determined against melanocortin-4 receptor\"],[\"Displacement of [35S](2S,3S,4S,5R,6S)-6-(4-((2S,3R)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-1-(4-(3-(methylsulfonamido)prop-1-ynyl)phenyl)-4-oxoazetidin-2-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid from rat intestinal brush border membrane NPC1L1 by single tube filtration assay\"],[\"SFRS protein kinase 2 Millipore kinase panel\"],[\"Inhibition of beef liver dihydrofolate reductase by amide-linked conjugate (regiospecific coupling) of MTX (4 M\\u002fM of IgG)and IgG1 in experiment 1\"],[\"Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of osmotic cell shrinkage-induced NHE1 activity in Pleuronectes americanus RBC upto 100 uM\"],[\"Displacement of [3H]resiniferatoxin from human TRPV1\"],[\"Inhibition of Matrix metalloprotease-2\"],[\"Inhibition of CDK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC\\u002fMS analysis\"],[\"Inhibition of PAK4 (unknown origin) using histone H3 as substrate\"],[\"Activation of NRF2 in mouse BV2 cells assessed as inhibition of LPS-stimulated iNOS expression preincubated for 3 hrs followed by LPS stimulation for 24 hrs by Western blot analysis\"],[\"In vitro inhibitory concentration against human COX-1 (Cyclooxygenase-1)\"],[\"Inhibition of radioligand binding to human KOR at 10 uM\"],[\"Antagonist activity at human GCGR assessed as inhibition of glucagon-induced cAMP accumulation in cell-based assay\"],[\"Binding affinity to wild-type human partial length CAMK2A (M1 to K328 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"V1A\\u002fHUM Cerep selectivity data (BI)\"],[\"Antagonist activity at CCR1 in human THP1 cells assessed as inhibition of CCL5\\u002fRANTES-induced chemotaxis\"],[\"Inhibition of TYR activity in mouse B16 cells assessed as increase in whitening at 20 uM preincubated for 72 hrs followed L-dopa substrate addition and measured after 4 hrs by fluorescence microscopy\"],[\"Inhibition of recombinant human full length His-tagged JNK2 expressed in baculovirus expression system at 3 uM by Z'-LYTE assay relative to control\"],[\"Agonist activity at human adenosine A2B receptor by cAMP assay\"],[\"Binding affinity to 3-hydroxyisobutyrate dehydrogenase in human MDA-MB-468 cells at 10 uM incubated for 2 hrs in presence of 12-amino-2-[4-[(1S)-1-[(4,5-dichloro-1,6-dimethyl-indole-2-carbonyl)amino]-2-hydroxy-ethyl]phenyl]sulfonyl-dodecanoic acid by quantitative chemical proteomics assay\"],[\"Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs\"],[\"Displacement of [3H](+)pentazocine from human sigma1-receptor at 10 uM after 120 mins by scintillation counting\"],[\"Displacement of [3H]diprenorphine from mouse delta opioid receptor expressed in CHO cells at 10 uM\"],[\"Inhibition of recombinant human CRIK at 200 nM using Ulight-ARTKQTARKSTGGKAPRKQLAGCG as substrate measured after 30 mins by LANCE method relative to control\"],[\"D2S\\u002fHU Eurofins-Panlabs selectivity data (BI)\"],[\"Binding affinity to human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1\\u002fGalphai1 relative to NECA\"],[\"Inhibition of recombinant human carbonic anhydrase 2 using p-nitrophenylacetate as substrate measured at 3 mins interval by spectrophotometric method\"],[\"Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis\"],[\"Binding affinity to human H4R expressed in HEK293T-SF-His6-CRE-Luc cells assessed as dissociation rate constant by saturation binding study\"],[\"Inhibition of human PIM2 assessed as residual activity using RSRHSSYPAGT as substrate at 1 uM after 30 mins\"],[\"Inhibition of rat liver lysosome alpha-glucosidase assessed as D-glucose release at 1000 uM after 30 mins by Glucose B-test\"],[\"Inhibition of N-terminal GST tagged full length human PARP6 expressed in baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone as substrate at 10 uM incubated for 1 hr in presence of biotinylated NAD+ and activated DNA by chemiluminescence based microplate reader assay relative to control\"],[\"Binding affinity to human partial length KIT V559D\\u002fT670I double mutant (Y545 to D952 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to human recombinant Abl\"],[\"Inhibition of GRP94 in human PANC1 cells assessed as down-regulation of integrin alpha2 levels after 36 hrs by Western blot analysis\"],[\"Inhibition of BRD4 in human HCT116 cells assessed as induction of autophagy by measuring p62 degradation at 0.5 uM measured after 24 hrs by Western blot analysis\"],[\"Inhibition of wild-type human full length GRK4 (M1 to C578 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of full-length recombinant human GST-tagged IKK-beta expressed in baculovirus expression system by Z'-LYTE assay\"],[\"Displacement of [3H]-SCH- 58261 binding at human Adenosine A2A receptor expressed in HEK293 cells; ranges from 3.4-4.2\"],[\"Inhibition of COX-2 in rabbit peripheral venous blood assessed as formation of 12-hydroxyheptadecatrienoic acid after 24 hrs in by HPLC presence of calcium ionophore A23188 and lipopolysaccharide\"],[\"Inhibition of recombinant human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay\"],[\"Binding affinity to Escherichia coli beta-lactamase in phosphate buffer at pH 7.4 at 6 10'-5M after 3 mins by fluorescence titration analysis\"],[\"Inhibition of MEK2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Inhibitory activity against cdc25B phosphatase at 10 uM\"],[\"Inhibition of human EPHA8 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Agonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling by fura 2-based digital epifluorescence microscopy\"],[\"Inhibition of SK3 in human MDA-MB-435 cells harboring SK3 shRNA assessed as reduction in Ca2+ influx at 1 uM measured after 1 hr by Fura2-AM dye based fluorescence assay\"],[\"Inhibition of S110B binding to human RAGE domain V expressed in CHO cells\"],[\"Inhibition of dCK in mouse L1210 cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake\"],[\"Inhibition of wild type recombinant human histone lysine methyltransferase GLP (951 to 1235 residues) expressed in Escherichia coli Rosetta BL21 DE3 PlysS assessed as zinc ions ejection from Cys4-Zn finger at 100 uM by FluoZin-3 based fluorescence assay\"],[\"Inhibition of recombinant mouse ATX expressed in HEK293 cells using LPC 17:0 as substrate after 30 mins by LC-MS\\u002fMS method\"],[\"Binding affinity to TSPO in white matter of patient with Alzheimer's disease\"],[\"Inhibition of human recombinant MST4\"],[\"Inhibition of human full length recombinant BRK using poly (Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis\"],[\"Inhibition of human UCHL1 at 31 uM\"],[\"Inhibition of recombinant human full length GST-tagged GRK7 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay\"],[\"Affinity for porcine Vitamin D3 receptor\"],[\"Inhibition of His-tagged BRD9 (unknown origin) after 30 mins by alphaScreen assay\"],[\"Inhibition of mouse recombinant IRAP using L-leucine-7-amido-4-methyl coumarin as substrate after 5 to 10 mins by fluorescence assay\"],[\"Inhibitory effect on Lactobacillus casei thymidylate synthase\"],[\"Displacement of [3H]-N-Methylscopolamine from human M3 receptor expressed in CHOK1 cells\"],[\"Displacement of [125I]MCH from MCHr1 expressed in IMR32 cells\"],[\"Inhibition of human Cav1.2\"],[\"Inhibition of human wild type EGFR at 1 uM by qPCR analysis\"],[\"Inhibition of IDH1 (unknown origin) using isocitrate as substrate after 60 mins by resazurin dye based fluorescence assay\"],[\"Irreversible inhibition of IKKbeta (unknown origin) using IkappaBalpha-derived 5FAMGRHDSGLDSMK-NH2 as substrate measured after 60 mins\"],[\"Induction of degradation of human ERalpha in human MCF7 cells by generation of singlet oxygen at 1 uM in presence of dithiothreitol by fluorescent probe based DCFH-DA assay\"],[\"Displacement of [3H]-diprenorphine from rat delta-type opioid receptor expressed in rat C6 cell membranes incubated for 1 hr in shaker by liquid scintillation counting method\"],[\"Inhibition of MAP3K6 (unknown origin) at at 1 uM relative to control\"],[\"Inhibition of recombinant human BACE1 (Ala8P to Ala326 residues) expressed in Escherichia coli BL21(DE3) using Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys (Dabcyl)-Arg as substrate by fluorescence assay\"],[\"Inhibition of delta opioid receptor (unknown origin) at 10 uM by PDSP assay relative to control\"],[\"In vivo receptor occupancy at CB1 receptor in mouse cerebellum assessed as inhibition of [3H]SR141716A binding at 30 mg\\u002fkg, po for 3 days measured after 1 hr post last dose\"],[\"Inhibition of recombinant human GST-tagged RET cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control\"],[\"EPHA4 ProQinase selectivity panel\"],[\"Displacement of [3H](S)-N-(2-(1H-pyrrol-1-yl)phenyl)-1-(2-(1-methyl-1H-benzo[d]imidazol-2-ylthio)acetyl)pyrrolidine-2-carboxamide from human OX2R expressed in CHOK1 cell membranes\"],[\"Inhibition of PASK (unknown origin) at 1 uM relative to control\"],[\"Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method\"],[\"Inhibition of wild-type human partial length MYO3B (M1 to D357 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Induction of c-Myc degradation in human HL-60 cells assesses as decrease in c-Myc protein level measured after 24 hrs by Western blot analysis\"],[\"Inhibition of SHP1 (unknown origin) assessed as inhibition rate at 90 uM\"],[\"Inhibition of N-terminal His6-tagged human PHGDH (4 to 315 residues) assessed as effect on NADH fluorescence incubated for 2 hrs using 3-PG substrate in presence of 250 uM NAD+ and PSAT1 by diaphorase based luminescence assay\"],[\"Displacement of [125I]APT from recombinant human histamine H2 receptor expressed in CHO cells at 1 uM after 120 mins by scintillation counting analysis relative to control\"],[\"Inhibition of human recombinant 11 beta HSD2 assessed as conversion of cortisol to cortisone measured 40 mins post-cortisol addition by fluorescent plate reader analysis\"],[\"Inhibitory activity against rat liver Dihydrofolate reductase\"],[\"Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis at 37 degC by spectrophotometrically\"],[\"Inhibition of Arbidopsis thaliana C-terminal His-tagged FAE1 expressed in Saccharomyces cerevisiae INVSc1 after 18 to 20 hr by GC\\u002fMS analysis\"],[\"Activation of NRF2 in mouse BV2 cells assessed as increase in HO1 protein expression at 3 uM incubated for 6 hrs by Western blot analysis\"],[\"Inhibition of NorA efflux pump in Staphylococcus aureus 1199 assessed as fold reduction of ciprofloxacin MIC at 6.25 ug\\u002fml\"],[\"Inhibition of SUV39H2 (unknown origin) up to 100 uM\"],[\"Binding affinity to BRD4 bromodomain-2 (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetric analysis\"],[\"Antagonist activity at human CXCR4 D171N mutant expressed in COS7 cells coexpressing G protein Gqi4myr assessed as inhibition of CXCL12-induced phosphatidylinositol turnover\"],[\"Binding affinity to human dopaminergic D3 receptor\"],[\"Inhibition of human N-terminal GST-tagged HDAC7 (518 to end residues) expressed in baculovirus infected Sf9 insect cells using Boc-Lys-TFA as substrate measured after 60 mins by fluorescence assay\"],[\"Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHOK1 cells at 10 uM incubated for 60 mins by radiometric enzymatic assay relative to control\"],[\"Agonist activity at mouse TGR5 expressed in CHO-K1 cells after 5 hrs by luciferase reporter gene assay\"],[\"Binding affinity to human His10-tagged CREBBP expressed in Escherichia coli BL21(DE3)-R3 using 3% DMSO by SPR assay\"],[\"Antagonist activity at ERalpha in human MCF7 cells assessed as reduction in E2-induced progesterone receptor mRNA expression at 1 uM by SYBR green dye based RT-PCR method\"],[\"Displacement of BODIPY-Bak conjugated peptide from GST-tagged human Bcl-2-like protein 1 A142G mutant expressed in Escherichia coli BL21 cells at 40 uM after 3 hrs by fluorescence polarization competition assay\"],[\"Inhibition of PI3K p110alpha (unknown origin) at 1 uM relative to control\"],[\"Inhibition of verapamil-stimulated ATPase activity of mouse cysteine-less MDR3\"],[\"Binding affinity to N-terminal His-tagged recombinant human CDK2 (1 to 298 amino acid residues) expressed in Escherichia coli BL21 assessed as inhibition of interaction with cyclin A3 by measuring 250 uM HHASPRK phosphorylation by ADP-Glo Max assay in presence of 750 uM ATP\"],[\"Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHOK1 cells after 60 mins\"],[\"Inhibition of CYP26A1 in human HepG2 cells assessed as upregulation of RARbeta mRNA expression at 1 uM after 24 hrs in presence of 100 nM atRA by RT-PCR method\"],[\"Inhibition of human DNA topoisomerase IIalpha assessed as reduction in enzyme-catalyzed supercoiling of relaxed circular pBR322 DNA by measuring linear DNA level at 125 uM after 60 mins by agarose gel electrophoresis\"],[\"Inhibition of human recombinant full-length HDAC1 using fluorophore conjugated substrate by fluorescence assay\"],[\"Intrinsic activity at human muscarinic M5 receptor expressed in CHO cells coexpressing Gq protein up to 30 uM by calcium mobilization assay in absence of acetylcholine\"],[\"Inhibition of Wee1 (unknown origin) at 1 uM relative to control\"],[\"Displacement of [3H]2-OG from human MGL at 2 uM treated for 30 mins before addition of 2-OG by liquid scintillation counting\"],[\"Activation of recombinant human ALDH1B1 using propionaldehyde as substrate at 100 uM preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis\"],[\"Displacement of [3H] N-methylscopolamine from human muscarinic M1 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis\"],[\"Inhibition of Staphylococcus aureus recombinant FabI using trans-2-octenoyl N-acetylcysteamine thioester as substrate preincubated for 60 mins\"],[\"Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after 2 hrs\"],[\"Inhibition of STS in human JEG3 cells at 10 uM using [6,7-3H]E1S as substrate after 3 hrs by liquid scintillation spectrometry\"],[\"Inhibition of recombinant human N-terminal GST-tagged full length SAPK2alpha expressed in Escherichia coli at 10 uM\"],[\"Inhibition of human recombinant PDE4B2 using fluorescein 3',5'-cyclic phosphate after 60 mins by IMAP fluorescence polarization assay\"],[\"Agonist activity at ER in human MCF7:WS8 cells assessed as pS2 gene expression at 10'-6 M after 48 hrs by RT-PCR analysis\"],[\"Inhibition of human ERG expressed in CHO-K1 cells by Qpatch assay\"],[\"Inhibition of full length ROR gamma (unknown origin) expressed in HEK293T cells cotransfected with 5X-RORE-luc assessed as suppression of Il17 promoter transcriptional activity after 20 hrs by luciferase reporter gene assay\"],[\"Inhibition of c-KIT (unknown origin) using poly(Glu,Tyr) as substrate preincubated for 60 mins prior to substrate addition measured after 2 to 4 hrs by luciferase-coupled chemiluminescence assay\"],[\"Inhibition of PASK (unknown origin) at 1 uM in presence of 100 uM ATP\"],[\"Inhibition of FGFR1 (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay\"],[\"Percent activity of eel acetylcholinesterase on 4 hours of incubation with 5 uM at 25 degree C followed by reactivation occurring spontaneously after 20h\"],[\"Inhibition of STAT3 in human MDA-MB-231 cells assessed as inhibition of Bcl-2 expression at 1 to 3 uM incubated for 3 to 24 hrs by immunoblotting analysis\"],[\"Binding affinity to human EP1 receptor by competitive binding assay\"],[\"Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay\"],[\"Percentage activity of human Fyn in the presence of 10 uM of compound and 10 uM of ATP in comparison with control\"],[\"Inhibition of AKT1 (unknown origin) at 200 nM by electrophoretic mobility shift assay\"],[\"Binding Affinity for Adenosine A1 receptor expressed in CHO-K1 cells compared to [3H]CCPA\"],[\"Inhibition of human TRPV1\"],[\"Agonist activity at PXR (unknown origin) by Gal4-Luc reporter gene assay)\"],[\"Inhibition of HDAC6 in human HCT116 cells assessed as increase in acetylated tubulin levels at 0.03 to 3 uM after 24 hrs by Western blot analysis\"],[\"Binding affinity to SK1 (unknown origin) assessed as inhibition of sphingosine phosphorylation\"],[\"Inhibition of electric eel AChE using acetylthiocholine chloride substrate as substrate preincubated for 15 mins by Ellman's method\"],[\"Activation of human PKM2 assessed as effect on Km of ADP at 10 uM by after 6 mins by fluorescent pyruvate kinase-lactate dehydrogenase coupled assay\"],[\"Inhibition of 6His\\u002fthrombin cleavage site-fused Avi-tagged dephosphorylated MER (unknown origin) (R528 to M999 residues) at 1 uM using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 120 mins by RapidFire LC-MS analysis relative to control\"],[\"Activation of human PPARalpha assessed as receptor-GST-TIF2 interaction by GST pull down assay\"],[\"Inhibition of recombinant human TAO1 (1 to 327 residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of human NEK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of ram seminal vesicle COX-1 assessed as PGE2 production from arachidonic acid after 20 mins enzyme immunoassay\"],[\"Inhibition of HDAC8 in human HeLa cells using Fluor-de-Lys as substrate up to 10 uM after 15 mins by fluorescence assay\"],[\"Inhibition of beta-galactosidase (unknown origin) by spectrophotometry\"],[\"Inhibition of human RSK2 at 10 uM relative to control\"],[\"Binding affinity to pig dopamine D1 receptor\"],[\"Inhibition of human IDO1\"],[\"Inhibition of NFkappaB p65 in human EOL-1 cells at 10 uM after 72 hrs by immunoblotting method\"],[\"Displacement of [33P]-S1P from human S1P4 receptor expressed on CHO-K1 cell membranes after 60 mins by scintillation counting method\"],[\"Binding affinity determined against trypsin by Dixon method\"],[\"Binding affinity to His-tagged human recombinant FABP4 expressed in Escherichia coli BL21 (DE3) at 0.1 mM by 1H-15N HSQC NMR spectroscopy\"],[\"Inhibition of human placenta beta-N-acetylglucosaminidase\"],[\"Inhibition of human ABCB1 expressed in NCI-ADR-RES cells assessed as potentiation of vincristine-induced cytotoxicity by measuring vincristine IC50 at 1000 nM after 72 hrs by MTT assay (Rvb = 3714.80 +\\u002f- 383.58 nM)\"],[\"Inhibition of recombinant human His-tagged KIT cytoplasmic domain (544 to 976 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control\"],[\"Activity of TMPK in human CEM cells assessed as level of triphosphate metabolites per 10^6 cells at 2 uM after 12 hrs\"],[\"Inhibition of human myc-TNNI3K expressed in HEK-MSR2 cells assessed as reduction in TNNI3K autophosphorylation preincubated for 30 mins followed by pervanadate addition and measured after 20 mins by DELFIA\"],[\"Antiandrogenic activity against human PC3 cell line transfected with wild-type AR by AR transactivation assay\"],[\"Binding affinity to wild-type human partial length HIPK2 (M153 to S564 residues) expressed in mammalian expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control\"],[\"Agonist activity at mouse MC5R expressed in HEK293 cells by cAMP functional bioassay\"],[\"Activity at 0.28 uM Aspergillus fumigatus FtmPT1 assessed as compound conversion at 1 mM after 2 hrs by HPLC analysis in presence of dimethylallyl diphosphate\"],[\"Substrate activity at human EAAT1 expressed in HEK293 cells assessed as increase in fluorescence level at 300 uM incubated for 30 mins by fluorescence-based FLIPR membrane potential blue assay\"],[\"Inhibition of human f10a using Mes-DArg-Pro-Arg-AMC as substrate by Dixon plot analysis\"],[\"Slow-binding inhibition of cobalt-substituted Escherichia coli PDF\"],[\"Inhibition of human CD38 extracellular domain expressed in Pichia pastoris using CHAPS and NAD by colorimetric-based assay\"],[\"Stimulation of [35S]GTP gamma-S binding in CHO cell membranes expressing human A3 receptor at 78.8 uM\"],[\"Binding affinity to Bcl-2 (unknown origin) by fluorescence polarization competition assay\"],[\"Antagonist activity on agonist stimulated [35S]GTP-gamma-S, binding in guinea pig caudate membranes (10 uM DAMGO as the agonist ligand for Mu-receptor)\"],[\"Inhibition of LyP in human Jurkat TAg T cells assessed as inhibition of TCR-induced ITAM zeta phosphorylation at 30 uM after 45 mins by immunoblotting\"],[\"Inhibition of recombinant full-length human ZAK at 1 uM using MBP as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Competitive inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as reduction in benzoquinone-mediated BoNT\\u002fA inactivation by SNAPtide FRET based assay\"],[\"Reversible inhibition of human recombinant MAOA assessed as 4-hydroxyquinoline formation by fluorimetry\"],[\"Inhibition of recombinant human AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured after 5 mins\"],[\"Inhibition of recombinant full length GST-tagged human BRAF expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control\"],[\"Inhibition of human neutrophil elastase using Suc(OMe)-AAPV-pNA as substrate after 30 mins\"],[\"Agonist activity at human 5HT6 receptor expressed in CHOK1 cells assessed as increase in 5HT-induced intracellular calcium level at 0.1 to 10 uM by FLIPR assay\"],[\"Inhibition of human recombinant PDE10A expressed in baculovirus-SF21 cell system assessed as hydrolysis of [3H]cAMP after 1 hr by liquid scintillation counting\"],[\"Inhibition of KRAS-PDEdelta interaction in unstimulated KRAS-dependent human Capan1 cells assessed as downregulation of unstimulated AKT phosphorylation at S473 at 10 uM after 1 hr by Western blot analysis\"],[\"Inhibition of EGF-induced EGFR phosphorylation in human A431 cells pretreated for 1 hrs followed by EGF-stimulation by immunoblot analysis\"],[\"Inhibition of human COX2\"],[\"Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting\"],[\"Inhibition of BRD4 BD2 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay\"],[\"Reduction of HSP1 dephosphorylated at S326A mutant stability in human NCI-H460 cells up to 7.5 hrs by Western blot analysis in presence of cyclohexamide\"],[\"Inhibition of human ROCK2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human monocyte COX2 by whole blood assay\"],[\"Inhibition of human recombinant LSD1 (157 to 852 aa) expressed in Escherichia coli BL21(DE) using H3K4me2 as substrate at 0.5 to 12.5 uM after 60 mins\"],[\"Inhibition of recombinant human C-terminal FLAG-tagged FBXL11 expressed in baculovirus infected Sf9 cells using H3K36me2-biotin labelled peptide as substrate measured after 1 hr by AlphaScreen assay\"],[\"Antagonist activity at P2Y1 receptor in human platelets by FLIPR assay in presence of 2-methylthio-ADP\"],[\"Inhibition of human GST-rTEV-tagged IGF1R (957 to 1367 residues) expressed in baculovirus infected insect Sf9 cells assessed as decrease in biotin-aminohexyl-AEEEEYMMMMAKKKK-NH2 phosphorylation after 1 hr by fluorometer\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 6 mins followed by substrate addition measured up to 180 secs by spectrophotometric-based Ellman's method\"],[\"Inhibition of wild-type human partial length WNK2 (V47 to D482 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Agonist activity at rat mGlu7 receptor at 10 uM by thallium flux assay relative to L-AP4\"],[\"Stability constant for DNA topoisomerase I complex in competitive DNA assay\"],[\"Inhibition of recombinant human carbonic anhydrase 1 at 10 uM preincubated for 15 mins by phenol red dye based stopped flow CO2 hydration assay (Rvb = 0%)\"],[\"Inhibition of AChE-induced amyloid beta 40 (unknown origin) aggregation at 100 uM by thioflavin-T fluorescence assay relative to control\"],[\"Displacement of [14C]Gly-Sar from human PEPT1 in Caco-2 cells\"],[\"Displacement of [125I]-pyr-1-apelin-13 from EGFP-tagged wild-type rat apelin receptor expressed in CHO cell membranes by gamma counting method\"],[\"Inhibition of TRKC (unknown origin) at 100 nM\"],[\"Transactivation of glucocorticoid receptor in human SKGT4 cells at 100 uM after 16 hrs by luciferase reporter gene assay\"],[\"Inhibition of survivin homodimerization in human PC3 cells assessed as increase in survivin degradation by measuring survivin half life at 10 uM incubated up to 6 hrs in presence of cycloheximide by Western blot analysis (Rvb = 2.2 hrs)\"],[\"Inhibition of N-terminal His6-tagged SIRT1 I347A mutant (unknown origin) expressed in Escherichia coli BL21(DE3) using ac-RHKKac-AMC as substrate after 45 mins by fluorometric analysis\"],[\"Displacement of [3H]-ketanserin from 5HT2A receptor (unknown origin)\"],[\"Inhibition of recombinant human DMPK (1 to 549 residues) at 1 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Agonist activity at the mutant MC4R F184A expressed in HEK293 cells by cAMP accumulation\"],[\"Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control\"],[\"Inhibition of full length recombinant rat LOXL2 expressed in CHO cells assessed as reduction in H2O2 production using DAP as substrate preincubated for 2 hrs followed by substrate addition measured every 2 minutes for 50 minutes in presence of BSA by Amplex red dye based fluorescence assay\"],[\"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry\"],[\"Inhibition of HDAC1 in human Hep3B cells assessed as increase in p53 phosphorylation at Ser15 residue at 1 to 5 uM after 48 hrs by Western blot method\"],[\"Induction of ERalpha degradation in human MCF7 cells by immunofluorescence assay\"],[\"Inhibition of human sEH using cyano(6-methoxynaphthalen-2-yl)methyl((3-phenyloxiran-2-yl)methyl)carbonate as a substrate assessed as reduction in 6-methoxynaphthaldehyde formation by fluorescence microplate reader assay\"],[\"Inhibition of human HDAC11 using fluorogenic peptide Class2a Substrate (Boc-Lys(trifluoroacetyl)-AMC) as substrate by fluorescence method\"],[\"Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated luciferase expression at 50 uM after 24 hrs in presence of p38 inhibitor SB203580\"],[\"TESK2 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Binding affinity to human BRD4 1\\u002f2 bromodomain by fluorescence anisotropic assay\"],[\"Inhibition of beef liver dihydrofolate reductase by amide-linked conjugate of MTX (4 M\\u002fM of IgG) and rabbit IgG (NRG) in experiment 2\"],[\"Activity of human MRCKbeta kinase at 1 uM\"],[\"Inhibition of adrenergic alpha2C receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay\"],[\"Inhibition of human USP7 using Ub-rhodamine 110 as substrate\"],[\"Inhibition of human BLK assessed as enzyme activity at 1 uM relative to control\"],[\"Inhibition of human recombinant HDAC1 at 10 uM preincubated for 10 mins followed by addition of substrate fluor De Lys SIRT1 deacetylase measured after 30 mins by fluorescent plate reader analysis relative to control\"],[\"Inhibition of bovine C-terminal truncated GRK5 (561 residues) assessed as decrease in phosphorylation of urea-washed bovine rod outer segments preincubated for 30 mins followed by ATP addition and light exposure measured after 5 to 10 mins by SDS-PAGE analysis\"],[\"Inhibition of human recombinant full length GST-tagged MAPK1 expressed in Escherichia coli\"],[\"Binding affinity to exonuclase deficient human recombinant DNA polymerase gamma E200A mutant\"],[\"Agonist activity for retinoic acid receptor RXR beta in transcriptional activation assay; NA=Not active\"],[\"Inhibition of EGFR at 1 uM\"],[\"Inhibition of sulfasalazine-stimulated ABCB1 ATPase activity (unknown origin) expressed in baculovirus infected Sf9 insect cells using ATP as substrate measured after 1 hr by colorimetric assay\"],[\"Displacement of [3H]MSX2 from adenosine A2A receptor in rat striatal membrane at 3 uM\"],[\"Inhibition of AURKA in human HCT116 cells assessed as reduction in PLK1 phosphorylation measured after 24 to 48 hrs by Western blot analysis\"],[\"Inhibition of human ERG binding\"],[\"Inhibition of TNAS binding to human sepiapterin reductase by 19F-NMR spectra analysis\"],[\"Inhibition of rat intestinal alpha-glucosidase using para-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 5 min prior to substrate addition measured after 5 min by spectrophotometric analysis\"],[\"Inhibitory concentration against human immunodeficiency virus type 1 reverse transcriptase\"],[\"Inhibition of human SIRT-1\"],[\"Binding affinity to recombinant SIRT2 (unknown origin) assessed as detection of tryptic peptide with amino acid sequence 175-IAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMK-210 at 400 uM in presence of NAD+ and peptide substrate by LC-MS\\u002fMS method\"],[\"Inhibition of recombinant human wild-type N-terminal His-tagged PDIA1 expressed in Escherichia coli strain BL21(DE3) at 10 uM using bovine insulin as substrate preincubated for 1 hr followed by substrate addition in presence of N-acetyl cysteine\"],[\"Ratio of compound IC50 to Aliskiren hemifumarate IC50 for human plasma renin\"],[\"Inhibition of human recombinant PLK-1 T210D mutant after 90 mins by DELFIA Kinase Assay\"],[\"Inhibition of recombinant full-length human SAPK3 at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of GAL4-fused human PPARdelta transcriptional activity expressed in CHOK1 cells after 2 days by luciferase reporter gene assay\"],[\"Inhibition of GST fused human Hdm2 in human RPE cells at 1 to 10 uM after 8 hrs by immunoblotting\"],[\"Inhibition of 5-HT transporter (unknown origin) at 1 uM relative to control\"],[\"Inhibition of BLM in human HCT116 cells assessed as potentiation of cisplatin-induced cytotoxicity by measuring combination index at 1 to 2 uM measured after 48 hrs by MTT assay\"],[\"Displacement of [3H]-di-o-tolylguanidine from sigma2 receptor in rat liver membranes incubated for 120 mins by scintillation counting method\"],[\"Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of human COX2 at 10 uM preincubated for 5 mins measured after 5 mins\"],[\"Activity at human 5HT6 receptor at 10 uM\"],[\"Inhibition of human KDR cytoplasmic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of human SGK1 assessed as residual activity at 10 uM using KGSGSGRPRTSSFAEG as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of COX-2 in PH-PDT-treated mouse RIF1 cells assessed as suppression of PGE2 production at 800 uM after 24 hrs by spectrophotometric analysis\"],[\"Activity of human UCK1 expressed in Huh7 cells assessed as phosphorylation up to 1 mM by coupled enzyme assay\"],[\"Binding affinity to presenilin-1 in UV irradiated human HeLa cells assessed as enzyme photolabeling at 10 uM in presence of 2 uM L-685,458 by SDS-PAGE based photocross linking study\"],[\"Inhibition of recombinant Yersinia enterocolitica YopH using p-nitrophenyl phosphate as substrate preincubated for 10 mins followed by substrate addition and measured every minute for 10 mins by UV-VIS spectrophotometric analysis\"],[\"Inhibition of LPS\\u002finterferon gamma-stimulated TNFalpha release from HPBMC\"],[\"Inhibition of wild type HIV1 p66\\u002fp51 reverse transcriptase assessed as apparent Km of substrate at 150 nM using 10 to 500 uM poly(rA)\\u002foligo(dT) as templates in presence of fixed concentration of [3H]dTTP by Michaelis-Menten analysis (Rvb = 49 +\\u002f- 9 nM)\"],[\"Displacement of radio-labeled U69,593 from rat kappa opioid receptor expressed in HEK293 cell membranes\"],[\"Displacement of [3H]DAMGO from rat brain mu opioid receptor incubated for 60 mins by microbeta scintillation counting method\"],[\"Binding affinity to human GCN5L2 (E726 to K837 residues) expressed in bacterial expression system by BROMOScan assay\"],[\"Inhibition of recombinant matriptase (unknown origin) using Boc-Gln-Ala-Arg-7-amido-4-methyl coumarin hydrobromide at 5 uM\"],[\"Inhibition of recombinant human His-tagged PDGFRB expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control\"],[\"Inhibition of human BChE using butyrylthiocholine as substrate by spectrophotometry\"],[\"Time for which maximum percent inhibition persists was determined against trypsin (14.6 nM); * =no enzyme activity was recovered over 2 h\"],[\"Inhibition of adrenergic beta3 receptor (unknown origin) at 10 uM by PDSP assay relative to control\"],[\"Binding affinity to STAT3 in human DU145 cell lysates assessed as reduction in pronase-induced STAT3 digestion by measuring ratio of STAT3 protein level to GAPDH protein level incubated for 1 hr in absence of pronase by Western blot analysis\"],[\"Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to recombinant full-length N-terminal hexahistidine-tagged c-Myc (353 to 437 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS) assessed as changes in alpha1H signals of Phe 374 to 375 and Tyr 402 residues at 500 uM by NMR spectroscopy\"],[\"Inhibition of human truncated recombinant carbonic anhydrase 4 by CO2 hydration stopped-flow assay\"],[\"Inhibition of PI3K-G (unknown origin) at 100 nM\"],[\"Activation of FXR in human HepG2 cells assessed as upregulation of SHP mRNA expression at 10 uM by RT-PCR method\"],[\"In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line\"],[\"Inhibition of NPC1 in human fibroblasts assessed as increase in cholesterol accumulation after 24 hrs by filipin staining-based assay\"],[\"Binding affinity constant for Benzodiazepine receptor in normal rat brain homogenate\"],[\"Inhibition of HPV1a recombinant E2 protein-DNA interaction by electron mobility shift assay\"],[\"Binding affinity to wild-type TTR (unknown origin) assessed as formation of hydrogen bond between K76 and E89 at 2:1 ratio of compound to protein by 2D TROSY [1H-15N] spectroscopy\"],[\"Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control\"],[\"Binding affinity to andrenergic alpha1A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay\"],[\"Inhibition of Homo sapiens (human) arylamine N-acetyltransferase 1\"],[\"Blocking of 5HT3A receptor (unknown origin)\"],[\"Transactivation of PPARdelta (unknown origin) relative to control\"],[\"Inhibition of Vaccinia H1-related phosphatase (unknown origin) by fluorescence emission assay\"],[\"Inhibition of human NNMT expressed in HEK293 cells assessed as reduction in 1-methyl-nicotinamide formation measured after 24 hrs by RapidFire Mass spectroscopy\"],[\"Inhibition of human recombinant GST-tagged EGFR L858R\\u002fT790M mutant using pEY as substrate incubated for 30 mins by ELISA\"],[\"Uncompetitive allosteric inhibition of human plasmin assessed as substrate Km at 1.6 uM using chromogenic substrate spectrozyme PL by Michaelis-Menten plot analysis (Rvb = 0.050 to 0.083 mM)\"],[\"Inhibition of N-terminal His6-tagged human BRD2 BD1 (73 to 194 residues) after 1 hr by TR-FRET assay\"],[\"Inhibition of recombinant human MAO-B using kynuramine as substrate after 20 mins by fluorescence spectrophotometric analysis\"],[\"Inhibition of Itk\"],[\"Inhibition of Tyrosinase (unknown origin) at 150 uM using tyrosine as substrate incubated for 20 mins followed by substrate addition and measured every 10 mins for 30 mins relative to control\"],[\"Inhibition of rat CPT1 in rat mitochondria\"],[\"Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay relative to DHT\"],[\"Inhibition of human FIH\"],[\"KinomeScan assay: inhibition of PFTAIRE2\"],[\"Displacement of [3H]HU-243 from CB2 receptor (unknown origin) transfected in human COS7 cells\"],[\"In vitro rate of EPMP-inhibited acetylcholinesterase reactivation, by the protonated (oxime) form.\"],[\"Displacement of [125I]LTT-SRIF-28 from human sst4 receptor by autoradiography\"],[\"Induction of full length androgen receptor degradation in human LNCaP cells assessed as reduction in AR protein half life at 10 uM measured up to 24 hrs in presence of CHX by immunoblotting analysis\"],[\"Inhibition of NLRP3 inflammasome activation in LPS-primed immortalized mouse BMDM cells assessed as reduction in ATP-induced mature IL-1beta expression in supernatant at 5 to 20 uM by western blot analysis\"],[\"Inhibition of PKBalpha in presence of 10 uM ATP\"],[\"Inhibition of human non-glycosylated PAI1 using tissue type plasminogen activator substrate by direct chromogenic assay\"],[\"Inhibition of LPA1 (unknown origin)\"],[\"Inhibition of SGK2 (unknown origin) at 0.164 uM relative to control\"],[\"Agonist activity at YFP-fused human NOPR expressed in HEK293 cells assessed as inhibition of forskolin-mediated cAMP accumulation measured immediately by luminescence assay relative to control\"],[\"Binding affinity to wild-type human partial length CIT (M68 to E432 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of wild-type human full length CSNK1A1L (M1 to N337 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of Usp5 in Vemurafenib-sensitive human A375 cells\"],[\"Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Displacement of [3H]CGS21680 from human A2A adenosine receptor expressed in HEK293 cells at 10 uM after 60 mins by liquid scintillation counting\"],[\"Inhibition of human BRD2 bromodomain 2 expressed in bacterial expression system\"],[\"Inhibition of MASTL in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Binding affinity to FKBP12 (unknown origin)\"],[\"Agonist activity at ER alpha in human MCF7 cells assessed as PR gene expression after 24 hrs by laser scanning imaging cytometer analysis\"],[\"Inhibition of P38a (unknown origin) after 120 mins by HotSpot assay\"],[\"Inhibition of Dyrk3 (unknown origin) using Woodtide as substrate after 30 mins by P81 membrane assay in presence of [33P]-g-ATP\"],[\"Displacement of [3H]spiperone from cloned human dopamine D4.2 receptor in HEK298 cells\"],[\"Binding affinity to heme in recombinant human IDO1 assessed as Soret band shift from 404 nm to \\u003e 420 nm at 75 microM measured after 30 mins by UV-Visible absorption spectroscopy\"],[\"Inhibition of recombinant human Cathepsin K expressed in Pichia pastoris X-33 using Z-Gly-Pro-Arg-AMC as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins by fluorescence based microplate reader assay\"],[\"Transrepression of GCR in human HeLa cells assessed as suppression of DEX-induced GILZ mRNA expression at 0.4 to 2 uM after 24 hrs by Taqman-based real-time PCR analysis\"],[\"Inhibition of human TRPV1 transfected in HEK293T cells assessed as reduction in capsaicin-induced calcium influx measured after 60 mins by Fluo-4 AM dye based fluorescence analysis\"],[\"Displacement of [125I]CCK from CCK2R (unknown origin) expressed in CHO cells\"],[\"Bayer in-house kinase assay with FGFR1\"],[\"Inhibition of BMX (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of porcupine (unknown origin) in HEK293T cells transfected with pLibin-WNT3A plasmid assessed as reduction in Wnt3A secretion into cell culture medium at 0.1 uM after 48 hrs by Western blot technique\"],[\"Inhibition of DNA-tagged human IGF1R assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Competitive binding affinity to wild type EGFR expressed in human H292 cells assessed as protein labeling pretreated with compound followed by subsequent addition of copper-catalyzed azide-alkyne cyclo with rhodamine azide incubated for 2 hrs by in-gel fluorescence assay\"],[\"CaMKK2(h) Eurofins kinase panel\"],[\"Inhibition of recombinant NLRP3-ATPase (unknown origin) assessed as hydrolysis of ATP at 10 uM\"],[\"Hill coefficient value was measured against Opioid receptor kappa 1 in guinea pig cerebellum membrane homogenates\"],[\"Inhibition of 5-LOX in human 1483 cells assessed as eicosanoid level incubated for 15 mins by LC\\u002fMS\\u002fMS analysis\"],[\"Binding affinity to nonacylated mouse TEAD4 at 0.5 mM by 1H-15N HSQC spectra analysis\"],[\"Inhibition of human AURORA B assessed as remaining activity at 10 uM preincubated for 15 mins followed by substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay\"],[\"Binding affinity to N-terminal EGFP-tagged SERT (unknown origin) expressed in HEK293 cells at 20 nM by confocal laser scanning microscopy\"],[\"Antagonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as inhibition of 5HT-induced intracellular Ca2+ mobilization incubated for 1 hr by Fluo-4 dye based fluorescence assay\"],[\"Induction of normalization of single channel closed state of PKA phosphorylated RyR2 P2328S mutant (unknown origin) assessed as channel open probability level at 0.1 umol\\u002fL (Rvb = 14.4%)\"],[\"Inhibition of recombinant human activated IR (1005 to 1310 residues) at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibitory activity was tested against neutral endopeptidase\"],[\"Inhibition of P-gp in doxorubicin-resistant human HepG2 cells assessed as potentiation of doxorubicin cytostatic effect at 6.25 uM by MTT assay\"],[\"Displacement of [3H]MLA from nAChR alpha7 receptor in human SH-SY5Y cells by scintillation counting\"],[\"Ratio of dihydrotestosterone Ki to compound Ki for rat androgen receptor in ventral prostate cytosol relative to control\"],[\"Inhibition of telomerase activity in human HeLa cell lysate at 0.156 to 2.5 uM in presence of [32P]-labeled template primer by TRAP assay\"],[\"Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA\"],[\"Binding affinity to N-terminal GST-tagged BCL-XL (unknown origin) assessed as equilibrium dissociation constant by SPR analysis\"],[\"Agonist activity at human MT2 receptor expressed in CHO cells coexpressing Galpha protein 16z25 assessed as increase in calcium mobilization measured for 3 mins by FLIPR assay\"],[\"Inhibition of PAK4 (unknown origin) using substrate S2 after 60 mins by HTRF assay\"],[\"Inhibition of FLT3 in human MV4-11 cells assessed as reduction in STAT5 phosphorylation after 12 hrs by Western blot method\"],[\"Inhibition VEGFR2 (unknown origin) for 30 mins by ELISA\"],[\"Agonist activity at human FXR transfected in HEK293 cells assessed as transcriptional activity by luciferase reporter gene assay relative to GW4064\"],[\"Percent inhibition against human immunodeficiency virus protease in fluorescence assay\"],[\"Inhibition of human MELK assessed as enzyme activity at 1 uM relative to control\"],[\"Competitive inhibition at human recombinant N-terminus His6-tagged AKR1B10 Gln114Thr mutant expressed in Escherichia coli BL21 DE3 assessed as inhibition of NADP+ linked geraniol oxidation by fluorescence analysis\"],[\"Inhibition of N-terminal His-tagged CSE extracted from human HepG2 cells expressed in Escherichia coli BL21 (DE3) using methylcysteine as substrate measured for 10 mins by CPM probe-based fluorescence assay\"],[\"Inhibition of MUSK (unknown origin) at 100 nM relative to control\"],[\"Inhibition of human liver mitochondrial KMO by measuring the 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 mins followed by substate addition and measured after 30 mins by LC-MS\\u002fMS analysis\"],[\"Inhibition of N-terminal GST-tagged recombinant human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by chemiluminescence method\"],[\"Transactivation of FXR in human HepG2 cells assessed as BSEP mRNA expression at 3 uM after 8 to 16 hrs by SYBR green based qRT-PCR analysis relative to DMSO control\"],[\"Displacement of ephrin-B1-Fc from EphB6 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA\"],[\"Inhibition of recombinant human topoisomerase-2alpha expressed in Saccharomyces cerevisiae assessed as increase in double-stranded DNA cleavage at 0 to 1000 uM using supercoiled pBR322 DNA as substrate incubated for 6 mins measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\"],[\"Inhibition of human C-terminal FLAG-tagged KDM6B (1043 residues) expressed in baculovirus infected sf9 cells using H3K27me3 as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by AlphaLisa assay\"],[\"Inhibition of [3H]- citalopram binding to Serotonin transporter\"],[\"Estrogenic activity at estrogen receptor in human Ishikawa Var-1 cells assessed as stimulation of alkaline phosphatase activity measured by metabolism of p-nitrophenol phosphatase after 72 hrs\"],[\"Displacement of [3H]5-CT from human recombinant 5-HT1A receptor expressed in CHO cells measured after 60 to 90 mins by radioligand completion assay relative to control\"],[\"Inhibition of CDK8 (unknown origin) assessed as residual ligand binding level at 0.5 uM by kinome scan assay relative to control\"],[\"Agonist activity at human CB1 receptor transfected in HEK293 cells assessed as reduction in forskolin-stimulated cAMP accumulation after 30 mins\"],[\"Inhibition of recombinant human N-terminal His6-tagged TGFBR1 (200 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control\"],[\"Displacement of [3H]spiroperidol from cloned human dopamine receptor D3 in CHO cell membrane\"],[\"Inhibition of human CA9 catalytic domain by CO2 hydration stopped flow assay\"],[\"Displacement of [3H]ethanolamine from human recombinant FAAH by liquid scintillation counting\"],[\"Displacement of [13C]-2OG from catalytic domain of PHD2 (181 to 426) (unknown origin) expressed in Escherichia coli\"],[\"Inhibition of recombinant human MAOB expressed in baculovirus infected BTI insect cells at 100 uM using p-tyramine as substrate measured after 15 mins by Amplex red reagent based fluorescence assay relative to control\"],[\"Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype\"],[\"Antagonist activity at muscarinic M3 receptor (unknown origin) by PDSP assay\"],[\"Displacement of [3H]5-CT from human serotonin 5-HT1B receptor expressed in HEK cells at 10 uM after 90 mins by microbeta counting analysis\"],[\"Binding affinity to MAO-B in human brain at 4 MBq\\u002f200 ml after 90 mins by autoradiography analysis in presence of 10 uM pirlindole\"],[\"Inhibition of bovine GRK5 assessed as decrease in phosphorylation of tubulin after 5 mins by SDS-PAGE analysis\"],[\"Inhibition of human recombinant CA1 by CO2 hydration based stopped flow assay\"],[\"Inhibition of PRL-3-mediated cell migration in human HEK293 cells expressing PRL-3 (unknown origin) assessed as reduction of cell migrated at 25 uM after 0 to 20 hrs by wound healing assay\"],[\"Partial agonist activity at human 5-HT2B receptor expressed in HEK293E cells assessed as increase in intracellular calcium level by FLIPR assay\"],[\"Inhibition of human S6K1 T412E mutant (1 to 421 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control\"],[\"Inhibition of GST-tagged human recombinant GGDPS expressed in BL21 gold bacteria\"],[\"Competitive inhibition of human CSE using varying levels of L-Cys as substrate and fixed PLP levels\"],[\"Inhibition of C-MYC in human Jurkat cells assessed as decrease in GLS level at EC50 measured after 24 hrs by RT-qPCR analysis\"],[\"FXR Indigo Bioscience nuclear receptor screen\"],[\"Inhibition of wild-type human partial length EPHA5 (T627 to V930 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of NDR2 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of PIM3 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay\"],[\"Inhibition of recombinant human N-terminal GST-tagged SYK cytoplasmic domain expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control\"],[\"Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced AKT phosphorylation at 0.1 to 1 umol\\u002fL pretreated for 2 hrs followed by EGF challenge by Western blotting analysis\"],[\"Inhibition of PDK4 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of JNK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNIVVK probe by mass-spectrometric analysis relative to control\"],[\"Inhibition of VEGFR2 phosphorylation in HEK293 cells by cell-based ELISA\"],[\"Activity of Streptomyces antibioticus wild-type OleD assessed as conversion rate of compound to produce glucoside 3 using NDP sugar UDP-glucose after 3 hrs by HPLC\"],[\"Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide from human A3AR expressed in CHO cells\"],[\"Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured every 30 secs for 1 hr by Ellman's assay\"],[\"Inhibition of RNase H activity of full length recombinant HIV1 reverse transcriptase assessed as reduction in nonspecific internal cleavage up to 25 uM using HTS1 substrate\"],[\"Displacement of [3H]CP55940 from recombinant human CB1R expressed in HEK293 cell membranes incubated for 90 mins by Cheng-Prusoff equation analysis\"],[\"Inhibition of cell growth in human DoHH2 cells overexpressing Bcl2 in presence of 3% FBS\"],[\"Inhibition of HCV NS5B polymerase S282T mutant assessed as blocking of full length RNA product formation by single-nucleotide incorporation assay\"],[\"Inhibition of human His-tagged ADAMTS-5 using QF-peptide as substrate at 10 uM by FRET method\"],[\"Inhibition of VDR in human HL60 cells assessed as effect on CYP24A1 gene expression at 7.5 uM after 18 hrs by RT-PCR analysis\"],[\"Inhibition of recombinant human MAO-A using kynuramine as substrate assessed as 4-hydroxyquinoline production after 30 mins by fluorescence spectrophotometry analysis\"],[\"In vitro histamine H3 receptor antagonist activity was determined on guinea pig jejunum\"],[\"Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of [3H]raclopride binding to Dopamine receptor D2 of bovine striatum\"],[\"Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay\"],[\"Inhibition of equine serum BuChE using BTC as substrate preincubated with enzyme for 5 mins followed by substrate addition for 5 mins by Ellman's method\"],[\"Antagonist activity at full length human mineralocorticoid receptor in expressed in human U2OS cells by luciferase reporter gene assay relative to control\"],[\"Binding affinity to human V1a receptor at 10 uM by radioligand binding assay\"],[\"Inhibition of recombinant aurora kinase A (unknown origin) expressed in Escherichia coli\"],[\"Inhibition of human partial length BRWD1 (A1310 to E1430 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control\"],[\"Binding affinity to BRD2 bromodomain-1 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric analysis\"],[\"Inhibition of recombinant GST-tagged human CLK2 catalytic domain(137 to 498 residues)expressed in baculovirus expression system at 1 uM by FRET assay relative to control\"],[\"Binding affinity to transthyretin in dog serum assessed as protein stabilization at 10 uM by by Western blot\"],[\"Inhibition of human recombinant PKCalpha at 10 uM by radiometric assay\"],[\"Inhibition of human GST\\u002f6His-tagged VEGFR2 using Biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate incubated for 90 mins in presence of ATP by TR-FRET assay\"],[\"Inhibition of recombinant human HDAC1 using Fluor de Lys-SIRT1 as substrate assessed as remaining activity at 100000 nM incubated for 15 mins by fluorescence assay relative to control\"],[\"Agonist activity at human cloned mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding at 1 nM relative to DAMGO\"],[\"Inhibition of recombinant human MLK1 at 20 nM using Ulight-FLGFTYVAP as substrate measured after 60 mins by LANCE method relative to control\"],[\"Ratio of compound activity over verapamil activity for inhibition of MRP1-mediated doxorubicin transport activity in human 2008\\u002fMRP1 cells\"],[\"Inhibition of human BACE1 at 1 mM\"],[\"Antagonist activity at the mutant MC4R Y268F expressed in HEK293 cells by cAMP accumulation\"],[\"Inhibition of HIV1 integrase strand transfer activity by ELISA\"],[\"Partial agonist activity at recombinant rat GluA2(Q)i expressed in xenopus oocytes assessed as L-glutamate-induced intracellular calcium levels by two electrode voltage clamp method in presence of 0.1 mM cyclothiazide\"],[\"Inhibition of human STK33 at 10 uM after 60 mins by TR-FRET assay\"],[\"Inhibitory concentration against human steroid 5-alpha-reductase 2 receptor expressed in CHO 1829 cells\"],[\"Inhibition of wild-type human full length CK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of human PDE5A at 50 uM relative to control\"],[\"Inhibition of human alpha galactosidase\"],[\"Agonist activity at FGFR2 in human MDA231 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis\"],[\"Inhibition of recombinant human full length GST-tagged CLK3 expressed in baculovirus expression system in presence of 150 uM ATP\"],[\"Relative affinity for type 1 Angiotensin II receptor of bovine adrenocortical membranes compared to angiotensin\"],[\"Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C in rat cerebral cortex membrane up to 50 uM after 1 hr by scintillation counting analysis\"],[\"Binding affinity to ferric form of human recombinant IDO-1 in absence of oxygen\"],[\"Inhibition of HCV NS5B RNA-dependent RNA polymerase assessed as chain termination of RNA synthesis by measuring reduction in UTP incorporation at 100 uM using 33P-labeled 5'-GG-3'\\u002f5'-AUGUAUAAUUAUUGUAGCC-3' as primer\\u002ftemplate measured after 2 hrs by phosphor-screening analysis\"],[\"Ability to inhibit the binding of [3H]PGD-2 radioligand to membranes of CHO cells stably expressing mouse Prostaglandin E receptor EP3\"],[\"Inhibition of RAF1 Y340D\\u002fY341D double mutant (unknown origin) at 10 uM relative to control\"],[\"Agonistic activity towards hPR-B (human progesterone receptor) in terms of efficacy expressed as percent relative to progesterone 100%.\"],[\"Inhibition of human GCK (2 to 812 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay\"],[\"Inhibition of CDYL in human SH-SY5Y cells assessed as decrease in enrichment of CDYL at BDNF promoter site at 150 uM incubated for 24 hrs by ChIP-qPCR analysis\"],[\"Inhibition of human MAOB at 10 uM relative to control\"],[\"MEK1 Kinase panel\"],[\"Inhibition of recombinant full-length human N-terminal GST-fused BTK (2 to 659 residues) expressed in baculovirus expression system using biotin-labelled peptide as substrate measured after 50 mins by TR-FRET assay\"],[\"Binding affinity to rat recombinant L-FABP low affinity site expressed in Escherichia coli BL21(DE3) at 25 deg C by fluorimetric assay\"],[\"Inhibition of antiCD58-FITC binding to CD58 in human Caco-2 cells at 180 uM after 1 hr by fluorescence analysis relative to control\"],[\"Inhibition of PCAF (unknown origin) using H4-15 peptide substrate at 10 uM incubated for 10 mins by radiometric filter binding assay in presence of [14C]acetyl-CoA relative to control\"],[\"Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells by microplate beta scintillation counter\"],[\"Binding affinity to rat dopamine D2 receptor\"],[\"Inhibition of rabbit muscle FBA assessed as inhibition of FBP cleavage by spectrophotometry\"],[\"Binding affinity to PI5P4Kbeta (unknown origin) assessed as change in melting temperature at 63 uM by thermal shift assay\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MYLK3 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of MAST1 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Agonist activity at human 5-HT2B receptor expressed in HEK293E cells assessed as increase in intracellular calcium level by FLIPR assay\"],[\"Inhibition of phosphodiesterase 5 isolated from human platelets\"],[\"Activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as agonist-receptor ternary complex remaining by [35S]GTPgammaS binding assay\"],[\"Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding relative to U69593\"],[\"Inhibition of human BRD1 (E556 to A688 residues) at 10 uM by DiscoverX assay relative to control\"],[\"Inhibition of STAT3 in human Hela cell lysate assessed as inhibition of protein and DNA interaction upto 20 uM cells preincubated 1 hr by electrophoretic mobility shift assay\"],[\"Inhibition of BRSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control\"],[\"Uncompetitive inhibition of human N-terminal His6-SUMO-tagged SIRT2 catalytic domain (43 to 356 residues) deacetylase activity expressed in Escherichia coli using alpha-tubulin-acetylLys40 peptide as substrate up to 5 uM after 45 mins by Lineweaver-Burk double reciprocal plot analysis\"],[\"Inhibition of human ABL1 H396P mutant (27 to end residues) assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Induction of GSTP1 degradation in human HeLa cells assessed as reduction in total JNK expression at 20 to 80 uM measured after 3 hrs by Western blot analysis\"],[\"Inhibition of Arabidopsis thaliana AHAS at 100 mg\\u002fL colorimetric assay\"],[\"Inhibition of full length wild type human SAPK2alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control\"],[\"Inhibition of human Rsk1 assessed as enzyme activity at 1 uM relative to control\"],[\"Inhibition of DYRK1A (unknown origin) by [33P]-ATP filter binding kinase assay\"],[\"Inhibition of human recombinant MAO-A expressed in baculovirus infected BTI-TN-5B1-4 insect cells assessed as inhibition of hydrogen peroxide production from p-tryptamine after 15 mins by fluorimetric method\"],[\"Inhibition of human CAMKK1 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP\"],[\"Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay\"],[\"Inhibition of mouse GAT3-mediated [3H]GABA uptake stably transfected in HEK293 cells assessed as residual uptake at 100 uM relative to control\"],[\"Inhibition of human HIPK3 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human topoisomerase-2 alpha expressed in baculovirus infected insect cells assessed as reduction in enzyme-meditaed supercoiled pRYG DNA substrate relaxation at 100 uM in presence of buffer containing DTT after 30 mins by agarose gel electrophoresis method\"],[\"Antagonist activity at androgen receptor in human LNCaP cells assessed as inhibition of DHT-induced AR nuclear translocation at 10 uM after 12 hrs by immunofluorescence assay\"],[\"Inhibition of human PAK5 using RRRLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human full length NEK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Reversible inhibition of electric eel AChE assessed as residual enzyme activity using acetylthiocholine iodide as substrate at 0.1 times IC50 incubated for 30 mins by Ellman's method\"],[\"Inhibition of human PTP1B using pNPP as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins\"],[\"Transactivation of GAL4-fused human PPARdelta LBD expressed in HEK293 cells assessed as activity percentage at 10 uM after 18 hrs by luciferase reporter gene assay relative to control\"],[\"Inhibition of human ROCK1 at 10 uM by kinase inhibition assay\"],[\"Correction activity at CFTR F508 deletion mutant in primary human BE cells assessed as change in CFTRinh-172-inhibited CFTR chloride current at 0.15 uM coadministered with CFTR corrector lumacaftor and potentiator ivacaftor preincubated for 24 hrs followed by Coon's F12 culturing and subsequent addition of compounds followed by forskolin\\u002fbenzamil addition measured over 60 mins by TEEC-24 assay relative to lumacaftor and ivacaftor\"],[\"Inhibition of mTOR (unknown origin) at 10 uM by lance ultra assay\"],[\"Inhibition of recombinant human PRK2 (501 to end residues) using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis\"],[\"Inhibition of recombinant full length human PKAcbeta assessed as residual activity at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of COX2 in human whole blood assessed as inhibition of lipopolysaccharide-stimulated PGE2 production after 24 hrs by enzyme immunoassay\"],[\"Covalent binding affinity to of HSP72-NBD (unknown origin) at 20 uM by intact protein mass spectrometry\"],[\"Displacement of Halo-tagged Histone H3.3 from Nanoluc-ATAD2 BD (962 to 1119 residues) (unknown origin) transfected in human HCT116 cells incubated for 18 hrs in presence of efflux inhibitor reversan by NanoBRET assay\"],[\"Inhibition of PKC-iota (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Allosteric inhibition of recombinant human N-terminal His6-tagged ABL (27-end residues) T315I mutant expressed in baculovirus infected sf21 cells assessed as Vmax for ATP at 20 uM incubated for 10 mins in presence of [gamma32P]ATP by scintillation counting method (Rvb = 22.4 to 25.3 pmol\\u002fmin)\"],[\"Inhibition of VEGFR2 phosphorylation in HUVEC by chemiluminescence assay\"],[\"BRDT BD2 Bromoscan (DiscoverX)\"],[\"Activity at GSK3beta (unknown origin)\"],[\"Binding affinity to human phosphorylated ABL1 (229 to 512 amino acid residues) expressed in mammalian expression system assessed as percent control number at 1 uM by KINOMEscan assay\"],[\"Inhibition of CH24H expressing human 293-F cells for 15 minutes using [14C] cholesterol as substrate and measured after 5 hrs by trypan blue staining based thin-layer chromatography\"],[\"Time dependent inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 200 uM by SNAPtide FRET based assay\"],[\"Inhibition of ULK1 mediated autophagy in human A549 cells assessed as decrease in beclin1 level at 2 to 8 uM measured after 1 hrs by Western blot analysis\"],[\"Binding affinity to human serotonin transporter at 10 uM by antagonist radioligand assay relative to control\"],[\"Allosteric antagonist activity at NPY1R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport at 30 uM by electrophysiology\"],[\"Inhibition of ABCB1 in human K562\\u002fA02 cells assessed as potentiation of adriamycin-induced cytotoxicity by measuring reduction in ADR IC50 at 2.5 uM measured after 48 hrs by MTT assay relative to ADR alone\"],[\"Allosteric activity at mGlu1 (unknown origin)\"],[\"CA+\\u002fDILSI\\u002fR Cerep selectivity data (BI)\"],[\"Inhibition of human full-length N-terminal GST-tagged PARP1 expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay\"],[\"Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Thr-308 residue at 10 nM after 1 hr by Western blot analysis\"],[\"Displacement of [3H]-Pyrilamine from human H1 receptor expressed in CHO-K1 cell membranes incubated for 60 mins by scintillation counting method\"],[\"Inhibition of EGFR at 1 nM\"],[\"Ratio of selegiline IC50 to compound IC50 for recombinant human MAO-B\"],[\"Inhibition of AChE (unknown origin) at 100 uM using acetylthiocholine iodide as substrate measured after 30 mins by Ellman's method\"],[\"Inhibition of HIV1 RT Y188L mutant\"],[\"Correction activity at CFTR F508 deletion mutant in primary human BE cells assessed as forskolin-stimulated Chloride current at 0.15 uM coadministered with CFTR corrector lumacaftor and potentiator ivacaftor preincubated for 24 hrs followed by Coon's F12 culturing and subsequent addition of compounds followed by forskolin addition measured over 60 mins by TEEC-24 assay (Rvb = 7.5 +\\u002f- 0.44 uA\\u002fcm2)\"],[\"Activity of HIV1 Reverse transcriptase P119S mutant\"],[\"Inhibition of LIMK1-mediated cofilin Ser3 phosphorylation in human HT1080 cells\"],[\"Inhibition of LSD1 in human THP1 cells assessed as increase in CD86 expression at 50 nM incubated for 48 hrs by flow cytometric analysis relative to control\"],[\"Inhibition of cKit (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay\"],[\"EphA1(h) Eurofins Kinase panel\"],[\"Agonist activity at human PXR in human primary hepatocytes assessed as slight increase in CYP3A4 level at 0.5 to 5 uM incubated for 72 hrs by Western blot analysis\"],[\"Inhibition of HCK (unknown origin) at 500 nM\"],[\"Inhibition of Cathepsin K (unknown origin) at 10 uM\"],[\"Chaperone activity at Lysosomal alpha-mannosidase H72L mutant in human fibroblasts derived from alpha-Mannosidosis patient assessed as increase in Lysosomal alpha-mannosidase activity at 20 uM using 4-methylumbelliferone alpha-D-mannopyranoside as a reporter substrate incubated for 4 days by fluorescence method relative to control\"],[\"Selectivity index as ratio of IC50(processing) to IC50(integration)\"],[\"Inhibition of MAP3K3 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC\\u002fMS analysis\"],[\"Inhibition of human CAMK2beta using [KKALRRQETVDAL] as substrate\"],[\"Binding affinity to ER (unknown origin) expressed in UAS-bla GripTite 293 cells by Select screen competitive binding assay\"],[\"Inhibition of OGT (unknown origin)\"],[\"H1-Histamine receptor agonism on Guinea pig aorta was evaluated as Intrinsic activity given as 1.0 with respect to histamine (paired 't'test;p\\u003e0.05)(SEM 0.01-0.12)\"],[\"Inhibition of RIP1 (unknown origin) at 2 uM using MBP as substrate preincubated for 15 mins followed by MBP\\u002fATP mixture addition measured after 90 mins by ADP-Glo kinase assay\"],[\"Inhibition of RET (unknown origin) at 0.1 uM incubated for 1 hr by ELISA relative to control\"],[\"Activation of Nrf2 in human BEAS2B cells assessed as increase in Nrf2 translocation in nucleus at 1 uM incubated for 6 hrs by DAPI staining based fluorescence microscopic analysis\"],[\"Inhibition of TFPI in plasma isolated from human patient with factor-8 deficiency assessed as increase in thrombin generation by measuring FEIBA at 10 uM using thrombin-specific fluorogenic substrate Z-Gly-Gly-Arg-AMC by calibrated automated thrombography\"],[\"Inhibition of cytochrome c (unknown origin) assessed as half-time reaction\"],[\"Inhibition of ITK (unknown origin) at 0.45 uM relative to control\"],[\"Inhibitory activity was calculated for the model Acetylcholinesterase (Expt-1)\"],[\"Inhibition of nsp15 in Human coronavirus 229E infected in human embryonic lung fibroblast cells assessed as reduction in viral RNA synthesis at early stage of RNA synthesis at 15 uM treated 6 hrs post infection by RT-qPCR based time-of-addition assay\"],[\"Activity at human recombinant MOR transfected in CHO cells assessed as reversal of stimulation of [35S]GTP-gamma-S binding\"],[\"Binding affinity to biotinylated-KDM4A (unknown origin) at 300 nM by bio-layer interferometric method\"],[\"CDK9CYCLIN Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of recombinant full length His-tagged human BMX expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay\"],[\"Inhibition of FGFR2 (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Displacement of [3H]MSX2 from adenosine A2A receptor in rat brain striatal membrane at 25 uM\"],[\"Non-competitive inhibition of Mycobacterium tuberculosis recombinant InhA assessed as inhibitory dissociation constant for the enzyme-inhibitor complex by measuring NADH oxidation to NAD+ using varying 2-trans-dodecenoyl-CoA substrate and fixed NADH levels by UV\\u002fvisible spectrophotometry\"],[\"Inhibition of BDNF-activated full length TRKB (unknown origin) by Cell-based beta-galactosidase PathHunter assay\"],[\"Inhibition of PDK1 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay\"],[\"Binding affinity to recombinant human BRPF3 expressed in bacterial system by bromoscan assay\"],[\"Inhibition of NBCn1 in human MCF7 cells assessed as decrease in Na(+) -dependent pHi recovery rate at 30 uM\"],[\"Binding affinity to Grb2-SH2 domain by surface plasmon resonance\"],[\"Displacement of [3H][D-Ala2,D-Leu5]enkephalin from human cloned delta opioid receptor at 10 uM\"],[\"Inhibition of human cloned muscarinic M3 receptor by competitive binding experiment\"],[\"Inhibition of human CFTR expressed in rat FRT cells coexpressing halide indicator YFP-H148Q assessed as inhibition of halide influx preincubated for 15 mins by FLIPR assay\"],[\"Displacement of [3H]LSD from human recombinant 5-HT2B receptor expressed in HEK cells after 90 mins by scintillation counting analysis\"],[\"Agonist activity at human MC4 receptor expressed in CHO cells assessed as stimulation of cAMP production\"],[\"Inhibition of human BuChE using butyrylthiocholine iodide as substrate preincubated with enzyme for 1 min followed by substrate addition and measured after 10 mins by Ellman's method\"],[\"Inhibition of ovine cyclooxygenase 1 assessed as prostaglandin F2alpha level at 10 uM by enzyme immunoassay relative to control\"],[\"Irreversible inhibition of human recombinant MAO-B at 200 nM preincubated for 30 mins followed by 100 fold enzyme dilution and p-tyramine hydrochloride substrate addition measured after 40 mins by Amplex red fluorescence based spectrophotometry\"],[\"Downregulation of PHB2 in human HL60 cells at 0.1 to 10 uM after 24 hrs by Western blot analysis\"],[\"In vitro inhibitory concentration against COX-2 enzyme\"],[\"Inhibition of FPPS in human SH-SY5Y cells assessed as blocking of tau metabolism by measuring ratio of tau phosphorylation to total tau level at 100 nM after 24 hrs by ELISA (Rvb = 0.012 no-unit)\"],[\"Displacement of [3H]R1881 from AR in human LNCaP cells at 0.1 nM to 30000 nM after 2 hrs by scintillation counting analysis\"],[\"Inhibition of HDAC10 (unknown origin) using fluorogenic peptide p53 residues 379-382 (RHKK(Ac)AMC) as substrate measured after 1 to 2 hrs by fluorescence assay\"],[\"Ratio of EGCG IC50 to compound IC50 for HSP90 (unknown origin)\"],[\"Inhibition of HIV1 reverse transcriptase at 80 ug\\u002fml\"],[\"Inhibition of LKB1 (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of nucleation phase of HFIP-treated 15N-labelled wild type Amyloid beta (1 to 42) (unknown origin) assessed as time required for nucleation at 50 uM by Thioflavin-T fluorescence assay in presence of fibril seed (Rvb = 1 to 4 hrs)\"],[\"Inhibition of human MDR1 overexpressed in human KB cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 uM incubated for 1 hr prior to vincristine challenge measured after 4 days by MTT assay relative to verapamil\"],[\"Inhibition of porcine pancreatic lipase using tributyrin as substrate incubated for 30 mins measured at 1 min time interval for 5 mins in presence of NaTDC in incubation medium by pH-Stat method\"],[\"Inhibition of human TRKA expressed in human AD293 cells assessed as reduction in TrkA phosphorylation at Tyr490 residues preincubated for 20 mins followed by NGF-stimulation measure after 5 mins by ELISA\"],[\"Inhibition of human pancreatic alpha-amylase using CNPG3 as substrate by spectrophotometric analysis in presence of 40 mM G3F as donor compound and 25 mM 5FIdoF as acceptor compound relative to control\"],[\"Binding affinity to PSMA in human PC3 cells assessed as cell surface binding in presence of 100% calf serum\"],[\"Inhibition of recombinant full length human CYP51 expressed in Escherichia coli incubated for 1 min using [3H] lanosterol as substrate by HPLC analysis\"],[\"Inhibition of telomerase in human PC3 cell-free extracts incubated for 48 hrs by TRAP assay\"],[\"Binding affinity to APC (unknown origin) at 37 degC by ITC method\"],[\"Inhibition of PDE10 in PDGF-BB-induced human pulmonary artery smooth muscle cells assessed as increase in alpha-SMA expression at 0.1 to 1 uM after 22 hrs by Western blot analysis\"],[\"Displacement of Ins(1,3,4,5)P4 from recombinant human N-terminal His-tagged SHIP2 (419 to 832 residues) expressed in Escherichia coli BL21 (DE3)\"],[\"Inhibition of recombinant full-length human COX2 expressed in baculovirus infected Sf21 cells at 10 uM using arachidonic acid as substrate after 5 mins by ELISA\\u002fEIA relative to control\"],[\"CaMKIγ(h) Eurofins Kinase panel\"],[\"Inhibition of recombinant full-length human TTK S389A mutant assessed as residual activity at 10 uM using MBP as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of alpha-Mannosidase\"],[\"Inhibition of Cdk4-mediated phosphorylation of pRB in Calu1 cells at ser 807\\u002f81 residue after 24 hrs by Western blot analysis\"],[\"Antagonist activity at TLR8 in human PBMC cells assessed as inhibition of compound 1f-induced TNFalpha production incubated for 16 hrs by immunoassay\"],[\"Binding affinity towards dopamine receptor D2 in rat striatal membrane using [3H]spiperone\"],[\"Inhibition of AChE in human erythrocytes using acetylthiocholineiodide as substrate pre-incubated for 10 mins followed by substrate addition and measured for 6 mins by DTNB reagent based Ellman's method\"],[\"Inhibition of recombinant SETD8 catalytic domain (unknown origin) (232 to 393 residues) expressed in Escherichia coli assessed as reduction in incorporation of [3H]-labeled methyl group into biotinylated H4 (1 to 24) peptide measured after 5 hrs using [3H-SAM] by scintillation proximity assay\"],[\"Displacement of [3H]-di-o-tolylguanidine from sigma-2 receptor in rat liver membranes incubated for 120 mins measured for 5 mins by scintillation counting method\"],[\"Displacement of [3H]AMPA from rat iGluR2 receptor expressed in Sf9 cells baculovirus system after 1 to 2 hrs by liquid scintillation counting\"],[\"Inhibition of human recombinant DDO expressed in sf9 insect cells assessed as degradation of D-serine by fluorescence assay\"],[\"Inhibition of NaPi2a in human primary proximal tubule cells assessed as reduction in uptake of 33P-radiolabeled Pi at 1 uM incubated for 30 mins followed by substrate addition measured after 5 mins by liquid scintillation counting method relative to control\"],[\"Inhibition of radioligand binding to human adrenergic alpha1d receptor\"],[\"Agonist activity at human kappa opioid receptor expressed in U2OS cells assessed as beta-arrestin2 recruitment incubated for 90 mins by PathHunter assay\"],[\"Inhibition of HIV1 reverse transcriptase p66\\u002fp51 mediated single strand incorporation into DNA at +6 position using polypurine tract PPT+6\\u002fPPT57 template after 3 mins by gel based assay\"],[\"Inhibition of rat UT-B incubated for 15 mins\"],[\"Inhibition of chymotrypsin-like activity 20S proteasome beta subunit 5 of human MCF7 cells using fluorogenic substrate Suc-LLVY-AMC after 1 hr by fluorescence analysis\"],[\"Inhibition of human VRK1 at 10 uM by radiometric assay relative to control\"],[\"Displacement of radiolabeled CP-55940 from human CB1 receptor\"],[\"Inhibition of human endothelin ETA receptor at 10 uM\"],[\"Inhibition of 5-LO in human PMNL using arachidonic acid as substrate assessed as product formation incubated for 15 mins prior to substrate addition measured after 10 mins by HPLC analysis\"],[\"Binding affinity to BTN3A1 in human PBMC assessed as stimulation of Vgamma9 Vdelta2 T cells at 100 nM incubated for 3 days and measured after 11 days post compound removal by flow cytometry\"],[\"Inhibition of human epidermal growth factor receptor\"],[\"Chaperone activity at recombinant human GALNS expressed in Escherichia coli BL21 (DE3) assessed as increase in extracellular enzyme activity at 0.001 to 1 uM using 4-methylumbelliferyl-beta-D-galactopyranoside-6-sulfate as substrate measured after 24 hrs by fluorescence assay relative to control\"],[\"Inhibition of PRMT7 (unknown origin) at 1 uM using biotin-labeled peptide as substrate and [3H]-SAM measured after 1 hr by scintillation proximity assay\"],[\"Activation of human Opioid receptor kappa 1 expressed in chinese hamster ovary cells to enhance [35S]GTP-gamma-S, binding compared to U50,488H; ND=Not determined\"],[\"Inhibition of recombinant human HDAC1 using fluorogenic substrate by fluorescence assay\"],[\"Inhibition of human Histamine H3 receptor using [3H]N-alpha-methyl histamine\"],[\"Increase in human pancreatic recombinant 1B PLA2 activity expressed in Escherichia coli assessed as hydrolysis rate of 1,2-dimyristoyl-sn-3-glycerophosphocholine vesicles at 0.08 mol fraction relative to control\"],[\"Antagonist activity at human NOP receptor expressed in HEK293 cells assessed as inhibition of N\\u002fOFQ-induced [35S]GTPgammaS binding after 1.5 hrs by scintillation proximity assay\"],[\"Agonist activity at PPARgamma (unknown origin)\"],[\"Inhibition of human 5-HT3 receptor at 10 uM\"],[\"Inhibition of recombinant CDK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis\"],[\"Inhibition of 26S proteasome beta 1 in human HEK293 cell lysate assessed as residual activity at 0.006 uM after 1 hr\"],[\"Binding affinity to human XIAP-BIR3 (241 to 356 residues)\"],[\"Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay\"],[\"Inhibition of MAO-B (unknown origin) using MAO substrate incubated for 1 hr by MAO-Glo assay\"],[\"Inhibition of MAO-A (unknown origin) assessed as oxidative deamination of kynuramine to 4-hydroxyquinoline after 30 mins by fluorescence assay\"],[\"Effect on PPARalpha transactivation activity in HEK293 cells\"],[\"Inhibition of recombinant human N-terminal GST-tagged MET (956 to end residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control\"],[\"Inhibition of recombinant human His-tagged TrkA kinase domain (441-796 residues) expressed in baculovirus expression system at 1 uM incubated with enzyme\\u002fATP mixture for 20 mins by HTRF assay relative to control\"],[\"Binding affinity to human N-terminal His-tagged SIRT5 (34 to 302 residues) expressed in Escherichia coli assessed as equilibrium dissociation constant at 600 uM by isothermal titration calorimetry\"],[\"In vitro antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cells\"],[\"Inhibition of human recombinant MAOB using kynuramine as substrate by fluorimetry\"],[\"Inhibition of MARK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Binding affinity to human AKT1-PH domain assessed as change in beta-sheet content at 1:3 molar ratio of protein to compound by CD spectra analysis\"],[\"Inhibition of chymotrypsin-like proteasome activity of human 20S proteasome\"],[\"Inhibition of human carbonic anhydrase 1 assessed as inhibition constant incubated for 15 mins prior to testing by phenol red based stopped-flow CO2 hydration assay\"],[\"Reversible inhibition of rat liver mitochondrial MAO-B using phenylethylamine as substrate assessed as substrate consumption at 100 nM preincubated for 30 mins measured up to 420 mins\"],[\"Inhibition of human ERG expressed in human HEK293 cells at 30 uM whole-cell patch clamp assay relative to control\"],[\"Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells\"],[\"Percent efficacy for retinoic acid receptor RAR beta in CV-1 cell transcriptional activation assay\"],[\"Inhibition of Bak-BH3 peptide binding to FLAG-tagged human Mcl1 expressed in HeLa cells after 2 hrs by immunoblot analysis\"],[\"Inhibition of human IDO1 expressed in HEK293 cells assessed as effect on kynurenine production incubated for 24 hrs by LC-MS analysis\"],[\"Binding affinity to Duffy (unknown origin) at 10 uM by radioligand displacement assay\"],[\"Displacement of [125I][Tyr14]N\\u002fOFQ from ORL1 receptor transfected in CHO cells\"],[\"Inhibition of human neutrophil elastase-induced antiproliferative activity expressed in BEAS2B cells assessed as cytoprotectivity by MTT assay\"],[\"Binding affinity to human KIT V559D,T670I mutant incubated for 1 hr by kinase binding assay\"],[\"Displacement of [125I][Tyr14]nociceptin FQ from human cloned nociceptin receptor expressed in CHO cells\"],[\"Antagonist activity at H4R in human eosinophils assessed as inhibition of imetit-induced shape change by GAFS assay\"],[\"Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA\"],[\"Inhibition of factor 11a (unknown origin)\"],[\"Inhibition of recombinant human topoisomerase-2alpha expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in enzyme-mediated [gamma32P]ATP hydrolysis up to 50 uM after 8 mins\"],[\"Agonist activity at 5-HT4 receptor in guinea pig colon relative to 5-HT\"],[\"Ratio of Michaelis-Menten constant and inhibition constant for aromatase enzyme; Competitive inhibition\"],[\"Inhibition of human full length CSE using L-cysteine as substrate at 30 to 300 uM preincubated with enzyme for 1 hr followed by substrate and PLP addition for 2 hrs by AzMC probe based fluorescence analysis\"],[\"Binding affinity to PRKAB2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay\"],[\"Inhibition of CYP51 in Candida albicans ATCC SC5314 assessed as lanosterol composition of the total sterol fraction in membrane at 8 ug\\u002fml after 16 hrs by GC-MS analysis (Rvb = 2.9%)\"],[\"Displacement of BODIPY FL vindoline from GST-tagged human PXR LBD incubated for 60 mins by TR-FRET assay\"],[\"Ratio of Kcat to Km of Serratia marcescens AmpC assessed as drug hydrolysis by spectrophotometry\"],[\"Inhibition of recombinant human cytosolic carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay\"],[\"Activation of Nrf2 in wild type mouse Hepa1c1c7 cells cytosolic fraction assessed as induction of quinone reductase activity at 10 uM using 2,6-DCIP as substrate in presence of NADH incubated for 48 hrs measured for 1 min relative to control\"],[\"Inhibition of CHK1 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Binding affinity to DNMT3a in human PC3 cells cytoplasm at 5 uM after 6 hrs by antibody staining\"],[\"Reactivation of TEPP inhibited mouse brain AChE at 30 uM\"],[\"Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in rabbit ventricular myocytes\"],[\"Inhibition of PRMT8 (unknown origin) using biotin-labeled histone substrate assessed as residual activity at 50 uM in presence of [3H-Me]SAM by scintillation proximity assay relative to control\"],[\"Inhibition of pig brain TRH-DE using Glp-His-ProAMC as substrate by DPP-4-based continuous fluorometric method\"],[\"Binding affinity to recombinant Prx1 C52A\\u002fC83A\\u002fC173A mutant (unknown origin) expressed in human HEK293T cells at 1 uM incubated for 20 hrs by Western blot analysis\"],[\"Intrinsic activity at rat beta3-adrenergic receptor relative to isoproterenol\"],[\"Displacement of [3H]CGS21680 from human A2A adenosine receptor expressed in HEK293 cell membranes at 1 uM after 60 mins by gamma counting method relative to control\"],[\"Inhibition of N-terminal FLAG-tagged ERK1 (unknown origin) expressed in baculovirus expression system at 100 nM using myelin basic protein as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 60 mins by topcount scintillation counting method relative to control\"],[\"Binding affinity to human SMARCA4 assessed as dissociation constant up to 1 uM by BROMOscan assay\"],[\"Inhibition of SPHK1 in human U937 cells assessed as reduction of sphingosine 1-phosphate level at 10 nM after 2 hrs by LC\\u002fMS\\u002fMS analysis\"],[\"Reversible inhibition of human recombinant MAOB after washing with sodium phosphate buffer at 3 nM by centrifugation-ultrafiltration method\"],[\"Inhibition of Trypanosoma cruzi cruzain using Z-FR-AMC as substrate by fluorescence assay\"],[\"Inhibition of cAMP accumulation in CHO cells expressing human adenosine A3 receptor; range 2.5-9.3\"],[\"Inhibition of human salivary alpha-amylase using GalG2CNP as substrate\"],[\"In vivo inhibition of ram seminal vesicle Prostaglandin G\\u002fH synthase 1 activity by determining PGE-2 by RIA\"],[\"Inhibition of human recombinant smMLCK (475 to 838 residues) expressed in Escherichia coli at 1 uM using KKRPQRATSNVFA as substrate after 30 mins\"],[\"Inhibition of recombinant mouse SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate in presence of [gamma-33P]ATP by scintillation counting method\"],[\"Inhibition of human pancreas chymotrypsin C up to 0.78 mM using N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide as substrate pretreated for 5 mins followed by substrate addition measured after 30 mins by colorimetric method\"],[\"Displacement of [3H]diprenorphine from human mu opioid receptor expressed in CHO cells\"],[\"Inhibition of human CAMK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Displacement of [125I]NDP-alpha-MSH from human recombinant MC4 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control\"],[\"Binding affinity to amyloid beta (1 to 42) (unknown origin) assessed as amyloid beta (25 to 42)-adduct formation at 10 uM measured after 24 hrs by ESI-HRMS analysis\"],[\"Binding affinity to BSEP (unknown origin)\"],[\"Inhibition of EGF-induced STAT3 phosphorylation in human MCF7 cells at 1 uM by ELISA\"],[\"CYSLT1_HS Eurofins-Panlabs selectivity data (BI)\"],[\"Inhibition of PIK3C3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled TEDGGKYPVIFKHGDDLRQDQLILQIISLMDK probe by mass-spectrometric analysis relative to control\"],[\"Displacement of 2-[1251]-iodomelatonin from human MT2 receptor expressed in CHO cells incubated for 1 hr by gamma counting method\"],[\"Inhibition of human thrombin by Dixon-plot method\"],[\"Binding affinity to amyloid beta (1 to 42) (unknown origin) at 0.5 uM by fluorescence analysis\"],[\"Inhibition of FLT3 (unknown origin) at 5 uM relative to control\"],[\"Inhibition of mPGES-1 in human HeLa cells using PGH2 as substrate assessed as inhibition of IL-1beta\\u002fTNFalpha-stimulated PGE2 production at 1 to 10 uM after 24 hrs by LC-MS\\u002fMS analysis\"],[\"Inhibition of recombinant full length human His-tagged CLK1 expressed in Escherichia coli assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control\"],[\"Inhibition of His-tagged human SkMLCK expressed in Escherichia coli at 1 uM\"],[\"Binding affinity to bovine brain calmodulin at 0.033 ug\\u002fmL after 1.5 hrs by electrophoretic mobility assay in presence of calcium chloride\"],[\"Inhibition of human factor 10a in compound treated monkey plasma using S-2222 as substrate at 1 mg\\u002fkg, po after 1 hr by spectrophotometry\"],[\"Inhibition of full length recombinant human N-terminal His-FLAG-tagged DHX29 RNA dependent ATPase activity expressed in baculovirus infected Sf9 insect cells using single stranded poly(U) RNA as substrate after 30 mins by ADP-Glo luminescence assay\"],[\"Inhibition of human RON using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of mouse recombinant NNMT using nicotinamide and SAM as substrate assessed as reduction in 1-methyl-nicotinamide formation incubated for 22 to 24 hrs by RapidFire Mass spectroscopy\"],[\"Inhibition of DNMT1 in human HeLa cells assessed as 2'-deoxytymidine phosphate level by two-dimensional thin layer chromatography analysis\"],[\"Agonist activity at Smo in mouse C3H10T1\\u002f2 cells assessed as effect on Gli2 expression at 1 uM after 48 hrs by RT-PCR method relative to vehicle-treated control\"],[\"Binding affinity to human PRKCepsilon at 50 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of human GAT-1 expressed in thymidine kinase deficient mouse LM cells assessed as decrease in [3H]GABA uptake after 10 mins by scintillation counter method\"],[\"Electrophysiological assay: Blocking of AITC ( allylthiocyanate, 100 µmol\\u002fL)-evoked currents\"],[\"Displacement of BODIPY-labelled cyclopamine from human Smo receptor expressed in HEK293 cells after 2 hrs by fluorescence microscopy\"],[\"Inhibition of TC-PTP (unknown origin)\"],[\"Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control\"],[\"Antagonist activity at human MT1 receptor expressed in CHO cells assessed as inhibition of melatonin-induced response by [35S]GTPgamma binding assay\"],[\"Inhibition of NOX4 in human B1647 cells assessed as reduction of ROS production after 20 mins by DCFH-DA fluorescence assay\"],[\"Inhibition of AGT in human SF763 cells assessed as increase in dG-dC crosslinking at 0.4 mM incubated for 12 hrs by HPLC-ESI-MS\\u002fMS analysis relative to ACNU\"],[\"Inhibition of Prostaglandin G\\u002fH synthase 1 isolated from ram (sheep) seminal vesicle at 300 uM\"],[\"Inhibition of human EphA8 assessed as remaining enzyme activity at 1 uM\"],[\"Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of SIRT1 in human MCF7 cells assessed as increase in acetylation of H3-K9 up to 50 uM after 24 hrs by Western blot analysis\"],[\"Binding affinity to wild-type human partial length HIPK3 (M153 to N562 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control\"],[\"Activity at human M4 receptor up to 10 uM\"],[\"Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay\"],[\"Displacement of [3H]-muscimol from human recombinant GABAA1 at 10 uM after 120 mins by scintillation counting analysis relative to control\"],[\"Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor at 10 uM after 90 mins by microbeta scintillation counting method\"],[\"Displacement of [3H]DTG from sigma2 receptor in rat liver membranes incubated for 120 mins by solid scintillation counting method\"],[\"Inhibition of human HPGD in human ME180 cells assessed as downregulation of TNFalpha-induced NF-kappaB expression at 647 pM to 38.2 uM incubated for 15 mins prior to TNFalpha addition measured after 4 to 24 hrs by beta-lactamase reporter gene assay\"],[\"Activation of Oct3\\u002f4 (unknown origin) transcriptional activity expressed in in human NCCIT cells at 20 uM by luciferase reporter gene assay relative to control\"],[\"Inhibition of Mycobacterium smegmatis DNA gyrase B ATPase activity at 33.3 uM after 100 mins relative to novobiocin-treated control\"],[\"Inhibition of human SGK1 at 1 uM relative to control\"],[\"Inhibition of human MAOB using p-tyramine as substrate at 100 uM after 15 mins by Amplex Red MAO assay\"],[\"Agonist activity at human mGlu2R expressed in CHO cells relative to control\"],[\"Inhibition of PRAK (unknown origin) at 50 uM\"],[\"Inhibition of eIF4E (unknown origin)\"],[\"Inhibition of human EPHB1 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP\"],[\"Competitive inhibition of pig kidney DAAO using D-Alanine as substrate by Michaelis-Menten plot analysis\"],[\"Modulation activity at human mineralocorticoid receptor in human EA.hy926 cells assessed as induction of nuclear translocation of mineralocorticoid receptor in absence of aldosterone by receptor translocation assay\"],[\"Ratio of EC50 for drug to U69593 at human kappa opioid receptor by [35S]GTPgammaS binding in CHO cells\"],[\"Inhibition of BRD4 in human HLF1 cells assessed as reduction in collagen-1 mRNA expression at 1 uM measured after 24 hrs by RT-PCR analysis\"],[\"Activation of recombinant human wild-type STING expressed in 293T cells measured after 30 mins in presence of digitonin A by bright Glo-luciferase reporter gene assay\"],[\"Inhibition of recombinant N-terminal GST-tagged human SphK1 (1 to 384 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay\"],[\"Binding affinity to biotinylated PB1BR5 (645 to 766 amino acid residues) (unknown origin) expressed in Rosetta2 cells by bio-layer interferometry method\"],[\"Inhibition of NCDase in human HeLa cells expressing ASAH2 assessed as increase in Sph level at 10 uM after 1 hr by LC-MS\\u002fMS analysis\"],[\"Inhibition of mouse SMO expressed in NIH-3T3 cells\"],[\"Inhibition of BRAF V600E mutant in human A375 cells assessed as reduction in ERK phosphorylation by Western blot analysis\"],[\"Displacement of [3H]paroxetine from SERT in brain membranes\"],[\"Inhibition of human carbonic anhydrase 2 using 4-nitrophenylacetate as substrate after 3 mins by spectrophotometric analysis\"],[\"Inhibition of recombinant tPA at 2.5 uM\"],[\"Activation responses to that evoked by ACh at human Nicotinic acetylcholine receptor alpha-7 expressed in xenopus oocytes at 100 uM\"],[\"Inhibition of VEGFR2 phosphorylation in human Endothelial progenitor cells at 5 to 10 uM measured after 10 mins by Western blot analysis\"],[\"Agonist activity at human LXRalpha ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay relative to T0901317\"],[\"Binding affinity against opioid receptor kappa from guinea pig brain, using [3H](-)-bremazocine as radioligand.\"],[\"Antagonist activity at PAR2 in human neutrophils assessed as inhibition of chemotactic migration of cells towards tryptase relative to control\"],[\"Inhibition of recombinant human carbonic anhydrase 2 by stopped flow CO2 hydration assay\"],[\"Binding affinity to IDO1 in IFNgamma-stimulated human HeLa cells at 5 nM measured after 5 mins by Hoechst staining based confocal fluorescence imaging analysis\"],[\"Displacement of Eu-DTPA-NDP-a-MSH chelate from human melanocortin-4 receptor expressed in HEK293 cells after 1 hr by competitive DELFIA assay\"],[\"Displacement of [125I-CCK] from human CCK2R V3.28T, S3.29T mutant expressed in CHO cells after 60 mins by scintillation counter\"],[\"Inhibition of AKT1 (unknown origin) at 1 uM relative to control\"],[\"Inhibition of human EGFR L861Q mutant at 10 uM after 60 mins by TR-FRET assay\"],[\"Inhibition of recombinant full-length human TSSK3 at 1 uM using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of mTORC2 in human MDA-MB-231 cells assessed as SGK1 phosphorylation by Western blot analysis\"],[\"Inhibitory activity against bee secretory Phospholipase A2 enzyme when pre-incubated for 15 minutes\"],[\"Inhibition of human FGFR4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay\"],[\"Inhibition of human TNKS1 incubated for 1 to 2 hrs by fluorescence polarization assay\"],[\"Effect on HSP90alpha in human U-937 cells assessed as HSP70 protein level at 10 uM after 48 hrs by Western blot analysis (Rvb = 0.83 No_unit)\"],[\"Inhibition of Wild-type Streptococcus mutans UA159 glucosyltransferase D by zymography\"],[\"Inhibition of human mTOR expressed in mammalian expression system at 10 uM\"],[\"Agonist activity at Mincle in human PBMC assessed as increase in TNF-alpha production at 1 to 1000 uM incubated for 18 to 24 hrs by ELISA\"],[\"Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 50 uM measured after 24 hrs by ThT fluorescence assay relative to control\"],[\"Inhibition of PDE9A2 catalytic domain (181 to 506 residues) (unknown origin) expressed in Escherichia coli BL21 cells\"],[\"Inhibition of PPARgamma activity in human U373 cells at 3 uM after 6 hrs by spectrophotometric analysis relative to control\"],[\"Inhibition of human Nav 1.8 assessed as reduction in peak channel current at 1 uM measured at 0.1 Hz by manual patch clamp assay\"],[\"Inhibition of GST-tagged CD45 (unknown origin) using phospho-EGFR Asp-Ala-Asp-Glu-Tyr[PO3H2]-Leu-Ile-Pro-Gln-Gln-Gly as substrate preincubated for 30 mins before substrate addition measured after 30 mins by phosphatase activity assay\"],[\"Activity at human carbonic anhydrase I by spectrophotometry at pH 7.5\"],[\"Inhibition of thromboxane-stimulated PAR1-mediated platelet aggregation in human washed platelets at 3 uM by ChronoLog 680 aggregation system analysis\"],[\"Displacement of [3H]ZM241385 from human adenosine A2a receptor expressed in HeLa cells after 30 mins\"],[\"Binding affinity to GABA-A alpha3 (unknown origin) assessed as reduction in DMCM induced current relative to control\"],[\"Inhibition of recombinant human acid beta-glucosidase at 100 uM using p-nitrophenyl-glycopyranoside or 4-methylumbelliferyl-glycopyranoside as substrate by spectrophotometric method relative to control\"],[\"Agonist activity at human FFA1 receptor expressed in CHO cells assessed as increase in intracellular calcium flux at 10 uM by Fluo 4AM dye-based FLIPR assay relative to TAK-875\"],[\"Inhibition of recombinant full-length human Pim-1 at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Activity at human P2X4 receptor at 10 uM\"],[\"Binding affinity to human GABAA receptor alpha1 assessed as photolabeling at 0.7 uM after 30 mins by Coomassie blue staining based fluorographic method relative to control\"],[\"Inhibition of muscarinergic M1 receptor (unknown origin) at 10 uM relative to control\"],[\"Displacement of [6,7-3H]17 beta-estradiol from human recombinant ERalpha relative to estradiol\"],[\"Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed in baculovirus infected Sf21 insect cells using fluorescein-labeled polyGAT peptide substrate measured after 30 mins by TR-FRET assay\"],[\"Inhibition of 26S proteasome beta 3 in human HEK293 cell lysate assessed as residual activity at 3 uM after 1 hr\"],[\"Displacement of [3H]BTCP from human recombinant dopamine transporter expressed in CHO cells at 10 uM after 120 mins\"],[\"SRPK2 ProQinase selectivity panel\"],[\"Inhibition of human placental 17beta-HSD1 cytosolic fraction using [2, 4, 6, 7-3H]-estrone as substrate after 10 mins by HPLC analysis\"],[\"Displacement of [3H]MRE3008-F20 from human Adenosine A3 receptor expressed in HEK cells; range 1.42-1.79\"],[\"Inhibition of FAK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of GPIbalpha-human vWF binding assessed as decrease in arterial shear-induced platelet adhesion to vWF measuring number of platelets adhered during flow at 100 uM preincubated for 5 mins by parallel plate flow assay with real time imaging microscopy\"],[\"Inhibition of Trypanosoma cruzi cruzain at 50 uM pre-incubated for 10 mins followed by addition of Z-Phe-Arg-aminomethylcoumarin as substrate measured after 5 mins by spectrofluorimetry\"],[\"Inhibition of equine serum BuChE using butyrylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Ellman's method\"],[\"Binding affinity to human recombinant CB2 receptor expressed in african green monkey COS cells by radioligand binding assay\"],[\"Inhibition of AKR1C3 in human HL60 cells assessed as potentiation of etoposide-induced cytotoxicity by measuring reduction in cell viability at 0.1 uM coincubated with etoposide at 1 uM after 72 hrs by MTS assay (Rvb = 40%)\"],[\"Inhibition of recombinant human full-length His6-tagged NTMT1 (1 to 222 residues) expressed in Escherichia coli BL21-CodonPlus(DE3)-RIL competent cells assessed as Me2RCC1 level at 10 uM pre-incubated for 0 mins before RCC1 substrate addition and measured after 15 mins by Western blot analysis relative to control\"],[\"Inhibition of C-terminal His-6-tagged recombinant human SIRT1 expressed in Escherichia coli BL21(DE3) at 50 uM by luminescence assay relative to control\"],[\"Inhibition of human TrkA (440 to end residues) assessed as residual activity at 0.5 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria\"],[\"Inhibition of human HIPK2 using MBP as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of human FAK (D402 to R696 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control\"],[\"Binding affinity to immobilized human TFPI-1alpha assessed as inhibition of biotinylated tracer peptide JBT-0131 binding incubated for 1.5 hrs by measuring horseradish peroxidase-conjugated streptavidin-mediated conversion of TMB substrate by screening ELISA based competition assay relative to JBT-0477\"],[\"Agonist activity at human wild-type AVPR1A receptor expressed in CHO-K1 cells assessed as calcium level by FDSS assay\"],[\"Inhibition of human cloned CA2 pre-incubated with enzyme for 15 mins by phenol red based CO2 hydration stopped-flow assay\"],[\"Mixed-type inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Lineweaver-Burk plot analysis\"],[\"Inhibition of BK calcium channel in human AD293 cells assessed as relative fluorescence unit by cell-based fluorescence assay\"],[\"Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysis\"],[\"Inhibition of HDAC6 (unknown origin) assessed as fluorescence intensity measured after 60 mins incubation at room temperature by trypsin-free microfluidic lab-on-a-chip assay\"],[\"Allosteric inhibition of human plasmin using chromogenic substrate spectrozyme PL preincubated for 5 mins followed by substrate addition measured over 20 to 120 secs in presence of 285 uM unfractionated heparin by spectrophotometric method\"],[\"Inhibition of coffee beans alpha-galactosidase using p-nitrophenyl glycopyranoside preincubated for 5 mins followed by substrate addition measured after 20 mins by visible absorption spectroscopic method\"],[\"Inhibition of [3H][Ile5,6]deltorphin II binding to opioid receptor delta from rat brain membranes\"],[\"Inhibition of FITC-GDA binding to human TRAP1 incubated for 2 hrs by fluorescence polarization assay\"],[\"Allosteric inhibition of recombinant wild type ABL (unknown origin) assessed as Vmax for ATP at 10 uM incubated for 10 mins in presence of [gamma32P]ATP by scintillation counting method (Rvb = 16.35 to 17.7 pmol\\u002fmin)\"],[\"Inhibition of TYK2 JH1 domain (unknown origin) in presence of Km ATP\"],[\"Antagonist activity at CXCR4 in human HT-29 cells assessed as inhibition of CXCL12-dependent cell migration after 18 hrs by Transwell assay\"],[\"Inhibition of recombinant human carbonic anhydrase-9 assessed as reduction in CO2 hydration preincubated for 10 mins measured for 5 to 10 secs by stopped flow assay\"],[\"Binding affinity to human TRKA at 500 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of Wee1 in human MM1S cells assessed as decrease in CDK1 phosphorylation at Tyr15 at 0.1 to 10 uM after 6 hrs by Western blot method\"],[\"Inhibition of [3H]CHA binding to Adenosine A1 receptor in rat cerebral cortical membranes\"],[\"Binding affinity to MTH1 in human K562 cells assessed as concentration required to achieve half of the maximal stabilization of protein at 54 degC after 60 mins by cellular thermal shift assay\"],[\"Inhibition of wild-type human partial length MAPKAPK2 (V48 to D345 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of LSD1 in human PA1 cells assessed as downregulation of OCT4 protein expression at 20 uM after 16 hrs by Western blot analysis\"],[\"Displacement of [125I]-GRO-alpha from human recombinant CXCR2 receptor expressed in CHO cell membranes\"],[\"Agonist activity at human PPARalpha expressed in CV1 cells by receptor transactivation assay\"],[\"Effective concentration required for the activation of human R285A mutant strain P2Y1 receptors expressed in COS-7 cells for the accumulation of inositol phosphate\"],[\"Inhibition of human CXCR3 at 10 uM relative to control\"],[\"Displacement of [125]MCP1 from human CCR2 receptor in THP1 cell membrane\"],[\"Inhibition of FGFR\"],[\"Agonist activity at human recombinant TGR5 receptor expressed in CHO cells assessed as cAMP accumulation after 30 mins by spectrophotometry\"],[\"Inhibition of human erythrocytes AchE using acetylthiocholine iodide as substrate at 50 uM after 15 mins by Ellman's method\"],[\"Binding affinity to human 5HT2C receptor per mg of protein expressed in HEK293 cells by saturation binding method\"],[\"Inhibition of recombinant human MMP7 expressed in Escherichia coli using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH2 as substrate by fluorescence spectrophotometric method\"],[\"Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay\"],[\"Inhibition of JAK2 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay\"],[\"Binding affinity to wild-type human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Tested for growth hormone secretagogue activity in A93 cell line using a calcium flux assay at 10 uM (Relative to compound T1); NA means not active\"],[\"Agonist activity at human TLR5 expressed in HEK293 cells assessed as induction of NF-kB activation-mediated SEAP production after 24 hrs by HTS assay\"],[\"Binding affinity to human MAG by surface plasmon resonance assay\"],[\"Inhibition of c-Met (unknown origin) using poly (Glu, Tyr) 4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 2 to 4 hrs by luciferase coupled chemiluminescence assay\"],[\"Agonist activity at human mGlu3 receptor expressed in CHO cell membranes by GTPgammaS binding assay\"],[\"Antagonist activity at human delta opioid receptor expressed in CHO cells by [35S]GTPgammaS assay\"],[\"Synergistic potentiator activity at CFTR F508del mutant (unknown origin) expressed in CFBE41o cells assessed as increase in short-circuit current at 1 uM treated after SBC040 addition by Ussing chamber assay\"],[\"Displacement of [3H]lysergic acid diethylamide from human recombinant 5HT2B receptor at 1 uM\"],[\"Inhibition of human recombinant PDE3A assessed as cAMP hydrolysis after 60 mins by fluorescence polarization assay using fluorescein-tagged cAMP as substrate\"],[\"Induction of N-terminal 6x-His-tagged BRAF W450A mutant (unknown origin) dimer formation at 15 uM by sedimentation velocity method\"],[\"Inhibition of bovine pancreatic RNase A assessed as tRNA degradation at 0.50 mM after 2 hrs by precipitation assay\"],[\"Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of cell growth arrest at 20 uM after 24 hrs by propidium iodide staining-based flow cytometry\"],[\"Inhibition of [3H]DAGO binding to rat brain membrane Opioid receptor mu 1\"],[\"Intrinsic activity at GAL4 tagged human PPARalpha ligand binding domain expressed in HEK293 cells at 1 uM by luciferase reporter gene assay relative to 1 uM GW2331\"],[\"Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every minute for 10 mins by Ellman's spectrophotometric method\"],[\"Inhibition of recombinant human TNF-alpha converting enzyme (TACE)\"],[\"Antagonist activity at human 5HT2B receptor expressed in human SHSY5Y cells by FLPR assay\"],[\"Inhibition of CDC20 in human HepG2 cells assessed as increase in Bim protein levels at 30 uM incubated for 48 hrs by Western blot Analysis\"],[\"Inhibition of ITK in human Jurkat cells assessed as decrease in phosphorylation of PLC-gamma1 by immunodetection assay\"],[\"Inhibition of purified fascin (unknown origin) assessed as reduction in bundle activity at 50 uM pre-incubated for 30 mins before polymerized actin addition and followed by Alexa fluro 488 phalloidin addition after 30 mins and measured after 1 hr under dark condition relative to control\"],[\"Displacement of [3H]PK11195 from rat brain PBR after 90 mins by scintillation counting method\"],[\"Inhibition of CDK2-mediated Rb phosphorylation at Ser 807\\u002f811 in human A673 cells at 0.25 uM after 24 hrs by immunoblotting analysis\"],[\"Induction of recombinant FLAG tagged-ULK1 N86A mutant (unknown origin) kinase activity expressed in HEK293T cells assessed as mAtg13 phosphorylation at Ser318 co-transfected with GST-tagged mAtg13 for 20 mins measured by Western blot analysis relative to control\"],[\"Inhibition of human SIK (1 to 281 residues) using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry\"],[\"Antagonist activity at MOR (unknown origin) assessed as inhibition of DAMGO-induced agonism\"],[\"Inhibition of human recombinant PTP1B assessed as p-nitorphenol production after 30 mins\"],[\"Inhibition of recombinant human His-tagged PRKACA expressed in Escherichia coli at 10 uM in presence of ATP relative to control\"],[\"Antagonist activity at human S1P1 receptor expressed in CHO cell membrane by cAMP assay\"],[\"Inhibition of full length GST-tagged human recombinant FAK expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM\"],[\"In vitro inhibitory activity against Prostaglandin G\\u002fH synthase 2 in murine J774 cells\"],[\"BZD\\u002fCENTR\\u002fR Cerep selectivity data (BI)\"],[\"Inhibition of [3H]GABA binding to Gamma-aminobutyric acid (GABA-A) receptor of rat brain homogenates at 5*10e-4 M\"],[\"Reduced radioligand binding following 30 min intravenous 10 mg\\u002fkg PK11195 in blood\"],[\"Agonist activity at full length human PPAR-gamma transfected in human HepG2 cells by luciferase reporter gene assay\"],[\"Reactivation of paraoxon-inhibited electric eel AChE using ACh as substrate measured for 375 mins by 1H NMR analysis relative to control\"],[\"Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR\"],[\"Agonist activity at OT receptor assessed as oxytocic activity in absence of magnesium\"],[\"Inhibition of Plasmodium falciparum SHMT using L-serine\\u002f(6S)-THF as substrate by methylene tetrahydrofolate dehydrogenase coupled enzyme assay\"],[\"Binding affinity to HER2 domain-4 (unknown origin) by SPR assay\"],[\"Inhibition of mu-calpain (unknown origin) expressed in HEK293T cells assessed as reduction in p35 cleavage at 5 uM using p35 as substrate measured after 210 mins by fluorescence microplate reader assay\"],[\"Inhibition of recombinant DYRK1A (unknown origin) assessed as residual activity at 1 uM relative to control\"],[\"Antagonist activity against rat adenosine A1 receptor\"],[\"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis\"],[\"Inhibition of recombinant human PKCdelta (2 to end residues) at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"SLK DiscoveRx kinase panel\"],[\"Inhibition of recombinant human GST-tagged full length SGK2 (54 to 427 residues) expressed in baculovirus expression system using Ser\\u002fThr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of PKCdelta\"],[\"Inhibition of recombinant full length human GST-tagged CK1apha expressed in baculovirus at 5 uM using peptide as substrate after 3 hrs by kinase-glo luminescent assay\"],[\"Agonist activity at human GAL4-fused PPARdelta ligand binding domain expressed in COS-1 cells after 20 hrs by luciferase reporter gene transactivation assay relative to L165041\"],[\"Inhibition of human NEK6 at 0.1 uM relative to control\"],[\"Inhibition of BuChE (unknown origin) at 20 uM relative to control\"],[\"Displacement of [3H](-)CGP 12177 from human recombinant beta2 adrenergic receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting\"],[\"Inhibition of recombinant human full length GST-tagged CLK4 expressed in baculovirus expression system\"],[\"Agonist activity at rat alpha7 nAChR expressed in Xenopus laevis oocytes after 4 to 5 days at -60 mV holding potential by patch clamp assay\"],[\"Activation of full-length GST-tagged recombinant human SIRT1 assessed as enzyme activity obtained without subtraction of intrinsic fluorescence using H3K9 as substrate at 50 uM after 30 mins by SIRTainty assay\"],[\"Inhibition of human Nav1.3 expressed in HEK293 cells after 600 secs at -60 mV holding potential by ion works barracuda population patch clamp method\"],[\"Binding affinity to recombinant truncated N-terminal hexahistidine-tagged c-Myc (400 to 439 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS) by fluorescence polarization assay\"],[\"Inhibition of HOXA9 in mouse MigA9 cells assessed as induction of nuytten-ezh2-targets-up genes by gene set enrichment analysis\"],[\"Potency against CYP19 relative to aminoglutethimide\"],[\"Displacement of [3H]CP55940 from recombinant human CB2 expressed crude membranes after 90 mins by liquid scintillation counting method\"],[\"Binding affinity to N-terminal His-tagged human PPARgamma LBD (207 to 474 residues) expressed in Escherichia coli Rosetta (DE3) pLysS assessed as induction of M348 cross-peak shift at 1 mol equiv by 2D 1H-15N HSQC NMR analysis\"],[\"Inhibition of human recombinant thrombin using H2N(EEdansyl)GKQLRVVNGG (KDabcyl)-NH2 as substrate by fluorometric analysis\"],[\"Inhibition of human calcitonin receptor at 10 uM relative to control\"],[\"Inhibition of human BGT1 Y453A mutant expressed in tsA201 cells assessed as reduction in [3H]GABA uptake after 3 mins by scintillation counting method\"],[\"Antagonist activity at human OTR expressed in CHO cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay\"],[\"Binding affinity to Bid (unknown origin) assessed as micelles formation at 0.25 to 5 equivalent by 1H NMR spectra analysis\"],[\"Displacement of [3H]DTG from sigma 2 receptor in rat liver membranes at 1 uM measured after 120 mins by scintillation counting method\"],[\"Activation of TREK1 (unknown origin) expressed in Xenopus oocytes assessed as increase in channel currents\"],[\"Inhibition of human CARM1 assessed as inhibition of PABP methylation\"],[\"Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay\"],[\"Inhibition of human ALK2 (147 to end residues) using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay\"],[\"Binding affinity to wild-type human partial length DAPK1 (M1 to F296 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of human recombinant carbonic anhydrase 2 by CO2 hydration stopped-flow assay\"],[\"Inhibition of anthrax lethal factor by FRET assay\"],[\"Displacement of [125I]IL-8 from CXCR2 receptor (unknown origin) at 10 uM relative to control\"],[\"Inhibition of Bach1 in normal human lung fibroblasts assessed as induction of HMOX protein expression at 2.5 uM incubated for 16 to 18 hrs in presence of 0.156 uM Nrf2 activator Bardoxolone methyl by immunostaining relative to control\"],[\"Displacement of [3H]ketanserin from 5-HT2 receptor in porcine cerebral cortex homogenate after 60 mins by scintillation counting analysis\"],[\"Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 8.5\"],[\"Uncompetitive inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells at 0.5 to 2 uM preincubated for 10 mins followed by AMP addition measured after 10 mins by double-reciprocal plot analysis\"],[\"Inhibition of human TGFBR2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant human GST-tagged MAP3K8 catalytic domain expressed in baculovirus expression system using serine\\u002fthreonine-3 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay\"],[\"Ratio of trimethorpin IC50 to compound IC50 for Cryptosporidium parvum recombinant DHFR\"],[\"Inhibition of human GCN5L2 by AlphaScreen assay\"],[\"Inhibition of LRRK2 G2019S mutant (1326 to 252 aa) (unknown origin) stably expressed in HEK293 cell lysate using [gamma-32P] after 15 mins by Cerenkov counting method\"],[\"Inhibition of human plasma kallikrein using H-(D)-Pro-Phe-Arg-pNA as substrate after 10 to 120 mins at 37 degC by spectrophotometric method\"],[\"Displacement of propidium iodide from bovine erythrocyte AchE at 1 uM incubated for 6 hrs followed by addition of propidium iodide and measured after 15 mins by thioflavin T-fluorescence assay\"],[\"Competitive binding affinity to human TTK at 1 uM in presence of immobilized ligand relative to control\"],[\"Inhibition of N-terminal His6-tagged recombinant human c-Kit V560G mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB p65 phosphorylation at 30 uM pretreated with compound for 1 hr followed by LPS stimulation for 30 mins in presence of PPARgamma antagonist GW9662 by Western blot assay\"],[\"Inhibition of DNA-tagged human CSNK1G1 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Anticoagulant potency in human plasma as measured by activated partial thromboplastin time\"],[\"Activation of recombinant human HDAC8 assessed as increase in Kcat using Fluor-de-Lys as substrate by spectrofluorometry relative to control\"],[\"SAPK2a(h) Kinase panel\"],[\"Binding affinity to recombinant human flag\\u002fHis-tagged IL-23R (1 to 353 residues) expressed in HEK293F cells measured over 90 secs by surface plasmon resonance assay\"],[\"Positive allosteric modulation of human muscarinic acetylcholine M3 receptor expressed in CHO cells in presence of acetylcholine at EC20 concentration by calcium mobilization assay\"],[\"Inhibition of recombinant human His-tagged cytoplasmic FLT3 expressed in baculovirus expression system at 10 uM after 1 hr by lexaFluor-ADP-based FRET assay\"],[\"Inhibition of human group 3 sPLA2 at 100 uM\"],[\"Inhibition of SOS1 in overnight serum-starved human MIAPaCa2 cells assessed as reduction in MEK phosphorylation at 20 to 40 uM by Western blotting analysis\"],[\"Inhibitory activity against human PTP1B\"],[\"Displacement of [3H]tiotidine from human recombinant histamine H2 receptor after 1.5 hrs by microbeta scintillation counting analysis\"],[\"Binding affinity to human angiotensin receptor 2 at 10 uM by radioligand binding assay\"],[\"Activation of tumorigenic wild type B-Raf in human IPC-298 cells with Ras mutation assessed as phosphorylation of ERK\"],[\"EphA4(EPA4LGF1) Takeda global kinase panel\"],[\"Inhibition of Src by HTRF kinase assay\"],[\"Agonist activity at human CB1 receptor expressed in Sf9 cells assessed as stimulation of [35S]GTPgamma binding incubated for 15 mins prior to [35S]GTPgamma addition measured after 35 mins by scintillation proximity assay\"],[\"Displacement of radioligand [3H]osanetant at human NK3 Y247A mutant expressed in HEK293 cells\"],[\"Maximum binding of [3H]ORG2058 to human progesterone receptor at 310K\"],[\"Binding affinity to wild-type human partial length MEK5 (L98 to P448 residues) expressed in mammalian expression system by Kinomescan method relative to control\"],[\"Inhibition of JAK3 (unknown origin) expressed in mouse BA\\u002fF3 cells assessed as reduction of STAT5 phosphorylation at 300 nM incubated for 3 hrs followed by washout measured after 4 hrs by immunoblotting analysis\"],[\"Inhibition of BACE1 in human H4 cells overexpressing APP assessed as increase in CTFbeta intracellular level incubated for 24 hrs by Western blot analysis\"],[\"Inhibition of HIF2alpha in human RCC4 cells coexpressing HIF1alpha assessed as reduction in TGFalpha mRNA expression at 79 uM after 48 hrs by RT-PCR analysis\"],[\"Displacement of [3H]N-methylspiperone from human recombinant dopamine D4 receptor after 90 mins by scintillation counting method\"],[\"Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 42 deg C by fluorimetric assay\"],[\"Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method\"],[\"Displacement of [3H]-QNB from human recombinant M4 receptor expressed in HEK293 cells at 10 uM after 60 to 90 mins by scintillation counting\"],[\"Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 10 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay\"],[\"Inhibition of mushroom tyrosinase activity using L-tyrosine as substrate at 20 uM after 30 mins by spectrophotometric analysis\"],[\"Inhibition of human topoisomerase 2alpha assessed as reduction in decatenation of kinetoplast DNA by agarose gel electrophoresis method\"],[\"Inhibition of recombinant human GALC at pH 5.2 pre-incubated for 10 mins followed by 4-methylumbelliferyl-beta-D-galactopyranoside substrate addition and measured after 20 mins by fluorescence assay\"],[\"In vitro inhibition of substance P induced contractions of the guinea pig ileum at 10 uM.\"],[\"Effect on Acetylcholinesterase activity in rat erythrocytes\"],[\"Inhibition of CDK7 (unknown origin) assessed as ratio of Kinact to Ki\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by DTNB addition for 5 mins and subsequent addition of substrate measured after 3 mins by Ellman's method\"],[\"Inhibition of MERTK (unknown origin) assessed as residual activity measured at 1 uM\"],[\"PLK2 DiscoveRx kinase panel\"],[\"Antagonist activity at EphA2 receptor in human PC3 cells assessed as blockade of cell rounding at 12.5 to 50 uM pretreated for 15 mins by fluorescence microscopy\"],[\"Inhibition of human recombinant ACVR1B assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Inhibition of recombinant RPS6K1 (unknown origin) by FRET-based Z'-LYTE assay\"],[\"Inhibition of ERK1 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of recombinant human C-terminal 10His-tagged KLK12 (18 to 248 residues) expressed in mouse NS0 cells using fluorogenic Boc-VPR-AMC peptide as substrate by fluorescence based assay\"],[\"Displacement of [3H]2-[p-(2-carboxyethyl)phenyl-ethylamino]-5'-N-ethylcarboxamidoadenosine from human A2A receptor expressed in HEK293 cells at 10 uM by radio ligand binding assay relative to control\"],[\"Inhibition of human AT1 receptor\"],[\"Inhibition of SYK (unknown origin) at 10 uM after 40 mins by scintillation counting analysis\"],[\"Inhibition of human SAPK3 activity at 10 uM by radiometric assay\"],[\"In vitro inhibitory concentration against Butyrylcholinesterase of horse serum; value ranges from 0.45-1.08\"],[\"Agonist activity at rat delta opioid receptor expressed in rat C6 cell membranes assessed as stimulation of [35S]GTPgammaS binding measured after 1 hr\"],[\"Tissue distribution in ovaries 1 hr after [18F]4 injection into estrogen-primed immature rats at normal dose\"],[\"Anti-Proliferation assay: SK-MEL 30\"],[\"Displacement of bis-ANS from C-terminal His6-tagged human MD2 expressed in Pichia pastoris GS115 up to 30 uM by fluorescence spectroscopic assay\"],[\"Inhibition of human recombinant HDAC3 using Boc-Lys(Ac)-AMC as substrate after 30 mins by fluorescence assay\"],[\"Agonist activity at human KOR expressed in CHO cells at 10 uM after 1 hr by [35S]GTPgammaS binding assay relative to U69,593\"],[\"Inhibition of JAK3 in human PBMC assessed as reduction in IL2-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot\"],[\"Binding affinity to human FLT3 at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Agonist activity at human GPR40 expressed in CHO cells assessed as increase in intracellular calcium level after 60 mins by FLIPR assay\"],[\"Inhibition of FITC-Bak-BH3\\u002fFITC-Bim-BH3 binding to MCL1 (172 to 327 residues) (unknown origin) expressed in Escherichia coli BL21 CodonPlus (DE3) RIL after 1.5 hrs in presence of 1% FBS by fluorescence polarization assay\"],[\"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 after 30 mins by HTRF assay\"],[\"Binding affinity to FABP3 (unknown origin) at 1:1 ratio by fluorescence based thermal shift assay\"],[\"Inhibition of Syrian hamster HMGR\"],[\"Displacement of [3H]R1881 from rat AR relative to R1881\"],[\"Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production at 10 uM by scintillation proximity assay\"],[\"Inhibition of LSD1 in human A549 cells assessed as increase in histone H3K4me1 accumulation after 24 hrs by Western blot analysis\"],[\"Inhibition of human CLK1 expressed in bacterial expression system at 1 uM\"],[\"Blockade of Kv1.5 channel expressed in LTK cells at 1 uM by patch clamp method\"],[\"Displacement of [3H]estradiol from human recombinant ERalpha assessed as relative binding affinity after 1 hr by liquid scintillation counting relative to estradiol\"],[\"Binding affinity to human PCFT expressed in Chinese hamster R2\\u002fPCFT4 cells assessed as intracellular drug transport rate at 37 degC at pH 5.5 measured over 2 mins by Lineweaver-Burk plot analysis\"],[\"Noncompetitive inhibition of mushroom tyrosinase assessed as Vmax at 0.0017 uM using L-DOPA as substrate by Lineweaver-Burk plot analysis\"],[\"Inhibition of recombinant human GST-tagged full length ERK2 expressed in baculovirus expression system using Ser\\u002fThr 03 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of PIM3 in the presence of 5uM ATP\"],[\"Activation of human Nav1.1 expressed in HEK293 cells assessed as ratio of compound activation AUC to baseline activation AUC at 3.3 uM at -120 mV holding potential by Qpatch assay\"],[\"Inhibition of Cav1.2 (unknown origin) by QPatch assay\"],[\"Inhibition of PDGF-BB-stimulated Rac1-mediated cellular events in mouse 3T3 cells assessed as induction of membrane ruffling formation at 25 uM after 48 hrs by fluorescent microscopy\"],[\"Binding affinity to human vasopressin V1A receptor at 10 uM by radioligand binding assay\"],[\"Agonist activity RXRgamma (unknown origin)\"],[\"Inhibition of human Tdp1 expressed in Escherichia coli assessed as blockade of enzyme-mediated hydrolysis of phosphodiester linkage between tyrosine and 3^-end of N14Y DNA substrate at 1 mM by SDS-PAGE electrophoresis\"],[\"Inhibition of human RIPK5 assessed as enzyme activity at 30 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Cathepsin H (h) Eurofins-Cerep enzyme and uptake assay\"],[\"Negative allosteric modulation of rat mGlu1 receptor\"],[\"Inhibition of KRas mutant in human HCT116 cells pretreated with GSK3-beta assessed as cell viability by measuring ATP\"],[\"Inhibition of wild-type human partial length ULK2 (M1 to S301 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to rhesus monkey histamine H3 receptor\"],[\"Inhibition of recombinant human SIRT3 (118 to 399 residues) defatty-acylase activity expressed in Escherichia coli using SFP3 as substrate measured at 5 mins interval for 60 mins in presence of NAD+ by fluorescence assay\"],[\"Inhibition of HSP90 in human SKBR3 cells assessed as downregulation of ERK protein expression after 36 hrs by Western blotting analysis\"],[\"Non competitive inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as enzyme Km at 342 uM preincubated for 10 mins followed by substrate addition measured after 20 mins by Lineweaver-Burk plot analysis (Rvb = 0.4 to 0.83 mM)\"],[\"Inhibition of recombinant human CA9 incubated for 15 mins by phenol red dye based stopped flow CO2 hydration assay\"],[\"Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA\\u002fF3 cells assessed as inhibition of ERK phosphorylation at 0.01 to 1 uM incubated for 2 hrs by Western blot analysis\"],[\"Inhibition of wild-type human partial length autoinhibited KIT (Y545 to D952 residues) expressed in mammalian expression system at 100 nM by Kinomescan method relative to control\"],[\"Inhibition of SETD7 (unknown origin) at 1 to 50 uM by scintillation proximity assay\"],[\"Binding affinity to recombinant human muscarinic M1 receptor at 10 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Binding affinity to HSPD1 in HEK293 proteomes assessed as spectral count ratio at 20 uM incubated for 16 hrs by TAMRA biotin-azide dye based LC-MS\\u002fMS analysis relative to control\"],[\"Displacement of [3H]U69593 from kappa opioid receptor in rat brain homogenate after 1 hr by liquid scintillation counting\"],[\"Inhibitor activity against Beta-lactamase, derived from the Gram negative bacteria Enterobacter cloacae at pH 7\"],[\"Displacement of [3H]ZM241385 from A2A receptor in human HeLa cell membranes at 10 uM after 30 mins by beta-scintillation counting method\"],[\"Induction of abnormal recombinant HSP27 (unknown origin) dimerization after 3 hrs by Western blot analysis\"],[\"Inhibition of mouse 11betaHSD1 by scintillation proximity assay\"],[\"Binding affinity to ENO1 in HEK293 proteomes assessed as spectral count ratio at 20 uM incubated for 16 hrs by TAMRA biotin-azide dye based LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of DRAK1 (unknown origin) using 500 uM ATP by biochemical assay\"],[\"Binding affinity to human 5-LOX-linoleic acid complex at \\u003c10 uM by Lineweaver-Burk plot analysis relative to human 5-LOX\"],[\"Binding affinity to MAP2K2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay\"],[\"WNK1(h) Millipore kinase panel\"],[\"Inhibitory activity against Sortase A from Staphylococcus aureus\"],[\"Inhibition of DOCK5 in mouse osteoclasts assessed as induction of podosome belt organization defects at 100 uM incubated for 4 hrs followed by compound wash out by overnight recovery by immunofluorescence based assay\"],[\"Inhibition of recombinant human EGFR T790M\\u002fL858R mutant (696 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of delta 8-7 isomerase in mouse Neuro2a cells assessed as decrease in 7-DHC levels at 1 uM by LC-MS\\u002fGC-MS analysis\"],[\"Displacement of [3H]PDBu from PKC alpha at 100 uM; range 20 to 40\"],[\"Inhibition of MBP-fused recombinant human neuraminidase 2 expressed in Escherichia coli using 4MU-NANA as substrate preincubated for 15 mins followed by substrate addition measured every 1 min for 30 mins by fluorescence analysis\"],[\"Inhibition of recombinant human Ron (983 to end residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of recombinant human cathepsin S at 1 uM using cbz-val-val-arg-7-amino-4-methylcoumarin as substrate preincubated for 5 mins followed by substrate addition measured for 15 mins by fluorescence assay relative to control\"],[\"Inhibition of MLK2 (unknown origin) at 10 uM relative to control\"],[\"Inhibition of GST-tagged full length human recombinant LYNA expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM\"],[\"Inhibition of Lyp in antiCD3-antibody-stimulated human Jurkat T cells over-expressing Lyp assessed as activation of TCR-mediated and IL-2 promoter driven NFAT\\u002fAP1 transcriptional activation incubated for 1 hr by dual luciferase reporter gene assay\"],[\"Inhibition of human recombinant HDAC3 expressed in baculovirus using fluorogenic peptide p53 residues 379-382 (RHKK(Ac)AMC) as substrate by Fluorescence analysis\"],[\"Inhibition of JNK1 (unknown origin) after 1 hr by homogeneous time-resolved fluorescence assay\"],[\"Inhibition of wild-type human partial length MAP3K4 (G1319 to E1608 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Inhibition of MYST2 (unknown origin)\"],[\"Binding affinity to Hsp90 nucleotide binding domain in human BT474 cells\"],[\"5-HT2B (h) Eurofins-Cerep Cellular and Nuclear Receptor Functional Assays\"],[\"Binding affinity to human CB1 receptor at 13 uM\"],[\"Inhibition of recombinant human cKIT V560G mutant (544 to end residues) at 1 uM using GGMEDIYFEFMGG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of re-uptake of [3H]-5-HT at human SERT expressed in HEK293 cells preincubated for 5 mins followed by [3H]-dopamine addition measured after 1 min by liquid scintillation counting\"],[\"Inhibition of human Phosphodiesterase 4A from peripheral blood mononuclear cells\"],[\"Inhibition of polyhistidine tagged yeast prion protein Sup35 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid polymerization at 50 uM in presence of 1% seed fibres by thioflavin T fluorescence assay relative to untreated control\"],[\"In vitro inhibitory activity was evaluated against angiotensin converting enzyme from rabbit in bovine buffered base\"],[\"Inhibition of human bradykinin 2 receptor at 10 uM by radioligand binding assay\"],[\"Displacement of [3H]-methyltrienolone from human progesterone receptor expressed in HEK293 cells\"],[\"Agonist activity at human dopamine D2 receptor at 10 nM\"],[\"Inhibition of STAT3 in human HeLa cells assessed as decrease in phosphorylation of STAT3 at Tyr705 after 1 hrs by Western blot analysis\"],[\"Inhibition of full length N-terminal GST-tagged human HDAC6 expressed in baculovirus expression system assessed as inhibition of fluorophore 7-amino-4-methylcoumarin release by fluorescence assay\"],[\"Inhibition of sEH in human HepG2 cells using 14(15)-EET-d11 as substrate assessed as reduction in conversion of 14(15)-EET-d11 to 14(15)-DHET-d11 preincubated for 15 mins followed by substrate addition measured after 10 mins LC-MS\\u002fMS analysis\"],[\"Binding affinity to MDH2 in human HCT116 cells using alexa 488 tagged compound by photo-affinity conjugation and 2D PAGE method\"],[\"Inhibition of human CK2alpha2 at 1 uM using as [RRRDDDSDDD] substrate\"],[\"Displacement of [125I]Tyr3-neurotensin from human recombinant NTS1 receptor expressed in CHO cells at 10 uM after 60 mins\"],[\"Inhibition of NAE-mediated neddylation in human MGC-803 cells assessed as cullin4A-Nedd8 adduct formation at 2.5 to 7.5 uM measured after 24 hrs by western blot assay\"],[\"Inhibition of F13-A in human plasma assessed as inhibition of fibrin clot formation at 7.5 X 10'-8 M by biotin incorporation assay\"],[\"Displacement of [3H]MLA from alpha-7 nACh receptor in rat brain\"],[\"Inhibition of human recombinant AChE-induced human amyloid beta (1 to 40 residues) aggregation at 100 uM after 24 hrs by thioflavine T fluorescence method\"],[\"Activity of human NTPDase8 expressed in COS7 cells assessed as amount of inorganic phosphate released using ATP as the substrate at 100 uM after 15 mins by malachite green reagent method\"],[\"Inhibition of diphenolase activity of mushroom tyrosinase at 10.4 mM preincubated with compound for 10 mins before addition of L-DOPA as substrate by spectrophotometric analysis\"],[\"Inhibition of human recombinant topoisomerase 1 assessed as blocking of supercoiled pHOT DNA relaxation at 50 uM incubated for 25 mins at 37 degC by ethidium bromide staining based agarose gel electrophoresis\"],[\"Inhibition of recombinant human full length GST-tagged DYRK1A expressed in baculovirus expression system using serine\\u002fthreonine-18 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay\"],[\"Inhibition of TNIK in human NCI-H1703 cells transfected with lentiviral vector 7TFP assessed as reduction of GSK3 inhibitor X activated TNIK-mediated Wnt\\u002fTCF\\u002fbeta-catenin-dependent transcription at 10 uM after 24 hrs by luciferase reporter assay\"],[\"Activation of human recombinant CA2 by stopped-flow CO2 hydration method\"],[\"Activation of human TAAR1 expressed in CHOK1 cells coexpressing Galpha16 assessed as calcium accumulation at 10 uM relative to beta-phenethylamine\"],[\"Inhibition of STS (unknown origin) at 60 uM\"],[\"PEK(h) Millipore kinase panel\"],[\"Inhibition of mouse GAT3 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake at 100 uM measured after 35 mins by liquid scintillation method\"],[\"ErbB4(h) Eurofins kinase panel\"],[\"Binding affinity to RPS6KA4 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Displacement of [3H]]isoVa-RYYRIK-NH2 from human ORL1 receptor high affinity binding site expressed in African green monkey COS7 cells after 90 mins by topcount analysis\"],[\"Inhibition of recombinant full length human GRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of NEIL1 (unknown origin) assessed as effect on DNA lesions per 10'6 DNA bases using 5-OH-5-MeHyd substrate incubated for 1 hr by GC-MS\\u002fMS assay\"],[\"Inhibition of PDE5 (Phosphodiesterase) from human corpus cavernosum\"],[\"Displacement of [3H]CP-55940 from mouse CB1 receptor expressed in HEK293 cells\"],[\"Binding affinity to rabbit CK-MM at 20 uM\"],[\"Inhibition of horse serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins by Ellman method\"],[\"Displacement of [3H]SYM2081 from full length recombinant rat GluK3 receptor expressed in sf9 cells by liquid scintillation counting\"],[\"Inhibition of EGFR (unknown origin) expressed in BaF3 cells assessed as inhibition of cell proliferation after 72 hrs by CelltiterGlo assay\"],[\"Inhibition of EZH2 in human PRC2 complex preincubated for 30 mins followed by histone h3 peptide (21 to 44 residues) and S-adenosylmethionine and measured after 90 mins\"],[\"Inhibition of Shh-mediated Gli2 mRNA transcription in human synthetic skin by real-time quantitative PCR analysis\"],[\"Ratio of IC50 for FLT3-L-stimulated wild type full length human FLT3 autophosphorylation expressed in MEF to IC50 for human wild type FLT3\"],[\"Inhibition of recombinant human 6His-tagged SENP1 catalytic domain expressed in Escherichia coli preincubated for 15 mins followed by addition of SUMO1-AMC as substrate measured after 1 hr by fluorescence analysis\"],[\"KinomeScan assay: inhibition of SNARK\"],[\"Inhibition of type-3 17 beta-hydroxysteroid dehydrogenase expressed in HEK293 cells at 37 degree C pH 7.4; Not determined\"],[\"Inhibition of human cloned EAAT1 expressed in HEK293 cells up to 300 to 1000 uM by [3H]-D-Asp uptake assay\"],[\"Inhibition of Pin1 in human HeLa cells assessed as increase in PML level at 0.1 to 1 uM by Western blotting\"],[\"Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition measured after 15 mins by Ellman's method\"],[\"Inhibition of VEGFR1 phosphorylation in growth factor-stimulated HUVEC\"],[\"Inhibition of KDM4C (unknown origin) at 1 uM relative to control\"],[\"Inhibition of recombinant human cathepsin S expressed in insect cells using Z-Phe-Arg-AMC as substrate measured after 60 mins by fluorimetric assay\"],[\"Inhibition of human TP receptor by radioligand binding assay\"],[\"SNF1LK2 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of human recombinant CA12 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method\"],[\"Inhibition of wild-type human partial length SRMS (L208 to P488 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Displacement of [125I]-[Nle75,Tyr77][Pyr1]-Ape13 from YFP-tagged human APJ expressed in HEK293 cell membranes assessed as inhibition constant incubated for 1 hr by scintillation counting method\"],[\"Displacement of (-)-[3H]CGP-12177 from human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as remaining radioligand binding at 10 uM after 120 mins by scintillation counting method relative to control\"],[\"Inhibition of G9a in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 100-300 nM relative to control\"],[\"Activation of Nrf2 in mouse Hepa1c1c7 cells assessed as increase in NQO1 activity at 0.625 uM\"],[\"Inhibition of Fyn (unknown origin) after 60 mins by TR-FRET assay\"],[\"Inhibition of Lyn\"],[\"Chaperone activity at human Lysosomal alpha-mannosidase C55F mutant transfected in human MAN21B knockout HAP1 cells assessed as enzyme activity enhancement at 20 uM incubated for 96 hrs relative to control\"],[\"Inhibition of tracer 236 binding to recombinant human GST-tagged full length MLK2 expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control\"],[\"Inhibition of FAAH in rat cerebellum membranes assessed as [3H]anandamide hydrolysis\"],[\"Activation of Nrf2 in human BEAS2B cells assessed as increase in Keap1 protein expression at 5 uM incubated for 24 hrs by immunoblot analysis\"],[\"Inhibition of N-terminal GST-tagged recombinant human wild-type FLT3 (564 to end residues) expressed in baculovirus infected sf21 cells using Abltide as substrate in presence of [gamma33P]ATP after 10 mins by scintillation counting method\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation at 25 uM measured after 48 hrs by ThT-assay\"],[\"Inhibition of P13Kalpha (unknown origin)\"],[\"Inhibition of Mycobacterium tuberculosis recombinant MbtA expressed in Escherichia coli by ATP\\u002fPPi exchange assay\"],[\"Inhibition of recombinant p300 catalytic domain (unknown origin) using N-terminal histone H3 substrate at 52 uM by orthogonal fluorescence assay in presence of [3H]acetyl-CoA relative to control\"],[\"Agonist activity at human PPARgamma ligand binding domain expressed in MEF cells co-transfected with Gal4-responsive luciferase vector assessed as photinus\\u002frenilla luciferase activity at 30 uM by transactivation assay relative to control\"],[\"Inhibition of full-length recombinant human PRKCZ expressed in baculovirus system at 100 nM by Z-lyte assay\"],[\"Inhibition of human topoisomerase-2alpha assessed as rate of ATP hydrolysis at 50 uM using linear pBR322 DNA as substrate measured up to 30 mins in presence of 0.75 mM ATP by pyruvate kinase\\u002flactate dehydrogenase enzyme coupled assay (Rvb = 3.180 microM\\u002fmin)\"],[\"Inhibition of GST-tagged recombinant PDGFRbeta (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay\"],[\"Inhibition of Kit exon 11 deletion (557 to 558 residues) and V654A mutant (unknown origin) transfected in mouse BA\\u002fF3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay\"],[\"Inhibition of [3H]5-HT uptake into human SERT expressing HEK293 cells\"],[\"Competitive binding affinity to PAK6 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Antagonist activity against 5HT3 receptor assessed as inhibition of 5HT-induced contraction of guinea pig ileum\"],[\"Inhibition of recombinant human TLK2 (387 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of GST-tagged mouse CK1delta transcription variant 1 mutant expressed in Escherichia coli at 15 degC for 14 hrs using GST-p53 (1 to 64 residues) by SDS-PAGE based autoradiography\"],[\"Displacement of 5'FAM-LTFEHYWAQLTS from human recombinant N-terminal domain of MDM2 (1 to 118 residues) expressed in Escherichia coli BL21 (DE3) cells measured after 15 mins by fluorescence polarization assay\"],[\"Displacement of [3H]estradiol from full-length human estrogen receptor beta assessed as relative binding affinity by radiometric assay relative to estradiol\"],[\"Inhibition of iso glutaminyl cyclase (unknown origin)\"],[\"Inhibition of human recombinant MMP10 at 10 uM\"],[\"Activity at PPARbeta\\u002fdelta by luciferase reporter gene transactivation assay in COS7 cells\"],[\"Agonist activity at human TLR7 expressed in HEK293 cells at \\u003c= 50 ng\\u002fml by QUANTI-blue SEAP reporter gene assay\"],[\"Binding affinity to human bradykinin B1 receptor\"],[\"Binding affinity to TAF1 in HEK293T cells assessed as increase in TAF1 level by ITDR analysis\"],[\"Inhibition of rat liver FAS by Coomassie blue staining\"],[\"Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay\"],[\"Binding affinity to recombinant SARS-COV2 S-RBD incubated for 5 mins by microscale thermophoresis analysis\"],[\"Deactivation of human BchE A328F mutant assessed as residual enzyme activity at 2.1 uM after 15 mins\"],[\"Inhibition of human recombinant full length IGF1R\"],[\"Inhibition of human ABL2 using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of C-terminal FLAG-tagged human KDM4A expressed in Escherichia coli at 50 uM pre-incubated for 4 hrs before substrate addition and measured after 1 hr by AlphaScreen assay\"],[\"Inhibition of recombinant human full length N-terminal GST-fused MPS1 (1 to 857 residues) using histone H3 as substrate measured after 2 hrs in presence of DTT by TR-FRET assay\"],[\"Inhibition of Pim1 kinase in human PC3 cells assessed as increase in p27 level at 8 to 16 uM after 24 hrs by Western blot analysis\"],[\"Inhibition of adrenergic beta-3 receptor (unknown origin) at 10 uM relative to control\"],[\"Binding affinity towards Opioid receptor kappa 1 on guinea pig cerebellum membranes by [3H]U-69593 displacement.\"],[\"Inhibition of LPS-stimulated NFkappaB p65 nuclear translocation in mouse RAW264.7 cells after 24 hrs by Western blot analysis\"],[\"Maximum response of drug relative to the response of 10e-5 isoproterenol after treatment with the compound\"],[\"Inhibition of human PDE1B1\"],[\"Inhibition of human SUV39H1 up to 50 uM using Biot-H3 (1-25) as substrate and in presence of [3H]-SAM incubated for 1 hr by scintillation proximity assay\"],[\"Inhibition of recombinant rat ALDH activity in liver mitochondria\"],[\"Binding affinity to human A3 receptor\"],[\"Inhibition of human PLK2 using casein as substrate by [gamma-33P]-ATP assay\"],[\"Mixed-type inhibition of human thrombin assessed as substrate Km at 10 uM using varying levels of spectrozyme TH as substrate measured after 10 mins by Michaelis-Menten plot analysis (Rvb = 8.6 +\\u002f- 2.8 uM)\"],[\"Inhibition of glutathione agarose conjugated Rac1 G15A mutant (unknown origin) in assessed as reduction in purified Tiam-1 DH\\u002fPH domain association with Rac1 G15A mutant at 5 mM by Western blotting based pulldown assay relative to control\"],[\"Inhibition of recombinant human Pim3 (2 to end residues) using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay\"],[\"Binding affinity to PKM2 in human HL60 cells at 20 uM after overnight incubation by Western blot method\"],[\"Inhibition of FDPS (unknown origin) using [14C] IPP and GPP as substrate preincubated for 10 mins followed by substrate addition and measured after 30 min by liquid scintillation counting method\"],[\"Displacement of [3H]diprenorphine from human KOP receptor expressed in CHO cell membrane\"],[\"Binding affinity to MOR (unknown origin) assessed as inhibition of ligand binding\"],[\"Inhibition of human ROCK1 using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] as substrate\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 lolA at 16 fold MIC after 16 hrs by spectrophotometry\"],[\"Inhibition of CDK2 K89T mutant\\u002fCycA3\"],[\"Inhibition of MTase in Zika virus infected in African green monkey Vero cells assessed as antiviral activity incubated for 5 days by inverted microscopic method\"],[\"Inhibition of CLK2 (unknown origin) at 10 uM relative to control\"],[\"Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of m-TOR at ser2448 at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA\"],[\"Binding affinity to recombinant KLK6 (unknown origin) at 2.5 to 50 uM pre-incubated with human LNCAP cells conditioned medium for 30 mins by alkyne-fluorophosphonate probe and azide-TAMRA fluorescent dye based by in-gel fluorescence assay\"],[\"Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method\"],[\"Inhibition of IL-5 in mouse pro-B Y16 cells at 50 uM after 48 hrs by WST1 assay\"],[\"Inhibition of recombinant human DNA topoisomerase-1-mediated relaxation of supercoiled pBR322 at 20 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\"],[\"Displacement of [3H]DPCPX from recombinant human A2B adenosine receptor expressed in HEK293 cell membranes measured after 60 mins by topcount scintillation counting method\"],[\"Inhibition of human GST fused Pim3 expressed in Escherichia coli after 30 mins\"],[\"Substrate activity at SIRT5 (unknown origin) assessed as compound-NAD covalent intermediate formation by measuring (S)-3,11-dioxo-1-phenyl-5-(phenylcarbamoyl)-2-oxa-4,10,12-triazapentadecan-15-oic acid level measured after 18 hrs by liquid chromatography-mass spectrometry method\"],[\"Inhibition of intracellular tyrosinase in mouse B16F0 cells at 25 uM using L-DOPA as substrate preincubated with compound followed by substrate addition and measured after 20 mins by UV-Visible spectrophotometric analysis relative to control\"],[\"Agonist activity at human recombinant CCR3 expressed in eosinophils\"],[\"Displacement of [125I]RTI-55 from dopamine transporter of rat brain membranes\"],[\"Inhibition of human cathepsin K using Z-Phe-Arg-AMC as substrate after 30 mins by spectrofluorimetric method\"],[\"Inhibition of human full length MST2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of mouse GAT2 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method\"],[\"Inhibition of N-terminal FLAG-tagged human PDE2A1 (2 to 941 residues) expressed in Baculovirus infected Sf9 insect cells at 5.5 uM using FAM-cAMP as substrate after 1 hr by fluorescence polarization assay relative to control\"],[\"Binding affinity to wild-type human partial length PIK3C2B (M1 to L1634 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method\"],[\"Ratio of semaxanib IC50 to compound IC50 for VEGFR2 phosphorylation in human U251 cells\"],[\"Inhibition of full length recombinant human GST-tagged PLK2 expressed in baculovirus expression system at 1 uM relative to control\"],[\"Activity at GST-tagged IAR3 of Arabidopsis thaliana assessed as ABA release per mg of protein after 7 hrs by HPLC\"],[\"Inhibition of AKT1 (unknown origin) at 5 uM after 120 mins\"],[\"Inhibition of [3H]GABA uptake at mouse GAT1 expressed in HEK293 cells after 25 mins by scintillation counting analysis\"],[\"Inhibition of human STK22D at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate\"],[\"Inhibition of Bos taurus (bovine) mitochodrial complex 1 isolated from heart submitochondrial particle by NADH oxidase assay\"],[\"Inhibition of recombinant human LMPTP-A using OMFP or pNPP as substrate by fluorescence assay\"],[\"Displacement of [125I]-NDP-alpha-MSH from human MC3R expressed in HEK2936E cell membrane measured after 16-23 hrs by 1450 microbeta trilux scintillation proximity assay\"],[\"Displacement of [3H]dexamethasone from human glucocorticoid receptor overexpressed in HEK293 cells by microbeta counting assay\"],[\"Displacement of [3H]Spiroperidol from cloned rat dopamine D2L receptor expressed in HEK293 cells by liquid scintillation counting analysis\"],[\"Agonist activity at human S1P4R receptor expressed in CHO cell membranes by [35S]GTPgamma binding assay\"],[\"Inhibition of GST-tagged PTP-sigma (unknown origin) by plate reader analysis using DiFMUP as substrate\"],[\"Inhibition of recombinant human EEF2K H23R mutant (2 to end residues) at 1 uM using RKKFGESEKTKTKEFL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of CHK2 phosphorylation at Thr68 in human HT-29 cells at 1 uM by gel electrophoresis\"],[\"Inhibition of GAL4-fused human RORalpha transcriptional activity expressed in CHOK1 cells after 2 days by luciferase reporter gene assay\"],[\"Partial displacement of [3H]PGE2 from human EP3 receptor in presence of 10% human serum\"],[\"Inhibition of adrenoceptor alpha 2A (unknown origin) relative to control\"],[\"Inhibition of human recombinant WNK1 assessed as reduction in substrate phosphorylation at 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method\"],[\"Displacement of [3H]-aldosterone to human mineralocorticoid receptor LBD by radiometric binding assay\"],[\"Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-3 adrenergic receptor\"],[\"Antagonist activity at NPY Y1 receptor in human SK-N-MC cells assessed as inhibition of NPY-induced calcium mobilization by FLIPR assay\"],[\"Biochemical assay (AKT2)\"],[\"Inhibition of eNOS phosphorylation at Ser-1172 in VEGF-stimulated HUVEC at 1 uM preincubated for 1 hr before VEGF induction measured after 1 hr by Western blot analysis\"],[\"Binding affinity to wild-type human partial length TIE1 (T819 to A1138 residues) expressed in bacterial expression system by Kinomescan method relative to control\"],[\"Antagonist activity at human recombinant P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of BzATP-induced pore formation flux by fluorometric assay\"],[\"Inhibition of human recombinant HDAC 1 by HDAC-Glo luminescent assay\"],[\"Inhibition of recombinant human His-tagged full length Hyl expressed in Escherichia coli expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Binding affinity towards thyroid hormone receptor (hTR alpha 1)\"],[\"Inhibition of MELK (unknown origin) at 10 uM\"],[\"Inhibition of PI4Kb (unknown origin) at 1 uM\"],[\"Inhibition of human Aurora B using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control\"],[\"Binding affinity to human M4 muscarinic receptor\"],[\"Inhibition of human RSK3 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of IL-6 signaling pathway in human HepG2 cells transfected with p-STAT3-Luc assessed as reduction in IL-6 induced STAT3 phosphorylation at 20 ug\\u002fml preincubated for 1 hr followed by IL-6 induction measured after 10 mins by immunoblot analysis\"],[\"Partial agonist activity at RXRbeta expressed in human Cos1 cells after 18 hrs by SEAP reporter gene assay\"],[\"Antagonist activity at human alpha-7 nAChR in tsA201 cells coexpressed with Ric3 by FMP assay\"],[\"Inhibition of SPHK2 (unknown origin) at 1 uM relative to control\"],[\"Agonist activity at GPR35 in human HT-29 cells assessed as receptor internalization at 10 uM after 1 hr by fluorescence confocal imaging\"],[\"Inhibition of PRKCB2 (unknown origin) at 10 uM relative to control\"],[\"KinomeScan assay: inhibition of CSNK1D\"],[\"Inhibition of recombinant human CA2 expressed in Escherichia coli using fluorescein diacetate as substrate at pH 3.5 by fluorometric esterase assay\"],[\"Inhibition of WDR5 in human MV4-11 cells assessed as reduction in WDR5 occupancy at RPS24 binding site at 600 nM after 4 hrs by chromatin immunoprecipitation assay relative to control\"],[\"Agonist activity at human VDR expressed in HEK293 cells expressing mouse osteopontin VDRE assessed as induction of receptor transactivation incubated for 16 hrs by luciferase reporter gene assay\"],[\"Inhibition of human recombinant KIT in presence of ATP by Z-lyte kinase assay\"],[\"Inhibition of Trypanosoma cruzi trypanothione reductase activity\"],[\"Covalent inhibition of FBPase S124A mutant (unknown origin) assessed as Vmax measured upto 45 mins by UV-visible spectrometry analysis\"],[\"Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) using acetylcholine iodide as substrate by Ellman method\"],[\"Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay\"],[\"Agonist activity at beta-2 adrenoceptor in guinea pig trachea assessed as inhibition of histamine-induced muscle contraction\"],[\"Inhibition of aromatase (unknown origin) at 1 uM\"],[\"Inhibition of cathepsin L (unknown origin) using Z-Phe-Arg-AMC as substrate after 5 mins by fluorimetric method\"],[\"Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay\"],[\"Inhibition of PI3Kbeta (unknown origin) up to 10 uM using L-a- phosphatidylinositol\\u002fOctylGlucoside as substrate after 10 mins by KinaseGlo luminescence assay\"],[\"Binding affinity to human mGluR5 expressed in HEK293 cell membranes expressing GLAST assessed as association kinetic half life by scintillation counting\"],[\"Antagonist activity RORalpha in human Th17 cells assessed as inhibition of cell differentiation by measuring IL-17A expression at 0.5 uM after 6 days by flow cytometry\"],[\"Displacement of [3]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 1 uM\"],[\"Inhibition of HSP90 (unknown origin) by luciferase refolding assay\"],[\"Inhibition of PKACalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis\"],[\"Displacement of biotinylated acetylated peptide from recombinant human partial length BRD2 isoform 1 bromodomain 1\\u002f2 (K71 to D455 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method\"],[\"Displacement of [3H]N-alpha-methylhistamine from human histamine H3 receptor expressed in CHO-K1 cells\"],[\"Inhibition of Met-mediated scattering in HGF-stimulated human MDCK cells at 10 uM pre-incubated overnight prior to HGF stimulation for 24 hrs measured after 24 to 48 hrs\"],[\"Inhibition of [3H]pirenzepine binding to mouse muscarinic acetylcholine receptor M1 from cerebral cortex\"],[\"Inhibition of human ULK1 (M1 to T309 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control\"],[\"Inhibition of human purified MPG binding to immobilized ethenoadenine containing 5'-TCGAGGATCCTGAGCTCGAGTCGACGXTCGCGAATTCTGCGGATCCAAGC-3' duplex oligonucleotide at 40 uM by SPR assay\"],[\"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay\"],[\"Inhibition of human recombinant CYP1A1 after 15 mins by 7-ethoxyresorufin-O-deethylation-based spectrofluorimetry\"],[\"Inhibition of full length recombinant human GST-tagged AURKC expressed in baculovirus expression system at 1 uM relative to control\"],[\"Agonist activity at Gal4-fused human PPARdelta\"],[\"Inhibition of purified human BACE1 by FRET assay\"],[\"Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay\"],[\"Mixed-type inhibition of electric eel AChE using acetylthiocholine iodide as substrate by Lineweaver-Burk plot analysis\"],[\"Effective concentration for cofactor association with recombinant liver X receptor-beta\"],[\"Inhibition of KDR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA\"],[\"Inhibition of Protein kinase C eta\"],[\"Displacement of [125I]3,5,3'-triiodo-L-thyronine from His-tagged human recombinant TRalpha1 by scintillation proximity assay\"],[\"Dose affording 50% of maximum transactivation for ecdysone receptor from Bombyx mori (BmEcR) and a beta-galactosidase reporter gene in HEK293 cell-line\"],[\"Inhibition of Bos taurus (bovine) mitochondrial complex 2 electron transfer activity measured per mg of protein\"],[\"Displacement of [125I]sauvagine from recombinant human CRF1 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control\"],[\"Inhibition of His-tagged human SHP2 PTP domain expressed in Escherichia coli BL21 using p-nitrophenyl phosphate as substrate preincubated for 30 mins followed by substrate addition\"],[\"Inhibition of SGK (unknown origin) at 2 uM relative to control\"],[\"Reversible inhibition of human recombinant MAOB using kynuramine as substrate assessed as residual activity at 100 times IC50 preincubated for 30 mins followed by 100 fold dilution measured after 20 mins by fluorescence spectrophotometry relative to control\"],[\"Inhibition of human cloned histamine H2 receptor by competitive binding experiment\"],[\"Inhibition of human FGFR2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Non-competitive inhibition of full length recombinant human ALDH1A1 expressed in Escherichia coli BL21(DE3) assessed as reduction in dehydrogenase activity by measuring NAD(P)H level using varying levels acetaldehyde in presence of NAD+ by Lineweaver-Burk plot analysis\"],[\"Percentage inhibition of angiotensin converting enzyme (rabbit lung) by the compound required to inhibit at 63 uM was evaluated\"],[\"Antagonist activity at human NPY Y2 receptor in KAN-TS cells by [35]GTPgammaS assay\"],[\"Intrinsic activity for Histamine H4 receptor\"],[\"Displacement of [3H]-HEMADO from human A3 receptor expressed in HEK293 cell membranes at 10 uM after 90 mins radioligand binding assay\"],[\"Effect on eNOS at S1177 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin\"],[\"Modulation of NOD1 (unknown origin)\"],[\"Inhibition of MB064 labelling of ABHD6 in mouse brain homogenates at 10 uM pretreated for 30 mins followed by MB064 addition and measured after 20 mins by activity based protein profiling assay relative to control\"],[\"Inhibition of human cloned SPHK2 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot\"],[\"Inhibition of human ABL Y253H mutant after 2 hrs by TR-FRET assay\"],[\"Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance\"],[\"Inhibition of recombinant human C-Src assessed as residual activity at 10 uM Cdc2 peptide as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Inhibition of CIAPIN1 in human KMS11 crude cell extracts assessed as induction of formation of high molecular weight complexes with CIAPIN1 at 20 uM incubated for 2 hrs in presence of GSH by immunoblot analysis\"],[\"Inhibitory activity against Acyl coenzyme A:cholesterol acyltransferase 1 obtained from rat liver microsomes\"],[\"Displacement of pan-PPAR fluormone from PPARalpha LBD by TR-FRET based LanthaScreen assay\"],[\"beta 2 (h)  CEREP ligand profiling\"],[\"Inhibition of CDK9 (unknown origin) at 1 uM\"],[\"Inhibition of Jak2 V617F mutant in human UKE1 cells assessed as inhibition of STAT5 phosphorylation after 1 to 24 hrs by Western blotting analysis\"],[\"Inhibitory activity against Dihydrohydrofolate reductase (DHFR) of Mycobacterium avium\"],[\"Inhibition of bovine brain mitochondrial Monoamine oxidase A (MAO-A) compared to toloxatone\"],[\"Agonist activity at human FFA1 receptor expressed in CHO cells by Fluo 4-AM dye based FLIPR assay\"],[\"Agonist activity at human kappa opioid receptor over-expressed in CHO cell membrane after 1 hr by [35S]GTPgammaS binding assay\"],[\"Inhibition of human recombinant nNOS expressed in baculovirus infected insect sf9 cells assessed as conversion of [3H]-L-arginine into [3H]-L-citrulline by radiometric method\"],[\"Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addition and measured at 20 secs interval for 10 mins by fluorescence assay\"],[\"Mixed noncompetitive inhibition of human recombinant MAO-A assessed as dissociation constant for enzyme-inhibitor complex by Lineweaver-Burk plot analysis\"],[\"Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor\"],[\"Inhibition of human cytosolic carbonic anhydrase 2 by stopped-flow CO2 hydration assay\"],[\"Displacement of [3H]SB-674042 from human orexin-1 receptor after 60 mins by scintillation counting analysis\"],[\"Inhibition of PTP1B (unknown origin) expressed in Escherichia coli expression system using p-nitrophenyl phosphate as substrate assessed as release of p-nitrophenol at 10 ug\\u002fmL incubated for 10 mins prior to substrate addition measured after 30 mins relative to control\"],[\"Agonist activity at recombinant human 5-HT2C receptor transfected in CHOK1 cells assessed as calcium mobilization by FLIPR assay\"],[\"Antagonist activity at histamine H1 receptor expressed in human PC3 cells inhibition of histamine-induced calcium influx by cell based assay\"],[\"Inhibition of recombinant Plasmodium falciparum PNP using inosine as substrate assessed as inhibition constant for slow onset inhibition of enzyme-inhibitor complex by xanthine oxidase coupling enzyme assay\"],[\"Inhibition recombinant human HIPK2 (165 to 564 residues) after 5 mins in presence of [33P] ATP by Topcount method\"],[\"Competitive binding affinity to RPS6KA6 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of c-Met in human EBC1 cells assessed as reduction in ERK T202\\u002fY204 phosphorylation at 0.1 to 10 uM incubated for 2 hrs by Western blot method\"],[\"Inhibition of partial length human RET expressed in bacterial system at 1 uM\"],[\"Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay\"],[\"Inhibition of human recombinant cytosolic human carbonic anhydrase-2 incubated for 15 mins prior to testing by stopped-flow CO2 hydrase assay\"],[\"Inhibition of human HDAC2 after 15 mins by trypsin-coupled fluorescence assay\"],[\"Farnesoid X-activated receptor activity compared to 50 uM chenodeoxycholic acid (CDCA)\"],[\"Inhibition of recombinant human GST-tagged CLK1 catalytic domain (129 to 484 residues) expressed in Escherichia coli using GRSRSRSRSRSRSRSR as substrate incubated for 15 mins in presence of [gamma-32P]ATP\"],[\"Inhibition of Plk1 in human A2780 cells assessed as reduction in CDC25C phosphorylation at Ser198 residue at 200 to 1000 nM measured after 24 hrs by Western blot analysis\"],[\"Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes\"],[\"Displacement of [3H]N-alpha-methylhistamine from recombinant rhesus monkey histamine H3 receptor transfected in CHO cells after 1 hr by scintillation counting analysis\"],[\"Inhibition of CCRK Lysine 1 labelling site (unknown origin) at 10 uM\"],[\"Competitive inhibition of human alpha7 nAChR expressed in Xenopus oocytes by electrophysiology assay\"],[\"Inhibition of human DNA topoisomerase-2alpha mediated decatenation using kinetoplast DNA as substrate at 50 uM incubated for 18 hrs\"],[\"Antagonist activity at human CBR1 assessed as [35S]GTPgammaS binding at 10 uM by luminescence assay relative to control\"],[\"Inhibition of human AC3 expressed in HEK293 cells assessed as remaining activity by measuring cAMP level at 30 uM relative to control\"],[\"Inhibition of RON (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM\"],[\"Inhibition of human ERG by QPatch HTX automated patch clamp system\"],[\"Inhibition of Tjp2 in mouse C2C12 cells assessed as reduction in phospho-sites occupancy at 4 uM after 5 hrs by SILAC based LC-MS\\u002fMS analysis relative to control\"],[\"Noncompetitive type inhibition of human AOX assessed as inhibitor dissociation constant by measuring changes in intercept of the double reciprocal plot using phthalazine as substrate by Michaelis-Menten analysis\"],[\"Displacement of [3H]-rauwolscine from human adrenergic alpha2C receptor stably expressed in MDCK cell membranes at 10 uM incubated for 90 mins under dark condition by scintillation counting analysis relative to control\"],[\"Inhibition of wild-type human partial length EPHA8 (Q608 to C920 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to Pseudomonas aeruginosa heme oxygenase\"],[\"Inverse agonist activity at PPARbeta\\u002fdelta in mouse C2C12 cells assessed as inhibition of Angptl4 expression after 24 hrs by RT-qPCR analysis\"],[\"Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis\"],[\"Inhibition of BChE (unknown origin) at \\u003e50 uM preincubated for 10 mins followed by addition of S-butyrylthiocholine iodide as substrate measured after 15 mins by spectrophotometric method\"],[\"Positive allosteric modulation of human mGlu1 receptor in HEK293 cells assessed as potentiation of glutamate-induced calcium mobiliztion by Fluo-4AM dye based fluorescence analysis\"],[\"Inhibition of CDYL in human SH-SY5Y cells assessed as decrease in enrichment of CDYL at MYT1 promoter site at 150 uM incubated for 24 hrs by ChIP-qPCR analysis\"],[\"Inhibition of full length recombinant human His-tagged GSK3beta expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control\"],[\"Binding affinity to RET V804L mutant (unknown origin)\"],[\"Inhibition of Mycobacterium tuberculosis InhA enzyme at 10 uM relative to control\"],[\"Inhibition of N-terminal His-tagged human PPARgamma LBD (207 to 474 residues) expressed in Escherichia coli Rosetta (DE3) pLysS assessed as reduction in S245 phosphorylation level at 10 uM incubated for 60 mins by ELISA\"],[\"Specific binding of [18F]AFA in rat thalamus after GBR-12935 treatment; n=3\"],[\"Inhibition of human placental microsome aromatase expressed in human MCF7 cells using [1beta-3H] androstenedione as substrate at 10 uM after 1 hr by liquid scintillation counting\"],[\"Inhibition of [3H]CGS-21680 binding to Adenosine A2A receptor expressed in CHO cells\"],[\"Inhibition of ERB-B4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control\"],[\"Binding constant for CAMK2D kinase domain\"],[\"Inhibition of NLRC4 in mouse J774A.1 cells assessed as inhibition of LPS and poly(dA:dT)-induced IL-1beta production incubated with LPS for 1 hr followed by poly(dA:dT) addition and further incubated for 8 hrs ELISA\"],[\"Inhibition of human PI3Kalpha\"],[\"Displacement of [3H]RX821002 form human recombinant alpha2B adrenergic receptor\"],[\"Average Binding Constant for PAK7\\u002fPAK5; NA=Not Active at 10 uM\"],[\"Inhibition of human MAO-B assessed as inhibition of p-tyramine oxidation to p-hydroxyphenyl-acetaldehyde at 100 uM after 15 mins by fluorimetric method\"],[\"Inhibition of MALT1 in human HBL1 cells assessed as decrease in RelB substrate cleavage at 8 uM preincubated for 30 mins followed by proteosome inhibitor MG-132 addition and measured after 2 hrs by Western blot analysis\"],[\"Inhibition of human alpha-thrombin using Glt-Gly-Arg-MCA as substrate after 30 mins\"],[\"Agonist activity at human MC5R expressed in HEK293 cells assessed as intracellular cAMP accumulation\"],[\"Inhibition of GFP-fused N-terminal full length human recombinant Wild type SMARCA2 transfected in human U2OS cells assessed as displacement of SMARCA2 from chromatin by measuring FRAP recovery time at 1 to 5 uM by laser scanning inverted microscopy relative to control\"],[\"Inhibition of human adrenergic receptor alpha2C expressed in CHO-K1 cells at 10 uM relative to control\"],[\"Mixed-type inhibition of calf intestinal alkaline phosphatase assessed as substrate Km at 0.015 uM using varying levels of p-NPP as substrate by Lineweaver-Burk plot analysis (Rvb = 0.833 mM)\"],[\"Agonist activity at mouse MC3R expressed in HEK293 cells at 100 uM by beta-galactosidase reporter gene assay relative to control\"],[\"Displacement of [3H]AMPA from recombinant rat GluA3 receptor flop isoform expressed in sf9 insect cells\"],[\"Inhibition of human thrombin by fibrinogen-clot assay\"],[\"Inhibition of MLCK2 (unknown origin) at 1 uM after 15 mins\"],[\"Inhibition of wild-type human non-phosphorylated ABL1 (S229 to K512 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Covalent inhibition of FBPase R254A mutant (unknown origin) assessed as Vmax measured upto 45 mins by UV-visible spectrometry analysis\"],[\"Binding constant for LCK kinase domain\"],[\"Inhibition of human ZAP70 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of human Cdc7 in human A2780 cells assessed as inhibition of Ser40 phosphorylation of Mcm2 protein after 4 hrs\"],[\"Activation of human TRPML3-YFP expressed in HEK293 cells incubated for 10 mins by Fluo-4 dye calcium imaging based FLIPR analysis\"],[\"Inhibition of human COX2 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 20 mins by colorimetric assay\"],[\"Inhibition of phosphatase activity of human PTPalpha using pNPP as a substrate after 10 mins by spectrophotometer analysis\"],[\"Inhibition of human full-length BMX (1 to 675 residues) expressed in baculovirus expression system at 0.3 uM by mobility shift assay\"],[\"Antagonist activity at androgen receptor in DHT-treated human LNCaP cells assessed as disruption of ZMIZ1 interaction at 6 uM incubated for 6 hrs by rapid immunoprecipitation mass spectrometry\"],[\"Agonist activity at NK1 receptor (unknown origin) at 12.5 uM relative to control\"],[\"Inhibition of human RSK1 (1 to 735 residues) at 1 uM by radioactive [33P]-ATP filter binding assay\"],[\"Inhibition of [3H]norepinephrine uptake at NET expressed in rat hypothalamic homogenate containing synaptosomes after 5 mins by scintillation counting analysis\"],[\"Displacement of [125I]-Sar1-Ile8-A II at the rabbit aorta angiotensin II receptor, type 1\"],[\"Agonist activity at human cloned adrenergic beta2 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol\"],[\"Inhibition of N-terminal GST-fused human ROCK2 catalytic domain ( 1 to 553 residues) expressed in baculovirus expression system using Long S6 Kinase as substrate incubated for 90 mins by Kinase-Glo luminescent assay\"],[\"Binding affinity to wild-type human partial length PLK1 (A33 to F325 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method\"],[\"Effect on human cytoplasmic thymidine kinase using [14C]thymidine at 5 mM after 10 mins by liquid scintillation spectrometer analysis relative to control in presence of Mg2+\"],[\"Inhibition of BRSK1 (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of N-terminal 6xHis-tagged human Cdc25A (336-523) catalytic domain expressed in Escherichia coli after 20 mins by fluorescent plate reader assay\"],[\"Relative inhibitory potency as ratio of kidney and liver pyruvate kinases\"],[\"Inhibition of human CLK2 at 1 uM using MBP as substrate\"],[\"Inhibition of Aspergillus nidulans RmtA at 91.8 uM\"],[\"Inhibition of mouse recombinant GST-tagged PDE10A using [3H]-cAMP as substrate after 30 mins by scintillation proximity assay\"],[\"Inhibition of HCV NS5B RNA polymerase\"],[\"Inhibition of recombinant human PDE2A using [3H]cAMP after 1 hr by scintillation proximity assay\"],[\"Inhibition of biotinylated Tat-AcK50 binding to GST-fused PCAF bromodomain (719 to 832 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) measured after overnight incubation by ELISA\"],[\"Inhibition of DNA-tagged human TNK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"ATP competitive inhibition of human c-Kit D816H mutant\"],[\"Inhibition of SPOP signalling in human A498 cells assessed as effect of PTEN mRNA expression at 5 to 15 uM incubated for 12 hrs by qRT-PCR analysis\"],[\"Displacement of [3H]-17beta-estradiol from human recombinant ERbeta expressed in rabbit reticulocytes\"],[\"Inhibition of nuclease activity of flag-tagged recombinant DNA2 (unknown origin) expressed in 293T cells at 250 uM using [32P]-labeled flap DNA substrate incubated for 15 mins by denaturing PAGE method\"],[\"Inhibition of Trypanosoma brucei rhodesiense rhodesain at 140 uM\"],[\"Inhibitory activity against VEGFR1 by HTRF assay\"],[\"Binding affinity to SMYD2 (unknown origin) by ITC assay\"],[\"Inhibition of human delta6 desaturase activity expressed in human HEpG2 cells\"],[\"Inhibition Assay: Previously, one of the following compounds discussed below have been studied in memapsin 2 inhibition (Ghosh et al., 2008), which the others are previously unpublished. Given the closely related substrate specificity for memapsin 1 and memapsin 2, the inventors chose to screen these previously identified memapsin 2 inhibitors for lead compounds as memapsin 1 inhibitors. Recombinant memapsin 1 ectodomain was prepared as described by Turner et al. (2002) and assayed using a commercially purchased fluorescent substrate.\"],[\"Inhibition of pro-BACE1 (unknown origin)\"],[\"Induction of PARP1 degradation in triple-negative human MDA-MB-231 cells assessed as fold change in PARP1 protein expression at 1 uM incubated for 48 hrs by Western blot analysis relative to control\"],[\"Inhibition of recombinant N-terminal GST-tagged EED (76 to 441 residues) (unknown origin) expressed in Escherichia coli BL21-CodonPlus(DE3)-RIL assessed as reduction in SAH production using H3[21-44,K27Me0) peptide as substrate measured after 20 mins by LC\\u002fMS\\u002fMS method\"],[\"Activation of Egr1 in human AGS cells assessed as induction of p21 promoter activity at 12.5 to 100 uM by dual luciferase reporter gene assay in presence of si-Egr1\"],[\"Inhibition of semi purified pig TACE\"],[\"Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins by stopped-flow CO2 hydrase assay\"],[\"Inhibition of microtubule-stimulated ATPase activity of human Kif4A at 200 uM by pyruvate kinase\\u002flactate dehydrogenase-linked assay\"],[\"Displacement of [125I]Lys3-substance P from rat NK1 receptor expressed in CHO cells\"],[\"Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of SCD in human liver microsomes expressing CYP4F11\"],[\"Inhibition of ovine COX1 at 10 ug\\u002fml using arachidonic acid substrate by TMPD dye based colorimetry\"],[\"Agonist activity at mouse BRS3 by functional assay\"],[\"Inhibition of human Kv1.5 channel\"],[\"Inhibition of human thymidylate synthase expressed in Escherichia coli BL21 at 100 uM\"],[\"Inhibition of GCN2 Lysine 2 labelling site (unknown origin) at 10 uM\"],[\"EPHA6 DiscoveRx kinase panel\"],[\"Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment\"],[\"Inhibition of STAT3 phosphorylation in human BxPC-3 cells at 0.5 uM after 16 hrs by western blot analysis\"],[\"Inhibition of mouse DGAT1 incubated for 60 mins using didecanoyl glycerol and [14C]decanoyl-CoA substrate by liquid scintillation counting and luminometry based flash plate assay\"],[\"Agonist activity at human prostanoid EP4 receptor expressed in HEK293 cells assessed as potentiation of PGE2-induced cAMP accumulation by scintillation proximity assay\"],[\"Inhibition of HDAC1 (unknown origin) using Boc-Lys(acetyl)-AMC as substrate preincubated for 5 mins followed by substrate addition by fluorescence assay\"],[\"Binding affinity to DAPK2 (unknown origin)\"],[\"Effective concentration against PR (progesterone receptor)\"],[\"Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes\"],[\"Inhibition of human CK1delta transcription variant 2 using GST-tagged mouse p53 (1 to 64 residues) as substrate in presence of radiolabelled-ATP by Cherenkov counting method\"],[\"Mixed inhibition of recombinant human AChE expressed in HEK293 cells assessed as dissociation constant for enzyme-substrate-inhibitor complex using varying levels of acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Line-weaver Burk plot analysis\"],[\"Binding affinity to human partial length PIK3CA I800L mutant (R108 to N1068 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control\"],[\"Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of ECG\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 ftsA at 4 fold MIC by microarray analysis\"],[\"Inhibition of calf thymus DNA topoisomerase 1 at 20 uM using pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\"],[\"Antagonist activity at thrombin receptor in human platelet rich plasma assessed as inhibition of thrombin-induced platelet aggregation preincubated for 3 mins followed by thrombin addition measured after 6 mins by aggregometer\"],[\"Inhibition of DDR2 phosphorylation in in collagen I stimulated human primary lung fibroblasts incubated for 8 hrs by immunoprecipitation and Western blot analysis\"],[\"Inhibition of full length unphosphorylated AKT3 (1 to 479 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotin-GRPRTSSFAEG as substrate preincubated for 20 mins followed by substrate addition measured after 30 mins by Alphascreen assay\"],[\"Binding affinity to human recombinant alpha1D adrenoceptor\"],[\"Inhibition of human recombinant HDAC4 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay\"],[\"Inhibition of SGK2 in human NCI-H929 cells by mass spectroscopic analysis\"],[\"Inhibition of IDO1 (unknown origin) assessed as reduction in N'-formlylkynurenine formation using D-Tryptophan as substrate in presence of aspartate and methylene blue\"],[\"Displacement of polymer supported probe 25 binding to GSG2 in human THP-1 cell lysates preincubated for 45 mins under shaking condition followed by probe addition and measured after 30 mins by mass spectrometry based chemoproteomic analysis\"],[\"Inhibition of human PKCmu at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of human FGFR1 assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of recombinant His-tagged human DNA polymerase lambda using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins\"],[\"Binding affinity to Cathepsin C in human THP-1 cells assessed as thermal stability measured at 10 uM incubated for 3 to 5 hrs by cellular thermal shift assay (Rvb = 49 degC)\"],[\"Potency index, ratio of Kd of RRLSLQLPILHHAYLPSI to Kd of compound for recombinant human 6X His-tagged KCTD12 T1 domain(27 to 131 residues) expressed in Escherichia coli BL21 DE3 cells by isothermal titration calorimetry\"],[\"Agonist activity at human kidney vasopressin V2 receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay\"],[\"Transport through ENT2 in mouse hepatocytes by oil filtration assay in presence 100 uM of transporter inhibitor NBMRP\"],[\"Inhibition of cyclin E phosphorylation in human Hep2 cells at 100 uM after 24 hrs by Western blot analysis relative to control\"],[\"Inhibition of SOS1 in overnight serum-starved human MIAPaCa2 cells assessed as reduction in ERK phosphorylation at 20 to 40 uM by Western blotting analysis\"],[\"PDGFRB Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of ABCB1 in human K562\\u002fA02 cells assessed as potentiation of adriamycin-induced cytotoxicity by measuring ADR IC50 treated for 48 hrs followed by compound washout measured immediately by MTT assay relative to ADR alone\"],[\"Binding affinity to human partial length CECR2 (P423 to D543 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control\"],[\"Inhibition of COT (unknown origin) at 10 uM relative to control\"],[\"NUAK2 Invitrogen Lab (UK) kinase screen (BI)\"],[\"Displacement of fluorescein-labeled 25-hydroxycholesterol from human N-terminal 6xHis-tagged ROR gamma LBD (residues 262 to 518) expressed in Escherichia coli BL21-CodonPlus(DE3)-RIL cells by fluorescence polarization assay\"],[\"Inhibition of human PRKCH assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of PDGFRalpha (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control\"],[\"Potentiation of progesterone receptor B in progesterone-stimulated human Ishikawa cells assessed as induction of PRE\\u002fLuc transcriptional activity at 10 uM measured after 24 hrs by luciferase reporter gene assay relative to control\"],[\"Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay\"],[\"Agonist activity at recombinant human beta-2 adrenergic receptor assessed as induction of cAMP levels at 10 uM by HTRF assay relative to agonist\"],[\"CK2-alpha1 ProQinase selectivity panel\"],[\"Agonist activity at human CXCR7 expressed in HEK293 cells assessed as reduction of receptor surface expression after 1 hr by ELISA based internalization assay\"],[\"Inhibition of human COT1 at 100 nM using MEK1 as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of human PKBbeta at 100 nM\"],[\"Binding affinity to EphA2-Fc receptor (unknown origin) treated for 90 secs by SPR analysis\"],[\"Inhibition of [3H]U-69593 radioligand binding to Guinea pig opioid receptor kappa 1.\"],[\"Inhibitory activity against HER1\"],[\"Inhibition of human ELOVL5\"],[\"Inhibition of HDAC2 (unknown origin) after 24 hrs by SAMDI mass spectroscopic analysis\"],[\"Inhibition of human PKCzeta using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay\"],[\"Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at human recombinant muscarinic M5 receptor by HTS cell based assay\"],[\"SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, liver isoform\"],[\"Inhibition of wild type recombinant human His6-tagged RIPK2 at 10 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay\"],[\"Agonist activity at human P2Y14 receptor expressed in human COS7 cells\"],[\"Inhibition of human recombinant full length CA2-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay\"],[\"Inhibition of FAAH-mediated [3H]AEA hydrolysis in rat RBL2H3 cells at 1 uM by liquid scintillation spectroscopy\"],[\"Displacement of [I125]CGRP from human CGRP receptor in SK-N-MC cells\"],[\"Binding affinity to wild-type human partial length NEK11 (M1 to E313 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to wild-type human partial length HIPK4 (M1 to V384 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Mixed inhibition of recombinant human GSTA1-1 expressed in Escherichia coli BL21 (DE3) using GSH as substrate at 15 to 60 uM\"],[\"Partial agonist activity at human muscarinic M1 receptor expressed in CHO cells calcium response relative to acetylcholine\"],[\"Antagonist activity at CCR4 in human whole blood assessed as F-actin polymerization in CD4+ CCR4+ lymphocytes by phalloidin staining based flow cytometry\"],[\"Non competitive inhibition of human thrombin assessed as substrate Vmax at 1 uM using varying levels of spectrozyme TH as substrate measured after 10 mins by Michaelis-Menten plot analysis (Rvb = 51.0 +\\u002f- 2.8 mAU\\u002fmin)\"],[\"Relative inhibition of [3H]glycylsarcosine uptake in HeLa cells expressing human Intestinal peptide transporter PepT1 compared to BDCRB\"],[\"Activity at recombinant human MAO-A expressed in baculovirus infected BT1 cells assessed as hydrogen peroxide generation rate per min\\u002fmg using p-tyramine as substrate at 200 uM preincubated for 30 mins by Amplex Red assay relative to control\"],[\"Binding affinity against Beta-2 adrenergic receptor was measured using [125I]CYP as radioligand\"],[\"Inhibition of human TXK assessed as residual activity at 100 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of Aurora C (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay\"],[\"Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 80 uM measured after 12 hrs by luciferase reporter gene assay relative to control\"],[\"Agonist activity at REV-ERBalpha in human U2OS cells assessed as suppression of BMAL1 oscillation measured for 72 hrs by luciferase reporter gene assay\"],[\"Inhibition of human SGK1 at 0.1 uM relative to control\"],[\"Inhibition of PKC-gamma (unknown origin) at 0.45 uM relative to control\"],[\"Inhibition of human histamine H2 receptor at 10 uM\"],[\"Inhibition of mu-opioid receptor (unknown origin) by [35S]-GTPgammaS binding assay\"],[\"Agonist activity at human TGR5 N93A mutant expressed in HEK293 cells assessed as reduction in forskolin-induced intracellular cAMP level at 0.1 to 10 uM incubated for 16 hrs by luciferase reporter gene assay\"],[\"Inhibition of human MEK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of Homo sapiens (human) recombinant PTP1B at 10 uM relative to control\"],[\"PAK5(h) Eurofins kinase panel\"],[\"Inhibitory activity against human adrenergic alpha-1A receptor at 10 uM concentration\"],[\"Displacement of [3H]-PGD2 from human CRTH2 receptor expressed in human HEK293 cells by scintillation counter in presence of 0.5% bovine serum albumin\"],[\"Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system using ERK K52R dead variant as substrate preincubated for 20 mins followed by incubation with 33P-ATP addition for 2 hrs by hotspot kinase assay\"],[\"Correction activity at CFTR F508 deletion mutant in primary human BE cells assessed as increase in CFTRinh172-inhibited Chloride current AUC at 0.018 uM coadministered with CFTR corrector lumacaftor preincubated for 24 hrs followed by Coon's F12 culturing and subsequent addition of compounds followed by forskolin\\u002fbenzamil\\u002fivacaftor addition measured over 60 mins by TEEC-24 assay relative to lumacaftor and ivacaftor\"],[\"Displacement of [3H]PSB11 from human adenosine A3 receptor\"],[\"Binding affinity to GR (unknown origin)\"],[\"Inhibition of HL-60 cell adhesion to recombinant human Selectin P at 50 mM\"],[\"Inhibitory concentration against HCV NS5B RNA dependent RNA polymerase\"],[\"Inhibition of histidine6-tagged FAAH from mouse kidney proteomes at 10 to 100 uM\"],[\"Inhibition of recombinant PI3Kalpha (unknown origin) using dioctanoylglycerol-PIP2 as substrate incubated for 30 mins in presence of TAMRA-PIP3 by fluorescence polarization assay\"],[\"Agonist activity at rat mGluR1 expressed in HEK293 cells assessed as Ca2+ mobilization by FLIPR assay\"],[\"Agonist activity at human TRPV1 expressed in CHO cells assessed as increase in capsaicin-induced intracellular calcium flux up to 1 uM by Fluo-3 AM dye based fluorescence assay relative to 1 uM capsaicin\"],[\"Inhibition of iNOS-mediated NO production in LPS-induced mouse BV2 cells\"],[\"Displacement of [3H]-N-methylscopolamine from muscarinic M3 receptor (unknown origin) at 1 uM\"],[\"Induction of AZT-resistant HIV1 reverse transcriptase assessed as rate of ATP-mediated excision of chain-terminating nucleotides by phosphorimaging analysis\"],[\"Activation of Nrf2 in human HepG2 cells assessed as cytoprotection against t-BHP-induced oxidative cell death at 5 uM incubated for 24 hrs followed by compound removal with subsequent incubation with 900 uM of t-BHP for 6 hrs in presence of 400 uM metal ion chelator EDTA for 1 hr prior to compound treatment by MTT assay\"],[\"Inhibition of HIV1 reverse transcriptase RNA-dependent DNA polymerase activity\"],[\"PLK2 Kinase panel\"],[\"Inhibition of human recombinant cyclophilin D using Suc-AAPF-MCA as substrate preincubated for 1 hr followed by substrate addition measured per millisec for 2 mins by real time fluorescence analysis\"],[\"Inhibition of HIV1 recombinant protease expressed in Escherichia coli\"],[\"Inhibition of human serum BChE using butyrylthiocholine as substrate by Ellman method\"],[\"Binding affinity of [3H]- RA to baculovirus expressed human RAR alpha\"],[\"Inhibition of recombinant human LRRK2 (970 to end residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of chymotrypsin-like activity of human 20S proteasome using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 10 mins followed by substrate addition measured after 1 hr by spectrofluorimetric method\"],[\"Inhibition of ChoKalpha in human MDA-MB-468 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis\"],[\"Inhibition of purified PDGFRbeta (unknown origin) at 1 uM after 60 mins by ELISA kinase assay\"],[\"Activity of human SIRT3 assessed as deacylation of compound at 50 uM after 1 hr by trypsin developer-based fluorescence assay\"],[\"Inhibition of p-glycoprotein in human LCC6\\u002fMDR cells assessed as increase of paclitaxel-induced cytotoxicity at 200 nM after 72 hrs by SRB assay relative to control\"],[\"Inhibition of full length C-terminal His-tagged human HDAC2 expressed in Sf9 cells using (Arg-His-Lys-Lys(Ac)) as substrate by plate reader analysis\"],[\"Inhibition of recombinant wild type human KNa1.1 expressed in human HEK-TREX cells at -80 mV holding potential by automated patch clamp assay\"],[\"Binding affinity to human progesterone receptor by competitive assay\"],[\"Inhibition of human STK16 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Antagonist activity at human TLR9 expressed in HEK-blue-HTLR7 cells assessed as inhibition of CpGB-induced NFkappaB activation measured after overnight incubation by SEAP-based spectrophotometry assay\"],[\"Competitive tight inhibition of recombinant human ALDH1A1 using 1000 uM NAD+ as cofactor by Lineweaver-Burk plot analysis in presence of 100 to 800 uM acetaldehyde\"],[\"Displacement of [125I](+\\u002f-)DOI from human recombinant 5-HT2B receptor expressed in CHO cells\"],[\"Inhibition of human PAK3 at 1 uM by radiometric Assay\"],[\"Inhibition of ATX (unknown origin) expressed in human HEK293 cells using TG-mTMP as substrate after 2 hrs by fluorescence based plate reader assay\"],[\"Inhibition of human recombinant MAOA expressed in insect cells using kynuramine as substrate at 50 uM preincubated up to 40 mins before kynuramine substrate addition measured after 30 mins\"],[\"Inhibition of biotinylated VEGF-A165 binding to rat NRP1\\u002fFC chimera at 10 uM after 40 mins by ELISA relative to control\"],[\"Percent Inhibition for binding of PGD-2 to hTP in hTP binding assay using HEK293 cell membranes\"],[\"Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of rat cortex AChE at 40 uM using acetylthiocholine iodide as substrate measured after 20 mins by Ellman's method relative to control\"],[\"Inhibition of HDAC6 (unknown origin) at 1 uM using Ac-peptide as a substrate pretreated for 15 mins followed by substrate addition relative to control\"],[\"Inhibition of AKT phosphorylation in human A549 at 5 uM after 24 hrs by Western blot analysis\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IL12B mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Inhibition of mushroom tyrosinase at 1000 uM\"],[\"Competitive inhibition of EGFP-fused human M1 receptor N-terminal truncated at 17 residues expressed in HEK293 cells at 10 uM after 4 hrs by FRET assay in presence of para-LRB-AC42\"],[\"Binding affinity to STAT3 SH2 in v-Src transformed mouse NIH\\u002f3T3 cells overexpressing human EGFR\"],[\"Inhibitory activity against Dihydrofolate reductase from Pneumocystis carinii was evaluated using 90 uM dihydrofolic acid as substrate\"],[\"Binding affinity to transthyretin in human serum assessed as protein stabilization at 2:1 compound to TTR ratio after 72 hrs by Western blot\"],[\"Inhibition of human transmembrane carbonic anhydrase 9 by stopped flow CO2 hydration assay\"],[\"Inhibition of human recombinant cathepsin B assessed as factor by which the product formation changes when the inhibitor binds to the enzyme-substrate complex using Z-Arg-Arg-AMC as substrate by fluorescence microplate assay\"],[\"Inhibition of recombinant human MAO-B assessed as production of hydrogen peroxide from p-tyramine up to 100 uM after 15 mins by Amplex Red assay\"],[\"Inhibition of recombinant Mycobacterium tuberculosis InhA expressed in Escherichia coli Rosette(DE3) pLysS using trans-2-decenoyl-N-acetylcysteamine as substrate by spectrophotometric method\"],[\"Inhibition of human DPP89\"],[\"Activation of Nrf2 in LPS-stimulated mouse RAW264.7 cells assessed as induction of HO-1 mRNA expression at 5 to 40 uM pre-treated for 6 hrs prior to LPS-challenge measured after 12 hrs\"],[\"Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay\"],[\"Agonist activity at human delta opioid receptor expressed in CHO cell membranes at 10 uM incubated for 60 mins by [35S]GTPgammaS binding assay\"],[\"Activation of PINK1 in human HeLa MKYP cells expressing PINK1 treated with FCCP\\u002foilgomycin assessed as increase in parkin recruitment and measured by ELISA assay\"],[\"Agonist activity at GAL4-fused human PPARgamma LBD expressed in HEK293T cells at 1 uM after 12 to 14 hrs by luciferase reporter gene assay\"],[\"Displacement of [125I]-CCK-2 from rat CCK1 receptor expressed in CHO cells after 90 mins by liquid scintillation counting\"],[\"Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"In vitro residual inhibitory activity in rat hepatocytes after 2 hour pre-incubation at 3 uM.\"],[\"In vitro inhibition for opioid binding site in guinea pig brain membrane using [3H]FOXY as radioligand\"],[\"Potency index, ratio of IC50 for stilbamidine to IC50 for test compouhnd for inhibition of PRMT1 (unknown origin) assessed as reduction in methyl transfer from [3H]-SAM to biotinylated histone H4 peptide H4-20-Biotin at 10 uM pre-incubated for 3 mins before [3H]-SAM addition and measured after 15 mins by scintillation proximity assay\"],[\"Inhibition of recombinant Aurora B phosphorylation in human HT29 cells\"],[\"Agonist activity at Gal4-tagged human PPARgamma ligand binding domain expressed in COS-7 cells measured after overnight incubation by dual-glo luciferase reporter gene assay\"],[\"Inhibition of [3H]anandamide binding to fatty acid amide hydrolase of rat brain membranes\"],[\"Binding affinity to human recombinant IFN-gamma by surface plasmon resonance assay\"],[\"Displacement of [3H]paroxatine from SET in rat cortical membranes\"],[\"Inhibition of human BMPR2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [3H]DAMGO from mu opioid receptor in rat brain synaptosomes P2 fraction\"],[\"Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting relative to control\"],[\"Agonist activity at GAL4-tagged human PPARalpha ligand binding domain expressed in HepG2 cells assessed as transactivation at 5 to 10 uM after 20 hrs by beta-galactosidase reporter gene assay relative to Wy-14643\"],[\"Displacement of [3H]nicotine from 5-hydroxytryptamine receptor 1A (unknown origin)\"],[\"Displacement of [3H]AB-MECA from human recombinant A3 receptor expressed in HEK293 cells\"],[\"Inhibition of human sst2 receptor expressed in CHO cells\"],[\"Inhibition of Chk2 phosphorylation in human SUM159 cells at 0.1 to 0.2 uM measured after 48 hrs by Western blot analysis\"],[\"Inhibition of recombinant VHZ (unknown origin) using pNPP as substrate by spectrophotometric analysis\"],[\"Inhibition of beef liver dihydrofolate reductase by amide-linked conjugate (regiospecific coupling) of MTX (7 M\\u002fM of IgG)and Dal K-20 in experiment 2\"],[\"Inhibition of human liver purified lactate dehydrogenase-A using pyruvate as substrate assessed as NADH oxidation for 3 mins by fluorimetric method\"],[\"Binding affinity to human amyloid beta (1 to 42) fibril assessed as increase in intrinsic fluorescence intensity at 2.25 uM relative to equimolar monomeric specie\"],[\"Inhibition of Caspase 10 (unknown origin) using Ac-LEHD-AMC substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs\"],[\"Inhibition of recombinant human HK2 using [U-14C]-labeled glucose as substrate in presence of ATP and NADP by G6PD enzyme coupled spectrophotometric assay\"],[\"Inhibition of recombinant full-length human HDAC8 using RHKK(Ac) as substrate measured after 2 hrs by fluorescence assay\"],[\"Inhibition of ThRs in mouse MEF cells expressing Perk (-\\u002f-) assessed as effect on phosphorylated eIF2alpha level at 5 uM by immunoblot analysis\"],[\"Inhibition of LSD1 in human THP1 cells assessed as increase in CD86 expression at 4 uM incubated for 3 days by flow cytometric analysis\"],[\"Inhibition of recombinant full length C-terminal His-tagged human Src cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control\"],[\"Inhibition of 5-HT2c (unknown origin)\"],[\"Inhibition of human Casein kinase 1 gamma 3 assessed as residual activity at 10 uM relative to control\"],[\"Percent activity of horse serum butyrylcholinesterase on 2 hours incubation with 5 uM of compound at 25 degree C followed by reactivation with 0.5 mM 2-PAM after 20h\"],[\"Agonist activity at human TAS2R5 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level at 20 mM by Calcium-3 dye based fluorescence assay relative to control\"],[\"Inhibition of CXCR2 at 10 uM\"],[\"Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis\"],[\"cAMP stimulation in HEK293 cells transfected with human MC4R\"],[\"Displacement of [3H]-N-methylspiperone from human D4.4 receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method\"],[\"Inhibition of HTLV-1 recombinant protease L40I mutant\"],[\"Displacement of [125I]CXCL12 from CXCR4 in human CEM cells\"],[\"Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by ELISA\"],[\"Binding affinity to TXNDC17 cysteine residue in human 786-O cell soluble proteomic lysate at 5 uM incubated for 1 hr followed by cell lysis by IA-alkyne probe based isoTOP-ABPP analysis\"],[\"Inhibition of full-length recombinant human His-tagged PTK6 expressed in baculovirus expression system by Z'-LYTE assay\"],[\"Inhibition of PRMT5 in human Granta-519 assessed as reduction in sDMA production incubated for 3 days by Western blotting analysis\"],[\"Inhibition of wild type HIV1 Reverse transcriptase assessed as reduction of biotin deoxyuridine triphosphate incorporation into the wild type HIV1 reverse transcriptase after 1 hr by ELISA\"],[\"Inhibition of LSD1 in human SH-SY5Y cells assessed as induction of H3K4me2 accumulation at 10 uM after 24 hrs by Western blot method\"],[\"Binding affinity to human BRSK2 at 10 uM relative to control\"],[\"Displacement of [3H]-(R)-2-(5-chloro-2,4-dihydroxybenzoyl)-N-ethylisoindoline-1-carboxamide from human his(6)-tagged HSP90alpha after 30 mins by scintillation proximity assay\"],[\"Displacement of [3H]-estradiol from estrogen receptor in rat uterine cytosol at 10'-5 to 10'-10 M after 16 hrs relative to estradiol\"],[\"Inhibition of PIP5K3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"Inhibition of human MMP20\"],[\"Antagonist activity at Wnt3a-stimulaed human frizzled-5 expressed in human HEK293superTOP flash cells at 10 nM incubated for 24 hrs by luciferase reporter gene assay\"],[\"Binding affinity to purified human transthyretin assessed as protein occupancy at 10 uM incubated for 6 hrs in pH 7.4 PBS buffer in presence of 600 uM albumin by fluorescent probe exclusion assay\"],[\"Binding affinity to muscarinic M4 receptor (unknown origin) expressed in CHO cells\"],[\"Inhibition of human ERG expressed in CHO cells at 21 uM at -70mV holding potential measured after 300 secs by IonWorks electrophysiology method relative to control\"],[\"Inhibition of K+ channel activity in CHO cells expressing HERG Kv11.1\"],[\"Reversible inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells assessed as residual activity at 1.5 uM incubated for 30 mins followed by dialysis using kynuramine as substrate by spectrophotometric analysis relative to control\"],[\"STK24 SGC Tm panel (DSF)\"],[\"Inhibition of MAPKAPK1B (unknown origin) at 1 uM\"],[\"Inhibition of human recombinant cathepsin K by fluorometric assay\"],[\"Inhibition of AMPK in mouse 3T3L1 cells assessed as inhibition of FAS level by Western blotting\"],[\"Inhibition of TPL2-mediated ERK phosphorylation in human monocytes\"],[\"Inhibition of human topoisomerase 1\"],[\"Agonist activity at D1 receptor (unknown origin) at 10 uM\"],[\"Binding affinity to NET (unknown origin) by competition binding assay\"],[\"Displacement of [125I]RTI55 from human DAT expressed in HEK293 cells\"],[\"Inhibition of SHMT1 (unknown origin) using serine\\u002fTHF as substrate after 50 mins by HPLC method\"],[\"Displacement of [3H]-DADLE from human recombinant DOR receptor expressed in stable HEK cells after 90 mins by microbeta scintillation counting method\"],[\"Agonist activity at human GLP-1 receptor expressed in HEK293 cells assessed as cAMP accumulation after 30 mins by HTRF assay\"],[\"Binding affinity to human BBOX by tryptophan fluorescence quenching binding assay\"],[\"Inhibition of human recombinant KDM1A expressed in Escherichia coli using biotin-histone H3 as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by TR-FRET assay\"],[\"Inhibition of recombinant human aromatase at 100 uM preincubated for 10 mins followed by substrate and beta-NADP+ addition and measured for 60 mins by fluorescence method\"],[\"Inhibition of human Matrix metalloprotease-1 (MMP-1) at 100 uM\"],[\"Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to human BTK at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"EphB2(EPB2LGY1) Takeda global kinase panel\"],[\"Binding affinity to human liver V1A receptor\"],[\"Inhibition of bovine brain mitochondria MAO-B using benzylamine substrate after 60 mins by fluorimetric method\"],[\"Inhibition of wild-type human partial length MUSK (M553 to V869 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Inhibition of PRK1 (unknown origin) at 1 uM\"],[\"Binding affinity to wild-type human partial length SLK (S14 to A307 residues) expressed in bacterial expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control\"],[\"Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.025 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry\"],[\"Inhibition of recombinant KLK7 (unknown origin) expressed in zymogen form in Pichia pastorisstrain X-33 using KHLY-pNA as substrate after 30 mins\"],[\"Induction of katanin p60 subunit-mediated microtubule fragmentation in human NCI-H1975 cells assessed as alpha-tubulin level in soluble form at 300 nM after 1 hr by immunoblot analysis (Rvb = 37%)\"],[\"Displacement of [3H]UR-MK114 from NPY1R in human SK-N-MC cells by radioligand binding assay\"],[\"Inhibition of AMPKA1 (unknown origin) at 1 uM relative to control\"],[\"Blockade of voltage-activated rat Kv1.1 potassium channel expressed in Xenopus laevis oocytes assessed as effect on evoked current upto 10 uM by two-electrode voltage clamp method\"],[\"Binding affinity to human CB1 receptor\"],[\"Inhibition of c-src\"],[\"Agonist activity at human GAL4-PPARalpha ligand binding domain expressed in human HepG2 cells by luciferase reporter gene assay\"],[\"Non-competitive inhibition of recombinant human MMP2 (110 to 452 residues) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 expressed in yeast expression system as substrate incubated for 15 mins followed by substrate addition and measured after 2 to 4 hrs by fluorescence based assay\"],[\"Inhibition of recombinant human His-tagged full length AKT2 expressed in baculovirus expression system using Ser\\u002fThr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control\"],[\"Inhibition of IRAK4 (unknown origin) at 0.078 uM relative to control\"],[\"Inhibition of porcine DPP4\"],[\"Inhibition of His-tagged full length human recombinant BTK expressed in baculovirus using fluoresceinated peptide substrate after 60 mins by fluorescent electrophoretic separation\"],[\"Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score=-12.4 kcal\\u002fmol\"],[\"Inhibition of human cloned CA2 by CO2 hydration assay\"],[\"Binding affinity to Beta amyloid aggregates in Alzheimer's disease patient brain by competitive binding assay\"],[\"Displacement of [125I][Sar1,Ile8]-AT-II from human recombinant AT1 at 10 uM after 120 mins by scintillation counting analysis relative to control\"],[\"In vitro inhibitory concentration against epidermal growth factor receptor\"],[\"Effect on Hh\\u002fGLI-mediated transcription in human HaCaT cells assessed as reduction of PTCH protein expression by Western blot\"],[\"Binding affinity to human recombinant muscarinic M3 receptor expressed in CHO cells after 90 mins by radioligand displacement assay\"],[\"LIMK2(h) Millipore kinase panel\"],[\"Inhibition of HDAC1 in human HeLa cells using Fluor-de-Lys as substrate up to 10 uM after 15 mins by fluorescence assay\"],[\"Binding affinity to human biotinylated N-terminal Hsp90alpha (9 to 236) by surface plasmon resonance assay\"],[\"Inhibition of human recombinant MGL\"],[\"Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 75 mins by flow cytometry\"],[\"Displacement of [3H]CP55490 from human recombinant cannabinoid CB1 receptor expressed in CHO cells\"],[\"Inhibition of [3H]NE uptake at human NET L169T mutant expressed in african green monkey COS1 cells after 48 hrs\"],[\"Upregulation of EGFR phosphorylation at Thr693 residue in human HCC cells at 30 uM by KEGG analysis relative to control\"],[\"Inhibition of TrkC (unknown origin) after 60 mins by TR-FRET assay\"],[\"Inhibition of human MIF tautomerase activity expressed in Escherichia coli BL21 (DE3) using 4-hydroxyphenyl pyruvic acid as substrate\"],[\"Inhibition of cyclophilin D in human SK-N-SH cells assessed as reversal of Abeta (1 to 42 residues) mediated reduction of cytochrome c oxidase activity at 10 to 20 uM after 48 hrs by spectrophotometrical analysis relative to vehicle control\"],[\"Irreversible inhibition of human leukocyte elastase assessed as recovery of enzyme activity using MeOSuc-AAPV-AFC substrate at 200 uM treated for 15 mins followed by dialysis measured up to 50 days by fluorescence assay\"],[\"Binding affinity to mouse CCK1 receptor\"],[\"Inhibition of PKC mu (unknown origin)\"],[\"Inhibition of STK23 (unknown origin) at 10 uM relative to control\"],[\"Cyclooxygenase COX-1 Eurofins-Panlabs enzyme assay\"],[\"Inhibition of CCL2 in human PBMC assessed as reduction of cell adhesion to VCAM1-Fc at 50 uM by flow based adhesion assay\"],[\"Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay\"],[\"Binding affinity to human MDM2 (17-125 residues) by NMR spectroscopic analysis\"],[\"Agonist activity at mouse PPARalpha transfected in Cos7 cells co-expressing with pBIND and pGL4.35 Gal4 UAS Luc reporter plasmid by measuring luciferase activity incubated for 16 hrs by luciferase reporter gene assay\"],[\"Binding affinity to human CLK4 at 10 uM relative to control\"],[\"Inhibition of PKCzeta (unknown origin) at 10 uM relative to control\"],[\"Binding affinity to plasmin\"],[\"Inhibition of Staphylococcus aureus DNA gyrase B using relaxed pNO1 DNA as substrate incubated for 30 mins and measured by sybrGOLD staining based fluorescence assay\"],[\"Binding affinity to hen egg white lysozyme at 2 x 10'-4 M by fluorescence spectroscopic analysis\"],[\"Binding affinity to wild-type human partial length SYK (D354 to N635 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of rabbit muscle glycogen phosphorylase-b assessed as release of inorganic phosphate from glucose-1-phosphate at 625 uM in presence of AMP and glycogen\"],[\"Stabilization of LDHA in human A673 cell lysate preincubated for 20 mins followed by incubation at 70 degreeC for 10 mins by cellular thermal shift assay\"],[\"Inhibition of human Rsk3 assessed as enzyme activity at 1 uM relative to control\"],[\"Inhibition of Pafah1b3 in mouse Neuro2a cells at 3 nM after 4 hrs by ABPP-SILAC assay\"],[\"Binding affinity to recombinant human KEAP1 Kelch domain (321 to 609 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation rate constant at 660 nM by surface plasmon resonance analysis\"],[\"Inhibition of human recombinant FPPS using GPP\\u002f[3H]IPP as substrate up to 10 uM incubated for 10 mins prior to substrate addition measured after 8 mins by scintillation counting analysis\"],[\"Inhibition of wild type EGFR in mouse BAF3 cells assessed as reduction in cell proliferation incubated for 72 hrs by Celltiter-Glo luminescent cell viability assay\"],[\"Transactivation of FXR in human HepG2 cells assessed as SREBP1c mRNA expression at 50 uM after 8 to 16 hrs by SYBR green based qRT-PCR analysis relative to DMSO control\"],[\"Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using KKKSPGEYVNIEFG as substrate relative to control\"],[\"Inhibition of MMP13 (unknown origin) up to 50 uM\"],[\"Displacement of [3H]U-69593 from human KOR expressed in HEK293 cells after 60 mins by scintillation counting analysis\"],[\"Percent inhibition measured as the production of HIV reverse transcriptase (RT) in culture supernatant of monocytic U937 on at 11 days at a concentration 0.2 uM\"],[\"Binding affinity to acylated N-terminal His6-tagged human TEAD4 (217 to 434 residues) expressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL cells assessed as covalent adduct formation at 8 equiv after 1 hr by ESI-MS spectrophotometric analysis\"],[\"Agonist activity at recombinant human 5-HT3 at 10 uM by aequorin reporter based assay relative to agonist\"],[\"Binding affinity at human prostaglandin EP2 receptor\"],[\"Inhibition of recombinant human N-terminal GST\\u002fflag-tagged HDAC1 expressed in baculovirus infected Sf9 insect cells after 3 hrs by fluorescence assay\"],[\"Positive allosteric modulation of rat muscarinic M3 receptor assessed as acetylcholine response\"],[\"Inhibition of 26S proteasome beta 2 in human HEK293 cell lysate assessed as residual activity at 1.5 uM after 1 hr\"],[\"Inhibition of human SETD8 catalytic domain expressed in Escherichia coli assessed as reduction in transfer of tritiated methyl group from [3H]SAM to biotinylated H4 (1 to 24) peptide substrate by scintillation proximity assay\"],[\"Inhibition of human recombinant MMP9 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry\"],[\"Inhibition of wild type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of topoisomerase 2 in human ARN8 cells assessed as induction of DNA damage by measuring increase in gammaH2AX level at 20 uM incubated for 1 hr by Western blot analysis\"],[\"Inhibition of HDAC6 (unknown origin) expressed in HEK cells using Boc-Lys(Ac)-AMC as substrate\"],[\"Inhibition of human HIF1alpha-mediated VEGF mRNA expression in wild type human U251 cells at 10 uM incubated for 16 hrs under hypoxic condition\"],[\"Substrate activity at NQO1 in human A549 cells assessed as induction of ROS-induced ERK phosphorylation at 10 uM after 3 hrs in presence of DIC by Western blot analysis relative to control\"],[\"Inhibition of AMCA-labeled MBP (83 to 99) binding to HLA-DR2b homodimer in human HTC-Lan B cells at 50 fold excess after 48 hrs by fluorescence spectrophotometric method\"],[\"Agonist activity at rat alpha7 nAChR expressed in rat GH4C1 cells assessed as calcium flux by FLIPR\"],[\"Binding affinity to wild-type human partial length DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol\\u002fL by Kinomescan method\"],[\"Inhibition of wild-type human partial length KIT (I571 to D952 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Competitive inhibition of c-terminal GFP-tagged human ABCG2 expressed in MDCK2 cells preincubated for 30 mins before Hoechst 33342 addition by Hoechst 33342 accumulation assay based Lineweaver-Burk plot analysis\"],[\"Displacement of [3H]deltorphin 2 from delta opioid receptor in rat brain P2 synaptosome\"],[\"Binding affinity to STAT3 in human DU145 cell lysates assessed as reduction in pronase-induced STAT3 digestion by measuring ratio of STAT3 protein level to GAPDH protein level at 1 uM incubated for 1 hr in absence of pronase by Western blot analysis (Rvb = 1 No_unit)\"],[\"Inhibition of human N-terminal His-tagged TDO expressed in Escherichia coli assessed as formation of N'-formyl-kynurenine at 1 uM using D-tryptophan as a substrate by methylene blue based assay relative to control\"],[\"Displacement of [125I]-(4-((2,4-diaminoquinazolin-5-yloxy)methyl)piperidin-1-yl)(3-iodophenyl)methanone from recombinant human N-terminal GST-tagged DcpS expressed in baculovirus-infected Sf9 insect cells at 10 uM after 90 mins in presence of [125I]-streptavidin by microarray assay\"],[\"Positive allosteric modulation of GluA2 receptor in rat embryonic cortex neuron assessed as increase of AMPA-induced membrane depolarization by fluorescence assay relative to AMPA\"],[\"Antagonist activity at 5HT3 receptor in spontaneously beating guinea pig right atrium assessed as inhibition of serotonin-induced maximum response by noncompetitive binding assay\"],[\"Inhibition of DOT1L in mouse bone marrow cell transformed with MLL-AF9 cells assessed as reduction in H3K79 methylation measured after 9 days by Western blot analysis\"],[\"Activity at ERalpha in PC3 cells relative to diethylstibesterol by transcription assay\"],[\"Positive allosteric modulator activity at rat mGluR5 receptor expressed in HEK293 cells assessed as potentiation of glutamate-induced response at 30 uM relative to glutamate\"],[\"Inhibition of self-induced Amyloid beta (1 to 42) (unknown origin) aggregation at 25 uM after 24 hrs by thioflavin T-based fluorometric assay relative to control\"],[\"Inhibition of human NMT expressed in Escherichia coli DH5alpha cells\"],[\"Inhibition of wild-type human partial length TLK2 (E424 to N749 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of N-terminal His6-thioredoxin tagged Mycobacterium tuberculosis H37Rv DprE1 expressed in Escherichia coli BL21(DE3) using FPR as substrate by resazurin dye-based fluorescence assay\"],[\"Effect on PPAR delta transactivation activity in Huh7 cells\"],[\"Inhibition of KRAS in human MCF7 cells assessed as reduction in Pan RAS protein level at 35 uM measured after 24 hrs by Western blot analysis relative to control\"],[\"Inhibition of IDO1 in interferon-gamma-induced human HeLa cells using L-tryptophan substrate incubated for 24 hrs\"],[\"Inhibition of recombinant human PI3Kgamma using PIP2\\u002fATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay\"],[\"Inhibition of human CK1gamma1 assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human CYP11B1 expressed in V79 MZ cells\"],[\"Binding affinity to Staphylococcus aureus PBP2a assessed as association constant by SPR assay\"],[\"In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells\"],[\"Displacement of [3H]NMS from human cloned muscarinic M5 receptor expressed in CHO cells\"],[\"Displacement of [3H]LSD from human 5-HT7 receptor by PDSP assay\"],[\"Agonist activity at PPARgamma in mouse 3T3-L1 cells assessed as increase in adipoq RNA expression at 0.1 to 2.5 uM by qRT-PCR analysis\"],[\"Residual PPIase activity of human GST-Pin1 S16E by protease free PPIase assay\"],[\"Inhibition of wild-type human presenilin-1 stably overexpressed in CHO cells co-expressing wild-type human amyloid precursor protein assessed as inhibition of amyloid beta 42 formation after 24 hrs by ELISA\"],[\"Increase in HIV1 reverse transcriptase activity at 18.9 uM relative to control\"],[\"Inhibition of human GST-tagged BRD4 BD1 (44 to 170 residues) expressed in Escherichia coli BL21 using biotinylated H4(1 to 21)K5\\u002f8\\u002f12\\u002f16Ac peptide as substrate after 30 mins by AlphaScreen assay\"],[\"Inhibition of recombinant human flag-tagged JNK2-beta-2 at 1000 nM\"],[\"Inhibition of human CAMK2 gamma catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Binding affinity to human alpha-2C adrenergic receptor by PDSP assay\"],[\"Inhibition of human FLT4 at 1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Activity at oxytocin receptor in rat uterus relative to oxytocin\"],[\"Inhibition of [3H]DAMGO binding to Opioid receptor mu 1 of rat brain tissue\"],[\"Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay\"],[\"Binding affinity to full length BRD3 BD1 in human HuT78 cell lysates incubated for 45 mins by liquid chromatography-mass spectrometry based chemoproteomic binding assay\"],[\"Binding affinity to wild-type human full length DLK (M1 to P859 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of equine serum BChE at 10 uM using butyrylthiocholine iodide as substrate preincubated for 20mins before the addition of substrate by Ellman's method\"],[\"Binding affinity to OGFR in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Ratio of compound Ki to isoproterenol Ki for recombinant human beta2 adrenoceptor expressed in HEK293T cells\"],[\"ATP competitive inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) in presence of varying level of ATP by Kinase-Glo reagent-based luminescence assay\"],[\"Inhibition of human cRAF using [33P-ATP] as a substrate by scintillation counting\"],[\"Activation of PERK in human A375 cells assessed as increase in CHOP expression at 1 to 2.5 uM after 48 hrs by Western blot analysis\"],[\"Inhibition of clasto-lactacystin binding to beta2 subunit of 20S proteasome in human HeLa cells at 1 uM by Western blotting analysis\"],[\"Displacement of [3H]4-DAMP from human recombinant muscarinic M4 receptor expressed in CHO cells\"],[\"Inhibition of IkappaB-alpha degradation in LPS-induced human BV2 cells pretreated for 30 mins followed by LPS stimulation for 30 mins by Western blot analysis\"],[\"Antagonist activity at human TRPC3 at \\u003c= 30 uM\"],[\"Ability to release growth hormone in a rat pituitary cell assay\"],[\"Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay\"],[\"Non-competitive inhibition of mushroom tyrosinase\"],[\"Inhibition of VHR in human TCR-stimulated Jurkat T cells\"],[\"Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC\\u002fMS analysis\"],[\"Inhibition of AKT1 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay\"],[\"Displacement of [3H]CP55,940 from human CB2 receptor expressed in CHO cells at 10 uM after 2 hrs by liquid scintillation counter\"],[\"Inhibition of recombinant human HDAC6 expressed in baculovirus infected sf9 cells using fluor-de-Lys-SIRT1 as substrate by fluorescence method\"],[\"Competitive binding affinity to partial length wild type human FLT3 D835Y expressed in bacterial expression system at 10 uM by kinomescan method relative to control\"],[\"Displacement of [3H]-C18-PAF from human PAF receptor at 10 uM incubated for 180 mins by scintillation counting analysis relative to control\"],[\"Binding affinity to SAP145 in human MDA-MB-468 cells at 1.5 uM by immunoblotting\"],[\"Inhibition of recombinant His-tagged human SK1 assessed as production of [32P]-S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control\"],[\"Induction of STAT5 degradation in human MOLM16 cells at 0.25 to 100 uM incubated for 4 hrs by Western blot analysis\"],[\"Binding affinity to N-terminal portion of human Brd2 containing bromodomain BD12 expressed in Escherichia coli by isothermal titration calorimetric analysis\"],[\"Inhibition of EGFR L858R (unknown origin) by mobility shift assay\"],[\"Inhibition of human PDE4B using [3H]cAMP as substrate at 100 nM incubated for 5 mins followed by substrate addition and measured after 10 mins by scintillation proximity assay relative to control\"],[\"Inhibition of human tyrosinase expressed in human SKMEL188 cell lysate using L- DOPA as substrate incubated for 8 hrs\"],[\"Inhibition of N-terminal GST-His 6 tagged full length human SGK1 (M1-L431) expressed in Sf9 insect cells using GSK3-derived peptide as substrate at 1 uM by Filter binding assay relative to control\"],[\"Displacement of [3H]methoxyPEPy from rat mGluR5 expressed in human HEK293 cells at 10 uM after 1 hr by scintillation counter\"],[\"Inhibition of PARP1 (unknown origin) at 10 uM\"],[\"Inhibition of ROCK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC\\u002fMS analysis\"],[\"Binding affinity to RORa-LBD (unknown origin) by radioligand binding assay\"],[\"Antagonist activity at human vasopressin V2 expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay\"],[\"Antagonist activity at CXCR7 (unknown origin)\"],[\"Inhibition of HDAC6 in human MDA-MB-231 cells assessed as increase in acetylated lysine at 5 to 20 uM by Western blot analysis\"],[\"Inhibition of StarD7 (unknown origin) using NBD-PC and donor and acceptor small unilamellar vesicles by fluorescence quench assay\"],[\"Inhibition of human IKKalpha assessed as residual activity at 100 uM using KKKKERLLDDRHDSGLDSMKDEE as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Covalent binding affinity to JNK3 C154A mutant (unknown origin) at 5 molar excess after 1 hr by LC-muESI-QTOF mass spectrometry\"],[\"Inhibition of human recombinant IRAP expressed in baculovirus infected cabbage looper ovary Hi5 cells using L-leucine-7-amido-4-methyl coumarin as substrate after 5 to 10 mins by fluorescence assay\"],[\"Inhibition of human PAK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM\"],[\"Inhibition of ABHD12 in PMA-differentiated human THP1 cells assessed as increase in CCL3 production treated simultaneously with IFN-gamma\\u002fLPS for 24 hrs and measured 6 to 24 hrs after stimulation\"],[\"Binding affinity to GST-tagged TSAD SH2 domain (unknown origin) up to 20 uM by fluorescence anisotropic assay\"],[\"Inhibition of recombinant Leishmania donovani trypanothione reductase expressed in Escherichia coli BL21 (DE3) using trypanothione disulphide as substrate at 100 uM preincubated for 5 mins followed by substrate addition by microplate reader analysis relative to control\"],[\"Inhibition of Tyk2 by HTRF kinase assay\"],[\"Binding affinity to wild-type human partial length AKT1 expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of HIF1alpha in human SK-RC-28 cells assessed as reduction in VEGFA expression at 20 uM after 48 hrs by RT-PCR analysis\"],[\"Inhibition of noradrenaline-stimulated Wistar rat vas deferens contraction at 1 uM\"],[\"Inhibition of HIV-1 reverse transcriptase at a concentration of 1 uM\"],[\"Displacement of [3H]-di-o-tolylguanidine from sigma-2 receptor in rat liver membranes after 180 mins by scintillation counting method\"],[\"Binding affinity to HIV1 protease I50V mutant\"],[\"Inhibition of PPM1D in human MCF7 cells assessed as increase in p53 phosphorylation at Ser15 by Western blot analysis\"],[\"Inhibition of human phosphorylated ABL1 H396P mutant (S229 to K512 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control\"],[\"Antagonist activity at LasR in Pseudomonas aeruginosa PAO1 assessed as inhibition of biofilm formation at 12 uM after 20 hrs by crystal violet staining assay\"],[\"Inhibition of recombinant full-length human mTOR at 10 uM measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of N-terminal 6-His-tagged IDH1 R132C mutant (unknown origin) expressed in Escherichia coli BL21 cells using alpha-KG as substrate in presence of NADPH incubated for 40 mins by fluorescence assay\"],[\"Inhibition of EGFR phosphorylation in human NCI-H1975 cells incubated for 8 hrs by Western blotting method\"],[\"Inhibition of wild-type human partial length SGK3 (M119 to L496 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity to His6-tagged recombinant human p70S6K by fluorescence anisotropy assay\"],[\"Inhibition of human recombinant cathepsin K using Z-Phe-Arg-AMC as substrate preincubated for 30 mins measured after 1 hr by quenched fluorescent resonance energy transfer assay\"],[\"Inhibition of mouse RORgamma ligand binding domain (Isoleucine 251 to Lysine 516) expressed in CHOK1 cells incubated for 2 days by Gal4 luciferase reporter gene assay\"],[\"Concentration required to inhibit A beta 42 peptide at 100 uM\"],[\"HGK [ZC1(M4K4CGP1)] Takeda global kinase panel\"],[\"Inhibition of HIV1 recombinant protease at 50 nM\"],[\"Inhibition of recombinant human Aurora C (35 to end residues) assessed as residual activity at 10 uM using AKRRRLSSLRA as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control\"],[\"Induction of BCl-2 dephosphorylation in human HL-60 cells assessed as increase in Bax expression at 5 to 15 uM measured after 24 hrs by coimmunoprecipitation method\"],[\"Inhibition of wild-type human partial length DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control\"],[\"Binding affinity to p38alpha MAP kinase (unknown origin) by NMR analysis\"],[\"Inhibition of Kir2.1 (unknown origin)\"],[\"Binding affinity to HRH1 (unknown origin) assessed as inhibition of ligand binding at 10 uM relative to control\"],[\"Antagonist activity at human recombinant PTH1 receptor expressed in HEK293 cells assessed as inhibition of PTH(1-34)-stimulated cAMP production\"],[\"Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM\"],[\"Inhibition of Mycobacterium tuberculosis IspC by photometric assay\"],[\"Competitive inhibition of IDO1 (unknown origin) using L-tryptophan as substrate incubated for 30 min assessed as reduction in conversion of N-formyl kynurenine to kynurenine by dixon plot analysis\"],[\"Inhibition of human RSK2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS\\u002fMS analysis relative to control\"],[\"Inhibition of P-glycoprotein-mediated [3H]vinblastine transport in human Caco-2 cells\"],[\"Inhibition of human CA2 incubated for 15 mins by stopped-flow CO2 hydration kinetic assay based Cheng-Prusoff equation analysis\"],[\"Inhibitory activity against Hepatitis C virus NS3 protease by ELISA\"],[\"Inhibition of IPTG-stimulated Escherichia coli K-12 murE at 4 fold MIC by microarray analysis\"],[\"Irreversible inhibition of human liver cathepsin B after 10 mins by mass spectrophotometric analysis\"],[\"Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation at protein to compound ratio of 5:1 after 100 hrs by ThT fluorescence assay\"],[\"Inhibition of DNA-tagged human PIP5K2B assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of ZIKV NS2B-NS3 protease expressed in Escherichia coli BL21(DE3) using Boc-Gly-Arg-Arg-AMC as substrate at 100 uM by FRET assay\"],[\"Inhibition of HDAC6 in imatinib-resistant human SUP-B15 cells assessed as increase in acetyl-alpha tubulin expression at 0.1 to 10 uM after 24 hrs by immunoblot assay\"],[\"Antagonistic activity against histamine H3 receptor in guinea pig ileum\"],[\"Inhibition of human AKT1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibitory activity against FAK\"],[\"Inhibition of human WNK3 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of VEGFR2 phosphorylation in human NCI-H460 cells after 12 hrs by Western blot analysis\"],[\"Inhibition of HIV1 RT Y181I mutant\"],[\"Inhibition of PAR1 (unknown origin)\"],[\"STK22D Invitrogen Lab (UK) kinase screen (BI)\"],[\"Binding affinity against Dopamine receptor D1 like from bovine retina membranes measured using [3H]SCH-23390 radioligand\"],[\"Inhibition of alpha2B adrenergic receptor (unknown origin)\"],[\"Binding affinity to wild-type human partial length PAK4 (Q144 to R438 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inverse agonist activity at human CB2 receptor expressed in CHO membranes by [35S]GTPgammaS binding assay relative to basal control\"],[\"Inhibition of human recombinant HDAC5 by Michaelis-Menten equation analysis\"],[\"Inhibition of PRSK2 (unknown origin)\"],[\"Binding affinity to FLT1 (unknown origin) by KinomeSCan assay\"],[\"Inhibition of serotonin 5-HT1D receptor (unknown origin) at 1 uM\"],[\"Inhibition of wild-type human partial length CAMK2B (M1 to Q380 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control\"],[\"Antagonist activity at human Gal4-fused ER-beta expressed in HEK293 cells assessed as inhibition of 17beta-estradiol-induced effect at 3 uM by luciferase reporter gene assay\"],[\"Inhibition of human SHP2 (246 to 527 residues) expressed in Escherichia coli strain BL21(DE3) using DiFMUP as substrate preincubated for 10 mins followed by substrate addition and measured after 10 mins by fluorescence assay\"],[\"Relative potency in guinea pig ileum whole segment; value ranges from 53 to 81\"],[\"Inhibition of ERK5 in human MKN74 cells harboring ERK1\\u002f2 siRNA assessed as reduction in ERK5 phosphorylation at 0.5 uM by immunofluorescence assay\"],[\"Inhibition of human GST-tagged c-SRC autophosphorylation using biotin-(6-amino caproic acid)-AAAQQIYGQ-NH2 as substrate after 40 mins by homogenous time-resolved fluorescence method\"],[\"Inhibition of recombinant human PTP1B assessed as hydrolysis of p-nitrophenyl phosphate at 25 uM after 30 mins relative to control\"],[\"Inhibition of human full length BMX expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of Ret isoform 9 C634W mutant in human TT cells assessed as reduction in MAPK phosphorylation at 0.3 to 30 nM measured after 2 hrs by Western blot analysis\"],[\"Inhibition of human LSD1 preincubated for 10 mins followed by H3(1-20)K4-dimethylated (K4me2) peptide substrate addition and measured after 30 mins by peroxidase-coupled reaction method\"],[\"Inhibition of BACE1 (unknown origin) using APP Swedish mutant harboring Lys-Met\\u002fAsn-Leu mutation in beta-secretase cleavage site as substrate by FRET assay\"],[\"Inhibition of recombinant human His-tagged DCN1 (58 to 259 residues) expressed in Escherichia coli BL21 (DE3) using MIKLFSLKQQKKEEESAGGTK-biotin as substrate incubated for 30 mins by HTRF assay\"],[\"Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated histone H3 at ser10 level measured at 1.25 to 40 uM after 3 hrs by Western blot analysis\"],[\"Inhibition of recombinant human MAO-A using p-tyramine as substrate at 100 uM preincubated for 15 mins followed by substrate addition by Amplex Red probe-based fluorometric analysis\"],[\"Inhibition of recombinant human ULK1 (1 to 314 residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"TrkB (h) Millipore kinase activity assay\"],[\"Inhibition of rabbit skeletal muscle SERCA1 assessed as reduction in calcium uptake preincubated for 10 mins followed by ATP addition and measured after 4 mins by scintillation liquid method\"],[\"Activation of human Y1R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay\"],[\"Displacement of [125I]alpha-bungarotoxin from alpha7 nAChR in rat brain membrane\"],[\"Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control\"],[\"Inhibition of recombinant human GST-tagged RON expressed in baculovirus system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay\"],[\"Binding affinity to human PIM1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibitory concentration of compound against LPS- induced TNF-alpha production in whole human blood assay\"],[\"Agonist activity at human 5-HT7A receptor expressed in HEK cell membranes incubated for 20 mins by cAMP functional assay\"],[\"Ratio of EC50 for JAK1 in human TF1 cells in presence of whole blood to EC50 for JAK1 in human TF1 cells in absence of whole blood\"],[\"Activation of glucokinase (unknown origin)\"],[\"Inhibition of IL5-mediated proliferation of mouse Y16 cells at 50 uM by WST1 assay\"],[\"Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay\"],[\"Inhibition of EphB1 (unknown origin) at 1 uM\"],[\"SNRK(h) Eurofins Kinase panel\"],[\"Inhibition of IRAK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled AIQFLHQDSPSLIHGDIKSSNVLLDER probe by mass-spectrometric analysis relative to control\"],[\"Inhibition of PI3Kbeta-mediated AKT phosphorylation at Ser473 in PTEN-deficient human MDA-MB-468 cells after 30 mins\"],[\"Inhibition of N-terminal GST-tagged human VEGFR2 cytoplasmic domain (790 to 1356 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method\"],[\"Inhibition of human PAK5 assessed as residual activity at 1 uM relative to control\"],[\"Reactivation of VX-inhibited hemoglobin free erythrocyte ghost human AChE using acetylcholine iodide as substrate at 0.05 mM measured for 1 hr by spectrophotometry based Ellman method\"],[\"Inhibition of human PrCP at 5 uM\"],[\"Inhibition of recombinant full-length human CSK at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of full length recombinant FLAG-tagged human MAO-B expressed in baculovirus infected sf9 cells at 1 uM preincubated for 15 mins followed by luciferin derived substrate addition measured after 60 mins by luciferase reporter gene assay relative to control\"],[\"Inhibition of human p97\"],[\"Displacement of [3H]naloxone from mu opioid receptor in rat brain membrane\"],[\"Displacement of [125I]NDP-alphaMSH from human MC1 receptor expressed in HEK293 cells\"],[\"Inhibition of human CaMK1alpha assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control\"],[\"Inhibition of adrenergic alpha2A receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay\"],[\"Inhibition of human recombinant MMP7 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay\"],[\"Displacement of [125I]-His5, D-Tyr6]GnRH from mutant GnRHR, GnRHR S124A\"],[\"Inhibition of p53 transfected in HEK293T cells assessed as gene transcription after 5 hrs by Renilla luciferase reporter assay\"],[\"Displacement of [3H]P4 from human recombinant progesterone receptor expressed in T47D cells\"],[\"Antagonist activity at histamine H3 receptor on rat cortex membrane by [35S]GTPgammaS binding assay\"],[\"DYRK1B Invitrogen Lab (UK) kinase screen (BI)\"],[\"Inhibition of human placental aromatase using [3H]-1beta-androstenedione as substrate after 16 hrs by [3H]-water method\"],[\"Agonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as calcium mobilization incubated for 15 mins by Fluo-4AM dye based fluorescence analysis\"],[\"Inhibition of human NPP3 expressed in COS7 cells assessed as amount of inorganic phosphate released using ATP as the substrate at 100 uM after 15 mins by malachite green reagent method\"],[\"Binding affinity to MCM4 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Inhibition of HDAC1 in human A549 cells assessed as increase in acetylated histone-H3 level at 0.1 to 1 uM after 24 hrs by immunofluorescence assay\"],[\"Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells at 10 uM after 60 mins\"],[\"Inhibition of human GRK3 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells\"],[\"Inhibition of HDAC6 in human A549 cells assessed as induction of alpha tubulin acetylation after 1 hrs by Western blot analysis\"],[\"Inhibition of PTP1B in mouse 3T3L1 cells assessed as stimulation of 2-NBDG uptake preincubated for 24 hrs followed by 2-NBDG addition measured after 30 mins by fluorescence reader analysis\"],[\"Binding affinity to HDGF2 (unknown origin) assessed as induction of thermal shifts at 200 uM measured for 25 mins by SYPRO orange dye thermal shift assay\"],[\"Inhibition of ATPase activity of human topoisomerase 2 alpha\"],[\"Displacement of [125I]peptide YY from NPY2 receptor in human KAN-TS cells\"],[\"Inhibition of human DAPK3 at 100 nM by direct-filter Binding radiometric assay relative to control\"],[\"Inhibition of ABCB1 in human SW620\\u002fAd300 cells assessed as potentiation of cisplatin-induced cytotoxicity by measuring cisplatin IC50 at 4 uM after 72 hrs by MTT assay (Rvb = 0.61 +\\u002f- 0.03 microM)\"],[\"Binding affinity to Mcl1 (unknown origin) at 5 uM incubated for 20 mins by fluorescence based assay\"],[\"Inhibition of CDK4 (unknown origin) by luciferase reporter gene assay\"],[\"Inhibition of human recombinant Pim2 by ATP depletion assay\"],[\"Antagonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as inhibition of 5HT-induced intracellular calcium release at 1 mM measured for 90 secs by fluorescence assay\"],[\"Displacement of [3H]AB-MECA from human recombinant adenosine A3 receptor expressed in HEK293 cells at 1 uM\"],[\"Inhibition of [Leu8,D-Trp22,125I-Tyr25]SRIF-28 binding to human somatostatin receptor type 5\"],[\"Inhibition of IDH1 R132C mutant (unknown origin) using alpha-ketoglutarate and NADPH incubated for 30 mins by fluorescence based assay\"],[\"Agonist activity at rat mu opioid receptor transfected in HN9.10 cells by [35S]GTPgammaS binding assay\"],[\"Inhibition of recombinant human MEK2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay\"],[\"Displacement of [3H]DTG from sigma 2 receptor in rat liver membranes measured after 120 mins by scintillation counting method\"],[\"Inhibition of human ERG assessed as inhibition of IKr current at 3 uM by patch express assay\"],[\"Inhibition of human recombinant UP1 expressed in Escherichia coli Rosetta (DE3) using URD and inorganic phosphate as substrate at 1 uM after 60 seconds by spectrophotometric analysis relative to control\"],[\"Inhibition of c-MET autophosphorylation in human A549 cells at 10 uM by Western blotting analysis\"],[\"Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as fold reduction of ciprofloxacin MIC at 100 ug\\u002fml\"],[\"Inhibition of wild-type human partial length PRP4 (D657 to I1007 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control\"],[\"Binding affinity towards N-terminal biotinylated Avi-tagged human CBL-B (36 to 427 residues) measured by surface plasmon resonance assay\"],[\"Displacement of [I125]-NDP-MSH from wild type human melanocortin-4 receptor expressed in HEK293 cells\"],[\"Binding affinity to COPB1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Agonist activity at AhR (unknown origin)\"],[\"Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins\"],[\"Tested for hydrolysis by Lactamase BCPII\"],[\"Agonist activity at human CB1 receptor expressed in CHO cells assessed as effect on [35S]-GTPgammaS binding after 30 mins by scintillation counting\"],[\"Inhibition of KAT7 (unknown origin) assessed as reduction in H3K9ac acetylation at 10 uM relative to control\"],[\"Inhibition of human MAPKAP-K2 assessed as remaining activity at 10 uM\"],[\"Inhibition of bovine carboxypeptidase A using N-(4-methoxyphenylazoformyl)-Phe-OH as substrate preincubated for 2 mins followed by susbtrate addition measured for 15 mins at 30 secs interval\"],[\"Positive allosteric modulation of wild type rat mGlu5 receptor A809V mutant expressed in human HEK293 cells assessed as glutamate concentration response curve at 1 uM\"],[\"Inhibition of MAPK1\\u002fERK2 (unknown origin) in presence of ATP\"],[\"In vitro inhibition of human T-cells voltage-gated potassium channel subunit Kv1.3\"],[\"Inhibition of recombinant N-terminal GST-tagged human HDAC6 (1 to 1215 residues) expressed in Baculovirus infected insect cells using RHKK-Ac as substrate by fluorimetric assay\"],[\"Inhibition of HIV1 RT E138K using 17-mer DNA\\u002fAlexa Fluor 488 5'-end labeled DNA\\u002fAlexa Fluor 555-aha-dUTP as primer\\u002ftemplate\\u002fsubstrate preincubated for 10 mins followed substarte addition measured after 30 mins by FRET assay\"],[\"Inhibition of human Aurora A using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Tested for inhibitory activity against beta-lactamase (groupII) staphylococcus aureus 39\\u002f2 strain in presence of ampicillin + 80 ug\\u002fmL of compound\"],[\"Inhibition of human CDC2L5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human PRK2 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control\"],[\"Antagonist activity against human CGRP receptor\"],[\"Binding affinity for rat adenosine A2A receptor of CHO cells using [3H]CGS-21680 \"],[\"MMP-3 (H) Eurofins SafetyScreen44 (BI)\"],[\"Binding affinity to human alpha-synphilin monomer expressed in Escherichia coli BL21 by fluorescence intensity assay\"],[\"Inhibition of DNA-tagged human BRAF V600E mutant assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Induction of GSTP1 degradation in human HeLa cells at 80 uM measured after 3 hrs in presence of vacuolar type H (+)-ATPase inhibitor bafilomycin A1 by Western blot analysis\"],[\"Inhibition of EGF receptor (unknown origin) at 10 uM\"],[\"Inhibition of TRKC (unknown origin) assessed as remaining activity at 10 uM relative to control\"],[\"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay\"],[\"Inhibition of Trypanosoma cruzi cruzaine without pre-incubation\"],[\"Inhibition of wild-type human partial length DYRK1A (H129 to S509 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by Kinomescan method relative to control\"],[\"Inhibition of AChE in human SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40) (unknown origin)-induced amyloid beta aggregation at 5 to 10 uM measured every 24 hrs for 7 days by Thioflavin T based fluorometric assay\"],[\"Displacement of [3H]WAY-100635 from human 5-hydroxytryptamine 1A receptor expressed in CHO cells\"],[\"Inhibition of human PEK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM\"],[\"Ratio of binding affinity to PKC delta C1b domain wild type versus mutant Q27V\"],[\"Activation of HNFalpha transcriptional activity in human HepG3\\u002fC3A cells transfected with ApoCIII-luc assessed as activation of luciferase reporter gene after 24 hrs\"],[\"Inhibition of HSGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRK(Biotin)-OH binding to recombinant human His6-tagged BRD4 bromodomain 1 expressed in Escherichia coli BL21 (DE3)-R3-pRARE2 cells preincubated for 30 mins followed by HSGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRK(Biotin)-OH addition and measured after 30 mins by Alphascreen assay\"],[\"Inhibition of ABCC10 (unknown origin) expressed in HEK293 cells assessed as reversal of paclitaxel resistance at 12.5 uM after 72 hrs by MTS\\u002fPMS assay\"],[\"Inhibition of P38alpha (unknown origin) at 1 uM relative to control\"],[\"Inhibition of N-terminal GST-tagged human recombinant ERBB4 expressed in baculovirus expression system\"],[\"Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in CHO cells after 90 mins by scintillation counting analysis\"],[\"Inhibition of HSF1 in human HeLa cells assessed as potentiation of radicicol and heat-induced increase in cell death at 60 nM relative to radicicol and heat alone\"],[\"Inhibition of recombinant human CA1 preincubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Inhibition of recombinant human PTP4A3 expressed in Escherichia coli BL21 (DE3) assessed as reduction in hydrolysis using DIFMUP as substrate incubated for 5 mins in presence of DTT\"],[\"Inhibition of human TBK1 assessed as residual activity at 100 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control\"],[\"Inhibition of recombinant human GST-tagged full length PKCdelta expressed in insect expression system using Ser\\u002fThr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control\"],[\"Agonist activity at glucocorticoid receptor in human ChaGoK1 cells assessed as inhibition of AP1-mediated transcriptional activity by measuring reduction in PMA-stimulated TRE-LacZ activity after 24 hrs in presence of MUG by fluorometric assay relative to dexamethasone\"],[\"Binding affinity to human CB1 receptor at 10 uM by radioligand binding assay relative to control\"],[\"Binding affinity to human WDR9 bromodomain 2 assessed as residual activity at 300 nM by BROMOscan method relative to control\"],[\"Binding affinity to GlyT1 in rat cortical brain homogenate after 60 mins by gamma counting\"],[\"Inhibition of human recombinant COX2 expressed in insect Sf21 cells assessed as inhibition of conversion of arachidonic acid to PGE2 at 10 uM preincubated for 15 mins before substrate addition measured after 5 mins by enzyme immunoassay\"],[\"Inhibition of monophenolase activity of mushroom tyrosinase assessed as reduction in steady state rate monophenolase activity for oxidation of L-tyrosine substrate at 0.5 to 16 uM by UV-Vis spectrophotometry\"],[\"Inhibition of thymidylate synthase in human 2008 cells assessed as downregulation of DHFR protein level at 5 uM after 48 hrs by Western blotting analysis\"],[\"Inhibition of human TOPK using MBP as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method\"],[\"Inhibition of full length recombinant human N-terminal GST-tagged HDAC6 expressed in baculovirus infected sf9 cells preincubated for 5 mins followed by biotinylated H3K9-Ac substrate addition and measured after 60 mins by HTRF assay\"],[\"Inhibition of human KIT V559D mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human ROCK2 at 10 uM after 1 hr by qPCR analysis relative to control\"],[\"Inhibition of full length C-terminal His8 tagged IDH1 R132H mutant (1 to 414 residues) (unknown origin) homodimer expressed in Escherichia coli BE3 cells assessed as maximal reduction in NADPH consumption using alpha-ketoglutarate as substrate after 60 mins by Diaphorase\\u002fResazurin dye based fluorescence assay relative to control\"],[\"Inhibition of human Carbonic anhydrase1 using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay\"],[\"Inhibition of N-terminal His6 tagged recombinant full length human JNK3 assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay\"],[\"Inhibition of human BBOX pre-incubated for 15 mins using TBS-protected fluorescein probe and Fe (II) (Fe(NH4)2(SO4)2 salt by fluoride release assay\"],[\"Inhibition of human cloned wild type BRAF by ELISA-based MEK phosphorylation assay\"],[\"Inhibition of [3H]- CGS 21680 binding to Adenosine A2A receptor of rat brain membranes\"],[\"Inhibition of FLT3 D835Y mutant (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control\"],[\"Reversal of Pgp-1-mediated multidrug resistance in human SW620\\u002fAd300 cells overexpressing ABCB1 assessed as potentiation of paclitaxel cytotoxicity at 1 uM treated for 2 hrs prior to paclitaxel challenge measured after 72 hrs by MTT assay relative to paclitaxel alone-treated control\"],[\"Inhibition of IR-HIS (unknown origin) at 10 uM\"],[\"Inhibition of human recombinant MAO-A expressed in baculovirus infected insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometry\"],[\"Inhibition of SIK2 (unknown origin) at 1 uM\"],[\"Inhibition of MEK2 (unknown origin)\"],[\"Inhibition of PRK2 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control\"],[\"NDR1(h) Millipore kinase panel\"],[\"Displacement of [3H]prazosine from rat alpha1D adrenoceptor expressed in CHO cells at 1000 nM after 20 mins by scintillation counting analysis relative to control\"],[\"Antagonist activity at human P2Y4 receptor expressed in AD293 cells assessed as inhibition of UTP-induced inositol-1-phosphate accumulation at 0.1 to 100 uM\"],[\"Displacement of [Sez6]-HO-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis\"],[\"Binding affinity to beta3 adrenoceptor (unknown origin) at 10 uM\"],[\"Inhibition of recombinant human RIPK2 (1 to 299 residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control\"],[\"Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of LRRK2 (unknown origin) at 10 uM by single point assay\"],[\"Inhibition of P-gp in human adriamycin-resistant A2780 cells up to 30 uM by Hoechst 33342 assay\"],[\"Inhibition of human HDAC6 expressed in human 293T cells preincubated for 15 mins in presence of [3H]acetyl-labeled histones measured after 30 mins by liquid scintillation counter method\"],[\"Inhibition of ghrelin-induced increase of intracellular [Ca2+] in CHO K cell FLIPR assay; ND=Not Determined\"],[\"Inhibition of reverse transcriptase M204I\\u002fS202G double mutant expressing entecavir-resistant hepatitis B virus capsid assembly in human Huh7 cells assessed as reduction in secreted DNA levels measured on day 7 by real-time PCR analysis\"],[\"Inhibition of human topoisomerase 1 using supercoiled pBR322 plasmid DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\"],[\"Displacement of [125I]BH-SP from NK1 receptor in human U373MG cells at 10'-5 M\"],[\"A-Raf(h) Eurofins Kinase panel\"],[\"Inhibition of human liver FBPase C38S mutant expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based assay\"],[\"Activation of human telomerase activity expressed in HEK293T cells at 60 uM incubated for 30 mins by modified TRAP assay and phosphorimage analysis\"],[\"Inhibition of AKR1C1 (unknown origin)\"],[\"Inhibition of human ERG by cell based by patch clamp assay\"],[\"Binding affinity towards human nicotinic acetylcholine receptor alpha 7 membrane expressed in GH4C1 cell using [3H]methyllycaconitine; NT denotes not tested\"],[\"Agonist activity at GAL4-DBD fused human PPARgamma-LBD (157 to 475 residues) expressed in human HepG2 cells at 0.1 to 20 uM after 24 hrs by dual luciferase reporter gene assay\"],[\"Displacement of doferilide from human ERG\"],[\"Inhibition of human PIM1 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control\"],[\"Inhibition of Stat3 dimer DNA binding activity in EGF-stimulated mouse NIH3T3 nuclear extract expressing human EGFR assessed as residual activity at 5 uM preincubated for 30 mins followed by addition of radiolabeled probe hSIE for 30 mins by EMSA\"],[\"Inhibition of recombinant human MET A1209G\\u002fV1290L\\u002fD1246H mutant (974 to end residues) at 10 uM using KKKGQEEEYVFIE as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method\"],[\"Inhibition of rat sucrase\"],[\"Inhibition constant against [3H]dihydrotetrabenazine binding to vesicular monoamine transporter-2 of rat synaptic vesicle membranes\"],[\"Binding affinity to wild-type human partial length ASK2 (M278 to R972 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control\"],[\"Inhibition of DNA-tagged human p38-beta assessed as percent of control at 50000 nM by qPCR analysis relative to control\"],[\"Inhibition of LPS binding to TLR4 in IFNgamma-stimulated mouse RAW264.7 cells assessed as effect on ratio of phosphorylated ERK to total ERK at 100 uM measured after 60 mins by Western blot analysis relative to beta-actin (Rvb = 3 No_unit)\"],[\"Inhibition of MEK4 (unknown origin)\"],[\"Inhibition of PRDM9 (unknown origin) at 100 uM incubated for 15 mins followed by substrate addition measured after 60 mins by AlphaLisa method\"],[\"Activity at human oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced inositol phosphate accumulation at 1 uM\"],[\"Inhibition of IRAK (unknown origin)\"],[\"Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique\"],[\"Inhibitory activity against human tissue plasminogen activator\"],[\"Activity of human EphA1 kinase at 1 uM\"],[\"Inhibition of HIV-1 integrase strand transfer activity after 1 hr by ELISA\"],[\"Inhibition of PDGFR-BETA (unknown origin) at 1 uM relative to control\"],[\"Inhibition of SAPK2b in presence of 10 uM ATP\"],[\"Inhibition of wild type EGFR in human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay\"],[\"Inhibition of human recombinant DDAH1 assessed as inactivation rate at 4.0 mM\"],[\"Inhibition of recombinant human p70S6K by radiometric assay in presence of [gamma-33P]-ATP\"],[\"Agonist activity at mouse TGR5 transfected in HEK293 cells assessed as cAMP accumulation after overnight incubation by luciferase reporter gene assay relative to lithocholic acid\"],[\"Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control\"],[\"Inhibition of PI3Kgamma (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control\"],[\"Time dependent inhibition of equine serum BChE at 25 to 250 nM\"],[\"Inhibition of AChE-induced amyloid beta (1 to 42 residues) (unknown origin) fibril formation at amyloid beta (1 to 42 residues)\\u002fAChE\\u002fcompound ratio of 100:1:100 after 6 hrs by ThT-based fluorometric method relative to control\"],[\"Membrane passage was expressed as mean percentage of compound transported from bottom to top and from top to bottom at 3 hr after adding the compound\"],[\"Inhibition of COX1 in human whole blood assessed as residual TXB2 level at 10 uM after 1 hr by LC-MS\\u002fMS analysis relative to control\"],[\"Displacement of [125I]+\\u002f-DOI from human recombinant 5-HT2B receptor at 1 uM after 60 mins by scintillation counting analysis relative to control\"],[\"Antagonist activity at P-selectin (unknown origin) by surface plasmon resonance-based dynamic assay\"],[\"Inhibition of recombinant AXL (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay\"],[\"Inhibition of ZIPK (unknown origin) assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of human IDO1 protein assessed as reduction in N-formylkynurenine formation using L-tryptophan as substrate by methylene blue reagent based enzymatic assay\"],[\"Binding affinity to NanoLuc-human A1 adenosine receptor expressed in HEK293-A cells assessed as binding constant (koff) by NanoBRET competitive binding assay\"],[\"Inhibition of DNase gamma (unknown origin) transfected in HeLa S3 cells\"],[\"Inhibition of human full-length recombinant HDAC6 expressed in baculovirus infected Sf9 insect cells using fluorogenic peptide RHKKAc as substrate after 2 hrs\"],[\"Inhibition of BIKE (unknown origin) assessed as residual activity at 10 uM relative to control\"],[\"Inhibition of cathepsin L (unknown origin) assessed as reduction in pNA release using chromogenic Z-Phe-Arg-pNA substrate measured over 1 hr by spectrophotometry\"],[\"Inhibition of human recombinant ALDH1A1 assessed as enzyme activity by measuring NAD(P)H formation at 20 uM incubated for 2 mins by spectrophotometry\"],[\"Inhibition of ovine COX-1 assessed as residual activity at 10 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition and measured after 5 mins by RP-HPLC method relative to control\"],[\"Inhibition of matriptase (unknown origin) using Boc-Gln-Ala-Arg-AMC as substrate at 50 uM after 15 mins by fluorescence assay\"],[\"Inhibition of PIM1 (unknown origin) assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control\"],[\"Inhibition of recombinant human ARK5 (2 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of FGFR1 in FGFR1 translocated human KG1 cells assessed as suppression of PLCgamma phosphorylation after 2 hrs by Western blot analysis\"],[\"Agonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay\"],[\"Antagonist activity at human cloned dopamine D4.2 receptor by dopamine-stimulated [35S]GTP-gamma-S binding assay\"],[\"Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells at 10 uM after 30 mins HTRF assay relative to control\"],[\"Inhibition of human Tdp1 expressed in Escherichia coli assessed as blockade of enzyme-mediated hydrolysis of phosphodiester linkage between tyrosine and double stranded DNA substrate bearing 5^-overhang end by SDS-PAGE electrophoresis\"],[\"Agonist activity at GR assessed as NF-kappaB-mediated transrepression of secreted placental alkaline phosphatase gene in human A549 cells\"],[\"Agonist activity at AHR in human HepG2 cells incubated for 4.5 hrs by Luciferase reporter assay\"],[\"Inhibition of human FBPase D127A mutant expressed in Escherichia coli BL21 (DE3) using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry\"],[\"Binding affinity to recombinant His-tagged Cbl-b (unknown origin) (39 to 368 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by biofilm interference assay\"],[\"Agonist activity at human A2B receptor expressed in HEK293 cells at 10 uM after 10 mins by HTRF assay relative to control\"],[\"Inhibition of human TXA2 receptor at 1 uM\"],[\"PI3KC2a(h) Eurofins kinase panel\"],[\"Binding affinity to human partial length EGFR L747-S752del\\u002fP753S mutant expressed in bacterial expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control\"],[\"Competitive binding to human GST-tagged PPAR-gamma by TR-FRET assay\"],[\"Inhibition of human ERG expressed in HEK293 cells at 100 uM by patch-clamp technique\"],[\"Displacement of [3H]-diprenorphine from recombinant DOR (unknown origin) expressed in rat C6 cells\"],[\"Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control\"],[\"Activity at human 5HT2C expressed in HEK293E cells assessed as elevation of intracellular calcium by 384-FLIPR assay\"],[\"Binding affinity to RET V804M mutant (unknown origin)\"],[\"Agonist activity at TLR8 in human PBMC assessed as increase of IL4 mRNA level at 10 ug\\u002fmL after 2 hrs relative to negative control\"],[\"Inhibition of recombinant human CYP1A1 expressed in Escherichia coli DH5aplha cells assessed as O-deethylation of ethoxyresorufin in presence of NADPH at 100 uM measured after 2 mins by spectrofluorometric method\"],[\"Inhibition of human recombinant MAO-B assessed as hydrogen peroxide production at 20 uM\"],[\"Inhibition of TRPC5 (unknown origin) expressed in HEK293\\u002fTREx cells assessed as reduction in intracellular calcium level measured for 3 mins by fluo4 dye-based fluorescence assay\"],[\"Inhibition of mouse recombinant Aurora A kinase expressed in insect Sf9 cells by radioactive flashplate assay\"],[\"Inhibition of Homo sapiens (human) NEU3 expressed in HEK293 cells using mixed ganglioside as substrate after 10 to 30 min by fluorometric analysis\"],[\"Competitive inhibition of human MMP1 using fluorogenic substrate at 50 uM by Dixon plot analysis\"],[\"Binding affinity to rat His-tagged PRMT1 (11 to 353 residues) expressed in Escherichia coli BL21(DE3) at 200 uM by 1D 1H CPMG-NMR spectroscopic method\"],[\"Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay\"],[\"Inhibition of full length human CA9 incubated for 15 mins by phenol red dye based stopped flow CO2 hydration assay\"],[\"Inhibition of MK2 (unknown origin) at 30 uM by microfluidic assay relative to control\"],[\"Negative allosteric modulation of rat mGlu3 receptor assessed as calcium mobilization by cell based fluorescence assay\"],[\"Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay\"],[\"Time-dependent inhibition of human acid ceramidase expressed in HEK293 cells assessed as ratio of Ki to KI using Rbm14-12 as substrate by fluorescence assay\"],[\"Inhibition of EGF-induced EGFR phosphorylation at Tyr-residue in human A549 cells at 5 uM preincubated for 2 hrs followed by EGF stimulation for 10 mins by Western blot analysis\"],[\"Antagonist activity at human mGlu 3 expressed in HEK293 cells at 10 uM by Ca+2 assay\"],[\"Inhibition of EGFR in human HCC827 cells assessed as reduction in Akt phosphorylation incubated for 36 hrs by Western blot analysis\"],[\"Inhibition of tyrosinase in mouse Melan-a cells assessed as decrease in L-DOPA Vmax at 120 uM by Lineweaver-Burk plot\"],[\"Downregulation of AhR expression in human MCF7 cells at 10 uM after 6 hrs by Western blot method relative to lamin B\"],[\"Inhibition of human mitochondrial RNA polymerase using 5'-32P-R12\\u002fD18 as RNA\\u002fDNA template assessed as single nucleotide incorporation rate at 500 uM after 0.17 to 30 mins by PAGE analysis\"],[\"Inhibition of human phosphorylated ABL1 M351T mutant (S229 to K512 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control\"],[\"Displacement of [3H]Prazosin from human Alpha1D receptor measured after 90 mins by microbeta scintillation counting method\"],[\"Inhibition of human nNOS expressed in Escherichia coli expression system assessed as reduction in NO production in presence of L-arginine measured for 30 sec by hemoglobin capture assay\"],[\"Inhibitory dose against human immunodeficiency virus 1 protease\"],[\"Inhibition of ABCB1 in human NCI-ADR-RES cells assessed as potentiation of colchicine-induced cytotoxicity by measuring colchicine resistance ratio at 200 nM after 72 hrs by MTT assay relative to parental OVCAR8 cells (Rvb = 59 No_unit)\"],[\"Inhibition of recombinant N-terminal 6His-tagged human Plk1 expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control\"],[\"Inhibition of human recombinant CSF1R using ATP\\u002fUlight-TK peptide at 50 nM incubated for 15 mins relative to control\"],[\"Inhibition of Cdk5 (unknown origin) at 100 nM\"],[\"Binding affinity to FKBP51 FK1 domain (unknown origin) assessed as change in enthalpy by isothermal titration calorimetric analysis\"],[\"Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay\"],[\"Inhibition of thrombin (unknown origin) assessed as fibrin clot formation\"],[\"Displacement of [3H]17-beta estradiol from GST-fused human recombinant ERbeta ligand binding domain expressed in Escherichia coli BL21alpha cells incubated for 1 hr by liquid scintillation counting method relative to BPAF\"],[\"Inhibition of human recombinant endothelin 1 receptor at 10 uM\"],[\"Inhibition of wild-type HIV1 integrase 3'-end processing activity\"],[\"Inhibition of mouse uPA using Z-Gly-Gly-Arg-AMC as substrate after 15 mins by fluorescence assay\"],[\"Inhibition of CK2alpha (unknown origin) using RRRADDSDDDD as substrate after 40 mins by ADP-Glo assay\"],[\"Inhibition of Human P450 17 and NADPH-P450 reductase co-expressed in Escherichia coli with 25 uM progesterone\"],[\"Inhibition of MAGL in mouse B16 cells assessed as increase in 2-arachidonoylglycerol level at 10 uM after 8 hrs by isotope dilution HPLC-MS method\"],[\"Inhibition of recombinant human ADAM-17 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 30 mins by fluorometric assay\"],[\"Inhibition of human recombinant PKCgamma expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay\"],[\"Inhibition of human HIPK3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control\"],[\"Inhibition of human CYP11B2 expressed in renal leiomyoblastoma cells\"],[\"Binding affinity to recombinant human Nav1.7 after 18 hrs by radioligand binding assay\"],[\"Agonist activity at rat recombinant alpha7 nAChR expressed in GH4C1 cells by patch clamp technique relative to control\"],[\"Antagonist activity at human dopamine D3 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis\"],[\"Inhibition of N-terminal His6-tagged recombinant human EPHB3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control\"],[\"Inhibition of PARP1 in MEF cells assessed as potentiation of MMC-induced cytotoxicity at 0.01 uM incubated for 1 hr by clonogenic survival assay relative to untreated control\"],[\"Binding affinity to Electrophorus electricus AChE peripheral anionic site\"],[\"Inhibition of ATX in mouse plasma assessed as inhibition of LPA production after 2 hrs by LC-MS\\u002fMS analysis\"],[\"Inhibition of human placental thymidine phosphorylase\"],[\"Binding affinity to human microsomal 11beta-HSD1 by radiometric competition assay\"],[\"Inhibition of human recombinant Gcn5 assessed as reduction in acetylated histone H3 level at 0.8 mM by Western blot analysis\"],[\"Inhibition of human His-DNMT1 using [methyl-3H]SAM as substrate at 100 uM after 2 hrs\"],[\"Inhibition of KLK14 (unknown origin) assessed as inhibition of release of AMC fluorescent product using H-VPR-AMC as substrate at 10 uM incubated for 30 mins by microplate reader relative to control\"],[\"In Vitro Inhibition Assay: In vitro inhibition of 11beta-HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluoresence) technology (cisbio international, France) detecting cortisol generated from cortisterone by human liver microsomes.\"],[\"Inhibition of human LCK (R207 to P509 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control\"],[\"Displacement of [3H]SR142801 from human recombinant NK3 receptor\"],[\"Inhibition of cMET (unknown origin) using FAM-labeled peptide as substrate pre-incubated for 5 to 10 mins followed by substrate addition and measured after 30 to 60 mins by mobility shift assay\"],[\"Binding affinity to ERRbeta (unknown origin) using fluorescein-conjugated coactivator PGC-1alpha incubated for 1 hr by TR-FRET assay\"],[\"Binding affinity to wild-type human partial length PIK3C2B (M1 to L1634 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by kinomescan assay relative to control\"],[\"In vitro inhibition constant (Ki) against human Tissue type plasminogen activator was determined\"],[\"Binding affinity to VASP in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay\"],[\"Agonist activity at human M1 receptor expressed in HEK293T cells by BRET based Gq protein activation assay\"],[\"Antagonist activity at T7 epitope tagged human cloned sst2 receptor expressed in HEK293 cells assessed as inhibition of receptor internalization upto 10 uM by ELISA\"],[\"Inhibition of human recombinant MAO-A assessed as oxidation of kynuramine to 4-hydroxyquinoline at 100 uM after 20 mins\"],[\"Inhibition of HDAC4 (unknown origin) expressed in HEK293 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting\"],[\"Activity at human D5 receptor at 10 uM\"],[\"Binding affinity to isotopically labeled and N-terminal thioredoxin-His6 tag with N-terminal thrombin-cleavage site containing recombinant BCL6 BTB domain C8Q\\u002fC67R\\u002fC84N\\u002fE99V mutant ( 1 to 129 residues) (unknown origin) expressed in Escherichia coli assessed as ligand efficiency values at 500 uM by 1H-15N HSQC NMR spectroscopy\"],[\"Inhibition of human MLK1 (V88 to W426 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control\"],[\"Binding affinity to PIM3 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay\"],[\"Competitive binding affinity to DMPK2 (unknown origin) at 10 uM in presence of ATP relative to control\"],[\"Inhibition of human BCATm after 10 mins by fluorescent assay\"],[\"Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Km for acetyl coenzyme A at 160 uM (Rvb = 4.8 +\\u002f- 0.5 uM)\"],[\"Inhibition of human synovial secretory PLA2\"],[\"Inhibition of DYRK1a (unknown origin) at 0.078 uM relative to control\"],[\"HCK Invitrogen selectivity data (BI)\"],[\"Displacement of [3H]-CP55950 from human CB2 receptor expressed in HEK cell membranes after 90 mins\"],[\"Inhibition of recombinant human bradykinin receptor 2 expressed in CHO cells\"],[\"Inhibition of recombinant rat nNOS overexpressed in Escherichia coli using L-arginine as substrate assessed as nitric oxide formation measured for 60 secs by hemoglobin capture assay\"],[\"Inhibition of human recombinant COX-2 at 100 uM using arachidonic acid as substrate preincubated for 15 mins followed by substrate addition and measured after 5 mins by ADPH-based fluorescence assay relative to control\"],[\"Mean inhibitory concentration against human peroxisome proliferator-activated receptor delta; (not tested)\"],[\"Agonist activity at wild type TGR5 (unknown origin)\"],[\"Inhibition of rat testicular Steroid 17-alpha-hydroxylase\\u002f17,20 lyase\"],[\"Inhibition of recombinant human C-Src using KVEKIGEGTYGVV as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis\"],[\"Inhibition of norepinephrine uptake at human cloned NET\"],[\"Antagonistic activity at histamine 1 receptor (unknown origin) after 10 mins by FLIPR assay\"],[\"Agonist activity at human wild type ERbeta expressed in human HeLa cells co-expressing ERE assessed as transactivation activity by luciferase reporter gene assay\"],[\"Agonist activity at GR in HFF cells assessed as suppression of IL-1-induced IL-6 production\"],[\"Inhibition of mouse anti-DNP IgE-induced Lyn phosphorylation in rat RBL2H3 cells at 10 uM preincubated for 15 mins followed by mouse anti-DNP IgE stimulation and measured after 3 hrs by Western blot analysis\"],[\"Agonist activity at human HCA2 receptor expressed in Flp-In-293 cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins pre-incubated in presence of 5% BSA\"],[\"Inhibition of NEIL1 (unknown origin) using Sp\\u002fGh substrate incubated for 40 mins by TAMRA fluorescence-based assay\"],[\"Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide as substrate pre-incubated for 30 mins followed by substrate addition by absorbance method\"],[\"Inhibition of N-terminal GST-tagged human recombinant PDE2A assessed as substrate hydrolysis using cAMP as substrate at 10 uM after 30 mins by homogenous time-resolved fluorescence method\"],[\"Inhibition of SMAD3 (unknown origin) phosphorylation transfected in NIH3T3-pCAGA12-Luc cells cotransfected with firefly luciferase at 10 uM by CAGA-based luciferase reporter assay relative to control\"],[\"Inhibition of Candida albicans SC5314 CYP51 assessed as lanosterol composition of total sterols at 8 ug\\u002fml by GC-MS method (Rvb = 3.5 %)\"],[\"Inhibition of rat AKR1B4\"],[\"Inhibition of TNFalpha-induced IkappaBalpha (unknown origin) phosphorylation expressed in human HeLa cells pretreated 30 mins before TNFalpha addition measured up to 120 mins by ELISA in presence of proteasome inhibitor MG-132\"],[\"Inhibition of 5LOX in human PBMC by EIA assay\"],[\"Binding affinity to recombinant full-length N-terminal His-FLAG-tagged PRKD2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay\"],[\"Inhibition of human recombinant GST-tagged SIRT1 using acetylated HeLa histones substrate\"],[\"Inhibition of PI4KA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control\"],[\"Induction of HIF1alpha protein in human T47D cells under normoxic condition at 100 uM after 4 hrs by Western blot analysis in presence of 100 uM iron(2)\"],[\"Inhibition of PKAC-alpha (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control\"],[\"Activation of PKM2 in human U118MG cells assessed as inhibition of STAT3 protein expression at 1 to 2 uM after 24 hrs by Western blot analysis\"],[\"Binding affinity to KLK5 in human VCAP cells conditioned medium at 50 uM pre-incubated for 30 mins by activity-based probe based in-gel fluorescence assay\"],[\"Inhibition of c-terminal hexa-His tagged human S-COMT expressed in HEK293-6E cell membrane homogenate using 7,8-dihydroxy-4-methylcoumarin as substrate after 1 hr in presence of SAM by MTase glo methyltransferase assay\"],[\"In vitro percentage inhibition againstAcyl coenzyme A:cholesterol acyltransferase derived from rat adrenals\"],[\"Inhibition of mmLDL-stimulated acid sphingomyelinase in human PBMC lysates up to 10 uM preincubated for 30 mins followed by mmLDL stimulation measured after 4 hrs by YO-PRO-1\\u002fHoechst 33342 staining based assay\"],[\"Inhibition of Akt2 at 5 uM ATP\"],[\"Inhibition of Rac1 binding to DOCK2 (unknown origin) by ELISA\"],[\"Inhibition of HIV1 protease at 50 nM\"],[\"Substrate activity at pig brain GABA-AT assessed as formation of M5 in presence of PLP by LC-MS\\u002fMS analysis\"],[\"Inhibition of 3 nM recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation at 10 uM after 4 mins by ethidium bromide staining based agarose gel electrophoresis\"],[\"Inhibition of recombinant human N-terminal GST tagged AXL (473-end residues) expressed in baculovirus infected Sf9 cells at 1 uM by Z'-Lyte assay relative to control\"],[\"Binding affinity to human His6-tagged CBP (R1081 to G1197 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM after 30 mins by SYPRO orange dye based fluorescence assay\"],[\"Binding affinity to BRD4 containing BD2 bromodomains (unknown origin) by TR-FRET assay\"],[\"Inhibition of Mitogen-activated protein kinase p38 beta at 1 uM\"],[\"Inhibition of HIV1 protease after 48 hrs by micro-titer plate assay\"],[\"Reversal of human ABCC1-mediated multidrug resistance in HEK293\\u002fMRP1 cells assessed as fold-change in etoposide IC50 at 25 uM after 72 hrs by CCK8 relative to etoposide IC50\"],[\"Binding affinity to human BBOX in presence of Fe(II) by tryptophan fluorescence quenching binding assay\"],[\"Inhibition of MAO-B in bovine brain mitochondria fluorimetric method\"],[\"Inhibition of wild-type human partial length autoinhibited KIT (Y545 to D952 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control\"],[\"Inhibition of human FES at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP\"],[\"Inhibition of PHGDH in Carney patient derived cells assessed as suppression of de novo serine synthesis at 30 uM preincubated for 1 hr followed by 13C6-glucose addition measured after 2 hrs by gas chromatography-mass spectrometry relative to control\"],[\"Agonist activity at human PPARdelta by transactivation assay relative to fenofibric acid\"],[\"Inhibition of Trypanosoma cruzi trypanothione reductase after 5 mins pre-incubation with NADPH in presence of 100 uM TS2 substrate\"],[\"Inhibition of MKK6 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay\"],[\"Binding affinity to human MKNK1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT\"],[\"Inhibition of recombinant human HDAC3 after 15 mins by fluorescence assay\"],[\"Non competitive inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as enzyme Km at 21.37 uM preincubated for 10 mins followed by substrate addition measured after 20 mins by Lineweaver-Burk plot analysis (Rvb = 0.4 to 0.83 mM)\"],[\"Activity at human GPR14 receptor at 10 uM\"],[\"Inhibition of human ITK assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control\"],[\"Binding affinity to human partial length KIT L576P mutant (Y545 to D952 residues) expressed in bacterial expression system at 1 uM by Kinomescan method\"],[\"Binding affinity to human ERbeta LBD expressed in Escherichia coli BL21(DE3) after 2 hrs by fluorescence tracer coumestrol based competitive fluorometric binding assay relative to 17beta-estradiol\"],[\"Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control\"],[\"Agonist activity at mouse PPARdelta\"],[\"Agonist activity at human AChR alpha7 transfected in rat GH3 cells assessed as increase in calcium influx incubated for 1 hr by fluo-4 dye based assay\"],[\"Inhibition of human caspase 14 using Ac-WEHD-AMC fluorogenic peptide as substrate by fluorescence assay\"],[\"Inhibition of human delta-6 desaturase assessed as ratio of [14C]C18:3n-3 to [14C]C18:4n-3 at 10 uM\"],[\"Inhibition of human ACK1\"],[\"Inhibition of recombinant TS (unknown origin)\"],[\"Inhibition of recombinant human N-terminal His-tagged JAK2 (826 to 1132 residues) expressed in baculovirus expression system at 30 nM relative to control\"],[\"Inhibition of recombinant full-length human CaMK4 at 1 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control\"],[\"Inhibition of beef liver dihydrofolate reductase by hydrazone-linked conjugate of MTX (6 M\\u002fM of IgG) and rabbit IgG (NRG) in experiment 1\"],[\"M1  (h) CEREP screen\"],[\"Percent inhibition against human immunodeficiency virus 1 protease\"],[\"Inhibition of aldose reductase in rat lenses\"],[\"Inhibition of human FER catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay\"],[\"Inhibition of COX2 in LPS-stimulated human whole blood assessed as PGE2 production by enzyme immunoassay\"],[\"Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 mins\"],[\"Inhibition of short-form RON (unknown origin) expressed in human HeLa cells assessed as phosphorylated RON levels after 4 hrs\"],[\"Agonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling at 10 uM by fura 2-based digital epifluorescence microscopy\"],[\"Inhibition of human ERG expressed in HEK293 cells by whole cell electrophysiology assay\"]],\"hovertemplate\":\"x=%{x}\\u003cbr\\u003ey=%{y}\\u003cbr\\u003edescription=%{customdata[0]}\\u003cextra\\u003e\\u003c\\u002fextra\\u003e\",\"legendgroup\":\"\",\"marker\":{\"color\":\"#636efa\",\"symbol\":\"circle\",\"opacity\":0.3,\"size\":5},\"mode\":\"markers\",\"name\":\"\",\"showlegend\":false,\"x\":[8.89049,13.502791,11.261323,12.993777,5.4811974,10.734519,5.9807677,12.218024,14.933937,8.181944,9.169692,12.363746,12.9182205,8.633029,12.722812,10.0015955,11.339536,13.159538,10.848145,13.9953,13.87318,10.322967,5.5900807,7.692412,7.5879946,10.989406,10.803146,8.458716,12.149067,10.865914,8.308719,8.601519,13.351544,11.611484,10.349904,11.848139,6.6048427,10.697061,12.431976,9.676696,12.845479,8.930742,11.690316,14.2148695,10.215419,10.587282,10.794509,11.531433,6.9994955,10.180319,14.015312,14.138543,4.5652223,11.2055855,10.330689,10.928907,5.7355084,13.681635,10.838376,10.120327,5.553217,12.090944,13.232783,12.042186,12.327008,10.966803,6.031504,12.795061,6.440294,13.847661,12.043984,10.02006,12.947192,10.816316,13.881122,10.341709,13.247818,8.928488,9.539657,6.379974,10.687016,13.9016485,13.851657,6.3420377,5.2473125,9.451247,14.073228,6.0340157,5.5053554,9.015105,8.7929325,9.948794,13.179343,10.895962,6.59394,14.502613,10.310397,9.022883,10.413243,5.8433075,8.969496,12.364742,11.819252,9.279382,5.8874393,12.264837,13.040133,12.602143,6.0636635,13.304493,5.4284325,8.635735,6.0098386,5.1988835,6.5969577,13.02159,10.056375,12.527819,13.522631,5.9001336,9.807183,14.407102,6.0770383,13.79169,10.748566,10.420627,14.697333,8.912548,9.774024,9.969111,10.058352,12.905283,6.7023983,12.970971,12.152229,12.915255,9.509648,8.351597,8.540705,10.700916,10.655331,12.798434,5.9152784,8.697377,10.762603,8.651325,10.808541,8.817984,13.182229,9.478339,12.68612,10.384528,8.27941,13.749333,11.50034,8.506649,6.3212676,9.458384,8.752667,7.6571765,8.847778,12.952249,8.543286,10.391306,8.869157,8.700596,11.2196045,12.806885,8.050963,10.623615,8.926655,11.79585,10.473244,14.654924,10.865634,12.9867115,11.033841,6.357255,6.9712725,14.052499,12.1087675,10.576892,9.73167,10.435372,14.449554,6.0490522,5.41489,5.9416265,6.1385036,12.267787,9.3127365,8.063902,5.9199576,13.348272,9.341046,5.6318984,8.870703,5.9529357,8.275825,12.829603,8.725169,12.574197,12.662703,7.5981154,12.942432,13.403175,8.706453,6.848241,8.771557,10.989388,13.900892,10.948906,8.606133,11.402788,8.724717,5.7393737,14.25598,10.880758,11.729419,7.7267966,10.07987,13.505799,4.4508333,9.333304,12.421593,5.8377895,7.384136,14.191875,11.2721815,5.760244,10.854565,13.876643,13.888355,12.880664,6.265579,11.323339,11.99084,11.561697,10.0737915,12.9542885,10.969306,10.187967,5.5266647,11.307732,9.352583,9.226694,9.084303,9.643962,12.824478,13.011805,8.585251,8.304617,12.856362,7.6281815,7.3418016,8.3884535,6.138975,7.330496,10.950611,9.380838,8.895736,12.84043,10.3547735,11.165629,9.43851,9.344751,7.512734,13.081393,13.262177,10.005973,13.004331,8.717958,9.166445,12.798981,8.007608,10.580082,13.444109,13.002539,9.867871,14.821729,7.057102,5.8878646,13.919973,8.562379,6.3525143,9.252952,12.113851,5.9821043,8.884022,10.251422,11.162491,10.140543,6.9344177,13.529567,10.397808,14.405039,10.793335,12.812343,13.62082,12.24529,6.1747274,12.784124,14.053816,12.305109,8.709918,8.639369,12.53638,6.4340615,11.171078,10.0710535,12.950558,10.986767,12.333424,6.0824633,10.856397,13.43738,11.724629,10.508854,13.571663,8.7878895,12.872062,13.311886,9.007258,13.257134,13.98221,12.886454,8.238991,9.915583,10.677087,13.957372,12.265328,5.8281775,8.129785,8.462488,9.749306,5.994276,10.433041,14.068393,5.739095,10.045337,13.860969,12.57983,13.508441,10.393196,14.224575,12.318498,5.536362,9.84612,11.107372,5.610722,8.486077,14.266042,11.108107,9.714361,11.36783,5.1334376,10.618194,9.641302,7.5082507,13.000436,8.462748,9.586594,12.652879,12.998141,12.055151,10.630771,8.523453,11.622817,4.4790273,6.2913523,12.824454,12.710585,10.760474,9.310633,13.515403,11.340315,13.124368,4.835774,14.76553,12.772595,12.570413,9.463298,5.4575987,14.089815,11.130512,9.790267,7.90288,11.293665,6.984208,4.7770095,11.40039,12.740934,6.810425,5.862643,5.8495936,12.407587,13.117206,12.960818,10.482964,10.080287,13.563538,8.664112,10.353119,8.581578,11.875501,9.767228,11.628259,10.307673,10.646009,8.645289,9.573853,9.380149,14.641938,6.0257998,11.933123,10.190663,6.3530197,8.725245,12.234585,11.160584,14.1537485,10.669404,6.9478927,13.299275,4.828676,10.587267,10.815238,6.3228526,10.430142,11.206263,12.0841675,13.758305,7.1125774,5.505114,8.829134,9.236128,12.387218,5.854522,12.997831,11.165662,12.656926,9.348998,8.311715,9.936545,12.311902,5.2939243,12.665808,7.94941,11.170502,12.312456,10.370674,11.890597,10.044681,12.31106,9.549331,8.085553,10.847934,13.483245,11.217579,8.17702,8.949633,8.54835,10.856813,8.457239,5.052024,7.7931976,10.940034,9.069229,12.440666,13.258803,11.002942,6.124652,12.212831,7.3036456,10.355346,9.397784,6.9688616,8.35191,10.148339,5.4390492,8.286582,5.4759917,11.917231,5.2570467,13.124896,11.129654,10.360481,8.771428,10.027886,9.241308,9.730865,12.567529,13.282909,12.70693,4.9974923,13.152211,10.287661,9.927429,11.131976,9.203492,12.525284,12.4248905,11.956443,8.157927,5.644657,12.888396,7.2394886,10.322482,9.587495,5.9797587,9.15355,12.249251,11.795192,10.127114,9.299998,5.0624437,10.834742,13.870818,11.347847,13.660757,14.208596,13.078055,12.89236,12.739795,6.0936065,8.789636,8.725032,12.953919,12.231137,12.327065,10.598824,9.655612,13.164659,14.4690485,8.606688,14.341367,13.723846,13.025136,11.596146,14.041907,6.0148234,13.447153,13.469472,9.169891,10.724519,14.325388,10.422236,12.658708,8.462162,13.061264,13.791153,4.7909317,9.815484,13.903971,9.929908,8.876928,14.245122,10.85149,11.5007305,9.26572,13.701017,6.933332,9.207781,8.764086,10.93607,10.036759,13.256385,10.20798,14.020837,14.884844,14.698076,10.064597,9.191026,6.1185427,9.118428,7.4946375,12.295182,12.456855,8.423278,9.875449,8.542081,13.3542185,8.49169,12.437902,8.458794,6.3093433,8.77033,14.089047,14.696287,6.7180996,11.912365,9.734519,9.97193,11.857074,6.2065544,5.4970846,8.615847,13.273603,10.6228695,7.775203,6.186579,8.40676,7.745712,13.793596,9.317143,11.986878,5.9925833,13.476086,10.280334,10.419111,8.859227,10.286998,12.712505,12.162727,12.504043,9.701039,13.3874035,13.776999,9.56961,12.615751,13.541325,9.440319,12.593068,10.058439,10.075702,12.750335,10.568363,14.370687,10.163737,4.7608547,8.495494,14.453998,9.108894,10.316901,9.348216,5.2957373,8.201016,14.182353,8.751847,9.338815,13.866336,9.950715,12.47771,13.324784,9.874589,14.297346,9.44448,10.034997,14.249123,10.227153,9.410674,8.297756,12.509513,12.938852,12.325745,5.9443464,10.136249,6.5953994,9.030478,12.668925,6.8671193,12.734712,14.264509,12.765657,6.981997,13.03768,8.356721,5.9916697,13.21707,6.2042685,9.446172,14.040795,8.368665,8.862706,9.510687,10.844871,10.009248,14.678371,13.975206,6.236906,6.089634,11.601636,10.000594,11.34943,13.44459,12.57916,8.705635,5.313451,14.208861,14.823657,6.227095,11.008335,13.346001,12.35875,10.242255,6.6021056,11.098579,13.228406,12.931521,10.195406,9.529159,10.623131,7.9828978,8.802522,12.230524,10.738142,13.1658125,8.592265,5.886284,8.491915,14.000792,8.979452,11.434345,7.628665,9.225523,7.602024,12.2143135,13.363014,12.35341,6.276554,12.980175,10.010938,9.283831,11.05624,11.800202,6.963961,13.881608,13.125355,12.22305,14.129512,8.372671,12.52941,14.716829,13.202624,13.535043,8.966609,8.61108,6.807041,10.669921,9.38131,9.543622,10.396066,7.663359,10.441986,11.580984,9.368242,14.967348,14.753743,14.037631,10.516866,9.18713,13.043978,13.800198,9.855305,12.543572,6.046889,6.0241213,7.8951845,12.557965,6.200535,13.898872,7.0820975,7.472154,10.2933235,11.42773,5.463979,12.414981,5.749444,9.327771,5.414864,12.753285,8.150556,6.887067,13.373855,11.749127,6.018159,9.093208,13.102806,12.501503,12.847917,12.079133,8.681632,6.706098,6.188735,12.305458,12.326579,12.955997,8.524308,9.201152,12.556434,7.7095428,13.15682,7.521306,11.78349,9.266982,4.770723,8.292195,9.768687,5.6233344,12.359472,11.951684,12.923132,10.465712,13.480394,6.183962,5.574991,9.666211,9.797205,10.536193,5.445289,8.882514,9.784186,14.467222,10.472627,5.8941145,9.3516035,11.548552,8.476694,12.241604,10.757823,5.9420757,10.29734,13.152197,8.012235,10.889399,13.027352,13.901706,14.939098,8.319608,5.630909,13.361235,11.548636,12.868709,8.517907,12.84634,13.72393,4.847676,8.562981,12.952117,14.478427,5.4769964,10.740347,8.60862,5.269623,12.4054365,10.134753,7.7183375,12.2665205,13.105733,7.4566464,14.350255,8.654483,13.692287,10.550784,10.312808,8.116692,4.510978,10.9679,9.014092,9.966741,7.876645,8.629705,10.107985,7.7032356,12.464313,10.66498,9.210297,13.321817,11.533206,14.384046,12.35521,13.059877,12.011827,14.981731,12.388959,6.324439,11.304537,12.591725,8.593702,10.834419,13.7713175,8.895091,9.631381,9.424972,9.357933,9.354449,8.230902,13.084949,10.654237,6.4651556,7.284513,14.029927,6.395081,13.594683,6.8369913,12.102105,10.818176,6.1225643,11.628949,7.7749424,9.409181,10.317359,12.861822,13.272578,8.850649,12.076554,4.48655,11.8558235,8.742804,9.539107,13.614168,10.294945,13.48961,14.784418,5.822312,11.289041,12.897425,10.506958,8.577923,7.758892,5.2735114,14.1659155,12.627856,10.382699,14.896075,9.725428,11.464689,9.998584,12.962321,13.276719,14.223071,8.44527,9.471795,10.422507,12.265981,11.979337,8.223387,5.718812,5.4172935,10.188814,8.437842,9.008279,6.8900003,10.093083,9.980265,12.603232,14.344689,6.0470233,6.3517084,12.766488,10.162656,12.675589,10.4654665,10.108181,12.876077,8.697393,6.0950513,6.757742,9.644432,10.343182,8.761328,9.788525,10.585636,6.081628,8.17837,12.319302,10.790774,13.632095,11.335189,9.395275,10.323905,10.346675,11.28409,10.444955,12.915381,12.736249,13.340995,8.042698,10.008638,11.572744,13.544889,6.612786,13.025968,6.3160157,12.840312,12.439657,14.485061,14.631784,6.997327,10.492059,11.682484,13.712981,8.839067,6.1798177,11.400016,10.615124,12.875459,5.449991,10.067547,8.979947,14.5759115,11.66056,13.059995,11.463615,6.0755997,13.247753,10.329619,5.700491,8.790135,6.3649106,5.302923,10.48608,12.878913,9.570483,10.964365,13.664936,13.994323,12.653566,12.962547,10.727021,9.997772,12.197705,13.499557,10.810787,12.659724,8.774997,14.282765,8.60343,6.41416,4.8625827,12.008049,8.98684,11.773812,9.808806,10.216028,11.746427,14.069858,12.88765,5.901577,10.14512,5.3230476,10.690788,13.951924,13.973983,9.319063,6.2816467,10.630238,5.895908,8.416694,12.4407625,8.53415,9.85568,9.465997,8.748828,11.2166195,13.323816,14.327166,9.663137,9.276955,13.492327,9.85926,9.328506,12.210943,14.330445,9.254101,12.392088,9.282161,12.387483,13.595653,10.335564,13.850262,10.358879,12.911947,11.372509,13.835271,5.879217,7.252887,7.7401032,12.716737,5.4433417,10.947974,10.830252,8.63024,13.9538965,13.425755,13.436755,13.657215,10.973144,6.605226,9.245469,14.05568,14.138781,12.229412,12.72257,9.1213,13.224683,11.54712,9.272406,13.484151,11.18541,9.297377,13.584669,9.084961,9.441908,8.300483,13.554316,11.000723,8.6018715,5.438423,5.2964025,12.271275,7.40178,12.483368,10.636431,4.8331814,10.963405,13.503522,13.289067,6.8187957,8.721198,13.196847,11.7941265,10.130343,6.075583,13.978061,13.439205,10.547134,8.432691,6.2300386,14.248558,11.256934,8.288558,9.513157,13.702631,12.910989,12.230474,8.716856,12.717502,13.113448,14.127635,13.456443,9.926617,5.5997043,7.514093,14.017423,7.8102694,8.59541,5.8623705,9.585424,6.807126,8.555988,10.254278,9.392148,13.872185,10.463539,12.533925,9.834689,5.934131,8.576532,13.511731,6.9018817,8.285592,8.503169,9.037546,6.058683,11.390255,8.593906,11.266088,9.394516,10.084816,9.276584,13.109742,13.167931,12.79188,8.307715,5.9869576,6.4129305,8.254789,9.586453,9.113209,9.958695,11.2234955,8.6854315,13.881606,13.566587,6.1251183,12.271616,13.369874,13.954909,14.74746,12.68365,11.118635,11.772615,11.76263,6.4613547,11.862654,8.350362,10.304755,11.950322,11.408772,10.629877,9.300977,4.434105,6.1479917,14.424339,6.0280685,6.9002576,6.12721,6.503479,4.5035496,11.122812,10.385943,12.544062,10.327316,6.980474,5.4315205,13.585327,12.528171,9.206133,9.862016,10.980499,10.395675,12.85327,7.901978,6.2252154,10.152336,6.3679175,13.126227,10.537968,7.8957863,12.421613,9.046025,12.423348,5.709945,10.382595,13.207115,12.848763,8.052129,8.944388,10.244293,12.192434,10.476145,8.050984,5.898693,12.506666,10.921421,13.249463,10.8942995,13.978862,11.340511,8.723854,10.128708,8.194785,11.152231,6.2606745,6.55787,10.855352,6.2897873,6.583006,10.344176,12.534318,9.309907,11.5717,13.354508,4.373136,10.284173,11.873542,5.463615,6.036635,12.407625,8.525664,5.957751,9.327913,12.074071,14.274255,10.830116,12.930617,8.80341,11.8850155,12.932866,13.913058,6.2360435,11.548944,9.950425,10.208225,12.310523,10.41358,11.206708,8.46358,7.744618,12.990562,14.739117,8.843679,8.590982,5.951107,9.210149,4.6251655,10.592789,13.701895,12.093081,8.868912,5.550713,11.839882,13.751459,8.363794,8.550867,8.1637945,5.7776875,14.236706,6.5982337,9.150691,6.08572,13.008126,14.828098,8.697912,7.516248,13.042102,9.526858,8.177558,8.59179,12.659292,11.817166,14.7895,8.328788,14.233612,6.339747,7.151911,8.430869,11.676927,8.287013,13.565167,12.410051,5.567296,7.7488976,13.393198,12.390716,10.5865755,14.194317,10.529409,6.0162773,8.943369,7.405196,8.923634,8.514359,11.90904,10.859899,12.2078495,10.330742,6.1332517,8.561914,10.889902,9.562586,6.923563,7.0598803,6.149789,11.569935,10.775181,10.10715,7.538553,5.9850383,10.77373,6.269339,9.255275,11.648659,8.855402,12.466078,14.001585,12.874524,13.593239,10.691154,5.471521,13.536788,14.219737,9.34635,13.37829,8.799501,12.381088,11.936041,10.304702,12.100229,10.354711,13.810134,6.0537195,14.506856,8.920624,8.651586,9.795499,6.1460724,12.990347,13.232996,14.535462,13.510093,8.655296,7.0061507,6.1169157,9.2536125,9.8238325,13.542925,14.213979,8.829396,8.879663,9.842965,7.9765773,6.151709,9.320878,14.761026,6.3129783,9.415747,10.78433,6.0855503,7.1588774,6.0731254,8.487179,5.619175,8.675621,10.19641,6.421249,7.2251015,9.735994,6.9269643,14.578923,9.519585,13.473182,5.565531,13.155192,13.10392,12.882763,6.673359,8.519141,13.07468,12.180375,12.144262,14.692612,9.5938835,12.882097,11.114184,9.582698,13.146803,6.4018464,7.393792,9.048098,11.04542,11.015575,9.006055,10.482552,12.361064,12.090804,14.2565,12.90863,8.350348,9.449245,10.24055,10.3094015,7.532151,7.2492237,7.1061172,11.182715,11.222783,12.754323,10.047864,14.090451,8.534763,11.901036,9.311657,14.778072,5.89077,5.993315,13.830255,7.9204836,8.315675,7.675002,10.54746,8.167014,13.668134,14.0931,10.161897,9.658324,7.3618994,14.465269,9.411914,13.188509,10.036952,12.187926,6.558114,5.945198,10.817909,13.187671,13.756093,8.877485,8.962674,8.218626,10.6003,10.983579,6.3693533,9.752394,14.042651,13.054015,8.643026,10.009968,9.922839,6.949993,5.4813943,10.515292,9.052831,13.209721,12.825433,11.332485,12.142098,8.907111,13.956636,13.526017,12.356798,8.663695,9.94814,8.338183,10.842726,10.559994,10.585684,6.083377,13.02702,10.952623,10.214835,9.218492,6.256722,6.218709,6.9690714,9.824016,14.80878,10.460465,8.625534,5.001849,9.479049,14.607494,14.001185,12.655554,12.563979,12.146515,13.613884,11.150816,8.266962,12.893938,10.733309,13.770894,9.220239,9.279553,10.207354,12.102082,11.453877,8.312164,13.591697,6.222348,12.22229,5.281937,6.1218762,8.312065,10.447357,8.470212,11.755093,13.826636,6.220664,13.614732,14.745672,12.258228,9.999827,10.774434,13.904523,12.823068,9.102581,12.8953,6.3384857,10.855266,9.673065,10.390818,7.5768685,8.563964,5.538117,13.2610445,10.29505,7.154572,8.654829,10.089988,8.5714655,9.357277,10.300939,13.450204,13.791455,6.3536963,10.272505,5.9413905,9.077505,10.385011,11.212592,10.118025,7.198755,6.646061,6.894199,13.156819,13.259554,9.372184,13.667935,10.727037,5.730959,10.137598,13.47254,10.447139,8.487848,12.983119,10.355246,6.6041365,5.6672773,11.494169,13.729038,8.651384,8.742776,5.9210577,9.553589,13.308714,12.294302,11.093409,6.335097,9.918387,5.9476113,13.226972,14.306002,6.0906396,9.438675,12.462303,10.031972,11.210247,13.838285,10.577365,8.4648695,13.317608,9.993035,14.457204,6.0654945,11.330937,9.441479,6.949595,5.972816,13.367018,8.536514,10.457791,13.169659,9.160255,14.398018,9.213833,10.988999,8.61064,11.426327,14.293517,10.317265,11.086302,6.387545,4.828908,12.955098,4.9130235,12.428921,6.3072605,14.591928,12.958855,5.3978076,13.50469,12.62235,5.8528085,9.835335,6.036278,5.9055533,5.514046,13.325478,5.501392,12.375938,7.0128307,9.193979,13.404758,9.069838,7.2770433,12.627916,14.121063,8.685388,4.497859,8.79449,9.028278,11.323438,5.534704,12.690463,9.163745,13.136751,10.874963,6.8341985,14.204465,8.230661,6.610896,13.009596,7.431598,8.664955,10.579697,9.254156,5.37955,9.813926,12.784436,7.430351,9.904451,9.763811,8.552965,13.931287,9.149424,13.2467575,12.122834,14.199422,7.0442123,6.683154,6.942891,11.167947,12.390229,11.709755,12.56052,8.750261,13.016007,5.918074,14.6344595,10.350715,8.2768955,11.444549,10.769737,14.234924,7.0149584,8.435912,5.4494777,6.3704467,8.697142,6.1675787,9.1686325,7.6832075,6.8782816,12.626283,13.935026,6.443599,12.514291,9.820869,9.349671,13.3516,12.184241,9.396026,10.06918,10.99567,14.973421,13.249891,7.725912,9.841545,8.2047205,5.16772,9.91811,11.248437,8.241343,12.033345,14.350021,14.125338,10.628756,13.942959,6.2387733,11.372969,8.666926,10.17701,10.572589,10.822043,8.05695,8.39885,13.306717,10.686949,11.514629,13.950882,10.820806,10.729456,10.312252,8.640118,6.1176667,13.768076,13.279114,14.078083,11.29386,8.070138,13.52785,13.039096,6.324895,5.484772,13.140236,12.689187,13.275055,14.050944,13.325925,12.351483,9.249995,13.428919,8.625206,13.542032,7.0450926,13.931738,14.168754,8.359684,10.226649,13.197022,7.0528083,10.333791,5.7700615,10.85636,10.234834,9.148019,12.090559,10.613308,13.037804,6.181668,6.3984327,14.316707,13.170247,11.079595,14.067668,10.131544,6.321761,13.428837,10.363967,12.312229,12.306562,8.553169,13.588091,13.445841,14.811039,12.711947,12.99275,11.967703,11.35626,12.568621,4.955127,14.001909,13.104271,12.710371,9.156291,8.349752,9.466094,9.2130575,14.318315,8.9051485,5.4761834,10.421422,10.871548,8.576043,11.142841,9.339591,8.826576,9.788073,9.30737,5.898822,12.289817,13.282028,12.5514765,8.135849,14.296337,14.282477,9.697009,5.7569356,12.048141,9.872017,10.6903305,12.607055,9.858901,7.656715,8.037356,12.921023,5.7949495,10.842755,11.140912,9.808551,11.490857,12.538086,13.186656,6.1447463,12.227776,10.96608,11.049103,9.4256,13.65292,13.277578,13.353841,10.858829,8.574062,11.584629,10.904136,7.3749967,8.57296,8.206556,11.102274,9.723634,6.556497,12.255274,10.617108,7.2580957,8.754412,7.790442,9.773332,13.933524,13.214714,7.0804205,7.2416024,8.245536,13.091231,11.338718,13.2382145,6.010955,8.622213,13.120151,11.017027,10.8891735,8.078147,6.0148907,9.494763,6.326788,13.623681,10.174104,13.282303,7.2540455,5.8381166,10.143649,14.716812,13.037829,13.757832,13.055067,13.08018,6.019101,9.9456835,13.693098,12.460902,10.0827875,8.522006,9.582169,6.594078,7.7346363,8.892374,12.898031,6.947497,12.334773,10.64929,13.932723,11.22664,13.729284,12.257197,11.179723,6.2050266,6.692425,5.8455524,11.603422,13.0767,7.7141976,9.479331,10.483745,13.130717,10.928237,6.2087045,10.35922,6.2942843,5.8984785,10.627626,10.544274,10.645239,8.333553,12.393658,10.420292,11.623787,9.847922,6.0860004,13.991808,6.686295,10.463007,12.8859415,8.554649,9.2666235,6.1353793,6.5726094,9.82508,12.295002,8.67076,10.355724,10.189228,14.02964,10.064947,8.304372,10.011897,10.828804,10.837125,10.71119,4.9252553,13.915932,10.743121,14.020286,12.363757,9.386039,13.288941,13.0808,6.130422,10.217327,9.348819,10.72119,9.951702,10.491056,6.746784,8.147312,10.330949,10.2472725,9.987872,9.727332,10.241194,11.338511,8.722996,12.8934765,7.033134,5.952889,12.743854,10.624985,7.365351,10.759014,9.607234,10.259347,14.074818,12.961507,10.208284,10.320923,8.162346,9.198982,11.573281,12.57405,5.642807,6.0897894,14.368593,8.642327,10.169513,9.404145,13.98424,10.137778,5.478865,8.090927,12.493073,5.5421977,7.423785,14.639379,13.827975,12.180908,10.9306135,8.357723,6.6311655,14.283466,13.186438,9.993362,12.43841,6.038298,10.530257,9.19648,8.038495,6.8972635,13.120409,13.263294,7.4416866,8.047498,6.2305493,9.542792,10.846356,8.916364,8.355875,4.4378505,5.5698333,9.667629,6.087939,13.651597,7.0611153,8.858137,6.5229926,6.4487624,8.908531,8.600592,8.289458,12.722913,12.481204,12.329288,11.59299,5.464222,13.276473,14.163286,13.05434,12.337256,12.619441,8.448934,5.87892,14.327794,13.152356,7.7289844,10.816925,12.982003,8.619608,13.8166,13.553698,13.499442,10.141399,5.922051,12.633884,12.642727,6.5999,14.560995,10.536434,11.304137,8.819098,13.315708,6.191458,10.165788,10.553777,7.311461,7.051545,5.867943,6.0015554,8.801902,12.680683,11.589536,8.673087,10.748219,13.9556,5.9831862,12.140968,13.6847515,8.693072,5.033381,5.582775,13.998173,10.408825,13.37242,13.932295,9.737989,10.407299,12.591177,14.400318,14.419712,12.05071,12.647218,7.616096,7.7546096,10.746795,6.9394355,9.116473,13.131503,10.374054,10.08987,10.957685,10.370655,6.872632,13.848605,9.652603,13.905246,13.461993,8.437345,9.770117,10.044929,8.155868,9.633231,9.54103,12.51556,7.9171953,13.714683,5.057139,6.232056,13.937242,12.0587635,11.027427,7.311788,13.145379,13.395374,10.229527,12.415389,9.899758,8.384354,9.557217,8.700037,10.852335,7.567229,5.44814,8.420332,9.249576,7.8833513,12.17469,6.346304,14.136909,8.173179,8.621849,13.506178,12.034561,9.250679,14.748174,5.6655526,12.420423,5.459183,13.7913685,12.265565,9.4197235,11.726047,13.248185,7.1092124,9.851023,13.076627,9.244893,9.561608,13.49369,6.1082473,10.1446295,12.797443,11.172941,9.238039,8.021054,8.164936,12.348165,6.191599,10.750962,10.375677,13.935919,13.909089,6.8733892,12.511047,12.583422,10.975031,14.187287,8.7191725,14.123967,12.5138855,9.154942,8.580183,10.001295,10.189853,6.0157204,8.614849,12.650402,13.725251,14.078398,13.719308,13.28345,11.37534,6.0727406,10.59397,12.045584,12.41541,6.814931,12.648012,11.3626795,4.8915334,13.67708,7.977197,14.155334,9.169519,12.332397,8.802504,9.615681,12.325095,9.207054,10.47405,14.969806,11.31027,7.5066175,9.726489,13.53668,4.4656115,10.550246,11.151113,13.260769,12.813673,13.693929,12.802557,6.0563574,9.524009,8.19228,14.965759,9.637403,8.525767,13.626015,10.167202,8.638414,13.05676,6.9967923,13.9198065,9.183283,12.976189,11.260025,9.688421,6.611294,6.294611,7.688162,13.062812,10.29862,5.9252343,9.891641,13.735971,12.074508,11.032636,13.338133,12.92348,9.772701,10.641265,7.651986,14.203789,5.799151,12.140684,7.568845,14.389423,11.795258,5.6567802,14.040988,13.103618,8.753387,6.18456,14.041267,13.372519,9.087006,12.071138,9.215918,11.228868,11.672485,10.124526,9.957911,13.929459,13.795371,6.625672,13.8847,11.585936,8.58681,12.795166,13.5313225,9.08445,10.821735,9.310966,8.650799,13.183216,9.765309,6.0332913,5.536351,14.265966,13.825159,8.2027025,6.121148,11.249643,12.175879,12.09278,14.666832,13.405778,14.145915,13.188889,6.2391386,7.445738,9.032573,13.856365,5.896298,13.745658,10.367902,10.542909,8.168474,7.008222,7.790492,11.1279,9.067898,8.294143,13.600831,8.01792,13.998896,9.49738,12.356808,8.900884,10.34687,8.599007,9.902713,14.810556,13.979415,14.108814,9.393309,14.1270685,13.520596,11.306018,9.112871,10.856487,6.8480215,9.298657,11.254882,10.358197,10.971721,9.363148,13.114204,5.8705525,7.510132,8.57702,5.486317,14.380914,14.396683,14.69913,13.38882,11.24877,4.3889875,7.140168,12.895855,10.622412,6.1112385,6.9433465,13.387484,6.245299,9.335236,7.515529,10.758856,13.641227,5.9316983,9.019765,6.3798122,8.387077,6.2651324,13.157827,10.011601,13.557316,13.395754,6.4702735,13.760316,14.168187,10.538258,10.209252,5.880794,12.355163,12.22832,9.573619,10.283158,9.163746,7.3811917,8.577185,9.364736,8.658773,9.516488,8.390416,7.299525,12.457096,9.384876,10.242871,8.80805,14.772519,4.411879,9.143016,13.953526,13.9148855,12.309963,5.550008,12.195731,5.8400917,13.020495,12.231817,12.27381,5.8983693,10.852765,8.700721,14.06258,13.227837,8.534396,5.943404,10.179185,12.847359,10.468291,5.909907,10.085848,13.165367,8.838404,9.046651,6.5671425,8.820155,8.702795,7.382187,12.742799,5.9530582,6.214302,5.967927,6.145759,10.922178,12.068207,12.568289,12.434378,14.125961,5.7711997,9.621757,14.733219,11.030068,12.664141,12.042545,9.994727,14.7508955,13.185116,9.09789,12.988441,8.565595,9.108598,13.843895,12.205653,5.777182,7.984013,10.427179,12.076407,7.340004,8.50625,7.870612,11.485498,10.281511,5.0517073,13.497708,12.559963,10.310698,12.834671,8.766456,12.219955,13.1754055,8.820196,13.482836,13.979304,14.126881,13.439543,13.15059,11.1654215,8.732469,9.002767,10.200247,10.599436,5.991748,9.740668,7.1993265,13.828037,10.548091,4.833705,9.569342,12.046296,10.390563,12.164256,4.4499073,5.780372,6.3357577,6.3326907,10.353837,12.4420805,8.919251,7.009775,8.834424,6.0643277,12.873262,9.0322695,7.0117764,6.7851186,11.237323,9.039392,12.538448,9.458819,8.576647,11.328719,10.240367,12.301213,13.208357,9.614959,9.025583,10.205428,10.943475,14.054925,8.417353,9.929726,12.131726,9.653534,10.22026,13.680128,10.2718725,14.769725,6.0528398,7.227676,8.322401,11.713201,10.485913,13.294104,5.9211006,12.0960655,8.364752,8.339823,13.640016,13.001383,11.0425005,11.073244,7.512805,9.582287,14.445952,12.732116,11.6412945,12.750859,13.833434,13.067964,12.537125,8.607804,8.76469,14.623709,8.976241,13.189535,9.713174,6.9535604,12.6305065,7.461473,12.7065325,6.117656,9.761517,12.651624,6.017893,12.363187,5.056968,6.0388837,10.429773,8.688487,14.712446,10.275958,6.920521,6.098533,12.964098,10.116626,10.411926,12.936731,10.936171,10.721801,11.166555,5.9078345,5.947357,12.413905,11.462336,13.987836,14.267226,11.339243,11.937786,5.9086924,7.454654,14.5204315,12.758036,12.430009,12.212817,11.481415,5.9079676,12.46546,14.500101,5.389459,13.041486,14.08764,6.1078224,13.198319,11.271934,12.676348,6.53047,10.429862,4.569085,11.628269,9.810271,10.096231,13.650054,8.389065,13.872369,10.541251,10.990677,7.3243876,14.194621,12.833966,13.361406,6.3386703,10.756823,12.799655,13.974424,9.482131,7.6845326,12.661066,6.339648,9.516719,13.2160425,10.143591,12.909693,10.639424,14.762641,8.218447,13.598233,10.117041,9.473003,13.0266285,14.054448,6.1309705,12.122985,12.287199,14.729972,5.58737,13.270138,12.371813,13.910761,7.5209155,7.0372343,6.2008104,12.416904,11.172563,8.853386,6.03299,13.181361,12.136949,9.080093,12.852954,12.920136,10.41042,10.956383,8.366018,5.9071946,9.961804,9.301118,12.87897,8.51403,10.050241,10.666409,5.648298,5.5922227,6.346901,9.773116,11.248828,4.4124885,8.321079,13.357756,13.207145,13.128098,8.822546,10.149459,11.500424,13.067121,14.052534,13.608344,10.947862,10.980682,11.184983,12.128364,9.601621,9.785239,5.0615396,10.154734,9.251212,7.6769557,6.0025735,8.879136,12.066402,14.303042,6.131336,11.292863,10.069073,7.363618,13.049938,13.684858,10.518988,14.192952,14.4465885,6.6300335,6.611204,7.0365605,5.963114,8.962014,9.917301,12.278064,10.358987,10.343135,11.241495,7.605764,13.913509,10.000392,14.370871,8.626462,9.213671,14.263604,13.434708,12.67558,10.081462,12.458673,9.595811,8.183087,6.0273848,6.269771,13.433258,8.139249,14.560343,12.144821,8.050495,14.13624,12.93028,13.48654,14.060185,7.521905,12.31671,5.45972,12.966193,10.78208,6.0735607,13.738835,5.46819,10.4792,10.560261,9.000848,12.179617,13.454839,10.936467,4.6068244,9.458638,12.532127,6.5905128,5.7865663,8.843547,9.974263,8.809645,6.9947753,12.912861,13.337353,9.857733,10.527773,13.074298,9.50261,7.87955,8.686119,12.455697,8.9568815,10.284886,12.156195,8.142868,10.020364,9.281224,10.838746,8.6530075,14.116453,12.755839,14.070799,8.327694,10.500509,13.31295,9.28943,12.659095,8.542149,13.460526,14.14028,4.9041357,14.368605,13.272706,13.713562,10.043358,8.932304,9.335477,6.9667215,9.500477,5.980794,8.687685,10.176186,10.285599,5.8252864,6.439797,13.145823,14.678381,14.338792,9.252488,9.175819,10.9188,8.378262,11.007494,5.87954,10.796621,12.248394,10.986769,13.623526,12.656086,9.495049,12.284683,13.199607,5.3554506,13.260199,4.9732375,7.4892507,11.241048,13.537827,5.457726,6.3946767,13.981845,5.4668803,10.137156,11.323144,10.830833,13.673649,6.13575,13.89018,12.264187,14.46941,10.996233,12.436675,8.068476,9.202102,10.0388565,8.507417,7.399167,8.763061,12.321944,6.2643466,13.268273,13.802585,12.972304,12.438521,10.472055,9.572638,13.278173,13.727487,9.756978,9.505656,4.9963365,5.9201345,8.335716,14.116591,9.746048,8.300657,9.820922,10.798733,13.325703,5.697006,8.560563,9.444954,10.508947,7.8133206,6.225002,6.063865,10.91658,7.7350307,9.425097,9.620383,8.600878,6.957953,8.681613,10.197973,6.2625093,13.724724,10.151526,7.658912,8.519164,14.145727,8.973664,10.821343,10.732515,12.346018,13.9038515,5.528618,8.1234255,13.583743,8.453801,14.3150425,12.88853,13.937082,8.417042,14.702066,11.335497,8.870897,10.908199,12.403076,10.052024,6.973529,13.401743,12.919868,8.934683,13.942135,6.2239137,5.7404194,14.054659,7.7632685,5.438351,6.305433,12.381515,10.435533,12.643628,5.9001317,8.552879,11.258092,13.864168,11.082827,10.239197,9.956624,10.097714,13.132067,8.3218775,9.763581,12.748441,6.019938,5.8185253,13.482084,8.615041,11.706061,8.468395,13.384187,12.69704,6.5934625,8.89201,10.972431,12.259112,9.082441,11.000499,10.653643,6.9695625,9.49464,5.962553,14.467632,10.992032,4.4169054,12.74266,8.457997,10.512598,13.6441965,10.857939,8.550203,13.778664,14.679761,12.561371,7.315938,7.611042,13.243647,9.050368,10.57814,13.363051,6.6273785,8.890723,5.456087,10.023257,10.853408,10.249539,10.478865,10.241524,8.54817,6.1099215,13.124075,8.730429,9.1476755,5.5706577,8.146906,12.288531,14.189902,13.576491,6.846697,8.2515135,7.3879323,11.162784,10.866059,6.9172893,11.267458,14.020931,10.165385,5.7534523,7.4965186,13.148023,12.829248,12.236147,9.882584,13.404401,12.605486,7.365784,13.178265,10.533397,13.742962,9.944597,12.188775,14.450803,13.428563,11.007036,6.332085,11.596759,6.9957833,11.3307295,13.385159,9.809261,9.977692,11.618125,13.976332,6.725265,8.866584,10.896245,14.3039875,9.581389,10.30075,6.2729244,10.084057,12.751719,9.682019,13.922195,12.545804,9.144044,12.2026,13.007675,9.9217,9.876745,9.670327,7.473705,6.3685274,9.377865,11.708579,6.867148,5.6627464,9.920432,8.798679,13.01073,13.965945,7.818471,12.859699,13.94019,12.642137,6.3200417,6.580175,10.574366,12.275745,6.4186826,9.383577,9.03293,8.615634,12.3158245,9.230513,11.595435,9.166387,9.7645035,13.887223,10.610868,10.743665,8.51695,13.472161,11.274505,11.396844,8.037251,10.341554,11.298922,5.4680963,6.3879647,9.461441,11.149059,5.070407,8.367615,12.810969,14.938236,10.584692,12.550351,13.999554,9.261237,13.327555,10.099431,12.411509,8.755421,10.261944,7.447923,8.973845,14.405943,13.729013,8.876776,13.003807,12.460347,9.401306,10.635351,5.872054,10.349894,8.331962,9.22906,14.496831,12.245098,12.664027,6.365557,7.471678,8.033328,12.752712,6.157758,12.184863,5.9254,14.367622,8.555878,9.841429,8.029379,10.210936,8.557964,12.057148,12.949342,11.594898,9.669065,6.09087,9.850437,11.070572,10.586821,13.013326,12.271737,9.685829,9.360724,5.88086,13.960765,6.3030224,8.805299,13.311773,14.259069,10.736792,11.195183,8.901484,7.4847827,13.286994,7.368996,14.030858,9.56102,5.896495,9.734938,14.072028,7.289956,10.021431,9.629474,9.324596,6.022738,8.819931,12.5074215,12.216026,8.693163,13.27982,9.081885,6.1455703,10.794077,11.2195635,6.0830636,10.227331,13.780557,8.89902,11.568309,10.404253,13.266025,12.981316,6.265171,8.423258,13.143849,5.8837185,11.913232,13.312849,11.945222,8.414561,14.276739,14.4731455,11.387754,12.96707,10.483055,5.941141,7.7244973,14.138656,12.407358,14.134303,10.339689,12.215303,14.053091,6.3857083,11.506296,10.725522,9.653612,13.383267,11.529423,8.531717,11.264107,11.712167,12.520848,11.092298,9.467441,13.42753,12.674529,9.347518,13.060809,13.793123,12.885667,12.633863,9.359069,12.50334,8.312646,10.3967705,8.703424,10.733782,4.9215193,7.319693,13.787966,9.362784,10.498663,10.404131,12.863719,13.529493,9.786981,13.774205,6.376932,13.642133,9.283564,12.331575,8.605592,10.39528,11.428942,10.1501045,12.387564,10.793073,5.9854383,10.778597,8.957107,13.777563,9.252697,10.428698,14.498312,6.9631333,6.059525,7.1788983,10.750139,11.282651,6.0225205,11.309533,9.594101,8.632458,9.792557,14.129525,12.664852,8.375219,8.7935,14.150209,12.026913,9.194817,13.218484,10.83283,14.517653,12.261128,9.837504,10.146565,12.687749,6.2180934,10.556076,13.501945,14.985435,9.6374,14.444209,9.576635,6.924515,9.121625,8.506964,6.103676,11.9676695,13.835503,12.073711,13.922002,5.928953,12.195057,5.9656134,10.389097,11.430362,9.189348,9.932809,8.609479,13.161727,13.792208,8.381352,11.345365,13.241768,8.677748,10.05543,11.667066,11.049471,8.821674,5.3776307,9.12212,8.388946,11.314694,13.290061,12.417647,11.279922,10.563742,9.864002,10.92173,9.038593,13.554931,12.746863,13.184733,8.251659,7.0644546,4.352549,12.91377,12.731232,10.675303,9.871918,13.907383,14.533787,12.349425,6.190266,9.085671,13.802883,4.536223,9.95043,8.935263,10.04989,10.332164,7.5512433,8.779477,9.87052,12.070461,12.030699,7.4584193,13.122587,14.403089,10.461493,9.296925,6.0783696,5.5682797,10.989591,12.573364,11.630777,5.9142942,9.9420595,9.631609,6.365062,12.872009,7.8247705,9.033233,6.443991,8.765431,10.191533,9.482963,9.431586,5.952755,11.347077,13.776698,12.451538,7.0148635,9.873517,11.094328,8.021498,5.038873,8.065863,9.950879,8.620499,13.127737,10.663054,9.16456,13.598515,4.4081063,9.566123,13.542341,4.4742913,9.362922,13.548904,10.809083,13.967119,5.975339,13.194877,13.796907,11.5970125,12.581722,12.958912,13.188475,10.389059,11.226768,14.875873,10.729451,13.15988,13.556016,10.630703,5.9122844,8.612952,11.711032,5.995815,13.830742,12.720493,10.489189,6.129168,6.097989,8.06134,7.51391,8.352759,12.826662,8.820499,12.90411,7.301077,13.095315,13.90201,13.065557,10.8377695,13.30836,8.99629,13.386077,12.4600315,12.372907,9.241331,14.300297,8.895935,6.317614,10.965168,12.683043,5.0211816,6.0407395,6.304004,10.326785,11.468339,8.559528,13.088463,10.096444,7.9393077,6.6648593,11.152772,10.065807,10.579623,10.47139,14.617328,10.399781,10.899035,13.663641,13.085627,10.332853,11.59412,7.5103855,8.979629,11.114934,13.307434,5.599113,6.507149,9.074111,9.979312,13.343181,5.81834,12.306684,8.886004,8.387642,10.308793,14.340841,8.45185,14.505117,14.210438,10.300746,4.546318,6.018544,12.182516,8.6107025,12.885847,10.948674,6.2343607,7.6240053,10.283581,9.23346,13.45032,12.987218,8.412305,9.203941,10.952761,11.209119,9.7505,8.540248,11.102341,13.026318,14.156992,13.973731,11.028333,10.45862,5.7701364,8.909621,14.4296055,13.743579,10.85051,8.048528,13.4502,13.868201,9.951107,13.868594,8.202872,13.73354,9.632327,6.1479115,10.63361,6.262688,13.889259,12.635751,8.372723,10.751818,10.85094,9.713704,8.437007,10.947011,11.397213,11.561867,10.676202,8.62642,7.555705,11.60557,9.084951,6.1551223,13.997574,8.680427,10.299595,9.421119,7.025402,9.324991,6.4707613,12.991657,6.2574067,12.042079,12.960012,14.285277,8.481095,6.943302,12.887616,11.233994,8.658006,8.735365,11.351917,12.3453455,13.161764,11.355163,10.3651905,13.985558,13.609393,5.977818,14.263378,11.812412,8.593324,10.104554,9.063337,11.78187,10.312428,14.129224,6.9583807,8.969105,12.336841,6.986359,9.54587,10.983253,7.6344223,5.709214,10.031837,8.252767,13.173528,10.512296,11.174758,12.710421,9.631637,6.0789185,11.5256405,12.369172,6.029455,12.643994,12.893462,6.4995036,5.878589,11.262474,12.659637,11.614437,9.747132,7.295807,14.14058,10.967426,13.619701,13.51875,13.363275,11.754789,7.7903037,13.206027,12.800027,13.824547,10.040412,13.722529,13.547121,13.419091,6.259692,13.391174,12.046117,11.610446,12.880055,10.43343,9.992226,9.206488,6.023343,6.3209424,11.639112,4.8588495,5.4609876,9.511087,10.259706,7.9827785,13.162841,10.245205,14.1765585,12.814961,10.488543,6.507281,12.859491,10.2842245,14.051793,12.752753,5.97024,9.141233,14.622899,6.2937765,8.458957,9.215648,9.483499,13.774762,9.585303,5.954468,10.211699,4.3688626,13.226458,12.977831,12.083983,10.664229,10.093237,10.683865,13.276861,5.9360347,10.5881405,12.787473,7.37916,9.652801,10.805999,14.116792,12.471944,9.78097,12.107472,5.69115,9.325748,12.42813,9.323336,11.522704,12.710957,5.932,8.542324,12.681,13.325371,10.441302,9.935295,9.183197,8.697105,10.359866,10.21579,10.291559,13.868276,10.497548,12.201472,8.488051,9.62101,13.804289,10.885958,13.893375,5.8118787,10.212412,4.9910493,8.557352,8.787391,8.504664,9.647339,10.532152,11.035001,12.512741,11.015979,6.26742,11.914241,11.475251,9.988875,12.040091,12.222368,6.329742,12.636741,6.4845576,10.591214,8.564821,9.988506,8.789412,13.189336,8.377199,10.385727,8.925654,12.269434,5.7129807,5.540082,12.115223,5.570886,12.911332,10.895693,10.367452,5.9796095,13.462771,12.859782,5.489351,7.4536405,14.83924,7.3369684,6.3623447,8.850298,10.580188,10.145267,12.597459,9.815524,13.8974695,6.172858,12.310188,9.648984,7.469065,13.727015,12.17444,13.825021,9.188987,8.571722,14.027051,5.6739783,12.025289,10.13822,14.481022,10.765596,13.841515,13.721638,12.2539215,11.297814,12.710113,7.209667,7.2937946,7.37714,12.717581,13.732848,10.328493,10.889352,13.811269,6.2156386,10.622179,7.5730915,12.368903,9.509896,11.358152,5.412771,10.05729,5.5407476,12.672325,6.220018,8.793096,8.12284,13.278849,9.186999,6.221439,9.19533,8.082011,6.665998,11.203771,10.868242,9.40337,10.467799,7.106644,10.205292,7.964073,4.7397466,12.748623,13.199454,6.9522767,8.653207,8.439856,8.5644045,6.6658397,12.092547,13.283443,4.6585374,10.1483555,8.399266,11.589305,11.140671,7.3884945,8.989888,7.506349,9.553876,5.864675,10.423099,11.370549,5.3988914,6.32661,14.04275,9.94196,10.172964,7.8273287,13.412563,8.569141,5.6426864,6.034039,12.172516,9.81817,10.740457,11.430204,13.508253,10.772927,6.845828,14.1586075,8.558499,8.550198,13.934278,13.658125,5.0152802,4.5671005,14.996706,12.756573,10.563862,13.04147,12.259692,6.350251,14.679594,8.631073,8.430659,7.033275,8.680397,7.795563,7.3398356,5.9767966,13.731853,10.237654,10.301422,13.239351,8.600302,9.472516,12.194692,9.50247,10.61492,12.96542,14.510006,7.108538,11.709054,8.403456,9.784663,10.523702,5.8236623,11.9884615,10.84468,5.914044,6.6202216,12.977051,7.534476,9.064983,9.499417,13.503305,12.871979,14.099548,13.5678,11.537108,10.093957,5.790273,9.194499,12.0622015,9.297183,4.7971106,5.9319987,6.9902515,5.87012,10.273018,13.915931,12.21807,13.409654,8.03575,6.406426,6.1307354,11.262991,6.000096,12.179875,12.89145,8.283724,14.686238,13.070693,7.7853036,10.612239,9.452461,12.933005,6.9801717,12.660891,14.029972,9.139281,7.4780087,5.0535345,9.250111,5.8966937,13.80938,7.9351835,8.642328,9.504703,8.200914,13.749388,13.43311,5.4240093,13.665988,6.4188,13.799133,5.648962,10.261983,10.05965,9.15231,14.020261,10.901964,7.2132325,8.978805,8.642443,7.7528567,13.079168,12.901421,10.543895,5.2327194,12.62532,8.607831,9.35335,12.063758,8.582945,8.814599,8.59909,5.6360636,7.763806,4.8038654,8.236614,10.72126,5.4613295,8.438049,9.963832,8.689577,9.3243885,13.149735,8.403115,6.356006,14.222159,12.6893635,13.703029,13.330047,10.467145,12.697288,12.88753,12.811789,5.661224,10.864001,9.463482,9.9383135,9.565238,6.113103,8.467422,10.853275,9.159484,5.682675,7.9042807,7.008672,9.158359,5.5180297,6.963671,6.6222034,11.969894,8.860514,13.382591,9.716705,6.091271,10.546227,13.327188,13.558081,6.283637,13.912496,6.2893553,13.6360445,9.537287,6.6001987,10.499767,14.287564,9.739261,14.193923,12.495765,14.683504,8.152054,6.0078998,5.5353603,14.615624,10.65948,6.401882,6.6562176,10.529418,10.188239,13.529129,8.258128,10.147108,12.4622555,8.888685,9.571756,13.264346,12.556938,11.344622,5.1770954,5.3810577,5.958666,13.896376,11.723592,13.746589,10.638154,13.028548,5.997255,13.954326,10.696183,4.7892013,12.130662,13.517371,8.133778,8.455572,9.532873,14.351335,6.091765,12.186396,13.437354,13.121644,10.531269,8.694704,13.701298,5.9286203,9.388684,10.705979,8.434054,13.537731,13.611221,12.179965,11.614712,10.0350895,10.591197,9.002423,9.269876,12.720225,7.160581,14.374666,6.6114397,13.19932,12.411187,11.240083,6.934101,14.358595,5.785521,9.03487,13.0453615,5.906875,13.203217,12.354035,7.474077,6.039623,11.045112,13.380734,10.701624,12.324552,6.509356,8.303195,6.5131946,9.463029,6.2024775,14.323668,13.053239,6.2308474,8.48272,11.090075,9.647274,5.4115696,14.384996,7.2700334,9.735046,14.322512,13.209356,9.858081,5.9384513,9.925345,11.280651,9.4192095,13.788219,10.197977,10.653091,10.317103,8.481365,11.6464815,10.092704,8.864491,12.358569,10.527234,6.1684246,9.7968025,12.995798,11.329009,12.31206,13.350133,14.914226,8.89721,8.819546,8.901079,14.2488,10.198287,8.025179,9.346878,13.348619,12.017086,10.2047825,9.710836,10.129367,8.663622,8.129486,14.574927,14.145662,12.05164,14.068817,10.8891535,13.046245,10.019237,9.848085,12.369058,4.8592544,6.3135257,5.702911,10.839912,10.432477,12.369685,13.7946615,13.616122,12.649606,11.463655,14.070604,12.345952,11.193814,13.304289,6.2638483,10.201157,13.375264,13.43869,7.287951,8.747977,10.17907,12.325031,8.797271,12.031541,13.922825,6.164261,13.165225,11.378015,13.328244,12.333327,10.25548,12.032626,9.598196,8.76373,8.811059,12.801238,13.666668,13.002483,8.478646,9.111128,14.750523,9.430533,7.315085,8.108616,12.819629,14.454494,13.497137,9.414861,8.917633,10.410478,9.065434,5.773963,10.891766,6.50755,10.046348,5.9819593,13.948863,12.701114,8.038635,5.4395757,14.072512,6.067192,8.506501,5.848626,13.360065,13.762787,10.522968,5.865449,7.9298654,13.162362,9.228169,13.875568,8.005669,10.189471,10.107567,9.404081,14.578364,9.91848,5.4612803,14.348388,9.430351,12.636665,11.6091,11.9988785,14.299619,8.7574005,8.276364,10.318575,12.966296,5.885805,9.434212,12.811334,9.223368,8.501237,10.17333,8.306272,8.640152,10.563881,14.126016,6.5051346,12.872196,12.451614,10.827479,14.7352915,12.999095,12.285223,14.09339,8.317584,6.075762,8.667952,12.441805,8.196134,8.419788,13.667431,14.811797,9.006553,11.48734,13.184165,13.872578,8.154454,7.688985,6.474867,13.710208,13.145156,10.57614,11.317833,4.342142,10.772112,6.2993917,6.380583,9.072468,6.2726703,8.901423,8.761452,13.039613,6.591405,9.20621,12.311293,11.27904,8.269143,13.333914,13.254988,11.013674,10.880617,8.973008,11.550478,14.062361,5.9268785,10.953669,11.991057,5.995695,7.1462545,10.6466055,9.286618,13.33056,7.6997766,7.673312,10.611929,8.253959,8.638299,8.027942,8.268556,12.293689,9.819708,14.472637,13.109041,10.382224,5.377788,14.167807,9.203736,10.363585,8.751541,6.01793,13.746775,14.344393,10.174682,6.0892434,11.05081,11.064075,7.736957,13.174792,9.414788,5.36696,8.851989,6.1494308,12.3362665,9.666119,9.834355,13.218356,12.605016,12.026678,7.4109626,13.408459,6.267231,5.8075743,11.54065,14.717698,12.633129,12.827984,7.7969246,9.778463,12.330953,5.4970756,8.669956,10.169861,11.1597595,13.111501,10.531398,12.775301,5.8261175,11.03111,9.595868,13.96855,8.6173725,9.249337,8.282606,4.458839,13.4821615,5.436958,12.275878,11.925732,6.2040877,5.9894195,8.485455,11.120671,9.783556,6.366287,10.106359,5.423765,12.538117,8.794787,8.868465,8.312387,8.49487,8.583948,13.712913,7.419314,9.433595,10.795248,13.608327,11.387352,4.777063,5.647553,11.928798,12.369405,11.927231,10.608722,9.79818,10.162334,8.223015,10.980278,10.805487,9.045049,8.868955,12.827313,9.160716,10.988631,12.477114,14.912926,5.9212685,5.9812694,13.039881,13.491351,13.206272,7.4997125,8.787157,5.683208,14.146009,4.381195,13.063295,6.0186195,10.079229,8.209699,7.465005,9.401396,11.009614,12.679118,13.046159,8.602969,13.617681,10.095289,11.030692,10.61769,8.738298,10.544629,6.316812,9.321792,12.139677,6.9575415,10.31375,5.5590243,5.334972,9.499591,12.84522,8.812693,13.112206,10.018611,13.729011,12.303713,13.475485,11.675766,10.905546,11.153787,12.369275,9.242177,7.019122,8.698444,13.0767,12.651656,13.953676,12.17748,7.3573446,5.595238,12.365,12.400532,10.251246,8.727788,10.528825,14.17411,10.830479,6.5761886,14.069701,6.267952,8.531159,6.053482,13.860004,8.583292,12.457266,10.295594,8.783016,10.192283,14.1841,9.712673,10.382337,8.620573,7.922999,14.497538,13.993959,9.484193,13.925068,9.719946,12.709574,14.352624,9.459095,14.175637,13.491707,5.9472957,12.435994,10.2080145,13.932658,6.4667544,5.4145694,7.6765785,12.121099,9.876125,10.22499,14.923103,10.874212,9.71886,5.4248657,8.91352,8.512346,10.812627,5.675741,11.805153,8.377018,14.392467,10.830958,14.3074465,8.905419,5.594961,12.218324,9.349375,12.313741,13.048945,13.135391,8.826995,9.67888,10.2110815,12.6101675,10.645555,6.2597003,11.175399,5.9251018,13.495467,7.4795504,12.981959,12.876663,13.780659,10.454769,13.372996,13.769352,12.911763,12.888869,5.278413,12.6663065,8.719533,6.584709,11.666837,13.766843,7.002346,10.10815,5.423456,11.534277,13.676179,9.855421,5.853187,10.453949,5.8916745,12.954418,11.324304,13.040649,10.538146,8.541033,12.609312,9.995571,8.7449255,14.536477,7.4469275,6.8510127,12.771074,13.319933,10.812868,8.695828,11.192061,7.549293,10.293906,10.170771,14.552814,6.312611,9.609403,7.7912984,9.427088,7.469841,10.9370165,8.940563,10.992339,9.38988,10.47729,12.085188,8.010555,13.467401,5.5444374,8.565179,13.771853,12.656229,10.198875,13.62594,8.222385,10.740084,5.0593615,11.318477,6.1361527,10.328951,13.016725,14.010368,9.581216,9.25358,14.178273,14.145952,12.814697,9.163715,10.153446,10.0113735,9.696487,10.769084,4.669593,8.7532835,10.258826,13.314878,8.540509,11.616214,10.795094,8.6051445,5.959159,8.60345,5.885548,13.508159,6.081371,9.35299,10.266629,14.791193,11.937287,12.88337,6.2683506,9.033082,9.107244,6.6038074,9.343223,13.337195,5.939388,8.999725,7.8530364,14.814221,9.950975,13.272419,7.5128884,5.6029596,13.794048,9.253491,12.276782,9.613799,9.603413,8.418416,9.471233,8.753894,13.979606,8.160284,12.098779,10.274727,5.4403105,8.220925,5.896674,12.815631,9.35218,13.927573,12.453083,9.472751,5.911172,12.617834,11.750183,10.989864,9.712085,13.70542,7.4786334,13.258723,12.88452,11.015686,9.919547,8.623445,13.380543,7.388903,6.316881,12.91239,9.594145,8.340638,5.703605,13.73362,12.322315,9.82217,10.952259,13.251329,14.62519,6.072519,12.31765,5.3607917,5.608322,9.313969,6.3205094,13.669323,10.354256,13.37525,12.811305,7.968631,4.478083,8.685636,13.581307,11.654224,7.1458116,12.725238,13.977622,10.363707,11.356906,8.535419,10.4082775,10.856417,13.220394,10.523655,8.339608,8.934088,8.492861,5.9471154,5.2630267,13.115971,12.687213,13.133833,8.3374195,9.682811,12.992084,8.94987,10.805047,9.142235,8.645355,6.3490148,8.025993,14.247551,13.741116,10.212645,13.296792,12.132665,10.837685,7.4243813,12.08396,9.473133,9.958019,6.0157495,8.581653,11.867301,12.403278,13.135457,9.47911,12.179299,14.038812,9.86002,8.923857,7.4659424,13.180207,6.6403832,9.028188,13.961702,8.798409,11.315198,10.413306,11.421698,9.514269,13.231207,10.2077,8.559027,8.621858,13.542984,4.464161,13.540494,11.390847,6.578146,8.774706,11.564109,8.380542,8.62808,10.241873,7.229709,12.340304,12.906608,10.261921,8.50854,12.145398,10.336142,10.390059,10.657586,9.116219,9.246007,13.330312,5.9548693,8.567973,7.8839145,13.758336,12.537644,8.57882,8.214747,11.287628,10.204126,12.211213,8.614147,13.348629,10.46114,8.9741535,6.0172777,11.991502,9.41491,8.612891,12.305014,6.6925406,9.805595,10.698919,10.375665,6.328616,6.304368,10.256705,11.981577,8.225252,9.324936,9.082923,9.890076,10.960289,6.334666,7.880947,13.41253,10.757121,9.570601,14.168436,8.668623,11.0695915,12.986357,6.928259,7.9336305,7.3119245,8.43701,10.857382,8.576402,13.274367,10.821461,10.578409,11.075279,14.335993,6.9446025,5.2760563,12.57734,13.9086275,8.61153,9.980328,9.325372,13.2580385,9.49202,6.239704,8.554667,10.440301,6.2340026,9.123246,13.545826,12.711601,5.8629003,8.012443,5.8345428,12.987343,10.399369,4.460606,8.530978,5.69945,12.126077,7.4099746,7.460704,14.576705,11.673202,8.61063,12.820159,9.331852,10.589534,6.889907,10.815231,11.047774,9.134748,5.890256,6.329193,5.032392,7.244192,13.169113,5.904312,12.13504,14.386931,10.456558,14.052919,12.723191,12.199445,8.109454,13.071693,13.236178,12.594477,13.868555,7.0194855,11.606444,8.29031,10.494549,12.234201,9.149799,13.636963,10.572775,13.357748,14.109768,9.295618,11.0371895,14.763207,14.081812,13.697004,8.530135,8.042088,5.2840724,13.528978,6.9505258,14.206395,11.871579,11.261721,6.346051,8.72407,9.08195,12.474739,10.374998,8.672119,8.713753,6.7573843,8.931306,14.771973,12.350025,8.733994,7.815558,11.614955,6.8301773,10.7420025,10.791958,8.609945,10.867767,12.826119,10.715902,7.3260245,12.921504,8.638227,9.365436,14.90763,14.131187,10.612763,5.91084,5.89424,5.6810822,12.140333,7.053512,6.5013986,8.152639,9.352355,10.231872,12.176399,7.753078,9.984296,10.994159,6.1771255,13.199704,13.388029,13.051182,5.5393767,13.942989,12.562723,14.226718,12.012163,10.63351,12.878335,8.794662,13.602863,10.188813,13.893887,10.218913,10.476762,8.9072,14.075616,9.742087,9.913608,10.530887,8.722413,9.38775,11.067957,9.186631,10.297569,13.716766,9.910916,9.114562,14.710948,8.606338,13.178501,12.887022,5.9452243,14.654828,6.029014,5.8966165,12.74617,12.089405,7.1562953,14.289836,12.165703,13.607891,13.000652,9.383246,11.220964,10.409025,5.938165,10.214039,13.598478,12.738704,8.320365,13.269821,4.7818174,10.781819,12.549524,9.360834,8.679329,12.90046,7.0170693,14.363438,6.571884,14.232207,9.894587,13.353025,5.9106393,7.004664,13.439359,8.357447,13.524447,8.873341,9.778688,13.92515,10.417926,9.154154,8.233864,12.801093,6.5955954,10.301703,12.360018,7.1736765,11.852527,5.830796,11.303547,9.827415,5.987764,10.5301075,4.9724975,11.375396,11.111729,8.77478,10.007027,14.772369,10.528354,13.326378,6.296837,10.487491,13.503275,10.040552,9.553694,8.371089,4.469464,11.627742,13.860469,14.015435,13.979041,13.683821,11.426878,13.570173,12.677558,12.228929,9.960421,9.552898,6.086346,6.1478524,14.305747,12.627022,13.093842,13.187754,5.919977,13.689354,12.96248,6.3661766,7.7513814,14.0742235,6.4553537,6.7321887,6.1797624,6.210335,9.403622,10.006591,13.040829,12.588016,9.891954,12.95409,14.210538,14.26303,13.811898,7.424692,12.965517,13.55801,9.621892,10.408111,10.356758,10.281277,10.618712,8.972081,9.053735,12.895848,10.420463,13.825156,7.7398148,12.203296,11.511778,9.586516,12.112395,12.795942,11.33171,8.436849,13.585721,7.580607,12.173336,14.093394,6.2396827,9.216194,8.154662,9.190524,13.987477,5.44796,9.502075,8.081537,10.491684,12.268316,10.0994005,6.401487,9.2305765,7.802189,8.571079,13.24922,5.7001276,9.924855,5.4373846,12.528724,10.922159,10.644978,13.564818,11.951018,12.180121,10.93494,10.914061,10.647718,10.209909,13.946264,9.800068,4.472576,11.0950165,12.617586,12.986108,9.295035,9.083203,13.069911,5.2893353,5.9821277,14.025795,9.040957,5.5087714,8.746922,9.684487,4.64155,8.89458,7.396003,8.427926,9.960702,6.033917,6.6367936,12.8317175,12.043308,10.261892,14.016242,12.233523,9.35662,13.043695,8.106201,5.8632016,8.727293,13.607392,11.242742,10.978603,14.198635,12.851625,5.8209105,5.0181775,10.6292925,14.168373,8.135961,12.379348,11.293471,13.083401,11.357449,6.309229,9.951651,7.877676,5.6979356,8.920685,12.794768,14.250385,9.973968,13.842424,9.412356,5.5049005,6.922873,14.363797,13.655485,13.904685,8.349061,12.954065,13.404213,14.341083,14.179952,5.430922,9.859098,13.022383,12.973265,14.014298,4.9965286,8.197189,10.005277,6.2921934,11.963651,13.748581,5.9274497,10.836312,13.137508,10.662608,13.613991,10.1836195,12.036584,6.7410016,8.552989,8.986345,7.580805,11.942789,5.8993793,11.072228,8.936475,9.407265,12.251568,13.14672,10.306847,8.736487,10.770326,14.312236,8.13146,13.606768,5.878984,11.382783,7.075474,11.395839,7.032559,6.0356073,9.026114,7.1105056,14.666216,12.367691,10.255727,10.127926,10.816527,11.735393,10.409789,12.271127,10.566076,14.0946455,12.601043,11.53614,11.247789,13.265317,10.645363,12.87847,11.023132,13.494873,10.830849,13.819704,7.721777,12.443262,12.347415,9.849277,9.719459,13.965976,14.257072,6.3421307,12.8580885,12.846415,5.985317,11.818136,7.029302,6.5054803,12.919022,7.7620964,7.8510437,7.010161,11.601371,10.099708,11.958964,11.576401,6.0488787,7.523056,6.8080997,10.243139,7.174445,10.319965,14.463156,13.384542,11.640546,8.457284,9.321234,9.148963,13.780417,8.627834,10.073984,7.7325835,11.014865,5.877916,5.893087,14.572194,13.045977,8.209115,12.839623,12.398841,6.08739,11.315545,14.681194,13.423431,11.279441,7.508982,5.7120504,9.656648,11.415658,12.262321,12.417343,8.624292,11.762722,5.9703526,13.642332,11.156979,10.408618,13.508539,6.3298507,6.0039444,13.926648,10.699892,8.054828,11.596153,7.3953075,13.7199,14.372457,12.6909685,9.141662,6.08276,12.004712,9.960974,12.750126,13.651959,9.585516,10.5447855,9.890223,6.0182524,7.4778695,13.091612,13.454163,7.0109334,8.141613,13.8404665,10.770576,8.363228,8.39092,4.7826557,9.6127615,9.321615,13.876519,13.199326,10.974862,10.449801,8.587795,10.363884,11.320462,9.154763,8.839896,9.541085,9.154911,7.7771792,6.08839,9.631029,10.804788,12.867482,12.580254,8.723858,10.602966,6.082741,5.8087273,12.668578,14.166557,8.550196,8.291969,9.082312,14.3635,8.127568,6.0208983,7.509341,8.693913,14.255536,6.9611297,13.059145,4.6078815,8.603241,13.867902,11.541987,10.018099,10.301152,8.348118,13.579912,12.229428,9.010276,6.4692073,13.967249,7.0119386,8.805422,13.997407,12.70822,8.455768,13.815933,7.2826495,8.731728,10.89556,8.42287,13.049586,13.454834,11.293852,10.241075,13.538529,8.507363,14.021732,10.2847595,13.438549,9.891823,12.205748,10.246956,8.044477,9.782772,13.678321,10.711103,12.065679,5.9318695,9.083107,5.5459685,9.411405,13.068976,11.406798,5.9223466,8.301941,5.68085,12.164936,8.223355,6.3344073,13.325164,4.8226085,8.851866,10.253495,8.546385,13.542197,8.55193,10.9826565,12.164916,8.823155,5.456885,10.1946125,7.025253,8.512295,12.089526,13.7521515,10.165749,8.3875475,9.364348,12.448711,7.764238,12.0524,9.636187,12.378145,6.00658,13.001135,10.587714,14.367136,9.073329,10.407761,10.247825,13.11661,6.769029,14.272914,12.97767,9.156665,11.285067,10.730437,9.398767,8.112304,10.060064,14.221371,9.938776,12.855417,12.449406,8.268433,13.783534,5.840052,12.483284,10.867823,10.0359745,8.200136,8.858842,13.679162,8.623875,8.593663,7.268187,13.713417,10.25522,9.701401,12.878596,12.79249,13.853216,9.434614,12.760826,12.847129,8.296284,14.083617,8.655216,13.027475,12.89217,10.586489,8.280259,13.338326,12.079103,9.370367,8.820604,13.762085,5.470156,10.774425,9.649913,9.860821,5.481644,9.96992,11.559066,9.114003,8.701443,8.165928,10.215008,11.556981,9.559035,6.403375,13.185071,13.434082,8.316408,10.748305,9.957393,8.461232,8.347405,7.3339806,8.355522,11.862949,9.966912,8.738144,13.714256,11.011133,9.014127,12.792555,14.388306,7.2803354,10.360181,10.235627,10.816416,9.383857,13.074368,13.912821,6.5354705,9.958808,10.997626,10.254555,12.85318,13.375625,6.5192566,6.0778255,8.016725,9.87833,10.274058,9.074529,8.814251,5.860288,6.8993254,10.002473,9.438534,13.272393,11.243209,13.124254,10.9999895,10.444238,5.904634,6.0333796,9.292805,10.886862,6.5734925,5.0614023,5.4322157,10.676432,8.686439,9.990734,7.606393,10.42447,8.568425,5.737757,9.422913,13.865294,8.167283,9.591495,14.130669,9.824311,13.620141,13.35201,12.717112,10.109933,10.062199,6.5251536,8.504704,14.156384,5.7963057,7.282065,11.267,7.21334,13.817687,10.498998,11.375971,6.958552,13.69859,6.0277753,6.2581058,12.760646,13.107618,9.706681,13.586326,11.653822,14.044478,5.6698966,4.9920144,6.539856,11.010936,7.8053355,5.303074,5.0463367,13.749248,12.173321,8.799804,9.100406,6.6358967,14.382749,6.5973945,8.627531,10.955979,12.231565,13.720628,12.158291,9.1121645,12.304234,6.5831933,14.646193,6.0632687,12.8781,6.0103474,13.854188,10.224642,11.582559,9.839378,9.211616,8.590212,11.031857,8.517251,13.498789,6.2959332,10.499775,8.399002,12.048908,14.528671,14.016393,4.903638,13.166684,7.723971,12.80606,10.16329,13.347001,7.47656,10.208491,10.706725,9.303631,13.858352,14.017056,11.015421,10.236157,12.041752,14.053721,7.146732,8.224162,11.585215,13.357922,5.491683,7.0125637,8.570362,4.853094,8.0573225,13.012635,8.614685,11.840061,11.309867,9.852208,14.039243,5.620015,10.862112,13.678235,11.910832,10.385164,8.980123,13.278265,10.603428,13.801659,11.431917,12.562718,8.841665,8.808929,14.072166,11.449829,6.1359878,7.1250653,6.4526334,7.6120076,12.546394,10.560354,8.559644,9.113635,14.041688,9.37594,12.073279,8.816407,13.501568,9.562678,14.946518,10.7701025,11.841101,7.076541,10.078928,7.24545,13.699345,8.136695,11.355286,14.315278,12.552102,10.255548,12.583218,8.33398,14.219009,7.8758106,13.504737,10.312232,6.082957,8.599492,8.349236,11.930507,5.9694695,13.738192,7.0269814,11.111347,6.439418,6.606361,11.378999,14.114,9.225866,13.90216,14.067477,7.5239463,12.50554,6.157113,8.671066,8.701761,13.25678,10.567931,7.173296,11.615408,5.5470767,10.200933,9.073916,13.797995,11.537903,9.5748825,11.000182,13.827226,9.345647,10.875351,8.678305,10.116802,14.689462,10.473296,8.107761,5.9908385,8.466632,9.156523,12.164953,6.9908805,7.5643654,6.1006165,8.577694,10.347937,5.939459,6.417703,8.70806,8.215537,11.133818,13.354871,12.113215,14.308481,12.393607,6.355824,5.987387,9.267276,13.128816,13.579981,9.461017,11.848202,5.6258636,9.148453,8.120568,9.323635,11.213462,13.394354,6.195023,5.2408257,13.944198,9.433869,9.264607,9.213632,12.9429,11.751001,8.892136,6.6107407,6.3803353,14.9937935,6.196915,5.880051,13.6506815,10.591573,5.1486745,8.478678,10.699197,12.377809,14.064041,6.982554,5.437815,9.175716,4.560054,13.205116,10.006392,5.387381,4.5909653,8.729941,12.944515,10.788353,13.140916,11.641209,11.353049,13.56484,13.108425,8.798376,10.865948,10.1498165,12.145653,8.704593,13.041444,13.903534,6.1438704,9.3002825,9.77276,4.47505,12.690635,12.197792,10.156749,12.625778,9.602947,12.697654,10.4937935,11.68035,6.9251223,13.040192,7.927302,10.553784,5.302411,9.0855465,7.4046555,12.632265,13.721073,12.652219,8.758388,8.992517,14.399778,13.816177,10.566333,11.039339,11.163066,14.729292,10.389171,10.321033,9.267913,10.699194,12.083216,8.585525,11.275918,13.349072,9.754722,9.258557,5.952018,13.593978,10.16885,12.805599,10.280356,14.744034,6.3692064,10.810704,6.4674706,11.07452,8.877968,8.881532,5.565341,5.289814,10.626786,7.4723063,8.11791,6.1576467,11.281254,10.572239,6.1718698,8.834884,10.464393,9.736039,10.551258,12.207034,12.539102,11.326102,12.232043,12.096765,9.161089,13.280901,11.869059,8.822267,12.769149,13.840066,12.430504,6.615145,11.137133,12.39339,11.261726,8.4893465,8.785775,13.027606,14.302328,12.970482,9.874957,12.997571,11.468815,8.996102,10.870773,12.581399,5.914828,9.910352,6.5439334,11.17194,13.919892,8.487028,8.823325,12.48616,10.5477,10.020604,13.36377,10.146389,10.257248,7.553942,8.775732,9.886383,12.625155,10.988666,13.944874,6.9291177,6.9569993,12.051765,6.091081,11.836946,13.996873,10.181419,7.101,8.569519,11.200791,9.222759,8.131522,8.462891,10.181707,8.503306,9.087472,10.110564,12.83501,13.8744955,8.175404,11.129995,11.019416,13.74493,6.3360467,9.0904045,13.882853,13.306459,13.128783,10.063556,11.546986,7.156177,13.412862,6.2865195,10.259778,10.02086,13.785573,13.902383,14.187152,12.70555,6.358466,11.216418,10.20874,10.585179,12.994532,9.25878,6.568191,9.138839,10.153608,14.203488,13.971131,13.454936,14.478485,8.419073,6.6136684,13.297638,10.434959,12.851782,12.386547,10.0039835,10.256168,13.147153,12.1957855,14.584642,13.250669,14.3576145,10.086179,12.966524,14.068823,14.107093,8.606304,10.706276,9.055394,13.000314,10.5598345,10.816058,13.0185,10.7834835,12.426923,10.733606,10.384372,13.57025,12.876724,7.7208633,11.012944,14.904012,6.2795353,10.072432,11.988557,13.129736,4.722724,9.739181,14.7856245,9.03158,10.240103,13.752016,9.077477,12.426135,8.938487,10.988897,13.077317,5.798606,10.51504,13.774276,4.977042,10.976786,10.014354,8.792133,11.985537,12.581269,8.553863,8.178988,8.6396885,13.099881,9.439649,7.1597614,8.060241,13.804638,9.818928,5.69991,11.149877,12.135341,5.665803,10.052497,10.086581,12.779477,10.712604,8.61497,5.8979816,13.887124,9.798063,8.156739,13.048322,12.619106,13.301748,7.361455,5.9068575,13.463489,13.145933,11.905579,12.57531,10.238207,12.659923,8.636326,13.242698,9.370233,11.507551,9.060625,8.419031,6.1271276,5.917284,14.770783,14.1398945,10.673374,6.111933,13.284996,13.417628,12.23285,13.101102,9.936304,6.3857627,10.780409,12.814123,12.612196,14.484459,8.778296,11.0617,13.336637,13.263906,13.130398,8.746316,13.189773,12.335433,8.41247,8.543198,14.635581,4.838765,11.10804,8.255695,13.188182,8.457603,11.313315,6.0597663,12.94641,10.940006,12.6246805,10.561314,13.991588,13.467394,10.037876,6.8256254,5.9132986,4.7814183,7.780702,14.439313,8.615975,5.9432373,8.232919,8.577728,9.044684,14.730397,10.367064,8.544951,14.19185,8.180905,13.22058,9.727381,12.647929,6.6416783,13.491919,10.630673,13.953838,6.1019473,9.583287,10.559229,11.196097,14.034483,6.535046,13.832919,4.8005443,11.140092,7.544228,8.447888,5.923946,10.079855,9.619845,14.071273,12.978909,13.535954,12.720358,9.964575,9.472696,8.528147,12.08818,10.785938,8.214604,9.753448,8.897485,8.2481785,8.08232,12.903721,11.050004,11.0418825,10.201788,5.7178187,6.1507435,13.638255,8.024942,9.935489,13.185307,7.859945,13.526681,11.452286,12.756962,5.407025,10.084479,14.91106,13.81494,12.21128,5.970992,12.046699,13.230338,12.811953,13.49369,8.344231,9.303772,13.951322,8.918472,10.096891,11.372311,9.7175045,12.960111,9.663593,4.732919,8.595642,4.38985,5.823715,14.56259,10.972314,5.454151,11.452672,8.59953,14.24097,8.464484,6.041951,10.52619,13.472077,13.981356,13.103346,9.5397625,7.516143,8.870051,13.888514,12.585142,8.169853,14.06498,7.865329,6.159301,6.793673,8.138931,12.1863785,14.517531,13.464212,10.315912,12.519552,12.486962,13.316181,10.482844,8.363801,10.127051,14.205165,5.8791156,12.360255,11.445202,6.3376727,9.513501,9.42195,5.3182435,8.716846,12.757501,7.3370914,7.008727,8.691123,12.995974,10.044442,9.839749,12.054308,7.179034,6.1744514,12.16423,13.220702,13.393529,10.472089,14.168966,5.730522,11.153102,13.239864,5.972673,8.195656,8.802463,5.5320845,9.3888855,13.038306,8.636414,13.046443,10.925385,9.748208,8.677464,9.600911,8.523435,8.511836,12.786246,8.685048,5.439687,7.19178,6.486145,11.007167,5.3400335,8.163536,8.469529,14.409599,9.386165,12.783411,10.459144,11.893955,12.696807,10.9874,13.262944,9.05237,8.813703,8.624392,8.898228,13.116753,13.197164,10.763164,12.93621,12.913093,10.385165,10.203683,11.305401,8.482773,12.781975,10.226669,14.070208,9.137841,5.5763307,11.451342,5.2754874,8.812053,14.262349,9.270214,6.099266,11.183996,12.604979,9.00437,9.045444,13.790757,5.205626,8.840564,12.884029,12.129377,8.965459,9.581777,10.49651,11.464936,13.072259,8.632251,10.930339,8.585637,9.961663,10.999097,5.4663286,9.831678,6.961532,7.5473847,14.444062,12.133176,13.392555,5.9842234,8.630093,9.818535,8.52385,11.821639,13.597142,8.278586,12.8829775,6.313267,10.617983,6.140836,14.772748,8.219631,10.375498,6.442392,11.9868965,12.417272,6.2221794,13.706212,8.7257395,8.323884,7.560041,12.558808,6.302225,9.750669,11.899337,13.820171,7.0352926,11.984412,10.700032,10.734939,8.385412,10.932703,9.129134,9.232826,8.782573,8.855345,13.049988,9.061128,13.233067,12.402468,13.595284,7.8695803,5.915781,9.492504,7.013962,9.398774,9.858096,11.929119,8.428539,11.073037,5.916624,12.737241,4.875307,8.891984,10.69537,10.251566,9.856799,8.545674,13.192492,6.827235,12.567819,12.1179285,11.291567,14.036084,10.289045,8.145328,10.1110935,11.770285,12.5804205,9.974391,10.863856,11.493194,8.393666,5.9064226,12.115609,8.1623535,14.233532,9.211885,13.012032,8.810667,10.007084,9.655934,14.14982,12.833838,13.192738,13.403712,5.6453705,8.463794,12.323933,13.694718,13.976709,5.0317097,9.227319,12.347352,13.915312,13.949432,6.0242496,12.319878,6.1635494,14.18349,10.312063,8.292158,11.349651,9.231931,9.311914,8.83208,7.120444,8.955597,12.616922,13.052549,13.297936,8.576292,13.935029,8.52415,9.587532,9.993442,13.536423,14.171879,10.202765,9.497874,5.4130936,9.3268385,12.129189,14.160906,9.275521,9.828148,12.079782,5.9267745,14.545201,14.291759,12.889565,5.4503236,5.523028,6.763746,12.891496,12.222527,12.49285,7.2135487,7.8771844,12.364189,11.05805,8.182772,11.071313,9.73838,10.634555,10.089013,11.468298,6.2294674,8.693066,14.117823,12.690681,9.865545,13.9516115,8.673275,8.614104,10.271681,11.675788,9.426657,10.0393915,13.213773,13.426072,7.593041,13.853085,12.299188,6.38865,8.672846,9.754666,10.617133,11.011863,9.355617,13.169332,11.043655,13.594079,5.923378,9.33393,12.887216,11.04156,10.603088,13.404804,13.551015,10.294721,9.426077,10.290915,12.478208,10.078519,13.684935,8.956251,13.975488,13.664494,9.893079,7.44022,6.224041,12.929381,10.373551,5.868937,9.796972,10.480309,13.468143,8.459453,13.182567,12.959226,13.504835,9.079841,11.919708,11.313841,14.230248,11.748898,4.9955854,11.964323,13.53733,10.244622,14.257596,7.2966347,10.770585,14.014214,6.0950894,5.66184,14.503826,13.462605,8.0348015,6.920389,10.397285,8.307816,13.27896,10.327598,12.68973,6.1386724,8.37759,12.5702305,8.508705,13.108162,10.576659,10.679447,12.943872,10.486301,12.968671,9.016937,12.289778,9.960901,13.628206,12.817489,9.265564,9.085055,7.233811,5.4169703,8.369974,9.375587,13.209727,12.76821,10.405156,10.233326,7.671071,13.725478,9.131731,7.5937004,13.184987,13.729032,13.775692,8.5201645,5.93154,10.474836,8.507543,8.351247,11.259536,10.170553,10.448745,9.771921,7.805216,10.139574,7.568791,11.009767,10.3458805,13.271245,12.687559,8.234405,10.61096,10.173374,6.865829,10.518557,9.752742,6.599513,12.695749,8.617823,13.689815,9.207963,9.856592,9.613501,12.805158,5.9060736,10.550297,10.065592,11.192692,7.966987,10.928166,9.096367,5.981065,11.616796,12.201888,9.020427,13.961152,6.0694895,6.9217076,6.4222174,12.971116,9.283779,8.831639,5.8763075,10.388475,10.666341,11.131921,13.696262,12.28527,8.521251,7.5066423,8.909816,11.429822,5.661312,7.7841697,8.994522,9.544297,10.512256,6.5383763,7.947146,14.651908,11.557354,12.108419,13.391917,5.452798,12.389399,6.2966,8.536642,5.4424825,7.694696,10.952945,5.919519,12.763531,5.4983745,13.935627,5.7936487,14.209288,9.59626,9.705947,6.983929,12.804874,7.478931,7.955564,5.846168,8.94321,5.5248938,7.285826,13.26461,11.109996,8.419588,11.893062,9.831516,10.946515,12.642691,5.9186344,6.3429117,10.373546,12.883107,14.328062,9.807135,13.792306,10.197435,13.956508,9.464665,5.7907615,13.749766,14.330207,10.408057,8.665356,9.754673,9.347049,14.885746,10.966592,10.883314,5.2701483,11.460326,13.8703575,8.427021,8.065712,12.31728,6.9133854,10.745506,8.78503,10.942269,5.9140244,13.816704,14.3671665,11.08832,14.118279,11.305005,12.466269,9.622985,5.8517914,9.494448,9.566458,9.84385,11.2431755,8.647257,9.538848,13.047242,5.845486,13.14977,12.321407,8.5314045,12.694054,8.990901,9.545054,14.815796,10.177289,12.864511,10.569235,6.170217,10.372439,11.569781,12.924772,4.4941287,9.208806,6.1314783,12.036598,13.628072,9.377964,14.282814,8.823415,10.846532,12.695391,10.148079,9.620259,10.68016,9.151955,8.193998,12.747142,7.42793,13.765428,13.51229,14.761471,13.642047,9.167571,7.026988,11.265159,13.562993,8.5054,10.7819605,14.034785,12.521759,10.759192,12.939092,9.574584,12.617233,13.987434,14.837989,14.114143,12.9393835,10.262599,12.28491,5.482188,9.660049,10.382299,13.707386,6.149396,9.602406,8.925901,13.282452,13.353398,8.014618,6.6064525,11.509679,9.134227,14.588305,9.633638,12.985638,11.293777,14.308595,9.267428,12.548212,5.9327416,6.659759,8.125288,13.28061,11.09575,13.284793,10.443272,7.604977,13.588341,11.663572,8.370222,14.170707,5.9602885,9.211649,12.239375,12.510431,10.175205,5.4466777,9.321862,9.821541,13.163035,10.990628,7.25212,9.20528,6.8313026,12.471907,6.0424786,13.787427,13.752143,10.674422,8.989081,10.154578,11.10879,10.775705,8.164542,5.425244,7.060828,10.567678,6.995936,9.334036,5.8624086,9.952569,6.380324,12.683315,13.710435,8.640584,14.699222,7.01671,8.464374,13.723256,9.064641,8.322433,8.504202,8.501411,8.79192,10.958962,10.603595,11.198315,14.046203,6.923928,13.196853,11.572982,5.5176573,8.82165,8.6048765,8.260721,7.510397,12.573408,11.282576,11.607042,5.9917784,10.184419,12.202971,9.887894,7.1592817,6.299402,8.503227,5.401543,12.933578,8.427616,10.990064,14.789609,10.448997,8.65211,7.4760737,11.2888775,11.335613,6.314545,10.346291,11.917224,11.61553,11.92324,6.1717806,9.9985285,12.296431,13.540792,8.102165,9.302428,13.890033,12.53472,6.831439,13.33727,6.984461,8.280815,13.29534,11.041327,9.268991,10.211409,7.2056623,11.76125,6.1028323,12.561784,13.755345,7.653357,13.641412,5.9254837,6.9558344,8.864794,12.639227,6.850295,9.991443,7.527235,14.423625,14.43302,13.4638195,13.456421,13.988456,12.858607,10.787187,7.02597,9.059832,10.719875,12.922356,10.772972,9.401169,11.506478,10.637064,12.092647,10.875842,12.526059,13.043603,13.918115,10.863285,9.466173,10.012918,8.120207,10.4460125,10.823743,12.063488,8.99409,11.268183,12.687152,10.05664,8.777442,5.9335775,8.768198,8.85223,12.076704,9.077952,9.416646,13.527562,12.326708,12.544404,12.386884,10.51333,10.939782,6.097589,8.687916,10.831079,11.742794,5.133112,14.049586,8.848006,7.2604094,14.061307,8.835216,9.884009,12.42274,8.371628,5.812679,9.820916,10.297786,8.29441,13.856953,9.214679,11.762299,6.8855953,12.939542,6.4057283,13.230691,6.0667834,9.26608,7.025329,8.949275,10.330794,12.791793,6.6744604,9.892136,10.073546,8.8210535,12.806969,11.818074,9.845846,14.386925,8.887723,13.172101,7.2592616,13.76185,10.727824,8.474279,12.20381,7.014278,10.992575,10.107111,7.4292536,10.189449,5.3917127,9.461072,8.786732,13.096395,7.0099216,6.866354,6.3912587,4.680414,13.839343,8.662255,10.247594,5.7219152,11.92948,12.499725,9.802192,9.58932,10.664677,10.222407,12.862234,11.005721,8.5923,12.99111,11.1742,10.814748,7.958102,9.553479,12.024203,9.249271,6.425854,5.457257,13.136967,6.3247886,5.912292,13.409108,10.614965,6.3610187,6.7883844,9.202368,7.3086905,14.090375,8.79008,13.181622,13.251364,8.720464,10.069718,10.854906,12.927312,8.933981,6.0191326,8.239931,13.259594,10.295735,8.555012,5.575477,10.51348,14.350531,12.668315,8.324409,9.246933,8.143805,10.699531,13.519975,12.008571,6.5981383,12.157196,9.906356,9.302509,5.2434297,11.856595,12.69661,8.145695,11.573614,9.785003,9.554593,9.123345,10.100853,8.58861,12.590074,12.892291,10.886657,5.47032,9.6964,13.771885,13.064147,12.613528,13.444789,5.4640927,10.548461,14.620132,10.074662,8.912865,13.314429,13.060602,9.515076,12.67833,13.419393,12.426565,6.4501595,8.836513,12.77258,10.874423,12.46851,7.0244803,5.499452,10.076502,14.308109,13.244215,13.806357,6.2106724,13.451934,9.786723,13.734908,12.092817,9.265448,12.305325,12.329488,7.033073,6.1699605,13.4589615,8.837245,6.3746266,13.293566,5.7127676,14.055855,4.7036343,11.670615,9.856273,14.688365,5.583298,12.679659,8.57839,10.273968,9.005083,12.243977,11.064185,10.856776,8.715701,12.653483,5.371827,8.681096,11.022854,13.056476,9.211427,4.453753,6.2643476,10.463578,6.9800267,12.088854,12.876804,10.354084,10.767001,14.115652,7.957384,12.196746,8.6332,8.084025,13.682446,13.107146,10.032619,9.69036,9.323333,8.41143,14.769463,12.016138,8.807096,12.38404,10.7434435,10.189317,12.136019,9.323409,8.902657,11.050571,10.416365,8.676268,9.770213,9.411928,9.320033,10.565612,12.712623,6.2089577,12.40196,9.161059,10.385112,9.253883,6.28491,4.493342,5.519858,13.957633,14.204701,14.030448,9.110961,8.521572,7.0022216,6.043536,12.240106,8.960155,10.869202,12.588437,11.21454,13.789219,5.2492557,9.36558,12.503577,6.594854,11.777025,13.592802,14.893482,12.315999,10.489158,12.50508,8.483463,7.7613554,12.942223,5.92304,11.011178,12.635495,6.2666564,6.0662885,13.450633,6.403632,13.402822,7.374825,9.856536,9.667984,8.744882,10.085321,12.466374,11.481804,9.2507925,14.197286,7.938017,5.703527,10.608407,12.844986,10.782873,12.207741,14.0406685,6.3863635,5.116676,4.420926,10.338497,14.153686,5.498348,8.566634,4.3796945,5.236819,10.394315,10.418288,6.1612415,5.0433965,8.557071,12.917033,13.835833,13.715588,13.72235,9.574841,14.162801,12.525891,9.232131,6.0199814,13.720341,10.323265,5.306065,6.060321,11.220058,12.143261,14.075839,7.1066284,14.182296,6.92261,13.593506,10.468222,10.680461,12.0789995,8.697446,9.687782,10.23306,6.6238813,9.18967,9.838315,6.1535263,13.7281885,5.4690566,10.177808,12.441006,13.618811,12.865541,10.657466,12.716006,10.326422,7.224504,13.598901,11.031427,7.766135,12.454093,8.279797,9.418243,9.461329,6.4475465,11.386095,5.268543,14.155857,9.898971,9.651481,9.978665,6.1003556,9.575424,12.99198,9.087252,8.708663,10.9699335,10.917459,11.066676,13.192869,13.66622,8.101841,12.572117,10.668349,13.271351,9.500334,11.33381,13.345095,9.058337,6.338348,9.755673,7.1696315,12.792702,5.8682785,6.540107,5.8536377,12.956646,8.896229,13.305413,14.051297,10.662219,6.1559987,10.260275,6.941982,7.1473403,6.4330235,6.2207484,10.30633,8.681745,7.089457,8.4525175,6.1657014,13.087371,10.335217,10.493211,10.161064,11.504436,6.351531,11.149639,8.775181,11.466733,9.248312,14.034089,13.47209,12.537085,14.677857,6.0843797,6.073233,9.894963,6.2807345,13.028297,8.027479,12.912278,10.412091,6.6284943,10.345458,11.631142,12.547913,4.912755,13.482125,6.6478777,8.515776,11.439924,12.353304,9.562378,5.500601,9.356005,10.487187,11.140768,7.761961,6.733416,6.7466416,10.520742,10.251616,12.329332,7.3062396,10.400339,6.963315,9.137325,11.5924835,11.872826,10.234281,5.0832906,8.204795,10.1996975,9.96027,10.299539,9.443014,6.1686106,6.6944003,7.299781,8.792462,14.320737,9.814677,10.836161,8.371625,6.386604,7.7493877,9.218437,9.649852,5.983196,7.1818223,9.588512,10.851042,12.196632,13.605912,5.42982,13.943745,11.925633],\"xaxis\":\"x\",\"y\":[5.0736265,7.27242,10.306951,10.756822,16.988134,10.124055,7.717263,9.270037,10.473792,7.220402,5.029368,8.580396,13.34363,8.708819,14.085154,7.33305,6.781671,6.6939,9.141437,10.036912,10.004075,6.4871683,16.66633,6.3891177,6.599431,8.829059,10.618837,4.7156177,12.30289,3.6500368,6.849521,4.987097,6.935223,10.203426,6.147214,8.906668,19.052408,7.8452234,12.638277,6.884853,12.824537,15.836417,10.36757,13.96814,8.298893,6.772699,11.475432,12.085151,5.794098,12.56077,9.75341,9.703877,8.816536,12.366322,5.17561,11.734881,7.487909,14.068505,9.129375,7.197911,9.163928,9.194148,7.3229704,11.087787,8.59824,8.896461,4.369792,7.389671,9.924152,10.95035,13.203636,11.408607,6.73869,12.561405,10.145119,10.524403,7.0694823,6.99216,7.5143366,18.717407,9.738764,14.121486,13.897416,7.5730004,16.678377,7.429007,13.470015,8.977966,9.206411,7.1708407,13.036548,12.218722,7.5402727,3.6294053,7.209913,10.144994,10.726645,15.684553,8.774334,16.995724,7.31859,8.851496,9.184316,6.282827,8.724199,9.062772,11.816126,13.374605,16.602766,8.161801,8.772803,8.704838,15.8824415,8.184966,19.066795,12.975207,5.6049385,13.658715,13.925107,7.663668,5.564119,11.165742,15.785803,10.067908,10.880136,11.188653,10.696821,5.1503263,6.719168,7.914655,11.269985,7.2513804,7.2192826,7.374183,11.824554,8.199579,11.944093,5.722234,7.0081215,12.15877,7.7211213,13.399446,16.277338,5.4529815,10.826503,4.716783,3.7234824,9.949161,11.258589,6.6287007,6.1968102,5.755166,13.342471,13.470177,7.0783973,16.608574,18.583624,5.2810626,5.1294446,13.596117,4.8008127,7.0327325,13.461378,11.588912,10.682042,16.158142,10.576288,13.899222,7.4678016,6.17979,7.496757,12.285343,11.233291,10.740231,10.354587,13.5166445,8.786899,6.946276,18.672451,10.190956,9.179781,6.3259463,11.980919,12.452047,10.976155,7.5814815,8.152396,7.500675,7.782856,8.538421,16.5288,13.394632,4.522752,7.2304173,6.879339,16.644482,6.50978,8.873734,7.222328,13.638974,10.06167,6.3926954,10.023517,13.521309,6.897572,9.732231,6.308709,4.483965,10.63159,8.833831,14.128822,10.532019,16.258192,12.486702,4.5706058,8.529826,14.036237,11.3992815,11.9375925,6.7108145,11.328624,11.919008,8.782895,12.195301,5.9641786,8.918279,4.954431,11.18542,12.265856,16.412088,3.6658576,11.291592,9.575043,3.9940765,7.081668,7.1694922,6.0654297,10.277369,7.739027,7.8653274,11.585847,5.873078,9.046366,6.705464,7.484184,6.434502,15.435382,12.098221,11.301822,6.989112,13.208335,16.618124,13.996553,5.18387,6.1890025,4.488781,4.7970724,6.2463703,11.693233,5.892136,6.7506967,6.889528,6.8995,10.873587,6.7993245,15.023454,13.683952,12.676764,11.650425,7.8563056,5.6177216,16.683092,6.8027596,8.168259,7.098977,12.088662,11.449538,7.596974,6.691715,11.453376,5.7626715,8.659354,13.536417,4.989338,7.5426874,16.609884,9.04086,8.556392,13.034375,7.517062,9.327251,5.7658124,18.519852,10.373464,6.439859,13.587105,9.202193,13.8355465,8.128597,8.261501,7.1007104,13.17396,14.154946,12.14737,4.6721654,5.702617,6.0517087,9.924598,10.945652,6.180827,7.604876,5.990142,9.007387,4.945385,3.6687949,12.710328,10.916508,9.501659,13.009291,7.379829,7.113472,7.564984,8.459784,7.45102,11.564533,4.021068,5.482309,7.67399,7.7250056,10.880274,8.569712,7.4480014,4.400683,13.2447195,6.2114434,7.2562013,9.642522,9.604637,16.17403,9.483038,13.325508,6.135509,8.231399,12.283101,13.92286,5.8868365,8.5485325,7.715525,9.094756,7.818135,16.573889,14.488126,10.888376,12.249293,7.56897,7.802247,12.280635,5.7497644,4.039863,5.612343,5.403429,13.664614,6.6018367,7.4199505,5.4664316,7.4947834,16.51849,10.209836,8.851761,3.9884002,13.145748,12.685696,6.8017716,15.140738,9.925896,12.514066,11.302111,8.55014,10.637146,13.587489,8.578729,5.222698,17.002537,10.189234,10.087091,12.119998,13.475315,6.8392105,5.679344,8.55436,11.89293,8.894309,10.328013,7.3744617,16.159973,13.307014,8.025812,6.8184075,6.312526,10.638518,14.156958,6.932102,7.350669,4.6223035,12.086458,12.527005,6.081671,5.129303,6.4572296,16.323177,12.581865,7.637827,10.735374,7.519741,8.267562,11.107502,7.2554517,5.4330993,8.482899,11.445055,9.956767,8.979838,18.681301,7.2935762,8.560001,6.9396687,11.434695,18.655094,8.0852785,10.939521,5.5220757,9.239516,4.889942,9.253694,16.648815,16.52644,9.001354,4.5222564,13.391988,9.502995,12.6641245,6.7554975,5.3880796,11.39042,9.027819,16.78994,13.450729,13.450624,10.639808,9.019586,6.4547467,9.184305,9.25915,6.6503196,7.2158957,7.196495,3.6798675,12.916778,10.996843,13.349501,4.3984156,4.4031315,3.6653633,10.524961,7.769617,6.578164,6.026961,6.114562,7.774787,7.3942666,8.847923,7.176928,7.3772244,5.085609,11.660551,6.818402,5.6596475,5.1649375,6.4335175,17.010744,10.184836,8.979341,11.701778,16.824268,7.8818464,10.273242,8.0370455,13.032532,8.122805,7.055065,12.292464,10.195337,7.9033847,12.329586,7.829595,7.562167,10.1071205,7.986413,12.277826,16.567888,13.724718,5.9113145,11.323137,10.660194,7.6010733,12.811905,6.4862075,6.468259,12.55763,8.716654,15.364847,6.7442446,9.255258,7.1864934,5.0541005,7.8099895,3.6990612,13.970791,6.9714427,11.431894,13.079464,11.195926,13.108512,6.25556,4.476967,8.721328,8.761021,8.058437,11.288137,8.132321,11.897312,12.364921,7.9894505,11.383293,6.0971885,10.501132,13.769398,8.0737505,8.665084,13.722471,15.964804,7.8035984,10.401968,6.6513233,8.727021,13.973864,8.155335,6.161517,10.243232,7.7924585,13.477563,8.75346,12.047174,12.829296,12.282898,10.666929,10.159646,9.214758,7.8415775,6.719635,13.461461,5.608096,4.961379,6.428215,9.79143,7.826593,7.3304725,5.688591,14.173094,10.754816,10.630199,11.860119,7.498348,8.37025,8.338521,4.963566,9.016496,8.502507,4.29642,6.141441,16.607637,12.98769,16.569075,8.57113,5.744878,18.654768,10.043776,11.544039,10.69366,4.864554,12.055482,12.285614,5.840493,10.609049,7.767255,9.429744,16.235794,7.0124135,11.892119,13.4991255,4.561627,13.3119955,5.878175,10.244676,6.8857865,9.209319,7.765841,11.101275,9.508235,10.510666,10.652897,11.701918,12.050903,9.209793,8.933789,12.500524,10.751127,10.918223,12.309245,14.137848,14.122157,7.051846,14.096969,9.607568,11.280763,6.52348,12.424523,13.902839,7.282544,8.932739,13.303195,10.782061,6.276182,8.077762,5.9014797,9.212926,5.304378,13.156349,8.6203165,15.126079,9.868996,12.167917,8.887431,13.420315,12.263794,11.439074,5.993708,6.314582,10.598534,8.450413,16.624483,7.390077,13.672379,7.50574,6.7583213,7.186124,9.760935,5.3458858,4.771147,14.192564,10.3231735,4.150591,11.347196,10.820536,5.6732535,6.018732,5.8151913,8.944907,10.817616,4.68275,7.6262455,11.205106,13.274685,5.421583,12.526725,6.850784,6.6124873,9.852568,14.116339,8.417822,7.314401,10.228165,6.9589252,12.088205,7.4529977,10.565053,8.673867,16.70968,11.151347,9.778077,4.888286,11.267495,7.268852,8.105633,7.1259365,4.4646864,10.731014,5.941612,4.206846,7.4751463,5.3445735,11.680507,13.451646,4.7853713,12.298073,7.7194405,13.357501,4.442893,16.036772,16.562914,9.531241,5.290546,12.46159,6.541769,15.538859,13.639864,12.120559,7.249042,13.390108,7.527168,14.120802,6.1847444,16.52788,8.82175,10.311735,18.665392,10.846261,7.3381567,6.8082857,10.505728,6.043659,10.457893,10.683735,13.65423,11.248825,8.529164,4.552201,4.169134,7.714175,12.597658,7.686208,11.155235,4.804585,5.2213807,12.192765,14.996671,10.365756,11.106278,11.440473,6.5075727,5.7228127,6.9510207,14.0794735,4.774083,8.133946,8.602139,8.963566,13.396364,13.426759,4.813781,11.2841215,5.816651,4.8550844,10.899343,12.172054,16.55873,8.900371,7.717517,15.107901,7.6481495,7.329327,10.644082,10.277406,7.6817107,12.215798,8.965698,5.6039004,7.9555335,6.038448,13.819434,12.052887,4.6930275,4.853596,4.766051,10.664494,6.2013974,7.2134514,5.9367456,12.31274,8.706147,6.471687,8.236963,4.0644317,9.511421,6.794188,8.578293,4.775629,6.14915,8.052176,9.194311,12.5048895,6.785792,7.252853,7.2892313,4.678606,7.4539294,6.4918995,4.8493495,8.879507,9.33872,6.249467,8.427354,10.060794,6.4113975,8.734011,12.225846,12.809102,5.1225834,10.642825,10.724285,4.421892,8.050193,6.640748,6.123785,10.518082,13.811707,13.403656,10.481901,16.602846,8.770383,8.0015955,10.188574,13.807622,16.61861,13.630298,13.515361,8.781148,4.5751963,13.6244545,10.29074,17.013037,9.318426,10.15928,16.653399,6.356914,7.2690673,6.5159473,8.78998,9.596031,5.9418836,11.345836,10.617274,13.874634,7.5725226,10.805381,13.403191,8.693246,8.838781,5.410617,6.2789364,13.530356,5.1960435,8.985006,6.197947,13.391776,5.8103995,6.0465574,13.814654,9.549646,10.446485,5.801409,13.33149,5.853852,10.608255,9.269665,7.1400833,10.471973,13.337155,10.030942,7.630878,11.425366,10.662108,6.0730085,7.61027,5.730259,12.141639,5.1126127,13.866601,9.9603195,7.5027843,4.9439297,13.253361,18.594763,10.816298,10.274926,5.538905,10.6845875,4.7831345,6.278428,6.651397,7.0124226,7.967016,4.020787,7.3157697,13.057299,5.5553513,8.846061,7.8359876,16.24593,7.045663,9.84717,7.060004,14.181454,10.860353,7.2776933,12.508518,13.002933,6.648193,13.50672,13.524273,16.807875,14.363629,6.2616715,11.177981,10.895716,4.8462944,12.505365,7.574068,6.8950267,13.618245,11.361464,5.8765764,12.002897,5.7477093,6.859829,9.483092,4.7829146,8.671366,8.857023,8.177709,5.3098598,4.8648653,18.610924,11.157307,7.8958135,6.0880637,10.874438,8.954338,8.301751,7.802452,9.481105,13.962881,8.221655,9.071502,6.45874,4.516446,8.028652,10.1908865,7.9060307,5.8785043,8.609102,5.4117217,10.529964,4.34861,5.1507425,7.921093,3.758875,9.843476,10.471903,16.61341,5.1536155,6.0320587,6.6608014,6.3505225,7.2826715,7.079953,7.347635,7.4647017,8.327268,12.270738,10.57764,19.072605,14.037728,3.9361343,13.216833,8.57543,10.532592,10.678892,5.721182,11.337825,11.720751,10.852294,5.9738774,8.347908,9.703668,11.493163,4.01315,9.309399,9.586155,4.805792,10.838526,10.167798,6.9562907,9.638302,8.620232,5.915579,11.771376,16.161102,6.184411,7.4866853,9.303144,6.141313,13.1175165,13.646947,12.311613,13.416703,10.678507,8.4144125,8.478259,7.819085,7.3744597,6.7694135,10.209942,6.0564375,13.926726,8.568194,10.782331,13.5356,18.803108,8.742482,11.290497,8.8164625,11.9819765,6.0849757,10.878093,9.132327,11.36007,6.714515,7.2505965,7.6278,7.8088803,8.334703,10.183774,14.355976,5.685105,7.100657,7.830301,7.68342,13.362674,12.694027,4.3701167,5.7765565,12.080995,6.5946035,6.1042776,8.563828,12.715042,4.890551,16.530737,10.371734,8.61797,7.391846,9.266951,11.449294,12.479896,9.423682,7.335127,8.933018,13.506418,11.649274,14.085334,11.586834,7.6268234,9.694066,11.620655,7.951521,6.4763107,5.8607707,11.318622,17.025288,8.860369,11.298596,13.123577,10.775797,10.882752,13.190495,13.447553,11.480771,4.427762,6.194647,9.57724,10.087346,13.013317,12.941096,6.5807486,11.12048,11.758792,6.498417,13.605547,10.540945,16.54986,13.671008,6.1666,16.646461,16.601734,9.971414,11.874309,8.703199,16.701422,16.816525,12.1803255,6.722988,9.003586,6.6801662,8.838019,11.219018,9.913446,8.518534,10.298719,16.072819,13.367752,11.207745,9.351772,15.788375,10.221463,7.21644,6.530149,5.5017185,7.3461556,11.249395,10.631405,4.621278,6.515129,14.048577,5.899467,7.7771244,5.2803802,13.526007,8.203084,11.510079,8.051989,8.036185,8.970218,13.630106,14.967751,5.8423586,10.438047,7.659437,12.649237,10.30492,9.928746,5.7491827,16.703959,9.614924,7.60931,8.296443,8.347041,15.980155,4.4977336,10.005655,5.7090306,6.563647,10.149416,5.234768,7.251551,11.951913,13.483254,7.965818,7.6505084,9.560025,5.9471283,13.119723,13.955479,13.357601,13.25667,7.517744,18.786182,7.2853723,13.652889,15.667036,8.141615,6.7524195,16.337004,9.902054,9.867639,8.433193,6.8177686,7.0009656,10.038175,9.922128,13.29855,11.705369,7.752258,11.340248,9.955776,12.2835045,5.902941,9.53095,11.373911,12.495747,11.196136,15.229034,8.814887,16.282045,9.857556,8.935554,13.855553,16.286343,7.0427747,8.8044195,10.373688,12.184753,13.728184,10.643869,5.694331,17.031775,9.7238,6.2031937,15.808226,8.936484,10.060067,9.698598,6.3924236,4.589538,7.065865,5.860836,18.711943,7.442727,6.085162,6.9276686,11.731201,7.162091,9.036058,16.123146,9.508125,11.287027,6.9059124,5.877835,4.986721,12.59393,7.7426906,6.738302,3.8453403,5.0730057,13.647306,8.829246,8.424158,11.5104885,9.866906,10.901575,4.588232,6.736866,6.89752,11.5658045,18.56743,18.99723,3.670382,7.7140956,4.5127063,10.955739,6.2388287,16.553501,11.261988,7.5231433,8.775174,11.080519,7.7879777,8.216504,8.443243,7.9828887,5.52742,7.9555664,16.51749,5.481108,11.518559,9.102586,14.087978,5.412433,9.198932,6.9462934,10.527938,7.023761,11.468248,11.392559,12.609841,6.779373,7.034286,10.178237,5.43584,6.748125,13.96346,10.34636,9.966328,13.466279,4.443775,4.993153,8.931433,5.9077306,14.243565,9.395992,6.774444,16.618097,12.065101,11.021856,10.260328,13.199869,7.396929,7.658286,10.852013,19.052425,6.033525,8.882469,5.6132197,11.260247,16.307478,4.0517497,7.1673656,7.688685,5.272729,5.41929,11.756354,11.851726,11.419341,4.6647673,11.046662,7.524402,5.5459948,5.207102,6.9207544,4.8348436,13.412556,8.948724,9.097421,6.5565186,11.503084,12.160144,12.798709,10.512618,7.8859954,4.7022033,6.5043077,6.391324,7.3712654,4.4980845,9.260169,11.463153,9.281931,7.9726753,16.242155,5.6209426,3.6231253,7.2149525,13.834995,13.788745,7.106523,10.281146,8.193821,11.587963,5.0890427,4.888921,3.835392,7.5428348,6.6543508,10.382199,10.654419,11.043567,10.094271,3.9945183,11.036162,7.7434673,16.996878,11.289506,9.937073,15.231956,7.270515,6.4832573,8.977452,7.525646,5.138031,11.352429,11.635546,14.231404,7.3471355,10.822535,5.5563498,13.403651,6.075296,4.784387,7.995219,6.9141154,11.112268,13.461317,4.473204,5.6571484,8.440807,12.293159,8.770341,7.1170664,10.482492,6.380736,6.506242,8.795167,3.9246254,7.82779,16.577978,10.001085,18.666452,12.062284,9.146099,16.627684,13.778819,7.5645266,13.254296,8.935625,8.692363,9.341301,18.630297,5.5498457,6.6020546,18.622433,10.961211,9.055719,8.165318,8.785507,13.701779,6.898577,7.584287,4.4127393,4.3663797,7.287207,12.678409,9.138591,11.492156,12.537938,7.625989,12.471886,11.863707,6.8173704,9.909019,13.602761,6.901964,8.782615,9.957249,16.301785,8.200258,8.651822,6.136908,11.542648,7.3156605,13.233641,11.939558,10.291984,10.689944,6.5651484,6.3581786,4.4816937,11.642454,12.417059,4.1246133,8.208292,13.718525,12.958117,8.2223625,6.686288,10.851136,4.522056,9.004463,14.03016,4.998247,13.099393,13.605883,10.99669,10.646431,10.904981,14.590565,9.088455,11.851917,6.521724,13.815079,5.391375,7.760015,6.3617215,12.532291,7.2137437,4.679912,3.7242112,7.393872,9.247525,5.152391,7.121547,13.4048195,6.4784346,11.676425,18.523148,8.597492,13.785064,7.614892,10.623995,6.2845597,7.9104533,18.579805,9.144465,6.387868,5.224622,13.562375,8.650583,11.851051,7.5379663,6.863324,13.932438,7.231233,8.910992,4.55973,7.825785,6.491757,8.694718,7.5186114,10.872588,4.7256618,13.724242,8.878478,5.6792073,12.2863655,18.567596,7.172896,10.203749,8.354274,10.57192,12.295741,4.491201,7.8477235,7.6084895,11.14007,9.983413,11.767957,11.666213,7.5205317,10.718525,8.056915,4.6082335,7.5383153,9.743516,13.402014,6.5780067,15.106325,11.786097,10.4354,9.832908,5.8050675,9.875507,4.0275426,8.873774,7.87798,7.57213,13.270546,8.391258,5.0159445,6.1888876,11.14099,7.0618753,14.29429,9.758609,5.7287064,8.238754,9.689441,10.131514,13.14197,5.8717074,8.09589,7.493693,3.6674573,12.464768,8.282643,5.482492,9.970784,16.453835,13.503503,7.1650605,5.606164,16.189098,9.413967,16.567675,16.688013,11.423264,7.4029617,8.054873,4.697155,10.314806,4.3744793,15.518625,5.1552577,6.7059073,9.1808405,5.5839705,4.393374,13.859769,7.727652,8.476474,16.62147,13.800938,7.563068,7.7156873,5.5339675,7.212349,10.3012495,5.5570946,14.054861,7.9871874,19.07594,8.404034,12.020287,11.224903,16.196426,12.957981,4.4975505,13.556761,7.4529343,9.060808,10.895299,18.642868,5.758045,4.3830466,5.923433,10.026929,8.360382,12.174177,5.9566784,8.0749235,6.277634,13.911278,12.802096,16.412304,9.689591,7.80368,10.837849,16.62189,12.49436,16.669449,5.619471,8.7619095,12.836518,16.602163,9.843106,8.088502,5.6133795,13.21345,5.638866,11.65552,10.437887,7.6085677,11.318222,11.5749035,11.625071,18.122465,8.8131,13.651141,8.631639,8.527108,3.9215562,11.176504,7.0640507,8.298507,14.216507,14.197581,8.650847,8.473843,4.524005,4.3871856,16.994446,13.469824,16.838968,5.7819858,13.767751,6.715049,14.19088,6.0897684,6.315683,12.731582,9.889086,5.3124433,8.811074,4.904117,15.852203,6.225111,16.59016,13.82802,5.849887,11.305555,12.01311,4.2671456,10.561456,4.92487,19.082354,7.5115128,4.927709,16.184456,6.2815137,15.239557,16.961422,12.310657,6.5377283,6.43251,11.571075,12.211166,16.437595,10.916266,7.2344937,9.926572,6.114407,14.6190605,10.133285,6.949651,5.630794,11.135078,9.397626,9.118683,6.0090656,8.609857,6.910002,8.883503,10.747565,8.349045,5.861253,9.758713,11.70106,9.985486,5.735381,4.4650927,17.02897,7.4639926,10.002571,4.688829,7.1650677,5.768412,10.237424,6.185085,9.4814415,4.766912,12.569761,8.472076,6.839387,12.2853,7.879925,7.275847,8.258716,10.380872,11.163231,7.3076086,5.8304033,9.576857,6.818621,7.9373207,5.671254,10.9508705,7.392866,11.458148,13.661416,11.1488,7.5381713,9.992081,7.0732975,11.360786,10.320657,7.2931314,9.10179,3.7189097,3.845615,13.106227,6.883678,5.900665,12.042499,13.85389,10.815355,9.797289,6.6527796,6.7857223,7.448006,9.899724,11.494268,11.484166,12.494765,6.736552,10.327624,6.6153493,18.706463,9.229485,7.5711875,7.80414,7.3181515,11.254418,7.3913803,8.583731,16.525135,14.199295,8.716859,11.469511,10.116741,13.726084,13.784294,13.04727,7.790851,12.752791,5.7605968,11.749276,7.539274,3.6646278,10.613982,6.3018346,10.895972,7.823425,7.973836,7.218959,6.8219423,10.243062,7.533536,6.090516,14.916437,11.418744,18.633377,7.439829,7.1762576,7.4720907,6.395772,13.381411,13.254278,7.03552,10.142424,13.143864,6.9558954,8.97507,11.371543,8.75527,9.193172,9.707735,6.6721706,10.8572035,15.627186,13.277265,7.037054,16.50842,10.292181,8.583571,16.732979,10.002245,10.592933,4.6349716,8.823856,16.630615,12.883968,8.655947,6.460234,7.2216506,6.614646,11.326955,6.800206,7.3139925,10.094222,13.008364,7.5219564,7.6586432,9.203164,12.279979,12.142022,7.1386247,8.874116,13.463629,4.8813977,12.884393,16.074427,8.855526,6.387464,9.03146,10.279727,13.324721,5.9357657,16.291388,6.6667576,8.7369375,10.178558,5.1666594,7.5475926,10.290534,6.926735,5.995887,10.506378,10.240345,9.836944,13.589541,16.569012,6.224712,11.210921,8.34145,4.3272657,8.598368,8.433014,6.3735347,8.619316,6.632746,5.577943,11.979417,5.917706,10.145919,4.997311,13.309937,7.954965,12.431135,7.9679184,7.1778507,7.447879,11.293119,8.838454,7.8726935,7.554928,8.898465,7.1497054,6.842079,14.112263,8.509082,9.622069,5.4857907,7.476228,8.202047,10.735841,13.98453,13.511882,13.221562,6.9048367,8.0472145,6.9156713,10.050545,5.8575907,10.87266,16.605051,12.306089,4.2130365,6.504202,7.261648,6.6091704,5.709958,13.398071,12.0627985,14.035444,11.7885,11.364084,6.5644126,8.103264,7.537163,4.177449,8.385208,10.202521,6.9684396,4.838332,7.6809387,12.324681,12.770121,11.058447,7.0712895,11.047639,8.354732,4.5828414,5.9940047,6.9243174,7.7228584,6.784396,5.9757433,10.99685,10.223563,6.6635222,8.187773,9.782732,4.2821636,5.225878,3.987579,4.677921,6.6315894,4.807698,4.6712446,5.569069,11.238143,13.029389,9.155924,11.325441,10.862,6.4893556,4.7012258,7.2686133,3.7063303,10.593094,10.95315,8.825581,11.02335,9.773012,9.968997,9.005805,15.0631275,11.832954,8.200045,8.754854,8.41898,7.359191,10.93334,9.089171,11.235542,4.1147084,13.405203,11.655721,10.654537,5.247457,5.512507,10.886302,11.45633,16.251968,7.433919,5.722585,7.5133185,12.756161,7.053331,6.3476334,9.026997,8.568691,12.597959,9.579885,6.990729,7.440891,11.510094,13.430323,16.259153,10.18706,13.440949,7.9240794,16.255272,10.622551,5.8429437,11.915783,6.671675,11.399089,10.527958,7.914457,13.393061,13.479024,7.453153,4.6511655,10.77491,10.956078,8.4479,9.777064,7.124686,4.4222608,9.681002,6.8639636,5.77725,8.954282,8.945544,7.9962234,6.3983107,7.4381304,4.1308928,13.763704,13.99949,4.0815496,3.9163048,10.590469,7.177212,9.579661,6.3668323,6.427002,8.844027,7.7406063,6.237179,15.768148,13.296993,5.6598783,4.952258,4.753136,4.6321244,6.644624,16.300993,4.4256635,6.5387583,6.397353,7.1312985,10.2286005,9.279703,12.939412,11.191771,6.8052735,9.047175,8.562038,6.5354548,4.4437604,9.810317,13.790379,6.517436,6.5566015,6.901775,10.023686,10.003094,13.45332,10.938978,9.449575,4.4799447,8.891872,6.178721,4.478276,10.435247,6.2628465,12.5008545,6.192183,7.355138,4.07119,6.8412886,8.77012,5.523063,4.448924,7.31275,7.4374633,5.4751773,6.352994,10.240502,5.5853868,11.818082,11.109703,16.016016,11.879379,11.126939,16.208796,7.8620863,16.370934,9.898943,11.58324,12.948718,11.288461,11.544705,11.798452,13.665077,13.803745,13.9949665,7.26173,13.725759,6.8046246,13.545989,10.907239,18.656994,6.9048057,11.718219,7.547709,6.293648,10.645214,8.830187,10.32524,13.654983,5.9666166,11.323416,8.052205,5.3524404,9.259682,7.711135,5.2736287,6.9125013,5.9647107,13.674017,13.495943,14.193989,8.464766,10.583143,10.968763,5.4596753,10.563313,6.274383,13.6404505,7.875702,10.9578285,9.017958,6.949047,4.3568544,13.680821,12.987424,5.976684,13.645324,17.031546,13.061721,5.5435987,13.516813,9.110887,3.9410071,9.411057,7.3162804,10.457158,10.049847,7.194104,6.2035017,9.743144,16.226566,8.72125,8.380952,10.80521,6.340895,12.082208,11.661355,13.865198,5.844474,5.628879,6.726678,15.215785,13.704786,12.666535,7.879219,8.938618,14.006522,6.065008,5.624904,3.8502429,7.057266,13.1911335,7.235629,11.030479,10.150901,9.525896,10.878594,10.331461,13.568643,11.7990055,11.015868,9.412594,4.7345204,14.652693,6.1187034,16.447468,16.246027,5.3458843,6.54945,7.3137174,13.132466,11.800053,10.232678,13.559351,10.821582,11.531704,9.733931,16.624142,8.9566765,5.5310197,13.066035,10.232636,10.89097,7.0006623,8.480253,7.6231537,3.9517212,10.443306,5.114642,8.530404,10.647631,7.818989,6.668186,4.877133,12.212056,13.483719,6.720548,13.537154,12.45227,13.739606,8.815645,11.225444,6.0327044,11.51636,7.2813973,14.011575,7.0598016,16.362665,8.946488,5.667023,10.650296,6.172049,4.2663393,8.16683,8.804366,16.33663,7.9808707,10.212941,10.439748,6.09531,12.918769,10.875237,6.2997766,4.417923,18.642197,4.718455,9.273017,8.051186,16.12384,6.9651837,13.617911,5.53092,8.974888,13.403085,7.578621,7.7466865,8.025816,4.6902275,9.385142,16.268156,10.45333,13.569881,9.921598,6.9346514,8.959137,11.558386,10.953535,8.6186,7.212697,10.484605,11.805878,12.437675,6.190996,16.32879,8.28418,12.107054,5.6142426,6.850596,13.171772,13.385601,4.394785,11.313999,12.230844,5.1456494,13.818629,11.393311,6.466798,6.143834,15.159971,4.6678762,7.3643503,12.366303,7.4339767,7.9337244,10.0100765,13.960317,7.3498244,16.197346,6.565494,7.4675975,5.48051,10.765464,7.082953,9.419685,7.3170342,10.582418,13.590011,15.589313,9.720383,4.4221544,13.581096,11.605472,10.798822,10.649659,5.6637907,6.7806115,10.502274,16.965912,5.3286066,8.094693,7.0400286,11.09814,7.0470896,8.967672,7.254292,6.2475,13.4583235,7.909018,10.591554,13.508031,11.207781,7.7910404,10.39758,8.600285,12.372215,6.9209523,3.664682,6.130528,5.9283347,12.436447,11.568433,11.589823,5.9563274,13.37453,4.4944425,4.023862,4.4662814,17.067938,13.815969,13.721979,10.102581,11.473491,10.460723,8.794651,5.9058557,4.0239353,7.836656,8.287986,18.670858,12.940777,7.087008,16.637093,4.0506935,10.705356,13.2709465,8.8234005,6.096431,18.691208,5.5109696,7.5344944,7.5241027,8.716982,10.457661,9.574483,18.861887,10.881419,13.84443,7.227494,10.30155,7.832945,8.890388,13.361726,11.745851,9.433792,16.892698,6.349601,13.384749,6.8549232,4.552647,7.1800203,5.3997827,5.509041,5.9746447,12.6788435,9.324441,12.78588,11.289141,8.804192,15.312843,10.12622,13.751192,8.826834,16.654755,7.4054956,8.694423,7.3240147,8.988366,7.154219,4.4145865,10.69058,4.586139,11.373398,7.8512216,4.329629,8.237789,7.6587977,13.345277,11.334639,4.556195,6.2873893,7.8665156,6.069891,15.659113,4.3234687,6.4325404,5.1771703,6.199872,13.363277,4.3737545,7.1258745,7.6535325,7.933948,8.913847,5.457915,13.402745,10.7715025,14.792316,7.2493906,7.66356,10.059255,10.23638,10.803942,6.4351864,11.478979,9.724897,11.618888,5.4074273,5.6400642,16.58191,5.0603085,11.273584,11.3822155,16.337017,3.906363,12.280953,9.198622,6.3388896,5.6793165,13.52988,11.576126,7.0549083,7.7809505,9.848647,6.110451,7.4953017,8.421891,13.176202,9.071201,6.7369084,16.612247,10.993358,11.064297,13.70454,10.344029,7.6645722,12.084287,8.602754,5.2877064,8.543458,9.710247,4.4113793,4.887643,5.5900397,13.8705435,7.560405,9.238732,9.040654,5.5025644,12.514358,7.1868114,8.815033,16.076693,7.4029775,6.872366,8.156052,6.696073,10.705096,5.727429,4.708574,8.075588,4.0044613,5.0508156,5.7141333,10.288242,6.1466904,4.719709,6.296515,5.8703656,16.530209,12.035652,6.157372,6.37267,13.399953,11.780686,6.7452974,9.463718,8.8661585,11.306726,4.7157245,6.2502146,11.658977,5.2589507,10.551264,11.093415,11.718802,10.171662,4.3368964,6.063092,4.560569,12.01851,6.4248238,7.786344,8.188867,9.271638,13.075025,13.3124895,10.04049,7.9842954,11.747517,11.880518,4.0384245,4.790977,10.58644,13.763477,12.4207115,4.1216187,13.930594,7.5279293,8.847267,13.105903,4.4702287,10.768216,6.6213865,12.755308,6.654908,18.700092,8.965833,13.736603,7.001007,4.2695255,12.008214,7.058147,8.571574,13.273348,7.773502,8.521817,11.14623,4.6999793,9.711224,11.668759,18.66044,8.268737,8.087688,5.865081,11.351006,14.058893,11.822208,8.376776,11.02115,16.022324,9.146871,8.934864,12.402579,13.298697,10.069708,6.916587,9.4592705,5.012888,13.72194,10.6929455,7.673774,9.178854,6.6470394,7.062311,5.1496234,6.0884466,11.053859,9.281436,7.890077,10.797051,4.851152,6.9698224,9.072018,7.6481223,4.6477356,11.03827,8.664243,8.840851,8.728901,9.16462,14.258891,10.430953,14.150507,11.817007,10.773418,6.366345,13.898298,9.974446,14.070477,3.9312403,9.723544,13.717085,14.090859,15.012077,4.816686,6.772287,3.9247625,5.741585,8.021131,6.46795,7.8733926,11.579224,9.739725,7.373119,10.783864,7.780068,8.729295,7.4467673,13.999306,7.5357685,8.495017,8.627092,9.756355,16.6504,13.7978,6.1067977,10.839839,13.608583,5.709638,8.688705,8.991115,10.830231,12.876775,7.369545,11.186051,9.177897,4.702605,13.976194,7.4192533,11.5641985,8.835217,10.247145,5.0706344,6.240551,5.326108,4.010712,16.543198,9.582135,8.170381,16.623701,9.191363,8.310783,8.612754,6.60854,8.765349,13.313225,7.1376114,8.337827,8.206098,12.907546,5.669485,12.435366,7.0374346,13.756559,12.65627,11.623986,7.8316298,11.982995,11.282516,7.7798305,12.523602,7.8201523,10.984277,16.557774,13.602039,8.970992,8.616862,5.485804,9.863949,7.765583,7.9848895,9.182134,13.709517,13.654661,10.036022,7.342663,13.94483,9.7692995,19.117977,4.4365807,10.14584,4.707222,6.8403482,12.0196085,6.752786,10.742616,11.452051,6.5814085,4.989073,13.954443,5.948063,13.068772,16.371033,12.370736,10.767075,10.30216,13.0947485,8.098613,13.53932,13.653787,13.383577,8.577232,18.648212,7.2034054,5.154229,10.693735,9.199451,3.8573964,13.078578,10.027163,11.125263,10.807748,13.706184,8.102314,17.003986,7.18352,9.746046,4.3622546,10.789857,9.296018,8.563954,8.16816,6.014584,12.648292,13.50355,10.54085,8.891336,7.8160186,12.6046295,4.445538,16.171192,6.745486,5.9792576,6.6229486,13.785797,4.140666,7.2457137,11.346318,6.4928274,7.544353,6.708379,4.6236973,5.9371686,8.840612,4.934377,10.132009,9.300863,7.353797,10.840974,15.198283,11.680091,8.711882,14.768041,13.557435,12.911948,13.121432,7.3726125,11.199665,16.55334,12.788974,16.547182,9.870829,13.031169,8.435278,10.130199,7.800699,13.627749,8.07478,8.777048,16.515968,5.743698,12.584289,4.842536,4.6583257,8.393784,6.6206374,8.873998,18.749317,11.620457,11.11403,11.564207,6.0773416,6.8130655,10.600212,4.6052976,6.1656585,4.451487,10.595446,8.618052,8.859854,8.39477,6.1750913,12.0124445,8.55725,11.348584,8.828622,5.962834,9.08608,13.624271,11.904607,11.182194,8.937878,18.73066,13.92057,8.911063,9.028506,9.324831,12.404193,13.529762,8.262859,11.037776,6.8398867,13.68133,11.588013,9.006688,5.1169233,16.573235,6.203714,5.728591,4.898184,8.587,12.786473,7.710251,13.4145,13.951831,7.447083,12.869907,6.7596564,13.678677,7.990111,12.732601,7.668697,12.246639,8.299146,4.43173,7.3660502,14.820569,12.08912,16.612022,6.68422,8.755321,12.852133,16.182768,5.0518007,5.804843,5.300602,6.199821,10.58098,7.7650094,9.034815,13.505426,5.8109627,12.655972,16.332474,10.213503,5.371073,9.603848,18.66672,13.535878,11.614923,6.6605887,5.1101336,14.44929,5.464388,10.665758,9.731924,8.492271,9.937909,9.294453,4.971637,9.981644,5.7223907,10.642794,3.9881718,14.067873,16.489988,9.996249,6.8564663,9.972065,10.292531,13.458028,5.8832664,18.670292,11.44147,4.04322,10.657132,10.608932,10.5859995,16.133675,11.344451,6.728508,17.096277,3.932122,13.7745075,6.105332,6.210201,7.7107224,16.575375,6.0657783,9.3362255,11.166771,10.213797,5.6133156,9.150885,13.156671,5.4201593,5.633808,7.9772654,8.282068,7.6467547,11.369094,8.702797,7.6772747,5.3409886,7.2623897,8.436954,4.685919,6.472914,11.788816,8.506753,16.97469,11.299865,8.989221,18.667439,11.994543,4.3544965,11.074245,11.132895,8.800635,13.151916,5.791165,11.468955,8.272782,8.695193,5.1960654,11.122302,9.789414,10.756895,4.956293,4.745051,13.4316435,12.732147,12.819778,11.462702,19.069626,12.61838,17.028818,9.283589,3.6727715,7.4520545,6.449669,8.147618,10.481323,7.8050303,11.314811,5.5745473,7.32122,7.962519,7.205534,9.068648,12.789864,11.350761,10.077222,5.743727,6.3943877,10.77793,10.454047,5.634127,11.878731,13.782474,7.3220954,7.5823045,5.0641403,14.072533,13.942738,9.158462,9.811848,11.110529,12.763633,6.3606296,9.468223,6.0762825,13.45467,6.158211,5.6699166,13.517842,7.308245,8.785348,18.66005,10.214037,13.781273,11.041134,9.450493,11.628807,7.2319655,8.803642,10.723037,10.237935,6.5052114,11.046228,10.484811,12.530975,7.094625,7.626184,10.214435,8.529907,11.721886,14.220467,13.615106,6.1254206,10.008417,8.846743,6.5529585,12.062184,12.47864,13.741559,6.8343935,7.494206,6.269318,10.346335,16.512371,8.4268465,10.647093,13.639705,14.15484,6.2236266,8.24713,10.183318,6.132259,7.616672,19.067701,10.674079,8.988145,4.5243716,5.7878084,5.1359606,16.208742,12.198067,16.52469,10.219479,12.841122,5.573035,9.353239,7.662415,11.512432,5.280317,10.134108,6.614855,7.9336615,4.703808,6.5983877,6.6850624,8.862791,3.9717908,6.1290517,12.4242325,7.8244157,4.3314157,7.885197,10.426267,12.792387,11.972972,10.033696,7.5447636,7.7091994,5.5796423,8.87353,9.905222,10.742033,6.2879558,12.542683,9.883251,10.992956,10.649785,13.857519,6.5997,14.938136,10.167461,8.661744,10.803684,5.205548,6.6873994,9.702578,5.67194,14.188013,3.8824751,13.565041,6.975927,7.2458315,8.478105,8.73183,4.3725033,13.722108,5.515724,5.731728,3.8736393,9.92793,16.296545,12.169477,7.178962,10.216705,11.5505705,15.795197,12.258276,6.159831,10.858099,7.2238646,5.702757,12.415746,6.629339,9.077386,11.875083,4.6878057,8.600695,10.053929,9.927919,6.8270445,5.999148,5.6949506,13.722876,9.938524,6.3925056,9.988897,9.095829,8.758338,12.335029,10.993922,6.358355,8.099263,14.822033,15.167733,8.120819,10.648309,6.189208,11.147845,6.7628336,13.56732,15.536613,8.108729,9.632314,12.098533,7.966666,8.172069,13.9262,5.1046586,10.219297,7.4065433,12.6938715,11.426253,8.160214,5.37216,14.03994,4.5021877,11.622879,7.7547436,7.6810665,4.355809,14.510306,9.869759,6.2067275,11.214884,7.00795,4.630978,6.531048,10.573903,6.2761574,11.088958,10.482308,6.2893014,10.991811,7.07717,7.719214,11.933817,7.779977,12.801435,10.308109,4.5468516,6.679058,12.289749,6.3154464,11.83946,7.500468,11.680895,8.270161,5.7376466,10.734802,13.60047,12.903629,6.900787,15.128683,6.0209513,16.529398,11.639557,4.855602,8.614342,8.047831,6.3707495,13.773763,16.596449,5.2220306,8.299834,13.936446,7.0399537,7.611885,8.039913,18.466078,8.12085,6.4563065,6.2149024,6.615406,9.863926,6.491475,6.9591928,8.857441,9.10958,15.917066,10.759602,15.508556,13.402171,6.636461,5.1990404,10.851921,18.657255,7.7710905,4.277085,10.839719,6.6657,7.9883933,12.462799,13.656792,4.463676,5.55013,9.902142,13.4873495,4.4926434,6.0414586,10.631353,12.147725,15.191785,13.685921,8.746842,10.868408,11.593183,8.234241,6.8105693,13.627633,10.592884,12.727353,13.380143,10.885276,7.0464177,10.715052,4.8522263,13.833998,7.0481763,4.353415,8.155522,8.952838,10.938742,9.174596,13.779975,4.3660245,6.7532215,4.3775635,8.331872,11.96934,12.453548,7.813256,13.434459,8.166745,13.045105,5.2256126,12.49338,11.245399,16.123663,7.1537004,8.666945,10.87223,4.593108,16.958755,8.491926,13.4274025,10.572436,6.96617,7.884186,12.474566,9.909668,7.5832844,10.4673,6.967577,8.200316,14.049881,7.1043944,13.314754,5.776317,8.781922,4.0777726,13.636907,8.996244,9.593263,13.498041,10.917405,8.528132,7.5410895,16.977076,11.352671,8.8399725,6.8143997,5.059469,9.613392,10.973182,13.635836,8.569261,12.054769,12.3803835,11.996244,13.5788555,8.092164,11.141545,12.321899,15.061004,7.2490044,8.778888,8.93716,13.359038,9.437818,5.019388,6.972499,7.98276,18.721283,6.9076214,6.4555254,15.684539,9.942448,9.962853,7.304399,6.4731927,7.602154,4.580067,9.888935,11.088023,13.120285,5.1393013,7.5927987,7.9393544,5.5727644,7.8397536,5.131152,6.397186,13.105587,6.613806,9.859722,5.34796,13.574774,8.735453,7.51638,10.206055,8.825793,15.129681,13.3973875,11.605347,10.979703,7.6786003,13.35097,10.990691,10.234846,6.178323,8.076526,7.9906983,6.2682843,10.587618,10.054865,9.978279,11.393472,11.401585,11.0162,5.0728045,13.452028,6.8450327,15.912058,10.146833,8.134147,5.1936097,16.286037,7.0638547,6.0871363,13.588109,13.0793295,7.94653,6.4252243,13.978346,13.621786,6.7677574,14.198495,13.344002,3.696209,11.365028,16.409979,11.02161,8.590289,12.1492,12.442275,13.671998,12.815376,7.3527775,8.355494,13.555903,7.78431,4.8385887,18.645966,11.618971,12.3069935,16.655186,13.284764,9.10014,13.448869,4.414883,11.63662,7.154564,10.002445,11.417698,10.818756,11.084207,6.580737,9.808496,7.3675265,7.4620275,10.265364,4.813708,6.2293506,10.923553,13.727055,7.4534187,4.246891,5.9511685,11.071955,7.3085656,7.9002376,9.069536,6.64528,5.276818,12.535404,10.941662,4.4476776,11.182127,11.30633,11.407502,8.897515,8.3538265,11.26098,5.5353065,8.571872,8.856184,8.034681,6.5302844,8.711281,6.902543,12.938309,7.4882054,10.273714,6.037911,5.931815,6.147757,8.429505,4.584096,6.1660414,13.745552,13.668109,14.201057,8.83594,12.325173,8.551629,8.758814,11.117421,9.744318,3.6768708,7.4377184,12.719751,11.066657,8.056595,11.3259115,6.742783,10.982561,7.763804,8.369942,9.725534,18.59321,12.620924,13.527093,4.414023,10.034442,6.077291,11.453359,4.4658937,10.648702,7.8461223,12.172584,11.104885,16.41829,13.577846,12.1519575,12.441193,4.7881665,9.615856,13.073901,9.909431,16.636238,13.781839,16.56913,7.009556,13.7826,7.029555,10.354495,7.2708106,9.850429,5.78822,18.672487,3.9918857,10.957385,4.548308,6.0629992,7.0197053,13.397657,6.9238315,6.7580895,7.476175,10.2544775,11.025645,8.238723,14.527503,11.750914,4.6616564,8.092882,6.2139683,11.764812,11.627044,12.624546,5.62428,5.312172,8.887198,4.167369,7.7454166,10.586494,4.9379163,8.895125,9.618991,13.40074,7.4263425,5.337583,12.48302,13.212534,8.182105,4.79996,10.950939,6.6972513,8.192305,14.19999,13.556101,4.335621,7.242335,6.973301,7.503469,10.192756,4.860842,6.3491263,10.049839,8.881504,10.872714,10.238812,7.4440393,12.312006,5.1990776,7.391161,12.832271,9.795279,9.627951,11.205695,7.1067777,7.566655,7.05176,14.166189,8.3540125,11.00653,3.997506,10.977088,11.131615,15.681199,4.664819,18.657879,12.298803,8.472599,16.541443,7.229923,11.346101,13.452229,11.201174,7.4728746,10.942136,12.876162,10.155649,18.92202,4.01437,10.557232,11.220845,8.2079,15.946125,16.559185,9.780581,18.642864,5.234499,5.9958615,6.874573,13.024057,13.713798,4.33278,10.200267,8.793206,10.185058,6.6869082,10.511235,6.9918733,9.227304,9.679166,7.70167,4.379747,10.771908,13.87046,4.960771,12.41545,7.639547,11.076178,10.948312,8.606048,6.894381,8.986645,7.534225,13.781589,16.607826,9.425203,4.1627164,4.401347,16.601917,6.261016,11.288735,6.1813254,11.180281,5.402714,13.203328,11.6507635,10.174293,6.67334,10.646647,5.279186,5.6332607,16.631123,5.913498,11.509163,9.318872,13.953478,8.780463,9.363709,7.9121933,4.8677783,5.942282,4.414935,7.730648,10.846753,8.04917,13.203773,11.556079,4.888945,8.288193,8.057671,5.1585836,5.527862,9.329,6.878359,11.809098,8.103934,11.578516,16.551634,6.253833,4.9126,11.398056,4.749876,10.322693,6.446058,8.476164,8.88374,9.285797,11.685966,16.531103,7.1263485,11.515348,5.8736615,4.973957,7.227276,11.222682,9.121025,6.4163327,10.34465,6.375775,6.809602,4.45459,12.768286,8.418194,13.552591,5.640787,10.97296,4.807359,13.369729,7.5438504,13.722696,13.746575,7.352183,13.257643,15.205931,5.843519,13.496776,8.9700985,6.436603,7.4420905,10.880725,9.102403,11.387967,11.380979,9.081981,6.6694365,8.233285,5.965288,6.349782,6.3700533,6.250836,13.467001,10.057314,8.328994,14.06091,8.573434,11.474726,6.1467247,12.140533,7.794295,12.340216,9.31856,5.922546,16.530062,13.586331,10.593519,5.313236,7.22872,8.500894,5.865495,10.589589,12.855107,7.5136356,4.2984405,12.532792,7.944206,5.866999,11.3676815,5.7409067,10.978708,13.433613,8.637285,4.107368,7.5599766,18.663149,16.240694,13.205411,16.493229,4.240391,11.334233,13.628976,8.681673,7.304504,13.076734,9.368524,6.61231,6.361273,6.3888707,4.984326,12.449137,16.161448,9.602658,6.7801113,16.986202,18.70081,11.106262,6.8518224,9.363584,13.399165,11.68848,8.731798,8.990845,7.503465,11.27269,8.447997,6.5688024,11.187714,10.716343,9.75004,10.319251,11.526189,5.446004,16.536695,9.756984,8.078278,7.805223,8.626441,11.4747505,13.964221,12.372514,13.441495,5.704822,3.9197993,11.046367,6.2214622,5.17922,10.276901,7.136985,13.537151,4.09557,7.58117,12.2747,6.4762454,9.2450075,7.155986,5.564335,7.109093,5.5619354,7.1025047,12.3801365,13.774957,10.917972,5.6381874,9.288563,5.4797125,6.3388042,5.3318057,7.821888,8.46205,9.227002,7.514626,4.4689236,7.4122353,4.985806,16.961678,7.7306046,13.442254,13.2609415,11.300836,14.258028,11.763859,9.606309,8.257126,16.435871,5.463793,4.9298544,8.508712,8.676503,10.004234,4.5194206,11.434419,13.532068,12.873016,7.3554034,3.9649596,18.748001,8.536448,12.424619,4.2846794,9.145908,7.242525,16.605467,10.721438,8.025926,6.242941,10.120902,16.641857,13.337098,5.6648417,6.223863,9.884911,8.453929,13.698082,9.169041,12.257251,5.069507,11.489004,6.0600553,8.70977,5.818102,4.5843253,13.819927,13.014702,9.265413,10.934224,18.60771,13.965975,16.518616,9.590998,11.281305,7.3871746,10.763177,10.315667,5.7657747,7.4187756,10.410031,6.5146823,8.280079,10.554977,11.113689,16.672674,6.987902,8.574489,12.178683,9.1562605,5.1451797,6.5884004,13.507606,7.6839666,4.5534916,8.898171,6.850237,8.560343,9.277526,4.3309374,8.648579,4.44301,16.619143,7.9007335,10.262066,18.550184,14.563913,10.795269,11.228887,11.527228,12.45162,8.144334,13.652034,10.7664795,16.596535,11.198289,11.972049,6.320895,13.701114,8.038229,4.716433,10.811914,6.664734,16.234478,6.6973467,4.1313534,6.0123053,8.238425,18.664135,4.8904285,7.5223846,7.3507276,7.2577133,5.8848977,4.7847705,6.174765,7.0287175,10.521028,6.960518,13.886757,7.6784945,8.051476,12.273161,19.058395,12.0766,9.985873,4.8516126,9.433498,6.0119567,10.645774,10.630133,8.038633,8.512415,9.755343,12.377483,16.406786,4.378334,10.958179,5.4729853,9.922416,4.623328,7.9071307,7.222798,5.3392553,13.638669,11.278811,6.646382,6.9130487,7.9991765,8.937684,7.542531,13.912503,12.284307,10.825902,9.001537,7.4856687,15.903686,13.444124,10.990122,9.159901,8.917186,13.381131,7.336388,10.542528,5.325667,13.691214,16.38341,7.38346,11.239028,6.882343,11.01819,4.9184575,13.906999,4.433407,6.7834935,9.484572,10.60356,13.22078,13.696262,10.217373,11.533232,11.014529,8.220519,6.1196613,7.08596,13.9552765,13.701965,13.41335,19.081215,7.757569,13.431706,11.567996,5.2391095,10.720973,8.888295,5.0673485,8.025639,8.319663,13.562898,12.125689,13.719014,16.527197,10.201763,7.995198,8.010307,8.950011,6.8875346,6.956348,18.952105,12.529324,7.058643,10.883109,7.967276,7.8312697,5.5679913,11.268123,11.745688,17.05838,12.667505,5.107709,5.906866,11.038132,7.7064123,12.037557,16.212635,6.3182545,8.100924,7.0826154,13.281525,10.565935,10.888598,10.202354,16.435562,11.942067,6.407042,6.75103,9.119834,11.100337,7.8047185,11.441737,7.1043854,6.83155,11.544852,12.371864,10.6156025,10.690952,5.738734,10.699955,11.322082,7.85924,7.437003,7.6025662,7.2887197,5.5194798,7.4204273,6.0755877,9.4792,16.274675,5.4044895,11.601005,11.231967,9.301964,11.211106,3.635968,10.005309,8.167924,7.207873,13.695769,8.717642,10.477737,7.650744,10.312108,10.332075,8.819543,14.132416,13.669377,8.433805,11.922346,10.967463,8.892621,6.9559855,7.5012846,4.2561936,7.948189,7.866748,12.195221,6.3294983,6.5544705,10.284117,6.7419033,9.987972,5.978907,13.830779,8.464148,7.059836,7.911742,10.720292,8.249269,10.611458,8.192384,12.555269,4.407136,4.448002,12.525264,11.211536,7.125355,6.07062,7.24917,10.405916,16.654001,6.2462416,7.0832033,8.183478,12.054423,10.120449,6.030327,8.652738,10.502219,12.646334,8.890275,11.596825,18.830961,7.39974,8.407065,10.480869,8.126151,13.423229,8.786474,13.490702,15.794501,4.4993405,16.16608,13.931491,11.321949,6.3387275,8.859549,6.9187317,13.833208,15.923291,11.592303,3.8942065,12.610198,7.012359,5.9126554,10.800113,7.400156,9.22852,10.542866,12.140465,13.633499,6.2820263,10.935235,13.874531,5.4853206,4.6581163,7.09218,9.578476,4.4820743,12.200625,13.907209,16.010168,16.606081,10.344315,10.57725,4.4272394,10.999931,10.498416,18.93026,4.0000324,6.219373,10.395853,9.877739,5.614426,8.663645,10.528237,4.9657583,15.785067,4.5010834,5.8933415,10.6357975,10.236669,8.1273365,9.728238,16.356726,7.182535,7.632713,13.678155,6.814223,13.493723,7.293065,7.8540974,13.631332,8.891939,6.8233333,8.7893,10.584799,3.988397,18.703863,4.9922767,4.660063,7.2812924,4.914797,13.826882,19.023727,15.883258,8.075529,7.401384,13.152245,8.380772,10.228786,6.21563,3.6343014,7.408648,12.493557,10.988186,4.485437,8.971474,5.4846225,7.856595,13.696401,7.709319,15.204975,7.583718,4.701903,5.1791806,7.1567764,7.334877,16.469591,3.9074898,5.342476,6.6484747,8.728039,10.949314,8.140422,11.299185,9.142498,11.04145,12.272121,11.575582,6.206953,7.5015693,10.133509,10.801241,7.476156,4.283143,11.743179,6.4140134,13.539265,13.91304,16.61034,16.935856,6.5077543,16.356512,6.5865545,12.515204,8.769336,13.857782,6.5427723,5.516553,13.73079,12.648379,7.611715,16.085508,11.199552,11.143369,13.889308,6.239971,6.1082783,12.436729,5.715278,7.988953,4.4449725,9.673629,10.905243,8.301476,5.2583737,6.854818,7.686157,6.0271583,11.810327,13.478788,8.69753,4.868748,16.60268,8.843005,7.277589,8.948819,6.4811234,11.698466,4.8216023,7.9151998,5.021841,12.245967,11.355177,18.698318,6.322292,17.09366,13.269858,4.749599,5.320738,4.3072987,16.565598,16.443281,11.743584,13.714251,5.805024,8.712682,14.173004,12.114806,8.557164,16.58553,10.464521,13.428336,12.0993805,8.138434,6.6953826,7.949744,4.967668,8.832533,8.104143,15.897321,5.4649963,7.052325,6.62997,8.851194,8.908797,10.848056,4.4628468,8.285317,8.281421,11.168378,6.7029977,4.036149,4.936407,16.190825,14.667549,8.762311,7.4327164,8.979871,9.428541,10.642,13.717464,16.626883,9.482405,6.1614976,13.580836,16.570314,9.708874,9.30094,12.16966,7.8706408,6.135714,8.936775,18.643318,6.586614,7.553895,18.662067,8.660434,16.550968,16.935793,7.1171484,11.4045515,5.153849,11.292081,12.127521,13.820896,8.463505,10.210624,12.2838,11.370618,10.756868,12.110931,7.133293,13.7644,9.74692,7.8667817,14.228747,13.42925,8.988323,6.3689704,16.522285,12.116969,8.971598,12.194585,10.579946,11.680781,9.885358,12.006822,6.8751693,13.438198,18.627811,13.1,15.851737,9.749193,16.365396,5.930454,7.3610992,6.0073414,7.6038785,9.802463,12.38332,10.752878,5.0935926,13.403266,11.201667,10.92011,5.8354697,14.057442,7.1844735,7.0406947,10.90408,5.8350086,13.994102,7.162367,8.770623,12.671537,10.981397,14.155113,18.879879,9.013515,13.563784,12.213582,6.676054,5.92031,11.024004,8.592379,9.241964,9.207739,10.6528845,4.3196363,6.2373595,7.421638,12.059195,10.172225,11.075202,3.6865237,9.654551,5.1468368,16.299223,11.296121,16.740362,6.678438,11.525766,13.181194,5.1013064,5.584695,11.295707,13.518911,10.897129,7.5628533,10.562353,4.463334,12.694293,13.601584,7.577995,13.281584,13.434097,10.264857,7.7084165,10.951053,6.6728883,3.9850578,16.649055,8.730933,4.6618237,19.030981,6.972994,10.88007,13.78248,7.044936,9.211098,7.857087,8.358324,6.431079,16.158163,12.323962,8.805211,13.78055,6.660695,7.6094117,10.857641,10.5327215,13.264032,9.152707,4.47081,11.134767,13.79793,10.309298,12.914922,13.942015,12.12374,5.039222,10.542255,13.555066,8.412296,10.467677,10.785982,18.5837,9.10857,5.0224915,7.605658,13.697349,8.842151,15.780623,10.71939,6.8531966,5.1943445,6.714692,4.304125,13.253283,16.61924,5.270367,9.844725,6.171663,9.40039,8.2492895,6.7673683,11.022874,7.8464694,12.303625,4.2218475,7.5091567,6.64775,13.617883,12.419782,6.1221027,13.13235,13.280074,10.07996,12.388566,5.623169,7.5678577,11.524594,7.998514,8.630369,9.980679,7.333193,11.070317,16.50861,12.792077,3.759925,16.526365,8.866033,8.737505,7.6095414,11.285952,16.649279,6.9539824,5.726608,10.080634,9.442534,4.019382,7.6268506,15.664699,5.5053573,4.431961,5.742542,11.7490425,4.484925,5.1025996,13.519351,10.65263,6.844845,7.533835,4.0474634,9.123994,13.753583,7.5877466,6.907876,11.959228,7.428725,5.358888,5.764739,6.9770837,9.98448,4.3934956,9.3452835,9.344211,17.103601,5.2627325,7.68591,6.3587904,15.18464,13.395961,7.608705,5.9047227,16.070723,10.658588,12.442675,8.841936,12.464122,13.420129,4.9805617,7.360913,7.775924,8.835196,6.792384,16.529272,13.319191,6.328882,6.9751487,13.955187,7.66429,13.072241,17.021988,13.877744,8.915714,6.0975127,11.13601,7.3560376,10.7731,16.407635,6.2059546,16.95041,8.030087,16.537735,3.9262626,7.612443,11.630373,12.5815325,13.51927,4.8539486,8.860353,13.063875,12.976469,8.741518,4.786774,10.065611,13.352584,7.8565593,6.9675546,16.58862,6.280592,3.6642416,12.882192,11.906308,13.043362,4.284783,16.598871,4.388476,8.469344,7.1745653,7.003115,11.356895,5.855092,12.521654,7.231157,6.949131,3.7510722,12.360686,5.1472173,6.9608827,7.4548125,10.532407,13.481707,10.980958,12.576132,6.5647974,12.227002,6.406225,5.510752,12.657386,12.263447,15.888103,16.305523,8.8979,13.532137,8.283432,6.287071,5.536039,9.967725,12.100691,7.28192,13.697276,8.298204,19.081036,6.1347404,10.7895155,10.680737,12.110928,5.1852922,7.6736426,7.1563897,7.441246,11.120271,4.6553364,9.9664755,13.443007,8.817389,11.066577,9.653555,4.4726195,16.22455,12.143797,4.968949,16.297699,6.862727,6.4904017,6.621775,13.971119,5.9862146,16.653324,9.305227,7.4536657,7.7709107,6.2834682,12.409036,4.9177046,6.8714895,8.916178,13.504488,6.103043,14.109293,8.680711,13.481634,7.2617335,7.7407446,7.7695904,11.674971,4.403876,9.479826,8.122763,4.8190928,8.055902,9.370291,12.627705,4.795762,8.891048,10.244679,4.862513,7.676527,6.9060216,4.6854477,18.61304,5.820553,11.344295,5.623472,16.609636,16.96403,6.348552,10.498515,18.613464,5.2175727,7.536489,12.195564,13.692548,9.878569,9.940126,6.365049,12.58375,13.841478,13.477159,6.2930346,5.395516,10.6794195,5.2484317,11.152228,3.7274451,12.831965,11.711886,11.005185,5.6638985,16.831814,13.400277,14.051968,4.453433,5.0583673,16.544914,7.5428076,7.1062436,7.206657,4.3993344,11.127734,10.584235,4.9779925,13.026232,4.1652474,16.902494,13.444949,7.2324667,7.3525953,7.8514986,8.707793,6.3367295,16.912659,7.7000766,4.956982,13.690547,10.766104,7.6426873,13.54608,13.152721,6.3746104,7.271122,13.86114,12.160807,9.400923,6.7747936,7.874083,3.930626,7.8159523,5.541414,13.347584,5.066377,5.5190897,13.9379425,9.523876,9.769362,6.468683,12.764411,7.2701445,13.724923,9.645708,6.394335,14.236343,5.6700296,10.194563,4.5754933,12.154831,13.286907,12.341823,11.769184,6.9344573,11.5613365,13.691603,7.5646296,11.010884,11.141744,10.618636,13.890849,16.583265,3.912653,9.295637,8.107039,18.638784,9.44306,7.7206063,12.471222,7.5768332,10.568975,15.654701,13.339058,11.53026,9.874733,13.105011,10.233451,6.1294794,11.412433,12.124191,10.357921,13.545959,7.2843833,4.947325,10.926278,10.855606,13.563224,3.6465948,11.164324,11.180686,6.342402,12.9208355,16.549786,6.8483753,11.174717,14.713226,10.959948,4.348295,8.8253975,16.181103,7.4144425,5.782775,4.2980494,7.29454,6.5520463,12.605937,9.358637,6.700856,9.574079,6.4459085,7.0603423,12.427197,7.533011,11.048773,16.350845,11.06274,13.441165,11.248716,7.9156966,7.4584727,11.047254,10.567438,8.047771,11.268837,13.448677,10.877089,5.214814,10.659924,11.529512,11.428516,6.459408,6.3815804,4.5972223,14.950326,6.355941,15.249505,8.454639,10.864158,7.005992,5.1997943,11.071394,16.633413,13.395672,3.9919019,7.7411804,10.74888,8.993389,5.028502,13.527176,9.742615,5.610611,11.3385105,11.337133,10.692381,7.039463,14.988632,11.18961,5.7940774,8.811783,10.6780405,10.965865,13.595598,16.609705,13.410288,9.062507,7.416294,11.819067,6.496011,16.192698,13.6383505,5.6970496,13.568978,6.9110403,14.531749,5.709731,11.426034,4.3987255,5.6762505,11.447473,5.7828,8.257661,16.524693,6.293277,12.843386,9.82805,12.340853,7.4166746,13.67405,6.8812327,10.39399,8.675929,13.759764,11.655136,4.5105147,10.263481,6.657854,7.581032,7.4250846,7.7999086,9.664578,6.005924,4.764381,11.833464,11.223137,9.769638,7.61094,6.8243303,8.306488,11.463409,11.080216,7.1630864,6.6623497,8.819758,10.732237,11.509596,13.795014,14.170139,13.358794,9.625183,10.091415,6.3265357,9.255459,5.315244,7.069946,7.3521366,8.412589,12.574936,11.782943,7.8305163,8.16776,4.5733576,14.058035,13.584993,7.4179907,6.0044427,13.30576,7.47713,4.165492,4.2552295,7.6053214,5.4082184,11.036856,7.460542,11.790771,6.8039227,7.716803,10.894568,14.506243,10.150562,6.810489,13.352791,10.720324,11.793743,5.2283635,11.19741,10.281047,12.309111,10.770731,5.2357774,8.294116,10.170391,13.446263,5.881625,11.2522135,11.413586,7.2480063,5.529621,13.926623,12.02144,6.583428,13.717984,13.57995,9.474491,14.868847,7.7489586,15.535812,7.3827844,6.066636,14.013496,9.3607,7.7172966,7.1743445,7.3471875,6.6805806,9.5805645,4.8916593,16.52196,13.532472,4.5280232,5.935619,16.334373,7.0480247,9.176044,6.963297,8.93705,7.365869,14.049293,9.364033,5.6109705,10.913196,11.368512,11.241888,7.721899,11.30142,8.629417,8.842652,6.5118837,14.156299,5.621211,6.2018647,8.468035,8.007873,16.646137,7.5913405,9.984874,7.2040505,9.255365,8.595423,7.8108354,8.627779,6.496647,6.43519,13.085134,6.5615,8.907297,4.424902,12.899593,9.310936,7.235279,11.47827,11.313016,7.3085737,12.706152,7.188356,8.81656,10.608243,8.084237,11.383545,6.3104877,11.32734,12.36535,7.710711,7.8001323,6.471564,11.137025,5.435206,8.906949,10.914986,7.3170147,7.081914,7.0888243,12.400987,6.8868785,7.4747815,10.653447,8.3691435,10.640727,11.064601,13.540627,14.903545,7.850145,5.605984,13.760931,9.824786,13.155907,10.579915,13.562643,11.86785,13.733034,10.246361,9.02507,11.389156,7.5332146,13.564061,14.094175,7.8553023,13.394851,11.9015,18.651197,7.219341,10.960007,4.5778055,9.092493,13.844864,10.907315,9.822219,6.415682,9.272888,4.148332,16.534897,6.3209825,5.1098785,11.951585,4.4015746,11.034992,6.6677556,6.8420553,9.267677,7.293489,8.257015,4.6403003,12.049824,9.893117,7.3023424,11.266623,7.72958,12.376603,5.735056,12.280863,13.762942,7.4417725,6.587755,5.860613,10.927817,8.073002,8.32217,9.852483,10.773662,11.839569,12.513628,9.097015,7.5846334,11.344769,8.969022,12.178456,9.675501,11.559096,7.617569,4.0128064,8.855673,11.2117605,10.674175,13.556509,5.8039193,12.907676,8.381962,12.11359,6.8943787,13.304417,10.088301,18.68555,4.0047874,7.4332023,8.204942,8.1715975,5.665608,7.284501,12.774237,13.43875,6.06921,5.647995,10.213851,7.3463173,11.258868,6.500102,7.55729,4.0512314,4.2093587,5.971591,5.575615,10.105943,10.542329,12.957424,8.757415,5.330898,5.6837163,7.5141854,14.156935,6.198121,6.4215117,6.5839176,8.787839,8.798318,8.706344,10.612256,6.6094775,5.1546335,13.967052,6.199958,8.887189,12.422106,10.613394,11.303384,11.897268,4.036086,16.44601,5.2572,9.665354,8.307868,13.808628,13.260731,7.739678,8.517125,8.037039,11.829767,11.666555,10.276495,3.8947854,16.482662,10.885653,7.525273,7.01124,12.000679,4.110791,14.021797,13.770995,14.19247,6.6421566,16.5999,12.71411,8.659372,6.9859266,11.791962,7.79829,7.4894843,5.2557187,4.240697,13.720821,7.3732557,7.239818,5.6120977,7.1587734,13.013095,6.450478,5.420607,10.360464,8.740466,12.499251,6.8284254,10.815494,7.1138983,10.5393095,7.623066,4.6859965,8.300214,12.492646,12.378044,6.0623693,12.599382,5.627339,13.557439,8.613787,6.8027534,11.325479,13.915668,13.674564,13.202687,11.07246,8.033889,7.53371,8.329763,13.953912,16.460041,4.7767487,15.527577,12.7606125,7.266099,15.886583,4.0441213,16.401373,14.518524,5.6014056,8.611196,8.892486,4.420111,14.260152,7.1796207,12.280222,7.22302,6.7247467,8.165142,7.531915,16.663193,9.983589,10.591874,13.765698,5.1785254,13.743887,10.878551,10.28852,9.699621,4.9117804,16.076883,8.751354,4.7044306,13.371334,8.108549,6.670143,10.109211,11.493277,16.593779,14.077657,6.3893127,13.701664,7.311797,6.466244,6.1879063,7.46269,6.8244953,9.864472,10.125387,5.4862356,7.4931645,16.39794,8.607552,8.7078705,7.630094,12.34584,8.941525,10.6092615,8.971387,12.708797,13.362198,18.450186,7.3601418,9.003947,8.768764,7.47408,4.4063206,10.025456,5.154914,8.871165,7.4919763,6.4883575,9.305937,11.906372,13.751787,13.29189,9.233848,13.86058,10.499221,10.24644,12.211427,5.951052,6.471128,7.4078274,6.37368,11.022435,4.2702155,11.431168,8.104931,10.6543045,7.061691,10.127103,8.93583,13.142175,10.267232,12.9253845,7.2444572,6.2742133,8.015371,8.009387,8.7702465,7.1681337,8.115072,11.068722,6.8021994,7.405467,8.994057,13.308747,13.546857,7.8133717,8.327717,3.655918,11.043287,5.5203643,5.444214,11.302665,4.629565,8.721073,6.399866,11.645953,10.653618,6.7246118,4.0033083,13.884518,14.003687,16.63069,10.70754,6.225147,4.757988,14.899998,4.4829865,11.892749,3.9822319,5.7859774,4.5594,7.356149,9.705316,5.1799326,6.4762106,7.945044,17.061066,11.356587,5.2459993,12.087588,9.036749,11.073724,10.239179,6.518645,4.6520157,7.490109,10.066736,11.260795,12.642591,7.016314,13.952556,7.387378,13.366532,9.217336,6.0189147,12.919806,13.291545,4.304966,4.7343917,10.903495,8.482316,6.044811,9.492154,9.591844,15.693545,7.947535,13.788612,6.1759787,10.515495,12.544504,3.7247791,6.9247437,7.631398,10.363638,4.3034363,6.3545427,10.442884,5.134113,13.781786,14.169592,4.6153407,7.3110437,7.099904,9.578922,7.34287,15.540012,10.040098,4.475551,4.1282606,9.30255,16.637508,8.394764,11.36044,7.8386393,12.542813,10.162841,5.0430274,7.7788363,15.101731,10.264252,19.017147,9.139479,8.940549,6.696365,6.6509013,5.9369287,6.636977,7.949155,13.473773,7.7960105,12.100643,10.250894,13.383728,13.629179,14.691766,7.753286,13.7099085,8.442486,6.337883,11.177696,8.72122,18.91428,16.580185,10.4182205,4.52681,6.3525095,10.021457,5.568976,13.425778,11.062591,9.553885,18.666216,9.935219,8.92227,7.593844,13.693153,10.242072,5.51172,8.10027,7.6325526,14.630511,16.422426,7.816102,7.160326,8.828174,5.001554,16.833794,7.8615584,10.972897,7.365366,10.637965,6.317881,4.520695,11.24709,7.7304053,4.4883103,10.324521,7.415393,14.029817,12.223824,7.099214,8.618227,10.126101,10.783819,8.042289,7.348377,8.9724865,10.550251,12.304099,10.240482,6.029683,5.5467525,16.32765,5.9856715,6.0778418,8.55756,7.914788,5.647331,4.519758,13.181106,10.255788,13.868192,8.463528,11.340411,6.424583,13.658539,9.505733,14.101724,5.35826,5.6783233,12.257465,15.175101,13.763444,13.415376,7.8008876,9.488462,5.4861836,11.541425,5.7443767,7.444151,10.398891,8.035746,17.008595,5.6349907,16.57324,8.719157,7.053424,7.6170726,16.493269,7.898513,10.1224785,6.651304,13.412611,7.9666133,7.382934,13.465513,9.488986,7.1818624,6.8862476,8.09187,7.5875936,11.561447,9.650607,13.310771,6.291489,8.593797,10.096595,12.357614,8.604731,5.597515,9.946493,6.431784,10.117996,11.079931,5.7580204,6.5803847,11.360794,7.3419127,10.73292,13.028796,11.794809,11.863908,10.870032,9.76087,10.846481,5.777741,12.097974,13.755033,10.113949,7.342879,12.47724,13.816978,10.245844,5.1271896,12.802963,16.591997,10.871221,5.801796,7.167489,11.822067,15.777921,5.345197,10.232298,8.268796,7.2809024,13.55318,13.751846,9.195921,9.917076,4.439146,9.606954,11.43375,12.242852,11.1720085,11.342327,6.525335,7.716464,8.439997,4.940601,4.5222516,7.6858277,11.021649,5.908808,10.206301,8.749309,5.7233667,7.1022973,10.142652,7.8152294,7.213304,6.267084,10.220684,6.8406897,3.6483202,8.689654,7.348853,9.746248,11.157686,4.1277404,9.011051,5.3868613,6.130392,7.4518266,10.170439,4.704927,8.371346,4.3722253,10.40689,16.268671,18.542246,9.879905,6.3231044,7.965715,7.0395365,12.326359,10.663318,6.5526385,18.519981,16.559319,6.5150433,7.6675305,13.510962,12.680371,11.736434,8.041389,12.342093,4.094554,12.19778,10.149479,7.4368587,7.7027664,16.687725,9.709234,16.63275,16.52966,4.89595,11.08222,7.7423015,7.3527207,9.868464,18.707584,11.375625,7.2665935,8.731176,8.027759,6.0049872,9.19292,16.65162,8.183715,6.3842545,10.9927845,10.104106,17.01749,5.671053,8.871898,13.926152,5.692477,8.78425,8.622039,10.498086,7.0523467,11.96421,13.626681,12.294347,7.7081065,13.4593725,11.325901,8.593107,8.842113,6.2953153,9.022244,12.969472,6.9131904,13.976359,7.1034403,16.377314,12.206701,8.788299,4.1432223,7.173745,7.3913083,6.514349,5.980266,9.936318,8.286273,9.52363,10.2293,6.625636,4.9804373,5.968654,16.868853,5.881103,13.730703,8.307194,9.885983,13.077915,8.56152,5.2352605,13.818177,14.195424,7.608434,6.078218,12.584846,10.940012,5.1507525,10.72783,6.166166,10.670051,13.22325,13.125106,6.2993608,9.706576,12.145302,4.9469223,7.2905464,12.646062,10.342216,13.56631,6.5566297,10.822782,18.485596,12.090737,7.047556,8.192592,10.730696,8.645214,8.542472,8.014641,11.535921,5.662523,5.4445353,4.80049,11.97432,7.9072585,8.428144,9.943097,11.090724,8.585783,7.4234195,11.262905,13.673577,11.609281,8.695657,7.5815353,15.184908,14.08186,7.8249373,9.910761,13.9315195,10.848065,8.870213,19.034664,6.496875,12.827426,10.726524,5.1496706,10.596982,6.6151547,10.114144,11.721367,8.834927,5.6311874,9.676829,10.555607,10.60571,11.910765,7.2028556,7.4353123,4.5197473,12.216251,13.258274,5.003435,10.259151,7.214061,7.6870227,9.131428,12.836294,10.573571,7.025258,6.3603926,6.021568,5.7354155,14.210519,8.834718,14.159446,10.108088,18.658293,9.336325,16.610683,7.7990694,13.847945,9.960046,10.24656,16.44872,6.0121303,7.0741653,7.6236935,10.353812,6.0535674,5.162031,7.290662,6.249291,7.3259544,9.776916,10.646978,7.5357137,8.872078,14.131303,18.682512,15.638759,11.119495,7.546383,6.772562,7.1664653,9.994988,5.6395187,7.43037,3.9826725,12.576942,8.001397,13.981723,13.7267275,13.820491,6.1636353,8.464295,6.790417,11.903839,7.6073747,11.491879,16.55418,19.012154,6.842335,8.030904,10.246026,13.545569,7.3581543,10.251236,5.729128,4.403037,7.418918,10.92766,8.00352,13.523913,8.46732,11.659755,11.828855,8.610783,9.825245,12.624066,10.523476,9.795852,10.154035,13.926963,13.782991,16.351566,9.759857,6.15389,8.055921,9.68124,3.7309666,11.326419,9.066284,8.003332,9.464776,11.463109,9.855023,3.9983404,6.634967,8.93111,11.429084,6.9409795,9.730368,8.85002,13.334602,8.934423,5.923478,10.807447,6.049502,12.544718,10.800622,15.669547,12.768031,5.519731,8.567944,13.719486,16.077984,6.329054,13.026708,7.7994037,6.678512,7.036454,8.5863085,12.581698,6.089311,4.483665,6.9605803,4.46286,12.464907,7.6426916,5.9257903,5.0020676,10.937459,8.487586,7.495498,8.620894,9.25252,7.7771134,7.162254,6.8428493,13.70564,9.078694,4.404723,8.78345,10.530939,8.359493,10.664273,6.9848447,13.227924,9.681947,6.287552,4.493016,7.5264497,14.0329895,11.51181,12.724659,11.720612,13.683105,13.492188,11.3039875,8.976818,12.491324,5.548887,5.4487805,8.064131,4.4771442,10.341466,10.0919695,12.1046295,7.3500495,11.587205,11.466603,5.558016,13.777242,6.9853044,8.264023,8.193121,7.942919,13.582534,9.993659,8.571626,11.132491,11.433577,7.7368455,7.3061957,4.609954,14.038596,8.62756,4.5553703,5.5408177,10.8210335,9.15742,9.179967,7.2989726,11.445937,7.438724,10.62477,16.525997,13.19973,12.180761,10.857506,7.7580833,11.245705,10.317297,6.3189573,10.300711,7.1833234,8.603096,13.422103,13.7307005,4.5003424,15.991449,5.585113,13.42644,7.030676,9.77289,11.597511,16.590797,13.970039,7.423301,11.639741,6.6469493,11.781803,4.305743,7.2121234,12.091144,13.696034,4.7578225,6.5578237,11.845983,7.7484965,10.657386,10.009251,14.244722,8.811538,9.062506,4.7249064,5.3856835,4.5398574,9.633621,11.931114,14.783998,5.6464024,13.354634,12.692302,5.3496923,7.040038,5.766775,11.602066,10.894011,5.1226115,6.584324,8.543643,10.673897,6.651602,6.603804,8.787257,12.368349,7.5711155,16.134272,4.767696,11.384758,7.048977,12.027828,7.4837584,13.491318,14.260043,12.409055,7.8339124,17.077538,11.122794,11.078258,10.326519,12.613409,4.4725614,5.4898705,7.589731,8.13355,14.123183,10.226827,5.6343193,14.019521,5.0660243,9.295405,7.0713625,5.4963913,13.019533,11.973783,8.926407,8.707589,8.772356,16.21076,10.458931,8.888232,8.71566,9.6122675,5.540041,13.403326,13.289775,8.987516,11.151939,12.708145,11.27329,13.904764,13.608919,5.08281,6.567952,11.506688,6.603869,10.646323,10.692931,4.739042,8.017259,10.206715,13.395785,12.902097,10.818624,7.2732663,11.342871,11.808234,12.633872,9.751046,7.6182485,5.935945,11.019511,10.992163,9.100262,8.241765,12.451561,18.503075,6.4257197,7.1041856,16.930405,13.07576,7.9672794,6.363255,13.771911,4.983066,8.098813,5.77219,8.439854,5.478161,6.190931,8.4888315,12.387154,9.636753,14.002931,8.2953205,13.637804,8.99106,10.298887,9.652844,8.571452,10.638537,10.633643,16.46968,12.198721,7.132802,4.7231455,6.9265103,11.023363,5.5140424,4.590285,5.398717,16.556673,7.430128,6.881584,6.1128383,9.062926,5.567107,18.813396,11.489811,16.935745,13.267658,4.399,13.700562,12.077991,4.0712857,7.7319245,12.057403,13.4435425,12.315545,8.052928,6.6913867,4.370589,10.467154,7.373411,13.387903,6.733109,6.957262,13.955185,4.067463,6.4280386,7.5132647,6.80118,5.641953,6.256702,9.500745,10.331279,16.517971,16.324564,7.683402,16.769972,10.648312,13.720939,6.339167,7.120704,10.832998,13.48403,12.931334,8.598208,14.136171,8.499325,6.1298237,8.101359,11.6239395,5.5209904,13.633281,6.3421082,7.805255,7.5099106,8.695137,10.476033,16.65768,7.690931,11.404851,17.00407,8.768674,5.6960406,4.795946,13.779485,8.377558,8.355108,8.992126,13.519821,7.097601,6.560669,8.16152,8.14766,5.1270103,3.9952335,18.662455,10.216033,7.334236,9.816533,7.243631,5.5672674,7.06834,5.6571174,13.380853,10.589501,11.361121,4.7505646,5.332128,4.948828,12.686096,18.668901,12.291794,11.229184,10.527773,13.757206,10.2349415,10.35211,9.059464,10.279564,9.921826,12.380214,6.7083845,5.637086,6.6463337,7.7079787,15.6339855,12.546978,9.073856,9.871539,13.509232,7.225582,11.939109,13.77294,7.626914,5.7818556,5.468741,5.3632164,11.957106,7.5599966,14.173237,9.101691,7.1635895,8.968046,11.686036,8.188479,16.523037,6.9651194,4.211278,8.640952,8.784102,6.6662006,13.967673,10.568729,4.397888,6.347023,11.787378,13.372416,8.042637,3.6595395,7.6262693,5.202894,4.454066,11.64351,7.3302903,10.624466,16.588165,13.074909,7.2131023,7.067351,8.106154,14.03586,13.500683,13.686026,11.412417,7.7996874,4.372804,8.866931,9.622643,14.198958,9.146496,6.15939,12.798411,11.982493,10.995897,15.912616,8.6833105,4.265651,11.275805,10.148984,6.075541,12.004754,16.575758,16.569878,6.1665797,13.707831,7.052265,6.1713076,10.599397,11.468225,16.460974,10.80312,16.61144,13.6369915,8.631129,7.078804,10.160757,9.231714,11.87334,7.938209,8.787268,9.309542,11.536178,16.477407,8.052496,11.263872,7.531194,10.912109,9.900911,13.411337,9.353263,9.086134,4.8391037,13.643146,8.502843,13.530101,5.985093,4.835681,8.698672,9.849211,7.354422,12.001954,11.726033,9.724984,8.027532,11.550376,7.685364,13.398355,13.700956,12.762744,7.2751904,14.240124,6.151197,16.458721,5.991623,12.269134,6.8297167,5.604954,9.829699,11.394551,13.573665,14.163365,8.070356,18.716564,5.7442155,7.605852,9.891149,11.811139,6.5495577,6.87776,11.972506,9.986432,16.14069,16.536638,6.9744673,11.278563,7.989453,11.146942,11.568327,6.6490927,5.8550696,7.47583,13.603767,9.723587,13.881426,5.081412,11.243295,10.983851,6.3453956,6.398074,10.589835,6.8369565,11.085134,7.3287,8.618218,9.945966,10.051985,5.5180287,6.7756124,13.790639,13.477437,16.97537,11.592783,6.6758647,10.443284,7.7648096,7.823067,11.158729,7.132828,7.3033967,13.539929,6.3055487,12.417365,9.515233,7.4592686,7.9555993,11.308102,7.06905,7.011181,18.535137,11.542361,4.713098,13.167092,6.4851475,13.298888,8.4502125,13.058889,6.140869,13.293858,13.902214,12.776859,7.717461,6.942042,8.488124,11.409234,5.03082,12.169313,5.9487934,11.742725,14.045378,12.262157,16.59417,6.4524164,7.94678,13.021137,6.7870975,7.4534554,9.065282,6.9168677,8.799114,6.627078,9.8017235,15.5875225,6.0071983,13.315716,13.46749,11.493235,5.700915,4.4649115,5.3909454,16.551907,5.605341,11.324553,11.21435,11.231771,6.8393292,13.538399,8.310612,4.850417,8.790785,10.137739,7.4884357,13.438501,5.559689,10.330423,10.689809,10.275833,10.891652,4.852536,19.117126,8.6849,4.4268403,7.869542,12.294247,8.7828455,7.598448,13.821209,4.5619535,10.949524,7.7347283,11.937264,13.449557,11.450526,16.964432,15.935518,12.314217,9.070596,5.892734,10.755543,7.2762275,18.638664,18.698786,13.272589,6.508028,8.3789015,4.4896364,10.207968,9.036149,7.245966,10.960556,8.5582,4.526813,13.570395,6.4117966,9.698059,7.5177402,5.2287335,7.091685,6.882173,5.2988133,4.4018073,4.024097,10.937968,8.210128,9.027999,7.263112,17.03789,6.4717894,4.3685102,16.590439,17.013756,4.5917025,8.797602,8.546362,7.1207185,8.933022,11.513939,16.077562,10.684317,7.743514,12.31456,10.152701,12.704577,13.68029,13.464157,8.980438,7.057612,8.075925,6.327986,11.496351,9.600958,6.6431026,11.734749,8.476948,8.646139,13.809586,4.4230604,3.9259408,6.7400594,11.422693,10.419058,5.6770144,13.301393,5.6810064,11.959445,7.083446,7.7345877,8.070333,9.897812,11.540167,16.152576,12.511723,15.014665,10.521326,8.851862,9.491757,16.687643,12.171321,14.0622425,5.7091017,4.0865808,13.292308,18.61324,10.992348,12.822207,8.736922,7.320991,11.198159,10.674054,10.436137,14.727228,7.27767,6.0726614,11.72288,16.035656,5.693192,11.859339,9.520585,11.224922,4.5920005,5.774149,7.7176476,8.796481,10.095556,6.7693653,5.672148,11.775499,12.886441,7.197784,10.409499,7.7549963,13.553744,10.901774,7.844068,6.0332284,8.5005245,12.930762,8.783408,8.812969,7.257728,9.35501,9.845951,12.634896,13.375125,10.661363,7.234713,10.046099,9.717152,5.5009837,7.6852612,5.6441784,13.410465,6.49444,5.182119,11.510856,7.256524,9.720312,13.513616,6.3848586,5.6721663,11.967785,13.828838,4.3039145,10.645982,10.037741,13.265857,12.1076565,14.096937,7.1284423,14.198127,13.618898,9.78947,14.816897,13.882312,11.238744,8.60164,8.80645,5.2487135,7.051439,10.912454,7.1441674,6.804683,6.567308,7.195699,7.556067,7.083109,19.079144,10.254912,8.6598,10.661447,12.5708475,7.9997334,12.441738,13.974884,12.208525,13.73755,7.497684,4.31594,7.0388694,7.1722646,7.2226853,6.9621677,12.321635,4.1824584,13.390385,8.723165,13.315938,10.524186,4.7774363,15.144042,11.234859,12.03937,5.680312,16.588657,16.512192,11.227036,7.979014,10.47175,13.774596,15.6412,10.331526,13.624846,7.9622827,14.190859,11.090007,10.830792,6.0103035,7.055674,11.287327,3.7922196,10.653076,17.080284,13.753214,8.052032,5.629755,16.504225,4.5071063,5.739441,7.421888,7.882364,13.987074,16.320929,11.331348,13.762499,13.466592,10.148733,4.926837,5.910672,16.596943,13.282225,6.7650566,8.870988,10.327995,12.479784,14.154393,13.839481,8.117891,12.49044,16.432365,6.4593472,9.966298,13.370151,4.043961,13.534337,8.086592,8.845972,8.979526,6.6031485,6.0987406,5.8307724,13.711692,18.653986,16.611864,16.988066,7.7876463,4.51224,11.798572,9.7304735,12.327183,16.197233,13.775029,6.643897,12.458382,3.98464,6.973039,8.341601,10.207562,8.589855,4.709522,6.525851,7.4783335,8.349822,5.286713,16.668442,14.011712,8.939655,4.142859,11.764109,13.7851925,6.8166804,11.275298,8.2178135,5.6894813,9.799848,5.9035506,7.0496597,7.397435,8.375921,9.685034,5.129567,10.919698,4.46108,5.7142215,5.5018644,14.221289,4.184945,5.6902075,4.090086,11.066607,11.364428,7.2233067,10.044393,11.433251,4.0126333,10.745108,5.7045326,5.5821548,11.439438,7.6985955,8.41281,6.0980935,10.321515,10.7722025,10.474074,11.215217,13.674147,13.642162,9.728303,10.214166,6.551528,12.05927,4.6477365,11.444825,3.7272177,12.331938,6.1617146,12.10681,13.521986,10.045245,10.55401,4.395365,8.605887,10.646327,11.6288805,6.8062353,7.7528834,7.643187,8.6412525,13.690876,8.896419,12.426689,12.20353,4.5788283,13.085024,10.548895,7.7401023,7.8711877,13.718186,6.461018,6.4800143,14.095935,10.670894,6.172518,8.7883005,10.19503,8.94433,6.667943,8.284699,5.521199,13.946438,16.570135,7.7475605,10.278672,10.845805,18.491745,7.5003824,7.92498,6.8564367,10.042619,5.5429015,7.480053,6.710341,10.179257,5.6843967,11.021714,9.898201,8.041767,12.235548,12.021662,13.754925,12.560155,7.6657486,6.490577,9.904594,8.328399,5.305612,9.179444,5.7257156,11.835441,7.1696267,6.027668,12.19009,17.086828,12.315968,4.61936,8.260739,5.6372147,10.258664,18.734276,8.916318,11.40011,7.421994,9.964423,7.3584495,8.255351,9.102445,8.727877,11.73096,9.0343485,10.251339,4.0151305,8.764183,5.679091,7.1926227,12.372636,3.7343183,13.51116,7.2059393,9.311518,12.246759,18.793184,17.03861,12.784379,18.698927,4.503379,11.591841,10.534519,18.711792,10.284516,15.920137,6.3328156,9.944481,5.115738,12.139394,7.1891756,5.966699,7.4371047,3.6667905,7.1458015,5.419938,7.701617,4.6385913,6.9765363,6.2872763,5.080902,16.642687,6.8735023,10.6761,13.341469,4.664604,5.661676,10.642926,10.84004,11.27455,11.64481,19.047197,8.896836,6.944184,16.524351,16.710983,7.827447,8.399823,5.4550943,10.21884,7.784724,12.544867,6.189977,5.624486,13.4579315,14.143293,13.835447,8.774533,8.996763,7.8750377,13.491838,7.999758,13.492907,11.486475,17.036299,6.7577195,10.765221,6.2169633,10.662739,7.4326077,13.329689,7.098394,13.5327425,7.6813755,6.3553596,9.91656,12.761852,14.014096,9.012106,5.980071,10.179339,9.16919,11.027755,11.311107,13.554114,13.37273,7.8320065,11.597544,8.377829,14.194684,10.842503,5.770419,9.151263,7.5772285,5.6516175,4.8338404,13.962031,10.652775,18.480104,13.261967,16.55838,10.914667,8.784605,10.077642,5.715558,11.333349,9.219918,11.677129,5.707104,5.101827,6.4778237,7.3989544,8.840445,8.780365,12.959103,12.8501835,16.947289,10.528962,8.810836,7.217188,16.381622,8.846584,7.2707453,10.131329,5.6568303,5.895525,13.803097,7.476403,11.575566,9.569402,4.175655,5.600504,16.182951,7.32912,13.610611,7.3393755,9.128715,5.8718467,6.84484,5.8715687,10.307498,12.314932,9.96495,12.651409,5.949755,6.6336956,7.3806586,7.3455496,5.4243727,8.783676,11.306384,4.468993,8.695352,7.0148096,6.040485,9.158308,13.187679,8.404344,6.3608365,16.545343,7.0167656,16.533775,18.635015,8.72679,16.410168,14.134644,11.253241,13.575008,15.682368,5.1405935,5.6773834,8.942272,6.886621,6.4783077,9.118276,6.97277,6.8346334,13.744071,16.723938,5.7218957,9.000223,19.049902,10.899947,13.771707,9.740863,13.663732,8.157415,7.483347,4.3839436,13.579366,13.048295,4.4372063,8.797498,6.1625667,18.657368,7.502469,11.155082,18.687988,13.948633,13.703009,12.163623,11.770072,16.428066,11.355201,7.5251713,10.250751,7.4402223,10.717015,5.767259,7.6182475,10.949832,4.013231,7.5293694,7.3852205,14.10553,9.988837,7.7642393,8.865908,7.1630454,12.586935,9.156627,6.4012256,8.824195,7.927499,6.609442,6.01713,7.2711377,7.851551,4.3590355,7.274348,10.847816,11.51048,11.739716,6.412132,10.131585,10.891324,5.6116695,4.9126306,11.835116,12.221947,16.818989,4.656164,11.239064,11.293847,14.6659975,5.7020774,10.910543,18.535263,9.839786,6.521625,8.014818,5.4868956,6.5483747,6.3905706,8.583965,4.104348,6.7542872,8.328537,8.488579,11.09738,8.968537,7.2830405,8.952613,11.601294,8.064395,7.6134377,8.588309,5.1807084,6.5100365,14.245215,7.3410635,13.462862,5.9852657,6.8423,7.495991,16.655394,10.084585,7.9019823,9.241864,13.370567,12.379108,11.659328,8.06714,7.7886333,7.686983,7.1734138,5.662333,6.0288024,8.862994,10.525278,11.710743,11.605897,11.075918,6.702339,7.555832,11.929099,8.070577,12.165294,12.092531,7.7249203,7.2798166,7.0544667,4.9148726,5.931933,13.832441,7.4622846,9.87308,4.4594316,12.030126,10.679985,11.455313,10.632358,7.776138,7.3216324,12.568555,4.1235895,5.9129148,9.9045515,10.594817,10.654635,4.499993,13.788885,16.617535,16.26455,13.284236,11.206301,6.8207254,5.9728594,11.212511,18.500393,10.45258,5.9963636,12.762099,15.245924,9.958339,10.221199,6.338438,11.020721,7.8994427,7.253352,6.7450886,8.3492985,6.680815,13.4567175,6.901934,10.628195,4.4502044,9.951114,8.775725,8.733728,8.403004,7.514219,4.361495,4.711834,10.617566,6.1833405,12.5447235,9.285834,12.580659,7.7253876,6.4268136,6.1644316,4.1755495,10.2646475,11.574287,10.312385,6.6507063,10.349111,8.672319,5.765242,6.922911,6.1467566,11.525828,7.4793057,7.78869,10.621738,10.40131,5.659201,12.584541,7.194607,4.1259704,4.614879,6.381155,13.066599,10.9638405,8.322572,6.419406,13.283115,18.720434,6.5008326,6.192422,5.297642,15.950709,13.724649,12.185895,3.6700423,7.5764203,10.487978,8.01765,10.845109,11.284017],\"yaxis\":\"y\",\"type\":\"scattergl\"}],                        {\"template\":{\"data\":{\"histogram2dcontour\":[{\"type\":\"histogram2dcontour\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"choropleth\":[{\"type\":\"choropleth\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}],\"histogram2d\":[{\"type\":\"histogram2d\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"heatmap\":[{\"type\":\"heatmap\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"heatmapgl\":[{\"type\":\"heatmapgl\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"contourcarpet\":[{\"type\":\"contourcarpet\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}],\"contour\":[{\"type\":\"contour\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"surface\":[{\"type\":\"surface\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"},\"colorscale\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]]}],\"mesh3d\":[{\"type\":\"mesh3d\",\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}],\"scatter\":[{\"fillpattern\":{\"fillmode\":\"overlay\",\"size\":10,\"solidity\":0.2},\"type\":\"scatter\"}],\"parcoords\":[{\"type\":\"parcoords\",\"line\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scatterpolargl\":[{\"type\":\"scatterpolargl\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"bar\":[{\"error_x\":{\"color\":\"#2a3f5f\"},\"error_y\":{\"color\":\"#2a3f5f\"},\"marker\":{\"line\":{\"color\":\"#E5ECF6\",\"width\":0.5},\"pattern\":{\"fillmode\":\"overlay\",\"size\":10,\"solidity\":0.2}},\"type\":\"bar\"}],\"scattergeo\":[{\"type\":\"scattergeo\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scatterpolar\":[{\"type\":\"scatterpolar\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"histogram\":[{\"marker\":{\"pattern\":{\"fillmode\":\"overlay\",\"size\":10,\"solidity\":0.2}},\"type\":\"histogram\"}],\"scattergl\":[{\"type\":\"scattergl\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scatter3d\":[{\"type\":\"scatter3d\",\"line\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}},\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scattermapbox\":[{\"type\":\"scattermapbox\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scatterternary\":[{\"type\":\"scatterternary\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"scattercarpet\":[{\"type\":\"scattercarpet\",\"marker\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}}}],\"carpet\":[{\"aaxis\":{\"endlinecolor\":\"#2a3f5f\",\"gridcolor\":\"white\",\"linecolor\":\"white\",\"minorgridcolor\":\"white\",\"startlinecolor\":\"#2a3f5f\"},\"baxis\":{\"endlinecolor\":\"#2a3f5f\",\"gridcolor\":\"white\",\"linecolor\":\"white\",\"minorgridcolor\":\"white\",\"startlinecolor\":\"#2a3f5f\"},\"type\":\"carpet\"}],\"table\":[{\"cells\":{\"fill\":{\"color\":\"#EBF0F8\"},\"line\":{\"color\":\"white\"}},\"header\":{\"fill\":{\"color\":\"#C8D4E3\"},\"line\":{\"color\":\"white\"}},\"type\":\"table\"}],\"barpolar\":[{\"marker\":{\"line\":{\"color\":\"#E5ECF6\",\"width\":0.5},\"pattern\":{\"fillmode\":\"overlay\",\"size\":10,\"solidity\":0.2}},\"type\":\"barpolar\"}],\"pie\":[{\"automargin\":true,\"type\":\"pie\"}]},\"layout\":{\"autotypenumbers\":\"strict\",\"colorway\":[\"#636efa\",\"#EF553B\",\"#00cc96\",\"#ab63fa\",\"#FFA15A\",\"#19d3f3\",\"#FF6692\",\"#B6E880\",\"#FF97FF\",\"#FECB52\"],\"font\":{\"color\":\"#2a3f5f\"},\"hovermode\":\"closest\",\"hoverlabel\":{\"align\":\"left\"},\"paper_bgcolor\":\"white\",\"plot_bgcolor\":\"#E5ECF6\",\"polar\":{\"bgcolor\":\"#E5ECF6\",\"angularaxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\"},\"radialaxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\"}},\"ternary\":{\"bgcolor\":\"#E5ECF6\",\"aaxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\"},\"baxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\"},\"caxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\"}},\"coloraxis\":{\"colorbar\":{\"outlinewidth\":0,\"ticks\":\"\"}},\"colorscale\":{\"sequential\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]],\"sequentialminus\":[[0.0,\"#0d0887\"],[0.1111111111111111,\"#46039f\"],[0.2222222222222222,\"#7201a8\"],[0.3333333333333333,\"#9c179e\"],[0.4444444444444444,\"#bd3786\"],[0.5555555555555556,\"#d8576b\"],[0.6666666666666666,\"#ed7953\"],[0.7777777777777778,\"#fb9f3a\"],[0.8888888888888888,\"#fdca26\"],[1.0,\"#f0f921\"]],\"diverging\":[[0,\"#8e0152\"],[0.1,\"#c51b7d\"],[0.2,\"#de77ae\"],[0.3,\"#f1b6da\"],[0.4,\"#fde0ef\"],[0.5,\"#f7f7f7\"],[0.6,\"#e6f5d0\"],[0.7,\"#b8e186\"],[0.8,\"#7fbc41\"],[0.9,\"#4d9221\"],[1,\"#276419\"]]},\"xaxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\",\"title\":{\"standoff\":15},\"zerolinecolor\":\"white\",\"automargin\":true,\"zerolinewidth\":2},\"yaxis\":{\"gridcolor\":\"white\",\"linecolor\":\"white\",\"ticks\":\"\",\"title\":{\"standoff\":15},\"zerolinecolor\":\"white\",\"automargin\":true,\"zerolinewidth\":2},\"scene\":{\"xaxis\":{\"backgroundcolor\":\"#E5ECF6\",\"gridcolor\":\"white\",\"linecolor\":\"white\",\"showbackground\":true,\"ticks\":\"\",\"zerolinecolor\":\"white\",\"gridwidth\":2},\"yaxis\":{\"backgroundcolor\":\"#E5ECF6\",\"gridcolor\":\"white\",\"linecolor\":\"white\",\"showbackground\":true,\"ticks\":\"\",\"zerolinecolor\":\"white\",\"gridwidth\":2},\"zaxis\":{\"backgroundcolor\":\"#E5ECF6\",\"gridcolor\":\"white\",\"linecolor\":\"white\",\"showbackground\":true,\"ticks\":\"\",\"zerolinecolor\":\"white\",\"gridwidth\":2}},\"shapedefaults\":{\"line\":{\"color\":\"#2a3f5f\"}},\"annotationdefaults\":{\"arrowcolor\":\"#2a3f5f\",\"arrowhead\":0,\"arrowwidth\":1},\"geo\":{\"bgcolor\":\"white\",\"landcolor\":\"#E5ECF6\",\"subunitcolor\":\"white\",\"showland\":true,\"showlakes\":true,\"lakecolor\":\"white\"},\"title\":{\"x\":0.05},\"mapbox\":{\"style\":\"light\"}}},\"xaxis\":{\"anchor\":\"y\",\"domain\":[0.0,1.0],\"title\":{},\"showticklabels\":false},\"yaxis\":{\"anchor\":\"x\",\"domain\":[0.0,1.0],\"title\":{},\"showticklabels\":false},\"legend\":{\"tracegroupgap\":0},\"title\":{\"text\":\"Assay descriptions space visualization\"},\"width\":700,\"height\":700},                        {\"responsive\": true}                    ).then(function(){\n                            \nvar gd = document.getElementById('262bc8df-1440-455a-a700-3d3c855a19b6');\nvar x = new MutationObserver(function (mutations, observer) {{\n        var display = window.getComputedStyle(gd).display;\n        if (!display || display === 'none') {{\n            console.log([gd, 'removed!']);\n            Plotly.purge(gd);\n            observer.disconnect();\n        }}\n}});\n\n// Listen for the removal of the full notebook cells\nvar notebookContainer = gd.closest('#notebook-container');\nif (notebookContainer) {{\n    x.observe(notebookContainer, {childList: true});\n}}\n\n// Listen for the clearing of the current output cell\nvar outputEl = gd.closest('.output');\nif (outputEl) {{\n    x.observe(outputEl, {childList: true});\n}}\n\n                        })                };                            </script>        </div>\n</body>\n</html>"},"metadata":{}}],"execution_count":12},{"cell_type":"code","source":"fig.write_html(\"umap_visualization.html\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-02-02T16:18:35.378024Z","iopub.execute_input":"2025-02-02T16:18:35.378506Z","iopub.status.idle":"2025-02-02T16:18:35.446050Z","shell.execute_reply.started":"2025-02-02T16:18:35.378472Z","shell.execute_reply":"2025-02-02T16:18:35.444905Z"}},"outputs":[],"execution_count":14}]}